SMILES,TITLE,Hybrid2,fragments,site
C[NH2+]Cc1cc(n(c1)S(=O)(=O)c2cccnc2)c3ccccc3F,vonoprazan,-14.130920,x0678,active-noncovalent
Cc1c(sc(n1)c2cccnc2)C(=O)Nc3ccccc3c4cn5c(csc5[nH+]4)C[NH+]6CCOCC6,SRT2104,-12.776212,x0161,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3)[NH2+]Cc4cccnc4,UCL-2077,-12.759785,x0678,active-noncovalent
c1cc(cnc1)[C@H]2[C@@H]3CC=C[C@@H]3c4cc(cc(c4N2)F)F,golgicide-a,-12.594658,x0678,active-noncovalent
c1cc(cnc1)[C@H]2[C@@H]3CC=C[C@@H]3c4cc(cc(c4N2)F)F,golgicide-A,-12.594658,x0678,active-noncovalent
COc1cc(ccc1c2[nH]c3c(n2)cccn3)[S@@](=O)C,sulmazole,-12.465656,x0678,active-noncovalent
COc1cc2c(cc1OCCC[NH+]3CCCC3)[NH+]=C(C24CCC4)N,A-366,-12.457256,x1077,active-noncovalent
c1cc(c(c2c1[C@@H](O[C@@H](C2)C34CC5CC(C3)CC(C5)C4)C[NH3+])O)O,A77636,-12.421812,x0749,active-covalent
c1ccc2c(c1)c3c4c(c5c6ccccc6[nH]c5c3[nH]2)C(=O)NC4=O,arcyriaflavin-a,-12.239515,x0678,active-noncovalent
CN1C(=O)c2c(nn(c2Nc3ccccc3)Cc4ccc(cc4)c5cccc(n5)F)N6C1=[NH+][C@H]7[C@@H]6CCC7,ITI214,-12.193553,x0434,active-noncovalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O,epigallocatechin-gallate-(-),-12.171526,x0831,active-covalent
Cc1c(c2cc(ccc2n1CC(=O)[O-])F)Cc3ccc4ccccc4n3,OC000459,-12.096975,x0830,active-covalent
c1cc(ccc1/C=C/c2cc(cc(c2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,polydatin,-11.783890,x0161,active-noncovalent
c1cc(ccc1c2ccc3cc(c(cc3c2)C45CC6CC(C4)CC(C6)C5)O)C(=O)[O-],CD-1530,-11.759232,x0104,active-noncovalent
CC(C)[NH2+]C[C@H](COc1cccc2c1cccc2)O,propranolol-(R),-11.744864,x0195,active-noncovalent
Cc1c(cnc(n1)C)OC[C@]2(C[C@H]2C(=O)Nc3ccc(cn3)F)c4cccc(c4)F,lemborexant,-11.741239,x0678,active-noncovalent
c1cc(cnc1)/C=C/C(=O)c2ccncc2,3PO,-11.732655,x0678,active-noncovalent
CO/[NH+]=C(\N)/c1ccc(cc1)c2oc(cc2)c3ccc(cc3)/C(=[NH+]/OC)/N,pafuramidine,-11.567801,x0104,active-noncovalent
c1cc(c(cc1[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O)O)O,epicatechin-gallate-(-),-11.565519,x0678,active-noncovalent
CCc1cc2c(s1)-n3c(nnc3C=N[C@H]2c4ccccc4Cl)C,etizolam,-11.564081,x0708,active-covalent
c1ccc(cc1)Oc2nc3c(c(n2)NC4CCCCC4)[nH]cn3,MRS-3777,-11.546358,x0678,active-noncovalent
c1ccc(cc1)Oc2nc3c(c(n2)NC4CCCCC4)[nH]cn3,MRS3777,-11.546358,x0678,active-noncovalent
c1ccc(cc1)OCc2ccc(cc2)CCC[NH+]3CCOCC3,fomocaine,-11.528082,x0104,active-noncovalent
C[N@H+]1CCc2cccc-3c2[C@@H]1Cc4c3c(c(cc4)O)O,r(-)-apomorphine,-11.522030,x0195,active-noncovalent
Cc1c(c2ccccc2[nH]1)CC[NH2+]Cc3ccc(cc3)CCC(=O)N=O,panobinostat,-11.509398,x0967,active-noncovalent
C[C@@]12CCc3c(cco3)[C@H]1CC[C@]45[C@H]2CC[C@H](C4)[C@](C5)(CO)O,cafestol,-11.504668,x0749,active-covalent
c1cc(ccc1c2coc3cc(ccc3c2=O)O)O,daidzein,-11.492462,x0749,active-covalent
c1cc(cc2c1cc(cc2)C(=O)[O-])c3ccc(c(c3)C45CC6CC(C4)CC(C6)C5)O,CD-437,-11.491298,x0161,active-noncovalent
c1cc(ccc1C2=Cc3ccc(cc3OC2)O)O,idronoxil,-11.462839,x0749,active-covalent
c1cc(ccc1c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F)O,SB-202190,-11.455310,x0434,active-noncovalent
CC(=O)NCCc1c2ccccc2[nH]c1Cc3ccccc3,luzindole,-11.436106,x0749,active-covalent
c1cc2cnccc2c(c1)S(=O)(=O)NCC[NH2+]C/C=C/c3ccc(cc3)Br,H-89,-11.430328,x0678,active-noncovalent
c1cc(ccc1Nc2cc3c(cc2Nc4ccc(cc4)F)C(=O)NC3=O)F,CGP-53353,-11.413448,x0678,active-noncovalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccc(cc4)C(=O)NO)C1,tubastatin-a,-11.396202,x0195,active-noncovalent
CNC(=O)c1ccccc1Sc2ccc3c(c2)n[nH]c3/C=C/c4ccccn4,axitinib,-11.394080,x0104,active-noncovalent
C[C@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],flurizan,-11.357160,x0678,active-noncovalent
C[C@]12CC[C@H]3c4ccc(cc4CC[C@@H]3[C@H]1C[C@@H]([C@@H]2O)O)O,estriol,-11.353638,x0749,active-covalent
CCOC(=O)NNc1c2ccccc2cnn1,todralazine,-11.343122,x0678,active-noncovalent
c1ccc2c(c1)ncc(n2)NS(=O)(=O)c3ccc(cc3)N,sulfaquinoxaline,-11.320952,x0678,active-noncovalent
c1ccc2c(c1)ccc3c2cc(c4c3cccc4)N,6-aminochrysene,-11.298630,x0749,active-covalent
Cn1cc2c3c1cccc3[C@H]4C[C@@H](C[N@H+]([C@@H]4C2)C)NS(=O)(=O)N(C)C,mesulergine,-11.295732,x0195,active-noncovalent
c1c(cc(c(c1O)O)O)c2c(cc3c(cc(cc3[o+]2)O)O)O,delphinidin,-11.289549,x0749,active-covalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccccc4)C1,mebhydrolin,-11.277544,x0195,active-noncovalent
C[N@@H+]1CCc2c(c3ccccc3n2Cc4ccccc4)C1,"mebhydroline-1,5-naphtalenedisulfonate",-11.277544,x0195,active-noncovalent
c1cc(ccc1c2ccc(o2)c3ccc(cc3)C(=[NH2+])N)C(=[NH2+])N,furamidine,-11.259153,x0395,active-noncovalent
c1cc(ccc1C[C@@H]2c3cc(c(cc3CC[NH2+]2)O)O)O,higenamine,-11.253945,x0195,active-noncovalent
c1cc(ccc1c2coc3cc(cc(c3c2=O)[O-])O)O,genistein,-11.252321,x0749,active-covalent
c1cc(c(cc1Oc2c(cc(cc2I)C[C@@H](C(=O)[O-])[NH3+])I)I)O,liothyronine,-11.238697,x0678,active-noncovalent
c1ccc2c(c1)cccc2C[C@@H]3c4cc(c(cc4CC[NH2+]3)O)O,CKD-712,-11.237705,x0195,active-noncovalent
c1cc(c(cc1/C=C/c2cc(cc(c2)O)O)O)O,piceatannol,-11.220980,x0749,active-covalent
C=Cc1cc(cc2c1oc(n2)c3ccc(c(c3)F)O)O,prinaberel,-11.213451,x0749,active-covalent
c1cc(ccc1c2c[nH]nc2)[C@@](C[NH3+])(c3ccc(cc3)Cl)O,AT13148,-11.206308,x1077,active-noncovalent
CCCC[NH+](CCCC)C[C@@H](c1cc(cc\2c1-c3ccc(cc3/C2=C/c4ccc(cc4)Cl)Cl)Cl)O,lumefantrine,-11.202807,x0161,active-noncovalent
c1cc(ccc1[C@@H]2Cc3ccc(cc3OC2)O)O,equol,-11.198337,x0749,active-covalent
c1cc(cc(c1)O)c2ccc(cc2)[C@H]3C[C@@H]3[NH3+],OG-L002,-11.191685,x0749,active-covalent
c1ccc(cc1)CNC(=O)c2csc(n2)Nc3ccncn3,thiazovivin,-11.191407,x0678,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3)SC[C@H](C(=O)[O-])[NH3+],S-Trityl-L-cysteine,-11.188899,x0678,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3ccnc4c3cc(c(c4)OCC5(CC5)[NH3+])OC,anlotinib,-11.164289,x0161,active-noncovalent
c1ccc2c(c1)[nH]c(n2)c3[nH]c4ccccc4n3,pibenzimol,-11.147039,x0678,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2ccs4)CC1,pizotifen,-11.140948,x0195,active-noncovalent
Cc1c([nH]cn1)CN2CCc3c(c4ccccc4n3C)C2=O,alosetron,-11.133524,x0195,active-noncovalent
c1ccc2c(c1)c(cn2Cc3ccc(cc3)Cl)C(=O)C(=O)Nc4ccncc4,indibulin,-11.127198,x0104,active-noncovalent
c1cc(ccc1c2cc(=O)c3c(cc(cc3o2)O)[O-])O,apigenin,-11.106043,x0749,active-covalent
CCc1c(c2c(n1Cc3ccccc3)cccc2OCC(=O)[O-])C(=O)C(=O)N,varespladib,-11.100426,x0830,active-covalent
c1ccc(cc1)Nc2cc3c(cc2Nc4ccccc4)C(=O)NC3=O,CGP-52411,-11.088956,x0678,active-noncovalent
c1cc(cnc1)C(=O)NCCCC(=O)[O-],pikamilone,-11.080033,x0678,active-noncovalent
Cc1ccc(c(c1)n2cnc3c2ccc(c3)C(=O)NCc4ccccc4Cl)C,NAB-2,-11.069983,x0161,active-noncovalent
C[NH+](C)CCCNC(=O)c1ccc(cc1)c2cc3cccnc3c(c2)O,ML324,-11.068521,x0104,active-noncovalent
CC(C)(C)[NH2+]C[C@H](COc1cccc2c1CCCC2=O)O,levobunolol-(+),-11.054565,x0104,active-noncovalent
C[C@H](CCc1ccc(cc1)O)[NH2+]C[C@@H](c2ccc(cc2)O)O,ractopamine,-11.050797,x0434,active-noncovalent
CC#CCn1c2c(nc1[N@]3CCC[C@H](C3)[NH3+])n(c(=O)n(c2=O)Cc4nc(c5ccccc5n4)C)C,linagliptin,-11.039680,x0104,active-noncovalent
CC1(Cc2c(c(c(n2C1)CC(=O)[O-])c3ccc(cc3)Cl)c4ccccc4)C,licofelone,-11.020183,x0830,active-covalent
CC#C[C@@H](CC(=O)[O-])c1ccc(cc1)OCc2cccc(c2)c3ccc(cc3)C(F)(F)F,AMG-837,-11.004150,x0104,active-noncovalent
c1cc2c(cc1C3CCCCC3)c4c5n2CC[NH2+][C@H]5CCC4,tetrindole,-10.997774,x0104,active-noncovalent
c1cc(cnc1)NC(=O)CCCCCCC(=O)NO,pyroxamide,-10.989407,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NCc4[nH]c5c(n4)cccn5)CC[C@@H]6[C@@]3(C=C(C(=O)N6C)F)C,MK-0773,-10.988971,x0161,active-noncovalent
C[N@H+]1CCc2cc3c(cc2[C@@H]1[C@@H]4c5ccc(c(c5C(=O)O4)OC)OC)OCO3,"hydrastine-(1r,-9s)",-10.987147,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O,estradiol,-10.985424,x0749,active-covalent
c1cc(ccc1CCO)OCCn2ccnc2,MR-948,-10.974442,x0678,active-noncovalent
CC/C(=C(/c1ccc(cc1)/C=C/C(=O)[O-])\c2ccc3c(c2)cn[nH]3)/c4ccc(cc4Cl)F,GDC-0810,-10.970829,x1077,active-noncovalent
CCO[C@@H](Cc1ccc(cc1)OCCn2c(ccc2c3ccc(cc3)SC)C)C(=O)[O-],saroglitazar,-10.959909,x0072,active-noncovalent
c1c2c(c(c(c1F)N3CC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,clinafloxacin,-10.959001,x0749,active-covalent
C[C@H](/C=C/[C@@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C\3/C[C@H](C[C@@H](C3=C)O)O)C,doxercalciferol,-10.957501,x0161,active-noncovalent
c1ccc2c(c1)c(c[nH]2)Cc3c[nH]c4c3cccc4,"3,3'-diindolylmethane",-10.956906,x0072,active-noncovalent
c1cc(c(c(c1)F)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F)F,TA-01,-10.956722,x0434,active-noncovalent
C[NH+](C)CCC=C1c2ccccc2C=Cc3c1cccc3,cyclobenzaprine,-10.952331,x0874,active-noncovalent
c1ccc2c(c1)cc(s2)Cc3cc(ccc3F)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,ipragliflozin-l-proline,-10.925068,x0195,active-noncovalent
c1cc(ccc1C[C@@H](C#N)c2ccc(cc2)O)O,diarylpropionitrile,-10.914790,x0749,active-covalent
C/C(=C/1\c2ccccc2C[C@@H]1CC[NH+](C)C)/c3ccccn3,dimetindene,-10.895865,x0749,active-covalent
C/C(=C/1\c2ccccc2C[C@@H]1CC[NH+](C)C)/c3ccccn3,dimethindene-(S)-(+),-10.895865,x0749,active-covalent
Cc1c(c2ccccc2n1CCC(=O)[O-])Cn3ccnc3,dazmegrel,-10.888386,x0830,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])O[C@@H]4[C@@H]([C@H]([C@H]([C@@H](O4)CO)O)O)O)O)O,hyperin,-10.881234,x0874,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cccc3,imipramine,-10.859057,x0195,active-noncovalent
c1cc(c(cc1c2ccc(c(c2Cl)O)CN=O)F)O,FERb-033,-10.850969,x0678,active-noncovalent
c1cc(ccc1c2nc3cc(cc(c3o2)Br)O)O,WAY-200070,-10.846251,x0749,active-covalent
CC[NH+](CC)CCOc1ccccc1C(=O)CCc2ccccc2,etafenone,-10.845141,x0104,active-noncovalent
CC(C)(c1ccn2c(c[nH+]c2c1F)c3ccc(c(c3)c4ccc(cc4C#N)F)F)O,TP-003,-10.843095,x0161,active-noncovalent
CC(C)(C)CC[NH+]1C[C@@H]2[C@H](C1)C2CNC(=O)c3cc(cc(c3)Cl)Cl,ML-218,-10.839355,x0104,active-noncovalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)[S@@](=O)C)F)CC(=O)[O-],sulindac,-10.827938,x0830,active-covalent
c1ccc(cc1)[C@]2(CCC(=O)NC2=O)C3CC[NH+](CC3)Cc4ccc(cc4)I,iododexetimide,-10.817308,x1077,active-noncovalent
c1ccc(cc1)CNc2c3c([nH]cn3)ncn2,6-benzylaminopurine,-10.815964,x0749,active-covalent
CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C3CC[NH+](CC3)C,naratriptan,-10.814455,x1077,active-noncovalent
c1cc(c(cc1O)O)c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-],morin,-10.805906,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(Cc5c[nH]nc5C4)C,stanozolol,-10.803458,x0749,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)CCCn2c3ccccc3c4c2cccc4,rimcazole,-10.797787,x0195,active-noncovalent
c1ccc(cc1)COCCCc2cnc[nH]2,proxyfan,-10.796000,x0678,active-noncovalent
c1cc(ccc1C[N@](c2c(cc(cn2)C(F)(F)F)Cl)S(=O)(=O)c3ccc(cc3)C(=O)[O-])OC(F)(F)F,RQ-00203078,-10.795522,x0678,active-noncovalent
CC1(CNc2c1ccc(c2)NC(=O)c3cccnc3NCc4ccncc4)C,motesanib,-10.789137,x0678,active-noncovalent
c1cc(c(cc1/C=C/C(=O)c2ccc(cc2O)O)O)O,butein,-10.785174,x1093,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccc(c2)O,oxantel,-10.779531,x0678,active-noncovalent
c1ccc(cc1)/C=C/c2ccnc(n2)N,TCN-238,-10.770400,x0749,active-covalent
c1cc(cnc1)C(=O)NCCON(=O)=O,nicorandil,-10.763849,x0678,active-noncovalent
c1ccc2c(c1)Sc3cccc(c3S2)c4cc(=O)cc(o4)N5CCOCC5,KU-55933,-10.763680,x0195,active-noncovalent
COc1ccc2c(c1)c3ccnc(c3[nH]2)c4cccc5c4cccc5,SP-141,-10.760232,x0946,active-noncovalent
c1cc(ccc1[C@@H]2C[NH2+]CCc3c2cc(c(c3Cl)O)O)O,fenoldopam,-10.734211,x1418,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C,dehydroepiandrosterone,-10.734205,x0749,active-covalent
c1cc(ccc1Nc2c3c(ncnc3[nH]n2)N)F,CGP-57380,-10.734002,x0678,active-noncovalent
COc1nc(ccn1)c2n(cnc2c3ccc(cc3)F)[C@H]4CC[C@@H](CC4)O,SB-239063,-10.733989,x0678,active-noncovalent
c1cc(ccc1[C@@H]2CC(=O)c3c(cc(cc3O2)O)[O-])O,naringenin,-10.727943,x0749,active-covalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,ergocalciferol,-10.727814,x0104,active-noncovalent
c1cc(ccc1C23C[C@H]4C[C@@H](C2)CC(C4)(C3)C(=O)NCc5ccncc5)Cl,ABC-294640,-10.723454,x0749,active-covalent
C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@H]2CC[C@]4([C@H]3CCC4=O)C)O,epiandrosterone,-10.719960,x0749,active-covalent
c1cc(c(cc1F)O)c2ccc(o2)/C=C\3/C(=O)[N-]C(=O)S3,AS-252424,-10.718079,x0107,active-noncovalent
Cc1cc(c2nc(cc(=O)n2c1)N3CCOCC3)[C@@H](C)Nc4ccccc4,TGX-221,-10.715137,x0195,active-noncovalent
c1cc(ccc1/C=C/c2cc(cc(c2)O)O)O,resveratrol,-10.714994,x0749,active-covalent
CC(=O)Oc1ccccc1C(=O)Oc2ccccc2C(=O)[O-],acetylsalicylsalicylic-acid,-10.713825,x0195,active-noncovalent
Cc1c(c(c(cn1)CSSCc2cnc(c(c2CO)O)C)CO)O,pyritinol,-10.710277,x0678,active-noncovalent
c1cnc(nc1)NCc2ccc(cc2)CNc3ncccn3,MSX-122,-10.709395,x0072,active-noncovalent
CC(C)(C)[C@@H](C(=O)N1CCc2cc(c(cc2C1)OC)OC)[NH2+]Cc3ccncc3,TCS-OX2-29,-10.707070,x0678,active-noncovalent
c1ccc(cc1)C(=O)Nc2cc3cc[nH]c3cn2,OAC1,-10.690377,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5,tivantinib,-10.690360,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1[C@H]([C@H]([C@@H]2O)O)O)O,estetrol,-10.688125,x0749,active-covalent
c1ccc2c(c1)C(=O)C(=Cc3cccnc3)C2=O,PRT4165,-10.681190,x0749,active-covalent
C[C@@H](c1ccc(c(c1)F)c2ccccc2)C(=O)[O-],flurbiprofen-(S)-(+),-10.678944,x0830,active-covalent
CCCNc1ccc2[nH+]cc(n2n1)c3ccc4c(c3)cn[nH]4,CHR-6494,-10.676763,x0434,active-noncovalent
Cc1ncc(c(n1)N)C[N@H+]2CCC(=CC2)c3ccccc3,Ro-10-5824,-10.673193,x0946,active-noncovalent
C[C@H](CNc1nccc(n1)c2cn(nc2c3cc(cc(c3F)NS(=O)(=O)C)Cl)C(C)C)NC(=O)OC,LGX818,-10.669018,x0161,active-noncovalent
C=CC[N@@H+]1CCc2cc(c(cc2[C@H](C1)c3ccccc3)O)O,SKF-77434,-10.665993,x1077,active-noncovalent
c1cc(cc(c1)F)N(Cc2cc(c(c(c2)F)F)F)C(=O)O[C@H]3C[NH+]4CCC3CC4,tarafenacin,-10.658381,x1093,active-noncovalent
c1cc(ccc1C(=[NH2+])N)N2CC[NH+](CC2)C3CC[NH+](CC3)CC(=O)[O-],GR-144053,-10.657013,x0395,active-noncovalent
CC(C)(C)NS(=O)(=O)c1cc(cnc1)c2cc(c3nc(nn3c2)N)F,CZC24832,-10.656200,x0161,active-noncovalent
c1ccc(cc1)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)Nc3ccc(cc3)C(=O)[O-],bentiromide,-10.649840,x0678,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c(o2)cc(c(c3[O-])O)O,baicalein,-10.648987,x0749,active-covalent
C[C@@H](CO)NC(=O)[C@@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,ergonovine,-10.648913,x0104,active-noncovalent
CC(C)(c1cccnc1)C(=O)c2cccnc2,metyrapone,-10.638231,x0678,active-noncovalent
C[N@@H+]1CCC2=C(C1)c3ccccc3Cc4c2cccc4,setiptiline,-10.631288,x0072,active-noncovalent
c1cc(ccc1/C=C/C(=O)[O-])c2ccc(c(c2)C34CC5CC(C3)CC(C5)C4)O,adarotene,-10.630851,x0104,active-noncovalent
COc1ccccc1OC[C@H](COC(=O)N)O,methocarbamol,-10.630556,x0678,active-noncovalent
c1cc(c(cc1[C@@H]2[C@H](Cc3c(cc(cc3O2)O)O)O)O)O,cianidanol,-10.630308,x0749,active-covalent
c1cc(c(c(c1)Cl)Cl)c2nnnn2Cc3cccnc3,A-438079,-10.628376,x0678,active-noncovalent
c1ccc(cc1)c2cccc(c2N3CCC[C@H](C3)[NH3+])/C=C\4/C(=O)[N-]C(=O)S4,AZD1208,-10.626678,x0678,active-noncovalent
c1ccc(cc1)COc2cc(ccc2)c3c4c(n(c3)[C@H]5C[C@H](C5)C[NH+]6CCC6)ncnc4N,NVP-AEW541,-10.623516,x0395,active-noncovalent
c1ccc(c(c1)c2cc(c3c(c2)nc([nH]3)C4=NOC5(C4)CCCCC5)C(F)(F)F)C(F)(F)F,TC-I-2014,-10.622856,x0161,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C\[O-])/C(=O)C4)C,oxymetholone,-10.615410,x0749,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)O,ethinyl-estradiol,-10.615116,x0749,active-covalent
C[NH+]1CCC(=C2c3ccccc3C=Cc4c2cccc4)CC1,cyproheptadine,-10.612666,x0195,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)Nc4ccccc4)C)C,phenserine,-10.606596,x0104,active-noncovalent
C[NH+](C)CC[C@H](c1ccc(cc1)Cl)c2ccccn2,chlorphenamine,-10.602145,x0072,active-noncovalent
C[C@H](Cc1ccc(c(c1)O)O)[C@@H](C)Cc2ccc(c(c2)O)O,masoprocol,-10.599864,x0678,active-noncovalent
c1ccc(cc1)c2cccc(c2)c3c(cnn3O)C4CC[NH2+]CC4,PHP-501,-10.599149,x0678,active-noncovalent
Cc1cc(on1)C(=O)Nc2cccc(c2)C(=O)Nc3cccc(c3)C(F)(F)F,T-5601640,-10.593467,x0161,active-noncovalent
COC(=O)c1cc2c(cc(cc2n1O)c3ccccc3)C(F)(F)F,NHI-2,-10.586697,x0195,active-noncovalent
Cc1ccnc(n1)[N-]S(=O)(=O)c2ccc(cc2)N,sulfamerazine,-10.585939,x0072,active-noncovalent
Cc1cc(c(cc1C)N(=O)=O)c2ccc(o2)/C=C\3/C(=NN(C3=O)c4ccc(cc4)C(=O)[O-])C,C646,-10.584769,x0161,active-noncovalent
Cn1ccc2c1cc3c(c2)N(CC3)C(=O)Nc4cccnc4,SB-206553,-10.582663,x0107,active-noncovalent
Cc1cnc(c2n1nc(n2)[C@@H]3C[C@H]3c4c(n5ccc6c(c5n4)cccn6)C)C,PDE10-IN-1,-10.581775,x0104,active-noncovalent
c1cc(ccc1c2coc3c(c2=O)ccc(c3[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,puerarin,-10.581175,x0161,active-noncovalent
CCCCC/[NH+]=c/1\ccn(c2c1cccc2)Cc3ccccc3,CP-339818,-10.577728,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CCC2=O)O,estrone,-10.575466,x0749,active-covalent
Cc1cc(cnc1)c2cc(c(cn2)c3nccs3)C(=O)NCc4ccc(c(n4)OC)OC,MK-3697,-10.562616,x0678,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC3c4ccccc4CCc5c3cccc5,deptropine,-10.555782,x0195,active-noncovalent
c1cnccc1c2[nH]nc(n2)c3ccnc(c3)C#N,topiroxostat,-10.553616,x0195,active-noncovalent
Cc1cccc2c1ccc-3c2C(=O)C(=O)c4c3occ4C,tanshinone-i,-10.552562,x0749,active-covalent
c1cc(ccc1C(=O)Oc2ccc3cc(ccc3c2)C(=[NH2+])N)NC(=[NH2+])N,nafamostat,-10.550766,x1077,active-noncovalent
CCCc1c(ccc(c1O)C(=O)C)OCCCCc2[n-]nnn2,tomelukast,-10.546258,x0678,active-noncovalent
c1ccc(cc1)c2nc(sn2)N3CCN(CC3)C(=O)Nc4ccccc4,JNJ-1661010,-10.544195,x0161,active-noncovalent
COc1ccc(cc1)C[NH2+]Cc2cccc3c2cccc3,ML133,-10.541782,x0104,active-noncovalent
CN1c2ccccc2C(=O)N(c3c1cccc3)CC[NH+](C)C,dibenzepine,-10.534156,x0195,active-noncovalent
Cc1cccc(c1)Nc2nc(cs2)c3ccncc3,STF-62247,-10.525797,x1093,active-noncovalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CC[NH2+]CC4,LY303511,-10.525321,x0434,active-noncovalent
C[C@@H](Cc1ccc(cc1)O)[NH2+]C[C@@H](c2cc(cc(c2)O)O)O,fenoterol,-10.524625,x0678,active-noncovalent
c1ccc(cc1)c2ccc(cc2)C(=O)CCC(=O)[O-],fenbufen,-10.521091,x0749,active-covalent
Cc1cc(cc(c1NC(=O)c2ccc(o2)c3cc(ccc3Cl)Cl)C)C[NH3+],CYM-50358,-10.507250,x1093,active-noncovalent
CC[NH+]1CCN(CC1)c2cc(c3c(n2)CCCCCC3)c4ccc(cc4)F,blonanserin,-10.503704,x0434,active-noncovalent
c1cc(cc(c1)F)CC[N@@H+]2[C@H]3[C@@H]4[C@H]5C[C@H]6[C@@H]4[C@@]2([C@@H]7[C@H]6[C@H]5[C@@H]73)O,TC1,-10.502048,x0678,active-noncovalent
C[NH2+]CCCC12CCC(c3c1cccc3)c4c2cccc4,maprotiline,-10.499575,x0195,active-noncovalent
COc1ccc(cc1O)[C@@H]2CC(=O)c3c(cc(cc3O2)O)[O-],hesperetin,-10.497662,x0749,active-covalent
C[C@H](CNC(=O)c1cccnc1)NC(=O)c2cccnc2,nicaraven,-10.497327,x0678,active-noncovalent
c1cc2c(cc1Cl)n(c(=O)s2)CC(=O)N3CC[NH+](CC3)CCO,tiaramide,-10.492104,x0161,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)C(=O)Nc3cccnc3,STF-31,-10.489787,x0387,active-noncovalent
c1cc(ccc1c2coc3c(c2=O)ccc(c3[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O,kakonein,-10.485851,x0161,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1c2ccc(cc2[nH+]c3c1cc(cc3)OC)Cl,mepacrine,-10.479791,x0195,active-noncovalent
Cc1c2cc(ccc2n(c1c3ccc(cc3)O)Cc4ccc(cc4)OCC[NH+]5CCCCCC5)O,bazedoxifene,-10.477118,x0161,active-noncovalent
Cn1c2cc(sc2c3c1c(=O)n(nc3)Cc4cccc(c4)N)[S@@](=O)C,TEPP-46,-10.473345,x0104,active-noncovalent
C[C@]1(CCSC(=[NH2+])N1)c2cc(c(cc2F)F)c3cncnc3,LY2811376,-10.471333,x0678,active-noncovalent
Cc1cc(cc(c1)C(=O)OC2C[C@H]3CC[C@@H](C2)[NH+]3C)C,"tropanyl-3,5-dimethylbenzoate",-10.465230,x0161,active-noncovalent
COC(=O)[C@H](c1ccccc1Cl)[N@H+]2CCc3c(ccs3)C2,clopidogrel,-10.458050,x0749,active-covalent
c1cc2c3c(c1)C(=O)N(C[C@H]3CCC2)[C@@H]4C[NH+]5CCC4CC5,palonosetron,-10.455042,x0195,active-noncovalent
c1ccc(cc1)n2cc(cc(c2=O)c3ccccc3C#N)c4ccccn4,perampanel,-10.445380,x0678,active-noncovalent
COc1ccccc1C2(CC[NH+](CC2)CCCn3c4ccccc4c5c3cccc5)O,NNC-05-2090,-10.444371,x0874,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cccc2,N-acetyltryptamine,-10.443379,x0195,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4ccc(cc4Cl)Cl,SB-216763,-10.443048,x0161,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@]3(C[C@@H]5[C@H](C4)S5)C,epitiostanol,-10.442616,x0749,active-covalent
c1c(cc(c(c1O)O)O)CNC(=S)/C=C/c2cc(c(c(c2)Br)O)O,NT157,-10.439401,x1093,active-noncovalent
CCc1c2cc(ccc2[nH]c1C(=O)NCCc3ccc(cc3)N4CCCCC4)Cl,org-27569,-10.433810,x0104,active-noncovalent
c1cc(c(cc1[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O)O)O,taxifolin,-10.427279,x0749,active-covalent
CCCc1c(nn(c1c2ccc(cc2)O)c3ccc(cc3)O)c4ccc(cc4)O,PPT,-10.424705,x0678,active-noncovalent
C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C,cycloheximide,-10.421345,x0678,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cccc3,doxepin,-10.418590,x0195,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,cholecalciferol,-10.417953,x0104,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)O,SN-38,-10.417257,x0161,active-noncovalent
C[N@H+]1Cc2cc(ccc2[C@@H](C1)c3ccc(c(c3)Cl)Cl)OC,diclofensine,-10.417254,x0104,active-noncovalent
Cc1nnc(s1)NS(=O)(=O)c2ccc(cc2)N,sulfamethizole,-10.416670,x0678,active-noncovalent
C[C@@H]1CCc2c3n1cc(c(=O)c3cc(c2N4CCC(CC4)O)F)C(=O)[O-],nadifloxacin,-10.409428,x0195,active-noncovalent
c1ccc(c(c1)C(=O)OC[C@@H](CO)O)Nc2ccnc3c2cccc3C(F)(F)F,floctafenine,-10.407729,x0195,active-noncovalent
c1ccc(cc1)n2cc(c3c2cccc3)/C=C(\C#N)/C(=O)[O-],UK-5099,-10.405793,x0678,active-noncovalent
C[C@H]1Cc2ccc3c(c2C(=O)C1)C(=O)c4cccc(c4C3=O)[O-],ochromycinone,-10.405521,x0749,active-covalent
c1ccc(cc1)c2cccc3c2oc(cc3=O)N4CCOCC4,LY294002,-10.403945,x0195,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,trifluoperazine,-10.390505,x0195,active-noncovalent
c1ccc2c(c1)ccc(n2)N3CC[NH2+]CC3,quipazine,-10.385775,x0749,active-covalent
c1ccc(cc1)Cn2c3ccccc3c(n2)OCC(=O)[O-],bendazac,-10.383814,x0678,active-noncovalent
c1cc2c(c[nH]c2c(c1)C(=O)N3CC[NH+](CC3)CCc4ccc(cc4)F)C#N,pruvanserin,-10.383598,x0104,active-noncovalent
C[C@@H](c1ccc-2c(c1)Cc3c2cccc3)C(=O)[O-],cicloprofen,-10.382397,x0749,active-covalent
c1cc(c(cc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O)O,quercetin,-10.377850,x0749,active-covalent
c1ccc2c(c1)cccc2CC3=[NH+]CCN3,naphazoline,-10.375788,x0195,active-noncovalent
c1cc(ccc1CCC(=O)c2c(cc(cc2O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,phlorizin,-10.370809,x0678,active-noncovalent
Cn1c(c([nH]c1=S)Cc2c[nH]c3c2cccc3)O,necrostatin-1,-10.369701,x0678,active-noncovalent
c1c2c(c(c(c1F)N3CCCC[C@H](C3)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])C4CC4,besifloxacin,-10.369646,x1334,active-covalent
Cc1cc(nc(n1)[N-]S(=O)(=O)c2ccc(cc2)N)C,sulfamethazine,-10.365470,x0072,active-noncovalent
Cc1cc(c2c3c1c4c(cc(c5c4c6c3c7c(c2O)c(cc(=O)c7c8c6c(c5O)c(cc8=O)[O-])[O-])O)C)O,hypericin,-10.361643,x0749,active-covalent
c1cc(c(cc1Cl)Cl)c2cc(c(c(c2)CP(=O)([O-])[O-])O)C[C@@H](C(=O)[O-])[NH3+],SDZ-220-040,-10.361155,x0749,active-covalent
c1cc(cc(c1)N)c2cc3c([nH]2)ncnc3Oc4cccc(c4)O,TWS-119,-10.360308,x0678,active-noncovalent
Cn1cc([nH+]c1C2CCN(CC2)c3c4c[nH]nc4ncn3)c5ccc(c(c5)C(F)(F)F)F,LY2584702,-10.358316,x0161,active-noncovalent
CC[C@@H](c1ccc(c(c1)F)F)n2c(c([nH]c2=S)c3ccno3)C(=O)OC,JNJ-27141491,-10.350121,x0678,active-noncovalent
Cc1ccc(c(c1)Oc2ccncc2C(=O)N3CC[N@](c4c3cccc4)C5CC5)C,TC-G-1005,-10.346515,x0107,active-noncovalent
C=CC(=O)N1CCN(CC1)C(=O)CNc2cc(c(cc2O)Cl)I,K-Ras(G12C)-inhibitor-12,-10.343950,x0195,active-noncovalent
c1ccc2c(c1)c(c([nH]2)O)C3=Nc4ccccc4C3=O,indirubin,-10.343945,x0195,active-noncovalent
C[C@@H](c1ccc2c3cc(ccc3[nH]c2c1)Cl)C(=O)[O-],carprofen,-10.343470,x0749,active-covalent
C[NH+](C)[C@@H]1CCc2c(c3cc(ccc3[nH]2)NC(=O)c4ccc(cc4)F)C1,LY344864,-10.343363,x0104,active-noncovalent
c1c(cncc1Br)C(=O)N2CCC(CC2)[NH+]3CCCC3,UNC669,-10.343193,x0107,active-noncovalent
c1ccc(cc1)C(=O)c2cccc(c2N)CC(=O)[O-],amfenac,-10.338215,x0830,active-covalent
c1cc(c(cc1c2cc(=O)c3c(cc(cc3o2)O)[O-])O)O,luteolin,-10.337856,x0749,active-covalent
c1cc(ccc1C(=O)C2CC2)OCCCc3cnc[nH]3,ciproxifan,-10.334455,x0678,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cccc(c5c4)N)O,9-aminocamptothecin,-10.332307,x0161,active-noncovalent
CCc1cncnc1N2CC[NH+](CC2)Cc3[nH]c4cc(ccc4n3)C(F)(F)F,PF-4708671,-10.327504,x0161,active-noncovalent
c1ccc(cc1)COc2ccc(cc2C(=O)Nc3cccnc3)c4ccnc(c4)F,GSK2578215A,-10.321705,x0107,active-noncovalent
CC[C@@](c1ccccc1)(c2cccc(c2)C(F)(F)F)O,flumecinol,-10.321628,x0749,active-covalent
c1cc(ccc1N)S(=O)(=O)Nc2ccc(nn2)Cl,sulfachlorpyridazine,-10.319646,x0678,active-noncovalent
c1cc(=O)oc2c1cc(c(c2)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,esculin,-10.316544,x0678,active-noncovalent
C[NH2+]CCC=C1c2ccccc2C=Cc3c1cccc3,norcyclobenzaprine,-10.315610,x0874,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1COCCO)N,acyclovir,-10.303643,x0397,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccc(cc3)O)[NH3+])C(=O)[O-])C,amoxicillin,-10.303358,x0831,active-covalent
CCCC(=O)c1cc(ccc1OC[C@H](C[NH2+]C(C)(C)C)O)F,butofilolol,-10.292184,x0195,active-noncovalent
CC(C)c1cc(c(cc1O)O)C(=O)N2Cc3ccc(cc3C2)CN4CC[NH+](CC4)C,AT13387,-10.289753,x0104,active-noncovalent
CCNC1=[NH+]c2ccc(cc2[C@@](O1)(C)c3ccccc3)Cl,etifoxine,-10.287774,x0305,active-noncovalent
c1ccc2c(c1)C(=O)OC2(c3ccc(cc3)O)c4ccc(cc4)O,phenolphthalein,-10.282137,x0770,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,norethindrone,-10.277848,x0749,active-covalent
CC(C)(C)c1cc(c(cc1O)C(C)(C)C)O,BHQ,-10.273196,x0749,active-covalent
CCC[N@@H+]1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4c3c2ccc4)CSC,pergolide,-10.273161,x1392,active-covalent
C=c1c(=O)/c(=C\NNC(=O)c2ccncc2)/c(c[nH]1)CO,pyridoxal-isonicotinoyl-hydrazone,-10.271133,x1093,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH2+]C3CCC(CC3)[NH3+],ORY-1001,-10.260633,x0678,active-noncovalent
c1cc2c(=O)cc(oc2c(c1)c3ccc(cc3)N)N4CCOCC4,PI-828,-10.258333,x0434,active-noncovalent
CC(C)c1ccc2c(c1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)C[NH3+])C,lylamine,-10.254182,x0749,active-covalent
c1c(cc(c(c1O)O)O)[C@@H]2[C@H](C(=O)c3c(cc(cc3O2)O)[O-])O,dihydromyricetin,-10.253414,x0749,active-covalent
C[N+]12CCC(CC1)[C@@H](C2)OC(=O)C(c3ccccc3)(c4ccccc4)O,clidinium,-10.250352,x1093,active-noncovalent
c1cc(c(c(c1C(=O)c2cc(c(c(c2)O)O)O)O)O)O,exifone,-10.247484,x0395,active-noncovalent
COc1cc2c(cc1OC)[C@@H](N=NC(=O)C2)c3ccc(cc3)N,CFM-2,-10.245515,x0195,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC=C3[C@H]1CCC2=O)O,equilin,-10.244355,x0749,active-covalent
Cc1nc2c(nc(nc2n1C(C)C)N3CCOCC3)c4cnc(nc4)N,SB-2343,-10.243778,x0678,active-noncovalent
C[NH+](C)CCCn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5,GF109203X,-10.235867,x1412,active-covalent
C[NH+]1CCC(CC1)c2c[nH]c3c2cc(cc3)O,BRL-54443,-10.234673,x0104,active-noncovalent
c1cc(cc(c1)Nc2c(cccn2)C(=O)[O-])C(F)(F)F,niflumic-acid,-10.234092,x0072,active-noncovalent
CC(C)c1ccc2c(c1)[C@@H](Cc3ccc(cc3S2)F)N4CC[NH+](CC4)CCO,isofloxythepin,-10.232785,x0072,active-noncovalent
c1cc(cc2c1ccc(n2)/C=C/C(=O)c3ccncc3)C(F)(F)F,PFK-158,-10.228459,x0195,active-noncovalent
C[C@H](CCC(=O)[O-])[C@@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,lithocholic-acid,-10.223473,x0072,active-noncovalent
CCc1ccc(cc1)Cc2ccc3c(c2)[C@]4([C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC3,tofogliflozin,-10.222880,x0107,active-noncovalent
c1ccc(cc1)c2c3ccccc3c(nn2)Nc4cccc(c4)Cl,MY-5445,-10.220787,x0195,active-noncovalent
C[N@H+]1CC[C@@H]([C@@H](C1)O)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)[O-])O,alvocidib,-10.214050,x0195,active-noncovalent
c1ccc(cc1)CCCNc2ccc(cc2C(=O)[O-])N(=O)=O,NPPB,-10.211312,x1093,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c(cc(cc3o2)O)[O-],chrysin,-10.210646,x0749,active-covalent
C[NH+](C)C[C@@H](Cn1c2ccc(cc2c3c1ccc(c3)Br)Br)O,wiskostatin,-10.209465,x0195,active-noncovalent
c1ccc2c(c1)c(n[nH]c2=O)Cc3ccc(c(c3)C(=O)N4CCN(CC4)C(=O)C5CC5)F,olaparib,-10.208745,x0161,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,alfacalcidol,-10.207401,x0104,active-noncovalent
Cc1c(n2c(n1)c(cc(n2)Cl)NCCNC(=O)C)c3cccc(c3)S(=O)(=O)N(C)C,MI-14,-10.206423,x0104,active-noncovalent
C[C@@H]1CCN(C[C@@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N,tofacitinib,-10.203341,x1077,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCc4c2nccc4)CC1,azatadine,-10.202832,x0195,active-noncovalent
c1cc2cc3cccc(c3c(c2c(c1)O)O)O,dithranol,-10.201751,x0195,active-noncovalent
c1ccc2c(c1)c(c([nH]2)O)c3c(c4ccccc4[nH]3)N=O,indirubin-3-monoxime,-10.200515,x0678,active-noncovalent
Cc1cc(c2nc(cc(=O)n2c1)N3CCOCC3)[C@@H](C)Nc4ccccc4C(=O)[O-],AZD6482,-10.198004,x0195,active-noncovalent
c1ccc(cc1)c2ccc3c(c2)c4c([nH]3)[C@@H](CCC4)[NH2+]CCO,casin,-10.194621,x0104,active-noncovalent
COc1ccc(cc1C23CC4CC(C2)CC(C4)C3)c5ccc6cc(ccc6c5)C(=O)[O-],adapalene,-10.193730,x0104,active-noncovalent
CN1c2ccccc2C(=O)N3[C@H]1c4c(c5ccccc5[nH]4)CC3,evodiamine,-10.184712,x1093,active-noncovalent
COc1ccc2c(c1)c(c3c([nH+]2)CCCC3)N,7-methoxytacrine,-10.180806,x0749,active-covalent
Cc1cccc(c1)NC(=O)/N=c\2/c(=O)n(c3c(c(n2)c4ccccc4)CCC=C3)C,L-365260,-10.180580,x0678,active-noncovalent
COc1ccc(nn1)NS(=O)(=O)c2ccc(cc2)N,sulfamethoxypyridazine,-10.180480,x0678,active-noncovalent
CC(C)[C@H]1c2ccc(cc2CC[C@@]1(CC[N@H+](C)CCCc3[nH]c4ccccc4n3)OC(=O)COC)F,mibefradil,-10.180197,x0874,active-noncovalent
c1ccc(cc1)CCNc2ccccc2C(=O)[O-],tromaril,-10.179571,x0749,active-covalent
C[NH+](C)CC/C=C/1\c2ccccc2CSc3c1cccc3,dosulepin,-10.176539,x0195,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCC3CC[NH2+]CC3,indalpine,-10.172886,x0072,active-noncovalent
Cc1cc(no1)NC(=O)Nc2cc(c(cc2OC)OC)Cl,PNU-120596,-10.172806,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34,nandrolone,-10.166504,x0749,active-covalent
COc1ccc(c(c1)OC)/C=C/2\CCCN=C2c3cccnc3,GTS21,-10.163243,x0107,active-noncovalent
COc1ccc(cc1)c2coc3cc(cc(c3c2=O)[O-])O,4-methylgenistein,-10.159066,x0749,active-covalent
c1ccc2c(c1)ccc(c2Cc3c4ccccc4ccc3O)O,ST-1859,-10.155929,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)CCCC(=O)[O-],3-indolebutyric-acid,-10.152559,x0072,active-noncovalent
c1ccc(cc1)COC(=O)CCC(=O)C[NH3+],aminolevulinic-acid-benzyl-ester,-10.151463,x0678,active-noncovalent
c1ccc(c(c1)Cn2c(=O)ccn(c2=O)C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],UBP-296,-10.146521,x0678,active-noncovalent
c1ccc(c(c1)Cn2c(=O)ccn(c2=O)C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],UBP-302,-10.146521,x0678,active-noncovalent
c1ccc2c(c1)c(c3ccccc3[nH+]2)N,acrisorcin,-10.145630,x0749,active-covalent
c1ccc2c(c1)c(c3ccccc3[nH+]2)N,9-aminoacridine,-10.145630,x0749,active-covalent
CN(C)c1ccc(cc1)/C=C/2\CCCN=C2c3cccnc3,DMAB-anabaseine,-10.145158,x0107,active-noncovalent
Cc1c(c(n(n1)c2ccccc2)C)/C=N/N3CC[NH+](CC3)Cc4ccccc4,SANT-1,-10.139997,x1077,active-noncovalent
c1cc(ccc1c2ccc3c(c2)cco3)n4c(n[nH]c4=O)C[C@@H]5CCN(C5)C(=O)C6CC6,GSK2194069,-10.139313,x0104,active-noncovalent
c1c2c(c(c(c1F)N3C[C@H](C4(C3)CC4)[NH3+])Cl)n(cc(c2=O)C(=O)[O-])[C@@H]5C[C@@H]5F,sitafloxacin,-10.137216,x0749,active-covalent
Cc1c(nc2n1Cc3c(cccc3Cl)N2)O,quazinone,-10.131096,x0195,active-noncovalent
C[N@H+]1CCC[C@H](C1)CN2c3ccccc3Sc4c2cccc4,mepazine,-10.129505,x0195,active-noncovalent
COc1cc2c(cc1O)occ(c2=O)c3ccc(cc3)O,glycitein,-10.129480,x0749,active-covalent
[H]/N=C\1/C=CC(=C(c2ccc(cc2)N)c3ccc(cc3)N)C=C1C,basic-fuchsin,-10.127342,x0831,active-covalent
c1ccc2c(c1)c(n[nH]2)/C=C/c3ccc(cc3)C(=O)N4CC[NH2+]CC4,KW-2449,-10.123824,x0874,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3c(n2)c4ccc(o4)CO,YC-1,-10.119238,x0195,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3c(c(c2=O)C(=O)NCC(=O)[O-])[O-],IOX2,-10.118774,x0195,active-noncovalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)CCCCn4c(c5c(c4O)CCCC5)O,perospirone,-10.118122,x0161,active-noncovalent
C[C@@H](Cc1c[nH]c2c1cc(cc2)OCc3cccs3)[NH3+],BW-723C86,-10.117145,x0749,active-covalent
C[NH+]1CCN(CC1)c2c(cc3c4c2SCCn4cc(c3=O)C(=O)[O-])F,rufloxacin,-10.116451,x0195,active-noncovalent
C[C@H](c1ccc(cc1)Br)C(=O)OC2C[C@H]3CC[C@@H](C2)[NH+]3C,PG-9,-10.110547,x0104,active-noncovalent
c1cc2c(cc1F)[C@@]3(C[C@H](O2)C(=O)N)C(=O)NC(=O)N3,fidarestat,-10.109543,x0195,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2CCC[NH+]3CCC(CC3)n4c5ccc(cc5[nH]c4=O)Cl,domperidone,-10.107753,x1077,active-noncovalent
Cc1c(cccc1Nc2c(cccn2)C(=O)[O-])C(F)(F)F,flunixin-meglumin,-10.107270,x0195,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1)Cc2nc(on2)c3ccc4c(c3)c(c[nH]4)CC[NH3+],L-694247,-10.105589,x0107,active-noncovalent
Cc1c(c(n[nH]1)C)Cc2c(c3c(=O)n(c(=O)n(c3s2)CC(C)C)C)C(=O)N4C[C@@H](CO4)O,AR-C155858,-10.105435,x1077,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc(c2F)F)C(=O)NOC[C@@H](CO)O,PD-0325901,-10.102144,x0434,active-noncovalent
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,dihydrotestosterone,-10.097753,x0749,active-covalent
c1ccc(cc1)COc2ccc(cc2Cl)CC(=O)[O-],benzofenac,-10.096598,x0830,active-covalent
Cc1cccc(n1)c2c(cn[nH]2)c3ccc(c(c3)c4cnn(c4)CCO)F,R-268712,-10.096083,x0161,active-noncovalent
c1cc(ccc1Nc2c3nccn3cc(n2)c4ccc5c[nH]nc5c4)N6CCOCC6,GS-9973,-10.093522,x0678,active-noncovalent
c1ccc(cc1)CCOC(=O)/C=C/c2ccc(c(c2)O)O,caffeic-acid-phenethyl-ester,-10.092237,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,oxandrolone,-10.088489,x0749,active-covalent
c1ccc(cc1)c2cc3c(c[nH]c3nc2)c4ccc(c(c4)C5CCCC5)C(=O)[O-],GSK650394,-10.086538,x0195,active-noncovalent
COC(=O)[C@H](Cc1ccc(cc1)N(=O)=O)NC(=O)c2cccc3c2cccc3,SB-328437,-10.085258,x0434,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1CCCC2=O)O,levobunolol,-10.079726,x0104,active-noncovalent
Cc1c(n2cccnc2n1)c3csc(n3)Nc4c(cc(cc4Br)OC)Br,PTC-209,-10.079254,x0830,active-covalent
C[NH2+]CC[C@@H](c1cccs1)Oc2cccc3c2cccc3,duloxetine,-10.075495,x0749,active-covalent
B(c1ccc(cc1)CSC(=[NH2+])N)(O)O,BC-11,-10.074545,x0195,active-noncovalent
C[NH+](C)CCCOc1c2ccccc2n(n1)Cc3ccccc3,benzydamine,-10.069408,x0104,active-noncovalent
C[N@H+]1C/C=C/CCOc2cccc(c2)-c3ccnc(n3)Nc4cccc(c4)C1,TG-02,-10.065139,x0104,active-noncovalent
Cc1cccc2c1CC[C@@H](C[C@@H]2O)C[NH+]3CCC(CC3)c4c(cccc4Cl)Cl,SB-612111,-10.064910,x1077,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)[C@@H]3CCc4c(nc[nH]4)C3,ramosetron,-10.062973,x0678,active-noncovalent
c1ccc(cc1)c2ccc(cc2)[C@@H](c3ccccc3)n4ccnc4,bifonazole,-10.061692,x0072,active-noncovalent
B(c1ccc(cc1)C[C@@H](C(=O)[O-])[NH3+])(O)O,boronophenylalanine,-10.061302,x0107,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)CCCC(=O)Nc3ccc(cc3)O)F,CMPD-1,-10.060765,x0749,active-covalent
Cn1cc(cc1C(=O)[O-])C(=O)c2cccc3c2cccc3,napirimus,-10.058837,x0830,active-covalent
Cc1ccc(c(c1)OCCCC(C)(C)C(=O)[O-])C,gemfibrozil,-10.056758,x0749,active-covalent
Cc1c(oc(n1)NS(=O)(=O)c2ccc(cc2)N)C,sulfamoxole,-10.055438,x0678,active-noncovalent
CC[C@H](C(=O)OC1C[C@H]2CC[C@@H](C1)[NH+]2C)Oc3ccc(cc3)Cl,SM-21,-10.054410,x0104,active-noncovalent
C[C@H](/C=C/[C@H](C1CC1)O)[C@H]2CC[C@@H]\3[C@@]2(CCC/C3=C\C=C/4\C[C@H](C[C@@H](C4=C)O)O)C,calcipotriol,-10.054131,x0161,active-noncovalent
Cc1nccn1C[C@H]2CCc3c(c4ccccc4n3C)C2=O,ondansetron,-10.053156,x0195,active-noncovalent
c1ccc(cc1)NC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,tyrphostin-AG-494,-10.051237,x0104,active-noncovalent
Cc1ccccc1O[C@H](CC[NH2+]C)c2ccccc2,atomoxetine,-10.050564,x0749,active-covalent
c1cc(c(cc1)Cl)C[NH2+]C[C@H]2CC[C@@H](CC2)C[NH2+]Cc3c(cccc3)Cl,AY-9944,-10.047373,x0161,active-noncovalent
c1ccc2c(c1)c(c(c(n2)C3CC3)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c4ccc(cc4)F,pitavastatin,-10.041875,x0195,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)c3c[nH]c4c3cccc4,tropisetron,-10.039702,x0749,active-covalent
Cc1nc(n(n1)C(C)C)c2cn3c([nH+]2)-c4ccc(cc4OCC3)c5cnn(c5)C(C)(C)C(=O)N,taselisib,-10.039515,x0104,active-noncovalent
c1ccc(cc1)COCc2cc(c(c3c2cccn3)O)C[NH+]4CCCC4,UC-112,-10.039283,x0104,active-noncovalent
c1cc(ccc1[C@H]2[C@H]3CCC[C@H]3c4cc(ccc4O2)O)O,erteberel,-10.036065,x0749,active-covalent
c1ccc(cc1)C(=O)COc2cccc3c2cc[nH]c3=O,UPF-1069,-10.033399,x1093,active-noncovalent
c1cc(c(cc1I)F)Nc2c(cc(c(c2F)F)Br)C(=O)NOC[C@@H](CO)O,PD-318088,-10.032454,x0434,active-noncovalent
c1cc(c2c(c1NCC[NH3+])C(=O)c3ccncc3C2=O)NCC[NH3+],pixantrone,-10.030553,x0195,active-noncovalent
c1ccc2c(c1)c(=O)n-3c(n2)C(=O)c4c3cccc4,tryptanthrin,-10.029137,x0749,active-covalent
c1ccc2c(c1)c3cccc(c3s2)c4cccc5c4oc(cc5=O)N6CCOCC6,NU-7441,-10.028452,x0195,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(=O)cc(oc4c3)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,diosmin,-10.027965,x0161,active-noncovalent
Cc1ccc2c(c1)c3c4n2CC[NH2+][C@H]4CCC3,pirlindole,-10.021654,x0195,active-noncovalent
c1ccc2c(c1)c(ccn2)c3cnn4c3ncc(c4)c5ccc(cc5)N6CC[NH2+]CC6,LDN193189,-10.017220,x0104,active-noncovalent
Cc1c(nc([nH]c1=O)Nc2nc(c3ccc(cc3n2)OC)C)C,madrasin,-10.015828,x0678,active-noncovalent
Cn1cccc1/C=C\2/c3ccccc3C(=O)NC2=O,BYK-204165,-10.014102,x0749,active-covalent
c1cc(ccc1c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-])O,kaempferol,-10.012438,x0749,active-covalent
CCc1cc(c(cc1F)Oc2ccc(cc2F)C(=O)N)O,MUT056399,-10.010752,x0678,active-noncovalent
Cc1ccc2c(c1C)n(c3ccccc3c2=O)CCC[NH3+],ER-27319,-10.010362,x0749,active-covalent
Cc1ccc(cc1Cc2ccc(s2)c3ccc(cc3)F)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,canagliflozin,-10.009044,x0161,active-noncovalent
CC1(CCN(CC1)c2cnc(c(n2)N)c3cccc(c3Cl)Cl)[NH3+],SHP099,-10.004807,x0678,active-noncovalent
Cc1c2cc(ccc2n(c1CC(C)(C)C(=O)[O-])Cc3ccc(cc3)Cl)F,L-655240,-10.004412,x0708,active-covalent
COc1cc2c(cc1C(F)(F)F)N(CC2)C(=O)Nc3cc(cc(c3)F)c4cccnc4,SB-228357,-10.004124,x0161,active-noncovalent
c1ccc(cc1)[C@@H](Cc2ccccn2)[NH3+],AZD6765,-9.999926,x0749,active-covalent
CCCCCCN(CCCCCC)C(=O)Cc1c2cc(ccc2[nH]c1c3ccc(cc3)Cl)Cl,FGIN-1-43,-9.999490,x0161,active-noncovalent
c1ccc2c(c1)ccc(c2SSc3c4ccccc4ccc3O)O,IPA-3,-9.994905,x0195,active-noncovalent
Cc1cccn2c1nc(c(c2=O)/C=C(\C#N)/c3nc4ccccc4s3)Oc5ccc(cc5)F,CCG-63808,-9.994629,x0161,active-noncovalent
c1ccc2c(c1)C[NH2+][C@H]3[C@H]2c4cc(c(cc4CC3)O)O,dihydrexidine,-9.993713,x0195,active-noncovalent
CC[NH+]1CCN(CC1)c2cc3c(cc2F)c(=O)c(cn3C4CC4)C(=O)[O-],enrofloxacin,-9.992853,x0749,active-covalent
c1cc(ccc1c2[nH]c(=O)c3c(n2)CCSC3)C(F)(F)F,XAV-939,-9.992168,x0678,active-noncovalent
c1ccc2c(c1)c(c3c([nH+]2)CCC[C@H]3O)N,"hydroxytacrine-maleate-(r,s)",-9.990036,x0195,active-noncovalent
CC(=O)c1c(c2n(c1O)C([C@H]3[C@@H]2c4c[nH]c5c4c(ccc5)C3)(C)C)O,cyclopiazonic-acid,-9.989053,x0195,active-noncovalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)CCCSC(=[NH2+])N,bisindolylmaleimide-ix,-9.986578,x0874,active-noncovalent
c1cc(c2cccnc2c1)c3cnn4c3ncc(c4)c5ccc(cc5)N6CC[NH2+]CC6,LDN-212854,-9.985906,x0104,active-noncovalent
c1ccc(cc1)/C=C/2\[C@@H](c3ccccc3C2=O)[NH2+]C4CCCCC4,CID-5458317,-9.983709,x0195,active-noncovalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2[C@@H](CC[C@]3([C@H]1C5)O)/N=N/C(=O)c6ccccc6)O,naloxone-benzoylhydrazone,-9.982453,x0678,active-noncovalent
CCN(c1c(nc(c(n1)N)C(=O)NC(=[NH2+])N)Cl)C(C)C,EIPA,-9.981775,x0678,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1cc[nH+]c2c1ccc(c2)Cl,chloroquine,-9.980066,x0874,active-noncovalent
c1ccc2c(c1)-c3cncn3[C@H]2C[C@H](C4CCCCC4)O,NLG919,-9.970563,x0434,active-noncovalent
CC(C)(C#N)c1ccc(cc1)n2c3c4cc(ccc4ncc3n(c2=O)C)c5cc6ccccc6nc5,NVP-BEZ235,-9.968787,x0161,active-noncovalent
c1ccc2c(c1)nc(n2Cc3ccc(cc3)Cl)C[NH+]4CCCC4,clemizole,-9.968238,x0195,active-noncovalent
CC(C)[NH2+]C[C@H](COc1ccc(cc1)CC(=O)N)O,atenolol-(+),-9.966724,x0104,active-noncovalent
CC(=O)c1cc2c(o1)C(=O)c3ccccc3C2=O,napabucasin,-9.965898,x0749,active-covalent
CSc1cc2c(cc1C(F)(F)F)N(CC2)C(=O)Nc3cccnc3,SB-221284,-9.965459,x0195,active-noncovalent
C[C@@H]1n2c3cc(c(cc3c(=O)c(c2S1)C(=O)[O-])F)N4CC[NH2+]CC4,ulifloxacin,-9.963349,x0749,active-covalent
Cc1ccccc1n2c(nc3cccc(c3c2=O)C)Cn4c5c(cn4)c(ncn5)N,PIK-293,-9.954947,x1077,active-noncovalent
c1ccc2c(c1)c(nnc2Nc3ccc(cc3)Cl)Cc4ccncc4,vatalanib,-9.954937,x0195,active-noncovalent
CCOc1ccc2c(c1)nc([nH]2)SCC[NH+]3CCOCC3,afobazole,-9.953567,x0161,active-noncovalent
Cc1c(sc[n+]1Cc2cnc(nc2N)C)CCO,thiamine,-9.952252,x0678,active-noncovalent
c1cc2c(cc1N(=O)=O)[nH]c(n2)COCc3[nH]c4cc(ccc4n3)N(=O)=O,VU591,-9.951073,x0104,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)(O)O,bortezomib,-9.949553,x0107,active-noncovalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,rolipram,-9.948129,x0749,active-covalent
c1ccc(cc1)[C@H]2CCc3cc(ccc3[C@H]2c4ccc(cc4)OCC[NH+]5CCCC5)O,lasofoxifene,-9.945914,x0874,active-noncovalent
c1ccc(cc1)CC/[NH+]=C(/N)\[NH+]=C(N)N,phenformin,-9.942698,x0104,active-noncovalent
c1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,sulfadiazine,-9.942277,x0072,active-noncovalent
CC/C(=C(/CC)\c1ccc(cc1)O)/c2ccc(cc2)O,diethylstilbestrol,-9.939643,x0678,active-noncovalent
CC[C@H](c1ccc(cc1)N2Cc3ccccc3C2=O)C(=O)[O-],indobufen,-9.939607,x0678,active-noncovalent
c1ccc2c(c1)CCC[C@H]2Nc3[nH]c4ccccc4n3,NS-8593,-9.938129,x0195,active-noncovalent
c1cc(c(cc1I)F)Nc2c(cc(c(c2F)F)CN3C(=O)CCCO3)C(=O)NOCCO,Ro-4987655,-9.936168,x0749,active-covalent
C1C2CC3CC1CC(C2)(C3)C[NH2+]CCCCC[NH3+],IEM1754,-9.934278,x0678,active-noncovalent
Cc1cccc(n1)C#Cc2ccccc2,MPEP,-9.933843,x0749,active-covalent
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)N(C)C(=O)c9ccccc9)OC,midostaurin,-9.931092,x0161,active-noncovalent
COC(=O)[C@@H]1[C@H](CC[C@H]2[C@@H]1C[C@H]3c4c(c5ccccc5[nH]4)CC[N@@H+]3C2)O,rauwolscine,-9.930837,x0104,active-noncovalent
C[C@](Cc1ccccc1)(c2ccccc2)NC(=O)C[NH3+],remacemide,-9.928029,x0749,active-covalent
CCOC(=O)c1ccc(cc1)OCCC2CCN(CC2)c3ccc(nn3)C,pirodavir,-9.927286,x0161,active-noncovalent
Cc1nnc2n1-c3ccc(cc3[C@@H](N=C2)c4ccccc4Cl)Cl,triazolam,-9.922110,x1077,active-noncovalent
c1ccc(cc1)C#Cc2c(nc3cccnc3n2)OCC[NH+]4CCCC4,GK921,-9.921986,x0678,active-noncovalent
COP(=S)(OC)Oc1ccc(cc1)Sc2ccc(cc2)OP(=S)(OC)OC,temefos,-9.921123,x0161,active-noncovalent
c1ccc(cc1)[C@@H]2OC[C@@H]3[C@@H](O2)[C@@H]([C@H]([C@@H](O3)O)O)O,KBG,-9.920143,x0749,active-covalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCN(CC3)C(=O)CO,eperezolid,-9.916245,x0104,active-noncovalent
c1ccc(cc1)c2c(c2=O)c3ccccc3,diphencyprone,-9.914463,x0749,active-covalent
Cc1cc(n(c(=O)c1/C(=N/c2ccccc2N)/C)[O-])[O-],SUN-B-8155,-9.914457,x0749,active-covalent
C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-],ammonium-perfluorocaprylate,-9.914093,x0678,active-noncovalent
Cn1c(=O)cc2c(c1c3cccc(c3)N(C)C)c(=O)n([nH]2)c4ccccc4Cl,GKT137831,-9.913996,x0195,active-noncovalent
CCC[NH2+]C[C@@H](COc1ccccc1C(=O)CCc2ccccc2)O,propafenone,-9.911856,x0195,active-noncovalent
C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,3-alpha-Hydroxy-5-beta-androstan-17-one,-9.911406,x0749,active-covalent
c1ccc(c(c1)/C=N/NC(=O)c2ccccc2O)O,SCS,-9.911241,x0678,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)OCC1c2ccccc2-c3c1cccc3,fmoc-l-leucine,-9.910428,x0678,active-noncovalent
C[C@]12CCC(=O)C(=O)[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,formestane,-9.908145,x0749,active-covalent
c1ccnc(c1)C#CCCc2cn3cc(ccc3[nH+]2)F,dipraglurant,-9.907878,x1093,active-noncovalent
c1ccc2c(c1)C[NH+](C2)CC3=[NH+]c4cccc5c4c(n[nH]c5=O)N3,E7449,-9.906825,x1093,active-noncovalent
Cc1ccc(c(c1)C)Sc2ccccc2N3CC[NH2+]CC3,vortioxetine,-9.906278,x0195,active-noncovalent
Cn1cc([nH+]c1c2ccc(cc2)OC[C@H](C[NH2+]CCOc3ccc(c(c3)C(=O)N)O)O)C(F)(F)F,CGP-20712A,-9.904745,x0161,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)/C=C(\C#N)/c3ccccc3Br,DG-172,-9.902700,x0104,active-noncovalent
CC(C)n1c2c(c(n1)c3cc4cc(ccc4[nH]3)O)c(ncn2)N,PP242,-9.901163,x0678,active-noncovalent
Cc1n(c2c([n+]1Cc3cnccn3)C(=O)c4ccccc4C2=O)CCOC,YM-155,-9.900012,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,lynestrenol,-9.898431,x0749,active-covalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)COCCOC(C)C)O,bisoprolol,-9.897141,x0161,active-noncovalent
c1ccc2c(c1)[C@]34CC[N@@H+]5[C@H]3C[C@@H]6[C@@H]7[C@@H]4N2C(=O)C[C@@H]7OCC=C6C5,strychnine,-9.895838,x0195,active-noncovalent
c1ccc(cc1)c2cc3c(c4cc(ccc4[nH]3)O)c5c2C(=O)NC5=O,PD-407824,-9.895704,x0195,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)c3csc4c3c(c(c(=O)[nH]4)C#N)[O-])O,A-769662,-9.895056,x0678,active-noncovalent
COC(=O)c1ccccc1c2c3ccc(cc3[o+]c4c2ccc(c4)N)N,rhodamine-123,-9.888324,x0830,active-covalent
C[NH2+]CCCC1c2ccccc2C=Cc3c1cccc3,protriptyline,-9.887832,x0072,active-noncovalent
c1cc(ccc1/C=C/C(=O)c2ccc(cc2O)O)O,isoliquiritigenin,-9.885802,x0072,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2cccc(c2)C(F)(F)F,flufenamic-acid,-9.884418,x1093,active-noncovalent
Cn1c2ccccc2c3c1CC[NH2+]CC3,PNU-22394,-9.883717,x0195,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc2ccccc2c1)O,pronethalol,-9.883446,x0161,active-noncovalent
C/C(=[NH+]/Cc1cccc(c1)C[NH3+])/N,1400W,-9.883380,x0195,active-noncovalent
c1ccc2c(c1)CCN(C2)C(=[NH2+])N,debrisoquin,-9.881007,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4=O)C,adrenosterone,-9.878235,x0749,active-covalent
CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6,ciclesonide,-9.877670,x1077,active-noncovalent
c1ccc2cc(ccc2c1)CC[N@H+]3CCC(=CC3)c4cccc(c4)C(F)(F)F,xaliproden,-9.877141,x0161,active-noncovalent
CCc1cc(c(cc1O)O)c2c(c([nH]n2)C)c3ccc4c(c3)OCCO4,CCT018159,-9.872569,x0195,active-noncovalent
CCCC(CCC)C(=O)NCc1ccc2c(c1)cnn2c3ccccc3OC,M-25,-9.869954,x0104,active-noncovalent
Cc1cc(cc2c1O[C@](CC2)(C)CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C)O,delta-Tocotrienol,-9.866880,x0967,active-noncovalent
C[C@@H](c1ccc2c(c1)Cc3cccnc3O2)C(=O)[O-],pranoprofen,-9.864224,x0749,active-covalent
C[N@@H+]1CC[N@]2c3ccccc3Cc4ccccc4[C@@H]2C1,mianserin,-9.861363,x0072,active-noncovalent
C[C@@H](Cn1c2c3cc(ccc3ncc2n(c1=O)C)c4cc(cnc4)C(C)(C)O)OC,LY3023414,-9.854416,x0195,active-noncovalent
Cc1ccc2c(c1)n3c(c[nH+]c3c(n2)NCC[NH3+])C,BMS-345541,-9.849402,x0195,active-noncovalent
c1ccc2cc3c(cc2c1)c(=O)n(cn3)N,centazolone,-9.845895,x0195,active-noncovalent
c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4cccnc4)NCCC(=O)[O-],GSK-J2,-9.844858,x0107,active-noncovalent
CCCCC(=O)O[C@@]1(CC[C@H]2[C@@]1(C[C@@H]([C@@H]3[C@@H]2CCC4=CC(=O)CC[C@]34C)O)C)[C@H](C=O)O,hydrocortisone-valerate,-9.843996,x1077,active-noncovalent
COc1ccc(cc1OC2CCCC2)[C@@H]3CC(=O)NC3,rolipram-S(+),-9.842790,x0749,active-covalent
CCCn1c2c(c(=O)n(c1=O)CCC)[nH]c(n2)C3CCCC3,DPCPX,-9.842395,x0678,active-noncovalent
c1ccc(cc1)[C@@H]2C[NH2+]CCc3c2cc(c(c3Cl)O)O,SKF-81297,-9.841992,x1392,active-covalent
CCn1cc(c(=O)c2c1c(c(c(c2)F)[N@]3CC[NH2+][C@@H](C3)C)F)C(=O)[O-],lomefloxacin,-9.841339,x0749,active-covalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)O)O,4-galactosyllactose,-9.840419,x0161,active-noncovalent
CN(C)C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c2ccc(cc2)[NH+]=C(N)N,camostat-mesilate,-9.839316,x0395,active-noncovalent
c1cc(cnc1)[C@@H]2CCCC[NH2+]2,anabasine,-9.837004,x0678,active-noncovalent
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34C[C@H]5C[C@@H](C3)CC(C5)(C4)O)[NH3+],saxagliptin,-9.835773,x0749,active-covalent
C[N@H+]1CCC2=C(C1)[C@@H](c3c2cccc3)c4ccccc4,phenindamine,-9.834886,x1418,active-covalent
C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,ercalcitriol,-9.834070,x0104,active-noncovalent
Cn1cc2c3c1cccc3[C@H]4C[C@H](C[N@H+]([C@@H]4C2)C)CNC(=O)OCc5ccccc5,metergoline,-9.831735,x0678,active-noncovalent
C[C@@H]1CN(CCN1C(=O)C(=O)c2c[nH]c3c2c(ccn3)OC)C(=O)c4ccccc4,BMS-806,-9.830076,x0107,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cccc4c3cccc4)O,naftopidil,-9.827548,x0161,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cccc2)O,propranolol-(S),-9.823749,x0104,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cccc2)O,propranolol,-9.823749,x0104,active-noncovalent
Cn1cc(cn1)c2ccc3[nH+]cc(n3n2)Cc4ccc5c(c4)cccn5,NVP-BVU972,-9.820287,x1418,active-covalent
C[NH+](C)CCNc1c2c(c3ccc(cc3n1)O)-c4ccccc4C2=O,TAS-103,-9.819729,x0195,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)N3Cc4ccccc4NC3=O,DAU-5884,-9.819455,x0749,active-covalent
c1cc2c(cc1NC(=[NH2+])N)c3c([nH]2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,GNTI,-9.819454,x0072,active-noncovalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)Cn3cncn3,rizatriptan,-9.819012,x0072,active-noncovalent
Cc1ccc(cc1)C(=O)c2ccc(n2C)CC(=O)[O-],tolmetin,-9.818548,x0830,active-covalent
CC(C)CC(=O)Nc1c2c([nH]n1)C(N(C2)C(=O)C3CC[NH+](CC3)C)(C)C,PHA-793887,-9.817928,x0195,active-noncovalent
CCOC(=O)Cc1ccc(cc1)c2ccccc2,felbinac-ethyl,-9.816342,x0749,active-covalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)C(F)(F)F,triflupromazine,-9.813185,x0161,active-noncovalent
CCC1(Cc2ccccc2C1)c3c[nH]cn3,atipamezole,-9.809377,x0749,active-covalent
CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C#C)O,gestrinone,-9.808918,x0749,active-covalent
c1cc(ccc1C[NH+]2CCOCC2)C(=O)N3CC[NH+](CC3)C4CC4,bavisant,-9.808836,x0946,active-noncovalent
c1ccc2c(c1)c(nn2Cc3ccc(cc3Cl)Cl)C(=O)[O-],lonidamine,-9.807531,x0678,active-noncovalent
CC(C)(C)c1ccc2cc(c(cc2c1)C#N)C#N,BRD-9876,-9.807121,x0749,active-covalent
CCn1c2ccccc2c3c1ccc(c3)C[NH2+]C,PhiKan-083,-9.805827,x0195,active-noncovalent
c1cc(cc(c1)O)c2nc3c4cccnc4oc3c(n2)N5CCOCC5,PI-103,-9.803667,x0749,active-covalent
CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,sitosterol,-9.803485,x0104,active-noncovalent
c1c(cc(c(c1O)O)O)c2c(c(=O)c3c(cc(cc3o2)O)[O-])[O-],myricetin,-9.803391,x0749,active-covalent
C[C@]1(C[C@@H](C1)c2n3c(c(ncc3)N)c(n2)c4cc5nc(ccc5cc4)c6ccccc6)O,linsitinib,-9.801770,x0161,active-noncovalent
C[NH+](C)CCN(Cc1ccccc1)c2ccccn2,tripelennamine,-9.801753,x0749,active-covalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)c3cc(cc(c3)Cl)Cl,bemesetron,-9.800955,x0161,active-noncovalent
C[NH+](C)CC/C=C\1/c2ccccc2Sc3c1cc(cc3)Cl,chlorprothixene,-9.799965,x0104,active-noncovalent
CCC[N@@H+]1CCO[C@H]2[C@@H]1COc3c2cc(cc3)O,PD-128907,-9.794686,x0195,active-noncovalent
C[NH+]1CCN(CC1)c2cc(nc(n2)N)c3ccccc3,VUF10460,-9.794000,x0104,active-noncovalent
Cc1c(c2ccccc2[nH]1)CCNC(=O)c3cccs3,CK-636,-9.793570,x1386,active-covalent
CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N3CCC[C@H]3C(=O)N,taltirelin,-9.792715,x0678,active-noncovalent
CN1CC[NH+](CC1)Cc2ccc(cc2)c3cc4c(c[nH]c4nc3)c5ccc6c(c5)cc[nH]6,URMC-099,-9.792511,x0104,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)Nc2c(nc3ccccc3n2)Nc4ccc5c(c4)nsn5,XL-147,-9.792378,x0678,active-noncovalent
c1cc(cc(c1)Cl)[C@@H](c2ccc3c(c2)nc[nH]3)n4ccnc4,liarozole,-9.791400,x0195,active-noncovalent
B(c1ccccc1)(c2ccccc2)OCC[NH3+],2-APB,-9.791046,x0072,active-noncovalent
C1C[C@@H]2[C@@H]3CCC[N@H+]4[C@H]3[C@H](CCC4)CN2C(=O)C1,matrine,-9.790839,x0195,active-noncovalent
c1cc(ccc1c2c[nH]nc2)C3(CC[NH2+]CC3)c4ccc(cc4)Cl,AT7867,-9.787711,x1077,active-noncovalent
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](c1ccccc1)C(=O)OC2CCCC2,tosedostat,-9.787008,x0434,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)CCc2[nH]c(=O)c3ccccc3n2,ME0328,-9.786962,x1093,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)CCc2[nH]c(=O)c3ccccc3n2,ME-0328,-9.786962,x1093,active-noncovalent
Cc1ccc(c2c1CCC2)OC[C@H]([C@H](C)[NH2+]C(C)C)O,"ICI-118,551",-9.786823,x0195,active-noncovalent
c1ccc(cc1)C[C@H](CS)C(=O)NCC(=O)[O-],thiorphan,-9.784503,x0678,active-noncovalent
CC(C)(C(=O)[O-])Sc1ccncc1c2ccc(c3c2cccc3)C#N,verinurad,-9.784450,x0830,active-covalent
C[NH+](C)CCC=C1c2ccccc2CCc3c1cccc3,amitriptyline,-9.784410,x0874,active-noncovalent
c1c(csc1COc2c3c([nH]cn3)nc(n2)N)Br,lomeguatrib,-9.783179,x0749,active-covalent
CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O,L-Ascorbyl-6-palmitate,-9.782143,x0967,active-noncovalent
C[C@@]12[C@](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)NC8)(CO)O,lestaurtinib,-9.778948,x0195,active-noncovalent
c1cc(cc(c1)Cl)Nc2c3ccncc3c4ccc(cc4n2)C(=O)[O-],CX-4945,-9.778694,x0434,active-noncovalent
Cc1ccccc1/N=N/c2ccc(c(c2)C)/N=N/c3c4ccccc4ccc3O,sudan-iv,-9.778320,x0104,active-noncovalent
C[NH+](C)CC[C@H](c1ccc(cc1)Br)c2ccccn2,brompheniramine,-9.775172,x0072,active-noncovalent
C[C@@H]1C[C@@H](CC(C1)(C)C)OC(=O)c2ccccc2O,homosalate,-9.773002,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CCC4=O)C)O,NPC-01,-9.772391,x0749,active-covalent
CC(C)Nc1cc(c(cn1)Cl)c2cc([nH]c2)C(=O)N[C@H](CO)c3cccc(c3)Cl,BVD-523,-9.771790,x0161,active-noncovalent
Cc1c2c(n[nH]1)Nc3cc(c(cc3C(=N2)c4ccccc4Cl)F)OC,RG1530,-9.771587,x0195,active-noncovalent
c1ccc2cnc(cc2c1)C3=[NH+]CCN3,BU226,-9.771079,x0195,active-noncovalent
C[C@@]12CC[C@@H]3[C@@H]([C@@H]1CC=C2)CC[C@H]4[C@]3(CCC(=O)C4)C,androstenone,-9.770131,x0749,active-covalent
C[NH2+]CCCN1c2ccccc2CCc3c1cccc3,desipramine,-9.767564,x0072,active-noncovalent
COc1cccc(c1N)c2cc(=O)c3ccccc3o2,PD-98059,-9.764787,x0195,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1C[C@@H]([C@@H](C2)O)O)O,nadolol,-9.761443,x0104,active-noncovalent
C[N@@H+]1Cc2ccccc2[C@H]3[C@H]1Cc4c[nH]c5c4c3ccc5,CY208-243,-9.759704,x0749,active-covalent
COc1ccc(cc1)c2coc3cc(ccc3c2=O)O,formononetin,-9.758073,x0749,active-covalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@]2(C#C)O)OC,mestranol,-9.755615,x0749,active-covalent
c1ccc(c(c1)[C@@H]2[C@@H](CO[C@@H](O2)C(F)(F)F)C/C=C\CCCC(=O)[O-])O,"ICI-185,282",-9.753593,x0678,active-noncovalent
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,dapagliflozin,-9.752493,x0874,active-noncovalent
C[C@@H](c1ccc(s1)C(=O)c2ccccc2)C(=O)[O-],tiaprofenic-acid,-9.752036,x0678,active-noncovalent
c1cc2c(cc[nH+]c2cc1Cl)NCCNc3cc[nH+]c4c3ccc(c4)Cl,NSC5844,-9.751589,x0104,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CC[C@@H]2O)OC(=O)c5ccccc5,estradiol-benzoate,-9.751526,x0161,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)Sc3ccccc3,fenbendazole,-9.749841,x0072,active-noncovalent
C[C@H]1COC2=C1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,cryptotanshinone,-9.748426,x0749,active-covalent
CNC(=O)c1ccc2cc(ccc2c1)[C@@]3(CCn4c3cnc4)O,orteronel,-9.747026,x0104,active-noncovalent
CC(C)(c1ccc(cc1)O)c2ccc(cc2)O,bisphenol-a,-9.745298,x0072,active-noncovalent
c1ccc(c(c1)c2cc(cc(c2)CP(=O)([O-])[O-])C[C@@H](C(=O)[O-])[NH3+])Cl,SDZ-220-581,-9.744349,x1392,active-covalent
c1cc(cc(c1)O)CNC(=O)Nc2nc(cs2)c3ccncc3,RKI-1447,-9.743959,x0678,active-noncovalent
CC[C@H](c1ccc(cc1)CC(C)C)C(=O)[O-],butibufen,-9.743702,x0678,active-noncovalent
c1ccc(cc1)CC[NH+]2CCC3(CC2)CNC(=O)O3,fenspiride,-9.741241,x0678,active-noncovalent
C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4c5ccccc5)C)O,17-PA,-9.739073,x0161,active-noncovalent
C[C@@H](c1cccc(c1)Oc2ccccc2)C(=O)[O-],fenoprofen,-9.739006,x0678,active-noncovalent
c1c(ccc(c1)Cl)S(=O)(=O)[C@]2(CC[C@H](CC2)CCC(=O)[O-])c3c(ccc(c3)F)F,MK-0752,-9.735870,x0195,active-noncovalent
CC1CC[NH+](CC1)CCCC(=O)c2ccc(cc2)F,melperone,-9.735436,x0104,active-noncovalent
C[N@H+]1CC[C@H]([C@@H]1CO)c2c(cc(c3c2oc(cc3=O)c4ccccc4Cl)[O-])O,P276-00,-9.734779,x1385,active-covalent
Cc1ccc2c(c1)c3c(n2CCc4ccc(nc4)C)CC[N@H+](C3)C,latrepirdine,-9.734228,x0104,active-noncovalent
c1cc(cc(c1)Cl)N/C(=[NH+]\C(=[NH2+])N)/N,m-Chlorophenylbiguanide,-9.733343,x0195,active-noncovalent
c1ccc(cc1)COc2c3c(nc[nH]3)nc(n2)N,O6-Benzylguanine,-9.733213,x0749,active-covalent
c1ccc(cc1)[C@@H]2CC(=O)c3c(cc(cc3O2)O)[O-],pinocembrin,-9.732360,x0749,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CC[C@@H]4[C@@H]3CCC(=C4)N=O,norelgestromin,-9.730318,x0749,active-covalent
Cn1c(ccc1/C=C/C(=O)c2cccc(c2)F)CCC(=O)N=O,MC1568,-9.729635,x0072,active-noncovalent
c1ccc2c(c1)ccn3c2nc(cc3=O)N4CCOCC4,compound-401,-9.728454,x0195,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2cc3cc(ccc3[nH]2)Cl,JNJ-7777120,-9.727457,x0107,active-noncovalent
Cc1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])O)C2=O,emodin,-9.725954,x0749,active-covalent
c1ccc2c(c1)C(=O)c3ccccc3C2=O,anthraquinone,-9.725620,x0749,active-covalent
CN(CCCNC(=O)[C@H]1CCCO1)c2nc3cc(c(cc3c(n2)N)OC)OC,alfuzosin,-9.724016,x0104,active-noncovalent
C[C@@](Cc1ccccc1)(c2ccccc2)[NH3+],FPL-12495,-9.724012,x0195,active-noncovalent
CC1(CCC(c2c1ccc(c2)C3(OCCO3)c4ccc(cc4)C(=O)[O-])(C)C)C,BMS-649,-9.723873,x0161,active-noncovalent
CC[NH+](CC)CCNc1ccc(c2c1c(=O)c3ccccc3s2)CO,hycanthone,-9.723572,x0104,active-noncovalent
Cc1ccc(c(n1)/N=N/c2ccccc2)O,SIB-1757,-9.723178,x0749,active-covalent
c1cc(ccc1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,arbutin,-9.722437,x0678,active-noncovalent
COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C,amsacrine,-9.721684,x0195,active-noncovalent
[H]/N=c\1/cc2cccc3c(=O)n(c(=O)c(c1)[C@@H]23)CC[NH+](C)C,amonafide,-9.721275,x0195,active-noncovalent
C[C@@H]1C[C@@H](CC(C1)(C)C)OC(=O)[C@H](c2ccccc2)O,cyclandelate,-9.718907,x0195,active-noncovalent
c1cc2c3c(c1)c4c(n3CC[NH2+]C2)CCCC4,WAY-629,-9.717195,x0195,active-noncovalent
c1cc(c(cc1C(=O)Nc2cnc(nc2)Cl)F)F,ICA-069673,-9.714758,x0678,active-noncovalent
CCCC(=O)Nc1ccc(c(c1)C(=O)C)OC[C@H](C[NH2+]C(C)C)O,acebutolol,-9.713871,x0104,active-noncovalent
c1cc(c(c2c1[C@H]3c4cc(c(cc4C[C@]3(CO2)O)O)O)O)O,hematoxylin,-9.711901,x0195,active-noncovalent
c1ccc(cc1)C(=O)Nc2ccc3c(c2)cc[nH]3,OAC2,-9.711063,x0749,active-covalent
c1cc(ccc1CCC(=O)c2c(cc(cc2O)O)O)O,phloretin,-9.710749,x1093,active-noncovalent
CC[n+]1c2cc(ccc2c3ccc(cc3c1c4ccccc4)N)N,homidium,-9.710552,x0195,active-noncovalent
COc1cc(cc(c1)OC)NC(=O)c2ccc(o2)c3ccc(cc3)Cl,A-803467,-9.708751,x0161,active-noncovalent
c1ccc2c(c1)c(c3c([nH+]2)CCCC3)N,tacrine,-9.708664,x0749,active-covalent
c1ccc2c(c1)nc-3c4c(=O)cc([nH]c4c(=O)cc3o2)C(=O)[O-],pirenoxine,-9.702729,x0749,active-covalent
Cc1c2ccc(c(c2c[n+]3c1-c4cc(c(cc4CC3)OC)OC)OC)OC,dehydrocorydaline,-9.700160,x0161,active-noncovalent
c1ccc(c(c1)C[NH2+]Cc2ccc(cc2)c3ccnc4c3cc[nH]4)F,OXA-06,-9.694568,x1077,active-noncovalent
C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,medroxyprogesterone,-9.692704,x0749,active-covalent
c1ccc(c(c1)C(=O)OC[C@@H](CO)O)Nc2ccnc3c2ccc(c3)Cl,glafenine,-9.691914,x0107,active-noncovalent
Cc1cc(nc(c1N)C#Cc2cccc(c2)F)C,ADX-10059,-9.691592,x0749,active-covalent
C[C@@H]1CCC[N@H+]1CCc2cc3cc(ccc3o2)c4ccc(cc4)C#N,ABT-239,-9.690766,x0161,active-noncovalent
c1cc2c(ccc(n2)NCC[NH2+]CCO)c(c1)NC(=O)CC34CC5CC(C3)CC(C5)C4,AZ-10606120,-9.688072,x0104,active-noncovalent
c1ccc2c(c1)CCN3[C@@H]2CN(CC3=O)C(=O)C4CCCCC4,praziquantel,-9.687691,x0195,active-noncovalent
CCCCC[C@@H](c1cccc(c1)OCc2ccc3ccccc3n2)O,REV-5901,-9.686962,x0161,active-noncovalent
c1ccc(cc1)CNC(=O)Cn2ccnc2N(=O)=O,benznidazole,-9.686180,x1093,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,calcifediol,-9.685010,x0104,active-noncovalent
c1cc(cc(c1)I)C[NH+]=C(N)N,iobenguane,-9.684940,x0195,active-noncovalent
c1ccc(cc1)COc2ccc(cc2)O,monobenzone,-9.683814,x0072,active-noncovalent
C[C@H](c1ccnc2n1ncn2)Oc3ccc(cc3)Cl,BTS-72664,-9.683633,x0749,active-covalent
CCCNC(=O)N1[C@H](c2cc3c(cc2C(=N1)c4ccc(cc4)N)OCO3)C,SYM-2206,-9.681863,x0708,active-covalent
c1ccc2c(c1)N(c3cc(ccc3S2)C(F)(F)F)CCC[NH+]4CCN(CC4)CCO,fluphenazine,-9.674680,x0161,active-noncovalent
c1ccc2c(c1)Nc3ccccc3S2,phenothiazine,-9.673660,x0749,active-covalent
c1ccc(cc1)c2c(oc(n2)CCC(=O)[O-])c3ccccc3,oxaprozin,-9.672239,x0678,active-noncovalent
c1cc(ccc1c2csc(n2)Nc3ccc(cc3)O)Cl,SKI-II,-9.671947,x1093,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCCCN3C(=O)c4ccccc4C3=O,NAN-190,-9.671356,x0874,active-noncovalent
COc1ccc2c(c1)c(c[nH]2)C3=CC[NH2+]CC3,RU-24969,-9.670182,x0195,active-noncovalent
COc1cc(ccc1O)[C@@H]2[C@H](Oc3ccc(cc3O2)[C@@H]4[C@H](C(=O)c5c(cc(cc5O4)O)[O-])O)CO,silibinin,-9.670175,x0104,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@@H](CO)O,levodropropizine,-9.670128,x0749,active-covalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@@H](CO)O,dropropizine,-9.670128,x0749,active-covalent
COc1ccc2c(ccnc2c1)NC(=O)Nc3cccc(n3)C(F)(F)F,A-1070722,-9.668767,x0104,active-noncovalent
Cc1cccc(c1NC(=O)CN2CCCC2=O)C,nefiracetam,-9.661541,x0678,active-noncovalent
c1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],phenindione,-9.660164,x0749,active-covalent
COc1cc(cc(c1O)CSc2nc3ccccc3s2)/C=C(\C#N)/C(=O)N,tyrphostin-AG-825,-9.659269,x0749,active-covalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)/[NH+]=C/N3CCCCCC3)C(=O)[O-])C,amdinocillin,-9.659259,x0831,active-covalent
CCC[N@@H+]1CCC[C@@H](C1)c2cccc(c2)O,preclamol,-9.658097,x0195,active-noncovalent
CCOC(=O)COc1ccc2c(c1)C[C@H](CC2)[NH2+]C[C@@H](c3cccc(c3)Cl)O,amibegron,-9.657269,x0161,active-noncovalent
c1cc(ccc1CC/C(=C\F)/C[NH3+])F,mofegiline,-9.656326,x0749,active-covalent
c1cc(ccc1/C=C\2/C(=O)NC(=[NH2+])S2)O,mirin,-9.653940,x0678,active-noncovalent
c1ccc(cc1)COC(=O)c2ccccc2,benzyl-benzoate,-9.652701,x0749,active-covalent
c1ccc2c(c1)cc(s2)c3ccnc(n3)Nc4ccc(cc4)C(=O)N5CCC(CC5)[NH+]6CCCC6,IKK-16,-9.651804,x0161,active-noncovalent
CCOc1ccc2c(c1)c(c3ccc(cc3[nH+]2)N)N,ethacridine-lactate-monohydrate,-9.650339,x0749,active-covalent
C=CCc1ccc(c(c1)c2ccc(c(c2)CC=C)O)O,honokiol,-9.649654,x0195,active-noncovalent
Cc1ccc(cc1)N(CC2=[NH+]CCN2)c3cccc(c3)O,phentolamine,-9.647328,x0195,active-noncovalent
c1c(nc[nH]1)C[C@H](C(=O)[O-])[NH3+],copper-histidine,-9.647011,x0397,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH3+],ethylnorepinephrine,-9.646006,x0195,active-noncovalent
c1ccc(cc1)NNC(=O)c2ccncc2,plurisin-#1,-9.645025,x0749,active-covalent
c1ccc2c(c1)CCN(CC2)c3cc(nc(n3)c4ccccn4)NCCC(=O)[O-],GSK-J1,-9.643823,x1077,active-noncovalent
c1ccc2c(c1)cc(c(c2Cc3c4ccccc4cc(c3O)C(=O)[O-])O)C(=O)[O-],pyrantel,-9.639339,x0830,active-covalent
CC(C)Oc1cc(ccc1C2=[NH+][C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)c4ccc(cc4)Cl)c5ccc(cc5)Cl)OC,nutlin-3,-9.638498,x1077,active-noncovalent
Cc1c2cc(ccc2n[nH]1)c3cc(cnc3)OC[C@H](Cc4ccccc4)[NH3+],A-674563,-9.633895,x0107,active-noncovalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cc(cc3)Cl,chlorpromazine,-9.633637,x0161,active-noncovalent
CCOc1ccccc1/N=N/c2c([nH]n(c2=O)c3nc(cs3)c4ccccc4)C,BAM7,-9.632661,x0104,active-noncovalent
c1cc(ccc1C#N)N2CCN(CC2)C(=O)COc3ccc4c(c3)c(c[nH]4)CC[NH3+],donitriptan,-9.632194,x0104,active-noncovalent
C[C@]12c3ccccc3C[C@H]([NH2+]1)c4c2cccc4,dizocilpine-(-),-9.631378,x0072,active-noncovalent
C[C@H](c1ccccc1)Nc2c3cc([nH]c3ncn2)c4ccc(cc4)O,PKI-166,-9.631264,x0946,active-noncovalent
CN([C@H](C[NH+]1CCCC1)c2ccccc2)C(=O)Cc3ccc(c(c3)Cl)Cl,ICI-199441,-9.630332,x1093,active-noncovalent
CC1(C(=O)N(C(=O)N1CCCCO)c2ccc(c(c2)C(F)(F)F)C#N)C,RU-58841,-9.630137,x0749,active-covalent
c1ccc(cc1)S(=O)(=O)c2cc3cccc(c3nc2)N4CC[NH2+]CC4,SB-742457,-9.629297,x0195,active-noncovalent
Cc1ccc(c(c1)OC[C@H](C[NH2+]C(C)C)O)Cl,1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,-9.622923,x0195,active-noncovalent
c1ccc2c(c1)cc3ccccc3c2C(=O)N4CCC(CC4)[N@@H+]5CCC[C@H](C5)C(=O)N6CCOCC6,CP-640186,-9.622921,x0161,active-noncovalent
COc1cc2c(cc1OC)N3[C@@H]4[C@]25CC[N@@H+]6[C@H]5C[C@@H]7[C@H]4[C@H](CC3=O)OCC=C7C6,brucine,-9.618737,x0195,active-noncovalent
B1(c2ccc(cc2CO1)Oc3ccc(cc3)C#N)O,crisaborole,-9.617744,x1093,active-noncovalent
Cc1ccc2c(c1)C(=O)[C@@]3(CCN(C3=[NH+]2)c4ccccc4)O,blebbistatin-(-),-9.617001,x0195,active-noncovalent
COc1cc2c(cc1OC)C(=O)[C@H](C2)CC3CC[NH+](CC3)Cc4ccccc4,donepezil,-9.616495,x0104,active-noncovalent
C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,androsterone,-9.616280,x0749,active-covalent
c1ccc(cc1)C(c2ccccc2)(C3CC[NH2+]CC3)O,azacyclonol,-9.615924,x1418,active-covalent
C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C,paricalcitol,-9.615711,x0104,active-noncovalent
c1ccc(cc1)c2cc([nH]c(=O)c2C#N)c3cc(ccc3O)Br,TCS-PIM-1-1,-9.615360,x0195,active-noncovalent
CC(C)n1c2c(c(n1)C#Cc3ccccc3)c(ncn2)N,SPP-86,-9.614809,x0678,active-noncovalent
c1cc(cc(c1)N2CC[NH+](CC2)CCNC(=O)N)C(F)(F)F,fluprazine,-9.612432,x0161,active-noncovalent
CN1c2ccc(cc2[C@@H](N=CC1=O)c3ccccc3)Cl,diazepam,-9.608867,x1077,active-noncovalent
c1cc(ccc1n2cc(c(=O)c3c2cc(c(c3)F)N4CC[NH2+]CC4)C(=O)[O-])F,sarafloxacin,-9.608677,x0434,active-noncovalent
Cc1c(cccc1C(F)(F)F)Cn2c(nc3c2cc(cc3C(=O)[O-])N4CCOCC4)C,GSK2636771,-9.607597,x0195,active-noncovalent
c1ccnc(c1)NCc2ccc(cc2)CNc3ccccn3,WZ811,-9.606249,x0107,active-noncovalent
Cc1c(c2ccccn2c1C(=O)c3ccc(c(c3)C(=O)[O-])N)OC,SSR128129E,-9.605569,x0967,active-noncovalent
c1cc(c(cc1/N=N/c2ccc(c(c2)C(=O)[O-])O)C(=O)[O-])O,olsalazine,-9.605501,x0749,active-covalent
CC1(CCC(c2c1cc3c(c2)N(c4ccccc4C(=N3)c5ccc(cc5)C(=O)[O-])C)(C)C)C,LE-135,-9.604280,x0104,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)[O-])C,ampicillin,-9.604071,x0831,active-covalent
c1cc(ccc1Nc2nccc(n2)N3CCCc4c3ccc(c4)O)S(=O)(=O)NCC5CC5,pyrintegrin,-9.601891,x0161,active-noncovalent
C[C@@H](c1cccc(c1)Br)/N=N/C(=O)[C@H]2[C@@H](CNC2=O)c3ccccc3,AC-264613,-9.600739,x0831,active-covalent
COc1ccc2c(ccnc2c1)OCc3nnc4n3nc(cc4)c5ccccc5,AMG-208,-9.600263,x0195,active-noncovalent
[H]/N=C\1/[C@H]([C@@H](c2c(nn(c2O1)C)C)c3ccc(cc3)C(F)(F)F)C#N,BQU57,-9.599390,x0749,active-covalent
CC(C)c1ccc(c(c1)c2c(=O)[nH]c3ccccc3n2)NC(=O)c4cccs4,ML-281,-9.597235,x0831,active-covalent
c1ccc(cc1)CCNc2nc(cs2)c3ccccc3,fanetizole,-9.592484,x0434,active-noncovalent
CCCCCCN(CCCCCC)C(=O)Cc1c2ccccc2[nH]c1c3ccc(cc3)F,FGIN-1-27,-9.589483,x0161,active-noncovalent
C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)OC,2-methoxyestradiol,-9.589324,x0749,active-covalent
Cc1nnc2n1nc(cc2)c3cccc(c3)C(F)(F)F,CL-218872,-9.588747,x0749,active-covalent
CC(C)c1ccc(cc1)N(Cc2ccc(cc2)N(C)C)C(=O)[C@@H]3CCCc4c3cc(cc4)OC,W-54011,-9.588084,x0434,active-noncovalent
C[NH+](C)Cc1cccc(c1)/N=C(/c2ccccc2)\c3c4ccc(cc4[nH]c3O)C(=O)N,BIX-02188,-9.587477,x0830,active-covalent
c1cc2c(cc1C(=O)[O-])CC[C@H]3C2=NN([C@H]3C4CCCC4)c5ccc(c(c5)Cl)C#N,PF-03882845,-9.584240,x0072,active-noncovalent
c1ccc2c(c1)c(c(nc2Cl)C(=O)NCC(=O)[O-])O,FG-2216,-9.583687,x0830,active-covalent
c1cc2c(cc1O)[C@@]34CCCC[C@]3([C@@H](C2)[N@H+](CC4)CC5CCC5)O,butorphanol-(+)-tartrate,-9.583044,x0072,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@](O2)(C)CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)C,alpha-tochopherol,-9.583036,x0161,active-noncovalent
C[C@]12CC[C@H]3[C@@H]([C@H]1CC[C@]2(C#C)O)CCC4=C3CCC(=O)C4,noretynodrel,-9.583004,x0749,active-covalent
COc1cc2c(cc1OC)n(cn2)c3cc(c(s3)C(=O)N)OCc4ccccc4C(F)(F)F,GW-843682X,-9.581621,x0161,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)C2=O,aloe-emodin,-9.581317,x0749,active-covalent
c1ccc2c(c1)c3c([nH]2)-c4nc5ccccc5c(=O)n4CC3,rutaecarpine,-9.580831,x0678,active-noncovalent
Cn1c(=O)c(c(nc1NC[C@H](Cc2ccccc2)[NH3+])c3ccncc3)c4ccc5ccccc5c4,AMG-548,-9.579217,x0104,active-noncovalent
COc1ccc(cc1OC2CCCC2)[C@H]3CC(=O)NC3,rolipram-R(-),-9.575525,x0749,active-covalent
C1CCC(CC1)/[NH+]=C(\NC23CC4CC(C2)CC(C4)C3)/N5CCOCC5,PNU-37883,-9.572372,x0678,active-noncovalent
c1cc(ccc1c2c(c3ccc(cc3s2)O)C(=O)c4ccc(cc4)OCC[NH+]5CCCCC5)O,raloxifene,-9.570901,x0161,active-noncovalent
Cc\1c(c(=C)[nH]/c1=C\c2c3ccc(cc3[nH]c2O)c4ccccc4)CCC(=O)[O-],SU-16f,-9.570639,x0161,active-noncovalent
c1(n[n-]nn1)[C@H](C(=O)[O-])[NH3+],tetrazol-5-yl-glycine-(RS),-9.570541,x0397,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2ccc(cc2)N)C,sulfafurazole,-9.569996,x0678,active-noncovalent
Cn1c(=O)cc(n(c1=O)Cc2cc(ccc2C#N)F)N3CCC[C@@H](C3)[NH3+],trelagliptin,-9.569387,x0434,active-noncovalent
CC[N@@+]1(CCC[C@H](C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C,pipenzolate,-9.568846,x0195,active-noncovalent
c1c(cc(c2c1C[C@H](CC2)n3c(c[nH]c3=S)C[NH3+])F)F,nepicastat,-9.567325,x0678,active-noncovalent
c1ccc(cc1)CC[NH2+]Cc2ccccc2,benethamine,-9.567063,x0072,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,levonorgestrel,-9.566316,x0749,active-covalent
c1ccc(c(c1)c2nc(no2)c3cccc(c3)C(=O)[O-])F,ataluren,-9.564470,x0749,active-covalent
C[C@H](c1ccc2cc(ccc2c1)OC)C(=O)Oc3ccc(cc3)C(=S)N,ATB-346,-9.563510,x0161,active-noncovalent
c1ccc(cc1)[C@@H]2C[NH2+]CCc3c2cc(c(c3)O)O,SKF-38393,-9.561873,x1418,active-covalent
c1cnc(c2c1n(cn2)[C@@H]3C=C([C@H]([C@H]3O)O)CO)N,3-deazaneplanocin-A,-9.561747,x0195,active-noncovalent
COC(=O)c1csc(n1)C(=O)c2c[nH]c3c2cccc3,ITE,-9.561477,x0678,active-noncovalent
Cc1ccc2c(c1)c(c(c(=O)[nH]2)C3=NN([C@@H](C3)c4ccc(cc4)Br)C(=O)CCC(=O)[O-])c5ccccc5,DQP-1105,-9.560537,x0874,active-noncovalent
Cc1cccc(n1)c2c(c[nH]n2)c3ccc4c(n3)cccn4,repsox,-9.559493,x0397,active-noncovalent
CCc1c(c2ccccc2o1)C(=O)c3ccc(cc3)OCC(=O)[O-],KT-433,-9.558836,x0072,active-noncovalent
c1cc(c(cc1c2c(c(=O)c3ccc(cc3o2)O)[O-])O)O,fisetin,-9.558637,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34,allylestrenol,-9.558498,x0749,active-covalent
c1cc(c(cc1C[C@H](C(=O)[O-])OC(=O)/C=C/c2ccc(c(c2)O)O)O)O,rosmarinic-acid,-9.556393,x0107,active-noncovalent
C[C@@H]([C@H]1[C@@H](C[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)[NH2+]C)C)C)O)[NH2+]C,cyclovirobuxin-d,-9.553797,x0749,active-covalent
CCC(=O)NS(=O)(=O)c1ccc(cc1)c2c(onc2c3ccccc3)C,parecoxib,-9.553621,x0161,active-noncovalent
Cc1cc(c(c(c1)C)C2=NO[C@@H]3[C@H]2[C@H]4CC[C@@H]3C4)C,SN-2,-9.552051,x0749,active-covalent
Cn1cc(cn1)c2cnn3c2nc(c(c3N)Br)[C@@H]4CCC[NH2+]C4,SCH-900776,-9.551287,x0195,active-noncovalent
CC(=O)OC[C@@H]1CS[C@@H]2/C(=N\C(=O)CSc3ccncc3)/C(=O)N2[C@H]1C(=O)[O-],cephapirin,-9.547893,x0830,active-covalent
c1cc(ccc1C(c2ccc(cc2)C(F)(F)F)OCC[N@H+]3CCC=C(C3)C(=O)[O-])C(F)(F)F,CI-966,-9.545257,x0678,active-noncovalent
c1ccc(c(c1)C2(CCC(CC2)(F)F)c3ccc(cc3)O)F,AC-186,-9.544689,x1392,active-covalent
Cc1c(ssc1=S)c2cnccn2,oltipraz,-9.544348,x1418,active-covalent
CC1=C(C(=O)C(=C(C1=O)C)[C@@H](CCCCCC(=O)[O-])c2ccccc2)C,seratrodast,-9.544056,x0830,active-covalent
C[C@H]1c2ccccc2C[N@@H+]1CC3=[NH+]CCN3,BRL-44408,-9.541772,x0678,active-noncovalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)c(ccn2)c4ccncc4,GSK1059615,-9.541095,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,testosterone,-9.540448,x0749,active-covalent
c1ccc2c(c1)nc3c(n[nH]c3n2)N,CDK1-5-inhibitor,-9.539415,x1077,active-noncovalent
C/C=C(/C(=C/C)/c1ccc(cc1)O)\c2ccc(cc2)O,dienestrol,-9.537957,x0749,active-covalent
CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,nandrolone-decanoate,-9.537725,x0161,active-noncovalent
c1ccc(cc1)C[NH+]2CCC3(CCc4c3cccc4)CC2,L-693403,-9.536598,x1093,active-noncovalent
COc1ccc(cc1)Nc2nccc(n2)NCCO,cardiogenol-c,-9.535964,x0678,active-noncovalent
c1ccc(cc1)c2c3c(c4ccccc4o3)n[nH]2,GTP-14564,-9.532358,x0434,active-noncovalent
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)c4ccc(cc4)Cl)F,vemurafenib,-9.531456,x0195,active-noncovalent
c1cc(ccc1CNc2c3cc(ccc3ncn2)F)F,spautin-1,-9.531191,x0749,active-covalent
c1cc(ccc1OCCCCCCN/C(=N\C#N)/Nc2cc[nH+]cc2)Cl,GMX1778,-9.529283,x0161,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2ccc(cc2)CCc3ccc(c(c3)Cl)Cl,PD-118057,-9.527108,x0195,active-noncovalent
CCCCc1c(n(n(c1=O)c2ccccc2)c3ccc(cc3)O)[O-],oxyphenbutazone,-9.525076,x0678,active-noncovalent
c1ccc2c(c1)C(OS2(=O)=O)(c3ccc(cc3)O)c4ccc(cc4)O,phenolsulfonphthalein,-9.524931,x0770,active-covalent
c1ccc(cc1)c2c(c3ccccn3n2)c4cc5c([nH]nc5nn4)N,FR-180204,-9.524750,x0678,active-noncovalent
c1ccc(cc1)CN(C2CCCCC2)C(=O)c3ccc(cc3)Cl,FPS-ZM1,-9.524418,x0678,active-noncovalent
c1ccc(cc1)C[NH+]2CCN(CC2)C(=O)c3cc4ccccc4o3,befuraline,-9.522125,x0104,active-noncovalent
COc1ccc(cc1O)c2cc(=O)c3c(cc(cc3o2)O)[O-],diosmetin,-9.520951,x0749,active-covalent
CC(C)c1ccc2c(c1)c(=O)c3cc(c(nc3o2)N)C(=O)[O-],amlexanox,-9.520159,x0072,active-noncovalent
CC[C@H](c1ccc(cc1)O)[C@H](CC)c2ccc(cc2)O,hexestrol,-9.519726,x0749,active-covalent
c1cc(oc1)[C@H]2Cc3c(cnc(n3)N)C(=O)C2,NKY-80,-9.516014,x0749,active-covalent
c1cc2c(nc1)-c3c(c4cc(ccc4[nH]3)Br)CC(=O)N2,1-azakenpaullone,-9.514343,x0678,active-noncovalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)SC,thioridazine,-9.513909,x0104,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,17-alpha-methyltestosterone,-9.511111,x0749,active-covalent
C[NH2+][C@H]1CC[C@@H](CC1)N(C(=O)c2sc3c(c2Cl)cccc3)Cc4cc(ccc4)c5ccncc5,SAG,-9.509186,x0678,active-noncovalent
c1cc2c(cc1/C=C\3/C(=O)[N-]C(=O)S3)OC(O2)(F)F,AS-604850,-9.508310,x0967,active-noncovalent
c1c2c(cc(c1F)N3CC[NH2+]CC3)n(cc(c2=O)C(=O)[O-])C4CC4,ciprofloxacin,-9.507915,x0749,active-covalent
CC(C)COC[C@H](CN(Cc1ccccc1)c2ccccc2)[NH+]3CCCC3,bepridil,-9.507546,x0678,active-noncovalent
Cc1coc-2c1C(=O)C(=O)c3c2ccc4c3CCCC4(C)C,tanshinone-iia,-9.505550,x0749,active-covalent
C[NH+]1CCN(CC1)[C@@H]2Cc3ccccc3Sc4c2cc(cc4)SC,metitepine,-9.503560,x0874,active-noncovalent
[C@H]([C@@H]([C@@H](C(=O)[O-])O)O)([C@H](C(=O)[O-])O)O,glucaric-acid,-9.503366,x0397,active-noncovalent
c1cc2c(c(c1)OC[C@@H]3C[NH2+]CCO3)CC=C2,indeloxazine,-9.502079,x0195,active-noncovalent
c1ccc(cc1)c2cc3c(ccn4c3n[nH]c4=O)nc2c5ccc(cc5)C6(CCC6)[NH3+],MK-2206,-9.500685,x0161,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)[NH3+])O)[NH3+],kanamycin,-9.500005,x0107,active-noncovalent
CS(=O)(=O)Nc1c(ccc2c1CCC[C@H]2C3=[NH+]CCN3)O,A61603,-9.497537,x1385,active-covalent
CS(=O)(=O)Nc1c(ccc2c1CCC[C@H]2C3=[NH+]CCN3)O,A-61603,-9.497537,x1385,active-covalent
C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](c3ccccc3)O)C,homatropine-methylbromide,-9.496749,x0072,active-noncovalent
COc1ccccc1OC[C@@H](CO)O,guaifenesin,-9.496183,x0195,active-noncovalent
c1cc(ccc1N(=O)=O)Oc2cc(cc(c2)Oc3ccc(cc3)N(=O)=O)C(=O)[O-],compound-w,-9.494440,x0678,active-noncovalent
Cc1ccc(cc1)c2c3c([nH]n2)C(=O)N([C@@H]3c4cccc(c4)O)c5ccc(cc5)C(=O)[O-],CID-16020046,-9.493827,x0104,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc(cc2)/N=N/C(C#N)C#N,levosimendan,-9.492462,x0749,active-covalent
CC#CCOC(=O)c1c([nH+]c2c(c1N)c3c(s2)C[C@H](CC3)O)C,SB-205384,-9.492442,x0195,active-noncovalent
c1cc(c(cc1c2c(cc3c(cc(cc3[o+]2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,kuromanin,-9.491004,x0749,active-covalent
C[C@@H](Cc1ccc(cc1)Cl)C(=C)N=O,AP-18,-9.489348,x0749,active-covalent
c1cc2c(cc1c3cn(nc3c4ccncc4)CCO)CC[C@@H]2N=O,GDC-0879,-9.489038,x0678,active-noncovalent
Cc1c(cnn1c2nc(cs2)c3cccc(c3)C(F)(F)F)C(=O)NCCCO,RWJ-50271,-9.487402,x0161,active-noncovalent
C[N@@H+]1CC[N@]2c3c(cccn3)Cc4ccccc4[C@@H]2C1,mirtazapine,-9.484286,x0072,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CC(C)(C)C)O)CCC4=CC(=O)C=C[C@]34C)O,prednisolone-tebutate,-9.484262,x0161,active-noncovalent
CC(C)[NH+]1CCN(CC1)c2ccc(cc2)C(=O)c3c4ccc(cc4sc3c5ccc(cc5)O)O,Y-134,-9.483355,x0678,active-noncovalent
CC[N+](CC)(Cc1ccccc1)CC(=O)Nc2c(cccc2C)C,denatonium-benzoate,-9.482736,x0161,active-noncovalent
COC1CCN(CC1)C(=O)c2cc(ccc2F)Cc3c4ccccc4c(=O)[nH]n3,AZD2461,-9.481410,x0161,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3=CC[N@H+](CC3)CCCC(=O)c4ccc(cc4)F,droperidol,-9.478012,x0107,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(C(=O)N)[NH+]3CCCCC3)F,pipamperone,-9.476883,x0161,active-noncovalent
c1cc(nc(c1C(F)(F)F)Cl)N2CC[NH2+]CC2,Org-12962,-9.476280,x0749,active-covalent
CCOC(=O)[C@](C)(Cc1ccc(c(c1)O)O)[NH3+],methyldopate,-9.474243,x0678,active-noncovalent
c1ccc2c(c1)c(=O)c(co2)C/N=N/C(=S)N,FPA-124,-9.471546,x0678,active-noncovalent
C[NH+]1C[C@H]2CC(C[C@H]2C1)COc3cc4c(cc3OC)c(ncn4)Nc5ccc(c(c5F)Cl)Cl,XL-647,-9.470898,x0104,active-noncovalent
c1ccc(c(c1)NC(=O)N[C@@H]2CCN(C2)c3ccc(cn3)C(F)(F)F)Br,SB-705498,-9.470862,x0161,active-noncovalent
c1ccc2c(c1)C3=[NH+]CCN3[C@@]2(c4ccc(cc4)Cl)O,mazindol,-9.469434,x0195,active-noncovalent
CCNC(=O)N1CC[NH+](CC1)CCCC(c2ccc(cc2)F)c3ccc(cc3)F,amperozide,-9.468991,x0434,active-noncovalent
CC(=O)Oc1cccc2c1C(=O)c3c(cc(cc3OC(=O)C)C(=O)[O-])C2=O,diacerein,-9.468814,x0749,active-covalent
c1ccc(cc1)CNC(=O)Cc2ccc(cn2)c3ccc(cc3)OCC[NH+]4CCOCC4,KX2-391,-9.468529,x0104,active-noncovalent
c1cc(cc(c1)[C@@]2(c3cccc(c3[C@H]([NH2+]2)N)F)c4ccnc(c4)C(F)F)c5cncnc5,AZD3839,-9.467543,x0678,active-noncovalent
c1cc(ccc1c2c[nH]cc(c2=O)C(=O)Nc3ccc(c(c3)F)Oc4ccnc(c4Cl)N)F,metatinib,-9.466895,x0104,active-noncovalent
C[n+]1c2cc(ccc2cc3c1cc(cc3)N)N,acriflavine,-9.463461,x0749,active-covalent
C[n+]1c2cc(ccc2cc3c1cc(cc3)N)N,acriflavinium,-9.463461,x0749,active-covalent
COc1ccc2c(c1)/C(=C/c3c[nH]cn3)/C(=O)N2,SU9516,-9.462580,x0749,active-covalent
c1ccc2c(c1)/C(=C/CC[NH+]3CCN(CC3)CCO)/c4cc(ccc4S2)Cl,zuclopenthixol,-9.462299,x0161,active-noncovalent
c1cc(ccc1C#N)[C@H]2CCCc3n2cnc3,fadrozole,-9.461576,x0161,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cc[nH]2)O,pindolol-(-),-9.460906,x0104,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1cc[nH]2)O,pindolol,-9.460906,x0104,active-noncovalent
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C,ergosterol,-9.460039,x0161,active-noncovalent
c1ccn2c(c1)[nH+]cc2C3=C(C(=O)NC3=O)c4cn5c6c4cc(cc6CN(CC5)C(=O)N7CCCCC7)F,LY2090314,-9.459563,x0161,active-noncovalent
CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3c1cccc3)C(C)C,propantheline,-9.459325,x0195,active-noncovalent
c1ccc2c(c1)C(=O)c3ccc(c(c3C2=O)[O-])O,alizarin,-9.459037,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(C[C@H](C(=O)[C@H]4O5)C#N)C,trilostane,-9.456862,x0749,active-covalent
c1ccc2c(c1)c(=O)c3cccc4nnc2[C@H]34,pyrazolanthrone,-9.455590,x0195,active-noncovalent
CCC(CC)(CC(=O)Nc1cccc(c1)/C=C/c2nc(cs2)C3CCC3)C(=O)[O-],cinalukast,-9.455110,x0161,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C,stetaderm,-9.453985,x0749,active-covalent
C[C@H](CCc1ccc(cc1)O)[NH2+]CCc2ccc(c(c2)O)O,dobutamine,-9.449571,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@H]1CC[C@]2(C#C)O)CCC4=Cc5c(cno5)C[C@]34C,danazol,-9.449312,x0749,active-covalent
CCCOc1ccn2c(c1)c(cc2C(=O)C)c3ccccc3S(=O)(=O)C,GSK2801,-9.446163,x0708,active-covalent
c1cc(ccc1[C@@H]2[C@H](C(=O)N2c3ccc(cc3)F)CC[C@@H](c4ccc(cc4)F)O)O,ezetimibe,-9.445126,x1077,active-noncovalent
c1ccc(cc1)C(=O)Nc2nc3ccc(cc3s2)NC(=O)C45CC6CC(C4)CC(C6)C5,NVP-231,-9.444038,x0104,active-noncovalent
Cc1cc2c(cc1C(F)(F)F)N(CC2)C(=O)Nc3ccc(nc3)Oc4cccnc4C,SB-243213,-9.443547,x0161,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])N(CCCl)CCCl,melphalan,-9.443293,x0107,active-noncovalent
Cc1ccc(cc1)C(=O)[C@@H](C)C[NH+]2CCCCC2,tolperisone,-9.442404,x0104,active-noncovalent
c1ccc(c(c1)C(=O)/C=C/[N@H+]2C[C@H]3C[C@@H]2C[N@]3c4ccccn4)O,PFI-3,-9.441746,x1093,active-noncovalent
C[N@]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],marbofloxacin,-9.439663,x0195,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@H]([C@H]([C@H](CO)O)O)O,riboflavin,-9.437819,x0759,active-covalent
COc1ccc(cc1)Cn2ccc3c2cc(cc3)C(=O)NO,PCI-34051,-9.436438,x0195,active-noncovalent
c1cc(ccc1[C@@H]2CC(=O)c3ccc(cc3O2)O)O,MF-101,-9.436436,x0749,active-covalent
CC(C)[NH2+]C[C@@H](COc1cccc2c1c3ccccc3[nH]2)O,carazolol,-9.434849,x0104,active-noncovalent
C[n+]1cc2c(ccc3c2OCO3)c4c1c5cc6c(cc5cc4)OCO6,sanguinarium-chloride,-9.434637,x0749,active-covalent
COc1ccc(cc1OC)CCO[C@@H]2CCCC[C@H]2[N@H+]3CC[C@H](C3)O,vernakalant,-9.433910,x0946,active-noncovalent
Cn1c(=O)cc(n(c1=O)Cc2ccccc2C#N)N3CCC[C@@H](C3)[NH3+],alogliptin,-9.431739,x0434,active-noncovalent
c1ccc2c(c1)ccc3c2oc(cc3=O)N4CCOCC4,NU-7026,-9.431209,x0195,active-noncovalent
c1cc(ccc1C/N=N/C(=O)N)Oc2ccc(cc2)F,co-102862,-9.429238,x0161,active-noncovalent
Cc1cc(c2ccccc2[n+]1CCCCCCCCCC[n+]3c(cc(c4c3cccc4)N)C)N,dequalinium,-9.428643,x1077,active-noncovalent
c1cc(ccc1/[NH+]=C(/N)\NC2C3CC4CC(C3)CC2C4)I,IPAG,-9.427999,x0946,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CC(=O)[O-],felbinac,-9.427928,x0749,active-covalent
c1ccc(cc1)OCCC[N+]23CCC(CC2)[C@H](C3)OC(=O)C(c4cccs4)(c5cccs5)O,aclidinium,-9.427677,x0161,active-noncovalent
Cc1ccc2c(c1)n(c(=O)nc2c3ccccc3)C(C)C,proquazone,-9.426495,x0434,active-noncovalent
COc1ccc(cc1)c2cnc3c(cnn3c2)c4cccc5c4cccn5,ML347,-9.426319,x0104,active-noncovalent
Cc1cccc(c1C)OC[C@H](C[NH2+]C(C)(C)C)O,xibenolol,-9.426226,x0104,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)O)O,N-salicoylaminophenol,-9.424944,x0749,active-covalent
Cc1ccccc1n2c(nc3ccc(cc3c2=O)N)CF,afloqualone,-9.424483,x0749,active-covalent
Cc1c(nc(nc1N2CCc3ccccc3[C@@H]2C)Nc4ccc(cc4)F)C,revaprazan,-9.420653,x0195,active-noncovalent
CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc3c1cccc3,methantheline,-9.419333,x0195,active-noncovalent
C[NH+](C)CCCn1c2ccc(c3c2c(n1)-c4cc(ccc4N3)OC)N(=O)=O,pyrazoloacridine,-9.419282,x0195,active-noncovalent
C=CCCCCCCCCC(=O)[O-],undecylenic-acid,-9.418491,x0678,active-noncovalent
CC[NH+](CC)CCn1c2ccccc2nc(c1=O)Cc3ccc(cc3)OC,caroverine,-9.418475,x0104,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Oc2cccc(c2)CON(=O)=O,NO-ASA,-9.416669,x0749,active-covalent
Cc1cccc(c1)Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C,torasemide,-9.416163,x0107,active-noncovalent
c1c(nc[nH]1)/C=C\C(=O)[O-],cis-urocanic acid,-9.415903,x0397,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,dexlansoprazole,-9.415019,x0195,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCC(F)(F)F,lansoprazole,-9.415019,x0195,active-noncovalent
C[N@@H+]1C[C@@H]2C[C@H]1C[N@@]2c3cc4c(cc3F)c(=O)c(cn4C5CC5)C(=O)[O-],danofloxacin,-9.414551,x0104,active-noncovalent
c1ccc(cc1)Cn2c(=O)n(sc2=O)c3cccc4c3cccc4,tideglusib,-9.413855,x0678,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)c3c4c(ncnc4n(n3)C5CCCC5)N,PCI-29732,-9.412631,x0104,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)c3c(=O)c4ccc(cc4[nH]c3[O-])Cl,L-701324,-9.412169,x0161,active-noncovalent
c1ccc(cc1)OC(=O)c2ccc(cc2O)N,phenyl-aminosalicylate,-9.412144,x0678,active-noncovalent
CCCC[NH+](CCCC)CC[C@@H](c1cc2c(cc(cc2Cl)Cl)c3c1ccc(c3)C(F)(F)F)O,halofantrine,-9.411906,x0161,active-noncovalent
Cc1cccc(c1NC(=O)/[NH+]=C\2/CCCN2C)C,xilobam,-9.410540,x0678,active-noncovalent
c1cc(c(cc1C[C@@H](C(=O)[O-])[NH3+])O)O,levodopa,-9.410147,x0107,active-noncovalent
CCOc1ccc(cc1)Nc2nc(cs2)c3c(nc4n3cccc4)C,JK-184,-9.409678,x0104,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CC(=O)Nc3ccccn3,difenpiramide,-9.409120,x0161,active-noncovalent
c1ccc(cc1)[C@H]2CN3CCSC3=[NH+]2,levamisole,-9.408648,x1093,active-noncovalent
c1ccc2c(c1)c(=O)c3ccccc3o2,xanthone,-9.408072,x0749,active-covalent
CCC(=C)C(=O)c1ccc(c(c1Cl)Cl)OCC(=O)[O-],etacrynic-acid,-9.406878,x0678,active-noncovalent
c1c([nH]cn1)C2CCN(CC2)C(=S)NC3CCCCC3,thioperamide,-9.405118,x0072,active-noncovalent
c1cc(sc1)C(=O)c2c3cc(ccc3n(c2O)C(=O)N)Cl,tenidap,-9.399836,x1418,active-covalent
CCCCNC(=O)[C@@H]1Cc2ccccc2N1C(=O)[C@H](CC)[NH3+],butabindide,-9.398643,x0678,active-noncovalent
C[N@](c1ccc(cc1)NC(=O)Nc2ccccc2)S(=O)(=O)c3cnn(c3)c4ccc(cc4)F,BTT-3033,-9.395916,x0161,active-noncovalent
c1ccc2c(c1)CN3C(=O)c4ccccc4CN3C2=O,diftalone,-9.394883,x0749,active-covalent
c1c(cc(cc1C(F)(F)F)C(F)(F)F)c2ncn(n2)/C=C\C(=O)N3CC(C3)(F)F,KPT-276,-9.394169,x0195,active-noncovalent
c1cc(c2c(c1)OCCO2)N3CC[NH+](CC3)Cc4cc(cnc4)c5ccc(cc5)F,adoprazine,-9.393971,x0161,active-noncovalent
c1cc(cc(c1)n2c(=O)ccc3c2c4cc(ccc4nc3)c5ccc(nc5)N)C(F)(F)F,torin-2,-9.393524,x0678,active-noncovalent
c1ccc2c(c1)/C(=C/CC[NH+]3CCN(CC3)CCO)/c4cc(ccc4S2)C(F)(F)F,flupentixol,-9.392056,x0161,active-noncovalent
Cn1cc(c2c1cccc2)C[C@H](C(=O)[O-])[NH3+],indoximod,-9.391203,x0195,active-noncovalent
CC[C@H](c1ccc(o1)C)Nc2c(c(=O)c2=O)Nc3cccc(c3O)C(=O)N(C)C,navarixin,-9.390433,x0195,active-noncovalent
CCOC(=O)c1ccc(cc1)N(C)c2csc(n2)c3ccccc3,neuropathiazol,-9.388290,x0104,active-noncovalent
c1cc(cnc1)CSc2ncccn2,tasuldine,-9.387920,x0678,active-noncovalent
c1ccc2c(c1)[NH+]=C(c3cc(ccc3O2)Cl)N4CC[NH2+]CC4,amoxapine,-9.387011,x0749,active-covalent
c1ccc2c(c1)CC[C@H](C2=O)C[NH2+]CCc3ccc(cc3)O,BE-2254,-9.386230,x1093,active-noncovalent
c1ccc(cc1)N/C(=[NH+]\c2ccccc2)/N,diphenylguanidine,-9.385555,x0749,active-covalent
C[NH+]1CCN(CC1)c2ccc3c(c2)[nH]c(n3)c4c(c5c(cccc5F)[nH]c4=O)N,dovitinib,-9.384596,x0161,active-noncovalent
Cc1ccccc1n2c(nc3cccc(c3c2=O)C)Cn4c5c(c(n4)c6cccc(c6)O)c(ncn5)N,PIK-294,-9.383097,x0161,active-noncovalent
COc1ccc(cc1)n2c(cc(n2)C(F)(F)F)c3ccc(cc3)Cl,SC-560,-9.382140,x1093,active-noncovalent
c1cc(ccc1C(=O)[O-])OCCn2ccnc2,dazoxiben,-9.382040,x0749,active-covalent
c1ccc(c(c1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,salicin,-9.380294,x0678,active-noncovalent
c1c2c3c4c(cc(c(c4oc2=O)O)O)c(=O)oc3c(c1O)O,ellagic-acid,-9.379889,x0195,active-noncovalent
CCC[NH+](CCC)[C@H]1CCc2cccc(c2C1)O,8-hydroxy-DPAT,-9.379035,x0195,active-noncovalent
COC(=O)C[C@H]1CC(=NO1)c2ccc(cc2)O,ISO-1,-9.377195,x0749,active-covalent
CCCCC/C=C\C=C\CCCCCCCCC(=O)[O-],"trans-10,cis-12-Conjugated-linoleic-acid",-9.376455,x0104,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[S@](=O)CC(=O)NO,adrafinil,-9.376151,x0678,active-noncovalent
c1cc2c(cc1C[NH+]3CCN(CC3)C(=O)Nc4cnccc4Cl)OC(O2)(F)F,JNJ-42165279,-9.376109,x0107,active-noncovalent
c1cc(ccc1/C=C/c2ccc(cc2O)C(=[NH2+])N)C(=[NH2+])N,hydroxystilbamidine,-9.374925,x0874,active-noncovalent
CCc1cccc2c1[nH]c3c2CCO[C@@]3(CC)CC(=O)[O-],etodolac,-9.373430,x0749,active-covalent
c1cc(cc(c1)Oc2ccc(cn2)C(F)(F)F)CC3CCN(CC3)C(=O)Nc4cccnc4,PF-3845,-9.372594,x0195,active-noncovalent
CC(=O)NCCCOc1ccc(cc1)C(=O)N2CCC(CC2)N3c4ccccc4CCC3=O,OPC-21268,-9.372251,x0161,active-noncovalent
CC(C)(C)[NH2+]Cc1cc(c2c(c1O)CCCC2)Nc3ccnc4c3ccc(c4)Cl,naphthoquine-phosphate,-9.372123,x0678,active-noncovalent
CCn1c2ccccc2n(c1=O)[C@H]3CCC[N@](C3)c4nccc(n4)c5cc6ccccc6o5,TC-F-2,-9.372011,x0161,active-noncovalent
CC(C)NC(=O)N1CC[C@@H](C1)NC2=[NH+]c3cc(ccc3N(c4c2cc(cc4)Cl)CC(F)F)F,NVS-PAK1-1,-9.371656,x0678,active-noncovalent
CCCC1(CCC2(CC1)CC[N@@H+](C2)CCC[NH+](CC)CC)CCC,atiprimod,-9.370800,x0104,active-noncovalent
Cc1c2c(c(s1)C)C(=CCC2)c3c[nH]cn3,TC-G-1000,-9.370176,x0195,active-noncovalent
CCOc1cc(cnc1)/C=C/CC[NH2+]C,TC2559,-9.369229,x0397,active-noncovalent
c1ccc(cc1)[C@H]2CN3CCSC3=[NH+]2,tetramisole,-9.368332,x1093,active-noncovalent
CC(C)(C(=O)[O-])OCc1c2ccccc2n(n1)Cc3ccccc3,bindarit,-9.366777,x0678,active-noncovalent
C[NH2+]CCC=C1c2ccccc2CCc3c1cccc3,nortriptyline,-9.365887,x0072,active-noncovalent
C[N@@H+]1[C@H]2C[C@@H](C[C@@H]1[C@H](C2)O)OC(=O)[C@H](CO)c3ccccc3,anisodamine,-9.365223,x0749,active-covalent
C[NH+]1CCN(CC1)c2cccc(c2)Nc3nc4c(cccn4n3)c5ccc(cc5)S(=O)(=O)C,CEP-33779,-9.364603,x0195,active-noncovalent
c1cc(ccc1CCNC(=S)N2CCCc3cc(c(cc3C2)O)O)Cl,capsazepine,-9.364472,x1093,active-noncovalent
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,calcitriol,-9.360444,x0104,active-noncovalent
C[C@]12CC[C@@H](CC1=CC[C@H]3[C@@H]2CC[C@]4([C@@H]3CC=C4n5cnc6c5cccc6)C)O,galeterone,-9.359307,x1077,active-noncovalent
c1cc2c(cc1Cl)c3c(o2)c(=O)[nH]c(n3)[C@@H]4CCC[NH2+]4,BMS-863233,-9.357981,x0195,active-noncovalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH+](CC3)C)C(=O)[O-],pefloxacin,-9.355707,x0749,active-covalent
Cn1cc(c(n1)c2ccc(cc2)OCc3ccc4ccccc4n3)c5ccncc5,PF-02545920,-9.352696,x0161,active-noncovalent
C[N@@H+]1CCCC[C@H]1Cn2cc(c3c2cccc3)C(=O)c4cc(ccc4I)N(=O)=O,AM-1241,-9.352086,x0104,active-noncovalent
c1ccc(c(c1)C[N@H+]2CCc3c(ccs3)C2)Cl,ticlopidine,-9.350121,x0749,active-covalent
CC1=C(C(=O)C(=C(C1=O)C)CCCCC#CCCCC#CCO)C,docebenone,-9.349504,x0161,active-noncovalent
c1cc(cnc1)Cc2ccc3c(c2)cc(o3)C(=O)[O-],furegrelate,-9.349466,x0072,active-noncovalent
CC(C)NC(=[NH2+])N/C(=[NH+]\c1ccc(cc1)Cl)/N,proguanil,-9.348683,x0104,active-noncovalent
c1cc(c2c(c1C(=O)N)C[C@H](CO2)[NH+](C3CCC3)C4CCC4)F,robalzotan,-9.348658,x0434,active-noncovalent
c1cc(ccc1/C=C\2/C(=O)[N-]C(=O)S2)OCC(=O)[O-],TCS-3035,-9.348617,x0678,active-noncovalent
C[NH+]1CCN(CC1)c2nc3ccccc3c(n2)C4=C(C(=O)NC4=O)c5c[nH]c6c5cccc6,sotrastaurin,-9.348500,x1077,active-noncovalent
C[C@@H](C(=O)NCC(=O)[O-])SC(=O)c1cccs1,stepronin,-9.348361,x0678,active-noncovalent
CNC(=O)c1cccc2c1ccc(c2)Oc3ccnc4c3cc(c(c4)OCC5(CC5)[NH3+])OC,lucitanib,-9.345954,x0678,active-noncovalent
CC(C)Oc1ccc(cc1)Cc2ccc(cc2)NC3=[NH+]CCN3,Ro-1138452,-9.345444,x0195,active-noncovalent
C[NH2+][C@H]1CCC[N@](C1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)F,balofloxacin,-9.345179,x1385,active-covalent
CC(C)(C)Cn1c2c(ccc(n2)c3c([nH]c(n3)C(C)(C)C)c4ccc(cc4)F)nc1N,LY2228820,-9.344195,x0397,active-noncovalent
c1cc(ccc1c2c3cc(ccc3no2)c4ccnc(n4)N)Cl,PIM-1-Inhibitor-2,-9.343785,x0195,active-noncovalent
C[C@H]1CCc2cc(cc3c2n1cc(c3=O)C(=O)[O-])F,flumequine,-9.342581,x0195,active-noncovalent
CC(=O)N[C@H](COC)C(=O)NCc1ccccc1,lacosamide,-9.341306,x0678,active-noncovalent
Cn1cc(cn1)c2cc(ccn2)Oc3cc(c(cc3F)NC(=O)C4(CC4)C(=O)Nc5ccccc5)F,DCC-2618,-9.340615,x0161,active-noncovalent
CCc1ccccc1OC[C@H](C[NH2+][C@H]2CCCc3c2cccc3)O,SR-59230A,-9.340592,x0104,active-noncovalent
c1ccc2c(c1)cc3ccccc3c2C(=O)[O-],9-anthracenecarboxylic-acid,-9.340424,x0195,active-noncovalent
c1ccc(c(c1)c2nc(n(n2)c3ccc(cc3)C(=O)[O-])c4ccccc4O)O,deferasirox,-9.340232,x0195,active-noncovalent
CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3N)O)O,NECA,-9.339545,x0195,active-noncovalent
c1cc(c(cc1Cl)Cl)[C@@H]2CS/C(=C(/C#N)\n3ccnc3)/S2,luliconazole,-9.338475,x0678,active-noncovalent
C[C@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],levofloxacin,-9.338314,x0195,active-noncovalent
CN(C)C(=O)c1cc(cnc1)c2cc3c(c[nH]c3nc2)c4ccccc4OC,PPY-A,-9.337721,x0104,active-noncovalent
c1ccc(c(c1)C(=O)Oc2ccccc2C(=O)[O-])O,sasapyrine,-9.337203,x0749,active-covalent
c1cc2c(c(c1)C(F)(F)F)nn(c2c3ccc(cc3)F)Cc4ccc(cc4Cl)F,LXR-623,-9.337075,x0195,active-noncovalent
C[NH+]1CCC(CC1)COc2cc3c(cc2OC)c(ncn3)Nc4ccc(cc4F)Br,vandetanib,-9.335220,x0104,active-noncovalent
CCCC[NH+]1CCC(CC1)CCC(=O)c2cc(c(cc2OC)N)Cl,RS-67333,-9.334247,x0161,active-noncovalent
c1ccc(cc1)NC(=O)N[C@H]2C[C@@H](Nc3c2c(cc(c3)Cl)Cl)C(=O)[O-],L-689560,-9.334015,x0434,active-noncovalent
C[NH+]1CCN(CC1)c2c(nc3ccccc3n2)Cl,VUF10166,-9.333606,x0749,active-covalent
CCC(=O)NCC[C@@H]1CCc2c1c3c(cc2)OCC3,ramelteon,-9.332843,x0104,active-noncovalent
C[C@@H](c1ccc(cc1)C[C@H]2CCCC2=O)C(=O)[O-],loxoprofen,-9.331327,x0678,active-noncovalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH2+]C3CC[NH2+]CC3,GSK-LSD-1,-9.330963,x0749,active-covalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,norgestrel,-9.329967,x0749,active-covalent
C[N@H+]1CC[C@@H]2C[N@@]3CCc4c3c(ccc4)[C@@H]2C1,SDZ-SER-082,-9.329713,x0195,active-noncovalent
Cc1cccc(c1)NC(=O)C[NH+]2CCC(CC2)c3ccccn3,A-412997,-9.328516,x0104,active-noncovalent
Cc1c(cc(cc1F)C(=O)NC2CC2)c3c(cn4c(c3F)nnc4C(C)(C)C)F,AL-8697,-9.326617,x0161,active-noncovalent
Cc1ccc2c(c1)[C@@H]3C[N@H+](CC[C@@H]3N2)C,stobadine,-9.324917,x0195,active-noncovalent
c1ccc(cc1)OC(=O)c2ccccc2O,phenyl-salicylate,-9.324636,x0749,active-covalent
C[NH+](C)Cc1ccc(cc1)c2nc3cccc4c3n2CCNC4=O,AG-14361,-9.323046,x0161,active-noncovalent
C[N@H+]1[C@@H](CCC[C@@H]1CC(=O)c2ccccc2)C[C@@H](c3ccccc3)O,lobeline,-9.322324,x0749,active-covalent
Cn1cc(c2c1cccc2)/C=C\3/c4c(cccn4)NC3=O,GW-441756,-9.322012,x1093,active-noncovalent
Cc1nnc(o1)c2ccc3c(c2)c(co3)c4ccc(cc4)[S@@](=O)C,TCS2002,-9.321280,x0195,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cc(c(c6c5c4[C@H](CC6)[NH3+])C)F)O,exatecan-mesylate,-9.319754,x0104,active-noncovalent
c1ccc(cc1)C2CC[NH+](CC2)[C@@H]3CCCC[C@H]3O,vesamicol,-9.319476,x0104,active-noncovalent
CC[C@@H](/C(=C/c1ccc(cc1)F)/C)N=O,A-967079,-9.319243,x0678,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,gestodene,-9.319020,x0749,active-covalent
C[NH+]1CCN(CC1)c2cc3c(cc2F)c(=O)c(cn3c4ccc(cc4)F)C(=O)[O-],difloxacin,-9.318671,x0195,active-noncovalent
Cc1cc(nc2c1cccc2)N3CCCCC3,ML204,-9.317640,x0195,active-noncovalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O)C,S-111,-9.317621,x0161,active-noncovalent
Cc1ccc(cc1)[C@]23C[C@H]2C[NH2+]C3,bicifadine,-9.315760,x0161,active-noncovalent
CC(C)(C)n1c2c(c(n1)c3cccc4c3cccc4)c(ncn2)N,1-naphthyl-PP1,-9.314613,x0830,active-covalent
C[C@@H](c1ccccc1)N/C(=N\C#N)/Nc2cccc3c2cccn3,A-804598,-9.313267,x0104,active-noncovalent
C[C@]1(C(=O)N(C(=O)N1C)c2cc(cc(c2)Cl)Cl)Cc3ccc(cc3)Br,BIRT-377,-9.311330,x0195,active-noncovalent
c1cc(ccc1c2cc(c(s2)NC(=O)N)C(=O)N)F,TPCA-1,-9.310594,x0749,active-covalent
CC1([C@H]2CC[C@@H]([C@@H]1C2)CCOCC[N+]3(CCOCC3)Cc4cc(c(cc4Br)OC)OC)C,pinaverium,-9.310009,x0161,active-noncovalent
CCCCOc1c2c[nH]nc2ncc1C(=O)c3c(cc(cc3F)C)F,BMS-265246,-9.309546,x0107,active-noncovalent
Cc1ccc(cc1)C(=O)NCCCCCC(=O)Nc2ccccc2N,RG2833,-9.308838,x0874,active-noncovalent
COc1cc(cc(c1OC)OC)C[C@@H]2c3cc(c(cc3CC[NH2+]2)O)O,trimethoquinol,-9.308619,x1077,active-noncovalent
c1ccc2c(c1)ccc3c2ccc(c3)c4cc(nn4c5ccc(cc5)NC(=O)C[NH3+])C(F)(F)F,AR-12,-9.305825,x0072,active-noncovalent
c1ccc2c(c1)C(=O)OC23c4ccc(cc4Oc5c3ccc(c5)O)O,fluorescein,-9.304455,x0831,active-covalent
c1ccc(cc1)/N=N/c2ccc(nc2N)N,phenazopyridine,-9.304213,x0749,active-covalent
Cc1cc(c(c(c1/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C)C)C)OC,acitretin,-9.304125,x0104,active-noncovalent
Cc1c(noc1NS(=O)(=O)c2cccc3c2cccc3N(C)C)C,BMS-182874,-9.303789,x0107,active-noncovalent
c1ccc(cc1)CNC(=O)N2CCC(=O)N3[C@@H]2CN(C(=O)[C@H]3Cc4ccc(cc4)O)Cc5cccc6c5cccc6,ICG-001,-9.300878,x0161,active-noncovalent
C[NH2+][C@H](CC(=O)[O-])C(=O)[O-],NMDA,-9.300823,x0397,active-noncovalent
c1cc(cc(c1)C(=O)N)c2cccc(c2)OC(=O)NC3CCCCC3,URB597,-9.300161,x0434,active-noncovalent
c1ccc(cc1)C(CC[NH2+]CC(=O)N)c2ccccc2,N20C,-9.300006,x0678,active-noncovalent
COc1ccc(cc1)c2cc(=S)ss2,anethole-trithione,-9.299651,x0749,active-covalent
C[C@H](C(C)(C)C)/N=C(/NC#N)\Nc1cc[nH+]cc1,pinacidil,-9.298676,x0434,active-noncovalent
Cc1cc(ccn1)c2ccc(cc2)CC(=O)Nc3ccc(cc3)c4cccnc4,wnt-c59,-9.297937,x0161,active-noncovalent
CC[NH+](CC)CCOC(=O)c1ccc(cc1)N,procaine,-9.296793,x0104,active-noncovalent
CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCc4c3ccc(c4)O)C,estradiol-valerate,-9.296108,x0161,active-noncovalent
c1ccc(cc1)CC[C@@H](C(=O)[O-])[NH2+][C@@H](CCCC[NH3+])C(=O)N2CCC[C@H]2C(=O)[O-],lisinopril,-9.295654,x0967,active-noncovalent
Cc1cccc(n1)/C=C/c2ccccc2,SIB-1893,-9.295340,x0749,active-covalent
C[NH2+][C@@H]1CCc2c(c3cc(ccc3[nH]2)C(=O)N)C1,frovatriptan,-9.294839,x0749,active-covalent
Cc1ccccc1CN2C3=C(C[N@@H+](CC3)Cc4ccccc4)C(=O)N5C2=[NH+]CC5,TIC10,-9.294329,x0104,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@@H]([C@@H]([C@@H](COP(=O)([O-])[O-])O)O)O,riboflavin-5-phosphate-sodium,-9.291402,x0195,active-noncovalent
C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(cc1)c2ccc(cc2)CCNS(=O)(=O)C,mibampator,-9.289641,x0104,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)NC)C)C,physostigmine-salicylate,-9.288752,x0104,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)OC(=O)NC)C)C,physostigmine,-9.288752,x0104,active-noncovalent
CCn1c(c(c(=O)c2c1nc(cc2)C#C[C@](C)(COC)O)C(=O)NC)N,SAR131675,-9.288326,x0104,active-noncovalent
C[C@@H]1COCCN1c2cc(=O)n3c(n2)N([C@@H](CC3)C(F)(F)F)Cc4cc(cnc4)Cl,SAR405,-9.288322,x0195,active-noncovalent
C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4c5cccnc5)C)O,abiraterone,-9.287674,x1077,active-noncovalent
CNC(=O)c1ccc2c(c1)S(=O)(=O)c3ccccc3C2=O,BW-616U,-9.285107,x0749,active-covalent
c1ccc2c(c1)cccc2Nc3cc(c(c4c3C(=O)c5ccccc5C4=O)N)S(=O)(=O)[O-],PSB-06126,-9.282421,x0831,active-covalent
C#CC1(CCCCC1)OC[C@H](C[NH+]2CCN(CC2)c3cccc(c3)C(F)(F)F)O,terciprazine,-9.282175,x0161,active-noncovalent
C[C@@H](c1ccc(cc1)N2Cc3ccccc3C2=O)C(=O)[O-],indoprofen,-9.282115,x0678,active-noncovalent
c1ccc2c(c1)COc3ccc(cc3C2=O)CC(=O)[O-],isoxepac,-9.281301,x0678,active-noncovalent
CC1(COC1)COc2ccc3c(c2)ncn3c4ccc5cccc(c5n4)N6CCC(CC6)[NH3+],crenolanib,-9.280574,x0104,active-noncovalent
c1cc(cc(c1)Br)C(=O)N2CCC(CC2)[NH+]3CCCC3,UNC-926,-9.279716,x0104,active-noncovalent
C[C@@]12CC[C@H]([C@@]([C@H]1CCC(=C)[C@H]2C/C=C/3\[C@@H](COC3=O)O)(C)CO)O,andrographolide,-9.277561,x0161,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C(=O)OC3C[C@H]4CC5C[C@@H](C3)[NH+]4CC5=O,dolasetron,-9.275893,x0072,active-noncovalent
Cc1cc(c(c(c1OC(=O)C)C)C)OC[C@H](C[NH2+]C(C)C)O,metipranolol,-9.275808,x0104,active-noncovalent
C[C@H]1COc2c(c(cc3c2n1cc(c3=O)C(=O)[O-])F)C4(CC4)[NH3+],pazufloxacin,-9.275057,x1334,active-covalent
c1c(o[nH]c1=O)[C@H](C(=O)[O-])[NH3+],ibotenic-acid,-9.273909,x0397,active-noncovalent
c1ccc(cc1)[C@@H](C(=O)c2ccccc2)O,benzoin,-9.273787,x0749,active-covalent
CC#CCOC(=O)C1=CCC[N@@H+](C1)C,arecaidine-but-2-ynyl-ester,-9.273554,x0161,active-noncovalent
CC(C)(C)c1ccc(cc1)C[N@H+](C)Cc2cccc3c2cccc3,butenafine,-9.271509,x0072,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2CC[NH+]3CCN(CC3)c4cccc(c4)C(F)(F)F,flibanserin,-9.269520,x0107,active-noncovalent
c1ccc(cc1)[C@@H]2C[NH2+]Cc3c2cccc3,"4-phenyl-1,2,3,4-tetrahydroisoquinoline",-9.268827,x0195,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)Oc2c(=O)c3c(cc(cc3oc2c4cc(c(c(c4)O)O)O)O)[O-])O)O)O,myricitrin,-9.268699,x0874,active-noncovalent
c1cc(ccc1NC2C3CC4CC(C3)CC2C4)Br,bromantan,-9.268532,x0749,active-covalent
Cc1ccc(c(c1)N)NCCCc2ccccc2,NFKB-activation-inhibitor-II,-9.268364,x0161,active-noncovalent
CCCc1c(n2c(nc3ccc(cc3n2c1=O)C)N(C)C)[O-],azapropazone,-9.268265,x0749,active-covalent
c1cc(ccc1CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)CO)O)O)O,gastrodin,-9.266933,x0678,active-noncovalent
c1ccc(cc1)c2nc(c3c(n2)[nH]cc3)N[C@H]4CC[C@@H](CC4)O,SLV-320,-9.266621,x0759,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C,cortodoxone,-9.263071,x0749,active-covalent
c1ccc(cc1)COCC[N+]23CCC(CC2)(CC3)C(c4ccccc4)(c5ccccc5)O,umeclidinium,-9.261590,x0161,active-noncovalent
c1cc(=O)[nH]c2c1[nH]cc2C3=CC[NH2+]CC3,CP-93129,-9.261219,x1334,active-covalent
c1cc2c(cc1F)CC[C@@H](O2)[C@@H](C[NH2+]C[C@H]([C@@H]3CCc4cc(ccc4O3)F)O)O,nebivolol,-9.259331,x0161,active-noncovalent
c1cc(c(cc1I)Cl)Nc2c(ccc(c2F)F)C(=O)NOCC3CC3,PD-184352,-9.259220,x0678,active-noncovalent
CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C,deflazacort,-9.258884,x0874,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,pregnenolone,-9.257950,x1077,active-noncovalent
c1ccc2c(c1)[nH]c(n2)c3cscn3,tiabendazole,-9.257359,x0749,active-covalent
Cc1ccccc1C(=O)Nc2ccc(c(c2)C)C(=O)N3CCC[C@H](c4c3ccc(c4)Cl)O,tolvaptan,-9.257117,x0874,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cnc(c(n2)C(=O)Nc3ccccc3)N,VE-821,-9.255527,x0104,active-noncovalent
CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,testosterone-enanthate,-9.254783,x0104,active-noncovalent
c1ccc2c(c1)[nH]c(n2)C[N@@H+](CCCC[NH3+])[C@H]3CCCc4c3nccc4,AMD11070,-9.253605,x0678,active-noncovalent
c1ccc2c(c1)c3cc(nn3c(=O)[nH]2)CO,pirquinozol,-9.251904,x0195,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)CNc3ccc(cc3)CCC(=O)[O-],GW-9508,-9.251542,x0072,active-noncovalent
CCN(CC)c1ccc(cc1)C(=C2C=CC(=[N+](CC)CC)C=C2)c3ccccc3,brilliant-green,-9.250998,x0161,active-noncovalent
c1ccc(cc1)c2ccccc2OC[C@@H](CC(=[NH2+])N3CCCCC3)O,AH11110,-9.250823,x0104,active-noncovalent
CCc1ccc(cc1)C(=O)[C@@H](C)C[NH+]2CCCCC2,eperisone,-9.250213,x0104,active-noncovalent
c1cc(c(cc1Cl)C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)O,IKK-2-inhibitor-V,-9.247657,x0195,active-noncovalent
c1ccc(cc1)CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-],phenylacetylglutamine,-9.244794,x0678,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc3n2cnc3)C(=O)NOCCO,GDC-0623,-9.244441,x0107,active-noncovalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)NCCO,mabuprofen,-9.242089,x0946,active-noncovalent
Cc1c([nH]c(=O)[nH]1)C(=O)c2ccc(cc2)SC,enoximone,-9.241360,x0104,active-noncovalent
c1ccc(cc1)c2cc(c3ccccc3n2)C(=O)[O-],cinchophen,-9.241156,x0434,active-noncovalent
c1cc(ccc1NC(=O)C[C@@H](C(=O)[O-])[NH3+])Oc2cc(c(cc2Br)F)F,WAY-213613,-9.239523,x0072,active-noncovalent
c1ccc(cc1)c2ccc(cc2)C(=O)CN3c4ccccc4N5C3=[NH+]CC5,CCT-031374,-9.237420,x0434,active-noncovalent
c1ccc2c(c1)nc(n2Cc3ccc(cc3)F)NC4CC[NH2+]CC4,tecastemizole,-9.233396,x0195,active-noncovalent
CN(C(=O)N1[C@](SC(=N1)c2cc(ccc2F)F)(CCC[NH3+])c3ccccc3)OC,filanesib,-9.232491,x1093,active-noncovalent
Cn1c(c(c2c1nccc2)/C=C/C(=O)N3CCc4cc(c(cc4C3)OC)OC)c5ccccc5,SIS3,-9.230306,x0161,active-noncovalent
c1cc(oc1/C=N/N2CCOC2=O)N(=O)=O,furazolidone,-9.228660,x0749,active-covalent
c1cc(c(c(c1)Cl)S[C@@H](CCc2ccc(cc2)Cl)Cn3ccnc3)Cl,butoconazole,-9.227482,x0678,active-noncovalent
c1cc(c(cc1c2ccc(cc2F)F)C(=O)[O-])O,diflunisal,-9.227050,x0749,active-covalent
CC(=O)[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,hydroxyprogesterone,-9.225187,x0749,active-covalent
Cc1ccccc1CN2C(=O)C3=C(CC[N@H+](C3)Cc4ccccc4)N5C2=[NH+]CC5,ONC201,-9.224460,x0161,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-],icosapent,-9.224005,x0107,active-noncovalent
CNC(=O)c1cc2c3ccccc3[nH]c2cn1,FG-7142,-9.223627,x0195,active-noncovalent
C[C@@H](c1cccc(c1)C(=O)c2ccccc2)C(=O)[O-],ketoprofen,-9.223348,x0830,active-covalent
C(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,perflubron,-9.221680,x0749,active-covalent
Cc1cccc(c1)C(=O)Nc2cccc(c2)NC(=O)c3ccccc3OC,ML-365,-9.220985,x0104,active-noncovalent
CC(C)c1cccc2c1O[C@H](C(=S)N2CC(=O)[O-])C(C)C,AD-5467,-9.219696,x0830,active-covalent
C[C@@H](Cc1ccccc1)[NH2+]CCC(c2ccccc2)c3ccccc3,prenylamine,-9.219307,x1093,active-noncovalent
Cc1cc(cc(c1Nc2ccnc(n2)Nc3ccc(cc3)C#N)C)/C=C/C#N,rilpivirine,-9.219070,x0831,active-covalent
C[C@@H]1c2cc(c(cc2CC[NH2+]1)OC)OC,"isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",-9.219020,x0195,active-noncovalent
COc1ccc2cc-3[n+](cc2c1OC)CCc4c3cc5c(c4)OCO5,berberine,-9.217529,x0161,active-noncovalent
c1ccc2c(c1)c(c([nH]2)c3c4ccc(cc4[nH]c3O)Br)N=O,GSK-3-inhibitor-IX,-9.216043,x0678,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)CCCn3c(=O)c4ccccc4[nH]c3=O,pelanserin,-9.215606,x0946,active-noncovalent
CC(=O)Oc1ccc(cc1)C(c2ccc(cc2)OC(=O)C)c3ccccn3,bisacodyl,-9.214246,x1077,active-noncovalent
Cc1cccc(c1/[NH+]=C\2/NCCCS2)C,xylazine,-9.213903,x0434,active-noncovalent
C[C@H]/1CC[C@@H]2C[C@H](C[C@@](O2)([C@@H]3CSC(=O)N3)O)OC(=O)/C=C(\CC/C=C1)/C,latrunculin-b,-9.213891,x0104,active-noncovalent
CN(C)c1ccc(cc1)/C=C\2/c3ccccc3NC2=O,SU-4312,-9.213451,x0749,active-covalent
COC(=O)CN1CN(C2(C1=O)CC[NH+](CC2)Cc3cccc4c3cccc4)c5ccccc5,NNC-63-0532,-9.212130,x1077,active-noncovalent
CCC[N@H+](C/C=C/I)[C@H]1CCc2cccc(c2C1)O,8-hydroxy-PIPAT,-9.210985,x0104,active-noncovalent
C[C@H](c1ccccc1)[NH2+]CCC(c2ccccc2)c3ccccc3,fendiline,-9.210018,x0195,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CC(=O)C(=O)[O-],indole-3-pyrubate,-9.208225,x0072,active-noncovalent
c1ccc(cc1)c2ccc(o2)/C=C\3/C(=NN(C3=O)c4ccc(c(c4)C(=O)[O-])Cl)C(F)(F)F,EN460,-9.207842,x0161,active-noncovalent
c1ccc(cc1)[C@@H](CO)NC(=O)Nc2ccc(cc2)c3ccncc3,AS-1892802,-9.207526,x0161,active-noncovalent
COCCOc1ccc2c(c1)ncn2c3ccc4cccc(c4n3)N5CCC(CC5)[NH3+],CP-673451,-9.206402,x0161,active-noncovalent
c1ccc2c(c1)Cc3ccccc3N4[C@H]2C[NH+]=C4N,epinastine,-9.204981,x0072,active-noncovalent
C/C=C(/C)\C(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H]([C@H](C=C(C2=O)[C@H]4[C@H](C4(C)C)C[C@H]3C)CO)O)O)C,ingenol-mebutate,-9.204975,x0678,active-noncovalent
c1ccc(c(c1)[C@@H]2[C@@H](CO[C@@H](O2)c3ccccc3Cl)C/C=C\CCC(=O)[O-])O,ICI-192605,-9.204534,x0434,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2C(=O)C[C@@H]4[C@@]3(CCC(=O)C4)C)C,dehydrocholate,-9.204472,x0874,active-noncovalent
c1cscc1c2cc(c(s2)C(=O)N)N,IKK-2-inhibitor,-9.202543,x0195,active-noncovalent
COc1c2c(cc(c1N3C[C@@H]4CCC[NH2+][C@@H]4C3)F)c(=O)c(cn2C5CC5)C(=O)[O-],moxifloxacin,-9.202506,x0195,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,cholesterol,-9.201381,x1077,active-noncovalent
CC1([C@H]([C@@H](c2cc(ccc2O1)C#N)OC3=CC(=O)CC3)O)C,PCO-400,-9.199242,x0195,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)[O-],dihomo-gamma-linolenic-acid,-9.198960,x0874,active-noncovalent
c1ccc2c(c1)ccc3c2CCC(=O)O3,splitomycin,-9.198786,x0749,active-covalent
CCn1/c(=C\c2cccc[n+]2CC)/s/c(=C/3\N(c4ccccc4S3)C)/c1=O,MKT-077,-9.196421,x1077,active-noncovalent
c1cc(oc1C(=O)N2C[C@H]3C[NH2+]C[C@H]3C2)Cl,AZD1446,-9.195782,x0161,active-noncovalent
c1ccc2c(c1)c3c4c(c5c6ccccc6n7c5c3n2[C@H]8CC[C@@H]7O8)C(=O)NC4=O,SB-218078,-9.194160,x0195,active-noncovalent
c1ccc2c(c1)-c3c(c4cc(ccc4[nH]3)Br)CC(=O)N2,kenpaullone,-9.193865,x0678,active-noncovalent
c1ccc(cc1)C(=O)O[C@H]2C[NH+]3CCC2CC3,benzoclidine,-9.192346,x0072,active-noncovalent
CC(C)(C)[C@]1(CC[N@@H+]2C[C@@H]3c4ccccc4CCc5c3c(ccc5)[C@H]2C1)O,butaclamol,-9.191461,x0104,active-noncovalent
C1CCC(CC1)n2c(c(c(=O)n(c2=O)C3CCCCC3)C(=O)NCC(=O)[O-])[O-],daprodustat,-9.189902,x0434,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,diphenhydramine,-9.189106,x1093,active-noncovalent
C[NH+](C)CCOC(c1ccccc1)c2ccccc2,dimenhydrinate,-9.189106,x1093,active-noncovalent
c1cc(c(cc1Cl)c2nc3c(c(n2)Nc4ccncc4)nccn3)F,SD-208,-9.188960,x0678,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1[C@H]3[C@@H]([C@@H]([C@@H](O3)CO)O)O)N,guanosine,-9.188747,x0397,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)O)C,brivanib,-9.187219,x0434,active-noncovalent
c1ccc2c(c1)C(=[NH+]c3ccccc3S2)N4CC[NH+](CC4)CCOCCO,quetiapine,-9.185753,x0161,active-noncovalent
CCc1c(c(nn1c2ccccc2c3cccc(c3)OCC(=O)[O-])c4ccccc4)c5ccccc5,BMS-309403,-9.183868,x0195,active-noncovalent
C[C@]12CC/C(=N\OCC[NH3+])/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,istaroxime,-9.181981,x0161,active-noncovalent
c1ccc(c(c1)C2CC2)OCC3=[NH+]CCN3,cirazoline,-9.181396,x0104,active-noncovalent
c1c[nH]c2c1c(ncn2)c3cnn(c3)[C@@H](CC#N)C4CCCC4,ruxolitinib-(S),-9.179305,x0749,active-covalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)[O-])O)O,alprostadil,-9.179181,x0678,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)CCNc3c4cc(ccc4ncn3)N,EVP4593,-9.177666,x0104,active-noncovalent
Cc1cc(ccc1Oc2ccn3c(c2)ncn3)Nc4c5cc(ccc5ncn4)/[NH+]=C\6/NC(CO6)(C)C,tucatinib,-9.176535,x0072,active-noncovalent
COc1ccccc1CN[C@H]2CCC[NH2+][C@H]2c3ccccc3,CP-99994,-9.176131,x0072,active-noncovalent
CC[NH+](CC)CCCN(c1ccccc1)C2Cc3ccccc3C2,aprindine,-9.176032,x0195,active-noncovalent
CC(=O)c1ccc2c(c1)N(c3ccccc3S2)CCCN4CC[NH+](CC4)CCO,acetophenazine,-9.175442,x0104,active-noncovalent
Cc1c(sc(n1)N)c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4,CYC116,-9.174115,x0195,active-noncovalent
c1cc(c(cc1Oc2c(cc(cc2I)C[C@H](C(=O)[O-])[NH3+])I)I)O,liothyronine-(isomer),-9.173932,x0678,active-noncovalent
CC(=CCC[C@@](C)(C=C)/C=C/c1ccc(cc1)O)C,bakuchiol,-9.173650,x0195,active-noncovalent
CCCCOC(=O)c1ccccc1Nc2cccc(c2)C(F)(F)F,ufenamate,-9.172576,x0434,active-noncovalent
c1ccc2c(c1)[C@H]3C=CC[C@H]3[C@H](N2)c4cc5c(cc4Br)OCO5,G-15,-9.172030,x0195,active-noncovalent
Cc1cccc(c1NC(=O)[C@@H]2CCCC[N@H+]2C)C,mepivacaine,-9.171832,x0195,active-noncovalent
c1ccc(cc1)N/C(=[NH+]\C(=[NH2+])N)/N,1-phenylbiguanide,-9.171133,x0195,active-noncovalent
C/C=C/1\C(=O)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,GR-235,-9.170068,x0749,active-covalent
Cc1cc2c(cc1C(=C)c3ccc(cc3)C(=O)[O-])C(CCC2(C)C)(C)C,bexarotene,-9.169219,x0161,active-noncovalent
CCOC(=O)c1c(n(c2c1c(c(c(c2)Br)O)C[NH+](C)C)C)CSc3ccccc3,arbidol,-9.169143,x0874,active-noncovalent
COc1ccc2c(c1)c(c3cc(ccc3n2)Cl)SCCC[NH3+],LDN-209929,-9.169050,x0104,active-noncovalent
c1c(ccc(c1)Cl)S(=O)(=O)[C@]2(CC[C@H](CC2)NS(=O)(=O)C(F)(F)F)c3c(ccc(c3)F)F,MRK-560,-9.167199,x0072,active-noncovalent
C[C@H]([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)[NH2+]C)O)[NH3+])[NH3+])[NH3+])[NH2+]C,gentamycin,-9.166148,x0874,active-noncovalent
CCCCC/[NH+]=C(\N)/N=N/Cc1c[nH]c2c1cc(cc2)OC,tegaserod,-9.165915,x1385,active-covalent
CNc1cc2c(cn1)ncnc2Nc3cccc(c3)Br,PD-158780,-9.165236,x0749,active-covalent
C[C@H](C1=[NH+]CCN1)Oc2c(cccc2Cl)Cl,lofexidine,-9.164065,x0678,active-noncovalent
Cc1c(cc(c(=O)[nH]1)C#N)c2ccc3nccn3c2,olprinone,-9.161945,x0678,active-noncovalent
c1ccc(cc1)C(=O)c2ccc3n2CC[C@@H]3C(=O)[O-],ketorolac,-9.161427,x0749,active-covalent
CC1=NC(=O)C[C@@H]([C@H]1C(=O)Nc2cc3c[nH]nc3cc2F)c4ccc(cc4)C(F)(F)F,GSK429286A,-9.161307,x0107,active-noncovalent
CC#CC[C@H](C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/C2)O)O,iloprost,-9.159988,x0195,active-noncovalent
c1cc(ccc1[C@H]2[C@H]3CC=C[C@H]3c4cc(ccc4N2)S(=O)(=O)N)Br,4BP-TQS,-9.159706,x0161,active-noncovalent
COc1ccc(cc1OP(=O)([O-])[O-])/C=C\c2cc(c(c(c2)OC)OC)OC,fosbretabulin,-9.159322,x0195,active-noncovalent
C[NH2+]CC[C@@H](c1ccccc1)Oc2ccccc2OC,nisoxetine,-9.158139,x0434,active-noncovalent
c1ccc2c(c1)c(cc(=O)[nH]2)C[C@H](C(=O)[O-])NC(=O)c3ccc(cc3)Cl,rebamipide,-9.158004,x0967,active-noncovalent
Cc1cc(sc1)c2c3ccccc3c(nn2)Nc4ccc(cc4)Oc5c(cccn5)c6ccnc(n6)N,AMG900,-9.154729,x0104,active-noncovalent
CCCC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(c3ccccc3c2OC)C#N,nafadotride,-9.154069,x0195,active-noncovalent
Cc1c(c2ccc(cc2n1c3ccc(cc3)OC)O)N(=O)=O,ID-8,-9.153130,x0195,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCn3c(=O)c4c(c5ccccc5[nH]4)[nH]c3=O,3-MPPI,-9.152433,x0874,active-noncovalent
CC[NH+](CC)[C@@H](C)CN1c2ccccc2Sc3c1cccc3,profenamine,-9.151715,x0195,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@]34C,desoxycortone,-9.151583,x1077,active-noncovalent
c1cc(ccc1c2c(n(cn2)C3CCCCC3)c4ccnc(n4)N)F,PF-670462,-9.150079,x0678,active-noncovalent
Cc1ccc(cc1)/C(=C\C[NH+]2CCCC2)/c3cccc(n3)/C=C/C(=O)[O-],acrivastine,-9.149762,x1077,active-noncovalent
C[NH+]1CCN(CC1)c2ccc3ccccc3n2,N-methylquipazine,-9.148675,x0749,active-covalent
c1ccc(cc1)c2cc(n(n2)c3ccccc3)NC(=O)c4cccc(c4)C#N,CDPPB,-9.147143,x0874,active-noncovalent
c1cc(ccc1C(=O)Nc2ccc(nc2)Cl)Cl,ICA-110381,-9.147057,x0678,active-noncovalent
C[C@H]([C@@](Cn1cncn1)(c2ccc(cc2F)F)O)[NH+]3CCC(=C)CC3,efinaconazole,-9.144269,x0831,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C,dydrogesterone,-9.143844,x0749,active-covalent
Cc1ccc2c(=O)c3cccc(c3oc2c1C)CC(=O)[O-],ASA-404,-9.143008,x0195,active-noncovalent
CC(C)Oc1ccc(cc1)c2cnc3c(cnn3c2)c4ccnc5c4cccc5,DMH1,-9.141401,x0104,active-noncovalent
C[C@@H]1Cc2cc3c(cc2C(=NN1C(=O)C)c4ccc(cc4)N)OCO3,talampanel,-9.141388,x0161,active-noncovalent
c1ccc(cc1)c2cn3c([nH+]2)sc(n3)S(=O)(=O)N,AEG3482,-9.141166,x0678,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)F)c3[nH]c4c5cccnc5c6c(c4n3)cccn6,APTO-253,-9.140422,x1077,active-noncovalent
CC(C)(C)OC(=O)N1CCC(CC1)COC(=O)Nc2ccccc2OC,GW-542573X,-9.138774,x0104,active-noncovalent
c1ccc2c(c1)c(=O)c(c(o2)[O-])Cc3c(=O)c4ccccc4oc3[O-],dicoumarol,-9.137878,x1093,active-noncovalent
Cc1ccsc1/C=C/C2=[NH+]CCCN2C,morantel,-9.137700,x0678,active-noncovalent
C[NH2+][C@@H]1Cc2cccc3c2n(c(=O)[nH]3)C1,sumanirole,-9.137506,x0195,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cc(sc2c3ccc(cc3)F)Br,DUP-697,-9.136870,x0072,active-noncovalent
c1ccc(cc1)c2c(c3nc(cc(n3n2)C(F)(F)F)C(F)(F)F)c4ccc(cc4)O,PHTPP,-9.136705,x0161,active-noncovalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)[O-])[O-])C(=O)OC2,mycophenolic-acid,-9.135977,x0830,active-covalent
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)[O-])NC(=[NH2+])N2,2-iminobiotin,-9.135775,x0678,active-noncovalent
Cc1cn(c(=O)n(c1=O)Cc2ccsc2C(=O)[O-])C[C@@H](C(=O)[O-])[NH3+],UBP-310,-9.133450,x0678,active-noncovalent
c1ccc(cc1)CN(CC2=[NH+]CCN2)c3ccccc3,antazoline,-9.133289,x0749,active-covalent
CC1=C([C@H](C(=C(N1)C)C(=O)OC/C=C/c2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OCCOC,cilnidipine,-9.132248,x0161,active-noncovalent
COc1ccc(cc1C(=O)NCCc2ccc(cc2)C(=O)[O-])Cl,meglitinide,-9.131931,x0678,active-noncovalent
Cc1c(ccc2c1c3ccccc3n2C(C)C)NC(=O)N4CCOCC4,NPY-5RA972,-9.131223,x0161,active-noncovalent
CCn1c2ccccc2c3c1ccc(c3)C[NH2+]Cc4ccccc4OC,HLCL-61,-9.129971,x0161,active-noncovalent
C[C@@H]1COc2c3n1cc(c(=O)c3cc(c2N4CC[NH+](CC4)C)F)C(=O)[O-],ofloxacin,-9.128493,x0195,active-noncovalent
C[N+]1(CCC[C@H](C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C,mepenzolate,-9.126459,x0678,active-noncovalent
c1cc(c(cc1c2ccc(cc2F)C3(CC3)C(=O)[O-])Cl)Cl,CHF5074,-9.126347,x0749,active-covalent
C[C@H]1C[C@H]2[C@H]3CC[C@H]([C@]3(C[C@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C,medrysone,-9.125561,x1077,active-noncovalent
CC/C(=C(/c1ccc(cc1)OCC[NH+](C)C)\c2cccc(c2)O)/c3ccccc3,droloxifene,-9.123614,x0874,active-noncovalent
CC[C@]12CC(=C)[C@H]3[C@@H]([C@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@@H]34,etonogestrel,-9.121600,x0749,active-covalent
c1ccc(cc1)C(=O)OOC(=O)c2ccccc2,benzoyl-peroxide,-9.121383,x0749,active-covalent
Cc1c(c(on1)C)c2cc(cc(c2)O)[C@H](c3ccccc3)O,OXF-BD-02,-9.120838,x0161,active-noncovalent
c1cc(cc(c1)c2nc(no2)c3cccnc3)C#N,NS-9283,-9.119989,x0678,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)C(F)(F)F)C(=O)[O-],xenalipin,-9.118729,x0678,active-noncovalent
c1cc2c(c(c1)Cl)CN(C2)C3=[NH+]CCN3,RS-45041-190,-9.116029,x0195,active-noncovalent
CN(C)c1ccc(cc1)c2cccc(c2)NC(=O)N(C)C,atglistatin,-9.115718,x0195,active-noncovalent
Cc1ccc2c(c1)C3(CC[NH+](CC3)CCc4c(oc(n4)c5ccccc5)C)OC(=O)N2,RS-504393,-9.115561,x0161,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[S@](=O)CC(=O)N,armodafinil,-9.114628,x0678,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[S@](=O)CC(=O)N,modafinil,-9.114628,x0678,active-noncovalent
COc1cc(ccc1C(=O)N2CCC(CC2)Cc3ccccc3)SC,JX-401,-9.111429,x0946,active-noncovalent
C[N@H+]1CCC=C(C1)C(=O)OCC#C,arecaidine-propargyl-ester,-9.111406,x0195,active-noncovalent
C1CSC(=O)[C@H]1NC(=O)CSCC(=O)[O-],erdosteine,-9.110259,x0678,active-noncovalent
C[C@@H](/C=C/c1cccc(c1)Oc2ccc(cc2)F)N(C(=O)N)O,BW-B70C,-9.110114,x0195,active-noncovalent
c1ccc(cc1)C(=O)NCCC(=O)[O-],betamipron,-9.109447,x0678,active-noncovalent
CCCC(=O)Nc1cccc(c1)NC(=O)c2ccccc2Br,ML161,-9.109258,x0195,active-noncovalent
c1cc(ccc1C(=[NH2+])N)N/N=N/c2ccc(cc2)C(=[NH2+])N,diminazene-aceturate,-9.109124,x0395,active-noncovalent
Cc1cc(ccc1Oc2ccc(cc2)SC(F)(F)F)n3c(=O)[nH]c(=O)n(c3=O)C,toltrazuril,-9.108834,x0161,active-noncovalent
C[NH+](C)CCC[C@@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,escitalopram,-9.108678,x0678,active-noncovalent
C[N@@H+](Cc1cc(cc(c1N)Br)Br)C2CCCCC2,bromhexine,-9.108104,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CC[C@]34C,desoxycorticosterone-pivalate,-9.106156,x0161,active-noncovalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CC(=O)[O-],alrestatin,-9.106066,x0195,active-noncovalent
c1cc(c2ccncc2c1S(=O)(=O)NCC[NH3+])Cl,CKI-7,-9.104425,x0678,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@H]2[C@@]1(C[C@@H]([C@@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)O,prednisolone-acetate,-9.103774,x0692,active-covalent
c1cc(c(cc1Cl)Cl)CO/N=C(\Cn2ccnc2)/c3ccc(cc3Cl)Cl,oxiconazole,-9.102717,x0107,active-noncovalent
Cc1cc(ccc1SC)OP(=S)(OC)OC,fenthion,-9.102233,x0749,active-covalent
Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc2ccc(c(c2)O)C(=O)[O-],STAT3-inhibitor-VI,-9.102181,x0072,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH+](C)C,"N-methyl-(-)ephedrine-[1r,2s]",-9.101809,x0195,active-noncovalent
CC(C)c1ccc(cc1)C(=O)NCCOc2ccc(cc2)C(=O)[O-],OCO-1112,-9.101601,x0678,active-noncovalent
CCNC(=O)c1c(c([nH]n1)c2cc(c(cc2O)O)Cl)c3ccc(cc3)OC,VER-49009,-9.101141,x1392,active-covalent
C[C@H]1C[C@H]2[C@H](CC[C@]3([C@@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,medroxyprogesterone-acetate,-9.100740,x1077,active-noncovalent
Cc1cccc(c1)C(=O)NC[NH+]2CCN(CC2)c3ccccc3C#N,PD-168077,-9.100672,x0161,active-noncovalent
c1ccc2c(c1)C3(CC[NH+](CC3)CCc4ccc(cc4)C(F)(F)F)OC(=O)N2,RS-102895,-9.099960,x0161,active-noncovalent
CC(C)OC(=O)/C=C\n1cnc(n1)c2cc(cc(c2)OC)C(F)(F)F,KPT-185,-9.099607,x0195,active-noncovalent
C[C@H](CCC(=O)N=O)/C=C(\C)/C(=O)c1ccc(cc1)N(C)C,trichostatin-a,-9.099092,x0749,active-covalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC4CCCC4,N6-cyclopentyladenosine,-9.099028,x0946,active-noncovalent
CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3,efloxate,-9.098845,x0195,active-noncovalent
CC(=O)c1ccc2c(c1)N(c3ccccc3S2)CCC[NH+]4CCC(CC4)CCO,piperacetazine,-9.098739,x0104,active-noncovalent
c1ccc(c(c1)[C@@H](c2ccc(cc2)Cl)C(Cl)Cl)Cl,mitotane,-9.097783,x0072,active-noncovalent
c1cnn(c1)c2ccc(cc2)[C@@](Cc3[nH]cc([nH+]3)CC4(CC4)C(F)(F)F)(C(F)(F)F)O,MK-5046,-9.097631,x0678,active-noncovalent
CC[NH+](CC)CCCC[C@H](c1ccccc1)NC(=O)c2ccc(cc2)N(=O)=O,nibentan,-9.097618,x0161,active-noncovalent
CC(C)NC(=O)COc1cccc(c1)c2nc3ccccc3c(n2)Nc4ccc5c(c4)cn[nH]5,KD025,-9.097225,x0161,active-noncovalent
CC(C)c1cc(c(cc1O)O)c2n[nH]c(=O)n2c3ccc4c(c3)ccn4C,ganetespib,-9.095671,x0195,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3ccccc3Sc4c2cc(cc4)Cl,clotiapine,-9.093609,x0678,active-noncovalent
C[N+]1(CCC(=C(c2ccccc2)c3ccccc3)CC1)C,diphemanil,-9.092729,x0831,active-covalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CCCC(=O)[O-],isodibut,-9.092201,x0831,active-covalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)[O-],indomethacin,-9.092182,x0831,active-covalent
CCC[NH2+]C(C)(C)COC(=O)c1ccccc1,meprylcaine,-9.091915,x0161,active-noncovalent
Cn1c2ccccc2c(c1O)C3=c4ccccc4=NC3=O,meisoindigo,-9.091804,x0072,active-noncovalent
COc1ccc(cc1O)/C=C\c2cc(c(c(c2)OC)OC)OC,combretastatin-A-4,-9.089901,x0195,active-noncovalent
CN(C)c1ccc(cc1)c2ccc(cc2)CN(c3cccc(c3)/C=C/C(=O)OC)C(=O)C4CCCCC4,fexaramine,-9.089888,x1077,active-noncovalent
CCN(CC)C(=O)Nc1ccc(c(c1)C(=O)C)OC[C@H](C[NH2+]C(C)(C)C)O,celiprolol,-9.089760,x0104,active-noncovalent
C[C@H](CN1c2ccccc2CCc3c1cccc3)C[NH+](C)C,trimipramine,-9.088980,x0072,active-noncovalent
c1cc(c(cc1[C@@H]2[C@H](Cc3c(cc(c(c3O2)[C@H]4c5c(cc(cc5O[C@@H]([C@@H]4O)c6ccc(c(c6)O)O)O)O)O)O)O)O)O,procyanidin-b-2,-9.088621,x0161,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)Nc3ncc4c(n3)-c5c(c(nn5CCO)C(=O)N)CC4)OC(F)(F)F,NMS-1286937,-9.085902,x1093,active-noncovalent
C/C(=C\c1ccccc1F)/CN(CC[C@H]2CCC[N@@H+]2C)C(=O)c3cc(c(c(c3)OC)OC)OC,VUF11207,-9.084807,x0874,active-noncovalent
COc1ccc(cc1OC)Cc2cnc(nc2N)N,diaveridine,-9.084249,x0678,active-noncovalent
CCCn1c2c(c(=O)n(c1=O)CCC)[nH]c(n2)C34C[C@@H]5C[C@H](C3)CC4C5,KW-3902,-9.082354,x0678,active-noncovalent
C[N@@H+]1CCC[C@H]1c2cccnc2,nicotine,-9.081602,x0678,active-noncovalent
c1ccc(cc1)C(=O)c2cccc(c2N)CC(=O)N,nepafenac,-9.081283,x0749,active-covalent
C[C@]12CC[C@H]3[C@@]4(CCC[C@@]([C@H]4CC[C@@]3(C1)CC2=O)(C)C(=O)[O-])C,isosteviol,-9.080267,x0749,active-covalent
CCCC[C@@H](CC)COC(=O)c1ccccc1O,octisalate,-9.079791,x0195,active-noncovalent
CN1CC(=O)N2[C@@H](C1=O)Cc3c4ccccc4[nH]c3[C@H]2c5ccc6c(c5)OCO6,tadalafil,-9.077617,x0678,active-noncovalent
C[C@@H]1CC2=C(CCC(=O)C2)[C@@H]3[C@H]1[C@H]4CC[C@]([C@]4(CC3)C)(C#C)O,tibolone,-9.076203,x0749,active-covalent
c1ccc(cc1)c2[nH]c3cc(ccc3n2)S(=O)(=O)[O-],phenylbenzimidazole-sulfonic-acid,-9.076019,x0678,active-noncovalent
c1cnccc1c2cc3c([nH]2)CCNC3=O,PHA-767491,-9.075813,x0678,active-noncovalent
c1ccc2c(c1)cc(o2)C3=[NH+]CCN3,2-BFI,-9.075667,x0749,active-covalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])C(=O)[O-])C2=O,rhein,-9.074903,x0749,active-covalent
Cc1cc(c(n1Cc2ccccc2)C)C(=O)Cn3cc(ccc3=O)C#N,CYM-5520,-9.072673,x0749,active-covalent
c1ccc2c(c1)nc(s2)SN3CCOCC3,N-oxydiethylenebenzothiazole-2-sulfenamide,-9.072179,x0749,active-covalent
c1cc(ccc1N)S(=O)(=O)c2ccc(cc2)N,dapsone,-9.071971,x0072,active-noncovalent
CC[N@@H+]1CCC[C@H](C1)OC(=O)C(c2ccccc2)c3ccccc3,piperidolate,-9.071856,x0195,active-noncovalent
COc1ccc(cc1OC)CCN2CC[NH+](CC2)CCCc3ccccc3,cutamesine,-9.071821,x0161,active-noncovalent
C[NH+](C)CCO[C@@H](c1ccc(cc1)Cl)c2ccccn2,carbinoxamine,-9.071591,x0678,active-noncovalent
CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO,CB-03-01,-9.071207,x0749,active-covalent
c1ccc2c(c1)ccc(c2/C=N/S(=O)(=O)c3cccs3)O,STF-083010,-9.070529,x0195,active-noncovalent
c1ccc(c(c1)[C@H]2CS/C(=C(/C#N)\n3ccnc3)/S2)Cl,lanoconazole,-9.069508,x0072,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CSc1ccccc1C(=O)[O-])/C)/C)C,salirasib,-9.068083,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)C(=O)OCC[NH+]3CCCCC3,SB-203186,-9.067726,x0831,active-covalent
Cn1c(c([nH]c1=O)Cc2c[nH]c3c2cccc3Cl)[O-],necrostatin-2,-9.066577,x0749,active-covalent
c1cc(ccc1c2ccc(o2)/C=N/N3CC(=O)NC3=O)N(=O)=O,dantrolene,-9.066478,x1077,active-noncovalent
c1cc(ccc1c2ccc(o2)/C=C/3\C(=O)[N-]C(=O)S3)F,CAY10505,-9.066477,x0195,active-noncovalent
Cc1nc2ccccc2n1Cc3ccc(cc3)Cl,chlormidazole,-9.066476,x1093,active-noncovalent
C[N@H+]1CCC[C@@H]1CCSc2ccc(cc2)O,SIB-1553A,-9.063419,x0161,active-noncovalent
c1cc(ccc1CO[C@H]2Cn3cc([nH+]c3OC2)N(=O)=O)OC(F)(F)F,PA-824,-9.063246,x0161,active-noncovalent
CO[C@H]1CC=C2CC[N@H+]3[C@]2(C1)C4=CC(=O)OC[C@H]4CC3,NSC-9965,-9.062446,x0072,active-noncovalent
CC(C)C[C@H](C(=O)[O-])NC(=O)OCC1c2ccccc2-c3c1cccc3,NPC-15199,-9.061985,x0678,active-noncovalent
CCC1(C(=O)N(C(=O)N(C1=O)COC)COC)c2ccccc2,eterobarb,-9.061070,x0678,active-noncovalent
c1ccc(cc1)/C(=C(/c2ccccc2)\c3ccc(cc3)OCCO)/CCCl,ospemifene,-9.060997,x0434,active-noncovalent
c1c(onc1C(=O)N(C2CCCCC2)C3CCCCC3)C4CC4,CYM-5541,-9.060060,x1093,active-noncovalent
CCN(Cc1ccncc1)C(=O)[C@@H](CO)c2ccccc2,tropicamide,-9.059565,x0749,active-covalent
c1[nH]c2c(n1)c(nc(n2)N)OCC3CCCCC3,NU-2058,-9.059414,x0831,active-covalent
CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@H]2[C@@H]5O)[N@H+]3[C@@H]1O)c6ccccc6[N@@]4C,ajmaline,-9.059394,x0749,active-covalent
CCOC(=O)c1ccc(cc1)OC(=O)CCCCC[NH+]=C(N)N,gabexate,-9.058656,x0104,active-noncovalent
CCC(CC)n1c2c([nH]c1=O)ncc(n2)C#C,tirasemtiv,-9.057319,x0195,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1OCC=C)O,oxprenolol,-9.056771,x0874,active-noncovalent
C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3)C,methylatropine-nitrate,-9.056665,x0749,active-covalent
c1ccc2c(c1)c(c[nH]2)C[C@H](C(=O)[O-])NC(=O)c3ccc(cc3)Cl,benzotript,-9.056155,x0678,active-noncovalent
c1cc(ccc1Oc2ccc(cc2)Cl)S(=O)(=O)CC3(CCOCC3)C(=O)NO,CTS-1027,-9.055531,x0161,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)c2ccccc2/N=C/c3c4ccccc4ccc3O,sirtinol,-9.055193,x0831,active-covalent
c1ccnc(c1)C(=O)c2cnn3c2nccc3c4ccncc4,ocinaplon,-9.055147,x0195,active-noncovalent
C[C@@H](c1ccc(cc1)C(=O)c2cccs2)C(=O)[O-],suprofen,-9.055114,x0749,active-covalent
CC[NH+](CC)Cc1cc(ccc1O)Nc2ccnc3c2ccc(c3)Cl,amodiaquine,-9.054550,x1077,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O,semaxanib,-9.054338,x0195,active-noncovalent
c1cc(cc(c1)C(F)(F)F)[C@H]2C[NH2+]CCO2,flumexadol,-9.054163,x0195,active-noncovalent
Cn1c2c(cn1)c(nc(n2)c3cccc(c3)O)N4CCOCC4,ETP-45658,-9.053819,x1392,active-covalent
CC(=O)NCCc1c2cc(ccc2[nH]c1c3ccccc3)OC,2-phenylmelatonin,-9.053698,x0678,active-noncovalent
c1cc(sc1)C(=O)Oc2ccc3cc(sc3c2)C(=[NH2+])N,BCX-1470,-9.053535,x0107,active-noncovalent
C1C[C@H]([C@H](O[C@@H]1C[NH3+])O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)[NH3+])O)[NH3+])[NH3+])[NH3+],dibekacin,-9.051243,x0678,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)[C@H]2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,aloin,-9.050865,x1093,active-noncovalent
c1cc(cc(c1)Cl)c2ccc(o2)C(=O)Nc3ccc(cc3)C[NH+]4CCOCC4,CID-2011756,-9.050509,x0104,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)NC(C)C,ramifenazone,-9.050013,x0104,active-noncovalent
Cc1cc(c(n1c2ccc(cc2)F)C)C(=O)C[NH+]3CCCC3,IU1,-9.049490,x0195,active-noncovalent
CC1(CN(C1)C(=O)c2ccc(cc2)c3cccc4n3nc(n4)NC(=O)C5CC5)C,solcitinib,-9.048704,x0161,active-noncovalent
Cc1cc2c(s1)Nc3ccccc3[NH+]=C2N4CC[NH+](CC4)C,olanzapine,-9.048552,x0195,active-noncovalent
Cc1c2c(c3cc(ccc3[nH+]c2n[nH]1)OC)NCCOCCO,SCH-51344,-9.047336,x0107,active-noncovalent
c1c(cc(c(c1I)Oc2cc(c(c(c2)I)[O-])I)I)C[C@@H](C(=O)[O-])[NH3+],levothyroxine,-9.045209,x0678,active-noncovalent
COc1cc(ccc1O)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)O)/O,curcumin,-9.044683,x0104,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)Cl)c2ccccn2,chloropyramine,-9.043710,x0195,active-noncovalent
CCCCn1ccc(c(c1=O)Cl)N2CCC(CC2)c3ccccc3,JNJ-40411813,-9.043389,x0104,active-noncovalent
c1ccc2c(c1)c3c(o2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,naltriben,-9.043026,x0072,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)/C=C(\C#N)/C(=S)N,tyrphostin-AG-879,-9.042148,x0195,active-noncovalent
Cc1cc(=O)oc2c1cc3cc(oc3c2C)C,trioxsalen,-9.041206,x0749,active-covalent
C[C@@]12C[C@@H]([C@@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O,flunisolide,-9.040825,x0830,active-covalent
CCN(C)C(=O)Oc1cccc(c1)[C@H](C)[NH+](C)C,rivastigmine,-9.040291,x0107,active-noncovalent
c1cc(oc1)CNc2c3c([nH]cn3)ncn2,kinetin,-9.040161,x0749,active-covalent
c1c[nH]c2c1c(c(c[nH+]2)C(=O)N)NC3[C@@H]4CC5C[C@H]3CC(C4)(C5)O,peficitinib,-9.039919,x0072,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)([C@H]3C[C@@H]4C[C@H]3C=C4)O,biperiden,-9.039534,x0195,active-noncovalent
COc1c(cc2c(c1O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC2=O)O,bergenin,-9.039062,x0195,active-noncovalent
CC(=O)O[C@H]1CC[C@@]2([C@@H]3CC[C@]4([C@@H]([C@H]3CC=C2C1)CCC4=O)C)C,prasterone-acetate,-9.039054,x1077,active-noncovalent
c1ccc(cc1)CCCC[NH+]2CCC(CC2)c3ccccc3,4-PPBP,-9.038963,x0161,active-noncovalent
CCCCCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C,norethisterone-enanthate,-9.037788,x0161,active-noncovalent
c1ccc(cc1)[C@@H](c2ccc(cc2)Cl)OCC[NH+]3CCCCC3,cloperastine,-9.037077,x0195,active-noncovalent
Cc1c(sc(n1)N(C)C(=O)Cc2ccc(cc2)c3ccccn3)S(=O)(=O)N,pritelivir,-9.035913,x0161,active-noncovalent
COc1cc(cc(c1OC)OC)/C=C/C(=O)N2CC[NH+](CC2)CC(=O)N3CCCC3,cinepazide,-9.034895,x0104,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCOCC3,linezolid,-9.034732,x0104,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)O,digoxigenin,-9.034569,x0395,active-noncovalent
Cc1c(c2ccccc2o1)CNC(=O)NCc3cccs3,S-07662,-9.032615,x0104,active-noncovalent
C=CC[N@H+]1CC[C@]23CCCC[C@H]2[C@H]1Cc4c3cc(cc4)O,levallorphan,-9.031611,x0072,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,exemestane,-9.030524,x0749,active-covalent
C[C@@H](c1cc2ccc(cc2nc1c3ccccn3)F)Nc4c5c([nH]cn5)ncn4,AMG319,-9.029361,x0678,active-noncovalent
C[C@@H](c1cc2ccc(cc2nc1c3ccccn3)F)Nc4c5c([nH]cn5)ncn4,AMG-319,-9.029361,x0678,active-noncovalent
CC1(CCC(c2c1ccc(c2)C3(SCCS3)c4ccc5cc(ccc5c4)C(=O)[O-])(C)C)C,MM-11253,-9.029353,x1077,active-noncovalent
c1cnc2cc3c(cc2n1)[C@@H]4C[C@H]3C[NH2+]C4,varenicline,-9.029347,x0195,active-noncovalent
Cc1c2c(nc(n1)N)C[C@@H](NC2=O)c3ccc(cc3c4cccc(n4)OC)F,NVP-HSP990,-9.027154,x0678,active-noncovalent
C[C@H](CC[C@H](C(C)C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,tacalcitol,-9.025872,x0104,active-noncovalent
CC1(CCC2=C(O1)c3ccccc3C(=O)C2=O)C,beta-lapachone,-9.025756,x0195,active-noncovalent
c1cc2cccc3c2c(c1)C(=O)N(C3=O)CCCCCC(=O)NO,scriptaid,-9.025402,x0195,active-noncovalent
CC[C@@](C/C=C/c1ccccc1)(c2ccccc2)[N@@H+](C)CC3CC3,igmesine,-9.025148,x0072,active-noncovalent
C[C@@H](c1ccccn1)/N=N/C(=S)N2CCC2,NSC-319726,-9.023738,x1418,active-covalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])N(=O)(CCCl)CCCl,melphalan-n-oxide,-9.023522,x0107,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])N(=O)(CCCl)CCCl,PX-478,-9.023522,x0107,active-noncovalent
c1cc2c(cc1C#N)c(c([nH]2)O)c3ccc(cn3)C[NH+]4CCOCC4,AZD1080,-9.022916,x0195,active-noncovalent
Cc1cc(c(c2c1[nH]c(=O)c3c2ccs3)c4ccc(cc4)[C@@H](C)C[NH3+])O,OTS514,-9.022333,x0708,active-covalent
c1ccc2c(c1)c3ccccc3s2,dibenzothiophene,-9.022096,x0749,active-covalent
C[NH+](C)C/C=C/C(=O)Nc1cccc(c1)C(=O)Nc2cccc(c2)Nc3ncc(c(n3)c4c[nH]c5c4cccc5)Cl,THZ2,-9.021342,x0161,active-noncovalent
C[C@H](CCc1ccccc1)[NH2+][C@@H](C)[C@H](c2ccc(cc2)O)O,buphenine,-9.020359,x0434,active-noncovalent
Cc1ccccc1N2CC[NH+](CC2)CCc3nnc4n3CCCC4,dapiprazole,-9.019834,x0107,active-noncovalent
c1ccc(cc1)CCNc2c3c4ccccc4c(=O)c5cccc(nc2=O)[C@H]53,BRD-7389,-9.018826,x0195,active-noncovalent
c1cc(ccc1c2nn(c(=O)o2)Cc3cc(ccc3O)Cl)C(F)(F)F,BMS-191011,-9.018175,x0946,active-noncovalent
c1ccc2c(c1)[nH]c(n2)CCC(=O)[O-],procodazole,-9.017670,x0749,active-covalent
Cc1ccc(cc1S(=O)(=O)N)Nc2nccc(n2)N(C)c3ccc4c(n(nc4c3)C)C,pazopanib,-9.017019,x0678,active-noncovalent
CCOC(=O)Nc1ccc(cc1N)NCc2ccc(cc2)F,retigabine,-9.013970,x1093,active-noncovalent
C[C@@H]([NH3+])[C@H]1CC[C@@H](CC1)C(=O)Nc2ccncc2,Y-27632,-9.013731,x0749,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1cc([nH]2)C#N)O,cyanopindolol,-9.013508,x0104,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH2+]CCc2ccc(cc2)O,ritodrine,-9.010501,x0678,active-noncovalent
c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,buparlisib,-9.009110,x0678,active-noncovalent
CC(C)(C=C)c1cc(c(cc1O)OC)/C=C/C(=O)c2ccc(cc2)O,licochalcone-a,-9.008456,x0195,active-noncovalent
CC(=CCc1c(cc(c2c1oc(c(c2=O)[O-])c3ccc(cc3)C(F)(F)F)[O-])O)C,SNG-1153,-9.008386,x0161,active-noncovalent
CC(=O)c1ccc2c(c1)N(c3ccccc3S2)CCC[NH+](C)C,acepromazine,-9.007215,x0161,active-noncovalent
COc1ccc2c(c1)cc([nH]2)C(=O)c3ccccc3,D-64131,-9.004910,x0749,active-covalent
c1ccc2c(c1)CN3CCCC3=[NH+]2,desoxypeganine,-9.004529,x0749,active-covalent
Cc1cc(no1)c2nncc3n2nc(c3C(C)(C)C)OCc4ncnn4C,MRK-016,-9.003543,x1418,active-covalent
C[NH+](C)CC[C@](c1ccccc1)(c2ccccc2Cl)O,clofedanol,-9.003261,x0072,active-noncovalent
Cc1ccc2c(cc(c(c2n1)OC(=O)c3ccccc3)Br)Br,broxaldine,-9.002949,x0830,active-covalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cccc(c3)c4ccccn4,DRF053-(R),-9.002911,x0161,active-noncovalent
C[NH+]1CCC(=C2c3ccccc3CCn4c2[nH+]cc4C=O)CC1,alcaftadine,-9.002264,x0195,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3cc(ccc3Nc4c2cccc4)Cl,clozapine,-9.001734,x0195,active-noncovalent
CC(C)Oc1ccc2c(c1)occ(c2=O)c3ccccc3,ipriflavone,-8.999832,x0749,active-covalent
CC[C@@H](c1nc2cccc(c2c(=O)n1c3ccccc3)F)Nc4c5c(nc[nH]5)ncn4,idelalisib,-8.999259,x0678,active-noncovalent
Cc1cc2c(n1C)nc(nc2N3CCCC3)N4CCCC4,PNU-89843,-8.999031,x0195,active-noncovalent
c1csc(c1)/C=C\2/C(=O)/C(=C/c3sccc3)/CCC2,tenylidone,-8.998743,x0161,active-noncovalent
CC[C@@H](CO)NC(=O)[C@H]1C[N@H+]([C@@H]2Cc3cn(c4c3c(ccc4)C2=C1)C)C,methysergide,-8.998618,x0104,active-noncovalent
c1ccc(cc1)NC[C@@H](Cn2c3ccc(cc3c4c2ccc(c4)Br)Br)O,P7C3,-8.998287,x0195,active-noncovalent
c1ccc(c(c1)C(=O)[O-])Nc2cc(ccc2C(=O)[O-])Cl,lobenzarit,-8.995890,x1093,active-noncovalent
c1cc(ccc1Nc2ncnc(n2)N)Cl,chlorazanil,-8.995859,x0830,active-covalent
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3F)Br)C(=O)NOCCO,MEK162,-8.995431,x0749,active-covalent
Cn1cc2c3c1cccc3[C@]4(C[C@H](C[N@H+]([C@@H]4C2)C)COC(=O)c5cc(cnc5)Br)OC,nicergoline,-8.995126,x0107,active-noncovalent
c1cc(c(cc1Cl)Cl)CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl,miconazole,-8.993138,x0195,active-noncovalent
c1ccc(c(c1)Cn2c3c(cccn3)c(n2)c4ncc(c(n4)N)C5CC5)F,BAY-41-2272,-8.991726,x0195,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1ccccc1C2CCCC2)O,penbutolol,-8.989674,x0195,active-noncovalent
c1ccc(cc1)C(CC[NH+]2CCCCC2)(c3ccccc3)O,pridinol,-8.988610,x0678,active-noncovalent
c1ccc2c(c1)c(ns2)N3CC[NH+](CC3)C[C@@H]4CCCC[C@H]4Cn5c(c6c(c5O)[C@H]7CC[C@@H]6C7)O,lurasidone,-8.988393,x0874,active-noncovalent
CC(C)[NH+](CCc1c[nH]c2c1cccc2)C(C)C,DIPT,-8.988087,x0072,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)C(=O)c3ccc(cc3)F,flubendazole,-8.986604,x0161,active-noncovalent
C[NH+]1CCN(CC1)c2c(cc3c(c2F)n(cc(c3=O)C(=O)[O-])CCF)F,fleroxacin,-8.985910,x1077,active-noncovalent
c1cc(ccc1Cn2ccnc2)/C=C/C(=O)[O-],ozagrel,-8.985313,x0072,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1n2cccc2)O,isamoltane,-8.984540,x0195,active-noncovalent
Cc1cnc(nc1c2cc([nH]c2)C(=O)N[C@H](CO)c3cccc(c3)Cl)Nc4ccc(cc4Cl)F,VX-11e,-8.984134,x0161,active-noncovalent
COC(=O)[C@@H](c1ccccc1)[C@H]2CCCC[NH2+]2,methylphenidate,-8.984003,x0195,active-noncovalent
C[C@H](c1ccc(cc1)C(=O)Nc2ccnc3c2cc[nH]3)[NH3+],Y-39983,-8.983973,x0749,active-covalent
c1cc(c(c(c1)F)C(=O)n2c(nc(n2)Nc3ccc(cc3)S(=O)(=O)N)N)F,JNJ-7706621,-8.983945,x0161,active-noncovalent
Cc1cnc(c(c1OC)C)Cn2cc(c3c2nc(nc3Cl)N)C#CCC(C)(C)O,EC-144,-8.982940,x0434,active-noncovalent
CS(=O)(=O)[N@@](Cc1ccco1)C[C@@H](Cn2c3ccccc3c4c2cccc4)O,KL-001,-8.982489,x0195,active-noncovalent
CCN(CC)C(=O)[C@@]1(C[C@@H]1C[NH3+])c2ccccc2,milnacipran,-8.981915,x0678,active-noncovalent
CCCCc1c(n(n(c1=O)c2ccccc2)c3ccccc3)[O-],phenylbutazone,-8.981514,x0678,active-noncovalent
Cc1c(=O)c2cccc(c2oc1c3ccccc3)C(=O)OCC[NH+]4CCCCC4,flavoxate,-8.981435,x0195,active-noncovalent
CN1CC(=O)[NH+]=C1NC(=O)Nc2cccc(c2)Cl,fenobam,-8.981092,x0678,active-noncovalent
C[C@@H]1c2ccc(cc2C[NH2+]1)c3ccc4c(c3OC(F)F)n(cc(c4=O)C(=O)[O-])C5CC5,garenoxacin,-8.981041,x0874,active-noncovalent
C=CCc1cccc(c1O)/C=N/NC(=O)CN2CC[NH+](CC2)Cc3ccccc3,PAC-1,-8.979566,x0104,active-noncovalent
C[NH+](C)CCC[C@]1(c2ccc(cc2CO1)C#N)c3ccc(cc3)F,citalopram,-8.976013,x0072,active-noncovalent
Cn1c(ncn1)[C@H]2c3c4c(cc(cc4N[C@@H]2c5ccc(cc5)F)F)c(=O)[nH]n3,talazoparib,-8.975266,x0195,active-noncovalent
C[NH+](C)CC(=O)Nc1ccc2c(c1)c3ccccc3c(=O)[nH]2,PJ-34,-8.975261,x0195,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@@H]3Cn4cnc[n+]4C3)C(=O)[O-])[C@@H](C)O,biapenem,-8.974404,x0749,active-covalent
c1c[nH]c2c1c(ncn2)c3cnn(c3)[C@H](CC#N)C4CCCC4,ruxolitinib,-8.974321,x0831,active-covalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N3CCCC3,almotriptan,-8.972091,x0946,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCSCC3,sutezolid,-8.969722,x0104,active-noncovalent
CCCCCCCCCCC[C@@H](c1cc(ccc1O)C)N=O,1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime,-8.969067,x0072,active-noncovalent
c1cc(ccc1C(=O)OC[C@@H](CO)O)N,lisadimate,-8.968984,x0195,active-noncovalent
c1cc(ccc1O)Oc2c(cc(cc2I)CCC(=O)[O-])I,diiodothyropropionic-acid,-8.968004,x0678,active-noncovalent
CC(=O)[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)O,cyproterone,-8.967553,x0749,active-covalent
CCn1cc(c(=O)c2c1cc(cc2)c3ccncc3)C(=O)[O-],rosoxacin,-8.966793,x0195,active-noncovalent
c1cc(ccc1Cc2cnc(s2)N)Br,NS-19504,-8.965410,x0678,active-noncovalent
Cc1c(c(n[nH]1)C(F)(F)F)Cc2c(c3c(=O)n(c(=O)n(c3s2)C(C)C)C)C(=O)N4C[C@](CO4)(C)O,AZD3965,-8.965068,x1077,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)C,cetrimonium,-8.964239,x0161,active-noncovalent
CCCOc1ccc2c(n1)c(c[nH]2)C3=CC[NH2+]CC3,CP-94253,-8.963996,x0195,active-noncovalent
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)[O-])C(=O)N,avibactam,-8.962753,x0397,active-noncovalent
CC[C@@](C)(C[NH+](C)C)OC(=O)c1ccccc1,amyleine,-8.962002,x0161,active-noncovalent
c1c2c(cc(c1Cl)Cl)[N@@]3CC[NH2+]C[C@@H]3C(=O)N2,WAY-161503,-8.961515,x0195,active-noncovalent
c1cc(c(cc1I)F)Nc2c(ccc(c2F)F)C(=O)N3CC(C3)([C@@H]4CCCC[NH2+]4)O,cobimetinib,-8.961427,x0161,active-noncovalent
c1ccc(cc1)C(=CCC[N@H+]2CCC[C@@H](C2)C(=O)[O-])c3ccccc3,SKF-89976A,-8.960825,x0678,active-noncovalent
CN(C(=O)CCc1cc(n(n1)c2ccc(cc2)OC)c3ccc(cc3)Cl)O,tepoxalin,-8.960777,x1077,active-noncovalent
Cc1ccc(o1)/C=N/NC(=O)c2ccccc2Oc3ccccc3,PNU-74654,-8.960410,x0678,active-noncovalent
Cc1cc(c(n1c2ccccc2)C)/C=c/3\c(=O)n4c5ccccc5nc4s3,ITX3,-8.959538,x0161,active-noncovalent
CC[NH+](CCCc1ccccc1)CCCc2ccccc2,alverine,-8.959128,x0104,active-noncovalent
Cc1ccc(c(c1)[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)O,tolterodine,-8.958519,x0195,active-noncovalent
C1C[C@H](N(C1)C(=O)C[NH2+]C23C[C@H]4C[C@@H](C2)CC(C4)(C3)O)C#N,vildagliptin,-8.958366,x0678,active-noncovalent
c1ccc(cc1)C(=O)NC2CC[NH+](CC2)CCc3c[nH]c4c3cccc4,indoramin,-8.957365,x0161,active-noncovalent
CN(C)c1ccc2c(c1)Sc3cc(ccc3N2)N(C)C,leucomethylene-blue,-8.957329,x0749,active-covalent
C[C@@H](c1ccccc1)NC(=O)c2c(ccs2)OCc3ccc(cc3)Cl,AS-1949490,-8.956342,x0749,active-covalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)O2)CCC4=CC(=O)C=C[C@]34C,testolactone,-8.955894,x0749,active-covalent
c1ccc(cc1)/C=c\2/c(=C\c3ccc(o3)c4ccccc4F)/c(=O)n([nH]2)c5ccc(cc5)C(=O)[O-],GS-143,-8.955709,x0434,active-noncovalent
CC(=O)Oc1ccccc1C(=O)Oc2ccccc2OC,guacetisal,-8.955244,x1093,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1CCC(=O)N2)O,carteolol,-8.953836,x0104,active-noncovalent
C=CCc1ccc(c(c1)c2cc(ccc2O)CC=C)O,magnolol,-8.953657,x0946,active-noncovalent
c1cc(oc1/C=N/N2C[C@H](OC2=O)C[NH+]3CCOCC3)N(=O)=O,furaltadone,-8.952264,x0104,active-noncovalent
CCC[NH+](CCC)[C@H]1CCc2ccc(cc2C1)O,7-hydroxy-DPAT,-8.951046,x0749,active-covalent
c1ccc2c(c1)[nH]c(n2)c3c(c4cc(ccc4[nH]c3=O)Cl)N[C@@H]5C[NH+]6CCC5CC6,CHIR-124,-8.950308,x0104,active-noncovalent
CCCCCCCCc1ccc(cc1)CCC(CO)(CO)[NH3+],fingolimod,-8.949097,x0161,active-noncovalent
c1ccc2c(c1)c(cs2)CNS(=O)(=O)N,JNJ-26990990,-8.946698,x0678,active-noncovalent
CC(C)OC(=O)c1cc2c([nH]1)cccc2OC[C@H](C[NH2+]C(C)(C)C)O,SDZ-21009,-8.945505,x0195,active-noncovalent
c1cc2cc(ccc2nc1)Cn3c4c(ncc(n4)c5cnn(c5)CCO)nn3,PF-04217903,-8.945086,x0072,active-noncovalent
C=CC(=O)c1ccc2ccccc2c1,JAK3-inhibitor-V,-8.944732,x0195,active-noncovalent
C=C[C@H]1[C@@H](OC=C2C1=CCOC2=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,gentiopicrin,-8.943614,x0107,active-noncovalent
c1cc2c(cc1Cl)[nH]c(c(c2=O)C(=O)C3CC3)[O-],L-701252,-8.942568,x0749,active-covalent
c1cc2c(cc[nH]c2=O)cc1OC3CC[NH2+]CC3,SAR407899,-8.942403,x0107,active-noncovalent
c1ccc2c(c1)C(=C(C2=O)c3ccc(cc3)Cl)[O-],chlorindione,-8.942376,x0749,active-covalent
CC(=O)Oc1cc2c(s1)CC[N@@H+](C2)[C@H](c3ccccc3F)C(=O)C4CC4,prasugrel,-8.942296,x0104,active-noncovalent
C[N@@]1CC[N@@]2c3c1cccc3[C@H]4[C@@H]2CC[N@@H+](C4)CCCC(=O)c5ccc(cc5)F,lumateperone,-8.941424,x0072,active-noncovalent
Cc1ccc(cc1)c2cn3c4c(sc3[nH+]2)CCCC4,pifithrin-cyclic,-8.940604,x0749,active-covalent
Cc1nc2ccc(cc2c(=O)n1C[C@H]3CCC[N@H+](C3)C(C)C)Oc4ccc(cc4)F,YIL-781,-8.939627,x0104,active-noncovalent
CC(C)n1c(ccn1)c2c(cccn2)COc3cccc(c3C=O)O,hemoglobin-modulators-1,-8.937109,x0195,active-noncovalent
COc1cc2c(cc1OC)nc(nc2NC3CCCCCC3)N4CCC(CC4)[NH+]5CCCCC5,C-021,-8.936455,x0434,active-noncovalent
C[C@@H]1C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1[C@H](C=O)O)C)O)F)C,desoximetasone,-8.936263,x0749,active-covalent
C1CCc2c(c(c3c([nH+]2)CCC3)N)C1,ipidacrine,-8.935726,x0749,active-covalent
c1cc2cnccc2c(c1)S(=O)(=O)NCC[NH+]=C(N)N,HA-1004,-8.935545,x0540,active-noncovalent
CCCCOc1ccc(cc1)CC/C=C\2/C(=O)N(C(=O)S2)CC[NH3+],K145,-8.935119,x1093,active-noncovalent
CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O)O,epoprostenol,-8.934647,x0161,active-noncovalent
c1cc(c(c(c1)F)Cn2cc(nn2)C(=O)N)F,rufinamide,-8.933000,x0678,active-noncovalent
Cc1cc(ccc1n2c(ccc2c3ccc(cc3)n4ccnc4)CCC(=O)[O-])C(=O)N,N6022,-8.932371,x0107,active-noncovalent
CCC[N@H+](CCc1cccs1)[C@H]2CCc3c(cccc3O)C2,rotigotine,-8.930602,x0678,active-noncovalent
Cc1cccc(c1)OC[C@H](C[NH2+]CCc2ccc(c(c2)OC)OC)O,bevantolol,-8.929432,x0104,active-noncovalent
CC[NH+](CC)[C@H](C)C(=O)c1ccccc1,amfepramone,-8.929401,x0161,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,hydrocortisone,-8.928353,x0072,active-noncovalent
c1cc(ccc1CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,salidroside,-8.927611,x0749,active-covalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)[C@H]3C[C@@H]4C[C@H]3C=C4,cyclothiazide,-8.927109,x0195,active-noncovalent
c1ccc(cc1)/[NH+]=C(/c2cccs2)\N,LTA,-8.926369,x1093,active-noncovalent
C[C@@H]1CCc2c(cc(c(c2Br)F)Br)N1C=O,CE3F4,-8.926040,x0195,active-noncovalent
CCSc1ccc2c(c1)N(c3ccccc3S2)CCCN4CC[NH+](CC4)C,thiethylperazine,-8.925845,x0195,active-noncovalent
CC(C)CNc1ccnc(n1)NCc2csc(n2)c3ccccc3,KHS-101,-8.925818,x0072,active-noncovalent
C[C@@H]1CCC[C@H](/C=C\C(=O)O[C@]23[C@@H](/C=C/C1)[C@@H](C(=C)[C@H]([C@H]2[C@@H](NC3=O)Cc4ccccc4)C)O)O,cytochalasin-b,-8.924711,x0195,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(c3ccc(cc3)Br)O)F,bromperidol,-8.924329,x0161,active-noncovalent
CC(C)(C)c1cc2nnc(n2nc1OCc3ncnn3C)c4cc(ccc4F)F,L-838417,-8.924032,x0195,active-noncovalent
C[C@@H](c1ccc2c(c1)c(=O)oc3c2cc(c(c3)OCc4ccc(cc4)OC)OC)O,palomid-529,-8.923805,x1077,active-noncovalent
CCOC(=O)C1=C(Oc2ccc(cc2[C@@H]1[C@@H](C#N)C(=O)OCC)Br)[NH3+],HA-14-1,-8.923680,x0195,active-noncovalent
CCOc1cc(cc(c1OCC)OCC)C(=O)Nc2ccc(c(c2)c3[nH]c4ccccc4n3)Cl,SANT-2,-8.923345,x0104,active-noncovalent
c1ccc2c(c1)c3c(o2)C(=NCC(=O)N3)c4cccc(c4)Br,5-BDBD,-8.923232,x0195,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,pyrantel-tartrate,-8.923189,x0678,active-noncovalent
CN1CCC[NH+]=C1/C=C/c2cccs2,pyrantel-pamoate,-8.923189,x0678,active-noncovalent
C[N@H+]1Cc2c(cccc2N)[C@@H](C1)c3ccccc3,nomifensine,-8.923178,x0161,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,progesterone,-8.923118,x1077,active-noncovalent
COc1ccc(cc1)C(=O)/C(=C/C(=O)[O-])/Br,bromebric-acid,-8.921595,x0749,active-covalent
Cc1c2cc(ccc2sc1S(=O)(=O)Nc3ccc(c(c3)N4CC[NH2+]CC4)OC)Cl,SB-271046,-8.921076,x0161,active-noncovalent
c1ccc(c(c1)C(=O)[O-])NC(=O)C23CC4CC(C2)CC(C4)C3,anthranilic-acid,-8.920912,x0749,active-covalent
c1cc(sc1)C(=O)c2ccc(c(c2Cl)Cl)OCC(=O)[O-],tienilic-acid,-8.919909,x0749,active-covalent
COCCOc1cc2c(cc1OCCO)c(ncn2)Nc3cccc(c3)C#C,OSI-420,-8.919124,x0161,active-noncovalent
c1ccc(cc1)C[NH+]2CCN(CC2)S(=O)(=O)c3ccc(cc3N(=O)=O)Cl,RN-1747,-8.918812,x0946,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCC2)(C3CCCCC3)O,procyclidine,-8.917593,x1093,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])N3C(=O)c4ccccc4C3=O,RG108,-8.916986,x0831,active-covalent
CC(=O)NCCc1c[nH]c2c1cc(c(c2)Cl)OC,6-chloromelatonin,-8.915622,x0161,active-noncovalent
C[NH+](C)CCn1c(=O)c2cccc3c/c(=N/C(=O)N)/cc(c1=O)[C@@H]32,UNBS-5162,-8.915493,x0195,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)OC,melatonin,-8.913157,x0104,active-noncovalent
COc1cc(ccc1O)C[C@@H](CO)[C@@H](Cc2ccc(c(c2)OC)O)CO,secoisolariciresinol-(-),-8.912988,x0161,active-noncovalent
CCc1ccc(cc1)OCc2ccccc2C(=O)Nc3ccc4c(c3)c(cc([nH+]4)C)N,JTC-801,-8.912385,x1093,active-noncovalent
Cc1ccc(cc1Nc2ccc3c(c2)c(=O)n(cn3)C)NC(=O)c4cccc(c4)C(C)(C)C#N,AZ-628,-8.911637,x0104,active-noncovalent
C/C(=C(/C#N)\C(=O)Nc1ccc(cc1)C(F)(F)F)/O,teriflunomide,-8.911253,x0749,active-covalent
c1cc(ccc1c2c(c(nc(c2C#N)SCC(=O)N)N)C#N)OCC3CC3,BAY-60-6583,-8.910889,x0195,active-noncovalent
CC(C)n1c2ccccc2c(c1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)c3ccc(cc3)F,fluvastatin,-8.910583,x0161,active-noncovalent
c1ccc(cc1)n2c(ccn2)NS(=O)(=O)c3ccc(cc3)N,sulfaphenazole,-8.909131,x0749,active-covalent
CCC[N@@+]12[C@H]3C[C@@H]([C@@H]([C@H]1O)CC)[C@H]4[C@@H]2C[C@@]5([C@H]3[N@](c6c5cccc6)C)[C@H]4O,neo-gilurytmal,-8.909109,x0749,active-covalent
Cc1ccc(cc1)CC2(CC[NH+](CC2)CCOc3ccc(cc3)O)O,CO-101244,-8.908525,x0434,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,alfaxalone,-8.907814,x0749,active-covalent
Cc1cc(nc2c1c(c(s2)C(=O)NCc3ccc(cc3)OC)N)C,VU-152100,-8.907442,x0161,active-noncovalent
CS(=O)(=O)c1cc(cc2c1n(c3c2CC[C@@H]3CC(=O)[O-])Cc4ccc(cc4)Cl)F,laropiprant,-8.907263,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C,ethisterone,-8.907250,x0749,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1cc(ccc1Cl)Cl)O,cloranolol,-8.906892,x0104,active-noncovalent
C/N=c\1/nc(n(s1)c2ccccc2)c3ccccc3,SCH-202676,-8.906518,x0195,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5ccccc5C4=O)[O-])(C(=O)C)O)[NH3+])O,idarubicin,-8.905663,x0161,active-noncovalent
CCC[N@@H+]1CCC[C@H]2[C@H]1Cc3c[nH]nc3C2,quinpirol-(-),-8.903880,x1418,active-covalent
CCC[NH2+][C@H]1CCc2c(sc(n2)N)C1,pramipexole,-8.901696,x0678,active-noncovalent
C[C@@H](Cc1ccccc1)[N@@H+](C)CC#C,selegiline,-8.901691,x0161,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,hyodeoxycholic-acid,-8.901196,x0104,active-noncovalent
C[C@H]1[C@H](Cc2ccccc2O1)[NH+](C)C,trebenzomine,-8.900448,x0195,active-noncovalent
CCn1c(c([nH]c1=O)c2ccccc2)[O-],ethotoin,-8.900129,x0195,active-noncovalent
c1ccc(cc1)Sc2c3cc(ccc3n(c2C(=O)[O-])Cc4ccc(cc4)Cl)Cl,nTZDpa,-8.899461,x1093,active-noncovalent
CC(C)c1ccc(cc1)c2cc(=O)c3ccccc3o2,MN-64,-8.896603,x0104,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CCC6)[C@@H](O2)[C@H](CC5)O)O)O,nalbuphine,-8.895498,x1077,active-noncovalent
c1ccc(c(c1)C2CCN(CC2)C(=O)Nc3ccccc3C(=O)[O-])C(F)(F)F,A-1120,-8.895464,x0161,active-noncovalent
Cc1cc(no1)C(=O)NNCc2ccccc2,isocarboxazid,-8.895260,x0678,active-noncovalent
c1ccc(cc1)S(=O)(=O)[N@@](CC(F)(F)F)c2ccc(cc2)C(C(F)(F)F)(C(F)(F)F)O,T-0901317,-8.894518,x1077,active-noncovalent
C[C@H](CCCCC(=O)Nc1ccc(cc1)C(F)(F)F)[NH2+]CCc2cnc[nH]2,HTMT,-8.894108,x0161,active-noncovalent
CCOP(=S)(OCC)Oc1ccc2c(c(c(=O)oc2c1)Cl)C,coumophos,-8.893631,x0749,active-covalent
Cc1ccc(c(c1)OCC2=[NH+]CCN2)C(C)C,tymazoline,-8.893587,x0195,active-noncovalent
c1cc2c(cc1C#N)c(c[nH]2)CCCC[NH+]3CCN(CC3)c4ccc5c(c4)cc(o5)C(=O)N,vilazodone,-8.891726,x0395,active-noncovalent
CCC[NH2+][C@@H]1CCc2c(cccc2OC)[C@@H]1C,AJ76-(+),-8.891234,x0195,active-noncovalent
C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)n2ccc(=O)[nH]c2=O)(C)F)O)Oc3ccccc3,sofosbuvir,-8.890982,x0195,active-noncovalent
C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)n2ccc(=O)[nH]c2=O)(C)F)O)Oc3ccccc3,PSI-7976,-8.890982,x0195,active-noncovalent
CC1(CCC(c2c1cc(c(c2)/C=C/c3ccc(cc3)C(=O)[O-])Cn4cccn4)(C)C)C,palovarotene,-8.890108,x1077,active-noncovalent
CCCCCCCCCCCCOS(=O)(=O)O,sodium-dodecyl-sulfate,-8.889218,x0072,active-noncovalent
CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)[NH3+])O,sphingosylphosphorylcholine,-8.889180,x0678,active-noncovalent
CCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)Br)[O-])Br,benzbromarone,-8.888633,x0831,active-covalent
CC(C)c1cc(c(cc1Cc2cnc(nc2N)N)OC)OC,RO-3,-8.888500,x0678,active-noncovalent
Cn1cc(c(=O)c2c1cc(cc2)F)[S@](=O)C,flosequinan,-8.887328,x0195,active-noncovalent
c1ccc2c(c1)ccc(n2)/C=C/C(=O)c3ccncc3,PFK-015,-8.886244,x0946,active-noncovalent
c1cc(c(cc1F)F)n2cc(c(=O)c3c2nc(c(c3)F)N4C[C@@H]5[C@H](C4)C5[NH3+])C(=O)[O-],trovafloxacin,-8.885742,x0749,active-covalent
C[C@@H]1COCC[N@@]1c2cc(nc(n2)c3cccc4c3cc[nH]4)C5(CC5)S(=O)(=O)C,AZ20,-8.885229,x0434,active-noncovalent
Cc1ccc(cc1)Sc2cncc3c2cc(s3)C(=O)N,A205804,-8.881916,x1093,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)COC(=O)C(C)(C)C)C)O)Cl)C)F,clocortolone-pivalate,-8.881009,x0161,active-noncovalent
CC[N+](CC)(CC)CCOc1ccc(cc1)/C=C/c2ccccc2,MG-624,-8.880240,x0104,active-noncovalent
COc1ccc(cc1)C2=C(c3ccccc3C2=O)[O-],anisindione,-8.880160,x0749,active-covalent
C[C@H](CCCC(C(F)(F)F)(C(F)(F)F)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,falecalcitriol,-8.879029,x0104,active-noncovalent
c1cc(ccc1CCCOCCC[NH+]2CCCCC2)Cl,BF2.649,-8.877316,x0195,active-noncovalent
Cc1c(cccc1Cl)Nc2ccccc2C(=O)[O-],tolfenamic-acid,-8.877217,x0749,active-covalent
C[NH+](C)CC/C=C\1/c2ccccc2COc3c1cc(cc3)CC(=O)[O-],olopatadine,-8.877043,x0072,active-noncovalent
CN1CCC[NH+]=C1COC(=O)[C@](c2ccccc2)(C3CCCCC3)O,oxyphencyclimine,-8.875534,x0104,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)NCCO,oleoylethanolamide,-8.875390,x0161,active-noncovalent
C[NH+](C)CC[C@H](c1ccccc1)c2ccccn2,pheniramine,-8.874435,x0195,active-noncovalent
c1ccc(cc1)CNC(=O)OCCO,buramate,-8.872669,x0678,active-noncovalent
C[C@H](CCC[NH3+])Nc1cc(cc2c1nccc2)OC,primaquine,-8.872667,x0195,active-noncovalent
CCCCc1ccc(cc1O)O,rucinol,-8.871273,x0195,active-noncovalent
Cn1c(ncn1)COc2c(cc3nnc(n3n2)c4c(cccc4F)F)C5CCC5,MRK-409,-8.870874,x0195,active-noncovalent
c1cc(ccc1c2c(c(nc(c2C#N)SCc3[nH]ccn3)N)C#N)O,LUF-5834,-8.869262,x0107,active-noncovalent
Cc1ccc(cc1C)n2c(=O)c(c([nH]2)C)/N=N/c3cccc(c3O)c4cccc(c4)C(=O)[O-],eltrombopag,-8.869245,x0072,active-noncovalent
COc1cccc(c1c2ccc(cc2)C[C@@H](C(=O)[O-])NC(=O)c3c(cccc3Cl)Cl)OC,SB-683698,-8.868683,x0161,active-noncovalent
c1ccc(c(c1)C[NH3+])Sc2ccccc2CO,bipenamol,-8.867262,x0434,active-noncovalent
CCOc1ccc(cc1OCC)Cc2c3cc(c(cc3ccn2)OCC)OCC,ethaverine,-8.866529,x0161,active-noncovalent
CC/C(=C(\c1ccc(cc1)O)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,afimoxifene,-8.866489,x0072,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH+]2CCC(CC2)(c3ccccc3)O,traxoprodil,-8.865337,x0072,active-noncovalent
Cc1c2c(oc1S(=O)(=O)[O-])-c3ccc4c(c3C(=O)C2=O)CCCC4(C)C,sodium-tanshinone-ii-a-sulfonate,-8.865053,x0104,active-noncovalent
Cc1cc(c(c(=O)o1)C2=NCCS[C@@H](C2)c3ccc(cc3OC)OC)[O-],KF-38789,-8.864925,x0195,active-noncovalent
c1ccnc(c1)c2c(cn[nH]2)c3ccnc(c3)c4ccc(cc4)C(=O)NC5CCOCC5,GW-788388,-8.864747,x0104,active-noncovalent
c1ccc2c(c1)ccc3c2nc(s3)N,SKA-31,-8.864293,x0195,active-noncovalent
C[C@@]12CC[N@H+]([C@@H]1[N@@](c3c2cc(cc3)O)C)C,eseroline-(-),-8.863729,x0195,active-noncovalent
CN(C)/C=[NH+]/c1c(cc(c(c1I)CCC(=O)[O-])I)I,iopodic-acid,-8.863449,x0195,active-noncovalent
[H]/N=C(/[C@H](C#N)c1ccccc1C(F)(F)F)\Sc2ccc(cc2)N,MEK1-2-inhibitor,-8.863404,x0830,active-covalent
COc1ccc(cc1OC)c2cc3nccn3c(n2)Nc4c(cccn4)C(=O)N,BAY-61-3606,-8.862119,x0195,active-noncovalent
CCCn1c(=O)c2c(nc[nH]2)n(c1=O)c3ccc(cc3)Cl,arofylline,-8.861078,x0195,active-noncovalent
c1cc2c(c(c1)N)CN(C2=O)[C@H]3CCC(=O)NC3=O,lenalidomide,-8.861050,x0195,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,deoxycholic-acid,-8.860939,x0072,active-noncovalent
c1cc2c(cc1Cl)c3c([nH]2)[C@@H](CCC3)C(=O)N,EX-527,-8.860684,x0195,active-noncovalent
Cc1cccc(c1)C#C[C@@]2(CCC[C@@H]3[C@H]2CCN3C(=O)OC)O,mavoglurant,-8.860550,x0161,active-noncovalent
c1ccc(cc1)CCCOC(=O)N,phenprobamate,-8.859355,x0072,active-noncovalent
c1ccc2c(c1)CCc3ccccc3C2[NH2+]CCCCCCC(=O)[O-],amineptine,-8.859223,x0072,active-noncovalent
COc1ccn2c(c1)c(cn2)c3c(cc4c(n3)[nH]nc4NC(=O)c5ccc(cc5)F)F,CW-008,-8.857870,x0104,active-noncovalent
c1cc(c(cc1[C@]23C[C@H]2C[NH2+]C3)Cl)Cl,amitifadine,-8.857072,x0749,active-covalent
C[NH+](C)[C@@H](CCOc1cccc2c1cccc2)c3ccccc3,dapoxetine,-8.856596,x0104,active-noncovalent
CC[NH+](CC)CCNC(=O)c1c(/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c1=C)C,sunitinib,-8.856371,x0161,active-noncovalent
c1cc(cc(c1)F)c2c3c(cccn3)cc(n2)C4CCC(CC4)C(=O)[O-],"trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",-8.855563,x0678,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2([C@H](C=O)O)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,triamcinolone,-8.855529,x0749,active-covalent
CCCCCCc1ccc(cc1O)O,hexylresorcinol,-8.853708,x0749,active-covalent
C[C@@H]1C[C@@H](c2c1c(ncn2)N3CCN(CC3)C(=O)[C@H](C[NH2+]C(C)C)c4ccc(cc4)Cl)O,GDC-0068,-8.851877,x0072,active-noncovalent
c1c(c(c(c(c1Cl)Cl)Cc2c(c(cc(c2Cl)Cl)Cl)O)O)Cl,hexachlorophene,-8.850200,x0830,active-covalent
CC1([C@@H]([C@H](c2cc(ccc2O1)C#N)N(Cc3[nH]ccn3)c4ccc(cc4)Cl)O)C,BMS-191095,-8.850122,x0678,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCCCn3c(ccc3O)O,MM77,-8.849784,x0195,active-noncovalent
CC(=O)Oc1ccc2c(c1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C,estradiol-acetate,-8.849564,x0749,active-covalent
C[C@@H](CCCC(C)(C)OC)C/C=C/C(=C/C(=O)OC(C)C)/C,methoprene-(s),-8.849092,x0195,active-noncovalent
c1ccc(cc1)C2=NO[C@H](C2)CC(=O)[O-],VGX-1027,-8.847785,x0830,active-covalent
C[N@@H+]1CCCC[C@H]1CCN2c3ccccc3Sc4c2cc(cc4)[S@@](=O)C,mesoridazine,-8.846491,x0195,active-noncovalent
c1cc2c(c[nH]c2nc1)C[NH+]3CCN(CC3)c4ccc(cc4)Cl,L-745870,-8.845886,x0161,active-noncovalent
CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34,desogestrel,-8.845607,x0749,active-covalent
c1ccc(cc1)C[C@@H](CN(C(=O)Cc2ccccc2)O)C(=O)[O-],CPA-inhibitor,-8.844980,x0397,active-noncovalent
C[C@@H]1CS[C@@H]2/C(=N\C(=O)[C@@H](c3ccccc3)[NH3+])/C(=O)N2[C@H]1C(=O)[O-],cephalexin,-8.844219,x0830,active-covalent
C1CCC(CC1)C(C[C@H]2CCCC[NH2+]2)C3CCCCC3,perhexiline,-8.843599,x0195,active-noncovalent
c1cc2cc(sc2c(c1)Cl)C(=O)N[C@H]3C[NH+]4CCC3CC4,EVP-6124,-8.843389,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,drospirenone,-8.842269,x0749,active-covalent
Cc1nc(c(nc1c2ccc(cc2)[C@H]3CC[C@@H](CC3)CC(=O)[O-])C(=O)N)C,AZD7687,-8.840893,x0104,active-noncovalent
Cn1cc(cn1)c2ccc3nnc(n3n2)C(c4ccc5c(c4)cccn5)(F)F,JNJ-38877605,-8.840340,x0830,active-covalent
C[N+](C)(CCOc1ccccc1)Cc2ccccc2,bephenium-hydroxynaphthoate,-8.840194,x0678,active-noncovalent
CCCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,bupivacaine,-8.840055,x0874,active-noncovalent
C[C@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4([C@@]3([C@H](C[C@]2([C@@]1(C(=O)CO)O)C)O)Cl)C,beclomethasone,-8.839439,x0874,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,pregnanolone,-8.838748,x0749,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,allopregnanolone,-8.838748,x0749,active-covalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,eltanolone,-8.838284,x0749,active-covalent
C=CCNC(=O)c1cc(cc2c1nc([nH]c2=O)Nc3ccc(c(c3)Cl)Cl)N(=O)=O,AZ-10417808,-8.838186,x0678,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1SC)O,tiprenolol,-8.836755,x0104,active-noncovalent
c1cc2c(cc[nH]2)cc1C(=O)N,SD-169,-8.835009,x0678,active-noncovalent
c1ccc(cc1)c2ccccc2NC(=O)CCCCCCCn3cc(nn3)c4cccnc4,GPP-78,-8.834772,x0161,active-noncovalent
c1ccnc(c1)[C@H](c2ccc(cc2)Cl)OC3CC[NH+](CC3)CCCC(=O)[O-],bepotastine,-8.834699,x0072,active-noncovalent
Cc1c(c2cc(ccc2nc1c3ccc(cc3)c4ccccc4F)F)C(=O)[O-],brequinar,-8.833302,x0104,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](c3ccccc3)O,homatropine,-8.832844,x0072,active-noncovalent
C(CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-])C[NH3+],alendronate,-8.832735,x0397,active-noncovalent
C[C@]12C[C@@H]([C@@H]3[C@H]([C@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C)O,prednisolone,-8.831224,x0967,active-noncovalent
C[N+]1(CCC(CC1)OC(=O)C(c2ccccc2)c3ccccc3)C,4-DAMP,-8.830452,x1093,active-noncovalent
c1cc(sc1)CCOC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,2-TEDC,-8.830167,x0107,active-noncovalent
c1ccc(cc1)C(=O)Oc2cccc3c2nccc3,benzoxiquine,-8.829908,x0195,active-noncovalent
c1ccc2c(c1)-c3ccccc3C2NC(=O)NC(=O)c4c(cccc4Cl)F,TMN-355,-8.828473,x0107,active-noncovalent
C=C[C@H]1C[N@@H+]2CC[C@H]1C[C@@H]2[C@@H](c3ccnc4c3cccc4)O,cinchonine,-8.828203,x0749,active-covalent
CCCCCCCC[N+](C)(C)Cc1ccccc1,benzyldimethyloctylammonium,-8.828173,x0161,active-noncovalent
c1cc(c(cc1[C@H]([C@@H](C(=O)[O-])[NH3+])O)O)O,droxidopa,-8.827576,x0107,active-noncovalent
c1cc(c(c(c1)Cl)C/N=N/C(=[NH2+])N)Cl,guanaben-acetate,-8.827070,x0195,active-noncovalent
CCn1c2ccccc2c3c1ccc(c3)Nc4ccnc(n4)NCCC[NH+]5CCOCC5,EHop-016,-8.826856,x0161,active-noncovalent
CC(=O)N1CCC(CC1)NC(=O)c2ccc(cc2)F,FK-962,-8.826716,x0749,active-covalent
C[NH+]1CCN(CC1)CC/C=C/2\c3ccccc3Sc4c2cc(cc4)S(=O)(=O)N(C)C,thiothixene,-8.825116,x1077,active-noncovalent
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c2c[nH]c3c2cc(cn3)Cl)F,PLX-4720,-8.823878,x1077,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)[C@H](c2cccc(c2)O)[N@]3C[C@H]([N@@H+](C[C@@H]3C)CC=C)C,BW-373U86,-8.823284,x0104,active-noncovalent
c1ccc(cc1)[C@H]2c3cc(ccc3N(C(=O)C=N2)CC(=O)NN)Br,gidazepam,-8.822670,x1077,active-noncovalent
c1ccc(cc1)Oc2c(cc(cc2S(=O)(=O)N)C(=O)[O-])N3CCCC3,piretanide,-8.822509,x1418,active-covalent
CCn1cc[nH+]c1C[C@H]2COc3ccccc3O2,imiloxan,-8.821628,x0749,active-covalent
CC[C@@]1(Cc2ccccc2O1)C3=[NH+]CCN3,efaroxan,-8.821620,x0434,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])[NH3+],methyldopa,-8.820736,x1374,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl,fenofibric-acid,-8.820396,x0072,active-noncovalent
c1cc2cccc3c2c(c1)[N@](S3(=O)=O)CCC[NH+]4CCN(CC4)c5ccc(cc5)F,fananserin,-8.819551,x0104,active-noncovalent
c1cc(ccc1CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,econazole,-8.819098,x0195,active-noncovalent
COc1ccc(cc1)CC[NH+]2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(cc5)F,astemizole,-8.818944,x0161,active-noncovalent
c1ccc2c(c1)nc(s2)SNC3CCCCC3,"CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide",-8.818037,x1093,active-noncovalent
CC(C)(C(=O)N1CSC[C@@H]1C(=O)[O-])Oc2ccc(cc2)Cl,timofibrate,-8.817378,x0749,active-covalent
C[NH+]1CCN(CC1)CC(=O)N(C)c2ccc(cc2)/N=C(/c3ccccc3)\c4c5ccc(cc5[nH]c4O)C(=O)OC,nintedanib,-8.815075,x0434,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccccc1Cl)O,clorprenaline,-8.815065,x0678,active-noncovalent
C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,dienogest,-8.813466,x0749,active-covalent
Cc1cccc(c1NC(=O)c2ccc(cc2)N)C,ameltolide,-8.813285,x0749,active-covalent
CN1CC[NH+](CC1)CCc2ccc(c(c2)Cl)Cl,BD-1063,-8.813173,x1077,active-noncovalent
c1ccc(cc1)c2cc(n(n2)c3ccccc3F)NC(=O)c4ccc(cc4)N(=O)=O,VU1545,-8.811732,x0104,active-noncovalent
c1cc(nc(c1)Cl)N2CCC(CC2)[NH3+],SR-57227A,-8.811656,x0195,active-noncovalent
COc1ccc2c(c1)c(ccn2)[C@@H]([C@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C)O,quinidine,-8.810711,x0104,active-noncovalent
CCc1c(c(on1)C)c2c(c3ccccc3[nH]2)[C@H](C[NH+](C)C)O,sari-59-801,-8.809806,x0708,active-covalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,dexamethasone,-8.809409,x0749,active-covalent
c1cc(nc(c1)Cl)SC2CC[NH2+]CC2,anpirtoline,-8.809197,x0195,active-noncovalent
C=CC(=O)Nc1ccc2c(c1)c(ncn2)Nc3cccc(c3)Br,PD-168393,-8.808498,x0874,active-noncovalent
CC[C@H](/C=C/[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C,stigmasterol,-8.808438,x0161,active-noncovalent
c1ccc(cc1)CNc2c3ccccc3nc(n2)NCc4ccccc4,DBeQ,-8.808304,x0434,active-noncovalent
c1c(ccc(c1)NC(=O)c2oc(nn2)Nc3cc(c(cc3)F)F)[C@H]4CC[C@@H](CC4)CC(=O)[O-],AZD3988,-8.806720,x0104,active-noncovalent
CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)[C@H](C=O)O,hydrocortisone-butyrate,-8.806053,x0967,active-noncovalent
Cc1ccc(cc-2c(cc(c12)S(=O)(=O)[O-])C)C(C)C,sodium-gualenate,-8.805702,x0749,active-covalent
CCCOC(c1ccccc1)(c2ccccc2)C(=O)OC3CC[NH+](CC3)C,propiverine,-8.805073,x0678,active-noncovalent
Cc1cc(cc(c1)OC[C@H]2CNC(=O)O2)C,metaxalone,-8.804835,x0749,active-covalent
c1ccc2c(c1)CCN([C@H]2c3ccc(cc3)C(F)(F)F)C(=O)Nc4ccc(cc4)F,TC-I-2000,-8.804070,x0434,active-noncovalent
c1cc(ccc1C(=O)c2c(cc(cc2Cl)Cn3c(c(nn3)C(=O)N)N)Cl)Cl,carboxyamidotriazole,-8.802904,x0195,active-noncovalent
c1cc(ccc1C(=O)NCCS(=O)(=O)c2ccc(cn2)C(F)(F)F)Cl,GSK3787,-8.802741,x0195,active-noncovalent
CC[NH+](CC)CC(=O)Nc1c(cccc1C)C,lidocaine,-8.802265,x0195,active-noncovalent
c1cc(ccc1OC[C@H](COC(=O)N)O)Cl,chlorphensin-carbamate,-8.801995,x0678,active-noncovalent
c1ccc2c(c1)c3c(cn2)c(=O)n([nH]3)c4ccc(cc4)Cl,CGS-9896,-8.801147,x0678,active-noncovalent
c1cc(c(cc1Cl)Cc2cc(ccc2O)Cl)O,dichlorophen,-8.800409,x0749,active-covalent
Cc1ccc(cc1C)N2CC[NH+](CC2)CC[C@H]3c4ccccc4C(=O)N3,PD-168568,-8.800306,x0161,active-noncovalent
CCC[NH+](CCC)C1Cc2cc(c(cc2C1)OC)OC,U-99194,-8.798027,x0104,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2,anthralin,-8.798023,x0749,active-covalent
Cc1ccc(cc1)S(=O)(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)OC,TAME,-8.797956,x0195,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F,fluoxymesterone,-8.796730,x1077,active-noncovalent
Cc1cccc(c1)COc2cccc(c2)/C=C/3\C(=O)NN(C3=O)c4ccccc4,Y16,-8.796130,x0161,active-noncovalent
CCOC(=O)Nc1[nH]c2ccccc2n1,lobendazole,-8.795105,x0678,active-noncovalent
CSc1[nH]c2cc(c(cc2n1)Oc3cccc(c3Cl)Cl)Cl,triclabendazole,-8.794949,x0195,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCC(=O)OC)O,esmolol,-8.792412,x0104,active-noncovalent
Cc1cc(nn1c2ccc3ccccc3c2)OCC[NH+]4CCOCC4,API-001,-8.789864,x0161,active-noncovalent
CC1(C(=O)N(C(=O)N1)c2ccc(c(c2)C(F)(F)F)N(=O)=O)C,nilutamide,-8.789750,x0195,active-noncovalent
c1ccc(cc1)C[N@H+]2CN(C(=S)SC2)Cc3ccccc3,sulbentine,-8.788582,x0749,active-covalent
CC[NH+](CC)CCCCN1c2ccccc2Oc3c1cc(cc3)Cl,10-DEBC,-8.788382,x0946,active-noncovalent
c1c(c2c(ncnc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C#N,toyocamycin,-8.788263,x0195,active-noncovalent
c1ccc(cc1)/C(=[NH+]/Nc2ccccc2)/N,CBS-1114,-8.788101,x0749,active-covalent
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,spironolactone,-8.788033,x1077,active-noncovalent
Cc1cc(ccc1NC(=O)[C@H](CCCC[NH3+])[NH3+])c2nc3cc(ccc3s2)F,phortress,-8.787956,x0104,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2nc(c(s2)c3ccc(cc3)OC)c4ccc(cc4)OC,FR-122047,-8.787952,x1093,active-noncovalent
Cc1c(c([nH]c1c2ccccc2F)N)C#N,NS-8,-8.787875,x0195,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])NC(=O)c2c(c3ccc(cc3s2)F)Cl,CU-CPT-4a,-8.787411,x0749,active-covalent
CN([C@H](C[NH+]1CCCC1)c2ccccc2)C(=O)Cc3ccccc3,N-MPPP,-8.785964,x0967,active-noncovalent
COc1cc(cc(c1OC)OC)c2cc(cnc2N)c3cccc(c3)O,K02288,-8.785391,x0104,active-noncovalent
C[NH+](C)CCCSc1ccccc1NC(=O)/C=C/c2ccccc2,cinanserin,-8.784956,x0161,active-noncovalent
CC(C)[NH+](CC[C@H](c1ccccc1)c2cc(ccc2O)CO)C(C)C,5-hydroxymethyl-tolterodine,-8.784799,x0195,active-noncovalent
c1ccc2c(c1)CCC[C@H]2C3=[NH+]CCN3,tetrahydrozoline,-8.784272,x0678,active-noncovalent
COc1cc(ccc1OCc2ccccc2)CN(CC[NH3+])C(=O)c3cccs3,M8-B,-8.782948,x0104,active-noncovalent
CCCc1ncc(c(n1)N)C[n+]2ccccc2C,amprolium,-8.782370,x1093,active-noncovalent
c1c2c([nH]c(=O)[nH]c2=O)n[nH]1,oxypurinol,-8.781333,x0678,active-noncovalent
c1ccc(cc1)[C@@H]2CC(=O)N(C2)CC(=O)N,phenylpiracetam,-8.780479,x0749,active-covalent
c1ccc2c(c1)C(=O)C(=C(C2=O)SCCO)SCCO,NSC-95397,-8.780443,x0749,active-covalent
C[NH+](C)CCCN1c2ccccc2Sc3c1cccc3,promazine,-8.780368,x0874,active-noncovalent
c1c(cc(c(c1)Cl)Cl)/C=C/c2c(cc(c(c2)/C=C/c3cc(c(cc3)Cl)Cl)N(=O)=O)N(=O)=O,NSC636819,-8.780025,x0104,active-noncovalent
CC(C)(C)c1cc(no1)C(=O)[C@H](C#N)/N=N/c2cccc(c2)Cl,ESI-09,-8.779360,x0195,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1CC=C)O,alprenolol,-8.778784,x0678,active-noncovalent
Cn1cc(c2c1ncnc2N)c3ccc4c(c3)CCN4C(=O)Cc5cccc(c5)C(F)(F)F,GSK2606414,-8.778352,x0104,active-noncovalent
COc1c(ccc(c1)/C=C\2/C(=O)/C(=C/c3cc(c(cc3)O)OC)/CCC2)O,cyclovalone,-8.778154,x1077,active-noncovalent
Cc1ccc(cc1)c2ccc(cc2COc3ccc(cc3)CCC(=O)[O-])F,TUG-891,-8.776892,x0072,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)Cc2ccccc2,DPPE,-8.776731,x1077,active-noncovalent
c1cc(cc(c1)NC(=O)Nc2ccc(cc2)Cl)c3cccc(n3)N4CCCC4,PSNCBAM-1,-8.776020,x0161,active-noncovalent
Cc1ccc(c(c1)OC[C@H](C[NH2+]C(C)(C)C)O)Cl,bupranolol,-8.774725,x0195,active-noncovalent
CC/C(=C(\c1ccc(cc1)O)/c2ccc(cc2)OCC[NH2+]C)/c3ccccc3,endoxifen,-8.774714,x0072,active-noncovalent
C#Cc1cccc(c1)Nc2c3cc4c(cc3ncn2)OCCOCCOCCO4,icotinib,-8.774289,x0946,active-noncovalent
C[C@@]12c3ccccc3C[C@@H]([NH2+]1)c4c2cccc4,dizocilpine-(+),-8.773538,x0072,active-noncovalent
c1cc2c(cc1C(=O)N3CCCCC3)nccn2,ampalex,-8.773388,x0072,active-noncovalent
C(CCCCC(=O)[O-])CCCC(=O)[O-],disodium sebacate,-8.772362,x0678,active-noncovalent
Cc1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2=O,chrysophanic-acid,-8.770328,x0195,active-noncovalent
c1ccc(cc1)NC(=O)c2ccccc2O,salicylanilide,-8.769087,x0749,active-covalent
CCC(=O)N[C@@H]1CCc2cccc(c2C1)OC,8-M-PDOT,-8.766774,x0195,active-noncovalent
Cc1ccc(cc1)c2csc3c2c(ncn3)SCCC(=O)[O-],TTP-22,-8.766476,x1077,active-noncovalent
[H]/N=C\1/[C@H]([C@@H](c2c(n[nH]c2O1)c3ccc4ccccc4c3)c5cc(ccc5OC)OC)C#N,RBC8,-8.766175,x0749,active-covalent
Cc1c(oc(=O)o1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4,faropenem-medoxomil,-8.765807,x0195,active-noncovalent
CCOC(=O)N1CCC(=C2c3ccc(cc3CCc4c2nccc4)Cl)CC1,loratadine,-8.764781,x0195,active-noncovalent
c1ccc2c(c1)C(=C(C2=O)c3ccc(cc3)Br)[O-],bromindione,-8.763946,x0195,active-noncovalent
c1ccc(cc1)CNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,AG-490,-8.763856,x0678,active-noncovalent
Cc1c(c(on1)C)c2ccc(c(c2)O[C@H]3CC[NH2+]C3)c4cc(c(s4)NC(=O)N)C(=O)N,AZD3264,-8.763084,x1077,active-noncovalent
C[N+](C)(C)[C@@H](Cc1c[nH]c(=S)[nH]1)C(=O)[O-],L-ergothioneine,-8.761266,x0678,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)CO,NSC-4644,-8.761217,x0104,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@]4(c5ccoc5)O)O)C)O,rostafuroxine,-8.760906,x0678,active-noncovalent
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC=C(C4)N=O)C)C,olesoxime,-8.759113,x0161,active-noncovalent
C1CCC(CC1)COc2c(c(nc(n2)N)N)N=O,NU6027,-8.758625,x0749,active-covalent
COc1ccc2cc(ccc2c1)OCC3(CN(C3)C(=O)c4ccc(cc4)F)C(=O)[O-],PF-04418948,-8.758461,x0678,active-noncovalent
c1cc(cc(c1)S(=O)(=O)N2CCCCCC2)C(=O)Nc3cccc(c3)Br,AK-7,-8.757119,x0195,active-noncovalent
CCC[N@@H+]1C[C@H](C[C@H]2[C@H]1Cc3cccc(c3C2)O)NS(=O)(=O)N(CC)CC,quinagolide,-8.756313,x0104,active-noncovalent
C[N@@]1c2cc(c(cc2C[C@H]1S(=O)(=O)[O-])/N=N/C(=O)N)O,carbazochrome,-8.756147,x0749,active-covalent
C[C@@H]([C@@H](Cc1ccc(cc1)Cl)c2cccc(c2)C#N)NC(=O)C(C)(C)Oc3ccc(cn3)C(F)(F)F,taranabant,-8.755572,x0434,active-noncovalent
Cc1ccc(cc1)n2c(=O)n(c(=O)s2)Cc3ccc(cc3)F,CCG-50014,-8.755327,x0195,active-noncovalent
c1cc(cc2c1cc3ccc(cc3n2)N)N,proflavine-hemisulfate,-8.755239,x0749,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c3c(c(=O)c(cn3C4CC4)C(=O)[O-])c(c2F)F)F,orbifloxacin,-8.754795,x0195,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N,carbamazepine,-8.754364,x0072,active-noncovalent
CCC[N@@H+]1CCC[C@H]2[C@H]1Cc3cnc(nc3C2)N,quinelorane,-8.753889,x0195,active-noncovalent
CC[NH+]1CCC(CC1)n2cc(nn2)CNc3cc4c(c(c3)Cl)ncc(c4Nc5ccc(c(c5)Cl)F)C#N,cot-inhibitor-2,-8.752113,x0161,active-noncovalent
c1cnccc1c2cc(c(=O)[nH]c2)N,amrinone,-8.751423,x1077,active-noncovalent
C[C@@H](C(=O)N)[NH2+]Cc1ccc(cc1)OCc2cccc(c2)F,safinamide,-8.751310,x0104,active-noncovalent
CN(c1c(nc(nc1N)c2c3cccnc3n(n2)Cc4ccccc4F)N)C(=O)OC,riociguat,-8.751081,x0195,active-noncovalent
Cc1cc(nnc1NCC[NH+]2CCOCC2)c3ccccc3,minaprine,-8.750826,x0195,active-noncovalent
CN(C)c1ccc2c(c1)sc-3cc(=[N+](C)C)ccc3n2,methylene-blue,-8.749982,x0749,active-covalent
CC(C)C[C@H]1C[N@H+]2CCc3cc(c(cc3[C@@H]2CC1=O)OC)OC,tetrabenazine,-8.749743,x0104,active-noncovalent
C1C[C@H]([NH2+]C1)C(=O)N[C@@H]2CCN(C2=O)CC(=O)N,PAOPA,-8.749611,x0678,active-noncovalent
CCN(C[C@@H](C)O)c1ccc(nn1)NNC(=O)OCC,cadralazine,-8.749064,x0195,active-noncovalent
C[C@@H](c1ccc2nccn2c1)n3c4c(ncc(n4)c5cnn(c5)C)nn3,savolitinib,-8.748552,x0678,active-noncovalent
c1c(c(=O)c2c(ncnc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=O)N,API-1,-8.748464,x1334,active-covalent
c1ccc2c(c1)[nH]c(=S)s2,benzo[d]thiazole-2(3h)-thione,-8.748226,x0678,active-noncovalent
c1cc(ccc1[NH+]=C(N)N)Cl,4-chlorophenylguanidine,-8.747316,x0195,active-noncovalent
CN1CC[NH+](CC1)C(c2ccccc2)c3ccccc3,cyclizine,-8.747169,x0831,active-covalent
CCc1cccc(c1)N(C)C(=[NH2+])Nc2cccc3c2cccc3,aptiganel,-8.746843,x0195,active-noncovalent
[H]/N=C/[C@H](C#N)c1c2ccc(c(c2n(c1C(=O)OCC)C)Cl)Cl,KH-CB19,-8.746327,x0749,active-covalent
C[C@@]12CCC(=O)C=C1CC[C@H]3[C@H]2[C@H](C[C@@]4([C@H]3CC[C@@]4(C(=O)COP(=O)([O-])[O-])O)C)O,hydrocortisone-phosphate,-8.746157,x0072,active-noncovalent
CC1=C([C@H](C2=C(N1)CC(CC2=O)(C)C)c3ccc(cc3)N(=O)=O)C(=O)OC4CCCCC4,FLI-06,-8.745344,x0195,active-noncovalent
CCn1c2c(cc(c1=O)c3ccn[nH]3)c(nc(n2)N)C,voxtalisib,-8.745018,x0678,active-noncovalent
c1cc(c(cc1C=C(C#N)C#N)O)O,tyrphostin-AG-18,-8.744196,x0161,active-noncovalent
CCCC[S@@](=N)(=O)CC[C@@H](C(=O)[O-])[NH3+],buthionine-sulfoximine,-8.744094,x0107,active-noncovalent
c1ccc(cc1)CC2=[NH+]CCN2,tolazoline,-8.743675,x0195,active-noncovalent
c1ccc(cc1)c2c3c(ncnc3oc2c4ccccc4)NC[C@@H]5CCCO5,AIM-100,-8.743301,x0161,active-noncovalent
c1ccc2c(c1)C(=O)C(=N2=O)c3ccccn3,PIT,-8.738877,x0195,active-noncovalent
c1ccc2c(c1)C[C@@H](c3ccccc3N2C(=O)N)O,licarbazepine,-8.738460,x0072,active-noncovalent
CCOC(=O)C[NH+]1CCN(CC1)C(=O)/C=C/c2cc(c(c(c2)OC)OC)OC,cinepazet,-8.738347,x0104,active-noncovalent
C[N+]1(CCc2cc3c(cc2[C@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3)C,bicuculline-methochloride-(-),-8.736514,x0195,active-noncovalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)N,sulfapyridine,-8.735435,x0678,active-noncovalent
c1ccc2c(c1)N(c3ccccc3S2)C[C@H]4C[NH+]5CCC4CC5,levomequitazine,-8.734183,x0072,active-noncovalent
c1cc(ccc1CC2(CCN(CC2)c3c4cc[nH]c4ncn3)[NH3+])Cl,CCT128930,-8.732200,x0072,active-noncovalent
CC[N@@H+](CCC[C@@H](C)Nc1cc[nH+]c2c1ccc(c2)Cl)CCO,hydroxychloroquine,-8.730425,x0874,active-noncovalent
c1cc(c(cc1/C=C(\C#N)/C(=O)N)O)O,tyrphostin-AG-99,-8.730337,x0678,active-noncovalent
Cc1c2c(ccn1)c3ccccc3[nH]2,harmane,-8.729801,x0195,active-noncovalent
Cc1cccc(c1NC(=O)c2ccccc2C(=O)[O-])C,ftaxilide,-8.728564,x0678,active-noncovalent
C/C/1=C\CC/C(=C/[C@@H]2[C@@H](CC1)C(=C)C(=O)O2)/C,costunolide,-8.727715,x0195,active-noncovalent
C[C@@H]1CC[C@H]([C@H](C1)P(=O)(c2ccccc2)c3ccccc3)C(C)C,DPO-1,-8.727564,x0692,active-covalent
c1cc(c(cc1C[NH+]2CCC(CC2)Nc3ccc(nn3)C(F)(F)F)F)F,JNJ-37822681,-8.727447,x0434,active-noncovalent
Cc1c(c(c2c(c1O)[C@@]3(C(=CC(=O)/C(=C(/C)\[O-])/C3=O)O2)C)C(=O)C)O,usniacin-(+),-8.726668,x0749,active-covalent
B([C@@H]1CCCN1C(=O)[C@H](C(C)C)[NH3+])(O)O,talabostat,-8.725707,x0104,active-noncovalent
C[N@@H+]1CCc2cc3c(cc2[C@H]1O)OCO3,hydrastinine,-8.725490,x0195,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)NC(=O)[C@@H]5CCC[NH2+]5,XL019,-8.724927,x0678,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOCC2CC2)O,levobetaxolol,-8.723422,x0104,active-noncovalent
CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CC[NH+](C)C,sumatriptan,-8.722964,x0072,active-noncovalent
c1ccnc(c1)CCNC(=S)Nc2ccc(cn2)Br,trovirdine,-8.722900,x0397,active-noncovalent
c1cc(cc(c1)C(F)(F)F)/C=C/2\C(=O)[N-]C(=O)S2,SMI-4a,-8.722842,x0395,active-noncovalent
c1cc(cc(c1)F)c2cc(c(s2)C(=O)N[C@H]3CCC[NH2+]C3)NC(=O)N,AZD7762,-8.721803,x0161,active-noncovalent
CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3)C,ipratropium,-8.721560,x1392,active-covalent
c1ccc(cc1)c2csc3c2c(=O)n(c(n3)SCC(=O)NN)c4ccccc4,LDN-27219,-8.721227,x0195,active-noncovalent
CNC(=O)Oc1cccc2c1cccc2,carbaril,-8.720993,x0195,active-noncovalent
CC(CC(=O)[O-])(CC(=O)[O-])O,meglutol,-8.720585,x0397,active-noncovalent
COc1ccc(cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3)Cl,glyburide,-8.720565,x0161,active-noncovalent
c1cc(cc(c1)c2c[nH]c3c2c(ncn3)N4CCOCC4)C#N,PF-06447475,-8.720521,x0387,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3ccccc3,mebendazole,-8.720441,x0195,active-noncovalent
c1ccnc(c1)CN(c2ccc(cc2)N3CC[NH2+]CC3)C(=O)c4ccc(o4)c5ccc(cc5)Cl,MK2-IN-1,-8.719788,x0874,active-noncovalent
Cc1cc2c(cccc2n1c3nc4c(c(n3)NCc5ccccc5)COCC4)C(=O)N,CB-5083,-8.719719,x0161,active-noncovalent
c1cc2c(cc1Cl)C(=O)N3[C@@H](O2)CCO3,seclazone,-8.719603,x0749,active-covalent
Cc1cc(c(n1c2ccccc2)C)/C=C/c3ccc4cc(ccc4[n+]3C)N(C)C,pyrvinium-pamoate,-8.719566,x0104,active-noncovalent
Cc1cc(c(n1c2ccccc2)C)/C=C/c3ccc4cc(ccc4[n+]3C)N(C)C,pyrvinium,-8.719566,x0104,active-noncovalent
CCCC[C@@H](CC)C[N@@]1CC(C[N@@](C1)C[C@H](CC)CCCC)(C)[NH3+],hexetidine,-8.719007,x1093,active-noncovalent
CO[C@]1(COc2ccccc2O1)C3=[NH+]CCN3,RX-821002,-8.718850,x0678,active-noncovalent
c1cc(cc(c1)Cl)N2CC[NH2+]CC2,mCPP,-8.718540,x0195,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C,vitamin-E,-8.718136,x0161,active-noncovalent
COc1cc(c(cc1Cl)Cl)n2c(=O)c3ccccc3[nH]c2=S,mdivi-1,-8.717098,x0195,active-noncovalent
c1ccc2c(c1)cccc2C(=O)N3CCc4c(c5cc(ccc5n4CC(=O)[O-])F)C3,setipiprant,-8.716733,x0107,active-noncovalent
Cn1cc(cn1)c2ccc3nnc(n3n2)Sc4ccc5c(c4)cccn5,SGX523,-8.716206,x0072,active-noncovalent
CN1c2cc(cc(c2OCC1=O)C(=O)N[C@H]3C[NH+]4CCC3CC4)Cl,azasetron,-8.715544,x0195,active-noncovalent
C=C(c1ccccc1OCc2cccc(c2)Cl)n3ccnc3,croconazole,-8.715119,x0967,active-noncovalent
CCOC(=O)Nc1cc2c(c([nH+]1)N)N=C([C@H](N2)C)c3ccccc3,mivobulin,-8.714993,x0104,active-noncovalent
C[C@H]\1CC[C@H](C/C1=C\C=C\2/CCC[C@@]3([C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](C)C(C)C)C)O,dihydrotachysterol,-8.714808,x0104,active-noncovalent
c1cc(ccc1c2c(n3ccsc3n2)/C=N/OCc4ccc(c(c4)Cl)Cl)Cl,CITCO,-8.714808,x0161,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCCCn3c(c4c(c3O)[C@H]5CC[C@@H]4C5)O,tandospirone,-8.714194,x0161,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)Nc3c(nns3)c4ccccc4)[NH2+]C,GDC-0152,-8.713861,x0678,active-noncovalent
C[C@@H](C(=O)N)[NH2+]Cc1ccc(cc1)OCc2ccccc2F,priralfinamide,-8.713419,x0104,active-noncovalent
c1cc2cc(c1)-c3ccnc(n3)Nc4ccc(c(c4)COC/C=C/COC2)OCC[NH+]5CCCC5,pacritinib,-8.712273,x0104,active-noncovalent
c1cc(ccc1NC(=O)C2(CC2)C(=O)Nc3cc(c(cc3F)Oc4ccnc(c4)NC(=O)C5CC5)F)F,altiratinib,-8.712025,x0104,active-noncovalent
CC1(Cc2ccccc2C1)C[NH3+],org-9768,-8.711792,x0195,active-noncovalent
CCOCc1nc2c(n1CC(C)(C)O)c3ccccc3nc2N,resiquimod,-8.711615,x1334,active-covalent
CCC1=C[C@H]2C[C@]3([C@@H]1[N@@H+](C2)CCc4c3[nH]c5c4cccc5)C(=O)OC,catharanthine,-8.710958,x0749,active-covalent
CC1=CC[C@H](CC1)[C@](C)(CCC=C(C)C)O,levomenol,-8.710808,x0161,active-noncovalent
Cc1cc(no1)[N-]S(=O)(=O)c2ccc(cc2)N,sulfamethoxazole,-8.710352,x0072,active-noncovalent
c1cc(ccc1NC(=O)Nc2ccc(c(c2)Cl)Cl)Cl,triclocarban,-8.708251,x0678,active-noncovalent
Cc1cccc(c1)N(C)C(=S)Oc2ccc3ccccc3c2,tolnaftate,-8.708003,x0072,active-noncovalent
CC(C)(c1[nH]c(c[nH+]1)c2ccc(cc2)OC(F)(F)F)N,PF-04885614,-8.707911,x0161,active-noncovalent
Cc1ccsc1C(=CCC[N@@H+]2CCC[C@H](C2)C(=O)[O-])c3c(ccs3)C,tiagabine,-8.707520,x1334,active-covalent
C1CC[C@H]2[C@@H](C1)C3=C(O2)CCc4c3nc(nc4N5CC[NH2+]CC5)N,A-987306,-8.706692,x0749,active-covalent
CCOC(=O)[C@H](Cc1ccc(c(c1)O)O)[NH3+],etilevodopa,-8.706562,x0749,active-covalent
C[C@@H](Cc1c[nH]c2c1cc(cc2)O)[NH3+],alpha-methylserotonin,-8.705218,x1385,active-covalent
c1ccc2c(c1)ccc(n2)C3=[NH+]CCN3,BU-224,-8.705074,x0195,active-noncovalent
c1cc(c(c(c1)Cl)Cl)c2cc(nc(n2)N)NC3CC3,TH588,-8.705000,x1093,active-noncovalent
CC(C)[C@](c1ccc2cc(c(cc2c1)OC(F)F)OC(F)F)(c3cn[nH]n3)O,VT-464,-8.704799,x0678,active-noncovalent
COC(=O)Nc1[nH]c2ccccc2n1,carbendazim,-8.704404,x0678,active-noncovalent
Cc1c(c2ccc(cc2n1CC[NH+]3CCOCC3)I)C(=O)c4ccc(cc4)OC,AM-630,-8.704353,x0161,active-noncovalent
C[NH+](C)CCOC(=O)COc1ccc(cc1)Cl,meclofenoxate,-8.703523,x0161,active-noncovalent
CN([C@H]1CCCC[C@@H]1[NH+]2CCCC2)C(=O)Cc3ccc(c(c3)Cl)Cl,U-50488-(-),-8.703189,x0434,active-noncovalent
CCOC(=O)c1c([nH]c2c1c3c(cc2)O[C@@H]4c5ccc(cc5CC[N@H+]4C3)OC)C,PD-102807,-8.702961,x0678,active-noncovalent
c1ccc(c(c1)Cc2ccc3c(c2)nc(s3)c4ccc(cc4F)C[NH+]5CC(C5)C(=O)[O-])F,TC-SP-14,-8.702904,x0104,active-noncovalent
CC(C)/C=C/CCCCC(=O)NCc1ccc(c(c1)OC)O,capsaicin,-8.702892,x0161,active-noncovalent
c1ccc2c(c1)[nH]c(n2)C[NH+]3CCN(CC3)c4ccccn4,ABT-724,-8.702614,x0946,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)CCCOc3ccc4c(c3)OCO4,BP-554,-8.701449,x0874,active-noncovalent
c1ccc2c(c1)C(=[NH+]c3cc(ccc3N2)Cl)N4CC[NH2+]CC4,desmethylclozapine,-8.701330,x0195,active-noncovalent
CC(C)(C)n1c2c(c(n1)c3ccc(cc3)Cl)c(ncn2)N,PP-2,-8.700075,x0678,active-noncovalent
CCCC[C@H](C)C[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCC/C=C/C(=O)[O-])O)O,limaprost-alfadex,-8.697995,x0104,active-noncovalent
c1cc2c(nc3cc(ccc3n2c1)F)NNC(=O)c4cnccn4,SC-144,-8.697574,x0397,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(cc2C(=O)c3ccn(=O)cc3)Cl,vercirnon,-8.697428,x0434,active-noncovalent
c1cc(ccc1N)S(=O)(=O)Nc2nccs2,sulfathiazole,-8.697274,x0678,active-noncovalent
CCCC[C@@H](CC)COC(=O)/C=C/c1ccc(cc1)OC,octinoxate,-8.695915,x0072,active-noncovalent
COc1cc(cc(c1)OC)/C=C/c2ccc(cc2)O,pterostilbene,-8.695619,x0749,active-covalent
c1ccc(cc1)CNC(=O)CCCl,beclamide,-8.695555,x0678,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@](O2)(C)COc3ccc(cc3)C[C@H]4C(=O)[N-]C(=O)S4)C,troglitazone,-8.695098,x1077,active-noncovalent
Cc1cc(cc(c1Cc2ccc(c(c2)C(C)C)O)C)OCC(=O)[O-],sobetirome,-8.693005,x0678,active-noncovalent
c1ccc(cc1)CCCNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,AG-555,-8.692240,x0434,active-noncovalent
CC1=C(C(C(=C(N1C)C)C(=O)OC)c2ccc(cc2)C(F)(F)F)C(=O)OC,bay-w-9798,-8.691492,x0161,active-noncovalent
Cc1nnc2n1-c3ccccc3[C@H](C=C2Cc4nnc(o4)C)c5ccc(cc5)Cl,BET-BAY-002,-8.691198,x0678,active-noncovalent
C[C@@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)[O-])OC2=O)O,MD-920,-8.689821,x0749,active-covalent
CCC(=O)O[C@@](Cc1ccccc1)(c2ccccc2)[C@@H](C)C[NH+](C)C,levopropoxyphene,-8.689008,x0678,active-noncovalent
Cn1cc(c2c1cncc2)c3ccnc(n3)Nc4ccc(cc4OC)N5CC[NH+](CC5)C,AZ191,-8.688478,x0161,active-noncovalent
COc1ccc(c(c1)O)C(=O)c2ccccc2O,dioxybenzone,-8.687089,x0678,active-noncovalent
Cc\1c(c(=C)[nH]/c1=C\c2c3ccccc3[nH]c2O)CCC(=O)[O-],orantinib,-8.684568,x0678,active-noncovalent
Cc1cccc(n1)NC(=O)c2ccc(cc2C(=O)[O-])C(F)(F)F,AF38469,-8.683684,x0195,active-noncovalent
CN(CC(=O)[O-])C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC,tolrestat,-8.682558,x0749,active-covalent
Cc1cc(ccn1)C(=O)Nc2nc3cccc(c3n2[C@@H]4CCCCN(C4)C(=O)/C=C/C[NH+](C)C)Cl,EGF816,-8.681888,x0104,active-noncovalent
C[C@@H](CC(c1ccccc1)c2ccccc2)[NH2+]C(C)(C)C,terodiline,-8.681395,x1093,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(C(=O)OC3C[C@H]4CC[C@@H](C3)[N+]45CCCC5)O,trospium,-8.681177,x0874,active-noncovalent
B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c2ccccc2)(O)O,delanzomib,-8.679836,x0161,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,atropine,-8.679650,x0072,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,hyoscyamine,-8.679650,x0072,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c(=C)c1C(=O)NCC[NH+]4CCCC4,toceranib,-8.679184,x1077,active-noncovalent
CCC[NH+](CCC)CCc1cccc2c1CC(=O)N2,ropinirole,-8.679131,x0195,active-noncovalent
Cc1cc(ccc1C[C@H](C)[NH3+])N(C)C,amiflamine,-8.678908,x0749,active-covalent
Cc1ccc(c(c1)C)Oc2ccccc2c3csc(n3)[NH+]=C4NCCCN4,abafungin,-8.678720,x0874,active-noncovalent
C1CCC(CC1)NC(=O)CN2CC[NH2+]CC2,esaprazole,-8.676890,x0678,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)N3CC[NH2+]CC3,C-1,-8.676439,x0749,active-covalent
CC1([C@@H]2C(=NC1=O)c3ccccc3C(=O)C2=O)C,BVT-948,-8.675575,x0195,active-noncovalent
C[C@H]1CC[C@@H](CC1)C(=O)N([C@H]2CC[C@H](CC2)O)c3c(sc(c3)C#CC(C)(C)C)C(=O)[O-],VX-222,-8.673647,x1093,active-noncovalent
Cn1cncc1[C@@](c2ccc(cc2)Cl)(c3ccc4c(c3)c(cc(=O)n4C)c5cccc(c5)Cl)[NH3+],tipifarnib,-8.673372,x0195,active-noncovalent
CC1=CCC23[C@H]1[C@@H]4[C@@H](CC[C@@]2(O3)C)C(=C)C(=O)O4,arglabin,-8.672435,x0195,active-noncovalent
c1ccc2c(c1)cnnc2NN,hydralazine,-8.671159,x0195,active-noncovalent
CCS(=O)(=O)N1CC(C1)(CC#N)n2cc(cn2)c3c4cc[nH]c4ncn3,baricitinib,-8.669307,x0072,active-noncovalent
c1ccc(cc1)N2CNC(=O)C23CC[NH+](CC3)C[C@H]4COc5ccccc5O4,spiroxatrine,-8.668324,x0161,active-noncovalent
c1ccc2c(c1)c(=O)c3ccccc3n2CC(=O)[O-],cridanimod,-8.667603,x0195,active-noncovalent
c1cnc(cn1)C(=O)N,pyrazinamide,-8.667175,x0397,active-noncovalent
C[C@H](c1cccc2c1cccc2)[NH2+][C@H]3CCCC[C@@H]3NC(=O)c4ccc(cc4)Cl,Calhex-231,-8.666510,x0195,active-noncovalent
C[NH2+][C@H]1CC[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,sertraline,-8.666471,x0195,active-noncovalent
Cn1c(c(cn1)Cl)c2cc(oc2Cl)C(=O)N[C@@H](Cc3ccc(c(c3)F)F)C[NH3+],uprosertib,-8.665205,x0161,active-noncovalent
c1ccc2c(c1)c(cn2Cc3ccc(cc3)Cl)C=O,oncrasin-1,-8.664866,x0072,active-noncovalent
COC(=O)Nc1[nH]c2cc(ccc2n1)C(=O)c3cccs3,nocodazole,-8.662644,x0195,active-noncovalent
C=CC[N@H+]1CCc2c(sc(n2)N)CC1,talipexole,-8.662112,x1077,active-noncovalent
CCOC(=O)Nc1ccc(nc1N)NCc2ccc(cc2)F,flupirtine,-8.661087,x1093,active-noncovalent
CC(C)(C)[NH+]1CCC(CC1)(c2ccccc2)c3ccccc3,budipine,-8.660541,x0678,active-noncovalent
CCc1cc2c(cc1CC)CC(C2)[NH2+]C[C@@H](c3ccc(c4c3ccc(=O)[nH]4)O)O,indacaterol,-8.660088,x0678,active-noncovalent
Cc1cc(ccc1OCC(=O)[O-])SCc2c(nc(s2)c3ccc(c(c3)F)C(F)(F)F)C,GW-0742,-8.659649,x0195,active-noncovalent
Cc1c(c2ccc(cc2o1)Oc3c4cc(c(cc4ncn3)OC)OC)C(=O)NC,fruquintinib,-8.659506,x0072,active-noncovalent
CC(=O)c1ccc2c(c1)[C@@H]3C=CC[C@@H]3[C@@H](N2)c4cc5c(cc4Br)OCO5,G-1,-8.659350,x0195,active-noncovalent
COC(=O)[C@H](Cc1ccc(c(c1)O)O)[NH3+],melevodopa,-8.659086,x0678,active-noncovalent
c1cc(ccc1C#N)c2csc(n2)/N=N/C3CCCC3,remodelin,-8.657978,x0195,active-noncovalent
C1CCc2c(c3c(=O)[nH]c(nc3s2)CCl)C1,"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",-8.656167,x0195,active-noncovalent
Cc1ccc(cc1)C(=O)c2cc(c(c(c2)O)[O-])N(=O)=O,tolcapone,-8.655296,x1418,active-covalent
CC(C)Cn1cnc2c1c3ccccc3nc2N,imiquimod,-8.654057,x0195,active-noncovalent
CC(C)n1cnc2c1cc(cc2C(=O)N[C@H]3C[NH+]4CCC3CC4)Cl,RS-16566,-8.653202,x0195,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cccc3)[NH+](C)C,promethazine,-8.653181,x0195,active-noncovalent
CC(C)(C)C(=O)[C@H](n1ccnc1)Oc2ccc(cc2)Cl,climbazole,-8.652415,x0107,active-noncovalent
c1cc(ncc1Cc2c[nH]c3c2cc(cn3)Cl)NCc4ccc(nc4)C(F)(F)F,pexidartinib,-8.651358,x1077,active-noncovalent
CCOC(=O)c1ccc(c(c1)N)NC2CCCCC2,ferrostatin-1,-8.651142,x0749,active-covalent
c1cc2c(c(c1)[O-])C(=O)c3c(cccc3[O-])C2=O,dantron,-8.650962,x0749,active-covalent
c1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)Cl,diclofenac,-8.650775,x0107,active-noncovalent
CCCCOc1ccc(cc1)CC(=O)NO,bufexamac,-8.650715,x0104,active-noncovalent
CC(=O)O[C@H]1Cc2ccccc2N(c3c1cccc3)C(=O)N,eslicarbazepine-acetate,-8.649990,x0072,active-noncovalent
Cc1ccccc1N/C(=[NH+]\c2ccccc2C)/N,ditolylguanidine,-8.648587,x0072,active-noncovalent
c1cc(c(c(c1)C(=O)c2ccc(cc2)Br)N)CC(=O)[O-],bromfenac,-8.648551,x0678,active-noncovalent
CC(C)c1cc(nc(n1)N)c2ccc(c3c2cccc3)F,RS-127445,-8.648408,x0195,active-noncovalent
C[C@@H](c1ccc2cc(ccc2c1)OC)C(=O)[O-],naproxen,-8.648243,x0749,active-covalent
c1cc(c(cc1N[C@@H](c2c(non2)N)N=O)Cl)F,IDO5L,-8.647515,x0678,active-noncovalent
CCCCC(=O)NCCc1c2ccccc2[nH]c1Cc3ccccc3,DH-97,-8.647331,x0161,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CO,indole-3-carbinol,-8.646740,x0195,active-noncovalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3c(n[nH]n3)C[NH+](C)C)c4ccc(cc4)F,L-760735,-8.646544,x1077,active-noncovalent
CCCCc1ccc(cc1)NS(=O)(=O)c2ccc(cc2)F,DC-260126,-8.644873,x0195,active-noncovalent
c1ccc(cc1)Oc2cccnc2,CI-844,-8.643821,x0678,active-noncovalent
CCOC(=O)c1cncn1[C@H](C)c2ccccc2,etomidate,-8.642980,x0161,active-noncovalent
Cn1ccc2c1ccc(c2)NC(=O)Nc3cccnc3,SB-200646,-8.642319,x0678,active-noncovalent
C#CC[NH2+][C@@H]1CCc2c1cccc2,rasagiline,-8.641811,x0104,active-noncovalent
CC[C@@](C)(C(=O)[O-])Oc1ccc(cc1)C2(CCCCC2)c3ccc(cc3)O[C@@](C)(CC)C(=O)[O-],clinofibrate,-8.641696,x0874,active-noncovalent
c1ccc(cc1)c2cc(=O)c3c(o2)cc(c(c3[O-])O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O)O)O,baicalin,-8.640272,x0195,active-noncovalent
c1cc(ccc1CCNS(=O)(=O)c2ccc(cc2)Cl)CC(=O)[O-],daltroban,-8.638590,x0831,active-covalent
c1ccc2c(c1)ncc(n2)C3=[NH+]CCN3,BU-239,-8.636136,x0107,active-noncovalent
c1cc(c(c2c1nccn2)Br)NC3=[NH+]CCN3,brimonidine,-8.636107,x0874,active-noncovalent
c1ccc2c(c1)c(ccc2n3c(nnc3Br)SCC(=O)[O-])C4CC4,lesinurad,-8.635230,x0678,active-noncovalent
Cc1cccc(c1)N2C[C@@H](OC2=O)CO,toloxatone,-8.634964,x0195,active-noncovalent
c1ccc2c(c1)C3c4ccccc4C2C5=C3C(=O)C=CC5=O,INCA-6,-8.634747,x0830,active-covalent
CCOC(=O)c1ccc(cc1)N2C(=O)/C(=C\c3ccc(o3)N(=O)=O)/C(=O)N2,PYR-41,-8.634676,x0161,active-noncovalent
c1cc(c(cc1O)[C@H](C(=O)[O-])[NH3+])Cl,CHPG,-8.634126,x1392,active-covalent
Cc1cc(ccc1Nc2c(cc(c(c2F)F)F)C(=O)NOCC3CC3)I,PD-198306,-8.633976,x0678,active-noncovalent
CN1c2ccc(cc2N(C(=O)CC1=O)c3ccccc3)Cl,clobazam,-8.632013,x0195,active-noncovalent
c1cc(c(cc1C[NH+]2CCC(CC2)Nc3c4cc(sc4ncn3)Cl)C#N)F,PRX-08066,-8.630962,x0161,active-noncovalent
CS(=O)(=O)c1ccc(c(c1)Cl)C(=O)Nc2ccc(c(c2)c3ccccn3)Cl,vismodegib,-8.629482,x0104,active-noncovalent
Cn1c(c(cn1)Cl)c2cc(sc2Cl)C(=O)N[C@@H](Cc3cccc(c3)F)C[NH3+],GSK2110183,-8.629450,x0874,active-noncovalent
c1c(n(cn1)CC[NH+]2CCOCC2)N(=O)=O,nimorazole,-8.626919,x0104,active-noncovalent
Cc1cc(cnc1)C[NH+]2CCC(=C3c4ccc(cc4CCc5c3nccc5)Cl)CC2,rupatadine,-8.626873,x0678,active-noncovalent
Cc1c(sc[n+]1CC(=O)c2ccccc2)C,alagebrium,-8.626831,x0749,active-covalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)NC(=O)C)O,practolol,-8.626266,x0104,active-noncovalent
CC(=O)N[C@H](Cc1c[nH]c2c1cccc2)C(=O)OCc3cc(cc(c3)C(F)(F)F)C(F)(F)F,"L-732,138",-8.626165,x1077,active-noncovalent
c1cc(ccc1n2cc(c3c2ccc(c3)Cl)C4CC[NH+](CC4)CCN5CCNC5=O)F,sertindole,-8.625791,x1077,active-noncovalent
Cc1ccc(c(c1)C)c2csc(n2)NC(=O)c3ccccc3,INH1,-8.625279,x0749,active-covalent
c1cc(ccc1C2=CC[N@H+](CC2)CCCC[C@@]34CCCc5c3c(ccc5Cl)NC4=O)Cl,DR-4485,-8.624872,x0161,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(c(c1)Cc2ccc(cc2Cl)Cl)O,clofoctol,-8.624871,x0161,active-noncovalent
c1ccc(cc1)c2cc(n3c(n2)c(cn3)C(=O)NCCC[NH+]4CCOCC4)c5ccccc5,reversan,-8.624632,x0161,active-noncovalent
CC[NH2+]C[C@@H](c1cccc(c1)O)O,etilefrine,-8.624472,x0434,active-noncovalent
c1cc2cnccc2c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,fasudil,-8.623689,x0072,active-noncovalent
c1ccc2c(c1)c(=O)n3c(n2)CCCCC3,RLX,-8.623666,x0749,active-covalent
c1ccc2c(c1)c(=O)n3c(n2)CCCCC3,"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",-8.623666,x0749,active-covalent
Cc1ccccc1[C@H](c2ccccc2)OCC[NH+](C)C,orphenadrine,-8.622473,x0195,active-noncovalent
c1ccc2c(c1)cc(s2)C(=O)Nc3ccccc3C(=O)N[C@@H]4CCCCNC4=O,ANA-12,-8.621393,x0692,active-covalent
c1ccc(cc1)CNC(=O)CCNNC(=O)c2ccncc2,nialamide,-8.621371,x0107,active-noncovalent
COc1ccc(cc1)Nc2ccn(n2)c3ccccc3,FPL-62064,-8.621202,x0946,active-noncovalent
c1cc2c(csc2c(c1)Cl)CO[C@H](Cn3ccnc3)c4ccc(cc4Cl)Cl,sertaconazole,-8.621009,x0195,active-noncovalent
C=CCOc1ccc(cc1Cl)CC(=O)[O-],alclofenac,-8.619066,x0749,active-covalent
COc1ccc(cc1OC)C[C@H]2COC(=O)[C@@H]2Cc3ccc(c(c3)OC)O,arctigenin,-8.618246,x0195,active-noncovalent
Cc1cccc(c1NC(=O)NC(=[NH2+])NC)C,lidamidine,-8.617196,x0104,active-noncovalent
c1cc(ccc1N2CCOCC2=O)N3C[C@@H](OC3=O)CNC(=O)c4ccc(s4)Cl,rivaroxaban,-8.616564,x0104,active-noncovalent
CC(C)n1c2c(c(n1)c3ccc4c(c3)nc(o4)N)c(ncn2)N,MLN0128,-8.616176,x0107,active-noncovalent
C[C@]1(CCC[NH2+]1)c2[nH]c3c(cccc3n2)C(=O)N,veliparib,-8.615685,x0104,active-noncovalent
CC(c1n(nc2c1cc(cc2)c3nc(ncc3)N[C@H]4CC[C@@H](CC4)[NH2+]C5CCOCC5)C)C,LY2857785,-8.615601,x0161,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)CC3CCCC3,cyclopenthiazide,-8.614271,x1093,active-noncovalent
C[NH+](C)CCN(Cc1cccs1)c2ccccn2,methapyrilene,-8.614017,x0434,active-noncovalent
c1ccc(c(c1)c2cn3c(csc3[nH+]2)CN4CC[NH2+]CC4)NC(=O)c5cnc6ccccc6n5,SRT1720,-8.613928,x0874,active-noncovalent
CC1(CCC(c2c1ccc(c2)C#Cc3ccc(cc3)C(=O)[O-])(C)C)C,EC-23,-8.613768,x0104,active-noncovalent
CC1CC[NH+](CC1)[C@H](c2ccc(cc2)F)c3ccc(cc3c4ccc(cc4)C(F)(F)F)[C@H](C)C(=O)[O-],TC-E-5006,-8.613317,x0161,active-noncovalent
c1ccc(c(c1)CC(=O)OCC(=O)[O-])Nc2c(cccc2Cl)Cl,aceclofenac,-8.611413,x0678,active-noncovalent
c1ccc(cc1)c2c(oc(n2)c3c(ocn3)c4cccc(c4)OCC(=O)[O-])c5ccccc5,BMY-45778,-8.611387,x0195,active-noncovalent
CC1CC[NH+](CC1)CC[C@H]2CCC[N@@]2S(=O)(=O)c3cccc(c3)O,SB-269970,-8.611213,x0072,active-noncovalent
CC[C@@H](C)N(C)C(=O)c1cc2ccccc2c(n1)c3ccccc3Cl,PK-11195,-8.610704,x0195,active-noncovalent
C[C@@H](c1ccccc1)Nc2cc(ccn2)c3c(nc([nH]3)SC)c4ccc(cc4)F,ML-3403,-8.609939,x0831,active-covalent
c1ccc(cc1)C2(C(=O)N(C(=O)N2)COP(=O)([O-])[O-])c3ccccc3,fosphenytoin,-8.609596,x0678,active-noncovalent
Cc1c[nH+]c2n1-c3ccc(cc3[C@H](N=C2CCC(=O)OC)c4ccccn4)Br,remimazolam,-8.609148,x0195,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,adenosine,-8.608617,x0195,active-noncovalent
CC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(CC[C@H]4[C@H]3CCC5=CC(=O)CC[C@]45C)C)O[C@@](O2)(C)c6ccccc6,algestone-acetophenide,-8.607859,x1077,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(c(c1)C#N)N)O,cimaterol,-8.607735,x0104,active-noncovalent
C[N@]1c2ccccc2[C@@H](c3ccc(cc3S1(=O)=O)Cl)[NH2+]CCCCCCC(=O)[O-],tianeptine,-8.607548,x1077,active-noncovalent
c1cc(ccc1C(=O)NCCC[NH+]2CCOCC2)Cl,eprobemide,-8.606370,x0946,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NCc2ccccc2,BTS,-8.606181,x1093,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N@@]2CCC[C@H]2c3ccc(cc3)F,Ro-67-7476,-8.605594,x1093,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)I,iodoantipyrine,-8.603910,x0195,active-noncovalent
c1ccc(cc1)c2cc(sc2C(F)(F)F)c3nc(no3)c4cccc(c4)C(F)(F)F,SEW-2871,-8.603834,x0161,active-noncovalent
COc1cc(ccc1Nc2ncc(c(n2)c3c[nH]c4c3cccc4)Cl)N5CCC(CC5)[NH3+],AZD3463,-8.602140,x0161,active-noncovalent
COc1cccc(c1)C[NH+]2C[Si](O[Si](C2)(C)C)(C)C,compound-58112,-8.602086,x0434,active-noncovalent
c1ccc(cc1)Sc2ccc(cc2)CO[C@H](Cn3ccnc3)c4ccc(cc4Cl)Cl,fenticonazole,-8.600594,x0107,active-noncovalent
CC(=O)O[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@@H]2CCC4=CC(=O)CC[C@H]34)C)C#C,norethindrone-acetate,-8.599212,x0749,active-covalent
CC(C)(C(=O)N1CCN(CC1)c2ccc(c(c2)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5)C(F)(F)F)O,TCS-21311,-8.599113,x0434,active-noncovalent
CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,budesonide,-8.598451,x1077,active-noncovalent
Cc1ccc(c(c1)CC(=O)[O-])Nc2c(cccc2Cl)F,lumiracoxib,-8.598218,x0195,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C,dexamethasone-sodium-phosphate,-8.597748,x0072,active-noncovalent
c1cc(cc(c1)O)c2c(nc3c(n2)c(nc(n3)N)N)c4cccc(c4)O,TG100-115,-8.597368,x0161,active-noncovalent
c1cc2c(cc1c3ccc4[nH+]cc(n4c3)C(=O)N5CCOCC5)nc(o2)N,MLN1117,-8.596728,x0107,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCC(=O)[O-],VP-20629,-8.596369,x0749,active-covalent
CCN(CC)C(=O)N[C@@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,lisuride,-8.596147,x1392,active-covalent
C[C@@H]1C[N@](CC[NH2+]1)c2c(cc3c(c2OC)n(cc(c3=O)C(=O)[O-])C4CC4)F,gatifloxacin,-8.595735,x0195,active-noncovalent
C[C@H]1CO[C@H]2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)[O-],cabotegravir,-8.595482,x0161,active-noncovalent
c1cn(c(n1)N(=O)=O)C[C@H](C[NH+]2CCCCC2)O,pimonidazole,-8.595352,x0104,active-noncovalent
C[C@H]1CCC/C=C/[C@@H]2C[C@@H](C[C@H]2[C@@H](/C=C/C(=O)O1)O)O,brefeldin-a,-8.594706,x0946,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc(cc2)N/C(=N\C)/NC#N,siguazodan,-8.593851,x0678,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)O)CC[NH3+],2-methyl-5-hydroxytryptamine,-8.592785,x0305,active-noncovalent
CCN(CC)c1ccc(cc1)C/N=N/C(=O)c2ccc(cc2)O,DY131,-8.592434,x0946,active-noncovalent
c1cc(c(cc1Br)c2[n-]nnn2)NC(=S)Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F,NS-11021,-8.592110,x0161,active-noncovalent
COc1ccc(cc1)n2c(=O)c3cnc4c(c3[nH]2)CCCCC4,CGS-20625,-8.591517,x0107,active-noncovalent
CC(C)C(=O)OC[C@@H]1[C@H]([C@@]([C@@H](O1)n2ccc(nc2=O)N)(C)F)OC(=O)C(C)C,mericitabine,-8.591146,x0678,active-noncovalent
c1cc(ccc1[C@H](C#N)c2c(cc(cc2Cl)n3c(=O)[nH]c(=O)cn3)Cl)Cl,diclazuril,-8.590385,x0161,active-noncovalent
C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(CC=C)O,altrenogest,-8.590300,x0104,active-noncovalent
c1cc(ccc1c2ccc(cn2)CO[C@H]3Cn4cc([nH+]c4OC3)N(=O)=O)OC(F)(F)F,TBA-354,-8.589870,x0104,active-noncovalent
c1ccc2c(c1)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],tryptophan,-8.588454,x0195,active-noncovalent
CCC[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(CCC(=O)[O-])O)C,RU-28318,-8.588359,x0830,active-covalent
c1ccc2c(c1)c3c([nH]2)[C@H]4[C@@]56CC[N@@H+]([C@@H]([C@@]5(C3)O)Cc7c6c(c(cc7)O)O4)CC8CC8,naltrindole,-8.588151,x0072,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(c(c2)OC(=O)c3ccc(cc3)Cl)N(=O)=O,BTB06584,-8.587694,x1077,active-noncovalent
CCOc1ccccc1O[C@H](c2ccccc2)[C@H]3C[NH2+]CCO3,reboxetine,-8.587440,x0678,active-noncovalent
C[NH+](C)CCCN1c2ccccc2CCc3c1cc(cc3)Cl,clomipramine,-8.586631,x0072,active-noncovalent
CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C,ethynodiol-diacetate,-8.586174,x0104,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)OC[C@H](c4ccccc4)C(=O)[O-],tropesin,-8.585983,x0161,active-noncovalent
Cc1ccc(cc1Nc2c3cnn(c3nc(n2)c4cccnc4)C)C(=O)Nc5cccc(c5)C(F)(F)F,NVP-BHG712,-8.585416,x0161,active-noncovalent
c1c2c(cc(c1Cl)Br)ncn(c2=O)CC(=O)C[C@@H]3[C@H](CCC[NH2+]3)O,halofuginone,-8.585073,x0161,active-noncovalent
c1cc2cn(nc2c(c1)C(=O)N)c3ccc(cc3)[C@@H]4CCC[NH2+]C4,niraparib,-8.584419,x0104,active-noncovalent
c1cc2c(cccc2Cl)c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,ML-9,-8.583404,x0946,active-noncovalent
Cc1cccc(c1C)Cc2c[nH]cn2,detomidine,-8.583353,x0678,active-noncovalent
CC(C)(C#N)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2,anastrozole,-8.583186,x0107,active-noncovalent
Cc1cc2c(cc1C=O)n(c-3nc(=O)[nH]c(=O)c3n2)C,Ro-08-2750,-8.583075,x0967,active-noncovalent
CCCCCCCCCCCC(=O)OC[C@@H](CO)O,glycerol-monolaurate,-8.582887,x0104,active-noncovalent
CC[C@@H](C)[C@H](c1ccccc1)C(=O)OCC[N+](C)(CC)CC,valethamate,-8.582633,x1093,active-noncovalent
c1c[n+](ccc1CN=O)COC[n+]2ccc(cc2)CN=O,obidoxime,-8.582040,x0195,active-noncovalent
COc1cc(cc(c1)OC)c2ccc3c(n[nH]c3n2)c4ccc(cc4)F,APcK-110,-8.582015,x0104,active-noncovalent
c1cc2c(cc1C(=O)[O-])oc(n2)c3cc(cc(c3)Cl)Cl,tafamidis-meglumine,-8.581557,x0749,active-covalent
c1ccc(cc1)C2=CC[N@H+](CC2)CCCCc3c[nH]c4c3cc(cc4)C(=O)[O-],carmoxirole,-8.581454,x0195,active-noncovalent
CCCCCCNC(=O)n1cc(c(=O)[nH]c1=O)F,carmofur,-8.581223,x0195,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccccc1OC)O,moprolol,-8.581197,x0104,active-noncovalent
CC(C)C(=O)c1ccc(c(c1)O)O,U-0521,-8.581099,x0195,active-noncovalent
c1ccc(cc1)OCCCCOc2c3ccc(=O)oc3cc4c2cco4,AS-77,-8.580244,x0195,active-noncovalent
C[NH+](C)Cc1ccc(cc1)S(=O)(=O)n2ccc(c2)CCC(=O)N=O,resminostat,-8.579951,x0072,active-noncovalent
CC1(CC1)/N=C\2/Nc3cc(sc3S(=O)(=O)N2)Cl,tifenazoxide,-8.579398,x0749,active-covalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)[NH3+])[NH3+],bekanamycin,-8.579332,x0678,active-noncovalent
CCCOc1ccc(cc1c2cc([nH]c2c3ccncc3)c4ccc(cc4)Cl)Br,L-168049,-8.579216,x0678,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F,benperidol,-8.578989,x0874,active-noncovalent
CCOC(=O)c1c2c3ccccc3c(=O)c4cccc(nc1=O)[C@@H]42,NQDI-1,-8.577385,x0195,active-noncovalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)Nc4ccc(cc4)O)c5ccc(cc5)Cl)C,OTX015,-8.576809,x0678,active-noncovalent
Cc1ccc2c(c1Sc3ccncc3)c(=O)[nH]c(n2)N,nolatrexed,-8.576667,x1077,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)C[C@H]3Cn4c(c5ccccc5nc4=O)N3,2-PMDQ,-8.576015,x0104,active-noncovalent
Cc1[nH]c2c(n1)-c3ccccc3N(CC2)C(=O)c4ccc(cc4)NC(=O)c5ccccc5c6ccccc6,conivaptan,-8.575799,x0104,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(c(c(c1)Cl)N)C(F)(F)F)O,mabuterol,-8.575526,x0104,active-noncovalent
COCCOc1cc2c(cc1OCCOC)ncnc2Nc3cccc(c3)C#C,erlotinib,-8.575371,x0161,active-noncovalent
C[C@](Cc1ccc(cc1)O)(C(=O)[O-])[NH3+],metirosine,-8.574902,x0678,active-noncovalent
Cn1c(cc(c1O)c2ccccc2)O,phensuximide,-8.574121,x0161,active-noncovalent
CC(C)[C@@H](C(=O)OC[C@@H](CO)OCn1cnc2c1nc([nH]c2=O)N)[NH3+],valganciclovir,-8.573707,x0397,active-noncovalent
c1ccc2c(c1)c(=O)cc(o2)C(=O)[O-],chromocarb,-8.573547,x0195,active-noncovalent
C[NH+](C)CC[C@@H](c1ccc(cc1)Cl)c2ccccn2,dexchlorpheniramine,-8.572924,x0072,active-noncovalent
c1ccc(cc1)C(c2ccc(cc2)F)(c3ccc(cc3)F)C(=O)N,senicapoc,-8.571761,x0195,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,isoprenaline,-8.569675,x0104,active-noncovalent
c1ccc(cc1)CCn2c3ccccc3nc2NC(=O)c4ccccc4,GW-438014A,-8.569530,x0195,active-noncovalent
C[NH+](C)CCCCSC(=[NH2+])N,SKF-91488,-8.569202,x0195,active-noncovalent
c1cc(cc(c1)C(F)(F)F)c2c(c(sn2)C(=O)[O-])N,amflutizole,-8.568046,x0678,active-noncovalent
Cc1cc(no1)NC(=O)[C@@H](c2ccccc2)N3CCCc4c3cccc4,CIM-0216,-8.567966,x0195,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)c4ccco4,prazosin,-8.567277,x0161,active-noncovalent
CC(=O)Nc1ccc(cc1)Cc2ccc(cc2)NC(=O)C,FH1,-8.566679,x0874,active-noncovalent
Cc1cc2ncc(cn2n1)C(=O)NCC(C)(C)[NH2+]CC(=O)N3CCC[C@H]3C#N,anagliptin,-8.566365,x0831,active-covalent
Cc1ccc(cc1)/C(=C\C=C\C(=C\C(=O)[O-])\C)/C=C/C2=C(CCCC2(C)C)C,SR-11302,-8.565340,x0072,active-noncovalent
c1ccc(c(c1)C(F)(F)F)n2ccnc2,TRIM,-8.563854,x0195,active-noncovalent
c1c(c(cnc1N)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F,PI3K-IN-2,-8.563664,x0107,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,retinol,-8.562407,x1077,active-noncovalent
C[C@H]1C(=NNC(=O)S1)c2ccc3c(c2)CCCN3C(=O)c4ccc(c(c4)OC)OC,EMD-53998,-8.562326,x0161,active-noncovalent
C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,diosgenin,-8.562021,x0104,active-noncovalent
CCCCCCCC/C=C/C(=O)[O-],trans-2-Undecenoic-acid,-8.561722,x0749,active-covalent
CC1(c2cc(ccc2NC(=S)O1)c3ccc(n3C)C#N)C,tanaproget,-8.561598,x0195,active-noncovalent
CN(C)/C(=[NH+]\CCC[C@@H](C(=O)[O-])[NH3+])/N,asymmetrical-dimethylarginine,-8.561573,x1385,active-covalent
CC(=O)c1ccc2c(c1)C(=O)C3(O2)CC3,spizofurone,-8.561432,x0749,active-covalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,dexmedetomidine,-8.560138,x0946,active-noncovalent
Cc1cccc(c1C)[C@H](C)c2cnc[nH]2,medetomidine,-8.560138,x0946,active-noncovalent
Cc1nccn1CCC(c2ccccc2)(c3ccccc3)C(=O)N,imidafenacin,-8.559649,x0678,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])[NH3+])O,plovamer-acetate,-8.559490,x0107,active-noncovalent
Cc1cc(c(nc1)c2cc(ncc2Cl)N3CCN(CC3)C(=O)CCS(=O)(=O)C)C,PF-5274857,-8.559119,x0161,active-noncovalent
c1c(c(cc(c1F)F)F)C[C@H](CC(=O)N2CCn3c(nnc3C(F)(F)F)C2)[NH3+],sitagliptin,-8.558857,x0072,active-noncovalent
c1cc(cc(c1)NC(=O)N2CCCC2)Nc3ncc(c(n3)NCCCNC(=O)c4cccs4)I,BX-795,-8.558571,x0161,active-noncovalent
Cc1ccc(=O)n(c1)c2ccccc2,pirfenidone,-8.558218,x0195,active-noncovalent
C[NH2+]CCCCOc1ccccc1Cc2ccccc2,bifemelane,-8.556965,x0678,active-noncovalent
C=C1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O,nalmefene,-8.556619,x1077,active-noncovalent
Cc1cccc(c1C)Nc2ccccc2C(=O)[O-],mefenamic-acid,-8.555771,x1093,active-noncovalent
c1cc(ccc1[C@H](C(=O)[O-])[NH3+])O,oxfenicine,-8.555549,x0678,active-noncovalent
C1C=CCc2c1c(n(c2O)SC(Cl)(Cl)Cl)O,captan,-8.555026,x0749,active-covalent
c1cc(cc(c1)N2Cc3cccc(c3C2=O)Cl)C(=O)N4CCC5(CCN(CC5)c6cc[nH+]cc6)CC4,ELN-441958,-8.554745,x0161,active-noncovalent
Cc1cccc2c1[nH]c3c2nnc(n3)/N=N/[C@@H](C)c4ccccn4,VLX600,-8.553681,x0397,active-noncovalent
Cc1cccc2c1[nH]c3c2nnc(n3)/N=N/[C@@H](C)c4ccccn4,VLX-600,-8.553681,x0397,active-noncovalent
CC1(c2ccccc2[C@](O1)(CCC[NH2+]C)c3ccccc3)C,talopram,-8.552657,x1392,active-covalent
C[C@H](C(=O)N1CCN(CC1)c2nc3cc(c(cc3c(n2)N)OC)OC)OC,metazosin,-8.552432,x0161,active-noncovalent
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@]34[C@@H]([C@H]([C@@H]([C@](O3)(CO4)CO)O)O)O,ertugliflozin,-8.552430,x0161,active-noncovalent
C[NH2+]CC[C@@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F,fluoxetine,-8.552185,x0874,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,epinephrine-(racemic),-8.552002,x1077,active-noncovalent
C[NH2+]C[C@@H](c1ccc(c(c1)O)O)O,epinephrine,-8.552002,x1077,active-noncovalent
CCCN(CCC)C(=O)Cc1c(nc2n1cc(cc2)Cl)c3ccc(cc3)Cl,alpidem,-8.551392,x0874,active-noncovalent
c1ccc2c(c1)c(ccn2)c3c[nH]nc3c4ccccn4,LY364947,-8.550219,x1077,active-noncovalent
Cc1c(c2c(cc1OCc3cccc(c3)c4ccc(cc4)C(=O)[O-])C[C@@H](C2=O)C5CCCC5)C,BINA,-8.549683,x0161,active-noncovalent
C[N@H+](CCCCCCOc1ccc(c(c1)F)C(=O)c2ccc(cc2)Br)CC=C,Ro-48-8071,-8.549349,x0104,active-noncovalent
CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,rofecoxib,-8.548874,x0195,active-noncovalent
c1cc(ccc1[C@@H]2CC[NH2+]C[C@H]2COc3ccc4c(c3)OCO4)F,paroxetine,-8.547364,x0434,active-noncovalent
c1cc2c(nc1)C(=C3CC[NH2+]CC3)c4ccc(cc4CC2)Cl,desloratadine,-8.546451,x0195,active-noncovalent
CN/C(=[NH+]\CCC[C@@H](C(=O)[O-])[NH3+])/N,targinine,-8.545168,x0678,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@@H]3CC[C@@]45CCC(=O)O5)C,canrenone,-8.545122,x0072,active-noncovalent
CC/C(=C(\c1ccccc1)/c2ccc(cc2)OCC[NH+](C)C)/c3ccccc3,tamoxifen,-8.545040,x0874,active-noncovalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2c(c(c3c(c2F)n(cc(c3=O)C(=O)[O-])C4CC4)N)F,sparfloxacin,-8.544739,x0749,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],ibuprofen-(s),-8.543620,x0830,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],ibuprofen-lysine,-8.543620,x0830,active-covalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)[O-],ibuprofen,-8.543620,x0830,active-covalent
Cc1c(cccn1)OC[C@@H]2CCC[NH2+]2,pozanicline,-8.543612,x0104,active-noncovalent
Cc1cc2c([nH]1)cccc2OC[C@H](C[NH2+]C(C)(C)C)OC(=O)c3ccccc3,bopindolol,-8.543556,x1093,active-noncovalent
Cc1c(c(no1)c2ccccc2)c3ccc(cc3)S(=O)(=O)N,valdecoxib,-8.543512,x0161,active-noncovalent
CC(=O)[C@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C,chlormadinone-acetate,-8.543476,x0874,active-noncovalent
c1c(sc(n1)Sc2nnc(s2)N)N(=O)=O,SU3327,-8.543318,x0678,active-noncovalent
COc1cccc(c1OC)[C@@H](C2CC[NH+](CC2)CCc3ccc(cc3)F)O,volinanserin,-8.542051,x0161,active-noncovalent
c1cc(ccc1C(=O)NCC[NH+]2CCC(CC2)n3c4ccc(cc4[nH]c3=O)Cl)F,halopemide,-8.542047,x0104,active-noncovalent
Cc1c(c(c([nH]1)C)C(=O)OC)C(=O)c2ccccc2Cc3ccccc3,FPL-64176,-8.540714,x1093,active-noncovalent
Cc1c(c(c(s1)C)C(=O)NC2(CC2)c3ccc(cc3)C(=O)[O-])Cc4ccc(cc4)C(F)(F)F,MK-2894,-8.538946,x0831,active-covalent
C[C@@H](c1ccccc1)Nc2cc3c(cn2)onc3c4ccc5c(c4)OCO5,TC-S-7005,-8.538513,x0195,active-noncovalent
C[NH+]1CCC(CC1)OC(c2ccccc2)c3ccccc3,diphenylpyraline,-8.538111,x0195,active-noncovalent
CC(C)/N=c/1\cc-2n(c3ccccc3nc2cc1Nc4ccc(cc4)Cl)c5ccc(cc5)Cl,clofazimine,-8.537830,x0161,active-noncovalent
Cc1cc(ccc1OCC(=O)[O-])SCc2c(nc(s2)c3ccc(cc3)C(F)(F)F)C,GW-501516,-8.537596,x0195,active-noncovalent
C1CSS[C@@H]1CCCCC(=O)N,lipoamide,-8.537354,x0749,active-covalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C,cortisone,-8.536163,x0749,active-covalent
c1ccc2c(c1)[C@H](OC2=O)OC(=O)c3cccnc3Nc4cccc(c4)C(F)(F)F,talniflumate,-8.536000,x0107,active-noncovalent
Cn1c2c(c(c(c1=O)F)Nc3ccc(cc3F)I)c(=O)n(cn2)C[C@H](CO)O,TAK-733,-8.535986,x0195,active-noncovalent
c1cc2c(cc[nH]c2=O)c(c1)S(=O)(=O)[N@]3CCC[NH2+]CC3,hydroxyfasudil,-8.535339,x1077,active-noncovalent
C[N@@H+]1CCc2cc(c(cc2[C@H](C1)c3ccccc3)O)Cl,SCH-23390,-8.534025,x0195,active-noncovalent
c1cc(ccc1O)OC[C@H](C[NH2+]CCNC(=O)N2CCOCC2)O,xamoterol,-8.532875,x0678,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O,digitoxigenin,-8.532637,x0678,active-noncovalent
CC[C@H]1C[N@H+]2CC[C@@H]1C[C@@H]2[C@H](c3ccnc4c3cc(cc4)OC)O,hydroquinidine,-8.532633,x0678,active-noncovalent
c1ccc(c(c1)CC#N)C#Cc2ccc(c(c2)F)CCC(=O)[O-],TUG-770,-8.532125,x0195,active-noncovalent
CC1=C(C(=O)c2ccccc2C1=O)C/C=C(\C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C,phytonadione,-8.531766,x0161,active-noncovalent
CC(=O)N[C@@H]1C(=O)Nc2ccccc2C(=N1)c3ccccc3,A-33903,-8.531731,x0161,active-noncovalent
C[C@@](c1ccc(cc1)c2[n-]nnn2)(C(=O)[O-])[NH3+],MTPG,-8.530491,x1077,active-noncovalent
c1cc(ncc1C2=CCC[C@@H]3CC[C@H]2[NH2+]3)Cl,UB-165,-8.528747,x0678,active-noncovalent
CC[C@]1(Cc2ccccc2O1)c3[nH]ccn3,KU14R,-8.528065,x0434,active-noncovalent
C/C(=C\C(=O)Nc1ccccc1C(=O)[O-])/c2ccc3ccccc3c2,BIBR-1532,-8.527380,x1334,active-covalent
C[C@@H](c1nc2ccc(cc2c(=O)n1c3ccccc3)F)Nc4c5c([nH]cn5)ncn4,acalisib,-8.527308,x0104,active-noncovalent
c1cc(c(c(c1)Cl)CO[C@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,isoconazole,-8.527010,x0678,active-noncovalent
c1cc(c(c(c1)F)N(c2ccc(c(n2)c3ccc(cc3F)F)C(=O)N)C(=O)N)F,VX-702,-8.525656,x0195,active-noncovalent
COc1ccc(c(c1)[C@H](CNC(=O)C[NH3+])O)OC,midodrine,-8.525501,x0678,active-noncovalent
Cc1c(sc(n1)c2ccc(c(c2)C#N)OCC(C)C)C(=O)[O-],febuxostat,-8.524560,x0749,active-covalent
CCCC[C@](C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)OC)O)O,misoprostol,-8.524277,x0161,active-noncovalent
Cc1cc(cc(c1)NC(=O)[C@@H]2CCC[N@]2S(=O)(=O)c3ccc(cc3)OC)C,ACT-462206,-8.523252,x0161,active-noncovalent
C[C@@H]1Cc2c3ccccc3[nH]c2[C@H]([N@@H+]1CC(C)(C)F)c4c(cc(cc4F)/C=C/C(=O)[O-])F,AZD9496,-8.523156,x0678,active-noncovalent
CC(=O)N(Cc1cc(ccc1OC)OC)c2cc(ccc2Oc3ccccc3)F,DAA-1106,-8.522312,x0678,active-noncovalent
c1cc(oc1)c2nc3c4cc(ccc4nc(n3n2)N)Cl,CGS-15943,-8.520206,x0161,active-noncovalent
CC1=CC(=O)c2ccccc2C1=O,menadione,-8.520124,x0195,active-noncovalent
C[C@H](c1cccc(c1)OC)[NH2+]CCCc2ccccc2Cl,tecalcet,-8.520090,x0072,active-noncovalent
c1cc(c(cc1F)F)n2cc(c(=O)c3c2nc(c(c3)F)N4CC[C@H](C4)[NH3+])C(=O)[O-],tosufloxacin,-8.519370,x0434,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@@H]3[C@H]1CC[C@]2(C#C)O)OC5CCCC5,quinestrol,-8.518817,x1077,active-noncovalent
CC1(CC(=O)c2c(nn(c2C1)c3cc(c(cc3)C(=O)N)N[C@H]4CC[C@@H](CC4)O)C(F)(F)F)C,SNX-2112,-8.518524,x0161,active-noncovalent
C=C[C@H]1C[N@@H+]2CC[C@H]1C[C@H]2[C@@H](c3ccnc4c3cccc4)O,cinchonidine,-8.518247,x0678,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)c3ccc(cc3)CC(=O)[O-])NC(=O)O[C@H](C)c4ccccc4,BMS-986020,-8.517549,x0104,active-noncovalent
Cc1c(sc[n+]1Cc2cnc(nc2N)C)CCO[P@@](=O)([O-])OP(=O)([O-])[O-],thiamine-pyrophosphate,-8.516066,x0072,active-noncovalent
c1ccc2c(c1)C(=O)C(=O)N2Cc3ccc(c(c3)Cl)Cl,apoptosis-activator-II,-8.515951,x0104,active-noncovalent
c1ccc(c(c1)C2=C(C(=O)NC2=O)Nc3ccc(c(c3)Cl)O)N(=O)=O,SB-415286,-8.515545,x0678,active-noncovalent
C[NH2+]Cc1ccc(cc1)c2c3c4c(cc(cc4[nH]2)F)C(=O)NCC3,rucaparib,-8.514799,x0104,active-noncovalent
C[N+](C)(C)CCCCC[NH2+]CC12CC3CC(C1)CC(C3)C2,IEM1460,-8.512132,x0946,active-noncovalent
Cc1cc(nc(c1C#N)N[C@@H](C)CCCC(C)(C)O)Nc2cc([nH]n2)C,TC-A-2317,-8.511038,x0678,active-noncovalent
CC(C)C[C@@H](C1(CCC1)c2ccc(cc2)Cl)[NH3+],BTS-54505,-8.511034,x0161,active-noncovalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)OC(C)(C)C)c4ccc(cc4)Cl)C,JQ1-(+),-8.510890,x0195,active-noncovalent
CC(C)(C)c1ccc(c(c1)C[NH2+][C@@H]2[C@@H](N3CCC2CC3)C(c4ccccc4)c5ccccc5)OC,maropitant,-8.510076,x0161,active-noncovalent
CN(C)C(=O)n1c(nnn1)Cc2ccc(cc2)c3ccccc3,LY2183240,-8.509767,x0072,active-noncovalent
C[C@@H](c1c(cncn1)F)[C@](Cn2cncn2)(c3ccc(cc3F)F)O,voriconazole,-8.509540,x0749,active-covalent
c1ccnc(c1)CNC(=O)Nc2nnc(o2)c3ccco3,NK-252,-8.509131,x0397,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CCC(=O)[O-])O)CCC4=CC(=O)C=C[C@]34C)O,prednisolone-hemisuccinate,-8.508732,x1077,active-noncovalent
c1cc(ccc1NNC(=[NH2+])N)/N=N/C(=S)N,ambazone,-8.507830,x0161,active-noncovalent
c1cc(ccc1/C=C(\C#N)/C(=O)[O-])O,CHC,-8.507710,x0678,active-noncovalent
c1cc(=O)oc2c1cc3ccoc3c2,psoralen,-8.506760,x0749,active-covalent
CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)N(=O)=O,nitazoxanide,-8.506630,x0678,active-noncovalent
c1ccc(cc1)C(=O)N[C@@H]2C[C@H](N(C2)C(=O)C[NH3+])C(=O)[O-],danegaptide,-8.506472,x0678,active-noncovalent
Cc1cc(c(n1c2cccnc2)C)/C=C\3/C(=O)N(C(=O)S3)c4ccccc4,iCRT-14,-8.506467,x0161,active-noncovalent
Cc1ccc(=O)n(c1)c2ccc(cc2)O,F351,-8.506185,x0195,active-noncovalent
Cc1c(ccnc1C[S@](=O)c2[nH]c3ccccc3n2)OCCCOC,rabeprazole,-8.506046,x0161,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)O[C@@H](c3ccccc3)c4ccc(cc4)Cl,3-CPMT,-8.505960,x1077,active-noncovalent
CCCCC/C=C\C/C=C\CCCCCCCC(=O)[O-],linoleic-acid,-8.505945,x0967,active-noncovalent
C[C@@H](Cc1ccccc1)[N@@H+](C)Cc2c(c(=O)n(n2C)c3ccccc3)C(C)C,famprofazone,-8.505906,x0749,active-covalent
c1cnc(c2c1n(cn2)[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O)N,3-deazaadenosine,-8.505610,x0195,active-noncovalent
c1ccc2c(c1)C(=O)N(S2(=O)=O)CC(=O)Nc3ccc(cc3)O,SCP-1,-8.505518,x1093,active-noncovalent
Cc1c(cccc1N)Cn2ccc(cc2=O)OCCc3cccs3,CG-400549,-8.504813,x0104,active-noncovalent
CN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)Cl,prochlorperazine,-8.504507,x0195,active-noncovalent
Cc1[nH+]cc(n1C(C)C)c2ccnc(n2)Nc3ccc(cc3)S(=O)(=O)C,AZD5438,-8.503536,x0195,active-noncovalent
CCn1cc(c(n1)c2ccc(cc2)NC(=O)N(C)C)c3ccnc4c3cc([nH]4)c5cccc(c5)C[NH+](C)C,GSK1070916,-8.503252,x0967,active-noncovalent
Cc1c(cno1)C(=O)Nc2ccc(cc2)C(F)(F)F,leflunomide,-8.502852,x0195,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)NC(=O)c3cccnc3,nifenazone,-8.502316,x0107,active-noncovalent
CN1/C(=C/C(=O)[O-])/S[C@H](C1=O)[NH+]2CCCCC2,ozolinone,-8.501673,x0678,active-noncovalent
c1ccnc(c1)C(c2ccc(cc2)OS(=O)(=O)[O-])c3ccc(cc3)OS(=O)(=O)[O-],sodium-picosulfate,-8.500985,x1077,active-noncovalent
CCCCCCCCCC[C@H](CCCCCCCC)CO,2-octyldodecan-1-ol,-8.500395,x0161,active-noncovalent
CC(C)(C)[NH2+]C[C@H](COc1c(nsn1)N2CCOCC2)O,timolol,-8.497485,x0195,active-noncovalent
c1ccc(cc1)c2ccc3c(n2)n(c(n3)c4cccnc4N)c5ccc(cc5)C6(CCC6)[NH3+],ARQ-092,-8.496807,x0397,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)C(=O)N[C@H]3C[NH+]4CCC3CC4,RS-56812,-8.496381,x1093,active-noncovalent
c1cc(ccc1C(=O)c2c3c(sc2N)CCCC3)Cl,T-62,-8.496325,x0749,active-covalent
COc1ccccc1CC(=[NH2+])N2C[C@H]3[C@@H](C2)C(CCC3=O)(c4ccccc4)c5ccccc5,RP67580,-8.495847,x1077,active-noncovalent
C1Cc2c([nH]nc2c3[n-]nnn3)C1,MK-0354,-8.495288,x0195,active-noncovalent
c1cc(ccc1CCSC(=[NH2+])N)OCc2ccc(cc2)N(=O)=O,KB-R7943,-8.494431,x0678,active-noncovalent
c1cc(c(c(c1)Cl)[NH+]=C2NCCN2)Cl,clonidine,-8.493985,x1385,active-covalent
COc1ccc(cc1)COc2ccc(cc2OC)Cc3cnc(nc3N)N,GW-2580,-8.493644,x0107,active-noncovalent
CC(=O)NCCc1cccc2c1cc(cc2)OC,agomelatine,-8.492036,x0195,active-noncovalent
Cc1ccc(cc1)/C(=C\C[NH+]2CCCC2)/c3ccccn3,triprolidine,-8.491549,x0678,active-noncovalent
C[NH2+]CC/C=C/c1cccnc1,rivanicline,-8.491385,x0397,active-noncovalent
c1cc(ccc1COC[C@@H]2[C@H]([C@H]([C@@H](O2)n3c4c(c(ncn4)N)nc3NCc5ccc(c(c5)Cl)Cl)O)O)C#N,VER-155008,-8.491158,x0104,active-noncovalent
C[NH2+][C@@H](C[C@H]1CCCOC1)CNC(=O)N2CCC[C@H](C2)[C@H](c3cccc(c3)Cl)OCCNC(=O)OC,VTP-27999,-8.490170,x0678,active-noncovalent
CCOC(=O)c1c(n(c2c1cc(cc2)O)C)C,mecarbinate,-8.489913,x0195,active-noncovalent
CCCCn1c(=O)c2c([nH]c(n2)C34C[C@@H]5C[C@H](C3)CC4C5)n(c1=O)CCCO,PSB-36,-8.489496,x0749,active-covalent
COc1c(nccn1)NS(=O)(=O)c2ccc(cc2)N,sulfametopyrazine,-8.488911,x0749,active-covalent
c1ccc(cc1)C[N@H+]2CCC[C@@H]2C(=O)NCCC[NH+]3CCC4(CC3)c5ccccc5CO4,BAN-ORL-24,-8.488327,x0678,active-noncovalent
c1cc(c(cc1Cl)Cl)c2c(cnc(n2)NCCNc3ccc(c(n3)N)N(=O)=O)n4ccnc4,CHIR-98014,-8.488226,x0161,active-noncovalent
c1ccc(cc1)CSCC[C@H](CCCCC(=O)[O-])SCc2ccccc2,CPI-613,-8.488104,x1077,active-noncovalent
C[C@H](CC[C@H](C(C)(C)O)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,secalciferol,-8.487970,x0104,active-noncovalent
c1cc(ccc1C(c2ccc(cc2)Cl)C(Cl)(Cl)Cl)Cl,"4,4'-DDT",-8.487745,x0072,active-noncovalent
CCC[N@H+](C/C=C/I)[C@H]1CCc2ccc(cc2C1)O,7-hydroxy-PIPAT,-8.487253,x0072,active-noncovalent
c1ccc(cc1)c2nc(c(s2)CC(=O)[O-])c3ccc(cc3)Cl,fentiazac,-8.486486,x0195,active-noncovalent
c1ccc(cc1)CN2C[C@@H](CC2=O)C[NH3+],nebracetam,-8.485782,x0072,active-noncovalent
c1cc(c(c(c1)Cl)C(=O)Nc2c[nH]nc2C(=O)NC3CC[NH2+]CC3)Cl,AT-7519,-8.484839,x1392,active-covalent
c1ccc(cc1)[C@H]2[C@H](CCC[NH2+]2)OCc3cc(cc(c3)C(F)(F)F)C(F)(F)F,L-733060,-8.484735,x0195,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3cccc(c3)Br,PD-153035,-8.484567,x0195,active-noncovalent
c1c(c(cc(c1O)O)O)CC[NH3+],oxidopamine,-8.484477,x1077,active-noncovalent
c1cc(c(cc1Cl)Cl)Nc2ncc(c(n2)C(F)(F)F)C(=O)NCC3CCOCC3,GW-842166,-8.483861,x0161,active-noncovalent
CCC(=O)NC[C@@H]1C[C@H]1c2cccc3c2CCO3,tasimelteon,-8.483717,x0195,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@H]3C(=O)C[C@@]2([C@]1(C(=O)CO)O)C)C,meprednisone,-8.483637,x0072,active-noncovalent
c1ccc2c(c1)ccc(n2)COc3cccc(c3)Nc4ccccc4C(=O)[O-],SR-2640,-8.483300,x0161,active-noncovalent
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCc2ccccc2)O)O)O,latanoprost,-8.483068,x0195,active-noncovalent
COc1ccc(cc1OC)CCC(=O)Nc2nc3ccc(cc3s2)Cl,KY02111,-8.481296,x0397,active-noncovalent
CC(=O)C[C@H](c1ccccc1)c2c(c3ccccc3oc2=O)[O-],warfarin,-8.481207,x1093,active-noncovalent
C/C(=C\c1ccccc1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)[O-],epalrestat,-8.480448,x0161,active-noncovalent
Cc1cccc(n1)c2c(c3n(n2)CCC3)c4ccnc5c4cc(cc5)C(=O)N,LY2157299,-8.479886,x0195,active-noncovalent
C[N@H+](CCCOc1ccc(cc1Cl)Cl)CC#C,clorgiline,-8.478968,x0104,active-noncovalent
c1ccc(cc1)C2(C[C@H]2C3=[NH+]CCN3)c4ccccc4,cibenzoline,-8.477521,x0678,active-noncovalent
CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)c2ccccc2)NC(=O)CCC(=O)[O-],sacubitril,-8.477490,x0107,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)C[C@@H](C(=O)[O-])[NH3+],5-hydroxytryptophan,-8.476649,x0678,active-noncovalent
Cc1c2cc(ccc2c(c(n1)C(=O)NCC(=O)[O-])O)Oc3ccccc3,FG-4592,-8.476649,x0104,active-noncovalent
C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(CCC(=O)[O-])O)C,potassium-canrenoate,-8.475823,x0678,active-noncovalent
c1cc(sc1S(=O)(=O)N[C@H](CO)C(C(F)(F)F)C(F)(F)F)Cl,begacestat,-8.474996,x0678,active-noncovalent
C[NH+]1CCN(CC1)c2cccc3c2oc(=O)[nH]3,pardoprunox,-8.474820,x0107,active-noncovalent
c1c(c(cc(c1Cl)Cl)Cl)OCC#CI,haloprogin,-8.474243,x0195,active-noncovalent
CC(C)(CC12CC3CC(C1)CC(C3)C2)[NH3+],somantadine,-8.473557,x0161,active-noncovalent
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4c5cccnc5)C)C,abiraterone-acetate,-8.472668,x0161,active-noncovalent
C[C@@]12CC3C[C@@](C1)(CC(C3)(C2)[NH3+])C,memantine,-8.472478,x1077,active-noncovalent
COC(=O)c1ccccc1NC(=O)c2ccc(cc2)F,EXO-1,-8.471998,x0195,active-noncovalent
Cc1c(c2c(c(c1O)C)CCC(O2)(C)C)C,APC-100,-8.471735,x0195,active-noncovalent
c1ccc(cc1)CCC[NH+]2CCN(CC2)CCOC(c3ccc(cc3)F)c4ccc(cc4)F,vanoxerine,-8.471379,x0395,active-noncovalent
C[NH2+][C@@H]1C[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,indatraline,-8.470644,x0749,active-covalent
c1ccc-2c(c1)Cc3c2ccc(c3)C(=O)NCCCC[NH+]4CCN(CC4)c5cccc(c5Cl)Cl,NGB-2904,-8.470403,x0104,active-noncovalent
CC1=C[C@H]2[C@@H](CC[C@]3([C@@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@]4(C1=CC(=O)CC4)C,megestrol-acetate,-8.468674,x0749,active-covalent
Cc1c(c(c(cn1)CO)C[NH3+])O,pyridoxamine,-8.467906,x0540,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)N[C@H](Cc1ccc(cc1)O)CO,OMDM-2,-8.466260,x0161,active-noncovalent
c1ccc2c(c1)c(=O)cc([nH]2)C(=O)[O-],kynurenic-acid,-8.466244,x0678,active-noncovalent
[H]/N=c\1/n(c2c(s1)CCCC2)CC(=O)c3ccc(cc3)C,pifithrin-alpha,-8.464807,x1093,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cc(cc3)Cl)O,oxazepam,-8.463932,x0434,active-noncovalent
Cc1cc(n[nH]1)Nc2cc(c3nc(c(n3n2)Cc4ccc(cc4F)Cl)C)C[NH+]5CCOCC5,LY2784544,-8.463860,x0434,active-noncovalent
c1ccn2c(c1)nc(c2NC(=O)c3ccc(cc3)Cl)c4cccs4,DS2-(806622),-8.463784,x0708,active-covalent
CC(C)(C)c1cc2c(c(c1)C(C)(C)C)OC(=O)[C@@]2(C(F)(F)F)O,rac-BHFF,-8.463651,x0195,active-noncovalent
C[N@H+]1CC[C@H](C1)Oc2cc(ccc2Cl)NS(=O)(=O)c3cc(c(cc3Br)OC)OC,SB-657510,-8.462646,x0195,active-noncovalent
C[NH+]1CCC(CC1)c2c3ccccc3cc(=O)c4c2ccs4,ketotifen,-8.461905,x0161,active-noncovalent
C[N@@H+]1CCC[C@H]1c2cc(cnc2)C#C,altinicline,-8.461845,x0678,active-noncovalent
CC[NH2+][C@@H](C)C[N@@]1CCc2c3ccccc3oc(=O)c2C1,CI-923,-8.461320,x0195,active-noncovalent
CC(=O)c1c(c2nc(ccc2[nH+]c1)c3cc(c(c(c3)Cl)[O-])Cl)N[C@H]4CC[C@@H](CC4)C[NH+](C)C,OTS167,-8.461239,x1077,active-noncovalent
C[C@@H](CN1c2ccccc2Sc3c1cc(cc3)OC)C[NH+](C)C,levomepromazine,-8.460957,x0104,active-noncovalent
CC(C)c1c(c2ccccn2n1)C(=O)C(C)C,ibudilast,-8.460682,x0678,active-noncovalent
CC[NH+](CC)CCNC(=O)COc1ccc(cc1)OC,mefexamide,-8.460430,x0195,active-noncovalent
CC1(CC(CC([NH2+]1)(C)C)Oc2ccc(nn2)c3ccc(cc3O)c4c[nH]nc4)C,LMI070,-8.460411,x0161,active-noncovalent
C=CC(=O)N1CCC[C@H](C1)n2c3c(c(n2)c4ccc(cc4)Oc5ccccc5)c(ncn3)N,ibrutinib,-8.460383,x0161,active-noncovalent
COc1ccc(cc1)c2ccc(=[NH2+])n(n2)CCCC(=O)[O-],gabazine,-8.459710,x0749,active-covalent
c1ccc(cc1)[C@H](CC[NH3+])Oc2ccc(cc2)C(F)(F)F,norfluoxetine,-8.459107,x0072,active-noncovalent
c1cc(ccc1c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F)Cl,SC-236,-8.458914,x0161,active-noncovalent
c1ccc(cc1)C(CCC[NH+]2CCCCC2)(c3ccccc3)O,diphenidol,-8.458512,x0195,active-noncovalent
CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O,flutamide,-8.456950,x0195,active-noncovalent
CCn1cnc2c1nc(nc2Nc3cccc(c3)Cl)N[C@@H]4CCCC[C@@H]4[NH3+],CGP-74514,-8.455705,x0195,active-noncovalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)[C@@H]2CC2(Cl)Cl,ciprofibrate,-8.455509,x0749,active-covalent
c1cc2c(ccc(c2nc1)[O-])N(=O)=O,nitroxoline,-8.454420,x0195,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=CC(=O)CC[C@]34C)C)OC(=O)C,"6,_7-dehydro-17-acetoxy-progesterone",-8.451935,x0161,active-noncovalent
Cc1nc(on1)COc2ccccc2OC[C@H](C[NH2+]C(C)(C)C)O,proxodolol,-8.451578,x0195,active-noncovalent
Cc1ccc(cc1n2c(cc(c(c2=O)Br)OCc3ccc(cc3F)F)C)C(=O)NC,PH-797804,-8.450583,x0874,active-noncovalent
c1ccc2c(c1)N(c3cc(ccc3S2)Cl)CCC[NH+]4CCN(CC4)CCO,perphenazine,-8.449662,x0195,active-noncovalent
C[C@@H]([C@H](c1ccccc1)O)[NH2+]C,ephedrine-(racemic),-8.449311,x0195,active-noncovalent
C/C/1=C/CC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,parthenolide-(-),-8.448843,x0195,active-noncovalent
Cc1c(n2cccc(c2n1)OCc3ccccc3)CC#N,SCH-28080,-8.448485,x0195,active-noncovalent
c1ccc(cc1)CCNC(=O)CCCl,fenaclon,-8.448026,x0161,active-noncovalent
CCC/C=C\1/C2=C(C=CCC2)C(=O)O1,ligustilide,-8.447991,x0195,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)C[NH+]3CCN(CC3)C(=O)OC(C(F)(F)F)C(F)(F)F,JW-642,-8.447926,x0104,active-noncovalent
CC(C)[C@H](C(=O)[O-])[NH3+],val,-8.447546,x0397,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)CSCCC(=O)[O-])NC(=O)O[C@@H](C)c3ccccc3Cl,KI-16425,-8.447453,x0161,active-noncovalent
c1ccc(cc1)CO[C@@H]([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],TBOA-(DL),-8.447106,x1418,active-covalent
Cc1ccccc1c2ccc(cc2)C(=O)N3C/C(=N\OC)/C[C@H]3C(=O)NC[C@H](c4ccccc4)O,OT-R-antagonist-1,-8.446954,x0107,active-noncovalent
C[C@@H]([C@H](c1ccc(cc1)O)O)[NH+]2CCC(CC2)Cc3ccccc3,ifenprodil,-8.446609,x0104,active-noncovalent
Cn1cc(c2c1cc(c(c2)C(=O)N3CCC(CC3)Cc4ccc(cc4)F)Cl)C(=O)C(=O)N(C)C,SX-011,-8.446242,x0161,active-noncovalent
C[NH+]1CCC(CC1)CNc2ccc3[nH+]cc(n3n2)c4cccc(c4)OC(F)(F)F,SGI-1776,-8.445366,x0434,active-noncovalent
C[NH+](C)Cc1cccc(c1)/N=C(/c2ccccc2)\c3c4ccc(cc4[nH]c3O)C(=O)N(C)C,BIX-02189,-8.444479,x1077,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH2+]C(C)C,isoetharine,-8.443722,x0749,active-covalent
C1CCC[NH+](CCC1)CCNC(=[NH2+])N,guanethidine,-8.443386,x1334,active-covalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O)C)O)C)O)C,hemomex-s,-8.442374,x0104,active-noncovalent
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C(=O)C=C2C1)CCC4=O)C)C,7-keto-DHEA,-8.440795,x0749,active-covalent
c1cc(cc(c1)O)c2cnc3c(n2)c(nc(n3)N)N,TG-100713,-8.440187,x0678,active-noncovalent
C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(cc1)c2ccc(cc2)C#N,LY-404187,-8.439507,x0104,active-noncovalent
C[N@H+]1CCC[C@H](C1)CC2c3ccccc3Sc4c2cccc4,metixene,-8.438705,x0678,active-noncovalent
COc1ccc(cc1)CN2c3ccc(cc3C(=O)C2=O)OC(F)(F)F,VU0238429,-8.438686,x0195,active-noncovalent
CCCOc1ccc(cc1N)C(=O)OCC[NH+](CC)CC,proxymetacaine,-8.438590,x0946,active-noncovalent
C1CCC(CC1)CCC[C@H](CC(=O)NO)c2nc(no2)C(=O)N,UK-383367,-8.437532,x0107,active-noncovalent
C[C@]12CC[C@@H]3[C@@H]([C@]1(CC[C@@H]2C4=CC(=O)OC4)O)CC[C@]5([C@@]3(CC[C@@H](C5)O)C=O)O,k-strophanthidin,-8.437345,x1077,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)Sc4cccc(c4)NC(=O)C=C)Cl,WZ8040,-8.436563,x1077,active-noncovalent
c1ccc(cc1)c2cc(=O)c3cccc(c3o2)CC(=O)[O-],mitoflaxone,-8.436230,x0678,active-noncovalent
CCCCCCCCCCCC(=O)N(CCO)CCO,lauric-diethanolamide,-8.434810,x0161,active-noncovalent
CCCC(c1ccccc1)(c2ccccc2)C(=O)OCC[NH+](CC)CC,proadifen,-8.434317,x0678,active-noncovalent
Cc1cnc(nc1NCc2ccc(cc2)n3ccnn3)c4ccccc4C(C)C,ML-323,-8.432630,x0072,active-noncovalent
CCN1C[C@H](C(C1=O)(c2ccccc2)c3ccccc3)CC[NH+]4CCOCC4,doxapram,-8.431566,x0678,active-noncovalent
Cc1ccc(cc1)/C=C\2/[C@@H]3CC[C@](C2=O)(C3(C)C)C,3-(4-methylbenzylidene)camphor,-8.429641,x0749,active-covalent
B1(c2ccc(cc2CO1)Cl)O,AN2718,-8.428252,x0195,active-noncovalent
C(C[C@@](C(F)F)(C(=O)[O-])[NH3+])C[NH3+],eflornithine,-8.426789,x0397,active-noncovalent
Cc1cccc(n1)c2c([nH]c(n2)C(C)(C)C)c3ccc4c(c3)nccn4,SB-525334,-8.426558,x0678,active-noncovalent
CCCn1cnc2c1c(=O)n(c(=O)n2C)CCCCC(=O)C,propentofylline,-8.425456,x0195,active-noncovalent
Cc\1cc(=C)[nH]/c1=C\c2c(cc([nH]2)c3cc4ccccc4[nH]3)OC,obatoclax,-8.424305,x1093,active-noncovalent
c1ccc(cc1)NC(=O)/C=C/c2c3c(cc(cc3Cl)Cl)[nH]c2C(=O)[O-],gavestinel,-8.424241,x1093,active-noncovalent
CCOC(=O)Nc1ccc(cc1N)NCc2c(cc(cc2C)C)C,AA-29504,-8.423727,x1093,active-noncovalent
CCCC[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(c3ccc(cc3)F)c4ccc(cc4)F,JHW-007,-8.423425,x0072,active-noncovalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N4[C@H]2CCC4)OC,"L-655,708",-8.423057,x1334,active-covalent
c1cc(cc(c1)O)Nc2ccc(nn2)Nc3cccc(c3)O,beta-amyloid-synthesis-inhibitor,-8.422981,x0946,active-noncovalent
CCOC(=O)C(C)(C)Oc1ccc(cc1)Cl,clofibrate,-8.421970,x0195,active-noncovalent
C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2([C@H](C=O)O)O)CCC4=CC(=O)C=C[C@]34C,prednisone,-8.420488,x0072,active-noncovalent
c1cc(cc(c1)F)/C=C/C(=O)NC2CC2,cinflumide,-8.419362,x0195,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[NH2+]C3,cytisine,-8.417797,x0195,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CCOC)O,metoprolol,-8.417479,x0104,active-noncovalent
c1cc(ccc1c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4)C(=O)NCC#N,cyt387,-8.417415,x0161,active-noncovalent
c1cc(ccc1OC(=O)N2CC[NH+]3CCC2CC3)Br,SSR-180711,-8.416765,x0749,active-covalent
c1cc(c(c2c1[NH+]=C3NC(=O)CN3C2)Cl)Cl,anagrelide,-8.416256,x0749,active-covalent
c1ccc(cc1)C(c2ccccc2)[NH+]3CCN(CC3)CCCn4c5ccccc5[nH]c4=O,oxatomide,-8.415870,x0967,active-noncovalent
C[C@H](CCc1ccccc1)[NH2+]C[C@@H](c2ccc(c(c2)C(=O)N)O)O,labetalol,-8.415393,x0107,active-noncovalent
COC(=O)[N-]C(=S)Nc1ccccc1NC(=S)[N-]C(=O)OC,thiophanate,-8.414536,x0749,active-covalent
c1cc(c(c(c1)Cl)CC(=O)NC(=[NH2+])N)Cl,guanfacine,-8.412230,x1334,active-covalent
Cn1c2cnc3ccc(cc3c2n(c1=O)c4ccc(c(c4)C(F)(F)F)N5CC[NH2+]CC5)c6ccc(nc6)OC,BGT226,-8.411229,x0161,active-noncovalent
C[C@H]1C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1([C@H](C=O)O)O)C)O)F)C,betamethasone,-8.410234,x0749,active-covalent
c1cc(c(cc1C(F)(F)F)NC(=O)c2ccncc2)N3CCCCC3,SRPIN340,-8.409800,x0195,active-noncovalent
C[N@@H+]1CCO[C@@H](c2ccccc2C1)c3ccccc3,nefopam,-8.408761,x1392,active-covalent
c1cc(sc1CO)c2ccc(o2)c3ccc(s3)CO,RITA,-8.408442,x1093,active-noncovalent
c1ccc(cc1)C[C@@H](CC(=O)N2C[C@H]3CCCC[C@H]3C2)C(=O)[O-],mitiglinide,-8.408325,x1093,active-noncovalent
CC(C)(C)OC(=O)c1c2n(cn1)-c3cccc(c3C(=O)N4[C@H]2CCC4)Br,bretazenil,-8.408072,x0874,active-noncovalent
c1ccc(cc1)NS(=O)(=O)c2cccc(c2)CCC(=O)N=O,belinostat,-8.407567,x0072,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)[C@H]4CCCO4,terazosin,-8.407208,x0161,active-noncovalent
c1cc(ccc1[C@@H](CC(=O)[O-])C[NH3+])Cl,baclofen-(R),-8.406635,x0759,active-covalent
c1cc(ccc1[C@@H](CC(=O)[O-])C[NH3+])Cl,baclofen,-8.406635,x0759,active-covalent
CC1(c2ccccc2C(=O)N(C1=O)CC[NH+]3CCN(CC3)c4ccccc4OC)C,ARC-239,-8.406599,x0161,active-noncovalent
CC(C)Oc1ccc2c(c1)oc3ccc(cc3c2=O)C(=O)[O-],AH6809,-8.406567,x0749,active-covalent
c1nc2c(n1[C@H]3C[C@@H]([C@H](O3)CO)O)NC[NH2+]CC2=O,pentostatin,-8.405374,x0749,active-covalent
C[C@]12CCC(=O)C=C1[C@H](C[C@H]3[C@@H]2[C@H](C[C@]4([C@@H]3C[C@@H]5[C@]4(OC(O5)(C)C)[C@H](C=O)O)C)O)F,fludroxycortide,-8.405338,x0874,active-noncovalent
c1ccc(cc1)NC(=O)CCCCCCC(=O)NO,vorinostat,-8.405173,x0678,active-noncovalent
c1cc2cccnc2c(c1)NC(=O)c3ccc(cc3)n4c(c5c(c4O)[C@H]6C[C@@H]5C=C6)O,endo-IWR-1,-8.403872,x0104,active-noncovalent
Cc1ccc(c(c1Cl)Nc2ccccc2C(=O)[O-])Cl,meclofenamic-acid,-8.403840,x1093,active-noncovalent
c1cc(ccc1c2nc(on2)[C@H]3CCCN(C3)C(=O)c4ccc(cc4)F)F,ADX-47273,-8.403830,x0195,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(cc2N(=O)=O)Cl,BTB1,-8.402944,x0072,active-noncovalent
CC1(c2ccccc2N(C1=O)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F)C,LY310762,-8.402941,x0072,active-noncovalent
Cc1c[nH+]c([nH]1)c2cnc(nc2c3ccc(cc3Cl)Cl)NCCNc4ccc(cn4)C#N,CHIR-99021,-8.402782,x0161,active-noncovalent
c1cc(ccc1C(CCC[NH+]2CCC(CC2)(c3ccc(c(c3)C(F)(F)F)Cl)O)c4ccc(cc4)F)F,penfluridol,-8.401995,x0104,active-noncovalent
CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO,betamethasone-valerate,-8.401898,x1077,active-noncovalent
CC(C)[C@@H](C(=O)OCCOCn1cnc2c1nc([nH]c2=O)N)[NH3+],valaciclovir,-8.401814,x1093,active-noncovalent
Cc1c(c(on1)c2ccc(cc2)CSCCC(=O)OC)NC(=O)O[C@@H](C)c3ccccc3Cl,ki16198,-8.401700,x0161,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O,corticosterone,-8.401367,x0967,active-noncovalent
C[C@H]1[C@@H]2Cc3ccc(cc3[C@]1(CC[N@H+]2CC=C)C)O,SK&F-10047-(+),-8.401029,x0678,active-noncovalent
CCCOc1ccc2c(c1)[nH]c(n2)NC(=O)OC,oxibendazole,-8.400433,x0195,active-noncovalent
c1ccc(cc1)C[C@@H]2Nc3cc(c(cc3S(=O)(=O)N2)S(=O)(=O)N)C(F)(F)F,bendroflumethiazide,-8.397747,x0195,active-noncovalent
c1cc2c(cc(c(c2nc1)O)I)I,iodoquinol,-8.397536,x0195,active-noncovalent
c1c(c(c(cc1F)F)Nc2n(c3nc(ncc3n2)N[C@H]4CC[C@@H](CC4)O)[C@@H]5COCC5)F,CC-930,-8.397164,x0161,active-noncovalent
C[N@@H+]1[C@@H]2CC[C@H]1C=C(C2)c3c(ccs3)Br,NS-3861,-8.397058,x0104,active-noncovalent
c1cc(cc(c1)O)Nc2c(cnc(n2)Nc3cccc(c3)O)F,R112,-8.395176,x1392,active-covalent
CC(=O)O[C@@H]1[C@H](C[NH2+][C@@H]1Cc2ccc(cc2)OC)O,anisomycin,-8.394763,x1385,active-covalent
c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=[NH2+])N,amiloride,-8.394518,x0397,active-noncovalent
c1ccc2cc(ccc2c1)O,beta-naphthol,-8.394147,x0195,active-noncovalent
c1cc2c(cc1n3c(nnc3Sc4ncc(s4)N(=O)=O)O)OCCO2,BI-78D3,-8.393758,x0107,active-noncovalent
C[N@@H+]1CCC[C@H](CC1)n2c(=O)c3ccccc3c(n2)Cc4ccc(cc4)Cl,azelastine,-8.393094,x0195,active-noncovalent
c1cc(ccc1CCCCCCCCCCCCCCC(=O)[O-])I,omega-(4-Iodophenyl)pentadecanoic acid,-8.392443,x0104,active-noncovalent
Cn1cc(cn1)[C@H]2c3cnnc(=O)c4c3c(cc(c4)NC(=O)[C@@H](C5CCCCC5)[NH3+])N2,PF-477736,-8.392074,x0104,active-noncovalent
CC[N@@H+](Cc1ccc(nc1)Cl)/C(=C/N(=O)=O)/NC,nitenpyram,-8.391289,x0678,active-noncovalent
c1cc(c(c(c1)Cl)C(=O)NCc2ccc3c(c2)OCO3)Cl,alda-1,-8.390648,x0749,active-covalent
C[N@@H+]1CCc2cc(c(cc2[C@H](C1)c3ccccc3)O)Br,SKF-83566,-8.390101,x1386,active-covalent
Cc1ccc(cc1)c2c3c(ncnc3n(n2)C(C)(C)C)N,PP-1,-8.388062,x0678,active-noncovalent
Cc1c(sc(c1C(=O)c2cccc(c2)C(F)(F)F)N)C,PD-81723,-8.388001,x0749,active-covalent
COc1c2ccc(=O)oc2cc3c1cco3,bergapten,-8.387637,x0195,active-noncovalent
Cc1cc(=O)oc2c1ccc(c2C=O)O,4-mu-8C,-8.387300,x0195,active-noncovalent
Cc1cc(n[nH]1)Nc2c(cc(c(n2)N[C@@H](C)c3ccc(cc3)F)C#N)F,AZ960,-8.386241,x0759,active-covalent
C[N@H+](C/C=C/c1ccccc1)Cc2cccc3c2cccc3,naftifine,-8.383686,x0104,active-noncovalent
Cc1cc(c(c(c1)C)/N=c/2\cc-3n(c(=O)n2C)CCc4c3cc(c(c4)OC)OC)C,trequinsin,-8.383359,x0195,active-noncovalent
c1ccc(cc1)[C@](CC[NH+]2CCCCC2)(C3CCCCC3)O,trihexyphenidyl,-8.383334,x0195,active-noncovalent
CCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,testosterone-undecanoate,-8.383152,x0161,active-noncovalent
CN(C)c1cccc(c1)Oc2cnc(nc2)Nc3cccc(c3)O,SEN-1269,-8.382158,x0161,active-noncovalent
CN1(=O)[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3,atropine-oxide,-8.381306,x0749,active-covalent
COc1cc(cc(c1OC)OC)Cc2cnc(nc2N)N,trimethoprim,-8.381269,x0678,active-noncovalent
c1cnccc1C(=O)NN,isoniazid,-8.380651,x0540,active-noncovalent
c1cnccc1C(=O)NN,pasiniazid,-8.380651,x0540,active-noncovalent
CC(=O)N(C)c1cccc(c1)c2ccnc3n2ncc3C(=O)c4cccs4,indiplon,-8.380480,x0195,active-noncovalent
CCc1c(/c/2c/c3c(c(/c(/n3)c/c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)O)CCC(=O)O)C)C)C=C)C,hemin,-8.380009,x0161,active-noncovalent
C[C@H](Cc1ccc(cc1)OCC(=O)[O-])[NH2+]C[C@@H](c2cccc(c2)Cl)O,BRL-37344,-8.379393,x0874,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)Nc2ccccc2C(F)(F)F)C,o-3M3FBS,-8.378460,x0678,active-noncovalent
Cc1csc(n1)NC(=O)CSc2ccc(nn2)c3ccccc3,VU-0240551,-8.378383,x0161,active-noncovalent
CCC(C)(C)c1ccc(cc1)C[C@@H](C)C[NH+]2C[C@H](O[C@H](C2)C)C,amorolfine,-8.377674,x0195,active-noncovalent
CCCOc1cc(ccc1C(=O)OCC[NH+](CC)CC)N,propoxycaine,-8.376968,x0104,active-noncovalent
c1c2c(=O)[nH]cnc2n[nH]1,allopurinol,-8.376930,x0678,active-noncovalent
CCCCCC/C=C\CCCCCCCC(=O)[O-],palmitoleic-acid,-8.376905,x0107,active-noncovalent
c1ccc2c(c1)OC[C@@H](O2)C[NH2+]CCN3C(=O)CC4(CCCC4)CC3=O,MDL-73005EF,-8.376335,x0104,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@H]2[C@@]1(CC=C3[C@H]2CCC4=CC(=O)CC[C@@]43C)C)O,anecortave-acetate,-8.374510,x0874,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)Cc3ccccc3)C(=O)[O-])C,benzylpenicillin,-8.374472,x0831,active-covalent
C[NH+](C)CCOc1ccc(cc1)/C(=C(/CCCl)\c2ccccc2)/c3ccccc3,toremifene,-8.373688,x0434,active-noncovalent
c1cc(c(cc1C(F)(F)F)N(=O)=O)C(=O)C2C(=O)CCCC2=O,nitisinone,-8.373479,x0749,active-covalent
CC(C)(C(=O)OCCOC(=O)c1cccnc1)Oc2ccc(cc2)Cl,etofibrate,-8.372146,x0107,active-noncovalent
CC[C@@H](CO)[NH2+]CCN[C@@H](CC)CO,ethambutol,-8.371911,x1093,active-noncovalent
c1cc2c(cc1Br)c3cc(ccc3n2C[C@H](CN4CC[NH2+]CC4)O)Br,BAX-channel-blocker,-8.371155,x0195,active-noncovalent
CCn1c2ccccc2[nH]c1=O,1-EBIO,-8.369204,x0678,active-noncovalent
Cc1ccc(cn1)NC(=O)Nc2cccc(c2F)C[NH+]3CCN(CC3)C(=O)OC,omecamtiv-mecarbil,-8.368703,x0161,active-noncovalent
CNC(=O)c1c2cc(c(cc2oc1c3ccc(cc3)F)[N@@](CCO)S(=O)(=O)C)C4CC4,nesbuvir,-8.368328,x0104,active-noncovalent
c1cc(oc1)C(=O)N2CC[NH+](CC2)CC(=O)Nc3cc(ccc3Cl)C(F)(F)F,ML-348,-8.368025,x0104,active-noncovalent
c1cc(c(cc1CC(=O)N2CCCC[C@@H]2C[NH+]3CCCC3)Cl)Cl,BRL-52537,-8.366723,x0678,active-noncovalent
c1ccc(c(c1)N)NC(=O)c2ccc(cc2)CNc3nccc(n3)c4cccnc4,mocetinostat,-8.365228,x0104,active-noncovalent
c1ccc(cc1)/C=C/Cn2cc(cn2)/C=C/C(=O)Nc3ccc(cc3N)F,RGFP966,-8.364725,x0104,active-noncovalent
Cc1cc(c(c(c1)C)NC(=O)[C@H]2C[C@@H]3CC[C@H]2C3)C,ML-213,-8.363173,x0161,active-noncovalent
c1ccc(c(c1)C2=NCC(=O)Nc3c2cc(cc3)N(=O)=O)Cl,clonazepam,-8.362827,x0072,active-noncovalent
CCCCCCCCCCCCCCC[C@H]([C@H](CO)[NH3+])O,safingol,-8.362826,x0161,active-noncovalent
c1cc(cnc1)/C=C/C(=O)NCc2ccc(cc2)C(=O)Nc3cc(ccc3N)F,chidamide,-8.361370,x0104,active-noncovalent
c1cc(c2c(c1)OCCO2)N3CC[NH2+]CC3,eltoprazine,-8.358266,x0195,active-noncovalent
C[N@+]12CCCC[C@@H]1CCC(=C(c3cccs3)c4cccs4)C2,tiquizium,-8.357582,x0749,active-covalent
CCCCOC(=O)c1ccc(cc1)O,butyl-paraben,-8.355982,x0749,active-covalent
Cc1ccc(c(c1)NCc2ccc3c(c2)n(c(n3)NCCC[NH+]4CCOCC4)Cc5c(ccc(n5)C)O)CCCO,TMC-353121,-8.355792,x0395,active-noncovalent
C[C@@H](Cc1ccc(cc1)OC)[NH2+]C[C@H](c2ccc(c(c2)NC=O)O)O,formoterol,-8.355700,x0107,active-noncovalent
CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@@]4(c5c(coc5C3=O)C(=O)O[C@@H]4COC)C)C,wortmannin,-8.354596,x0195,active-noncovalent
CC[C@@H]([C@@H](c1ccc(c2c1ccc(=O)[nH]2)O)O)[NH2+]C(C)C,procaterol,-8.353899,x0107,active-noncovalent
C[C@@H](c1ccc(cc1)C(=O)NCCC(=O)[O-])n2c(cc(n2)c3cc(cc(c3)Cl)Cl)c4ccc5cc(ccc5c4)OC,MK-0893,-8.353322,x0072,active-noncovalent
C[NH+]1CCN(CC1)C2=[NH+]c3ccccc3Oc4c2cc(cc4)Cl,loxapine,-8.351931,x0678,active-noncovalent
c1cc(cnc1)C[NH3+],picolamine,-8.351899,x0426,active-noncovalent
c1cc(cc(c1)Cl)Nc2nccc(n2)c3ccnc(c3)NCCCO,CGP-60474,-8.351830,x0946,active-noncovalent
COc1ccc(cc1)[C@H]2CC(=NN2c3ccc(cc3)S(=O)(=O)N)c4ccccc4,ML-141,-8.351234,x0161,active-noncovalent
c1ccc(c(c1)[C@@H]2c3cc(ccc3NC(=O)CS2)Cl)Cl,CGP-37157,-8.351077,x0072,active-noncovalent
c1ccc(c(c1)C(=O)OCCOCCO)Nc2cccc(c2)C(F)(F)F,etofenamate,-8.350521,x0434,active-noncovalent
Cc1cc(ccc1OCCCC(=O)NO)Cl,droxinostat,-8.350462,x0678,active-noncovalent
Cc1cccc(c1NC(=O)CC23CCC[NH+]2CCC3)C,pilsicainide,-8.349420,x0434,active-noncovalent
Cc1cc(cnc1c2ccnc(c2)C)CC(=O)Nc3ccc(cn3)c4cnccn4,LGK-974,-8.349251,x0161,active-noncovalent
Cc1cc(cc(c1CC2=[NH+]CCN2)C)C(C)(C)C,xylometazoline,-8.348288,x0161,active-noncovalent
CCNC(=O)CC1=N[C@@H](c2cc(ccc2-n3c1nnc3C)OC)c4ccc(cc4)Cl,I-BET-762,-8.347149,x1077,active-noncovalent
CCC[C@@H](c1ccccc1)NC(=O)/C(=C/c2cccc(n2)Br)/C#N,WP1130,-8.347046,x1077,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O,mevastatin,-8.346699,x0195,active-noncovalent
Cc1cccc(c1NC(=O)c2cc(c(cc2[O-])Cl)S(=O)(=O)N)C,xipamide,-8.346377,x0678,active-noncovalent
Cc1cnc(c(c1OC)C)CSc2[nH]c3ccc(cc3n2)OC,omeprazole-sulfide,-8.345440,x0434,active-noncovalent
C[NH+](C)C[C@@H]1CCCC[C@]1(c2cccc(c2)OC)O,tramadol,-8.345022,x0678,active-noncovalent
Cn1c2cc(c(cc2n(c1=O)C)N3CCCC3)NC(=O)c4ccccc4OC,PFI-4,-8.344585,x0195,active-noncovalent
COc1c2c(ccc(=O)o2)cc3c1occ3,methoxsalen,-8.344160,x0749,active-covalent
Cc1cc(ccc1OCC(=O)[O-])OCc2nc(cs2)c3ccccc3Cl,GPR120-modulator-1,-8.344146,x0161,active-noncovalent
CCOC(=O)[C@@]12C[C@@H]1[C@@H](c3ccccc3O2)N=O,CPCCOEt,-8.343886,x0072,active-noncovalent
c1cc2c(nc1)C(=O)/C(=N/CC[NH+]3CCOCC3)/[C@@H](C2=O)Cl,NSC-663284,-8.343728,x0195,active-noncovalent
C1CC[NH+](C1)CC#CCN2CCCC2=O,oxotremorine-sesquifumarate,-8.343220,x0749,active-covalent
C[C@@H](COc1ccccc1Cc2ccccc2)[NH+]3CCCCC3,benproperine,-8.342884,x0104,active-noncovalent
CCCCCCOc1ccccc1C(=O)N,exalamide,-8.340953,x1093,active-noncovalent
CN1C(=O)N(C(=O)[C@]12CN(C[C@H]2c3ccc(cc3)C#N)c4ccc(cn4)C(=O)[O-])c5cc(cc(c5)Cl)Cl,BMS-688521,-8.340836,x0072,active-noncovalent
CCc1cc(c(c(c1O)C(=O)NC[C@@H]2CCC[N@H+]2CC)OC)Cl,eticlopride,-8.340616,x0195,active-noncovalent
c1cc(c(c(c1)Cl)Cl)c2c(nc(nn2)N)N,lamotrigine,-8.340552,x0678,active-noncovalent
Cc1ccc(cc1)/C=C\2/C(=O)/C(=C/c3ccc(cc3)C)/C[NH2+]C2,NSC-632839,-8.339958,x0104,active-noncovalent
Cc1cccc(c1Nc2ncc3cc(ccc3n2)c4c(c(cc(c4Cl)OC)OC)Cl)NC(=O)C=C,BLU9931,-8.339640,x0104,active-noncovalent
CCC[NH2+]CCc1ccc(cc1)NS(=O)(=O)c2ccc(cc2)OC(F)(F)F,PNU-177864,-8.339514,x0161,active-noncovalent
c1cc(c(cc1Cl)Cl)[C@@H](Cn2ccnc2)OCc3ccsc3Cl,tioconazole,-8.339412,x0195,active-noncovalent
COc1ccc(c(c1)O)C(=O)c2ccccc2,oxybenzone,-8.339141,x0749,active-covalent
CC(C)(C)c1ccc(cc1)NC(=O)N2CCN(CC2)c3c(cccn3)Cl,BCTC,-8.338799,x0161,active-noncovalent
CCC(=O)N[C@@H]1Cc2ccccc2[C@H](C1)c3ccccc3,4-P-PDOT,-8.337657,x0678,active-noncovalent
C(CC[NH2+]CCC[NH3+])C[NH2+]CCC[NH3+],spermine,-8.337255,x0104,active-noncovalent
CCC(=O)O[C@]1([C@H](C[C@@H]2[C@@]1(C[C@H]([C@@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)CCl,halobetasol-propionate,-8.336428,x1077,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1ccc(c(c1)CO)O)O,levalbuterol,-8.336200,x0104,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1ccc(c(c1)CO)O)O,albuterol,-8.336200,x0104,active-noncovalent
C(C[C@H](CCC(=O)[O-])C(=O)[O-])CS,2-(3-mercaptopropyl)pentanedioic acid,-8.335565,x0397,active-noncovalent
c1c[nH]c2c1cc(cn2)c3c4c(ncnc4n(n3)C5CCCC5)N,PP-121,-8.334117,x0678,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1,benzyldimethylhexadecylammonium,-8.333984,x0161,active-noncovalent
CS(=O)(=O)N1CC[NH+](CC1)Cc2cc3c(s2)c(nc(n3)c4cccc5c4c[nH]n5)N6CCOCC6,GDC-0941,-8.333515,x0434,active-noncovalent
Cc1ccnc(c1)NC(=O)[C@@H](C)c2cccc(c2)C(=O)c3ccccc3,piketoprofen,-8.333107,x0678,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cccc(c5c4)N(=O)=O)O,rubitecan,-8.332558,x0104,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)[C@H]([C@@H](Cc1ccccc1)[NH3+])O,ubenimex,-8.332558,x0104,active-noncovalent
CC(C)(C#N)c1ccc(cc1)N2c3c4cc(ccc4ncc3COC2=O)c5cc6ccccc6nc5,ETP-46464,-8.331543,x0195,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],asiatic-acid,-8.331235,x1077,active-noncovalent
CC(C)c1ccccc1Cc2cc(c(c(c2O)O)O)C(=O)Nc3ccc(cc3)S(=O)(=O)c4ccccc4C(C)(C)C,TW-37,-8.329865,x0104,active-noncovalent
C[C@H]1C[C@H]2[C@H]3CC[C@@]([C@]3(C[C@@H]([C@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O,methylprednisolone-sodium-succinate,-8.329448,x1077,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N[C@@H](N2)C(Cl)Cl,trichlormethiazide,-8.328909,x0195,active-noncovalent
c1cc(ccc1O)O[C@@H]2CCCCO2,deoxyarbutin,-8.328835,x0678,active-noncovalent
C[C@@H]([C@H](c1cc(ccc1OC)OC)O)[NH3+],methoxamine,-8.327927,x1077,active-noncovalent
CC(=O)N(c1ccccc1/C=C/c2ccn(=O)cc2)S(=O)(=O)c3ccc(cc3)OC,HMN-214,-8.327533,x1077,active-noncovalent
c1cc(cc(c1)C(=O)N)c2cc(ncn2)Nc3ccc(cc3)OC(F)(F)F,GNF-2,-8.326980,x0107,active-noncovalent
COc1ccc(cc1O[C@H]2C[C@@H]3CC[C@H]2C3)C4CNC(=O)NC4,atizoram,-8.325622,x0749,active-covalent
c1cc(c(cc1F)[C@H]2CCCN2c3ccn4c(n3)c(cn4)NC(=O)N5CC[C@@H](C5)O)F,LOXO-101,-8.325197,x0195,active-noncovalent
COc1cc(ccc1NS(=O)(=O)c2ccsc2C(=O)OC)Nc3ccccc3,GSK-0660,-8.324645,x0161,active-noncovalent
C1CSS[C@@H]1CCCCC(=O)[O-],thioctic-acid,-8.323378,x0749,active-covalent
C[C@H]([C@H](c1ccccc1)O)[NH3+],"1s,2r-phenylpropanolamine",-8.323056,x0678,active-noncovalent
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CC[C@@H]4[C@@H]3CC=C(C4)N=O,norgestimate,-8.322652,x0749,active-covalent
CC(=CCC/C(=C/CC/C(=C/C=C/C(=C/C(=O)[O-])/C)/C)/C)C,peretinoin,-8.322544,x0072,active-noncovalent
c1cc(c(c2c1c([nH]n2)C[C@H](CC(=O)N3CCn4c(nnc4C(F)(F)F)C3)[NH3+])F)F,PK-44,-8.322359,x0195,active-noncovalent
c1cc2c(c(ccc2)S(=O)(=O)NC[C@H]3CC[C@@H](CC3)CNc4nc(c5c(n4)cccc5)N)cc1,CGP-71683,-8.321639,x0104,active-noncovalent
Cc1cc(c(cc1NC(=O)c2cc(cc(c2O)I)I)Cl)[C@@H](C#N)c3ccc(cc3)Cl,closantel,-8.321163,x0104,active-noncovalent
Cc1ccc(cc1S(=O)(=O)[N@](C)/N=C/c2c[nH+]c3n2cc(cc3)Br)N(=O)=O,PIK-75,-8.321043,x0195,active-noncovalent
CCOc1ccn(c(=O)c1C(=O)Nc2ccc(c(c2)F)Oc3ccnc(c3Cl)N)c4ccc(cc4)F,BMS-777607,-8.320773,x0104,active-noncovalent
Cc1ccc(c(c1)[C@H](C[NH2+]C(C)C)O)C,"benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]",-8.320657,x0195,active-noncovalent
c1ccc(cc1)C(c2ccccc2)([C@@H]3CC[N@@H+](C3)CCc4ccc5c(c4)CCO5)C(=O)N,darifenacin,-8.320539,x0104,active-noncovalent
CC(C)COC(=O)c1ccc(cc1)N,isobutamben,-8.320525,x0678,active-noncovalent
C[N@@H+]1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc4c3cc(cc4)OC,dextromethorphan,-8.320422,x0874,active-noncovalent
c1ccc2c(c1)C(=O)N[C@]2(c3ccc(c(c3)S(=O)(=O)N)Cl)O,chlorthalidone,-8.319755,x0830,active-covalent
Cn1c(=O)c-2nc(nn(c2nc1=O)C)c3ccc(cc3)C(F)(F)F,walrycin-b,-8.318973,x0397,active-noncovalent
C[N@H+](CCCN1c2ccccc2CCc3c1cccc3)CC(=O)c4ccc(cc4)Cl,lofepramine,-8.318087,x0946,active-noncovalent
Cc1c(c2ccc(c(c2o1)O)OC)C(=O)c3cc(c(c(c3)OC)OC)OC,BNC105,-8.318060,x0195,active-noncovalent
Cc1nc2ccccc2c(n1)N(C)c3ccc(cc3)OC,verubulin,-8.315365,x1093,active-noncovalent
c1cc(cnc1)N2CC[C@H](C2)[NH3+],ABT-202,-8.314229,x0195,active-noncovalent
Cc1c(oc2c1c(c3c(n2)CCCC3)NC(=O)CN4CCCC4=O)C,BCI-540,-8.313836,x0749,active-covalent
c1ccc(cc1)C(=O)N2CCC(CC2)CCCCNC(=O)/C=C/c3cccnc3,FK-866,-8.313380,x0434,active-noncovalent
c1cc(ccc1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)N(=O)=O,chloramphenicol,-8.312917,x0161,active-noncovalent
C[N@@H+]1C[C@@H]2c3ccccc3Oc4ccc(cc4[C@H]2C1)Cl,asenapine,-8.312070,x0072,active-noncovalent
CCc1cccc(c1[NH+]=C2NCCN2)CC,ST-91,-8.311742,x1385,active-covalent
CCCC[C@@H]1c2ccccc2C(=O)O1,butylphthalide,-8.311562,x0195,active-noncovalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,alfadolone-acetate,-8.309730,x0104,active-noncovalent
C[C@H](C[C@@H](C(=O)[O-])[NH3+])C(=O)[O-],SYM-2081,-8.308601,x0397,active-noncovalent
CC(C)Oc1ccccc1OC(=O)NC,propoxur,-8.308443,x0195,active-noncovalent
c1ccc(cc1)NC(=O)N2CCC(CC2)Cc3cc4ccccc4nc3,PF-750,-8.308383,x0161,active-noncovalent
CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@](C4)(C)O)C)C,ganaxolone,-8.307878,x0749,active-covalent
Cc1ccc(c(c1)Cl)NC2=[NH+]CCN2,tolonidine,-8.307787,x0195,active-noncovalent
C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,parthenolide-(alternate-stereo),-8.307545,x0195,active-noncovalent
C[NH+](C)CCCn1cc(c2c1ccc(c2)OC)C3=C(C(=O)NC3=O)c4c[nH]c5c4cccc5,go-6983,-8.305967,x0195,active-noncovalent
Cc1ccc(cc1)C(=O)c2ccc(cc2O)OC,mexeneone,-8.305769,x1093,active-noncovalent
CCCCOc1ccc(cc1Cl)c2cc(cnc2)C(=O)NCc3cccnc3N4CCOCC4,A-887826,-8.304589,x0161,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC2c3ccccc3Oc4c2cccc4,AH-7614,-8.304498,x0692,active-covalent
C[NH+]1CCC(=C2c3ccccc3Sc4c2cccc4)CC1,pimethixene,-8.302923,x0195,active-noncovalent
COc1cccc(c1)n2c(cc(n2)C(=O)[O-])c3ccc(c(c3)Cl)C4CCCCC4,TC-LPA5-4,-8.302910,x0072,active-noncovalent
CCn1c2c(cn1)c(c(cn2)C(=O)OCC)/N=N/C(C)C,etazolate,-8.302033,x0195,active-noncovalent
Cc1cc(c(c(c1)C)Nc2ccnc(n2)Nc3ccc(cc3)C#N)C,dapivirine,-8.301179,x0434,active-noncovalent
c1cc2c(ccc(c2nc1)O)Cl,cloxyquin,-8.300875,x0195,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(cc5c4)O)O,10-hydroxycamptothecin,-8.300719,x0161,active-noncovalent
Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)OCC[NH+]3CCOCC3)[O-])C(=O)OC2,mycophenolate-mofetil,-8.300500,x0195,active-noncovalent
CC(=O)Nc1ccc(cc1)OC[C@@](C)(C(=O)Nc2ccc(c(c2)C(F)(F)F)N(=O)=O)O,andarine,-8.299338,x0104,active-noncovalent
CCCCn1c(c(nc1c2ccccc2)c3ccccc3)C[NH+](Cc4ccc5c(c4)OCO5)Cc6ccc7c(c6)OCO7,NDT-9513727,-8.299243,x1077,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CC[C@@H]2OC(=O)CCC5CCCC5)O,estradiol-cypionate,-8.299145,x0874,active-noncovalent
Cc1ccc2c(c1)[C@]34CCCC[C@@H]3[C@H](C2)[N@@H+](CC4)C,dimemorfan,-8.298336,x1077,active-noncovalent
CC(C)(C)C(=O)Oc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)[O-],sivelestat,-8.297880,x0195,active-noncovalent
CCN(c1ccccc1C)C(=O)/C=C/C,crotamiton,-8.297319,x0678,active-noncovalent
CN(c1[nH]c(=O)ccn1)C2CCN(CC2)c3nc4ccccc4n3Cc5ccc(cc5)F,mizolastine,-8.296378,x0104,active-noncovalent
c1cc2c(ccc(c2nc1)O)N=O,NSC-3852,-8.295759,x0195,active-noncovalent
CCCCCn1cc(c(=O)c2c1ccc(c2)c3ccccc3)C(=O)NC45CC6CC(C4)CC(C6)C5,COR-170,-8.295734,x0161,active-noncovalent
Cc1cc(nc2c1c(c(s2)C(=O)NCc3ccc(cc3)Cl)N)C,VU10010,-8.295556,x0104,active-noncovalent
C[NH+](C)CCOC(=O)[C@@H](c1ccccc1)C2(CCCC2)O,cyclopentolate,-8.295277,x1093,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(cc1)N(=O)=O)O,nifenalol,-8.294984,x0749,active-covalent
CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,deoxycorticosterone-acetate,-8.294564,x0946,active-noncovalent
c1ccc(cc1)/C=C/C(=O)NCCO,brolitene,-8.294021,x0161,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)C,amidopyrine,-8.293386,x0749,active-covalent
c1cc2c(cc1C(=O)N)c(c[nH]2)CC[NH3+],5-carboxamidotryptamine,-8.293371,x0195,active-noncovalent
CCC[NH2+][C@H](C)C(=O)Nc1ccccc1C,prilocaine,-8.293068,x0195,active-noncovalent
C[NH2+]C[C@@H](c1cccc(c1)O)O,phenylephrine,-8.292872,x0434,active-noncovalent
c1cc(ccc1C(=O)NCC[NH+]2CCOCC2)Cl,moclobemide,-8.292768,x0161,active-noncovalent
CSc1nc(c(c(n1)NC2CCCC2)N(=O)=O)NC3CCCC3,GS-39783,-8.292576,x0195,active-noncovalent
CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)S(=O)(=O)C)F)CC(=O)[O-],exisulind,-8.292515,x0831,active-covalent
c1cc(cc(c1)OCC(C(F)F)(F)F)C[NH2+]CCc2c[nH]c3c2ccc(c3)F,idalopirdine,-8.291562,x0161,active-noncovalent
c1[nH]c2c(n1)c(=S)[nH]cn2,mercaptopurine,-8.290368,x0678,active-noncovalent
CCCCCCCCCCCCCCSCC(=O)[O-],tetradecylthioacetic-acid,-8.289843,x0104,active-noncovalent
c1cnc(cn1)C(=O)NC(=[NH2+])N,pyrazinoylguanidine,-8.288226,x0678,active-noncovalent
COc1ccc(cc1)Nc2c3cc(ccc3ncn2)OC,LY456236,-8.288116,x0072,active-noncovalent
Cc1cn2c(cc(n2)[C@@H]3CCCCN3C(=O)c4cc(ccc4NS(=O)(=O)C)Cl)nc1N5CC[C@@H](C5)[NH3+],presatovir,-8.286894,x0874,active-noncovalent
CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1,benzalkonium,-8.286427,x0195,active-noncovalent
CCCCCCCCCCCCCCCCCCO,octadecan-1-ol,-8.286419,x0161,active-noncovalent
C[C@H]1C[C@H]2[C@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,fluorometholone,-8.286389,x0749,active-covalent
c1ccc(cc1)C[C@@H](C(=O)[O-])[NH2+]Cc2ccc(cc2)Cl,BRL-26314,-8.286190,x0397,active-noncovalent
c1ccc(cc1)CCCCNC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,AG-556,-8.285829,x0678,active-noncovalent
c1cc(cc(c1)N2C(=O)/C(=C\c3ccc(cc3)C(=O)[O-])/SC2=S)C(F)(F)F,CFTRinh-172,-8.285606,x0072,active-noncovalent
CC(C)[NH2+]C[C@@H](c1cc(cc(c1)O)O)O,metaproterenol,-8.285376,x0434,active-noncovalent
C1COCCN1C(=[NH2+])NC(=[NH2+])N,moroxydine,-8.284554,x0195,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4[C@@](C2)(C(=O)OC)O)CC3,vincamine,-8.284317,x0195,active-noncovalent
c1cc(ccc1C(=O)[O-])NC(=O)CCn2cnc3c2nc[nH]c3=O,leteprinim,-8.284295,x0831,active-covalent
Cn1c2ccc(cc2nc1CCCC(=O)[O-])N(CCCl)CCCl,bendamustine,-8.284176,x0104,active-noncovalent
Cc1c(nc[nH]1)c2ccc(cc2)Cl,lofemizole,-8.284163,x0749,active-covalent
CN1(=O)[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4,scopolamine-n-oxide,-8.284106,x0072,active-noncovalent
c1c(cc(c2c1[nH]c(cc2=O)C(=O)[O-])Cl)Cl,"5,7-dichlorokynurenic-acid",-8.283470,x0678,active-noncovalent
C/C(=C\c1ccc(cc1)C(=O)[O-])/c2ccc3c(c2)C(CCC3(C)C)(C)C,TTNPB,-8.283151,x0104,active-noncovalent
C[C@@H](c1ccccc1)NC(=O)/C(=C/c2ccc(c(c2)O)O)/C#N,tyrphostin-AG-835,-8.282710,x0678,active-noncovalent
CCCCCCCCc1ccc(cc1)c2ccc(cc2)C(=O)[O-],AC-55649,-8.281613,x0161,active-noncovalent
CC(C)c1cc2c(cc1S(=O)(=O)[O-])[C@]3(CCC[C@@]([C@@H]3CC2)(C)C(=O)[O-])C,ecabet,-8.280455,x0749,active-covalent
c1cc(c(cc1Cl)O)Oc2ccc(cc2Cl)Cl,triclosan,-8.280219,x0749,active-covalent
Cc1nnc(n1C2C[C@H]3CC[C@@H](C2)[NH+]3CC[C@@H](c4ccccc4)NC(=O)C5CCC(CC5)(F)F)C(C)C,maraviroc,-8.279219,x0874,active-noncovalent
c1ccc2c(c1)c(=O)n(c(=S)[nH]2)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,altanserin,-8.278597,x0107,active-noncovalent
c1ccc2c(c1)cc(c(n2)C(=O)[O-])CC(=O)[O-],CCMQ,-8.278330,x0678,active-noncovalent
c1cc(cnc1)C(=O)NO,N-hydroxynicotinamide,-8.277518,x0397,active-noncovalent
Cc1cccc(c1OC[C@H](C)[NH3+])C,mexiletine,-8.276011,x0195,active-noncovalent
c1c(cc(c(c1Cl)[NH+]=C2NCCN2)Cl)N,apraclonidine,-8.275959,x1385,active-covalent
CC[C@@]1(CCC(=O)NC1=O)c2ccc(cc2)N,aminoglutethimide,-8.275949,x1385,active-covalent
CCCCCCCC/C=C\CCCCCCCC(=O)[O-],ethanolamine-oleate,-8.275096,x0678,active-noncovalent
c1cc(ccc1CS[C@@H](Cn2ccnc2)c3ccc(cc3Cl)Cl)Cl,sulconazole,-8.274795,x0678,active-noncovalent
c1cc(ccc1C(=O)[O-])N[C@@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,K-247,-8.274609,x0749,active-covalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(c(c3)Br)O,WHI-P154,-8.273545,x0195,active-noncovalent
Cc1c(c2c(c(c1O)C)CC[C@@](O2)(C)C(=O)[O-])C,trolox,-8.273417,x0749,active-covalent
Cc1cc(c(n(c1=O)C)Nc2ccc(cc2F)I)C(=O)NOCCO,AZD8330,-8.273303,x1392,active-covalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3cc(c4c(c3)O[C@@H](CC4=O)c5ccc(c(c5)O)OC)[O-])O)O)O)O)O)O,hesperidin,-8.271994,x0161,active-noncovalent
CC[C@H](c1ccccc1)c2c(=O)c3ccccc3oc2[O-],phenprocoumon,-8.271743,x0678,active-noncovalent
c1ccc(cc1)CCCn2c(nc(c2c3ccncc3)c4ccc(cc4)F)C#CCCO,RWJ-67657,-8.271724,x0161,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F,flumethasone,-8.271636,x0749,active-covalent
c1csc2c1[nH]cc(c2=O)C(=O)N[C@H]3C[NH+]4CCC3CC4,pumosetrag,-8.271628,x0749,active-covalent
C[NH2+][C@@H](CCC[NH+]=C(N)N)C(=O)[O-],L-monomethylarginine,-8.270660,x0678,active-noncovalent
CCn1c2cc(c(cc2[nH]c1=O)Cl)Cl,DCEBIO,-8.270514,x0195,active-noncovalent
COc1ccc(cc1OC)C(=O)N2CCN(CC2)c3ccc4c(c3)CCC(=O)N4,vesnarinone,-8.270296,x0104,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)OCC(=O)[O-],acemetacin,-8.270082,x0678,active-noncovalent
CC(C)(C)C(=O)[C@@H](Nc1ccc(cc1)Cl)/N=N/c2ccc(cc2)Cl,TY-52156,-8.269421,x0195,active-noncovalent
C[C@H](Cc1ccc(cc1)OC)[NH2+]C[C@@H](c2ccc(c3c2ccc(=O)[nH]3)O)O,carmoterol,-8.268541,x0434,active-noncovalent
CCOCCOC(=O)/C=C/c1ccc(cc1)OC,cinoxate,-8.268268,x0749,active-covalent
c1cc2c(cc1Cl)[nH]c(cc2=O)C(=O)[O-],7-chlorokynurenic-acid,-8.267561,x0749,active-covalent
CCn1cc(c(=O)c2c1cc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],norfloxacin,-8.265566,x0749,active-covalent
c1cc(c(c(c1)Cl)Cl)OCCC[NH2+]CCO,"2,3-DCPE",-8.264155,x0104,active-noncovalent
c1c([nH]cn1)CCSC(=[NH2+])N,imetit,-8.263945,x0195,active-noncovalent
CS(=O)(=O)c1ccc(c2c1[C@@H](C(C2)(F)F)O)Oc3cc(cc(c3)F)C#N,PT-2385,-8.263245,x0104,active-noncovalent
C[C@H](CSC(=O)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc2ccccc2)C(=O)[O-],alacepril,-8.263102,x0830,active-covalent
c1ccc(cc1)Cn2c3ccccc3nc2N4CC[NH2+]CC4,lerisetron,-8.262736,x0072,active-noncovalent
CC1(CCC(c2c1ccc(c2)C(=O)Nc3ccc(cc3)C(=O)[O-])(C)C)C,AM-580,-8.262286,x0104,active-noncovalent
c1cc2c(cc1I)/C(=C/c3cc(c(c(c3)Br)[O-])Br)/C(=O)N2,GW-5074,-8.262082,x0749,active-covalent
c1ccc2c(c1)CN(C(=O)O2)CC(=O)N,caroxazone,-8.262027,x0195,active-noncovalent
CC1(CCC(c2c1ccc(c2)NC(=O)c3ccc(cc3)C(=O)[O-])(C)C)C,tamibarotene,-8.261535,x1077,active-noncovalent
c1cnccc1Cc2cnc[nH]2,immethridine,-8.261357,x0749,active-covalent
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)N)c4ccc(cc4)Cl)C,CPI-203,-8.261066,x0831,active-covalent
CC[C@@H](c1ccccc1)NC(=O)c2c(c(nc3c2cccc3)c4ccccc4)C,SB-222200,-8.260946,x1077,active-noncovalent
C[C@H]1C[C@H](CC([N@@H+]1C)(C)C)OC(=O)[C@H](c2ccccc2)O,eucatropine,-8.260940,x0195,active-noncovalent
c1ccc2c(c1)CC[C@@H]2Nc3c4ccn(c4ncn3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N,pevonedistat,-8.260508,x0161,active-noncovalent
c1ccc(c(c1)C/C(=N\Nc2nc(cs2)c3ccc(c(c3)Cl)Cl)/C(=O)[O-])N(=O)=O,4EGI-1,-8.260505,x0678,active-noncovalent
C[C@]12CC[C@@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)[C@@]1(CC[C@H]2[C@](C)([C@@H](CCC(C)(C)O)O)O)O,20-hydroxyecdysone,-8.260140,x0161,active-noncovalent
c1cc2c(cc1F)[C@]3(CCO2)C(=O)NC(=O)N3,sorbinil,-8.259608,x0161,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CC[N@@H+](CCO)Cc3ccc(cc3)CCC(=O)N=O,dacinostat,-8.259498,x0749,active-covalent
c1cc(ccc1C[C@H](C(=O)[O-])[NH3+])I,4-iodo-L-phenylalanine,-8.258878,x1077,active-noncovalent
C[C@@H](c1ccc(cc1)CC(C)C)C(=O)NO,ibuproxam,-8.258434,x0749,active-covalent
c1cc(cc(c1)n2nccn2)Nc3c(cnc(n3)N[C@@H]4CCCC[C@@H]4[NH3+])C(=O)N,PRT062607,-8.258021,x0161,active-noncovalent
CC(S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)Nc2ncc(cc2)C(F)(F)F)(C)C,velneperit,-8.258002,x0104,active-noncovalent
CC[NH+](CC)CC(=O)Oc1ccc(cc1)NC(=O)C,propacetamol,-8.257581,x0104,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])O,D-Serine,-8.256297,x0397,active-noncovalent
C[C@@H](c1ccc(cc1)F)Nc2cc(cc(n2)Nc3cnccn3)c4cnn(c4)C,NS-018,-8.255767,x0678,active-noncovalent
CCOC(=O)[C@H]1[C@@H]([C@@H]2C(=NC1=C)CC(CC2=O)(C)C)c3ccc(cc3)c4ccccc4,ITD-1,-8.255048,x1077,active-noncovalent
c1cc(oc1)c2nnc3n2nc(s3)C4CCCCC4,cardionogen-1,-8.254781,x0708,active-covalent
c1[nH]c2c(n1)c(=O)[nH]cn2,hypoxanthine,-8.254661,x0678,active-noncovalent
CC[NH+](CC)CCC[C@@H](C)Nc1nc(cc(n1)Nc2ccc3c(c2)c(cc([nH+]3)C)N)C,NSC-23766,-8.253355,x0104,active-noncovalent
C[NH+]1CCN(CC1)C(=O)c2[nH]c3ccc(cc3n2)Cl,JNJ-10191584,-8.253301,x0195,active-noncovalent
CC(=O)N(C)c1cc(ccc1F)c2ccnc3n2ncc3C(=O)c4cccs4,lorediplon,-8.253090,x0104,active-noncovalent
CCOc1ccccc1OC[C@@H]2C[NH2+]CCO2,viloxazine,-8.250784,x0678,active-noncovalent
Cn1c(cc(=O)n(c1=O)C)NCCC[NH+]2CCN(CC2)c3ccccc3OC,urapidil,-8.250312,x0161,active-noncovalent
C[C@H](Cc1ccc2c(c1)OCO2)[C@@H](C)Cc3ccc(c(c3)OC)O,macelignan,-8.249751,x0072,active-noncovalent
c1cc2cc([nH]c2c(c1)N(=O)=O)C(=O)[O-],CRT0044876,-8.249027,x0195,active-noncovalent
C[NH2+]C[C@@H](c1ccc(cc1)O)O,synephrine,-8.247826,x0434,active-noncovalent
Cc1ccccc1C(=O)c2ccc(cc2Cl)Nc3ccc(cc3N)Br,EO-1428,-8.247787,x0161,active-noncovalent
Cc1ccc(cc1)NC(=O)CCCCCC(=O)Nc2ccccc2N,TC-H-106,-8.246964,x1385,active-covalent
COC1(CC[NH+](CC1)CCc2c[nH]c3c2cc(cc3)F)C[S@](=O)c4ccccc4,GR-159897,-8.246887,x1077,active-noncovalent
CC[N+](C)(C)c1cccc(c1)O,edrophonium,-8.246325,x0161,active-noncovalent
C[C@@H](Cn1ccc2c1cc(c(c2)F)Cl)[NH3+],Ro-60-0175,-8.245057,x0161,active-noncovalent
CC[NH2+][C@@H](C)Cc1cccc(c1)C(F)(F)F,dexfenfluramine,-8.244839,x0678,active-noncovalent
COc1ccc(cc1)c2c(c3ccc(cc3o2)OC)C(=O)c4ccc(cc4)C#N,LY320135,-8.244498,x1392,active-covalent
CCOC(=O)[C@@H]1[C@H]([C@@H](C(=C)N=C1C)C(=O)OCC)c2ccccc2/C=C/C(=O)OC(C)(C)C,lacidipine,-8.243956,x0195,active-noncovalent
C1CCC2(CC1)CC[NH2+]CC2,"4,4-pentamethylenepiperidine",-8.243912,x0678,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C,dehydroepiandrosterone-sulfate,-8.243103,x1077,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)NC4CCCC4,2-chloro-N6-cyclopentyladenosine,-8.243065,x0946,active-noncovalent
c1cc(cc(c1)Cl)N2CC[N@@H+](CC2=O)Cc3cncn3Cc4ccc(cc4)C#N,L-778123,-8.240721,x0161,active-noncovalent
C=CCO[C@H](Cn1ccnc1)c2ccc(cc2Cl)Cl,enilconazole,-8.240651,x0749,active-covalent
CCOC(=O)c1ccccc1OC(=O)N,ethyl-2-(carbamoyloxy)benzoate,-8.240365,x1418,active-covalent
CC[C@H]1[C@H](COC1=O)Cc2cncn2C,pilocarpine,-8.239864,x0107,active-noncovalent
CC[C@@H](C)[C@@H](C(=O)NCC[NH+]1CCOCC1)[NH3+],LM11A-31,-8.239474,x0434,active-noncovalent
COc1cc(nc(n1)OC)NS(=O)(=O)c2ccc(cc2)N,sulphadimethoxine,-8.239340,x1334,active-covalent
CC(C)[NH+](CC[C@](c1ccccc1)(c2ccccn2)C(=O)N)C(C)C,disopyramide,-8.237773,x0874,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccccc5c4)O,camptothecin,-8.237311,x0161,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4C(=O)C2)CC3,vinburnine,-8.237022,x0195,active-noncovalent
CC[NH+](CC)CCOC(=O)C1(CCCC1)c2ccccc2,caramiphen,-8.236529,x0195,active-noncovalent
c1ccnc(c1)C(=O)Nc2cccc(c2)Cl,VU0364770,-8.236387,x1093,active-noncovalent
COc1ccc2c(c1)c(ccn2)[C@H]([C@@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C)O,quinine,-8.236301,x0678,active-noncovalent
C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,artemisinin,-8.236082,x0195,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)([C@H](C=O)O)O,methylprednisolone,-8.234892,x0749,active-covalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+])[NH3+])O,sisomicin-sulfate,-8.234397,x0434,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)C[NH2+]C)[NH3+])[NH3+])[NH3+])O,micronomicin,-8.234350,x0874,active-noncovalent
CCCn1c2c(c(=O)n(c1=O)CCC)[nH]c(n2)c3ccccc3,"1,3-dipropyl-8-phenylxanthine",-8.233935,x0678,active-noncovalent
C[NH+]1[C@@H]2CC[C@H]1CC(C2)OC(c3ccc(cc3)F)c4ccc(cc4)F,3-alpha-bis-(4-fluorophenyl)-methoxytropane,-8.233776,x1077,active-noncovalent
c1ccc(c(c1)F)S(=O)(=O)[N@@]2CCOc3c2cccc3N4CC[NH2+]CC4,R-1485,-8.232874,x0072,active-noncovalent
CCOc1ccc(cc1)NC(=S)N2CCC(CC2)C(c3ccccc3)(c4ccccc4)O,SF-11,-8.232600,x1093,active-noncovalent
Cc1cccc(c1)Oc2c[nH]c(=O)nc2,tolimidone,-8.230483,x0195,active-noncovalent
CCOC(=O)C1=C(NC(=C([C@@H]1C#Cc2ccccc2)C(=O)OCc3ccc(cc3)N(=O)=O)c4ccccc4)C,MRS1334,-8.230335,x0161,active-noncovalent
c1ccc(cc1)N2CNC(=O)C23CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F,spiperone,-8.230008,x0434,active-noncovalent
c1ccc2c(c1)OC[C@H](O2)C3=[NH+]CCN3,idazoxane,-8.228940,x0195,active-noncovalent
c1ccc2c(c1)OC[C@H](O2)C3=[NH+]CCN3,idazoxan,-8.228940,x0195,active-noncovalent
C[C@@H](CCCCn1c(=O)c2c(ncn2C)n(c1=O)C)O,lisofylline,-8.228798,x0195,active-noncovalent
C[NH+](C)CCc1ccc(cc1)O,hordenine,-8.228170,x0161,active-noncovalent
c1ccc2c(c1)c3c(o2)c(ncn3)N4CCN(CC4)C(=S)NCc5ccc6c(c5)OCO6,amuvatinib,-8.228062,x0161,active-noncovalent
C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C,octamethyltrisiloxane,-8.226797,x0749,active-covalent
CC(C)(CC(=O)NCCn1ccc2c1c(ncn2)Nc3ccc(c(c3)Cl)Oc4cccc(c4)C(F)(F)F)O,TAK-285,-8.226374,x0161,active-noncovalent
C[C@H](C(=O)OC(C)(C)Cc1ccc(cc1)Cl)[NH3+],alaproclate,-8.226223,x1418,active-covalent
CCOc1ccc2c(c1)C(=CC(N2)(C)C)C,ethoxyquin,-8.226137,x0195,active-noncovalent
CC(=CCc1c(ccc2c1oc(=O)cc2)OC)C,osthol,-8.226069,x0195,active-noncovalent
Cc1c(nc(o1)c2ccccc2)CCC(=O)c3ccc(cc3)Cc4c([nH]c(=O)s4)[O-],darglitazone,-8.225974,x0072,active-noncovalent
CC(C)n1cnc2c1nc(nc2NCCc3ccc(cc3)O)c4csc5c4cccc5,stemregenin-1,-8.224808,x0831,active-covalent
c1ccc(cc1)[C@@H]2C[C@H]2[NH2+]CC3CC[NH+](CC3)Cc4ccc(cc4)C(=O)[O-],GSK2879552,-8.224319,x0749,active-covalent
C[N@@H+]1C[C@@H](C[C@H]1CCOc2ccccc2CCc3cccc(c3)OC)O,R-96544,-8.224092,x0195,active-noncovalent
CCCCCCC(=O)OC1CC([NH2+]C(C1)(C)C)(C)C,TMPH,-8.223905,x0161,active-noncovalent
COc1ccc(cc1)CNC(=O)Nc2ncc(s2)N(=O)=O,AR-A014418,-8.223884,x0678,active-noncovalent
CCC[NH2+][C@H](C)C(=O)Nc1c(csc1C(=O)OC)C,articaine,-8.223339,x0195,active-noncovalent
c1ccc(c(c1)N2CC=C(NC2=O)c3cccc(c3)N(=O)=O)O,icilin,-8.223249,x0161,active-noncovalent
C[C@@H](C(F)(F)F)Oc1ccc(cc1C(=O)N2CCN(CC2)c3c(cc(cn3)C(F)(F)F)F)S(=O)(=O)C,bitopertin,-8.223043,x1077,active-noncovalent
C[N@H+]1CCC[C@@H]1Cc2c[nH]c3c2cc(cc3)CCS(=O)(=O)c4ccccc4,eletriptan,-8.222871,x0874,active-noncovalent
c1ccnc(c1)c2c([nH]c(n2)c3ccc(cc3)C(=O)N)c4ccc5c(c4)OCCO5,D-4476,-8.222851,x0434,active-noncovalent
CCO[C@@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)(C)C)NC(=O)c3ccc(c(c3)Cl)N,VX-765,-8.220553,x0967,active-noncovalent
CCCCCCCCCCCC(=O)[O-],lauric-acid,-8.219894,x0678,active-noncovalent
C[C@H](Cc1ccc(c(c1)OC)OC)[C@@H](C)Cc2ccc(c(c2)OC)OC,terameprocol,-8.218856,x0195,active-noncovalent
CN(CCOc1ccc(cc1)C[C@H]2C(=O)[N-]C(=O)S2)c3ccccn3,rosiglitazone,-8.218854,x0749,active-covalent
c1cc2c(cc1OCCCCc3nnnn3C4CCCCC4)CCC(=O)N2,cilostazol,-8.217163,x1334,active-covalent
C1CCC(CC1)NC(=O)N(CCCl)N=O,lomustine,-8.215820,x0195,active-noncovalent
Cc1cccc(n1)c2c(nc([nH]2)C(C)(C)C)c3ccc4c(c3)OCO4,SB-505124,-8.215747,x0678,active-noncovalent
CC[NH+](CC)CCOC(=O)[C@@H](c1ccccc1)C2CCCCC2,drofenine,-8.215308,x1093,active-noncovalent
Cc1ccc(o1)CNc2c3cc(ccc3ncn2)c4ccc(o4)CO,ML167,-8.215120,x0104,active-noncovalent
C(CC(=O)[O-])C(=O)C(=O)[O-],2-oxoglutaric-acid,-8.215040,x0397,active-noncovalent
CCCCOc1nc(c2c(n1)[N@](CC(=O)N2)Cc3cccc(c3)C[NH+]4CCCC4)N,GS-9620,-8.214684,x0874,active-noncovalent
c1cc(c(cc1[C@@H](C(=O)[O-])[NH3+])C(=O)[O-])O,3-carboxy-4-hydroxyphenylglycine-(S),-8.213431,x1412,active-covalent
Cc1c(cno1)C(=O)N2CCCCC2,nerbacadol,-8.213220,x0195,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C,mometasone,-8.212431,x0874,active-noncovalent
CCN(CCNC(=O)Nc1ccccc1Br)c2cccc(c2)C,SB-452533,-8.212340,x0104,active-noncovalent
c1ccc2c(c1)CCC/C(=C\C(=O)[O-])/[C@@H]2O,NCS-382,-8.211833,x0749,active-covalent
CC(C)(C)[C@H](/C=C/c1ccc2c(c1)OCO2)O,stiripentol,-8.211080,x0749,active-covalent
CC[C@]1(CCCC[N@@H+](C1)C)c2cccc(c2)O,meptazinol,-8.210585,x0161,active-noncovalent
CCOc1cc(c(cc1OCC)OCC)C(=O)CCC(=O)[O-],trepibutone,-8.210217,x0678,active-noncovalent
COc1cc(cc(c1O)C(=O)NCCO)CC=C,alibendol,-8.210127,x0678,active-noncovalent
C[NH+]1[C@@H]2CC[C@@H]1CC(C2)OC(c3ccccc3)c4ccccc4,benztropine-mesylate,-8.210074,x0072,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N,tacedinaline,-8.209475,x1093,active-noncovalent
C[C@H](CN1c2ccccc2Sc3c1cccc3)C[NH+](C)C,alimemazine,-8.209431,x0195,active-noncovalent
C[C@H](CN1c2ccccc2Sc3c1cccc3)C[NH+](C)C,trimeprazine,-8.209431,x0195,active-noncovalent
c1ccc(cc1)[C@@H](c2ccccn2)/N=N/c3ccc(cn3)Cl,JIB04,-8.208703,x0749,active-covalent
Cc1cc(=O)c2c(o1)c(c3c(c2OC)cco3)OC,khellin,-8.208635,x0195,active-noncovalent
c1cc(c(cc1C(F)(F)F)NC(=O)Nc2cc(ccc2[O-])C(F)(F)F)[O-],NS-1643,-8.208409,x0874,active-noncovalent
CC[C@@]12CCC[N@H+]3[C@@H]1c4c(c5ccccc5n4C(=C2)C(=O)OCC)CC3,vinpocetine,-8.208232,x0195,active-noncovalent
CCc1c([nH]c(=O)[nH]1)C(=O)c2ccncc2,piroximone,-8.207845,x1382,active-covalent
Cc1nc2cnccc2n1Cc3ccc(cc3F)C(=O)c4cn(c5c4c(ccc5)C#C)C(=O)N(C)C,ABT-491,-8.207167,x1077,active-noncovalent
CCC(=O)O[C@@H]1CC[C@H]2[C@@]1(CC[C@@H]3[C@@H]2CC[C@@H]4[C@]3(C[C@@H](C(=O)C4)C)C)C,dromostanolone-propionate,-8.206539,x0072,active-noncovalent
CC[NH+](CC)CCOC(=O)C1(CCCC1)c2ccc(cc2)N(=O)=O,nitrocaramiphen,-8.206180,x0195,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CC(C)(C)CO,CGP-7930,-8.206158,x0195,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)OC)c2ncccn2,thonzylamine,-8.206113,x0874,active-noncovalent
C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,PYM50028,-8.205397,x0678,active-noncovalent
CCCCN(CC)c1c2c(c(n(c2nc(n1)C)c3c(cc(cc3C)C)C)C)C,antalarmin,-8.204543,x0104,active-noncovalent
c1cc(sc1)c2cc(no2)C(=O)NC3CC3,ISX-9,-8.204162,x0161,active-noncovalent
c1ccc2c(c1)cc(s2)C(=O)[O-],BL-5583,-8.203632,x0195,active-noncovalent
COC(=O)/C=C/C(=O)OCCn1c(ccc1O)O,diroximel-fumarate,-8.203455,x0195,active-noncovalent
CCCCCCCC/C=C\CCCCCC[C@H](C(=O)[O-])O,minerval,-8.203146,x0831,active-covalent
C[C@@H](c1ccccc1)NC(=O)[C@@H]2CSCN2C(=O)c3ccccc3,RS-0481,-8.202857,x0104,active-noncovalent
Cc1cc2c(c(c(c(c2C(C)C)O)O)C=O)c(c1c3c(cc4c(c3O)c(c(c(c4C(C)C)O)O)C=O)C)O,gossypol,-8.201283,x1077,active-noncovalent
CCC[N@@H+]1CCCC[C@H]1C(=O)Nc2c(cccc2C)C,ropivacaine,-8.200874,x0434,active-noncovalent
CC(C)(C)c1ccc(cc1)/C(=C/C(=O)c2ccc(cc2)OC)/O,avobenzone,-8.198940,x0161,active-noncovalent
Cc1cccc(n1)c2c([nH]c(n2)CNc3ccccc3F)c4ccc5ncnn5c4,EW-7197,-8.198914,x0874,active-noncovalent
COc1ccc(cc1OC2CCCC2)C3(CCC(CC3)C(=O)[O-])C#N,cilomilast,-8.198668,x0749,active-covalent
Cc1nc2ccsc2c(n1)Nc3c4c(n[nH]3)C(N(C4)C(=O)N[C@H](C[NH+](C)C)c5ccccc5)(C)C,PF-03758309,-8.198112,x0161,active-noncovalent
[2H]C([2H])([2H])C(CCO[C@@H](C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)(C([2H])([2H])[2H])O,maxacalcitol,-8.197425,x0874,active-noncovalent
CC[C@H]1C[N@H+]2CCc3cc(c(cc3[C@@H]2C[C@@H]1C[C@@H]4c5cc(c(cc5CC[NH2+]4)OC)OC)OC)OC,emetine,-8.197369,x0434,active-noncovalent
c1ccc(cc1)CCCc2c(=O)[nH]c3ccc(cc3n2)C(=O)NO,TCS-2210,-8.197081,x0195,active-noncovalent
Cc1c(c2ccccc2n1CC[NH+]3CCOCC3)C(=O)c4ccc(cc4)OC,pravadoline,-8.196087,x0072,active-noncovalent
Cc1cc(sc1[C@H](C(=O)[O-])[NH3+])C(=O)[O-],3-MATIDA,-8.195889,x1418,active-covalent
C(CSSCCNC(=[NH2+])N)NC(=[NH2+])N,guanidinoethyldisulfide-bicarbonate,-8.194515,x1334,active-covalent
c1ccc2c(c1)cc(s2)C3(CCCCC3)[NH+]4CCCCC4,CS-110266,-8.194106,x0434,active-noncovalent
CC1([C@H]([C@@H](c2cc(ccc2O1)C#N)N3CCCC3=O)O)C,levcromakalim,-8.192831,x0195,active-noncovalent
CC1([C@H]([C@@H](c2cc(ccc2O1)C#N)N3CCCC3=O)O)C,cromakalim,-8.192831,x0195,active-noncovalent
CCC1(C(=O)NCNC1=O)c2ccccc2,primidone,-8.191757,x0678,active-noncovalent
CCNC(=O)c1c(c(on1)c2cc(c(cc2O)O)C(C)C)c3ccc(cc3)C[NH+]4CCOCC4,NVP-AUY922,-8.191033,x1077,active-noncovalent
c1cc(c(c2c1c(c([nH]2)O)N=O)Cl)Cl,NS-309,-8.190699,x1385,active-covalent
c1cc(c(cc1NC(=O)c2ccc(cn2)F)[C@]34COC[C@@H]3CSC(=[NH+]4)N)F,LY2886721,-8.190559,x0678,active-noncovalent
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O,sotagliflozin,-8.190347,x0161,active-noncovalent
CCn1c2c(cncc2nc1c3c(non3)N)C[NH2+]C4CC[NH2+]CC4,SB-747651A,-8.190108,x0678,active-noncovalent
CCC[C@@H](C(=O)[O-])[NH2+][C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)[O-],perindoprilat,-8.189720,x0830,active-covalent
CC(C)Cn1c2c(c(=O)n(c1=O)C)[nH]c(n2)COC,MMPX,-8.189321,x0678,active-noncovalent
CCCCOC(=O)c1ccc(cc1)N,butamben,-8.188950,x0678,active-noncovalent
c1cn(cc(c1=O)[O-])C[C@@H](C(=O)[O-])[NH3+],mimosine,-8.187805,x0107,active-noncovalent
c1cn(cc(c1=O)[O-])C[C@@H](C(=O)[O-])[NH3+],L-mimosine,-8.187805,x0107,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)CNC(=O)c2ccc(c(c2)OC)OC,itopride,-8.187288,x0161,active-noncovalent
Cc1ccc(cc1O)C(C)C,antioxine,-8.187159,x0195,active-noncovalent
COc1cnc(nc1)[N-]S(=O)(=O)c2ccc(cc2)N,sulfameter,-8.186386,x0072,active-noncovalent
CC(C)[NH2+]C[C@@H](COc1ccc(cc1)CC(=O)N)O,atenolol-(-),-8.186227,x0104,active-noncovalent
c1cc2c(cc1OS(=O)(=O)N)oc(=O)c3c2CCCCC3,irosustat,-8.184781,x0072,active-noncovalent
c1ccc(cc1)C2=NCC(=O)Nc3c2c4c(s3)CCCC4,bentazepam,-8.184340,x0072,active-noncovalent
CC(=O)N[C@H]1CCc2cc(c(c(c2-c3c1cc(=O)c(cc3)SC)OC)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,thiocolchicoside,-8.184196,x1077,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Cl)Cl,chloroxine,-8.184093,x0195,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)[O-])C)C(=O)[O-],bevirimat-dimeglumine,-8.183790,x0104,active-noncovalent
CC(=O)N[C@H](Cc1ccc(cc1)O)C(=O)[O-],N-acetyl-tyrosine,-8.182658,x0161,active-noncovalent
Cc1cc2c(cc1Cl)nc(s2)NC(=O)Cc3ccccc3,LH846,-8.182569,x0161,active-noncovalent
C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,ursodeoxycholyltaurine,-8.182104,x0104,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3N2CCC[NH+]4CCN(CC4)CCO,opipramol,-8.182003,x0434,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],neomycin-sulfate,-8.181787,x0395,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],neomycin,-8.181787,x0395,active-noncovalent
CCCCCC(=O)O[C@@]1(CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)C,17-hydroxyprogesterone-caproate,-8.181354,x0874,active-noncovalent
CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)OCC,prednicarbate,-8.180903,x0104,active-noncovalent
CC(C)(C(=O)Nc1ccc(c(c1)C(F)(F)F)N(=O)=O)O,2-hydroxyflutamide,-8.178343,x0195,active-noncovalent
c1cc(c(cc1N)O)C(=O)[O-],aminosalicylate,-8.178270,x0678,active-noncovalent
CC(C)(Cc1ccc2ccccc2c1)[NH2+]C[C@H](COc3cccc(c3C#N)Cl)O,NPS-2143,-8.176714,x0161,active-noncovalent
C1CCC2(CC1)OC[C@H](O2)C[NH+]=C(N)N,guanadrel,-8.176382,x1334,active-covalent
CNC(=O)c1cccc(c1)NCC(=O)NCCc2ccc(c(c2)OC)OC,ecabapide,-8.176240,x0104,active-noncovalent
CC(=CCC/C(=C/CNCC[NH2+]C1C2CC3CC(C2)CC1C3)/C)C,SQ-109,-8.176208,x0104,active-noncovalent
COc1ccccc1OCC[NH2+]C[C@@H](COc2cccc3c2c4ccccc4[nH]3)O,carvedilol,-8.175734,x0195,active-noncovalent
B1(c2ccc(cc2CO1)F)O,tavaborole,-8.175386,x0195,active-noncovalent
COc1cc(c(c(c1)OC)C(=O)CCC[NH+]2CCCC2)OC,buflomedil,-8.175121,x0946,active-noncovalent
c1c(c(cc(c1N2CC2)N(=O)=O)N(=O)=O)C(=O)N,tretazicar,-8.174968,x0195,active-noncovalent
c1cc2c(cc1[C@@H]3[C@H]4CO[C@@H]([C@H]4CO3)c5ccc6c(c5)OCO6)OCO2,sesamin,-8.174314,x0195,active-noncovalent
CCCSc1ccc2c(c1)nc([nH]2)NC(=O)OC,albendazole,-8.174183,x0195,active-noncovalent
c1ccc(cc1)C(=NOCC[N@H+]2CCC=C(C2)C(=O)[O-])c3ccccc3,NNC-711,-8.173513,x0072,active-noncovalent
c1cc(ncc1C(=O)[O-])SSc2ccc(cn2)C(=O)[O-],carboxypyridine-disulfide,-8.172651,x0678,active-noncovalent
COc1cc(c(c(c1)OC)/C=C/2\c3ccccc3NC2=O)OC,IC261,-8.171141,x0195,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H]([C@](O2)(CO)CCl)O)F,ALS-8176,-8.170980,x0195,active-noncovalent
CC[C@@H]1Cn2c(c-3nc(nc3n(c2=O)C)c4ccccc4)N1,PSB-11,-8.170166,x0195,active-noncovalent
c1c(cc(c(c1Sc2cc(cc(c2O)Cl)Cl)O)Cl)Cl,bithionol,-8.169826,x0161,active-noncovalent
Cc1cc(nc(n1)c2ccc(cc2)Br)NCCO,AS-1269574,-8.169496,x0434,active-noncovalent
c1cc(ccc1C(=O)CCC[NH+]2CCC(CC2)(c3ccc(cc3)Cl)O)F,haloperidol,-8.169347,x0874,active-noncovalent
CC[NH+](CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,dicycloverine,-8.167810,x0195,active-noncovalent
C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C,pentolinium,-8.166785,x0749,active-covalent
CC(C)(C)[NH2+]C[C@@H](c1ccc(cc1Cl)O)O,meluadrine,-8.166273,x0678,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc3ccc(c(c3)N(=O)=O)F,CGK-733,-8.166167,x0195,active-noncovalent
CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCc2cccc(c2)Oc3ccccc3)C,phenothrin,-8.165730,x0072,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+])[NH3+])O,sisomicin,-8.165520,x1077,active-noncovalent
CN(Cc1cccc(c1)c2ccccc2)C(=O)Oc3ccc(cc3)c4ccc(cc4)C(=O)N,WWL-123,-8.165477,x0161,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO)N,dideoxyadenosine,-8.165439,x1334,active-covalent
CC(C)(C)[NH2+]C[C@@H](c1ccccc1Cl)O,tulobuterol,-8.163395,x0195,active-noncovalent
CCc1cnn2c1nc(cc2NCc3cccn(=O)c3)N4CCCC[C@H]4CCO,dinaciclib,-8.163247,x1077,active-noncovalent
COc1cc(ccc1O)C(=S)N2CCOCC2,vanitiolide,-8.162444,x0749,active-covalent
C[NH2+]CC[N@@](Cc1c([nH]nc1)c2ccc(cc2)O[C@H]3C[C@@H](C3)OCCC4CCOCC4)C,EPZ020411,-8.160522,x0161,active-noncovalent
CN1C(=O)N(C(=O)[C@]1(CO)c2ccccc2)c3ccc(c(c3)C(F)(F)F)C#N,GLPG0492-R-enantiomer,-8.160019,x0161,active-noncovalent
c1ccc(cc1)[C@H]2c3ccccc3CCN2C(=O)O[C@H]4C[NH+]5CCC4CC5,solifenacin-succinate,-8.159551,x0195,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)c2ccc(o2)N(=O)=O,NSC-697923,-8.158440,x0678,active-noncovalent
CN(C)/N=N/c1ccc(cc1)C(=O)[O-],CB-10-277,-8.156445,x0749,active-covalent
Cc1cc(c(cc1OC(=O)C)C(C)C)OCC[NH+](C)C,moxisylyte,-8.155870,x0195,active-noncovalent
CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)N[C@H]1c2ccccc2-c3ccccc3NC1=O,RG4733,-8.155630,x0874,active-noncovalent
c1cc2c(nc1)OC[C@@H]3CCCN3C2=O,org-26576,-8.155533,x0195,active-noncovalent
C[NH+]1C[C@@H]2CN(C[C@@H]2C1)c3ccc(nn3)c4ccccc4,A-582941,-8.154700,x0749,active-covalent
CCn1cc(c(=O)c2c1cc3c(c2)OCO3)C(=O)[O-],oxolinic-acid,-8.154512,x0749,active-covalent
c1ccc2cc(ccc2c1)C(=O)NCC[NH+]3CCC4(CC3)C(=O)NCN4c5cccc(c5)F,VU-0364739,-8.153996,x0195,active-noncovalent
C(CCCC(=O)NO)CCC(=O)NO,SBHA,-8.153867,x0161,active-noncovalent
c1ccc2c(c1)CC(=O)c3ccccc3N2C(=O)N,oxcarbazepine,-8.153791,x0161,active-noncovalent
C1CC(=[NH2+])N(C1)Cc2c(c(=O)[nH]c(=O)[nH]2)Cl,tipiracil,-8.153749,x0692,active-covalent
CC(C)NC(=O)c1ccc(cc1)CNNC,procarbazine,-8.153365,x0195,active-noncovalent
CC(C)(C)C(=O)Oc1ccc(cc1OC(=O)C(C)(C)C)[C@H](C[NH2+]C)O,dipivefrine,-8.152368,x0195,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)NO,L-asparagine-n-hydroxy,-8.151939,x0397,active-noncovalent
CCOc1ccc(cc1OCC)c2nc(no2)c3cccc4c3CC[C@H]4[NH2+]CCO,CYM-5442,-8.151823,x1077,active-noncovalent
C[N+](C)(C)CC#CCN1CCCC1=O,oxotremorine-m,-8.151625,x0749,active-covalent
C[NH+]1[C@@H]2CC(C[C@H]1[C@@H]3[C@H]2O3)OC(=O)[C@H](CO)c4ccccc4,scopolamine,-8.151495,x1392,active-covalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)NCc3ccc(cc3)c4ccccn4,CR8-(R),-8.151196,x0874,active-noncovalent
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COc2cccc(c2)C(F)(F)F)O)O)O,travoprost,-8.151101,x1077,active-noncovalent
CC(C)(C)OC(=O)c1c2n(cn1)-c3ccsc3C(=O)N(C2)C,Ro-19-4605,-8.150911,x0749,active-covalent
CC(=O)C(=Cc1cc(c(c(c1)O)[O-])N(=O)=O)C(=O)C,nitecapone,-8.150795,x0195,active-noncovalent
CCCCc1ccc(nc1)C(=O)N,bupicomide,-8.150414,x0749,active-covalent
CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)O,mifepristone,-8.149806,x1093,active-noncovalent
C1[C@H]([C@H](O[C@H]1N2C[NH+]=C(NC2=O)N)CO)O,KP-1212,-8.149708,x0397,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O,fluocinolone-acetonide,-8.149630,x0874,active-noncovalent
CC(=O)CCc1ccc2cc(ccc2c1)OC,nabumetone,-8.149064,x0195,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)[O-])/C)/C,isotretinoin,-8.148855,x0830,active-covalent
c1cc(ccc1c2c(n3c(n2)SCC3)c4ccncc4)F,SKF-86002,-8.148355,x0195,active-noncovalent
c1cnccc1C/N=N/C(=S)N,perchlozone,-8.145007,x0426,active-noncovalent
Cc1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])OC)C2=O,rheochrysidin,-8.144560,x0195,active-noncovalent
Cc1cc(c(c(c1NC(=O)C[NH+](CC(=O)[O-])CC(=O)[O-])C)Br)C,mebrofenin,-8.144441,x0830,active-covalent
Cc1cc(ccc1N)Cn2c3c(c(nc(n3)N)c4ccco4)nn2,vipadenant,-8.144427,x1093,active-noncovalent
c1cc2c(cc1Cl)[C@@](OC(=O)N2)(C#CC3CC3)C(F)(F)F,efavirenz,-8.143311,x0195,active-noncovalent
Cc1cc(c2ccccc2n1)NC(=O)NCC[NH+]3CCC(CC3)(Cc4ccccc4)O,palosuran,-8.140141,x0104,active-noncovalent
Cn1cnc2c1nc(nc2NCc3ccccc3)NCCO,olomoucine,-8.139955,x0708,active-covalent
c1cc(ccc1C(=O)N/N=C/c2ccc(o2)N(=O)=O)O,nifuroxazide,-8.139940,x1093,active-noncovalent
COc1ccc(c2c1c(=S)c3ccccc3[nH]2)OC,NSC-625987,-8.139662,x0195,active-noncovalent
CC[C@@H](c1ccccc1)NC(=O)c2c3ccccc3nc(c2O)c4ccccc4,talnetant,-8.138851,x0195,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@H]([C@@H](CF)NC(=O)C(Cl)Cl)O,florfenicol,-8.138136,x0104,active-noncovalent
CCc1c([nH]c2c1C(=O)[C@@H](CC2)C[NH+]3CCOCC3)C,molindone,-8.137992,x0195,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2c(c(=O)c3ccc(cc3o2)Cl)Cc4ccccc4)C(C)C,SB-743921,-8.137464,x1077,active-noncovalent
c1ccc2c(c1)c(c[nH]2)CCNc3ccc(cc3)Nc4ccncc4,serdemetan,-8.136547,x0195,active-noncovalent
C[NH2+]CCn1c2c3cc4c(cc3ncc2c5cc(c(cc5c1=O)OC)OC)OCO4,genz-644282,-8.135910,x0104,active-noncovalent
C[C@@H](Cc1ccc(cc1)O)[NH3+],hydroxyamphetamine,-8.135716,x1077,active-noncovalent
C[C@@H](CNS(=O)(=O)C(C)C)c1ccc(cc1)NC(=O)c2cc(cc(c2)F)F,LY450108,-8.135439,x0104,active-noncovalent
CC(C)OC(=O)Nc1cccc(c1)Cl,chlorpropham,-8.134335,x0195,active-noncovalent
c1cc(ncc1F)c2nc(on2)c3cc(cc(c3)F)C#N,AZD9272,-8.134156,x1093,active-noncovalent
CC[NH+](CC)Cc1nccn1c2ccc(cc2C(=O)c3ccccc3Cl)N(=O)=O,nizofenone,-8.134041,x0678,active-noncovalent
C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],glutathione,-8.133867,x0678,active-noncovalent
CC[S@](=O)c1nc(cc(n1)C(F)(F)F)c2cccc(c2)OCc3ccccc3,BETP,-8.133290,x0161,active-noncovalent
C1C[C@H]2C[NH2+][C@@H](C[C@H]2C[C@H]1CCc3[n-]nnn3)C(=O)[O-],LY215490,-8.132271,x0107,active-noncovalent
c1cc(c(cc1Oc2c(cc(cc2I)CC(=O)[O-])I)I)O,tiratricol,-8.131705,x0830,active-covalent
C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)[O-])C,artesunate,-8.131416,x0678,active-noncovalent
CCOC(=O)[C@H](Cc1ccc(cc1)N(=O)=O)NC(=O)c2ccccc2,SB-297006,-8.130223,x0434,active-noncovalent
Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F,celecoxib,-8.128628,x0161,active-noncovalent
Cc1ccc(cc1)/N=C/2\CC(=O)c3c(nc(s3)C)C2=O,ryuvidine,-8.127855,x0749,active-covalent
C[N@+]1(CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@@]3([C@H]1C5)O)O)CC6CC6,methylnaltrexone,-8.127031,x0678,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)C(=O)CC5)O)O,naltrexone,-8.126569,x0072,active-noncovalent
c1ccc(cc1)c2cc(ncn2)I,4-iodo-6-phenylpyrimidine,-8.125819,x0195,active-noncovalent
c1cc(ccc1NC(=O)c2cc(cc(c2O)Br)Br)Br,tribomsalan,-8.125379,x0749,active-covalent
C[C@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CC[NH2+]CC4,crizotinib,-8.124951,x0104,active-noncovalent
Cn1c(nnc1S(=O)(=O)C)c2ccccc2,MDL-27531,-8.124414,x0195,active-noncovalent
C1C[C@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2[N@@H+](C1)CCC4,sophocarpine,-8.124063,x0195,active-noncovalent
Cc1cc(c(cc1C2CC[NH2+]CC2)OC(C)C)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)C(C)C)Cl,ceritinib,-8.123479,x0161,active-noncovalent
c1ccc(c(c1)C2=N[C@@H](C(=O)Nc3c2cc(cc3)Cl)O)Cl,lorazepam,-8.123451,x0434,active-noncovalent
c1ccc(cc1)C(COC(=O)N)COC(=O)N,felbamate,-8.122873,x0161,active-noncovalent
C[C@@H]1Nc2ccc(cc2S(=O)(=O)N1)Cl,IDRA-21,-8.122155,x0195,active-noncovalent
c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F)(F)F)[C@H]([C@H]3CCCC[NH2+]3)O,mefloquine,-8.121846,x0195,active-noncovalent
C[NH+]1CCN(CC1)c2cc(ccc2OC)NS(=O)(=O)c3ccc(cc3)I,SB-258585,-8.121441,x0161,active-noncovalent
CN(c1cccc(n1)OC)C(=S)Oc2ccc3c(c2)CCCC3,liranaftate,-8.121175,x0072,active-noncovalent
c1cc(ccc1C[N@@]2CCCNCC[NH2+]CCC[NH2+]CC2)C[N@]3CCCNCC[NH2+]CCC[NH2+]CC3,plerixafor,-8.121090,x1077,active-noncovalent
COc1cccc(c1)N2CCN(CC2)C3=[NH+]c4c(cccc4F)[C@@H](N3c5cc(ccc5OC)C(F)(F)F)CC(=O)[O-],letermovir,-8.120955,x0874,active-noncovalent
c1ccc(cc1)NC(=O)[C@@]23C[C@@H]2[C@@H](c4ccccc4O3)N=O,PHCCC,-8.120083,x0195,active-noncovalent
CCOC(=O)CSCC[C@H]1[NH2+][C@H](CS1)C(=O)[O-],letosteine,-8.119851,x0830,active-covalent
Cc1cc(cc(c1)NC(=O)Cc2ccc(cc2)OC(C)(C)C(=O)[O-])C,efaproxiral,-8.119609,x0104,active-noncovalent
c1cc(nc(c1)NS(=O)(=O)c2ccc(cc2)c3ccc(cc3)C#N)N,PF-915275,-8.119098,x0104,active-noncovalent
COc1ccc(cc1)Oc2c(cnn(c2=O)C3c4ccccc4-c5c3cccc5)Cl,CYM-50769,-8.119084,x0946,active-noncovalent
CC1(CC(=O)c2c(nn(c2C1)c3cc(c(cc3)C(=O)N)N[C@H]4CC[C@@H](CC4)OC(=O)C[NH3+])C(F)(F)F)C,SNX-5422,-8.118729,x0161,active-noncovalent
CC[NH+](CC)CC(=O)N1c2ccccc2CCc3c1cc(cc3)NC(=O)OCC,CINPA-1,-8.118647,x0946,active-noncovalent
COC(=O)c1ccc2c(c1)nc(n2CCCc3ccccc3)NC(=O)c4ccccc4,BRD4770,-8.117898,x0434,active-noncovalent
c1cc(oc1)CNc2cc(c(cc2C(=O)[O-])S(=O)(=O)N)Cl,furosemide,-8.116973,x0072,active-noncovalent
CCCCc1ccc2c(c1)[nH]c(n2)NC(=O)OC,parbendazole,-8.116457,x1077,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2NC(=O)c3c[nH]c(=O)cc3C(F)(F)F)c4cccc(c4)C[NH+]5CCOCC5,OICR-9429,-8.115351,x0104,active-noncovalent
c1nc2c(=O)[nH]c(nc2n1CCC(CO)CO)N,penciclovir,-8.114223,x0397,active-noncovalent
C[NH+](C)CCN(Cc1ccc(cc1)OC)c2ccccn2,mepyramine,-8.113931,x0434,active-noncovalent
C[N+]1(CC[C@@H](C1)OC(=O)[C@](c2ccccc2)(C3CCCC3)O)C,glycopyrrolate,-8.113657,x1093,active-noncovalent
CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4([C@@H]2O)O7)COC6=O)C,triptolide,-8.112088,x0749,active-covalent
Cc1cc(=O)oc2c1ccc(c2)O,hymecromone,-8.111824,x0195,active-noncovalent
COc1ccc2cc-3[n+](cc2c1OC)CCc4c3cc(c(c4)OC)OC,palmatine-chloride,-8.111174,x0749,active-covalent
C[C@@](c1ccccc1)(c2ccc(cc2)Cl)OCC[C@H]3CCC[N@@H+]3C,clemastine,-8.110670,x0678,active-noncovalent
Cc1ccccc1OC[C@@H](CO)O,mephenesin,-8.110322,x0195,active-noncovalent
COc1ccc(cc1)OC[C@@H]2c3cc(c(cc3CCN2C(=O)c4cccc(c4)Cl)OC)OC,CIQ,-8.109567,x0161,active-noncovalent
c1cc(c(cc1[C@H](C[NH2+]CCCCCC[NH2+]C[C@@H](c2ccc(c(c2)O)O)O)O)O)O,hexoprenaline,-8.109411,x0678,active-noncovalent
CNC(=O)c1ccc(cc1F)c2cnc3[nH+]cc(n3n2)Cc4ccc5c(c4)cccn5,INC-280,-8.109189,x0678,active-noncovalent
Cn1c2ccccc2c(n1)C(=O)NC3C[C@H]4CCC[C@@H](C3)[NH+]4C,granisetron,-8.108163,x0749,active-covalent
CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C,fluocinonide,-8.105221,x1077,active-noncovalent
c1cc2c(c(c1)[O-])C(=O)c3c(cc(cc3[O-])CO)[C@@H]2O[C@H]4[C@@H]([C@@H]([C@H]([C@H](O4)CO)O)O)O,casanthranol-variant,-8.104877,x0161,active-noncovalent
COc1cc2c(ccnc2cc1OC)Oc3ccc(c(c3)F)NC(=O)Nc4ccc(cc4F)F,KI-8751,-8.103120,x0104,active-noncovalent
c1cnccc1c2c(c(sc2c3ccncc3)c4ccncc4)c5ccncc5,GANT-58,-8.102582,x0195,active-noncovalent
c1cc(nc(c1)Nc2nccs2)C[NH+]3CCN(CC3)C(=O)c4cccc(c4F)Cl,MK-8745,-8.102244,x1077,active-noncovalent
CCCCCC[C@@H](CCC)C(=O)[O-],arundic-acid,-8.101088,x0397,active-noncovalent
CCC(CC)n1ccc2c1cc(cc2C(=O)NCc3c(cc([nH]c3=O)C)C)C#N,EI1,-8.100223,x0104,active-noncovalent
C[NH+](C)Cc1c[nH]c2c1cccc2,gramine,-8.099701,x0072,active-noncovalent
CCc1c(c([nH]c1C(=O)Nc2cc(ccc2[O-])S(=O)(=O)N(CC)CC)C)C(=O)C,XD-14,-8.099055,x0678,active-noncovalent
C1CC1C(C2CC2)NC3=[NH+]CCO3,rilmenidine,-8.098516,x0678,active-noncovalent
C[N@]1[C@H](Nc2cc(c(cc2S1(=O)=O)S(=O)(=O)N)Cl)CCl,methyclothiazide,-8.097831,x0749,active-covalent
c1cc2c(cc(c(c2nc1)O)I)Cl,clioquinol,-8.097764,x0195,active-noncovalent
Cc1ccc-2c(c1)Cc3c2n(nc3C(=O)NN4CCCCC4)c5ccc(cc5Cl)Cl,GP1a,-8.097659,x0161,active-noncovalent
Cc1c(cccc1Cl)Nc2c(cccn2)C(=O)[O-],clonixin-lysinate,-8.096487,x0749,active-covalent
C1CC[NH+](C1)CC#CC[NH+]2CCCC2,tremorine,-8.095699,x0104,active-noncovalent
Cc1c(c(c2c(c1O)O2)O)O,terreic-acid-(-),-8.095338,x0678,active-noncovalent
CC(=O)N([C@@H]1c2cc(ccc2OC([C@H]1O)(C)C)C#N)OCc3ccccc3,Y-27152,-8.094987,x0195,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)OC)[NH3+],leucylleucine-methyl-ester,-8.094801,x0195,active-noncovalent
CCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(C[C@H]([C@@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C(=O)COC(=O)C,difluprednate,-8.094021,x1077,active-noncovalent
c1cc(ccc1C(=O)N[C@H]2C[NH+]3CCC2CC3)Cl,PNU-282987,-8.093317,x0749,active-covalent
C[NH+]1CCN(CC1)C(=O)Oc2c3c(c(n2c4ccc(cn4)Cl)O)nccn3,eszopiclone,-8.093206,x0195,active-noncovalent
CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)[NH3+])C(=O)OCC,oseltamivir-phosphate,-8.092500,x0387,active-noncovalent
CCC[NH+](CCC)[C@@H]1CCc2c(cccc2OC)[C@@H]1C,UH-232-(+),-8.091217,x0104,active-noncovalent
CC(C)S(=O)(=O)c1ccc(cc1)c2cnc(c(n2)c3cc(no3)c4ccc(cc4)C[NH2+]C)N,VE-822,-8.091070,x0104,active-noncovalent
Cc1ccc(nc1)c2ccc(cn2)C,abametapir,-8.090454,x0749,active-covalent
C[C@@H](c1ccc(c2c1cccc2)F)C(=O)Nc3cc(ccc3CCCC(=O)[O-])C#N,ONO-AE3-208,-8.090360,x0161,active-noncovalent
c1ccc(cc1)[C@@H](CC(=O)[O-])C[NH3+],fenigam,-8.090292,x1374,active-covalent
CC1(C(=C(C(=O)O1)OCC2CC2)c3ccc(cc3)S(=O)(=O)C)C,firocoxib,-8.090115,x0749,active-covalent
COc1cc2c(cc1OC)nc(cn2)c3ccccc3,tyrphostin-AG-1296,-8.089603,x0195,active-noncovalent
Cc1cc2c(o1)cc(cc2Oc3cnc(nc3)C(=O)N(C)C)C(=O)Nc4cnc(cn4)C,PF-04937319,-8.089417,x0161,active-noncovalent
Cc1ccccc1[C@H](C(=O)NC2CCCCC2)N(c3cccc(c3)F)C(=O)Cn4ccnc4C,AGI-5198,-8.088991,x0434,active-noncovalent
C[C@@H](c1cc2cccc(c2c(=O)n1c3ccccc3)Cl)Nc4c5c([nH]cn5)ncn4,IPI-145,-8.086636,x0678,active-noncovalent
c1ccc(cc1)C(C#N)(c2ccccc2)c3ccccc3Cl,TRAM-39,-8.086554,x0831,active-covalent
CC(C)c1ccc(cc1S(=O)(=O)C)C(=O)NC(=[NH2+])N,cariporide,-8.086206,x0874,active-noncovalent
C[C@H](CN1c2ccccc2Sc3c1cc(cc3)C#N)C[NH+](C)C,cyamemazine,-8.086164,x0195,active-noncovalent
Cc1c(cc(n1CCC[NH+]2CCOCC2)c3ccccc3)C(=O)Nc4cccc(c4)C(F)(F)F,HC-067047,-8.085832,x0678,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NCl,chloramine-t,-8.084645,x0195,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3cccc(c3)Cl,tyrphostin-AG-1478,-8.084390,x0195,active-noncovalent
Cc1cc(cc(c1OCCCc2cc(no2)C)C)c3nc(on3)C(F)(F)F,pleconaril,-8.083837,x0104,active-noncovalent
COc1ccc(cc1OC)c2cc(=O)c3c(o2)cc(c(c3[O-])OC)O,eupatilin,-8.083821,x0749,active-covalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)OC(=O)C,hydroxyprogesterone-acetate,-8.082519,x0161,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO,didanosine,-8.082516,x0874,active-noncovalent
COc1ccc(cc1[C@]2(c3ccc(cc3NC2=O)C(F)(F)F)F)Cl,flindokalner,-8.082101,x0072,active-noncovalent
CC[NH2+]Cc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C,LY231617,-8.080976,x0195,active-noncovalent
c1cc(c(cc1[C@H](C[NH3+])O)O)O,norepinephrine,-8.080631,x1077,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CCC2=O)OS(=O)(=O)[O-],estropipate,-8.079415,x0749,active-covalent
C[n+]1ccc(cc1)C(=O)NCc2ccccc2,enisamium-iodide,-8.078783,x0072,active-noncovalent
C[C@@H]1C[N@H+](CCN1C(=O)Oc2cc3c(cc2OC)ncnc3Nc4cccc(c4F)Cl)C,AZD3759,-8.078625,x0195,active-noncovalent
Cc1cccc(c1NC(=O)C[NH+]2CCCCCC2)C,pincainide,-8.077922,x0104,active-noncovalent
C[C@H]1C[N@@H+](CC[C@@]1(C)c2cccc(c2)O)C[C@H](C(C)C)NC(=O)[C@H]3Cc4ccc(cc4C[NH2+]3)O,JDTic,-8.077757,x1077,active-noncovalent
CC[NH+](CC)Cc1ccc(cc1)C(=O)N(CCc2ccccc2OC)[C@@H]3CC[NH2+]C3,PF-429242,-8.077729,x0161,active-noncovalent
C[N@@H+](CCc1ccc(c(c1)Cl)Cl)CCN(C)C,BD-1047,-8.077511,x0161,active-noncovalent
c1cc2c(cc1Nc3ccc(cc3F)F)CCc4ccc(cc4C2=O)OC[C@@H](CO)O,skepinone-l,-8.077421,x0104,active-noncovalent
Cn1cc(cn1)CCn2cnc(c2c3ccc(cc3)C#N)c4cnn(c4)C,BAZ2-ICR,-8.077212,x0678,active-noncovalent
c1cc2c(cc1)C[C@@H](CC2)C[NH2+]C[C@H]3CC[C@@H](CC3)CNS(=O)(=O)c4c(cccc4)N(=O)=O,NTNCB,-8.076832,x0104,active-noncovalent
CC(=CCc1c(cc(c2c1oc(c(c2=O)[O-])c3ccc(cc3)OC)[O-])O)C,icaritin,-8.076475,x0195,active-noncovalent
CC(=CCc1c(cc(c2c1oc(c(c2=O)[O-])c3ccc(cc3)OC)[O-])O)C,"5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dion",-8.076475,x0195,active-noncovalent
CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)/C=C/C[NH+]3CCCCC3)N(C1=O)S(=O)(=O)C,GW-311616,-8.075225,x0195,active-noncovalent
Cc1cc(=O)n(n1C)c2ccccc2,phenazone,-8.075042,x0195,active-noncovalent
CC1=NC(=C)[C@H]([C@@H]([C@H]1C(=O)OC)c2cccc3c2non3)C(=O)OC(C)C,isradipine,-8.074436,x0831,active-covalent
C[C@H]1C(=O)N(c2cnc(nc2[N@@]1CCC(C)C)Nc3cc(c(c(c3)F)[O-])F)C,BI-D1870,-8.074274,x0104,active-noncovalent
C[NH+](C)CCN(C)c1cc(c(cc1NC(=O)C=C)Nc2nccc(n2)c3c[nH]c4c3cccc4)OC,AZ5104,-8.074039,x0104,active-noncovalent
CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C23CCC3)c4cc(c(nc4)C#N)C(F)(F)F,apalutamide,-8.073809,x0161,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,finasteride,-8.073549,x0104,active-noncovalent
Cc1c-2c(on1)[C@@H](N=C(c3c2cccc3)c4ccc(cc4)Cl)CC(=O)N,CPI-0610,-8.072785,x0195,active-noncovalent
CCC[S@](=O)c1ccc2c(c1)[nH]c(n2)NC(=O)OC,albendazole-oxide,-8.072536,x0195,active-noncovalent
C[C@]12CC[C@H]([C@@]([C@@H]1CC[C@@H]3[C@@]24CC[C@@]([C@H](C3)C4)(CO)O)(C)CO)O,aphidicolin,-8.072189,x0749,active-covalent
COc1c(ccc2c1n/c(=[NH+]/C(=O)c3cnc(nc3)N)/n4c2NCC4)OCCC[NH+]5CCOCC5,copanlisib,-8.071752,x0104,active-noncovalent
COc1ccc(cc1S(=O)(=O)NC(=O)/C=C/c2ccccc2Cc3ccc4ccccc4c3)Br,"L-798,106",-8.071481,x0967,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)[O-],4-hydroxy-phenazone,-8.070366,x0195,active-noncovalent
CC(C)Sc1ccc2c(c1)[nH]c(n2)NC(=O)OC,methiazole,-8.070083,x0195,active-noncovalent
CC[C@H]1c2cc(c(cc2C(=NN=C1C)c3ccc(c(c3)OC)OC)OC)OC,tofisopam,-8.069748,x0434,active-noncovalent
Cc1cc(nc(n1)SCC(=O)Nc2ncc(s2)Cc3cccc4c3cccc4)C,SirReal-2,-8.067632,x0161,active-noncovalent
C1C[C@@H]2[C@@H]3CCCN4(=O)[C@H]3[C@H](CCC4)CN2C(=O)C1,oxymatrine,-8.066957,x0195,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)F)C,dexamethasone-acetate,-8.064781,x1077,active-noncovalent
c1ccc(cc1)C2(CCCCC2)C(=O)OCC[NH+]3CCOCC3,PRE-084,-8.063684,x0678,active-noncovalent
c1ccc(cc1)C[C@H](C(=O)[O-])[NH3+],D-Phenylalanine,-8.063537,x0195,active-noncovalent
c1cc2c(cc1O)c(c[nH]2)CC[NH3+],serotonin,-8.063527,x0678,active-noncovalent
CS(=O)(=O)c1ccc(cc1)Cn2c3c(cc(cc3F)F)c4c2[C@H](CCC4)CC(=O)[O-],L-670596,-8.063210,x0195,active-noncovalent
Cc1cc(c(cc1Br)NC(=O)Nc2cnc(cn2)C)OC[C@@H]3C[NH2+]CCO3,LY2603618,-8.061742,x0678,active-noncovalent
CCc1ccc(nc1)CCOc2ccc(cc2)C[C@H]3C(=O)[N-]C(=O)S3,pioglitazone,-8.061571,x0161,active-noncovalent
CC1([C@@H](N2[C@H](S1)/C(=N\C[NH+]3CCCCCC3)/C2=O)C(=O)OCOC(=O)C(C)(C)C)C,pivmecillinam,-8.060032,x0161,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CCc3ccccc3N(C2=O)CC(=O)[O-],benazepril,-8.059981,x1077,active-noncovalent
COc1cc(c(c(c1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)Nc3ccc(cc3F)I)F)F,refametinib,-8.058771,x0874,active-noncovalent
CC1(CCCCC1)COc2ccc(cc2)C[C@H]3C(=O)[N-]C(=O)S3,ciglitazone,-8.058140,x0072,active-noncovalent
CC(C)(C(=O)NO)NS(=O)(=O)c1ccc(cc1)Oc2ccc(cc2)F,CP-471474,-8.056687,x0161,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)O)O)O)[O-])O)O)O)O)O)O,rutin,-8.056040,x0161,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc4c(n3)N(c5ccccc5C(=O)N4C)C,ERK5-IN-1,-8.056010,x0161,active-noncovalent
CCC[NH+](CCC)CCc1ccc(c(c1)OCCc2ccccc2)OC,NE-100,-8.055286,x0946,active-noncovalent
CC(C)C[C@H]1c2c(c3ccc(cc3[nH]2)OC)C[C@@H]4N1C(=O)[C@@H](NC4=O)CCC(=O)OC(C)(C)C,Ko143,-8.055276,x0161,active-noncovalent
C[NH+]1CCC(CC1)NC(=O)c2cc(c(cc2F)Nc3ncc4c(n3)[N@@](CC(C(=O)N4C)(F)F)C5CCCC5)OC,TAK-960,-8.053601,x0104,active-noncovalent
CCNC(=O)/C=C/c1cccc(c1)Br,cinromide,-8.053030,x0104,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C,dihydroartemisinin,-8.052610,x0195,active-noncovalent
Cc1cc(c(cc1)/[NH+]=C/N(/C=[NH+]/c2c(cc(cc2)C)C)C)C,amitraz,-8.051087,x0104,active-noncovalent
Cn1c(ccn1)Nc2nccc(n2)c3ccn(c(=O)c3)[C@H](CO)c4ccc(c(c4)F)Cl,ravoxertinib,-8.050423,x0161,active-noncovalent
Cn1c(ccn1)Nc2nccc(n2)c3ccn(c(=O)c3)[C@H](CO)c4ccc(c(c4)F)Cl,GDC-0994,-8.050423,x0161,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N,ampyrone,-8.050354,x0195,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)N,oleamide,-8.049994,x0072,active-noncovalent
c1cc2c(cc(c(c2nc1)O)Br)Br,broxyquinoline,-8.049944,x0195,active-noncovalent
CCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C)C,rimexolone,-8.049366,x0104,active-noncovalent
CC(C)(CC(=O)N1CCCC1)[NH2+]CC(=O)N2C[C@H](C[C@H]2C#N)F,DBPR108,-8.048960,x0195,active-noncovalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4)CC5CC5,cimetropium,-8.048899,x0072,active-noncovalent
CN1c2c3c(cn(c3ncn2)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=[NH+]1)N,triciribine,-8.048512,x0104,active-noncovalent
c1ccc2c(c1)c(=O)n(c(=O)[nH]2)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,ketanserin,-8.048051,x0107,active-noncovalent
c1cc(ccc1SC(P(=O)([O-])[O-])P(=O)([O-])[O-])Cl,tiludronate,-8.047916,x0831,active-covalent
CCCCCCC[n+]1ccc(cc1)c2cc[n+](cc2)CCCCCCC,DHBP,-8.047262,x0161,active-noncovalent
Cc1c(c(c(c2c1O[C@@](CC2)(C)CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)C)C,alpha-tochopheryl-acetate,-8.047083,x0161,active-noncovalent
COc1cc(c(cc1C(=O)CCC2CC[NH+](CC2)CCNS(=O)(=O)C)Cl)N,RS-67506,-8.047054,x0104,active-noncovalent
CCCOc1ccc2c(c1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4OC)C,promestriene,-8.046851,x0104,active-noncovalent
CCOc1ccc(cc1)N/C(=[NH+]\c2ccc(cc2)OCC)/C,phenacaine,-8.046440,x0678,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)OP(=O)([O-])[O-],adaprev,-8.045837,x0397,active-noncovalent
CCc1c(c(n(n1)CCO)CC)Oc2cc(cc(c2)C#N)C#N,lersivirine,-8.045688,x0749,active-covalent
C[C@]12CCCC([C@@H]1CC[C@@]3([C@@H]2CC(=O)O3)C)(C)C,sclareolide,-8.045598,x1311,active-covalent
CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)[O-],bumetanide,-8.045586,x1418,active-covalent
CCCCOC(=O)c1ccccc1C(=O)OCCCC,dibutyl-phthalate,-8.044425,x0678,active-noncovalent
C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@]35[C@H](O5)C[C@@H]4c6ccc(=O)oc6)C)O,resibufogenin,-8.043370,x1077,active-noncovalent
c1ccc2c(c1)ncc3n2c(=O)on3,ODQ,-8.043167,x0195,active-noncovalent
C1CC[N@H+]2C[C@H]3C[C@@H]([C@H]2C1)C=C4[C@H]3[NH2+]CCC4,aloperine,-8.043051,x0831,active-covalent
C[NH+](C)CCc1c[nH]c2c1cc(cc2)/C=C/C(=O)NCc3ccc(cc3)OC,GR46611,-8.042381,x0161,active-noncovalent
COC(=O)/C=C/c1cc(ccc1O)O,erbstatin-analog,-8.041966,x0749,active-covalent
COc1cc(c(cc1C(=O)OCCC[NH+]2CCCCC2)Cl)N,RS-23597-190,-8.041738,x1311,active-covalent
CC(C)(C)c1cc(cc(c1O)Br)C=C(C#N)C#N,AG-1024,-8.041611,x0161,active-noncovalent
CCOC(=O)C(=O)Nc1cccc(c1C(=O)N)OC,Wy-16922,-8.041411,x0195,active-noncovalent
CC1(CN2C(=CSC2=[NH+]1)CS/C(=[NH+]/C3CCCCC3)/NC4CCCCC4)C,IT1t,-8.040545,x0967,active-noncovalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])O)O,tetracycline,-8.039650,x0831,active-covalent
CC(=O)NCCc1c2cc(ccc2[nH]c1I)OC,2-iodomelatonin,-8.039362,x0967,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(c(c3)Oc4ccc5c(c4)CC(=O)N5)C,DDR1-IN-1,-8.039228,x0395,active-noncovalent
CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)[O-],probenecid,-8.038395,x0678,active-noncovalent
CCOC(=O)CCNc1cc(nc(n1)c2cccnc2)N3CCc4ccccc4CC3,GSK-J5,-8.038395,x0678,active-noncovalent
c1c(c(=O)[nH]c(=O)[nH]1)N(CCCl)CCCl,uracil-mustard,-8.036856,x1077,active-noncovalent
C[N@@H+](CC#C)Cc1ccccc1,pargyline,-8.036759,x0678,active-noncovalent
C[C@H](c1cccc2c1cccc2)[NH2+]CCCc3cccc(c3)C(F)(F)F,cinacalcet,-8.036066,x1093,active-noncovalent
CC(C)CCOC(=O)/C=C/c1ccc(cc1)OC,isopentyl-4-methoxycinnamate,-8.035893,x0104,active-noncovalent
Cn1cnc2c1cc(c(c2F)Nc3ccc(cc3Cl)Br)C(=O)NOCCO,selumetinib,-8.035765,x1392,active-covalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@H]4C1=CC(=O)CC4,nomegestrol-acetate,-8.035282,x0749,active-covalent
CCn1c2cc3c(cc2c(=O)c(n1)C(=O)[O-])OCO3,cinoxacin,-8.035224,x0749,active-covalent
CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)/C=C/c2ccc(cc2)C(=O)[O-],CH55,-8.035036,x0072,active-noncovalent
c1cc2c(cc1COc3ccc(cc3CCC(=O)[O-])C(=O)c4ccc(cc4O)OC5CCCC5)o[nH]c2=O,T-5224,-8.034080,x0104,active-noncovalent
CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c3c2ccc(c3)Nc4ncc(c(n4)NC5CCC5)C(F)(F)F,PF-03814735,-8.033995,x0195,active-noncovalent
CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc2cccnc2,GPI-1046,-8.033459,x0678,active-noncovalent
c1ccnc(c1)c2c([nH]c(n2)c3ccc(cc3)C(=O)N)c4ccc5c(c4)OCO5,SB-431542,-8.032700,x0072,active-noncovalent
COc1ccc(cc1)C(=C(c2ccc(cc2)OC)Cl)c3ccc(cc3)OC,chlorotrianisene,-8.030936,x1077,active-noncovalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@H]3CC[C@H]([C@@H](N3C2=O)C(=O)[O-])Cl)[NH3+],loracarbef,-8.030867,x0830,active-covalent
CC(=O)O[C@H]1C[C@H]([C@@]2(CC[C@H]3C(=O)O[C@@H](C[C@@]3([C@H]2C1=O)C)c4ccoc4)C)C(=O)OC,salvinorin-a,-8.030253,x0678,active-noncovalent
C[NH2+]CCc1ccccn1,betahistine,-8.029685,x0195,active-noncovalent
CC(C)(Cc1ccccc1)[NH3+],phentermine,-8.028697,x0195,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCCCNC(=O)c3ccc4ccccc4c3,BP-897,-8.028259,x0161,active-noncovalent
CCN(CC)C(=O)N[C@H]1C[C@H]2c3cccc4c3c(c[nH]4)C[C@H]2[N@H+](C1)C,terguride,-8.027876,x0104,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)CCO)NC(=O)c3ccc(cc3)N(=O)=O,KS-176,-8.026518,x0708,active-covalent
Cc1ccc(cc1)S(=O)(=O)n2c3ccccc3nc2N,ML130,-8.024640,x1093,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2cccc3c2nccc3,salubrinal,-8.024623,x0874,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH2+]CCC(=O)c2cccc(c2)OC,oxyfedrine,-8.023825,x0749,active-covalent
C1C[C@@H]2[C@H](C1)[C@@H]3C[C@H]2C[C@H]3OC(=S)S,D609,-8.023685,x0195,active-noncovalent
CC(C)[C@@H](C(=O)[O-])NS(=O)(=O)c1ccc(cc1)c2ccc(cc2)Br,PD-166793,-8.023660,x0104,active-noncovalent
CC(C)Oc1ccc(cc1C#N)c2nc(no2)c3cccc4c3CC[C@@H]4[NH2+]CCO,ozanimod,-8.022897,x0104,active-noncovalent
c1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)nc[nH]3)N5CCOCC5,reversine,-8.022801,x0161,active-noncovalent
c1cc(ccc1C(=O)[O-])N[C@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,K-MAP,-8.022279,x0749,active-covalent
CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCC2,acetohexamide,-8.021811,x0434,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[C@@H](C[NH+]3CCN(CC3)c4cccc(c4)Cl)O,BRL-15572,-8.021626,x1077,active-noncovalent
c1cc2c(cc1/C=C/C(=O)N3CCCCC3)OCO2,ilepcimide,-8.019592,x0072,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C(C)(C)C)O)C)O)F)C)F,flumethasone-pivalate,-8.016963,x0104,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)NC(=O)c2ccccc2C(=O)[O-],phthalylsulfacetamide,-8.015586,x0104,active-noncovalent
CCOC(=O)O[C@@H](C)OC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2NC(=O)[C@@H](c3ccccc3)[NH3+])(C)C,bacampicillin,-8.015089,x0161,active-noncovalent
c1cc(cnc1)C(=O)N,nicotinamide,-8.013707,x0397,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4ccnc4,clotrimazole,-8.013454,x0678,active-noncovalent
c1cc(ccc1C[NH2+]CC[C@@H](C(=O)N2CCCCC2)[NH3+])Cl,UAMC-00039,-8.012881,x0104,active-noncovalent
CC[C@@H](C)C[NH2+]CC(=O)N1CCc2c(ccs2)[C@H]1COc3cccc(c3)C,RU-SKI-43,-8.011550,x0708,active-covalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)Cl)C)O,dichlorisone-acetate,-8.011309,x0195,active-noncovalent
Cc1c(c2cc(ccc2[nH]1)Cl)C3=CC[NH2+]CC3,EMD-386088,-8.011148,x0161,active-noncovalent
Cc1ccc(cc1)c2c3c(ncnc3n(n2)C(C)(C)CNC(=O)c4c(cccn4)C)N,WEHI-345-analog,-8.011008,x0434,active-noncovalent
C[C@H]1[C@@](OCC([NH2+]1)(C)C)(c2cccc(c2)Cl)O,radafaxine,-8.010698,x0195,active-noncovalent
Cc1c(ccc(c1Cl)C#N)n2c(c3n(c2=O)CC[C@H]3O)[O-],PS178990,-8.010637,x0749,active-covalent
c1ccc(cc1)OC[C@H](C[NH2+]CCOc2ccc(cc2)OCC(=O)[O-])O,"ICI-215,001",-8.010162,x0072,active-noncovalent
C[C@H](c1cc(cc2c1oc(cc2=O)N3CCOCC3)C(=O)N(C)C)Nc4cc(cc(c4)F)F,AZD8186,-8.009823,x0161,active-noncovalent
c1cc(c(c2c1ccc(=O)o2)O)O,daphnetin,-8.008783,x0195,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@H]5C[N@H+]([C@@H]6Cc7c[nH]c8c7c(ccc8)C6=C5)C,ergotamine,-8.008703,x0161,active-noncovalent
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)Nc4cc(ccc4C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,dutasteride,-8.006441,x0104,active-noncovalent
COc1nccc(n1)c2c(ncn2C3CC[NH2+]CC3)c4ccc(cc4)F,SB-242235,-8.006007,x0678,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)C[C@@H](CO)O,dyphylline,-8.004972,x0195,active-noncovalent
Cc1[nH]c(=O)c2cccc(c2n1)O,NU-1025,-8.004765,x0397,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)OCC3CC[NH+](CC3)CCNS(=O)(=O)C,GR-113808,-8.003805,x0946,active-noncovalent
C[C@H]1CCC[C@]2(C1=C[C@H]3[C@@H](C2)OC(=O)C3=C)C,alantolactone,-8.003726,x0161,active-noncovalent
c1ccc(cc1)CCCC(=O)[O-],phenylbutyrate,-8.003681,x0678,active-noncovalent
Cc1cccc(n1)CC(=O)N2CCc3c2ccc(c3F)c4cn(c5c4c(ncn5)N)C,GSK2656157,-8.003498,x0104,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4cccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)O,methacycline,-8.003436,x0831,active-covalent
C[NH2+]CCc1ccc(c(c1)O)O,deoxyepinephrine,-8.003169,x1077,active-noncovalent
C[C@H]1CCO[C@@H]2N1C(=O)c3c(c(=O)c(cn3C2)C(=O)NCc4ccc(cc4F)F)[O-],dolutegravir,-8.003065,x0161,active-noncovalent
c1ccc2c(c1)nc(s2)N3CC[NH+](CC3)Cc4ccc5c(c4)OCO5,2-[1-(4-piperonyl)piperazinyl]benzothiazole,-8.002810,x0946,active-noncovalent
CCCNC(=O)NS(=O)(=O)c1ccc(cc1)Cl,chlorpropamide,-8.002065,x0678,active-noncovalent
CC(C)[NH2+][C@@H]1CCn2c3c(cccc3[nH]c2=O)[C@H]1O,RU-42173,-8.001442,x0107,active-noncovalent
C[C@H]1C[NH2+]CCc2c1cc(cc2)Cl,lorcaserin,-8.000593,x1077,active-noncovalent
c1cc2n(c1)[C@@]3(CC(=O)NC3=O)C(=O)N(C2=O)Cc4ccc(cc4F)Br,ranirestat,-8.000050,x0434,active-noncovalent
COc1ccc(cc1)c2cc(=O)c3c(o2)c(c(c(c3OC)OC)OC)OC,tangeritin,-7.999967,x0104,active-noncovalent
CN1CC[NH+](CC1)C2=Cc3ccccc3Oc4c2cc(cc4)Cl,2-CMDO,-7.999454,x0195,active-noncovalent
c1cn2c(nc1=[NH2+])O[C@@H]3[C@H]2O[C@@H]([C@H]3O)CO,cyclocytidine,-7.998925,x0397,active-noncovalent
CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl,loteprednol,-7.998891,x1077,active-noncovalent
c1cc(cc(c1)NC(=O)C(=O)[O-])c2n[n-]nn2,acitazanolast,-7.997951,x0195,active-noncovalent
c1ccc(cc1)N2CNC(=O)C23CC[NH+](CC3)CCCC(c4ccc(cc4)F)c5ccc(cc5)F,fluspirilene,-7.997648,x0161,active-noncovalent
C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)[C@H](C=O)O)CCC5=CC(=O)C=C[C@@]53C)F)O,triamcinolone-acetonide,-7.995887,x0874,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC(=O)[O-],acefylline,-7.995131,x1418,active-covalent
COc1cc(ccc1O)[C@H]2[C@@H](Oc3cc(ccc3O2)[C@H]4[C@@H](C(=O)c5c(cc(cc5O4)O)[O-])O)CO,silymarin,-7.992285,x1077,active-noncovalent
c1cc(c(nc1)C/N=N/C(=S)N)N,triapine,-7.992079,x1093,active-noncovalent
c1ccnc(c1)c2c(c3n(n2)CCC3)c4ccnc5c4ccc(c5)OCC[NH+]6CCOCC6,LY2109761,-7.991952,x0161,active-noncovalent
CCOc1cc(ccc1Nc2ncc3c(n2)N(c4ccccc4C(=O)N3C)C)N5CCC(CC5)O,XMD8-92,-7.990553,x0161,active-noncovalent
c1ccc2c(c1)CN(c3cc(ccc3O2)Cl)C(=O)NNC(=O)CCc4ccncc4,SC-51089,-7.988515,x0678,active-noncovalent
c1cc(c(nc1)c2ccc3c(c2)ncnc3Nc4ccc(cc4)C(F)(F)F)C(F)(F)F,MK-2295,-7.988082,x1077,active-noncovalent
CC[NH+](CC)CCOC(=O)c1ccc(cc1)OCC,parethoxycaine,-7.987778,x0195,active-noncovalent
c1c(c(c(cc1Br)Br)N)C[NH2+][C@H]2CC[C@@H](CC2)O,ambroxol,-7.987587,x0749,active-covalent
c1cc(ccc1C(=O)Nc2ccc(cc2)C(C(F)(F)F)(C(F)(F)F)O)C(F)(F)F,SR-1078,-7.986461,x0104,active-noncovalent
c1cc(c(cc1F)F)C(Cn2cncn2)(Cn3cncn3)O,fluconazole,-7.986347,x0678,active-noncovalent
CC(C)C[C@@H](C(=O)OC)NC(=O)c1ccc(cc1c2cccc3c2cccc3)NC[C@H](CS)[NH3+],GGTI-298,-7.985645,x0434,active-noncovalent
Cc1cc(ccc1OCCOCC[N+](C)(C)Cc2ccccc2)C(C)(C)CC(C)(C)C,methylbenzethonium-chloride,-7.985348,x0104,active-noncovalent
C[C@@H](COc1ccccc1)[N@H+](CCCl)Cc2ccccc2,phenoxybenzamine,-7.985278,x0678,active-noncovalent
Cc1ccc(cc1[N@](CC(=O)Nc2c(cccc2F)F)S(=O)(=O)C)Cl,FPH1-(BRD-6125),-7.984847,x1093,active-noncovalent
Cc1ncc(c(n1)N)CNC(=O)N(CCCl)N=O,nimustine,-7.984723,x0678,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cccc(c3)Cl,purvalanol-a,-7.984373,x0195,active-noncovalent
CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc2ccc(cc2Cl)F,resatorvid,-7.982865,x0946,active-noncovalent
c1c(c(cc2c1NCNS2(=O)=O)S(=O)(=O)N)C(F)(F)F,hydroflumethiazide,-7.981071,x0749,active-covalent
CC(C)n1c2ccccc2n(c1=O)C(=O)NC3C[C@H]4CC[C@@H](C3)[NH+]4C,BIMU-8,-7.980006,x0104,active-noncovalent
CC(C)c1ccc(c(n1)SCCCCCCCC[NH+](C)C)C(=O)c2cccs2,Y-29794,-7.979596,x0104,active-noncovalent
Cn1c2ccccc2c(=O)c(c1[O-])C(=O)N(C)c3ccccc3,roquinimex,-7.979484,x0161,active-noncovalent
c1cc(c(cc1F)OC2CCN(CC2)c3cc(on3)c4nnn(n4)CC(=O)[O-])Br,MK-8245,-7.978674,x0104,active-noncovalent
c1cc(ccc1n2cc([nH]c2=O)N3CCOCC3)Cl,ADD-233089,-7.977933,x0874,active-noncovalent
CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],nafcillin,-7.977597,x0874,active-noncovalent
CC[NH+](CC)CCOC(=O)c1ccc(cc1Cl)N,chloroprocaine,-7.975324,x0104,active-noncovalent
Cc1cc(c2ccccc2n1)NC(=O)Nc3cc(ccc3OC)Cl,PQ-401,-7.974754,x0104,active-noncovalent
COc1cccc(c1OCC[NH2+]C[C@H]2COc3ccccc3O2)OC,WB-4101,-7.974638,x1093,active-noncovalent
C[C@@]12[C@@H]([C@@H](C[C@@H](O1)n3c4ccccc4c5c3c6n2c7ccccc7c6c8c5C(=O)N[C@H]8O)[NH2+]C)OC,7-hydroxystaurosporine,-7.973598,x0195,active-noncovalent
COc1ccsc1C[NH2+]CC[C@]2(CCOC3(C2)CCCC3)c4ccccn4,TRV130,-7.973586,x1077,active-noncovalent
c1cc(ccc1C(=O)NCCC(=O)[O-])/N=N/c2ccc(c(c2)C(=O)[O-])O,balsalazide,-7.973557,x0161,active-noncovalent
c1ccc(c(c1)c2ccnc3c2CN(C(=O)CO3)Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)F,GPBAR-A,-7.972985,x0830,active-covalent
Cc1ccccc1OC[C@H](C[NH2+]CCOc2ccc(cc2)C(=O)N)O,tolamolol,-7.972984,x0749,active-covalent
c1ccnc(c1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)[O-])O,sulfasalazine,-7.972161,x1077,active-noncovalent
c1cc(c(c2c1non2)N(=O)=O)Nc3cc(cc(c3)Cl)F,TC-S-7009,-7.971840,x0830,active-covalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)C(F)(F)F,trifluridine,-7.971839,x0195,active-noncovalent
CC(C)OC(=O)N[C@H]1Cc2c3cc(ccc3n(c2C1)Cc4ccccn4)C#N,LY2452473,-7.969918,x0161,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C)OC)OCCC[NH+](C)C,UNC0224,-7.969607,x0434,active-noncovalent
c1ccc(cc1)OCC[NH+]2CCC(CC2)n3c4ccccc4[nH]c3=O,oxiperomide,-7.969455,x0749,active-covalent
c1ccc(cc1)C(=O)Nc2ccc(c(c2)O)C(=O)[O-],benzoylpas,-7.969001,x1093,active-noncovalent
Cc1c(sc(n1)NC(=O)C(C)(C)C)c2ccc(c(c2)S(=O)(=O)Nc3ccc(cc3)O)OC,PI4KIII-beta-inhibitor-1,-7.968918,x0161,active-noncovalent
CC(=O)OCC(CCn1cnc2c1nc(nc2)N)COC(=O)C,famciclovir,-7.968711,x0678,active-noncovalent
c1cc(c(cc1c2c(sc(n2)N)c3ccncc3)Cl)Cl,CGH2466,-7.967635,x0195,active-noncovalent
C[C@@H](CC(c1ccccc1)(c2ccccc2)C(=O)N)[NH+](C)C,aminopentamide,-7.967306,x0195,active-noncovalent
CC(=O)N(C/C=C/c1cccc(c1)Oc2ccccc2)O,BW-A4C,-7.967043,x0195,active-noncovalent
CCN\1c2cc(ccc2S/C1=C\C(=O)C)OC,TG-003,-7.966709,x1077,active-noncovalent
CC[C@@H]1Nc2cc(c(cc2C(=O)N1)S(=O)(=O)N)Cl,quinethazone,-7.966033,x0749,active-covalent
c1c([nH]cn1)CC2CC[NH2+]CC2,immepip,-7.965981,x0387,active-noncovalent
C[C@@H](C[NH2+]C1CCCCC1)OC(=O)c2ccccc2,hexylcaine,-7.965596,x0104,active-noncovalent
c1cc(cc(c1)/C=N/N=C/c2cc(ccc2)F)F,DFB,-7.965388,x0678,active-noncovalent
C[C@H]1CC[C@@H](CC1)C(=O)N([C@H]2CC[C@@H](CC2)OC)c3c(sc(c3)C4=CCCCC4)C(=O)[O-],VCH-916,-7.965369,x0678,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)C2=CC3(CC[NH2+]CC3)Oc4c2c(ccc4)O,ADL5859,-7.965066,x0161,active-noncovalent
CNc1ccc(cc1n2cc(nc2)c3ccc(cc3)C(F)(F)F)N(=O)=O,CU-T12-9,-7.964957,x0104,active-noncovalent
CC(C)(CCCCCCC(C)(C)CO)CO,gemcadiol,-7.964784,x0161,active-noncovalent
c1cc(n2c(c1)nc(n2)NC(=O)C3CC3)c4ccc(cc4)CN5CCS(=O)(=O)CC5,filgotinib,-7.964261,x0831,active-covalent
c1cc(c(cc1[C@@H](C(=O)[O-])[NH3+])C(=O)[O-])C(=O)[O-],"3,4-DCPG-(S)",-7.963343,x0195,active-noncovalent
CC1=NN=C(c2cc3c(cc2C1)OCO3)c4ccc(cc4)N,GYKI-52466,-7.962801,x0195,active-noncovalent
Cc1cc(ccc1Nc2nc3c(c(n2)NC4CCCCC4)[nH]cn3)N5CCOCC5,MPI-0479605,-7.962461,x1077,active-noncovalent
CCCC(CCC)C(=O)OC1C[C@H]2CC[C@@H](C1)[N+]2(C)C,anisotropine,-7.960395,x0749,active-covalent
Cc1cccc(c1C)Nc2cc(nc(n2)SCC(=O)[O-])Cl,pirinixic-acid,-7.960026,x0678,active-noncovalent
Cc1ccccc1N2[C@H](Nc3cc(c(cc3C2=O)S(=O)(=O)N)Cl)C,metolazone,-7.959642,x0104,active-noncovalent
Cc1c(c(=O)n(n1C)c2ccccc2)N(C)CS(=O)(=O)[O-],metamizole,-7.959010,x0072,active-noncovalent
CC1=C[C@@H]2[C@H](CC[C@]3([C@@H]2CC(=C)[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,melengestrol-acetate,-7.957759,x1392,active-covalent
C[C@@H](c1ccccc1)NC(=O)/C(=C/c2cccc(n2)Br)/C#N,WP1066,-7.953921,x0195,active-noncovalent
CC[N+](C)(CC)CC(=O)Nc1c(cccc1C)C,N-methyllidocaine-iodide,-7.953074,x0434,active-noncovalent
C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,artemether,-7.952964,x0195,active-noncovalent
CC/C(=C(/CC)\c1ccc(cc1)OP(=O)([O-])[O-])/c2ccc(cc2)OP(=O)([O-])[O-],fosfestrol,-7.952000,x1077,active-noncovalent
C1CN(C(=O)N[C@@H]1O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,tetrahydrouridine,-7.951298,x0397,active-noncovalent
c1cc(cc(c1)Oc2ccc(cc2)N(=O)=O)N3C(=O)c4ccc(cc4C3=O)C(=O)[O-],H2L-5765834,-7.950715,x0195,active-noncovalent
C1CN(CCN1C(=O)CCBr)C(=O)CCBr,pipobroman,-7.950488,x0195,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(cc(c1)O)O)O,terbutaline,-7.949095,x0749,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1cccc2c1[nH]c(=O)[nH]2)O,CGP-12177,-7.948481,x0830,active-covalent
c1cc(ccc1C(=O)[O-])N[C@@H]2[C@H]([C@@H]([C@H](CO2)O)O)O,benaxibine,-7.947579,x0749,active-covalent
COc1cc(cc(c1OC)OC)/C=C/C(=O)N2CCCCCCC2,cinoctramide,-7.947321,x0161,active-noncovalent
Cn1c(nn(c1=S)C)c2cccc(c2)F,suritozole,-7.945951,x0161,active-noncovalent
C=CC(=O)Nc1cc2c(cc1OCCC[NH+]3CCOCC3)ncnc2Nc4ccc(c(c4)Cl)F,canertinib,-7.945840,x0104,active-noncovalent
c1ccc2c(c1)N3CCC[C@@H]3NS2(=O)=O,S18986,-7.944489,x0195,active-noncovalent
C[C@@H](COc1ccccc1)[NH2+][C@@H](C)[C@@H](c2ccc(cc2)O)O,isoxsuprine,-7.944475,x0195,active-noncovalent
c1cc2c(cc1OC(F)(F)F)sc(n2)N,riluzole,-7.944470,x0749,active-covalent
Cc1ccc2c(c1)c3c([nH]2)[C@@H]([NH2+]CC3)Cc4ccc(c(c4Cl)OC)OC,LY266097,-7.943959,x0072,active-noncovalent
CCCCCOC(=O)c1ccc(cc1)N(C)C,p-dimethylinamyl-benzoate,-7.943680,x0104,active-noncovalent
CN(C)/N=N/c1c([nH]cn1)C(=O)N,dacarbazine,-7.943605,x0161,active-noncovalent
c1cc(ccc1C(=[NH2+])N)OCCCCCOc2ccc(cc2)C(=[NH2+])N,pentamidine,-7.942265,x0946,active-noncovalent
CCCn1c(=O)c(cn2c1nc(n2)N)C,ICI-63197,-7.941606,x0195,active-noncovalent
C=CCSC[C@@H]1Nc2cc(c(cc2S(=O)(=O)N1)S(=O)(=O)N)Cl,althiazide,-7.939148,x0195,active-noncovalent
CC(=O)N([C@@H]1c2cc(ccc2OC([C@H]1O)(C)C)C#N)O,Y-26763,-7.938430,x0195,active-noncovalent
c1ccc(cc1)CCCCCCNS(=O)(=O)c2cccc3c2cccc3Cl,SC-9,-7.938409,x0946,active-noncovalent
C[C@@H](c1nc(cs1)c2ccc(cc2)C#N)[C@](Cn3cncn3)(c4cc(ccc4F)F)O,isavuconazole,-7.937481,x0161,active-noncovalent
C[N@H+](CC[C@H](c1ccc(cc1)F)Oc2ccc(cc2)c3ccccc3)CC(=O)[O-],ALX-5407,-7.937108,x0759,active-covalent
C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F,diflorasone-diacetate,-7.935430,x0749,active-covalent
CC(=O)OCC(=O)NCCCOc1cccc(c1)C[NH+]2CCCCC2,roxatidine-acetate,-7.934253,x0104,active-noncovalent
CC(C)c1cccc(c1OS(=O)(=O)[N-]C(=O)Cc2c(cc(cc2C(C)C)C(C)C)C(C)C)C(C)C,avasimibe,-7.933449,x0161,active-noncovalent
C[C@H](CC1CCCCC1)[NH2+]C,propylhexedrine,-7.932984,x0195,active-noncovalent
CC[NH+](CC)CCOC(=O)C(c1ccccc1)c2ccccc2,adiphenine,-7.931138,x0678,active-noncovalent
c1cc(cnc1)CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],risedronate,-7.930654,x0397,active-noncovalent
Cc1cc2c(cc1CC(=O)c3c(ccs3)S(=O)(=O)Nc4c(c(no4)C)Cl)OCO2,sitaxentan,-7.928009,x0749,active-covalent
C[C@@H](Cn1ccc(n1)c2ccc(c(c2)Cl)C#N)NC(=O)c3cc(n[nH]3)[C@H](C)O,ODM-201,-7.927373,x0104,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(cc(c1)OC(=O)N(C)C)OC(=O)N(C)C)O,bambuterol,-7.925732,x1077,active-noncovalent
C[N+]1(Cc2c(c(c(c(c2Cl)Cl)Cl)Cl)C1)CC[N+](C)(C)C,chlorisondamine-diiodide,-7.925576,x0195,active-noncovalent
CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N,ethoxzolamide,-7.925233,x0749,active-covalent
C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,eplerenone,-7.925105,x1077,active-noncovalent
c1cc(c(cc1C[C@H](C(=O)[O-])O)O)O,sodium-danshensu,-7.924992,x0397,active-noncovalent
C1C[NH+]2CCC1C(=O)C2(CO)CO,PRIMA1,-7.923908,x0354,active-noncovalent
c1cc(cc(c1)S(=O)(=O)n2cccc2/C=C(\C#N)/S(=O)(=O)c3ccc(cc3)F)N(=O)=O,AMZ30,-7.923602,x0107,active-noncovalent
CCCCC[C@H](CCCC(=O)[O-])O,M-14157,-7.923564,x0678,active-noncovalent
C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F,PF-06463922,-7.922224,x0195,active-noncovalent
Cc1cc(cc2c1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O,D-delta-Tocopherol,-7.922076,x1077,active-noncovalent
C[NH+](C)Cc1c2ccccc2oc1C(=O)NCCOc3ccc(cc3)C(=O)NO,PCI-24781,-7.921602,x0104,active-noncovalent
CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C,malotilate,-7.919761,x0195,active-noncovalent
CCO[C@@H]1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)O[C@@](CC3)(OO4)C)C)C,artemotil,-7.919469,x0195,active-noncovalent
C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)[NH+]5C)C,retapamulin,-7.919022,x1077,active-noncovalent
Cc1c(c(on1)C)c2cc3c(cc2OC)c4c(cn3)[nH]c(=O)n4[C@H](C)c5ccccn5,I-BET151,-7.918883,x0195,active-noncovalent
c1ccc2c(c1)cc(n2CC(=O)[O-])C(=O)Nc3nc(cs3)c4ccccc4Cl,SR-27897,-7.918825,x1392,active-covalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@]35C)O,desonide,-7.918822,x0161,active-noncovalent
c1cc(c(cc1[C@@H](C(=O)[O-])[NH3+])O)C(=O)[O-],4-carboxy-3-hydroxyphenylglycine-(S),-7.916189,x1334,active-covalent
CC[C@@H](CO)NC(=O)[C@H]1C[N@H+]([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C,methylergometrine,-7.915889,x0874,active-noncovalent
Cc1ccc2c(cc(c(c2n1)O)Cl)Cl,chlorquinaldol,-7.915258,x0195,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccccc3)[NH3+])C(=O)OCOC(=O)C(C)(C)C)C,pivampicillin,-7.914359,x0874,active-noncovalent
COc1ccc(cc1)C(=O)/C(=C(/c2ccc3c(c2)OCO3)\C(=O)[O-])/Cc4cc(c(c(c4)OC)OC)OC,PD-156707,-7.914145,x0678,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OCC,doconexent-ethyl-ester,-7.913710,x0967,active-noncovalent
c1ccc(cc1)CCCC[NH+]2CCC(CC2)C(=O)c3ccc(cc3)F,4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,-7.913655,x0946,active-noncovalent
Cc1c(oc(=O)o1)C[NH+]2CCN(CC2)c3cc4c(cc3F)c(=O)c(c5n4[C@H](S5)C)C(=O)[O-],prulifloxacin,-7.913574,x0195,active-noncovalent
COC(=O)Nc1[nH]c2ccc(cc2n1)[S@](=O)c3ccccc3,oxfendazole,-7.913330,x0749,active-covalent
c1c(cncc1F)CO,5-fluoro-3-pyridyl-methanol,-7.912810,x0397,active-noncovalent
COc1ccc(cc1)COc2ccc(cc2)CC#N,O4I1,-7.912587,x0678,active-noncovalent
c1cc(oc1/C=N/N2CC(=O)NC2=O)N(=O)=O,nitrofurantoin,-7.912397,x0749,active-covalent
c1ccc2c(c1)OC[C@@H](O2)C[NH2+]CCCCN3C(=O)CC4(CCCC4)CC3=O,MDL-72832,-7.912358,x0195,active-noncovalent
COc1ccc(cc1)C(=O)C[C@]2(c3c(ccc(c3NC2=O)Cl)Cl)O,YK-4-279,-7.910984,x0195,active-noncovalent
c1ccc(c(c1)C(=O)OCCO)O,2-hydroxyethyl-salicylate,-7.910770,x0195,active-noncovalent
C[C@H]1CS(=O)(=O)CC[N@]1/N=C/c2ccc(o2)N(=O)=O,nifurtimox,-7.910373,x0749,active-covalent
c12c(=O)[nH]c(nc1n[nH]n2)N,azaguanine-8,-7.909998,x0305,active-noncovalent
CCOc1ccc(cc1)NC(=O)C[C@H](C)O,bucetin,-7.908566,x0161,active-noncovalent
CCO[C@@H](Cc1ccc(cc1)OCCc2ccc(cc2)OS(=O)(=O)C)C(=O)[O-],tesaglitazar,-7.907948,x0874,active-noncovalent
c1cc(cc(c1)NC(=O)Nc2ccc(cc2c3[n-]nnn3)Br)C(F)(F)F,NS-3623,-7.906827,x0749,active-covalent
c1cc2c(cc1N(=O)=O)S(=O)(=O)C=C2,stattic,-7.906605,x0195,active-noncovalent
CN(C(=O)[C@@H]([C@H](Cc1ccccc1)NC(=O)c2cc3cc(ccc3[nH]2)Cl)O)OC,CP-316819,-7.906336,x0434,active-noncovalent
C[C@@H](Cc1cccc(c1)C(F)(F)F)[NH2+]CCOC(=O)c2ccccc2,benfluorex,-7.906297,x0397,active-noncovalent
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CC,betamethasone-dipropionate,-7.905554,x1077,active-noncovalent
c12c(c(c(c(c1Br)Br)Br)Br)n[nH]n2,"4,5,6,7-tetrabromobenzotriazole",-7.904695,x0195,active-noncovalent
CN1Cc2cc(ccc2NC1=O)NS(=O)(=O)c3ccccc3OC,PFI-1,-7.904339,x1077,active-noncovalent
CCCCN(Cc1ccc(cc1)C(=O)NO)C(=O)Nc2ccccc2,nexturastat-a,-7.903157,x0678,active-noncovalent
Cc1cc(nc(n1)O[C@H](C(=O)[O-])C(c2ccccc2)(c3ccccc3)OC)C,ambrisentan,-7.902950,x0678,active-noncovalent
Cn1c2c(c(nc(=O)c1=O)c3ccccc3)CC(=CC2)Cl,temazepam,-7.902535,x0161,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCC(=O)[O-],AGP-103,-7.902370,x0967,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],flucloxacillin,-7.901321,x0072,active-noncovalent
Cc1ccccc1N(C)C(=O)c2ccc(c(c2)N(=O)=O)[S@@](=O)c3nccs3,SB-268262,-7.900994,x0072,active-noncovalent
c1cc(c(cc1/C=C/C(=O)O[C@@H]2C[C@@](C[C@H]([C@H]2O)O)(C(=O)[O-])OC(=O)/C=C/c3ccc(c(c3)O)O)O)O,"1,5-dicaffeoylquinic-acid",-7.900674,x0305,active-noncovalent
COc1ccc(c2c1cccc2)C(=O)CCC(=O)[O-],menbutone,-7.900501,x0195,active-noncovalent
CCOC(=O)C1=C(N=C([C@@H]([C@H]1c2cccc(c2Cl)Cl)C(=O)OC)C)C,felodipine,-7.900434,x1077,active-noncovalent
C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)[O-])NC(=O)N2,biotin,-7.900241,x0678,active-noncovalent
Cc1ccc-2c(c1)Cc3c2n(nc3C(=O)NC4CCCCC4)c5ccc(cc5Cl)Cl,GP2a,-7.900201,x0161,active-noncovalent
Cc1c(cc(c(=O)[nH]1)C#N)c2ccncc2,milrinone,-7.899122,x1077,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)I,AM-251,-7.897401,x0161,active-noncovalent
c1ccc(cc1)C(=O)NS(=O)(=O)c2ccc(cc2)N,sulfabenzamide,-7.897392,x1093,active-noncovalent
CC(=C[C@@H]1[C@H](C1(C)C)C(=O)O[C@H]2CC(=O)C(=C2)C/C=C\C=C)C,pyrethrins,-7.897375,x0104,active-noncovalent
CC(C)C[C@H](C(=O)NCC(=O)N)NC(=O)[C@H]1CCC[NH2+]1,prolylleucylglycinamide,-7.896436,x0678,active-noncovalent
c1c(cc(c2c1[nH]c(c2CCC(=O)[O-])C(=O)[O-])Cl)Cl,MDL-29951,-7.895853,x0749,active-covalent
c1cc(c(cc1N(=O)=O)C(=O)Nc2ccncc2)Cl,T-0070907,-7.895780,x1093,active-noncovalent
c1ccc(cc1)NC(=O)c2cc(ccc2Cl)N(=O)=O,GW-9662,-7.895027,x0678,active-noncovalent
Cc1nc2cnc3ccc(cc3c2n1c4ccc(cc4)C(C)(C)C#N)C#Cc5cccnc5,BAG-956,-7.894453,x0161,active-noncovalent
CC(C)(C)c1ccc(cc1)O,4-tert-butylphenol,-7.894217,x0195,active-noncovalent
C[C@H]1C[NH2+]CCC[N@@]1S(=O)(=O)c2cccc3c2c(cnc3)F,ripasudil,-7.893481,x0072,active-noncovalent
C[NH+]1CCC(CC1)Nc2ncc3c(n2)c(ncn3)Nc4ccc(c(c4)Cl)F,BIBX-1382,-7.893158,x0195,active-noncovalent
CNC(=S)[C@]1(CCCS1)c2ccccn2,picartamide,-7.892972,x1093,active-noncovalent
c1cc(ccc1[C@H](CCC[NH+]2CCN(CC2)c3ncc(cn3)F)O)F,BMY-14802,-7.892874,x0397,active-noncovalent
CCCCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)I)OCC[NH+](CC)CC)I,amiodarone,-7.892573,x0104,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3c(n2)ccc(n3)OC,tenatoprazole,-7.892107,x0107,active-noncovalent
CCN(CC)C(=O)c1ccc(cc1)[C@H](c2cccc(c2)OC)[N@]3C[C@H]([N@@H+](C[C@@H]3C)CC=C)C,SNC-80,-7.892004,x0161,active-noncovalent
Cc1c2ccc(=O)[nH]c2ccn1,medorinone,-7.891969,x0195,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,edaravone,-7.889587,x0195,active-noncovalent
Cc1cc(=O)n([nH]1)c2ccccc2,N-demethylantipyrine,-7.889587,x0195,active-noncovalent
Cn1cnc2c1c(=O)n(c(=O)[nH]2)C,paraxanthine,-7.888196,x0195,active-noncovalent
c1cc(c(cc1OCC(F)(F)F)C(=O)NC[C@H]2CCCC[NH2+]2)OCC(F)(F)F,flecainide,-7.887606,x0195,active-noncovalent
CC[NH+](CC)Cc1ccc2cc(ccc2c1)COC(=O)Nc3ccc(cc3)C(=O)NO,givinostat,-7.887281,x0104,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)F,floxuridine,-7.886731,x0195,active-noncovalent
CCCCCCOc1cc2c(cc1N(C)c3ncc(cn3)C(=O)[O-])C(CCC2(C)C)(C)C,PA-452,-7.885966,x1077,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C=C(C#N)C#N,tyrphostin-A9,-7.885646,x1418,active-covalent
c1cc(ccc1[C@H](C[NH3+])O)O,octopamine,-7.885104,x0434,active-noncovalent
c1ccc(cc1)C/[NH+]=C(/N)\NC(=O)c2c(nc(c(n2)Cl)N)N,benzamil,-7.885048,x0104,active-noncovalent
COc1ccc(cc1)/C=C/C(=O)[O-],trans-4-Methoxycinnamic-acid,-7.884934,x0749,active-covalent
C1CC[N@@H+]2C[C@@H]3C[C@@H]([C@H]2C1)C[N@@H+]4[C@H]3CCCC4,sparteine-sulfate,-7.884753,x0072,active-noncovalent
CC(C)(C)c1ccc(cc1)c2[nH]c3cccc(c3n2)N4CC[NH+](CC4)Cc5ccc6c(c5)nccn6,WAY-207024,-7.883661,x0395,active-noncovalent
c1cc(ccc1OC[C@@H](CO)O)Cl,chlorphenesin,-7.883345,x0749,active-covalent
CC(C)c1cc(on1)CNc2nc(cc(n2)N3CC[NH+](CC3)C)Nc4cc([nH]n4)C5CC5,XL228,-7.883111,x0397,active-noncovalent
CC[NH+](CC)CCOC(=O)[C@@H](Cc1cccc2c1cccc2)C[C@@H]3CCCO3,naftidrofuryl,-7.882974,x0072,active-noncovalent
C[C@@H]1CC(=O)N=N[C@H]1c2ccc3c(c2)[nH]c(n3)c4ccc(cc4)OC,pimobendan,-7.882498,x1077,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)[O-],doconexent,-7.881674,x0830,active-covalent
C[C@@H]1Cc2ccccc2[N@@]1NC(=O)c3ccc(c(c3)S(=O)(=O)N)Cl,indapamide,-7.880660,x0104,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](CSc1nc(cs1)c2ccc(s2)C(=O)N)O,arotinolol,-7.880533,x0104,active-noncovalent
CC(C)c1ccc(cc1)CC(=O)N2CCC[C@H](C2)c3cccc(c3)OC(C)(C)C(=O)[O-],CP-775146,-7.878687,x0874,active-noncovalent
CC(C)c1c(c(=O)n(n1C)c2ccccc2)NC(=O)Nc3ccc(cc3)Cl,TC-FPR-43,-7.877841,x0161,active-noncovalent
c1ccc(c(c1)N)NC(=O)c2ccc(cc2)CNC(=O)OCc3cccnc3,entinostat,-7.877308,x0104,active-noncovalent
c1cc(c(c(c1)Cl)Cl)N2CC[NH+](CC2)CCCCOc3ccc4c(c3)NC(=O)CC4,aripiprazole,-7.875067,x0161,active-noncovalent
c1cc(cc(c1)Cl)NC(=O)Nc2ncc(s2)CCNc3c4c(ccs4)ncn3,SNS-314,-7.874863,x0104,active-noncovalent
C[S@](=O)c1ccc(cc1)c2[nH]c(c(n2)c3ccncc3)c4ccc(cc4)F,SB-203580,-7.873383,x0161,active-noncovalent
CN(C)C(=O)c1cc2cnc(nc2n1C3CCCC3)Nc4ccc(cn4)N5CC[NH2+]CC5,ribociclib,-7.872331,x0161,active-noncovalent
CC[NH+](CC)CCO[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C,U-18666A,-7.870731,x0104,active-noncovalent
CC([C@H]1CC[C@@H](CC1)C(=O)N[C@@H](C(=O)[O-])Cc2ccccc2)C,nateglinide,-7.870385,x0107,active-noncovalent
Cc1c(sc(n1)NC(=O)C)c2ccc(c(c2)S(=O)(=O)NCCO)Cl,PIK-93,-7.870296,x0072,active-noncovalent
Cc1cc(cc(c1OC(C)(C)C(=O)[O-])C)/C=C/C(=O)c2ccc(cc2)SC,elafibranor,-7.870007,x0161,active-noncovalent
c1ccc2c(c1)c(ccn2)CNc3ccsc3C(=O)Nc4ccc(cc4)OC(F)(F)F,OSI-930,-7.869781,x0770,active-covalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4)C,methscopolamine,-7.869523,x0072,active-noncovalent
c1c(cc(cc1O)O)[C@H](C(=O)[O-])[NH3+],dihydroxyphenylglycine,-7.868940,x0830,active-covalent
C[NH+](C)C[C@@H](c1ccc(cc1)OC)C2(CCCCC2)O,venlafaxine,-7.868102,x0678,active-noncovalent
c1ccc(cc1)N2CC[NH+](CC2)C3(CCOCC3)CNC(=O)c4cccnc4Sc5ccccc5,JNJ-47965567,-7.867516,x1077,active-noncovalent
COc1cc2c(cc1OC)C[N@@H+](CC2)CCc3ccc(cc3)NC(=O)c4cc(c(cc4NC(=O)c5cc6ccccc6nc5)OC)OC,tariquidar,-7.867481,x0395,active-noncovalent
CC(=O)Oc1cccc(c1)O,resorcinol-monoacetate,-7.866498,x0195,active-noncovalent
c1cc2cccnc2c(c1)NC(=O)c3ccc(cc3)n4c(c5c(c4O)[C@H]6C[C@@H]5C=C6)O,exo-IWR-1,-7.865381,x0104,active-noncovalent
CCc1nc(c(s1)c2ccnc(c2)NC(=O)c3ccccc3)c4cccc(c4)C,TAK-715,-7.864714,x0161,active-noncovalent
CCCCNc1c2cnn(c2[nH+]c(c1C(=O)OCC)C)CC,tracazolate,-7.864121,x0195,active-noncovalent
CCCC[C@@]1(Cc2cc(c(c(c2C1=O)Cl)Cl)OCCCC(=O)[O-])C3CCCC3,DCPIB,-7.863991,x0104,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,cortisone-acetate,-7.863702,x0161,active-noncovalent
c1ccc(cc1)c2[nH]c(c[nH+]2)C[NH+]3CCN(CC3)c4ncccn4,NGD-94-1,-7.863264,x0104,active-noncovalent
CC(C)COc1ccc(cc1)CNC(=O)N(Cc2ccc(cc2)F)C3CC[NH+](CC3)C,pimavanserin,-7.862399,x0161,active-noncovalent
CCc1cn(c(=O)[nH]c1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,edoxudine,-7.860795,x0195,active-noncovalent
CC[N+](CC)(CC)CC[C@@](c1ccccc1)(C2CCCCC2)O,tridihexethyl,-7.859320,x0195,active-noncovalent
C[C@H](c1ccc(cc1)CC(C)C)C(=O)OCc2ccccn2,ibuprofen-piconol,-7.859004,x0749,active-covalent
CCn1c2c(c(n1)C)NC(=O)CN=C2c3ccccc3,ripazepam,-7.858985,x0161,active-noncovalent
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)[O-])C(=O)NC3CC[NH2+]CC3,relebactam,-7.858875,x0678,active-noncovalent
CC(=C)[C@@H]1CC[C@@]([C@@H](C1)C(=C)C)(C)C=C,beta-elemene,-7.858797,x0195,active-noncovalent
CS(=O)(=O)Nc1ccc2c(c1)c3c(ccc(c3o2)OC(F)F)C(=O)Nc4c(cncc4Cl)Cl,oglemilast,-7.858404,x0434,active-noncovalent
c1cn(nn1)c2c[nH]n(c2=O)c3cc(ncn3)N4CCOCC4,molidustat,-7.858057,x0195,active-noncovalent
CCOP(=S)(OCC)Oc1c(cc(c(n1)Cl)Cl)Cl,chlorpyrifos,-7.857464,x0749,active-covalent
C=CC[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O,naloxone,-7.856458,x0831,active-covalent
C[N@@](CCc1ccc(c(c1)Cl)Cl)CC[NH+]2CCCC2,BD-1008,-7.855129,x0195,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,cyproterone-acetate,-7.855025,x1077,active-noncovalent
C[NH+](C)CCn1cc(c2c1nccc2)S(=O)(=O)c3cccc(c3)F,WAY-208466,-7.851625,x0072,active-noncovalent
C1C2CC3CC1CC(C2)(C3)[NH3+],amantadine,-7.850710,x0354,active-noncovalent
CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,MG-132,-7.849687,x0678,active-noncovalent
C[C@@H](c1ccc(c(c1)Cl)Cl)[NH2+]C[C@@H](C[P@@](=O)(CC2CCCCC2)[O-])O,CGP-54626,-7.849515,x0104,active-noncovalent
c1cc(ccc1Cc2c(nc3n(c2=O)CCS3)[O-])Cl,nuclomedone,-7.849031,x0161,active-noncovalent
c1cc(c2c(c1NCC[NH2+]CCO)C(=O)c3c(ccc(c3C2=O)[O-])[O-])NCC[NH2+]CCO,mitoxantrone,-7.848516,x1077,active-noncovalent
CO[C@H]1CC[C@H](CC1)C(=O)c2cc3c(nc4c(c3)CCCO4)cc2,JNJ-16259685,-7.848005,x0195,active-noncovalent
CC1(C(=O)N(C(=S)N1c2ccc(c(c2)F)C(=O)NC)c3ccc(c(c3)C(F)(F)F)C#N)C,enzalutamide,-7.847151,x0161,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CSc1ccccc1C(=O)N)/C)/C)C,farnesyl-thiosalicylic-acid-amide,-7.845528,x0072,active-noncovalent
c1cc2c(cc1C(=O)N[C@H]3C[NH+]4CCC3CC4)OCCO2,PHA-568487,-7.845007,x0749,active-covalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,fludarabine,-7.844747,x0195,active-noncovalent
CCCCCCCCCCCCCCCC(=O)NCCO,palmitoylethanolamide,-7.844695,x0161,active-noncovalent
COc1cn(nc(c1=O)c2ccnn2c3ccccc3)c4ccc(cc4F)n5cccn5,TAK-063,-7.844015,x0104,active-noncovalent
C[C@]1([C@@H]([C@H](O[C@H]1n2cnc3c2nc(nc3NC4CCCC4)Cl)CO)O)O,2'-MeCCPA,-7.843780,x0195,active-noncovalent
CC(=O)NCCc1c[nH]c2c1cc(cc2)NC(=O)OC,GR-135531,-7.842125,x0195,active-noncovalent
c1cc(ccc1c2[nH]c3cc(ccc3n2)c4[nH]c5ccc(cc5n4)N)N,Ro-90-7501,-7.841928,x0104,active-noncovalent
CC1CCC(CC1)NC(=O)N(CCCl)N=O,semustine,-7.841726,x0678,active-noncovalent
CC(=O)c1cc(c(s1)Sc2cccc(c2Cl)Cl)N(=O)=O,P5091,-7.841539,x0831,active-covalent
c1ccc(cc1)N2c3ccccc3C(C2=O)(Cc4ccncc4)Cc5ccncc5,linopirdine,-7.841304,x0678,active-noncovalent
CCOC(=O)[C@@H]1[C@H](NC(=S)N=C1C)c2cccc(c2)O,monastrol,-7.839993,x1392,active-covalent
CC(C)(C)C1CCC(CC1)CC2=C(c3ccccc3C(=O)C2=O)[O-],buparvaquone,-7.839726,x0161,active-noncovalent
CC(=O)NS(=O)(=O)c1ccc(cc1)N,sulfacetamide,-7.839550,x0678,active-noncovalent
Cc1cccc(c1NC(=O)C[NH+]2CCN(CC2)C[C@H](COc3ccccc3OC)O)C,ranolazine,-7.839061,x0161,active-noncovalent
c1ccc(cc1)NCCCO,3-anilinopropan-1-ol,-7.838931,x0678,active-noncovalent
CCOc1ccc(cc1OCC)CC2=NCCc3c2cc(c(c3)OCC)OCC,drotaverine,-7.838648,x0434,active-noncovalent
CCCOC(=O)c1ccc(cc1)O,propylparaben,-7.837325,x0678,active-noncovalent
CC(=O)[C@@]1(Cc2c(c(c3c(c2[O-])C(=O)c4ccccc4C3=O)[O-])[C@H](C1)O[C@H]5C[C@@H]([C@@H](CO5)O)O)[NH3+],amrubicin,-7.836733,x0161,active-noncovalent
C[C@]12CCCC([C@@H]1CC[C@@]([C@@H]2CC[C@](C)(C=C)O)(C)O)(C)C,sclareol,-7.836132,x0195,active-noncovalent
c1cc(ncc1Cl)C(=O)NCC[NH3+],lazabemide,-7.835135,x0678,active-noncovalent
C1CC[N@@H+]2[C@H](C1)[C@]34C[C@H]2C=CC3=CC(=O)O4,securinine,-7.834994,x0104,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Nc1ccc(cc1)O,AM-404,-7.834989,x0967,active-noncovalent
c1ccc(c(c1)NC(=O)Nc2ccc(cc2O)N(=O)=O)Br,SB-225002,-7.834857,x0749,active-covalent
CC(=O)O/N=C/1\c2cc(ccc2N(C1=O)Cc3cc(ccc3Cl)Cl)Cl,LDN-57444,-7.834804,x0195,active-noncovalent
c1cc2cccnc2c(c1)O,oxyquinoline,-7.834648,x0195,active-noncovalent
CCc1cccc(c1NC(=O)C[NH+](CC(=O)[O-])CC(=O)[O-])CC,etifenin,-7.834459,x0830,active-covalent
CCC(=O)O[C@H]1CC[C@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,testosterone-propionate,-7.833282,x0678,active-noncovalent
COc1cc(ccc1Cl)NC(=O)c2ccccn2,VU0361737,-7.832375,x0195,active-noncovalent
COc1cc(cc(c1OC)OC)[C@@H]2c3cc4c(cc3[C@@H]([C@@H]5[C@@H]2C(=O)OC5)O)OCO4,podophyllotoxin,-7.832320,x0161,active-noncovalent
CN1CC[NH+](CC1)CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,pirenzepine,-7.829867,x0104,active-noncovalent
C/C(=C(/C#N)\C(=O)Nc1cc(ccc1Br)Br)/O,LFM-A13,-7.829633,x0195,active-noncovalent
CC[N+](CC)(CC)CC(=O)Nc1c(cccc1C)C,QX-314,-7.829500,x0434,active-noncovalent
CCOCCn1c2ccccc2nc1N3CCC[N@H+](CC3)C,emedastine,-7.829353,x0434,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCNC(=O)C34CC5CC(C3)CC(C5)C4,adatanserin,-7.828271,x0104,active-noncovalent
c1ccc(cc1)NC(=O)C2C(=O)NC(=S)NC2=O,merbarone,-7.828114,x0678,active-noncovalent
Cc1c2c(cs1)C(=O)Nc3ccccc3N2C(=O)C[NH+]4CCN(CC4)C,telenzepine,-7.828099,x0195,active-noncovalent
CCC(=O)c1c(cc(cc1O)O)O,flopropione,-7.827406,x0195,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC(C)C,isopropyl-palmitate,-7.827374,x0161,active-noncovalent
Cc1c(nccn1)N2CCCCC2,modaline,-7.827106,x0387,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)[O-],gamma-linolenic-acid,-7.826504,x0967,active-noncovalent
c1cc2c(c(c1)N)C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O,pomalidomide,-7.825874,x0195,active-noncovalent
C[N@H+]1CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5c6c(cc(c5O)OC)CC[N+]([C@@H]6Cc7ccc(c(c7)O3)O)(C)C)OC,tubocurarine,-7.823708,x0104,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3cc(cc(c3)Cl)N,aminopurvalanol-a,-7.822013,x0678,active-noncovalent
CCCCOc1ccc(cc1)C(=O)CC[NH+]2CCCCC2,dyclonine,-7.821922,x0104,active-noncovalent
CN(c1ccc(cc1)OC(=O)c2ccco2)C(=O)C(Cl)Cl,diloxanide,-7.821535,x0749,active-covalent
C[C@@H](c1ccccc1)NC(=O)CNC(=O)c2cccc(c2)Cl,JNJ-63533054,-7.821272,x0104,active-noncovalent
CC(C)(Cc1c[nH]c2c1cc(cc2)Cl)[NH2+]CCOc3ccccc3OCC4CC4,RS-17053,-7.820681,x1077,active-noncovalent
c1cc2c(cc1Br)C=CC(=O)C2=O,bonaphthone,-7.819712,x0195,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=O)/C)/C,retinaldehyde,-7.819566,x0104,active-noncovalent
c1ccc2c(c1)ccc(=O)o2,coumarin,-7.819531,x0195,active-noncovalent
c1[nH]c2c(n1)c(ncn2)N,adenine,-7.817648,x0678,active-noncovalent
Cc1ccnc2c1NC(=O)c3cccnc3N2C4CC4,nevirapine,-7.817565,x0195,active-noncovalent
c1ccc(cc1)[S@](=O)c2ccc3nnnn3n2,Ro-106-9920,-7.817238,x0678,active-noncovalent
CCOC(=O)CCNc1cc(nc(n1)c2ccccn2)N3CCc4ccccc4CC3,GSK-J4,-7.815744,x1077,active-noncovalent
CCOC(=O)O[C@@H](c1ccnc2c1cc(cc2)OC)[C@H]3C[C@@H]4CC[N@H+]3C[C@@H]4C=C,quinine-ethyl-carbonate,-7.815491,x0107,active-noncovalent
CCn1c2c(cncc2nc1c3c(non3)N)C(=O)N4CC[C@@H](C4)[NH3+],SB-772077B,-7.815361,x0195,active-noncovalent
CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)[NH3+])C(=O)[O-],oseltamivir-carboxylate,-7.814522,x0678,active-noncovalent
CCCC[NH+](CCCC)CCCOC(=O)c1ccc(cc1)N,butacaine,-7.813479,x0104,active-noncovalent
Cc1cc(c(c(c1CC2=[NH+]CCN2)C)O)C(C)(C)C,oxymetazoline,-7.813391,x0104,active-noncovalent
CC(=O)c1cc(c(s1)Sc2ccc(cc2F)F)N(=O)=O,P22077,-7.811275,x1386,active-covalent
COCCCC/C(=N\OCC[NH3+])/c1ccc(cc1)C(F)(F)F,fluvoxamine,-7.810683,x0072,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H](C[C@H](O3)CO)O)N,cordycepin,-7.810182,x0107,active-noncovalent
CCCCOCCOc1c(sc(n1)c2ccc(c(c2)F)C(=O)[O-])C,AC-261066,-7.810064,x0749,active-covalent
CC[NH+](CC)CCc1nc(no1)c2ccccc2,oxolamine,-7.810038,x0161,active-noncovalent
c1ccnc(c1)CO,piconol,-7.810037,x0397,active-noncovalent
CC(C)NNC(=O)c1ccncc1,iproniazid,-7.809742,x0749,active-covalent
c1cc(ccc1OCC(=O)N2CC[NH+](CC2)Cc3ccc4c(c3)OCO4)Cl,fipexide,-7.809350,x0195,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCCC(c4ccc(cc4)F)c5ccc(cc5)F,pimozide,-7.808833,x0678,active-noncovalent
C[C@H](c1ccc(cc1)CC(C)C)C(=O)Oc2ccccc2OC,metoxibutropate,-7.807845,x0072,active-noncovalent
c1cnc(cn1)Cl,2-Chloropyrazine,-7.807575,x0397,active-noncovalent
c1cc(c(cc1Cl)Cl)/C(=C/n2cncn2)/Cl,loreclezole,-7.807415,x0678,active-noncovalent
c1c(cc(c(c1NC(=O)c2c(c(cc(c2Cl)Cl)Cl)O)O)Cl)Cl,oxyclozanide,-7.806450,x0104,active-noncovalent
CCn1c(n[nH]c1=O)c2ccc(cc2)Cl,"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",-7.805787,x0397,active-noncovalent
c1ccc(cc1)CC[NH+]2CCC(CC2)[C@@H](c3ccccc3)O,MDL-11939,-7.804554,x1093,active-noncovalent
CCOc1cccc(c1)NC(=O)c2ccc(c(c2)C(F)(F)F)N3CCCC3,EPPTB,-7.804005,x0104,active-noncovalent
c1ccc(cc1)C2(C(=O)NC(=O)N2)c3ccccc3,phenytoin,-7.802949,x1077,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,chenodeoxycholic-acid,-7.801655,x0104,active-noncovalent
C(C[C@@H](C(=O)[O-])[NH3+])C[NH3+],ornithine,-7.800433,x0107,active-noncovalent
Cc1ccc(cn1)c2c(cc(cn2)Cl)c3ccc(cc3)S(=O)(=O)C,etoricoxib,-7.799803,x0678,active-noncovalent
c1cc2c(c(c1)S(=O)(=O)N)c(cc3c2[nH]c(=O)c(=O)[nH]3)N(=O)=O,NBQX,-7.798525,x0749,active-covalent
CCCCCCC[N@H+](CC)CCC[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,ibutilide,-7.798430,x0072,active-noncovalent
CC[C@](CO)(c1ccccc1)C(=O)OC2C[C@H]3CC[C@@H](C2)[N+]3(C)C,troventol,-7.798120,x0161,active-noncovalent
C/C=C/C/C=C/CCC(=O)[C@@H]1[C@@H](O1)C(=O)N,cerulenin,-7.794919,x0749,active-covalent
CCCOC(=O)c1ccccc1,propyl-benzoate,-7.794863,x0195,active-noncovalent
CCOC(=O)C1=C(C(=O)N(C1)Cc2ccccc2)O,EBPC,-7.793982,x1386,active-covalent
Cc1cc(no1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@@]2C)O,isoxicam,-7.793593,x0678,active-noncovalent
CCC(CC)Nc1cc([nH+]c(c1C)Oc2c(cc(cc2C)C)C)C,CP-376395,-7.793513,x0104,active-noncovalent
CCOCCOc1ccccc1C(=O)N,etosalamide,-7.792745,x0195,active-noncovalent
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,fluticasone-propionate,-7.792624,x1077,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(cc1)OCCOCC[N+](C)(C)Cc2ccccc2,benzethonium,-7.791896,x0104,active-noncovalent
C[NH+]1C[C@H]2CCC[C@@H](C1)C2OC(=O)[C@](c3ccccc3)(C4CCCC4)O,levo-phencynonate,-7.791839,x0072,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])O)Cl)O,demeclocycline,-7.791792,x0749,active-covalent
CC[NH+](CC)CCNC(=O)c1ccc(cc1)N,procainamide,-7.791017,x0678,active-noncovalent
CCCCCCCCCCCCCCCC=O,1-hexadecanal,-7.790753,x0104,active-noncovalent
CC(C)Oc1cccc(c1)n2c(nc3ccccc3c2=O)CCc4c[nH]c5c4cc(cc5)Br,LY225910,-7.790017,x0104,active-noncovalent
CN(C)C(=O)[C@@H]([C@H](Cc1ccccc1)NC(=O)c2cc3cc(ccc3[nH]2)Cl)O,CP-91149,-7.788883,x0749,active-covalent
CCc1ccc(cc1)/C=C/2\C(=O)[N-]C(=S)S2,10058-F4,-7.788473,x1418,active-covalent
COc1cc(c(cc1S(=O)(=O)[O-])C(=O)c2ccccc2)O,sulisobenzone,-7.787257,x0749,active-covalent
CC(C)(C)c1cc(ccc1OCC[N@@H+](C)CC(=O)[O-])c2ccc3c(c2)OCO3,LY2365109,-7.786794,x0104,active-noncovalent
c1cc(ccc1C#N)C(c2ccc(cc2)C#N)n3cncn3,letrozole,-7.784835,x0072,active-noncovalent
CC(C)(C)C#C/C=C/C[N@@H+](C)Cc1cccc2c1cccc2,terbinafine,-7.784606,x0195,active-noncovalent
c1cc(c2c(c1O)CCC2)Cl,chlorindanol,-7.783982,x0195,active-noncovalent
c1ccc2c(c1)C(=O)c3ccccc3C2(Cc4ccncc4)Cc5ccncc5,XE-991,-7.783828,x1077,active-noncovalent
CC(C)(CS(=O)(=O)Nc1ccc2c(c1)CCN(C2)C(=O)COc3cccnc3)O,Nampt-IN-1,-7.783819,x0161,active-noncovalent
CC(=O)NNC(=O)N1Cc2ccccc2Oc3c1cc(cc3)Cl,SC-19220,-7.783723,x0678,active-noncovalent
C[C@@H](Cc1ccccc1OC)[NH2+]C,methoxyphenamine,-7.783570,x0678,active-noncovalent
C[C@@H](c1c(ccc(c1Cl)F)Cl)Oc2cc(cnc2N)c3cnn(c3)C4CC[NH2+]CC4,crizotinib-(S),-7.783271,x0946,active-noncovalent
c1cc(c(nc1)NCc2ccncc2)C(=O)Nc3ccc(cc3)C4(CCCC4)C#N,apatinib,-7.783111,x0678,active-noncovalent
C[C@H](Cc1c[nH]cn1)[NH3+],alpha-methylhistamine-dihydrobromide-(R)-(-),-7.782684,x0397,active-noncovalent
CCCCOc1cc(ccc1N)C(=O)OCC[NH+](CC)CC,oxybuprocaine,-7.781488,x0104,active-noncovalent
CCOc1cc(c(cc1C(=O)NC[C@@H]2C[N@@H+](CCO2)Cc3ccc(cc3)F)Cl)N,mosapride,-7.781440,x0946,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O,fludrocortisone-acetate,-7.780887,x1077,active-noncovalent
c1cc(c(cc1[C@H](C(=O)[O-])[NH3+])C(=O)[O-])O,3-carboxy-4-hydroxyphenylglycine-(R),-7.779323,x1334,active-covalent
C[NH+](C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2(C(=C(C1=O)C(=O)N)[O-])O)[O-])[O-])N(C)C,minocycline,-7.777530,x0161,active-noncovalent
C[C@@H]([C@@H](c1ccccc1)O)[NH2+]C,ephedrine,-7.777114,x0195,active-noncovalent
c1cc(ccc1S(=O)(=O)[N@@](Cc2ccc(cc2F)c3ncon3)[C@H](CCC(F)(F)F)C(=O)N)Cl,avagacestat,-7.776841,x1077,active-noncovalent
c1ccc(cc1)CCn2c3c(cn2)c4nc(nn4c(n3)N)c5ccco5,SCH-58261,-7.773768,x0195,active-noncovalent
CC(C)(CCCCCCCCCCC(C)(C)CC(=O)[O-])CC(=O)[O-],medica-16,-7.773540,x0072,active-noncovalent
Cc1ccccc1C(c2ccccc2C)[NH+]3[C@@H]4CC[C@H]3CC(C4)(c5ccccc5)O,SCH-221510,-7.772344,x0874,active-noncovalent
C=C1[C@H](C[C@@H]([C@H]1CO)O)n2cnc3c2nc([nH]c3=O)N,entecavir,-7.771270,x0874,active-noncovalent
Cc1c(c2c(cccc2n1CC(=O)[O-])NC(=O)C)Sc3ccc(cc3)Cl,AZD1981,-7.771173,x1077,active-noncovalent
C[N@@H+]1CC[C@@]23CC(=O)C(=C[C@@H]2[C@@H]1Cc4c3c(c(cc4)OC)O)OC,sinomenine,-7.769701,x0072,active-noncovalent
CCC1=C(CN(C1=O)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@@H](CC3)C)C,glimepiride,-7.768931,x0434,active-noncovalent
C[NH+](C)C[C@@H](c1ccc(cc1)O)C2(CCCCC2)O,desvenlafaxine,-7.768776,x0434,active-noncovalent
CCCCC[C@@H](/C=C/C=C\C/C=C\C/C=C\CCCC(=O)[O-])O,icomucret,-7.767545,x0749,active-covalent
CC(C)[C@@H](c1ccccc1)C(=O)Nc2ccc(cc2)C(=O)NO,AR-42,-7.766232,x0072,active-noncovalent
C[C@](Cc1ccc(c(c1)O)O)(C(=O)[O-])NN,carbidopa,-7.766119,x0678,active-noncovalent
Cc1cc(c(cc1Cl)C(C)C)O,chlorothymol,-7.765419,x1418,active-covalent
C[C@@H](C[NH+]1CCC(CC1)Cc2ccccc2)[C@H](c3ccc(cc3)O)O,Ro-25-6981,-7.764874,x0874,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)Nc2cccc(c2)C(F)(F)F)C,m-3M3FBS,-7.764846,x1093,active-noncovalent
Cc1cc(c(cc1c2cc(c(cc2C)OI)C(C)C)C(C)C)OI,thymol-iodide,-7.764456,x0874,active-noncovalent
C(CC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],L-glutamic-acid,-7.764096,x0397,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,flunarizine,-7.763595,x1077,active-noncovalent
c1cc2c(c[nH]c2nc1)Cc3ccc(nc3)NCc4ccc(cc4)C(F)(F)F,PLX-647,-7.763232,x1077,active-noncovalent
C1=C(c2c(c(c(c(c2Cl)Cl)Cl)Cl)C1=O)[O-],TCID,-7.762191,x0195,active-noncovalent
c1c(n(=O)c(nc1N2CCCCC2)N)N,minoxidil,-7.761233,x0104,active-noncovalent
c1cc(ccc1CCCC(=O)[O-])N(CCCl)CCCl,chlorambucil,-7.760257,x0678,active-noncovalent
c1cc(ccc1[C@@H](C[NH3+])CS(=O)(=O)[O-])Cl,saclofen,-7.759218,x1077,active-noncovalent
CN1CC[NH+](CC1)[C@H](c2ccccc2)c3ccc(cc3)Cl,chlorcyclizine,-7.758842,x0831,active-covalent
CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(ccc4[nH]3)NS(=O)(=O)C,delavirdine,-7.758618,x0104,active-noncovalent
CC1([C@@H]([C@H]1C(=O)O[C@H](C#N)c2cccc(c2)Oc3ccccc3)C=C(Cl)Cl)C,cypermethrin,-7.758310,x0161,active-noncovalent
CCn1cc(c(=O)c2c1nc(c(c2)F)N3CC[NH2+]CC3)C(=O)[O-],enoxacin,-7.758130,x0749,active-covalent
CC[N+](C)(CC)CCC[n+]1c2cc(ccc2c3ccc(cc3c1c4ccccc4)N)N,propidium-iodide,-7.757973,x1385,active-covalent
CCCCCCCC[NH2+][C@@H](C)[C@H](c1ccc(cc1)SC(C)C)O,suloctidil,-7.757906,x0195,active-noncovalent
COc1ccc(cc1)S(=O)(=O)Nc2cccnc2Nc3ccc(cc3)O,ABT-751,-7.754601,x0678,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],ursolic-acid,-7.754503,x0874,active-noncovalent
c1[nH]c2c(=S)[nH]c(nc2n1)N,thioguanine,-7.753992,x0540,active-noncovalent
CC(=O)N[C@@H](Cc1ccccc1)C(=O)[O-],afalanine,-7.753862,x0161,active-noncovalent
c1ccc2c(c1)c(=O)[n-]c(=O)o2,carsalam,-7.753559,x0195,active-noncovalent
CCC(=O)c1ccc(cc1)O,paroxypropione,-7.752612,x0195,active-noncovalent
CCN(CC)C(=O)c1cccnc1,nikethamide,-7.751633,x0107,active-noncovalent
C([C@H](C(=O)[O-])[NH3+])[C@@H](C(=O)[O-])F,BAY-85-8050,-7.750725,x0397,active-noncovalent
CCCC[N@@H+]1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O,miglustat,-7.750454,x0195,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)N4CCOCC4,BML-190,-7.749722,x0161,active-noncovalent
CC(=O)c1ccc2c(c1)[C@@H]([C@@H](C(O2)(C)C)O)NC(=O)c3ccc(c(c3)Cl)F,tonabersat,-7.749680,x0195,active-noncovalent
CCCCNc1ccc(cc1)C(=O)OCC[NH+](C)C,tetracaine,-7.748345,x0946,active-noncovalent
c1ccc(c(c1)C(=O)NCC(=O)[O-])I,2-iodohippuric-acid,-7.746661,x1418,active-covalent
CC1(CCCCCCC1)[NH+]2CCC(CC2)n3c4ccccc4nc3[C@@H]5CCC[NH2+]C5,MCOPPB,-7.746440,x0195,active-noncovalent
CN([C@@H]1CCCC[C@@H]1[NH+]2CCCC2)C(=O)c3ccc(c(c3)Cl)Cl,U-54494A,-7.744275,x0195,active-noncovalent
CCCN(CCC)C(=O)[C@@H](CCC(=O)[O-])NC(=O)c1ccccc1,proglumide,-7.744035,x0749,active-covalent
CCCCCCCCCCCCCCCCO,1-hexadecanol,-7.743927,x0104,active-noncovalent
c1ccc(cc1)S(=O)(=O)c2ccc(c(c2)S(=O)(=O)NC3CC[NH2+]CC3)C(F)(F)F,WAY-316606,-7.743923,x0107,active-noncovalent
COc1cc(ncn1)NS(=O)(=O)c2ccc(cc2)N,sulfamonomethoxine,-7.742991,x0678,active-noncovalent
c1cc(ccc1c2cnc3c(cnn3c2)c4ccncc4)OCC[NH+]5CCCCC5,dorsomorphin,-7.740695,x0104,active-noncovalent
Cc1c(scn1)CCCl,clomethiazole,-7.740016,x0195,active-noncovalent
Cc1ccc(cc1)C(=O)c2ccc(n2C)CC(=O)NCC(=O)Oc3ccccc3OC,amtolmetin-guacil,-7.739934,x0434,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C,retinyl-acetate,-7.739920,x0104,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C2CCCCC2,ciclopirox,-7.739372,x0678,active-noncovalent
c1ccc(cc1)CC(=O)Nc2nc3ccc(cc3c4n2nc(n4)c5ccco5)Cl,MRS-1220,-7.739103,x0161,active-noncovalent
CCCCC1=[NH+]C2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[n-]nnn5,irbesartan,-7.739009,x0874,active-noncovalent
c1cc(cnc1)CNc2cc3c(cn2)ncc(c3Nc4ccc(c(c4)Cl)F)C#N,TC-S-7006,-7.737694,x0678,active-noncovalent
CCN(CC)C(=O)/C(=C/c1cc(c(c(c1)O)[O-])N(=O)=O)/C#N,entacapone,-7.737253,x1418,active-covalent
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)[O-],arachidonic-acid,-7.736992,x0967,active-noncovalent
CCCCN(CC)c1c(cc(cc1N(=O)=O)C(F)(F)F)N(=O)=O,benfluralin,-7.736940,x0195,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccccc1I,I-BZA2,-7.736885,x0161,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCCO,hydroxyzine,-7.736731,x1093,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,vidarabine,-7.736373,x0195,active-noncovalent
CCc1c(c(nc(n1)N)N)c2ccc(cc2)Cl,pyrimethamine,-7.735847,x0678,active-noncovalent
c1cc(ccc1CC2CC[NH+](CC2)C[C@@H](c3ccc(cc3)Cl)O)F,eliprodil,-7.735111,x0161,active-noncovalent
c1c[nH]nc1CC[NH3+],betazole,-7.734958,x0397,active-noncovalent
CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](c2ccc(cc2)c3ccc(cc3)S(=O)(=O)C)C(F)(F)F)F,odanacatib,-7.734351,x0072,active-noncovalent
C[N@@H+](CCc1ccc(c(c1)Cl)Cl)C[C@@H](COc2ccc(cc2)NS(=O)(=O)C)O,AM-92016,-7.733725,x0161,active-noncovalent
CCc1cc2cc(c(cc2c(n1)Cc3ccccc3)OC)OC,moxaverine,-7.733162,x0195,active-noncovalent
C[C@](COc1ccc(cc1)C#N)(C(=O)Nc2ccc(c(c2)C(F)(F)F)C#N)O,ostarine,-7.732401,x0161,active-noncovalent
Cc1cc([nH]n1)Nc2c(cnc(n2)N[C@@H](C)c3ncc(cn3)F)Cl,AZD1480,-7.732144,x0397,active-noncovalent
Cc1cc2c(cc1S(=O)(=O)N)S(=O)(=O)CCC2,meticrane,-7.730537,x0749,active-covalent
C[N+](C)(C)CCCCCC[N+](C)(C)C,hexamethonium,-7.730157,x0749,active-covalent
c1ccc2c(c1)c3c(n2CCC(=O)[O-])CC[C@H](C3)NS(=O)(=O)c4ccc(cc4)F,ramatroban,-7.729426,x0874,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[NH+]3CCN(CC3)C[C@H](COc4cccc5c4cc([nH]5)C#N)O,DPI-201106,-7.729252,x0104,active-noncovalent
CCS(=O)(=O)N1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)NC4CC4)C(=O)N,PRT062070,-7.727309,x0161,active-noncovalent
c1cc(ccc1C(=O)NCC[NH+]2CCCCC2)I,N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide,-7.727271,x0195,active-noncovalent
COc1ccc(cc1)c2c(onc2c3ccc(cc3)OC)CC(=O)[O-],mofezolac,-7.726921,x0678,active-noncovalent
Cc1ccccc1N2CCN(CC2)S(=O)(=O)C[C@@]34CC[C@@H](C3(C)C)C[C@@H]4NC(=O)[C@H](CCS(=O)(=O)C)[NH3+],L-368899,-7.725110,x0104,active-noncovalent
c1cc2c(cc1/C=C/C=C/C(=O)N3CCCCC3)OCO2,piperine,-7.724535,x0946,active-noncovalent
c1cc2c(=O)cc[nH]c2cc1Cl,chloroxoquinoline,-7.723324,x1382,active-covalent
c1ccc(cc1)/C=C/2\C[C@]3([C@H]4Cc5ccc(c6c5[C@@]3(CC[N@@H+]4CC7CC7)[C@H](C2=O)O6)O)O,BNTX,-7.722379,x1077,active-noncovalent
CC(=C)C[N@H+]1CC[C@]23c4c5ccc(c4O[C@H]2c6c(c7ccccc7[nH]6)C[C@]3([C@H]1C5)O)O,SDM25N,-7.722163,x0434,active-noncovalent
CCCc1c2c(c(=O)[nH]c(n2)c3cc(ccc3OCC)S(=O)(=O)N4CC[NH+](CC4)C)n(n1)C,sildenafil,-7.720498,x1077,active-noncovalent
COc1ccc2c(c1)sc(n2)NC(=O)Nc3ccccc3,frentizole,-7.719878,x0161,active-noncovalent
C[C@@H](Cc1cccc(c1)O)[NH3+],gepefrine,-7.719238,x0195,active-noncovalent
Cc1ccc2c(c1CCC(=O)[O-])CC[C@H](C2)NS(=O)(=O)c3ccc(cc3)Cl,terutroban,-7.718481,x0104,active-noncovalent
CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCCCC(=O)[O-],GABA-linoleamide,-7.717864,x0830,active-covalent
Cn1c(c[nH+]c1COc2ccc(cc2)SC)N(=O)=O,fexinidazole,-7.717305,x0678,active-noncovalent
CC1([C@@H]([C@H]1C(=O)OCc2cccc(c2)Oc3ccccc3)C=C(Cl)Cl)C,permethrin,-7.716930,x0072,active-noncovalent
c1c([nH]cn1)CCCCC[NH3+],impentamine,-7.714113,x0161,active-noncovalent
COc1ccc(cc1)c2c(nc([nH]2)c3ccc(o3)c4cccc(c4)Cl)c5ccc(cc5)OC,neurodazine,-7.713920,x0434,active-noncovalent
Cc1cc(ccc1Cl)O,chlorocresol,-7.713615,x0678,active-noncovalent
c1cn(c(n1)N(=O)=O)CC(=O)NCCO,etanidazole,-7.710000,x0195,active-noncovalent
CC1(C(=O)N(c2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)COP(=O)([O-])[O-])C,fostamatinib,-7.709750,x0161,active-noncovalent
COc1ccc(c(c1C(=O)c2cnc(nc2N)NC3CCN(CC3)S(=O)(=O)C)F)F,R547,-7.708702,x0104,active-noncovalent
CCOc1c(cnn(c1=O)C)N2CCOCC2,emorfazone,-7.708623,x0195,active-noncovalent
c1cnccc1C[C@H](C(Cl)(Cl)Cl)O,PETCM,-7.708463,x0195,active-noncovalent
C[C@H]1C[N@](CC[NH2+]1)Cc2ccc(cc2)CC(=O)N3CCC(CC3)Nc4cccc(c4)F,camicinal,-7.708221,x0161,active-noncovalent
Cc1cc(cc(c1OCCO)C)c2[nH]c(=O)c3c(n2)cc(cc3OC)OC,apabetalone,-7.707962,x0678,active-noncovalent
CCC(=O)N1CCOc2c(cc(cc2OC[C@H]3CCC[N@H+](C3)C)c4ccc(c(c4)OC)OC)C1,I-CBP-112,-7.707639,x0678,active-noncovalent
CC1=NS(=O)(=O)c2cc(ccc2N1)Cl,diazoxide,-7.707629,x0678,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,lovastatin,-7.706153,x0678,active-noncovalent
CCCCCCOC(=O)CCC(=O)C[NH3+],hexaminolevulinate,-7.705358,x0195,active-noncovalent
COc1ccc(cc1)CCCO[C@H](Cn2ccnc2)c3ccc(cc3)OC,SKF-96365,-7.705253,x0434,active-noncovalent
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(c1=O)C,pentoxifylline,-7.704874,x0195,active-noncovalent
c1ccc2c(c1)nc(s2)[C@@H](C#N)c3ccnc(n3)OCc4ccc(cc4)C[NH+]5CCOCC5,PGL5001,-7.703079,x0434,active-noncovalent
CCn1c(nc(n1)C2CCN(CC2)C(=O)CCO)c3cnc(c(n3)c4nnc(o4)C(C)(C)C)N,AZD8835,-7.700245,x0104,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O,D-(+)-maltose,-7.700126,x0678,active-noncovalent
C(CC[NH3+])C[C@@H](C(=O)[O-])[NH3+],L-lysine,-7.699625,x0426,active-noncovalent
COc1cc2c(cc1OC)ncnc2Nc3ccc(cc3)Oc4ccccc4,SRC-kinase-inhibitor-I,-7.699623,x0161,active-noncovalent
COC(=O)[C@@H](c1ccccc1)NC(=O)c2cc(nc3c2cccc3)c4ccccc4,SB-218795,-7.697436,x0104,active-noncovalent
c1ccc(cc1)c2ccc(cc2)CNc3c(nnc(n3)c4ccccn4)c5ccccc5,ML-228,-7.695485,x0161,active-noncovalent
CCCCC(C(=O)CC[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)[O-])O)(F)F,lubiprostone,-7.695035,x0195,active-noncovalent
c1ccc(cc1)CC(=O)NC(=O)N,phenacemide,-7.692772,x1382,active-covalent
CNC(=O)c1cccc(c1)NC(=O)N2CCC(CC2)Oc3ccccc3Cl,A-939572,-7.692274,x0161,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)C[NH3+])O)[NH3+])[NH3+],tobramycin,-7.691922,x0161,active-noncovalent
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,simvastatin,-7.690138,x0678,active-noncovalent
Cn1c2cnc(nc2n(c1=O)C3CCCC3)Nc4ccc(cc4OC)OC5CC[NH+](CC5)C,AZ3146,-7.688654,x0107,active-noncovalent
Cc1[nH+]cc(n1C[C@H](C[NH+]2CCOCC2)O)N(=O)=O,morinidazole,-7.688618,x0678,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,idebenone,-7.688451,x0161,active-noncovalent
C/C=C/1\[C@@H]2Cc3c(ccc(=O)[nH]3)[C@]1(CC(=C2)C)[NH3+],huperzine-a,-7.687847,x0072,active-noncovalent
Cc1cnc(cn1=O)C(=O)[O-],acipimox,-7.687257,x0397,active-noncovalent
c1ccc2c(c1)c(=O)[nH]cn2,4-HQN,-7.686851,x0195,active-noncovalent
Cc1c(nc(n1c2ccc(cc2)F)C)C#Cc3ccnc(c3)Cl,basimglurant,-7.685889,x0161,active-noncovalent
Cc1nc2ccc(cc2o1)NC(=O)Nc3ccnc4c3nccc4,SB-334867,-7.683864,x0104,active-noncovalent
c1c(c(nc(=O)n1[C@H]2C[C@H]([C@H](O2)CO)O)N)Cl,cytochlor,-7.683834,x0749,active-covalent
Cc1ccc(cn1)c2ncn(n2)c3ccc(cc3)Nc4nccc(n4)c5cccc(c5)N6CCOCC6,SR-3306,-7.683475,x0104,active-noncovalent
CCNC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@@H](CCc2ccccc2)O)O)O,bimatoprost,-7.683450,x0161,active-noncovalent
C(CC(=O)N[C@@H](CSN=O)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],S-Nitrosoglutathione,-7.682157,x0678,active-noncovalent
Cc1cc(ccc1[N-]S(=O)(=O)c2cc(ccc2Cl)Cl)N(=O)=O,FH-535,-7.681582,x0072,active-noncovalent
CCCCc1cc2ccccc2c(n1)OCC[NH+](C)C,dimethisoquin,-7.679631,x0195,active-noncovalent
c1c(cncc1I)OC[C@@H]2CC[NH2+]2,5-iodo-A-85380,-7.677116,x0107,active-noncovalent
c1cc2c(cc1Cl)[nH]c(=O)o2,chlorzoxazone,-7.677007,x0678,active-noncovalent
CCCCCCCCCCCCCCCC(=O)C(F)(F)F,PACOCF3,-7.675981,x0161,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SCC(=O)[O-],SCMC-Lys,-7.675538,x0397,active-noncovalent
c1c(c(cc2c1[nH]c(=O)c(=O)[nH]2)N(=O)=O)C#N,CNQX,-7.675429,x0195,
c1ccn2c(c1)nn(c2=O)CCC[NH+]3CCN(CC3)c4cccc(c4)Cl,trazodone,-7.675406,x0195,active-noncovalent
C[C@H](CCC=C(C)C)[NH2+]C,isometheptene-mucate,-7.675300,x0195,active-noncovalent
CCCCOc1ccc(cc1)C(=O)Nc2ccc(cc2F)F,VU0357121,-7.675128,x0161,active-noncovalent
C[NH2+]CC(=O)c1ccc(c(c1)O)O,adrenalone,-7.675081,x0195,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)Cl,rimonabant,-7.674757,x0161,active-noncovalent
CC(=C)[C@@H]1CC[C@@]([C@H](C1)C(=C)C)(C)C=C,elemene,-7.674039,x0195,active-noncovalent
Cc1cnc(c(c1OC)C)C[S@](=O)c2[nH]c3cc(ccc3n2)OC,omeprazole,-7.673481,x0161,active-noncovalent
CCCCCCC[N+](CC)(CC)CCCCc1ccc(cc1)Cl,clofilium,-7.673071,x0434,active-noncovalent
Cc1cn(cn1)c2ccc(cc2OC)/C=C/3\CCCN(C3=O)[C@@H](C)c4ccc(cc4)F,E-2012,-7.672136,x0104,active-noncovalent
c1cc(cnc1)[C@H]2CCC[NH2+]2,nornicotine,-7.671556,x1418,active-covalent
Cc1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],AMPA-(RS),-7.671542,x0678,active-noncovalent
Cc1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],AMPA-(S),-7.671542,x0678,active-noncovalent
CCOC(=O)[C@@H](C)Oc1ccc(cc1)Oc2nc3ccc(cc3o2)Cl,fenoxaprop-p-ethyl,-7.670126,x0161,active-noncovalent
c1cc(ccc1CC[C@@H]2Cc3c(=O)[nH]c(nc3NC2)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],lometrexol,-7.668202,x0104,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C,teprenone,-7.666862,x1077,active-noncovalent
C[NH+]1CCN(CC1)CCCN2c3ccccc3Sc4c2cc(cc4)S(=O)(=O)N(C)C,thioproperazine,-7.666005,x0195,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)NCCc1ccc(c(c1)O)O,OLDA,-7.665141,x0104,active-noncovalent
CCNCCS(=O)(=O)NC[C@@]1(N([NH+]=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)c2ccccc2,litronesib,-7.664155,x0678,active-noncovalent
C1C[NH2+]Cc2c1c(=O)[nH]o2,gaboxadol,-7.662099,x0678,active-noncovalent
c1ccc(cc1)n2c(c(c(=O)n2c3ccccc3)CC[S@](=O)c4ccccc4)[O-],sulfinpyrazone,-7.660124,x0946,active-noncovalent
C(CO)CSC[C@@H](C(=O)[O-])[NH3+],fudosteine,-7.658846,x0397,active-noncovalent
C[N@@]1CCC[N@@H+](CC1)[C@H](c2ccccc2)c3ccc(cc3)Cl,homochlorcyclizine,-7.658725,x0072,active-noncovalent
c1cc(c(cc1N(=O)=O)Cl)NC(=O)c2cc(ccc2O)Cl,niclosamide,-7.658549,x0678,active-noncovalent
c1c(cc(cc1O)O)[C@@H](C(=O)[O-])[NH3+],"3,5-DHPG-(S)",-7.657719,x1093,active-noncovalent
CCOC(=O)[C@H]1CS[C@H]([NH2+]1)Cc2ccc(cc2)OCc3ccc(cc3)N(=O)=O,SN-6,-7.655899,x0104,active-noncovalent
c1nc(nc(=O)n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,azacitidine,-7.654997,x0967,active-noncovalent
c1cc(c(c(c1)F)C2=NCc3cnc(nc3-c4c2cc(cc4)Cl)Nc5ccc(cc5)C(=O)[O-])F,MLN-8054,-7.653778,x0161,active-noncovalent
c1ccc(cc1)CCCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O,salmeterol,-7.652020,x0678,active-noncovalent
C[C@H](c1ccc(cc1)CC(C)C)C(=O)NS(=O)(=O)C,reparixin,-7.651780,x0104,active-noncovalent
c1cc(ccc1OS(=O)(=O)c2ccc(cc2)Cl)Cl,chlorfenson,-7.651767,x0195,active-noncovalent
c1cc(c(cc1C(=O)NO)O)O,didox,-7.651239,x0678,active-noncovalent
Cc1cc(n(c(=O)c1)[O-])C[C@@H](C)CC(C)(C)C,piroctone-olamine,-7.650666,x1385,active-covalent
B([C@H](CC(C)C)NC(=O)CNC(=O)c1cc(ccc1Cl)Cl)(O)O,ixazomib,-7.650191,x1093,active-noncovalent
CCCCCCCCCCCCCCCC[n+]1ccccc1,cetylpyridinium,-7.649395,x0161,active-noncovalent
c1cc(ncc1C#N)NCC[NH2+]CC(=O)N2CCC[C@H]2C#N,NVP-DPP728,-7.649087,x0749,active-covalent
CC[NH+](CC)CC#CCOC(=O)[C@](c1ccccc1)(C2CCCCC2)O,oxybutynin,-7.648388,x1093,active-noncovalent
COc1c(c2ccc(cc2c(=O)o1)N)Cl,JLK-6,-7.648152,x0195,active-noncovalent
C[N@@H+]1CC[C@@]23C=C[C@@H](C[C@@H]2Oc4c3c(ccc4OC)C1)O,galantamine,-7.647754,x1418,active-covalent
CC1(O[C@@H]2[C@H]([C@H](O[C@@H]2O1)[C@@H](CO)O)OCCC[NH+](C)C)C,amiprilose,-7.647443,x1093,active-noncovalent
COc1cc(c(cc1C(=O)OCC[NH+]2CCCCC2)Cl)N,ML-10302,-7.647382,x0195,active-noncovalent
CCCCOC(=O)c1cc2c3ccccc3[nH]c2cn1,beta-CCB,-7.647235,x0161,active-noncovalent
CS(=O)(=O)c1cccc(c1)CNc2c(cnc(n2)Nc3ccc4c(c3)CCC(=O)N4)C(F)(F)F,PF-573228,-7.647145,x0678,active-noncovalent
C[C@](c1ccccc1)(c2ccccn2)OCC[NH+](C)C,doxylamine,-7.647050,x0678,active-noncovalent
c1cc2c(cc1C(=O)N3CCCCC3)OCO2,CX-516,-7.647049,x0749,active-covalent
Cc1cc(c(c(c1)OC)[C@@H]2C=C(CC[C@H]2C(=C)C)C)OC,O-1918,-7.646493,x0195,active-noncovalent
CC[C@](COC(=O)c1cc(c(c(c1)OC)OC)OC)(c2ccccc2)[NH+](C)C,trimebutine,-7.646284,x0104,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CCC(=O)OC/C=C(\C)/CCC=C(C)C)/C)/C)C,geranyl-farnesylacetate,-7.644895,x0161,active-noncovalent
CCn1cc(c(=O)c2c1nc(cc2)C)C(=O)[O-],nalidixic-acid,-7.643285,x0195,active-noncovalent
C[C@@H]1COC2(O1)CCN(CC2)c3nc(=O)c4cc(cc(c4s3)N(=O)=O)C(F)(F)F,BTZ043-racemate,-7.643061,x0104,active-noncovalent
c1cnc(cn1)/N=N/C(=O)CCn2cnc(n2)c3cc(cc(c3)C(F)(F)F)C(F)(F)F,selinexor,-7.642896,x0874,active-noncovalent
COc1cc2c(cc1OCCCCCCC(=O)NO)c(ncn2)Nc3cccc(c3)C#C,CUDC-101,-7.642329,x0874,active-noncovalent
COC(=O)c1cccnc1,methyl-nicotinate,-7.641403,x0397,active-noncovalent
CCN(Cc1ccccc1)C(=O)Cn2c3c(cnc(n3)c4ccccc4)n(c2=O)C,XBD173,-7.640609,x0161,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccc(cc1)I,I-BZA,-7.639282,x0104,active-noncovalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4C(=C(C(=C([C@]4(C3=O)O)O)C(=O)N)O)[NH+](C)C)O)[O-])O,doxycycline-hyclate,-7.638790,x0831,active-covalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)F)/[nH]c(=C)c1C(=O)NC[C@@H](C[NH+]4CCOCC4)O,SU014813,-7.636889,x0161,active-noncovalent
CCCCCCCCCCCCc1ccc(cc1)S(=O)(=O)Nc2nncs2,PHT-427,-7.636552,x0161,active-noncovalent
COc1ccnc(c1OC)C[S@](=O)c2[nH]c3ccc(cc3n2)OC(F)F,pantoprazole,-7.636497,x0195,active-noncovalent
CC(C)(C)c1c([nH]cn1)/C=c\2/c(=O)[nH]/c(=C\c3ccccc3)/c(=O)[nH]2,plinabulin,-7.636461,x1334,active-covalent
CC(C)(c1cc(oc1)S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)O,MCC950,-7.635713,x0678,active-noncovalent
COc1ccncc1C(=O)NC(=O)Nc2ccc(c(c2)C(F)(F)F)c3ccccc3,S1P1-agonist-III,-7.634964,x0104,active-noncovalent
C1C[N+]2(CCN1C(=O)CCBr)CC[N+]3(CCN(CC3)C(=O)CCBr)CC2,spirobromin,-7.634099,x1077,active-noncovalent
c1ccc(cc1)C#CS(=O)(=O)N,pifithrin-mu,-7.633925,x0195,active-noncovalent
CCC[C@@H](C)NC(=O)c1ccc(c(c1)Cl)Cl,NSC-405020,-7.632828,x0749,active-covalent
CS(=O)(=O)Nc1cc2c(cc1Oc3ccccc3)c(=O)c(co2)NC=O,iguratimod,-7.631998,x0072,active-noncovalent
c1ccc(cc1)[C@@](c2ccc(cc2)F)(c3ccccc3F)n4ccnc4,flutrimazole,-7.630484,x0830,active-covalent
Cc1ccc2c(n1)cccc2N3CC[NH+](CC3)CCc4cccc(c4)N5CCNC5=O,GSK163090,-7.630254,x0161,active-noncovalent
CCOP(=S)(OCC)Oc1cc(nc(n1)C(C)C)C,dimpylate,-7.629673,x0195,active-noncovalent
C[C@H]1O[C@@]2(C[NH+]3CCC2CC3)CS1,cevimeline,-7.629404,x0195,active-noncovalent
Cc1nc(nc(n1)N[C@H]2CCC[C@H](C2)C(=O)NCc3ccc(cc3C(F)(F)F)C#N)NC,GSK2256294A,-7.628737,x0195,active-noncovalent
c1cn(c(cc1=O)[O-])[C@@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,3-deazauridine,-7.628164,x0195,active-noncovalent
c1ccc(cc1)C[NH+]2CCC(CC2)NC(=O)COc3ccc(cc3)C(=O)c4ccccc4,adiporon,-7.628057,x0161,active-noncovalent
CC1=C([C@@H](C(=C(N1)C#N)C(=O)OC)c2cccc(c2)N(=O)=O)C(=O)OC(C)C,nilvadipine,-7.626749,x0946,active-noncovalent
CCCC[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@@H](CO)c4ccccc4)C,butylscopolamine-bromide,-7.626504,x0104,active-noncovalent
CCn1c2c(cnc(c2nc1c3c(non3)N)C#CC(C)(C)O)OC[C@H]4CCC[NH2+]C4,GSK690693,-7.626368,x0107,active-noncovalent
CCC(=O)Nc1cccc(c1)Oc2c(cnc(n2)Nc3ccc(cc3OC)N4CC[NH+](CC4)C)Cl,WZ4003,-7.625815,x0161,active-noncovalent
Cn1cnc2c1c(=O)[nH]c(=O)[nH]2,7-methylxanthine,-7.625719,x0678,active-noncovalent
CC(C)c1cccc(c1O)C(C)C,propofol,-7.624539,x0749,active-covalent
Cc1ccc(cc1)c2c(cnn2C)c3c4c(ncnc4N5CC[C@@H](C5)[NH+]6CCCCC6)n(n3)C,PF-4981517,-7.622152,x0161,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[NH+]4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,vecuronium,-7.619817,x0305,active-noncovalent
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,anandamide,-7.619699,x0195,active-noncovalent
c1cc(ccc1O)O,hydroquinone,-7.618016,x0678,active-noncovalent
CCCCNNC(=O)c1ccc(cc1)Br,UF-010,-7.616483,x0195,active-noncovalent
c1cc(c(cc1[C@H](C(=O)[O-])[NH3+])C(=O)[O-])C(=O)[O-],"3,4-DCPG-(R)",-7.615626,x1412,active-covalent
Cc1[nH]c(=O)c2c(n1)CCSC2,DR-2313,-7.615080,x0195,active-noncovalent
CC(C)c1c(c(nc(n1)[N@@](C)S(=O)(=O)C)c2ccc(cc2)F)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O,rosuvastatin,-7.613783,x1077,active-noncovalent
CC(C)(C)c1ccc(cc1)C[N@](Cc2cccc(c2)OCC(=O)[O-])S(=O)(=O)c3cccnc3,evatanepag,-7.612241,x0678,active-noncovalent
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,succinylcholine-chloride,-7.610557,x0195,active-noncovalent
C/C/1=C\CC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,parthenolide,-7.610229,x0195,active-noncovalent
CCCCc1nc2cc(ccc2n1CC[NH+](CC)CC)CCC(=O)N=O,SB-939,-7.608974,x0107,active-noncovalent
CCOC(=O)Nc1ccc2c(c1)N(c3ccccc3CC2)C(=O)C[NH+](C)C,tiracizine,-7.608211,x0678,active-noncovalent
CC(C)OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(=O)[O-])[NH3+],glutathione-monoisopropyl-ester,-7.608127,x0072,active-noncovalent
CCN(CC)c1ccc(cc1)n2nc3cc(c(cc3n2)N)C,ezutromid,-7.605188,x1077,active-noncovalent
CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)[O-],betulinic-acid,-7.604858,x0305,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCN3C(=O)CC4(CCCC4)CC3=O,BMY-7378,-7.603386,x0874,active-noncovalent
CCCCNc1nc(c2c(n1)n(c(=O)[nH]2)Cc3ccc(nc3)OCC[NH+](C)C)N,DSR-6434,-7.603218,x1077,active-noncovalent
CCn1cc(c(=O)c2c1nc(nc2)N3CC[NH2+]CC3)C(=O)[O-],pipemidic-acid,-7.601439,x0749,active-covalent
Cc1cccc(n1)N2CCC(CC2)CCNC(=O)OCC(=O)NC,SA-47,-7.601103,x0161,active-noncovalent
COc1ccc2c(c1OC)C[N@H+]3CCc4cc(c(cc4[C@@H]3C2)OC)OC,rotundine,-7.599979,x0104,active-noncovalent
c1ccc(cc1)[C@H]2[C@@H](N(NC2=O)C(=O)Nc3ccc(cc3)Br)c4ccccc4,LY288513,-7.596226,x0072,active-noncovalent
C(CCCC(=O)[O-])CCCC(=O)[O-],azelaic-acid,-7.595922,x1077,active-noncovalent
c1cc(cc(c1)/C=N/N=C/c2cc(ccc2)Cl)Cl,"3,3'-dichlorobenzaldazine",-7.595606,x0161,active-noncovalent
C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N)[NH3+])O,rapastinel,-7.594476,x0195,active-noncovalent
CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)c1cnc(c(n1)c2ccccc2)c3ccccc3,selexipag,-7.594406,x0161,active-noncovalent
CCOC(=O)c1c2n(cn1)-c3ccc(cc3C(=O)N(C2)C)F,flumazenil,-7.594099,x0161,active-noncovalent
CCOc1cc2c(cc1NC(=O)/C=C/C[NH+](C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)OCc4ccccn4,neratinib,-7.593379,x0072,active-noncovalent
Cc1cc(cc(c1)C(=O)NOCCCCCC(=O)NO)C,LMK-235,-7.592885,x0104,active-noncovalent
C[C@@H]([C@@H](c1cccc(c1)O)O)[NH3+],metaraminol,-7.592824,x0195,active-noncovalent
C12(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(C(C(C(C2(F)F)(F)F)(F)F)(F)F)F)F,perfluorodecalin,-7.591651,x0195,active-noncovalent
c1nc2c(nc(nc2n1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4,abacavir,-7.591563,x0161,active-noncovalent
Cc1[nH+]cc(n1C[C@H](C)O)N(=O)=O,secnidazole,-7.591474,x0195,active-noncovalent
COCCOc1ccc(cc1)Nc2ncc(c(n2)Nc3cccc(c3)NC(=O)C=C)F,AVL-292,-7.591451,x0678,active-noncovalent
c1cc(ccc1/C=C/C(=O)[O-])O,naringeninic-acid,-7.590920,x0678,active-noncovalent
c1cc2cc(ccc2nc1)/C=C\3/C(=O)N/C(=[NH+]/Cc4cccs4)/S3,Ro-3306,-7.589867,x0104,active-noncovalent
CC(C)(C)NC(=S)/N=N/Cc1c(cnn1c2ccc(cc2F)F)C(=O)OC,CID-2745687,-7.589744,x0874,active-noncovalent
CCCCCCCCC(=O)NCc1ccc(c(c1)OC)O,nonivamide,-7.589106,x0104,active-noncovalent
CC[NH+](CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2,carbetapentane,-7.588834,x0161,active-noncovalent
c1ccc(cc1)c2c(nc3c(n2)c(nc(n3)N)N)N,triamterene,-7.588733,x1385,active-covalent
CC(C)c1nnc(n1c2cccc3c2non3)c4ccc(nc4)c5ccccc5,ASP-2535,-7.588682,x0161,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)OC(CO)CO,2-Oleoylglycerol,-7.587991,x0397,active-noncovalent
Cc1cc(c(c(c1)C(C)(C)C)O)C(C)(C)C,butylated-hydroxytoluene,-7.587984,x0749,active-covalent
CCCC[C@H](c1ccccc1)O,fenipentol,-7.586759,x0072,active-noncovalent
CC[N+](CC)(CC)CCOc1cccc(c1OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC,gallamine-triethiodide,-7.586231,x0161,active-noncovalent
COc1ccc(cc1C(=O)NCc2cccnc2)C(=O)NCc3cccnc3,picotamide,-7.585968,x0434,active-noncovalent
c1ccc(cc1)C2([C@H]3CN(CCN3C(=O)O2)C(=O)NCc4ccc(cc4)F)c5ccccc5,SHA-68,-7.585949,x1077,active-noncovalent
CCOC(=O)c1ccc(cc1)N,benzocaine,-7.585262,x0678,active-noncovalent
CCCn1c(=O)c2c(nc([nH]2)c3cnn(c3)Cc4cccc(c4)C(F)(F)F)n(c1=O)CC,GS-6201,-7.584797,x0104,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCC(=O)[O-],levocetirizine,-7.584497,x1093,active-noncovalent
c1ccc(cc1)[C@H](c2ccc(cc2)Cl)[NH+]3CCN(CC3)CCOCC(=O)[O-],cetirizine,-7.584497,x1093,active-noncovalent
C[C@@H]1CC[C@@H]2[C@]13CC[C@@]([C@H](C3)C2(C)C)(C)O,cedrol-(+),-7.583910,x0195,active-noncovalent
CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C,neostigmine,-7.583836,x0161,active-noncovalent
CCO[C@@H](CN1CC[NH+](CC1)C[C@H](C)C(=O)c2ccccc2)c3ccccc3,eprazinone,-7.583731,x0161,active-noncovalent
Cc1c(nc(c(n1)C)C)C,chuanxiongzine,-7.582305,x0397,active-noncovalent
C[C@@H](C12CC3CC(C1)CC(C3)C2)[NH3+],rimantadine,-7.582181,x0354,active-noncovalent
C([C@@H](C(=O)[O-])O)C(=O)[O-],malic-acid,-7.582117,x0397,active-noncovalent
Cc1cc(n(n1)c2ccccc2)N3CCN(CC3)[C@H]4C[C@H]([NH2+]C4)C(=O)N5CCSC5,teneligliptin,-7.581713,x0161,active-noncovalent
C[N@H+]1CCc2cc(c(cc2[C@@H]1CCc3ccc(cc3)Cl)O)OC,Ro-04-5595,-7.579240,x0749,active-covalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC3OCCO3,doxofylline,-7.578553,x0749,active-covalent
c1cc2cn[nH]c2c(c1)N(=O)=O,7-nitroindazole,-7.578208,x0195,active-noncovalent
c1c(c2c([nH]1)c(=O)[nH]cn2)[C@H]3[C@@H]([C@@H]([C@H]([NH2+]3)CO)O)O,forodesine,-7.577288,x0195,active-noncovalent
CC1(CC(=C(C(=O)C1)[C@H]2c3ccccc3OC4=C2C(=O)CC(C4)(C)C)[O-])C,L-152804,-7.576981,x0195,active-noncovalent
Cc1c(sc2c1nc(nc2N3CCOCC3)c4cnc(nc4)N)C[NH+]5CCN(CC5)C(=O)[C@H](C)O,GDC-0980,-7.576761,x0434,active-noncovalent
CC(=O)C[C@H](c1ccc(cc1)N(=O)=O)c2c(c3ccccc3oc2=O)[O-],acenocoumarol,-7.575912,x1093,active-noncovalent
Cc1c(c(n(=O)c(c1Cl)C)Cl)c2nc(on2)c3cc(c(c(c3)O)[O-])N(=O)=O,opicapone,-7.575891,x0161,active-noncovalent
c1cc(c(cc1Cl)Cl)OCCOc2ccc(nc2Cl)CF,CYM-50260,-7.574833,x0104,active-noncovalent
C[C@@H]1CS[C@H]2/C(=N\C(=O)[C@@H](C3=CCC=CC3)[NH3+])/C(=O)N2[C@@H]1C(=O)[O-],cephradine,-7.574284,x0107,active-noncovalent
CCCC[NH+]1CCC(CC1)CNC(=O)c2c3ccccc3n4c2OCCC4,piboserod,-7.574043,x0195,active-noncovalent
CC1([C@@H]([N@@](CCS1)S(=O)(=O)c2ccc(cc2)OCC#CCO)C(=O)NO)C,apratastat,-7.573582,x0072,active-noncovalent
CC(C)[C@@H](c1ccc(cc1)Cl)C(=O)Nc2nccs2,4-CMTB,-7.572751,x0072,active-noncovalent
C[C@@H]1CC(=O)C=C([C@]12C(=O)c3c(cc(c(c3O2)Cl)OC)OC)OC,griseofulvin,-7.572611,x0161,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)NO)Cl,benurestat,-7.571667,x0946,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)C[C@@H](COc3cc(c(c(c3)OC)OC)OC)O,enciprazine,-7.571525,x0161,active-noncovalent
CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N1)C(C)C)CC(=O)[O-])Cc3c[nH]c4c3cccc4,BQ-123,-7.570893,x0678,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])[NH2+][C@@H](Cc1cncn1Cc2cc(cc(c2)Cl)Cl)C(=O)[O-],ORE1001,-7.570468,x0967,active-noncovalent
Cc1ccc(c(c1)O)C(C)C,thymol,-7.570327,x0749,active-covalent
C[C@]1(c2cc(c(cc2CC[NH2+]1)O)O)C(=O)[O-],salsolinol-1-carboxylic-acid,-7.570035,x0830,active-covalent
C[NH2+][C@H]1[C@H]([C@@H]2[C@H](C[C@H]([C@@H](O2)O[C@@H]3[C@H](C[C@H]([C@@H]([C@H]3O)O)[NH3+])[NH3+])[NH3+])O[C@@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)[NH3+])O)O)O,apramycin,-7.569222,x1077,active-noncovalent
Cc1cccc(c1)OC(=O)C,meta-cresyl-acetate,-7.568030,x0195,active-noncovalent
CC1([C@H]([N@@](CS1)S(=O)(=O)c2ccccc2)C(=O)N[C@@H](CNC(=O)NCc3ccccc3)C(=O)[O-])C,TC-I-15,-7.567400,x0107,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCC(=O)[O-])O,pantothenic-acid,-7.567369,x0678,active-noncovalent
COc1ccc(nn1)NS(=O)(=O)c2ccc(cc2)/N=N/c3ccc(c(c3)C(=O)[O-])O,salazodine,-7.567366,x0104,active-noncovalent
c1cc(ccc1CCc2c[nH]c3c2c(=O)[nH]c(n3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],pemetrexed,-7.566911,x0072,active-noncovalent
COc1ccc(cc1OC)CC[NH3+],homoveratrylamine,-7.565498,x1385,active-covalent
C[C@H](C(F)(F)F)Nc1c(c(nc2n1ncn2)Cl)c3c(cc(cc3F)OCCC[NH2+]C)F,cevipabulin,-7.565431,x0395,active-noncovalent
C[C@@H]1CCC[C@@H](N1C(=O)CCSC(=O)C)C(=O)[O-],methiopril,-7.564294,x0749,active-covalent
CC(C)Oc1ccc(cc1C#N)c2nc(no2)c3cccc4c3CC[C@H]4[NH2+]CCC(=O)[O-],RP-001,-7.560754,x1077,active-noncovalent
CC(=C)[C@H]1CCC(=CC1)CO,perillyl-alcohol,-7.558175,x0195,active-noncovalent
C/C=C/c1ccc(cc1)OC,anethole,-7.557606,x0749,active-covalent
C[C@@H](C(=O)N[C@@H]1c2ccccc2CCN(C1=O)C)NC(=O)[C@H](C(C)C)O,semagacestat,-7.557137,x0195,active-noncovalent
CCCCOc1ccc(cc1)OCCC[NH+]2CCOCC2,pramoxine,-7.554747,x1077,active-noncovalent
C#CC[C@H](c1nc2cc(ccc2c(=O)n1Nc3ccccc3)Cl)N(CCC[NH3+])C(=O)c4cccc(c4F)Cl,ARQ-621,-7.553823,x1077,active-noncovalent
Cc1nc(c(c(n1)Cl)[NH+]=C2NCCN2)OC,moxonidine,-7.553299,x1412,active-covalent
CC(C)(C)[NH2+]C[C@@H](COc1ccc(cc1)NC(=O)NC2CCCCC2)O,talinolol,-7.553074,x0104,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)F)C,betamethasone-acetate,-7.552953,x0749,active-covalent
CC(C)(C)c1ccc(cc1)/C=C/C(=O)Nc2ccc3c(c2)OCCO3,AMG-9810,-7.551974,x0104,active-noncovalent
CC1(CC[C@@H]([C@]23[C@@H]1C[C@]([C@]45[C@@H]2CC[C@H]([C@H]4O)C(=C)C5=O)(OC3)O)O)C,oridonin,-7.550424,x0874,active-noncovalent
C[N@H+]1CCc2cc3c(cc2[C@@H]1[C@H]4c5ccc6c(c5C(=O)O4)OCO6)OCO3,bicuculline-(+),-7.549971,x0161,active-noncovalent
c1cc(ccc1C(=O)NP(=O)(N)N)F,flurofamide,-7.549950,x0749,active-covalent
c1nc2c(=O)[nH]c(nc2n1COC(CO)CO)N,ganciclovir,-7.549510,x0397,active-noncovalent
CCOC(=O)c1c[nH]cn1,C-751,-7.548897,x0397,active-noncovalent
COc1ccc(cc1OC2CCCC2)C(=O)Nc3c(cncc3Cl)Cl,piclamilast,-7.547668,x0195,active-noncovalent
c1cc(c2ccsc2c1)N3CC[NH+](CC3)CCCCOc4ccc5ccc(=O)[nH]c5c4,brexpiprazole,-7.547366,x0195,active-noncovalent
CCCC[C@@H](CC)COC(=O)C(=C(c1ccccc1)c2ccccc2)C#N,octocrylene,-7.546808,x0195,active-noncovalent
C[NH+]1CCC(CC1)COc2cc3c(cc2OC)c(ncn3)Nc4cc(ccc4Cl)OC,AZM-475271,-7.545916,x0104,active-noncovalent
C[C@H]1COCC[N@@]1c2c3ccc(nc3nc(n2)[N@@]4CCOC[C@@H]4C)c5ccc(c(c5)CO)OC,AZD8055,-7.545352,x0434,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,pancuronium,-7.545088,x0104,active-noncovalent
c1cc2c(cc1)C(=O)C(=C(C2=O)[C@H]3CC[C@@H](CC3)c4ccc(cc4)Cl)[O-],atovaquone,-7.545006,x0104,active-noncovalent
c1c2c(=O)[nH]cnc2n(n1)[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O,allopurinol-riboside,-7.544447,x0104,active-noncovalent
COC(=O)c1ccccc1O,methyl-salicylate,-7.543220,x0195,active-noncovalent
c1ccc(cc1)Nc2nc(c(s2)NC(=O)C3CCCCC3)C(=O)N,UNC-3230,-7.542748,x0195,active-noncovalent
C[C@@H]([C@@H](c1ccc(c(c1)O)O)O)[NH3+],levonordefrin,-7.542301,x0678,active-noncovalent
c1cc(cc(c1)Cl)OCc2c3c(ncnc3n(n2)C4CCOCC4)N,PF-4800567,-7.540519,x0195,active-noncovalent
Cc1nnc(s1)Sc2c3cc(c(cc3ncn2)OC)OC,SKLB1002,-7.540480,x0195,active-noncovalent
C1C[C@](C[C@H]1C(=O)[O-])(C(=O)[O-])[NH3+],cis-ACPD,-7.539293,x0397,active-noncovalent
C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COP(=O)([O-])[O-])O)CCC4=CC(=O)C=C[C@]34C)O,prednisolone-sodium-phosphate,-7.539170,x0072,active-noncovalent
CC(C)[NH2+]CCCn1c2c(c(ncn2)N)nc1Sc3cc4c(cc3I)OCO4,PU-H71,-7.538965,x0830,active-covalent
c1ccn2c(c1)[nH+]cc2CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],minodronic-acid,-7.538495,x0831,active-covalent
c1ccc2c(c1)ccc(n2)COc3ccc(cc3)[C@@H](C4CCCC4)C(=O)[O-],veliflapon,-7.538077,x0107,active-noncovalent
c1ccc(cc1)Nc2cc(ccc2C(=O)N3CCC(CC3)[NH+]4CCCC4)C(=O)N5CCC(CC5)[NH+]6CCCC6,UNC1215,-7.536646,x0104,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)Br,broxuridine,-7.535619,x0195,active-noncovalent
CN1CC[NH+](CC1)[C@@H]2Cc3ccccc3Sc4c2cc(cc4)Cl,clorotepine,-7.535008,x1418,active-covalent
c1ccc(cc1)C2=C/C(=C\c3ccc(o3)c4ccc(cc4)N(=O)=O)/C(=O)N2c5ccc(cc5)C(=O)[O-],4E1RCat,-7.534995,x0104,active-noncovalent
c1c(c(nc(c1SC#N)N)N)SC#N,PR-619,-7.533534,x0195,active-noncovalent
COC(=O)c1ccc(cc1)O,methylparaben,-7.533010,x0678,active-noncovalent
Cc1cc(cc(c1Cl)C)O,chloroxylenol,-7.532886,x0195,active-noncovalent
C[C@@]1(CC(=O)N(C1=O)C)c2ccccc2,methsuximide,-7.531943,x0749,active-covalent
C[C@@H](CC(=O)[O-])C[NH3+],3-methyl-GABA,-7.530840,x0397,active-noncovalent
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)c5ccco5)C)O)Cl)C,mometasone-furoate,-7.530324,x0874,active-noncovalent
Cc1ccnc2c1CCC[C@H]2C(=S)N,isotiquimide,-7.529212,x1077,active-noncovalent
c1cc(c(cc1C(=O)Nc2c(cncc2Cl)Cl)OCC3CC3)OC(F)F,roflumilast,-7.528419,x0104,active-noncovalent
C[NH+](C)C1(CCCC1)CNC(=O)c2cc(c(c(c2)OC)OCc3ccccc3)OC,Org-25543,-7.528271,x0161,active-noncovalent
COc1ccc(c(c1)OC)/C=C/c2cc(cc(c2)OC)OC,TMS,-7.526848,x0749,active-covalent
C[C@@H](Cc1ccccc1)[NH3+],dextroamphetamine,-7.525565,x0195,active-noncovalent
C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(c4cccs4)(c5cccs5)O)C,tiotropium,-7.525481,x0874,active-noncovalent
Cc1cc(ccc1S(=O)(=O)Nc2cc3c(cc2OC)n(c(=O)n3C)C)Br,OF-1,-7.524962,x0104,active-noncovalent
Cn1c(nc2ccccc2c1=O)COc3ccc(cc3)C[C@H]4C(=O)[N-]C(=O)S4,balaglitazone,-7.524362,x0161,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1ccc(o1)C[NH+](C)C,ranitidine,-7.523872,x0104,active-noncovalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@@H]3[C@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O,polyinosine,-7.523212,x0397,active-noncovalent
C[N@]1c2c(oc(=O)n(c2=O)c3ccccn3)-c4ccccc4S1(=O)=O,droxicam,-7.522986,x0195,active-noncovalent
Cc1c(c(sn1)NC(=O)c2ccccc2)C(=O)Nc3ccc(cc3)Cl,denotivir,-7.522829,x0831,active-covalent
COc1ccc2cc(ccc2c1)c3c(nc([nH]3)c4ccc(cc4)[S@@](=O)C)c5ccncc5,tie2-kinase-inhibitor,-7.522776,x0104,active-noncovalent
c1ccc(c(c1)c2c3cc(c(c(c3oc-4c(c(=O)c(cc24)I)I)I)[O-])I)C(=O)[O-],erythrosine,-7.522429,x1385,active-covalent
c1cc2c(c(c1)N(=O)=O)[nH]nc2Br,3-bromo-7-nitroindazole,-7.522428,x0195,active-noncovalent
Cc1cccc(c1NC(=O)C[N+](C)(C)C)C,QX-222,-7.522398,x0678,active-noncovalent
c1ccc2c(c1)C=Cc3ccccc3C2=C4CC[NH+](CC4)CCNC(=O)C5CCN(CC5)C=O,AT-1015,-7.522274,x0874,active-noncovalent
c1nc2c(=S)[nH]c(nc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,tioguanine,-7.522156,x0397,active-noncovalent
CC1=C(C(=O)c2ccccc2C1=O)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C,menatetrenone,-7.521097,x0967,active-noncovalent
CC(C)C[C@@H](C1(CCC1)c2ccc(cc2)Cl)[NH+](C)C,sibutramine,-7.520057,x0678,active-noncovalent
C[C@@H]1[C@@H](CC[N@H+]1Cc2ccccc2)NC(=O)c3cc(c(cc3OC)NC)Cl,nemonapride,-7.518836,x0195,active-noncovalent
COc1ccc(c(c1OC)OC)CN2CC[NH2+]CC2,trimetazidine,-7.518697,x0195,active-noncovalent
COc1cc2c(cc1OC3CCN(CC3)C(=O)C=C)c(ncn2)Nc4ccc(c(c4F)Cl)Cl,poziotinib,-7.518446,x0161,active-noncovalent
C[NH+](C)C[C@@H](COc1ccccc1CCc2cccc(c2)OC)OC(=O)CCC(=O)[O-],sarpogrelate,-7.517602,x0195,active-noncovalent
CC[C@@H]1C[C@@H](c2cc(ccc2N1C(=O)OC(C)C)C(F)(F)F)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)C,CP-532623,-7.515710,x0434,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@H]2[C@@]1(C[C@@H]([C@H]3[C@@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,hydrocortisone-acetate,-7.515005,x0874,active-noncovalent
c1cc(c(cc1/C=C/C(=O)[O-])O)O,caffeic-acid,-7.514489,x0678,active-noncovalent
Cc1c(c(no1)c2c(cccc2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],dicloxacillin,-7.514229,x0072,active-noncovalent
C[N@H+]1CCc2cc3c(c(c2[C@@H]1[C@H]4c5ccc(c(c5C(=O)O4)OC)OC)OC)OCO3,noscapine,-7.513397,x0195,active-noncovalent
Cc1c2ccccc2oc1CN(C)C(=O)/C=C/c3cc4c(nc3)NC(=O)CC4,AFN-1252,-7.513005,x0678,active-noncovalent
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,citric-acid,-7.512378,x0397,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)[O-])/C)/C,tretinoin,-7.511844,x0104,active-noncovalent
CC1(C(=O)N(C(=O)N1C)C[C@@H]([C@@H](CC2CCCC2)C(=O)N3CCCCC3)C(=O)NO)C,cipemastat,-7.511179,x1077,active-noncovalent
Cc1cnc(c(c1OC)C)Cn2cnc3c2nc(nc3Cl)N,BIIB021,-7.510887,x0104,active-noncovalent
c1ccc2c(c1)cccc2c3cn(cc3C(=O)N4CCOCC4)Cc5cncn5Cc6ccc(cc6)Br,LB42708,-7.510770,x0678,active-noncovalent
c1cc(ccc1NC(=O)Nc2ccc(cc2)S(=O)(=O)N)F,U-104,-7.510766,x0678,active-noncovalent
Cn1cnc(c1Sc2nncn2C)N(=O)=O,MNITMT,-7.509956,x0195,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O,thiamphenicol,-7.508799,x0104,active-noncovalent
Cn1c2cccc(c2c(=O)c(c1[O-])C(=O)N(C)c3ccc(cc3)C(F)(F)F)OC,tasquinimod,-7.507373,x0830,active-covalent
C[C@H]1CC[C@@H]2[C@]13C[C@H]([C@](O3)(CC2=C)O)C(C)C,curcumol,-7.506904,x0678,active-noncovalent
c1cc(c(cc1Cl)c2nc(nc(n2)N)N)Cl,irsogladine,-7.506547,x0831,active-covalent
C(CC[NH2+]CCC[NH3+])C[NH3+],spermidine,-7.505499,x1334,active-covalent
c1c(c(nc(=O)n1[C@@H]2CS[C@@H](O2)CO)N)F,emtricitabine,-7.502925,x0967,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3ncc4cc(c(=O)n(c4n3)C5CCCC5)C#N,ON123300,-7.502903,x0161,active-noncovalent
COc1cc(c(cc1C(=O)NC2CC[NH+](CC2)Cc3ccccc3)Cl)N,clebopride,-7.502891,x0107,active-noncovalent
c1c2c(c(c(c1F)N3C[C@H]4[C@H](C3)OCC[NH2+]4)C#N)n(cc(c2=O)C(=O)[O-])C5CC5,finafloxacin,-7.502719,x1385,active-covalent
Cc1c(nc(o1)c2ccccc2)CCOc3ccc(c4c3ccs4)C[C@H]5C(=O)[N-]C(=O)S5,edaglitazone,-7.502297,x1077,active-noncovalent
CC(=O)Oc1cccc(c1OC(=O)C)C(=O)[O-],dipyrocetyl,-7.501822,x1334,active-covalent
CC(C)(C)c1cc(ccc1O)OC,butylated-hydroxyanisole,-7.501354,x0195,active-noncovalent
CS(=O)(=O)c1ccc(cc1)[C@@H](CC2CCCC2)C(=O)Nc3nccs3,Ro-28-1675,-7.501330,x0072,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(cc2)OC[C@H]3CO[C@](O3)(Cn4ccnc4)c5ccc(cc5Cl)Cl,ketoconazole,-7.500534,x0104,active-noncovalent
COc1ccc2cccc(c2c1)N3CC[NH+](CC3)CCNC(=O)c4ccc(cc4)F,S-14506,-7.500387,x0161,active-noncovalent
C[C@@H](Cn1cnc2c1c(=O)n(c(=O)n2C)C)O,proxyphylline,-7.499759,x0195,active-noncovalent
CNC(=O)c1cnn(c1)c2nc(c3c(n2)n(cn3)[C@H]4[C@@H]([C@H]([C@H](O4)CO)O)O)N,regadenoson,-7.499290,x0161,active-noncovalent
CC(C)c1cc(c(c(c1)C(C)C)c2csc(n2)N(CC[NH+](C)C)Cc3cccnc3)C(C)C,foropafant,-7.498280,x0874,active-noncovalent
Cc1c(c(c(cn1)CO)CO)O,pyridoxine,-7.498221,x0540,active-noncovalent
Cc1cc(no1)NC(=O)Nc2ccc(cc2Cl)Oc3ccnc4c3cc(c(c4)OC)OC,tivozanib,-7.497941,x0104,active-noncovalent
CCOC(=O)O[C@H](C)OC1=C([N@](S(=O)(=O)c2c1cccc2)C)C(=O)Nc3ccccn3,ampiroxicam,-7.497814,x1392,active-covalent
CCCCC(C)(C)[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)[O-])O)O,"16,16-dimethylprostaglandin-e2",-7.497766,x0195,active-noncovalent
Cc1c(sc(n1)N)CC[NH3+],amthamine,-7.496300,x0678,active-noncovalent
c1c2c(cc(c1N(=O)=O)N(=O)=O)[nH]c(=O)c(=O)[nH]2,DNQX,-7.496219,x0749,active-covalenta
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N,clofarabine,-7.496195,x1334,active-covalent
Cc1nc(cs1)/C=C(\C)/[C@@H]2C[C@H]3[C@H](O3)CCC[C@@H]([C@@H]([C@H](C(=O)C([C@H](CC(=O)O2)O)(C)C)C)O)C,epothilone-a,-7.496130,x0874,active-noncovalent
CCCCCCCCC(=O)NCc1cc(c(cc1I)O)OC,6-iodo-nordihydrocapsaicin,-7.494491,x0830,active-covalent
C[C@@H](c1ccc(c(c1)Cl)Cl)[NH2+]C[C@@H](C[P@@](=O)(Cc2ccccc2)[O-])O,CGP-55845,-7.494284,x0195,active-noncovalent
CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)C)O)C)C(=O)COC(=O)C,methylprednisolone-aceponate,-7.493558,x1077,active-noncovalent
Cc1c2c(nc(n1)Nc3cnn(c3)C4CC[NH2+]CC4)N(c5cc6ccccc6cc5C(=O)N2C)C,HTH-01-015,-7.493075,x0395,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)N[C@H]2CCC[NH2+]C2,troxipide,-7.492558,x0946,active-noncovalent
c1ccc(cc1)C(c2ccccc2)(c3ccccc3Cl)n4cccn4,TRAM-34,-7.491485,x0678,active-noncovalent
CCCC(CCC)C(=O)NCC(=O)N,valrocemide,-7.488742,x0749,active-covalent
CCCCNc1nc2n(cc(c2cn1)c3ccc(cc3)CN4CC[NH+](CC4)C)[C@H]5CC[C@@H](CC5)O,UNC2025,-7.488516,x0104,active-noncovalent
Cc1ccccc1c2cc(ncc2N(C)C(=O)C(C)(C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)N4CC[NH+](CC4)C,netupitant,-7.488314,x0967,active-noncovalent
CC(=O)Nc1nc2c(cccc2s1)Oc3cc(ncn3)c4ccc(cc4)C(F)(F)F,AMG-517,-7.487254,x0072,active-noncovalent
CC(C)(C(=O)OCCn1cnc2c1c(=O)n(c(=O)n2C)C)Oc3ccc(cc3)Cl,etofylline-clofibrate,-7.487112,x0072,active-noncovalent
CC(C)(C(=O)Nc1cccc(c1)S(=O)(=O)Nc2c(nc3ccccc3n2)Nc4cc(ccc4Cl)OC)[NH3+],pilaralisib,-7.486388,x0161,active-noncovalent
COc1cc(c(cc1OC)N(=O)=O)C=O,DMNB,-7.485889,x0195,active-noncovalent
CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC,beclomethasone-dipropionate,-7.484417,x1077,active-noncovalent
c1ccc(cc1)NC(=O)NCC[NH2+]C[C@@H](COc2ccccc2C#N)O,ICI-89406,-7.483131,x0946,active-noncovalent
CCCCCCCCCCCCCC[C@H]([C@H]([C@H](CO)[NH3+])O)O,phytosphingosine,-7.482892,x0104,active-noncovalent
C[C@H]1c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)O)[O-])O,doxycycline,-7.482436,x0831,active-covalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CC(C)(C)C=O,CGP-13501,-7.481975,x0195,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4c(c(cn4ncn3)OC[C@@H](C)OC(=O)[C@H](C)[NH3+])C,brivanib-alaninate,-7.480270,x0104,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3C[C@@H]([C@H](O3)CO)O)Cl)N,cladribine,-7.479826,x1334,active-covalent
C1CC[N@H+]2C[C@H]3C[C@@H]([C@@H]2C1)CN4[C@H]3CCCC4=O,lupanine,-7.478840,x0678,active-noncovalent
c1ccc(cc1)[C@H]2C[C@@H]2[NH3+],tranylcypromine,-7.476551,x0195,active-noncovalent
CCOC(=O)c1ccc(cc1)O,ethyl-paraben,-7.475868,x0749,active-covalent
C[C@]12CC[C@H](C1(C)C)[C@@H]([C@@H]2O)O,"cis-exo-camphanediol-2,3",-7.475666,x0354,active-noncovalent
CC(C)(C(=O)N[C@H](Cc1c[nH]c2c1cccc2)C(=O)N3CCC[C@](C3)(Cc4ccccc4)C(=O)N(C)N(C)C)[NH3+],anamorelin,-7.475605,x0161,active-noncovalent
CC[C@@H](c1cccc(c1)O)[C@@H](C)C[NH+](C)C,tapentadol,-7.474434,x0678,active-noncovalent
Cc1c(c(=O)c(c([nH]1)C)Cl)Cl,clopidol,-7.473747,x0678,active-noncovalent
C=CCNc1c2cc(ccc2ncn1)Br,SMER-28,-7.473435,x0104,active-noncovalent
C1CCCCCCCOC(=O)CCCCCC1,oxacyclohexadecan-2-one,-7.473433,x1311,active-covalent
c1cc2c(cc1O)oc(=O)s2,tioxolone,-7.473081,x0678,active-noncovalent
C=CCn1c2c(=O)[nH]c(nc2n(c1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,RWJ-21757,-7.471807,x0104,active-noncovalent
Cc1[nH+]cc(n1C[C@H](CCl)O)N(=O)=O,ornidazole,-7.469433,x0195,active-noncovalent
CCC(CC)(/C=C/C=C/[C@@H](C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)O,seocalcitol,-7.466984,x0104,active-noncovalent
C[C@@H](CN(c1c(cc(c(c1I)N)I)I)C(=O)C)C(=O)[O-],iocetamic-acid,-7.465908,x0749,active-covalent
C[C@H](C(=O)c1cccc(c1)Cl)[NH2+]C(C)(C)C,bupropion,-7.465584,x0195,active-noncovalent
c1ccc(cc1)C[NH+]2CCC(CC2)NC(=O)c3ccc(cc3)I,4-IBP,-7.465173,x1093,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(no1)Br)O,broxaterol,-7.464785,x0161,active-noncovalent
Cc1cc(ccn1)c2nc(co2)C(=O)Nc3cn(nc3C(=O)N)C4CCOCC4,AS-2444697,-7.464242,x0104,active-noncovalent
CC(C)[NH+]1CCN(CC1)c2ccc(cc2)OC[C@H]3CO[C@](O3)(Cn4cncn4)c5ccc(cc5Cl)Cl,terconazole,-7.463266,x0104,active-noncovalent
c1cc(cc(c1)N2CCN(CC2)c3cc(=O)n(c(=O)[nH]3)C4CCCCC4)C(F)(F)F,ML-179,-7.462735,x0104,active-noncovalent
c1cc(c(cc1N2C(=O)C(=C(C2=O)Cl)[NH+]3CCOCC3)Cl)Cl,RI-1,-7.462540,x0161,active-noncovalent
CCN(CC)CC[NH2+][C@H](c1ccccc1)C(=O)OCCC(C)C,camylofine-chlorhydrate,-7.462274,x0434,active-noncovalent
CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO,M-344,-7.459508,x0967,active-noncovalent
CC(=O)O[C@H]1C[NH+]2CCC1CC2,aceclidine,-7.459302,x0195,active-noncovalent
CCCCC/C=C\C[C@H](/C=C/C=C/C=C\[C@H](CCCC(=O)[O-])O)O,LTB4,-7.458946,x0749,active-covalent
CCCCOc1cc(c2ccccc2n1)C(=O)NCC[NH+](CC)CC,cinchocaine,-7.458789,x0195,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)F)N,fludarabine-phosphate,-7.458449,x0104,active-noncovalent
COc1c(c2cc(ccc2[nH]1)F)C(=O)OCC3CC[NH+](CC3)CCNS(=O)(=O)C,GR125487,-7.458382,x0104,active-noncovalent
C[N@](c1ccccc1CNc2c(cnc(n2)Nc3ccc4c(c3)CC(=O)N4)C(F)(F)F)S(=O)(=O)C,PF-431396,-7.458097,x0195,active-noncovalent
CNC(=O)O[C@H]1COc2ccc(cc2[C@@H]1NC(=O)c3ccc(cc3)F)N4CC[NH+](CC4)C5COC5,LY3000328,-7.456302,x0161,active-noncovalent
COc1c(ncnc1OC)NS(=O)(=O)c2ccc(cc2)N,sulfadoxine,-7.455932,x0678,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)[O-],L-Aspartic-Acid,-7.455688,x0426,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,chlorothiazide,-7.455159,x0749,active-covalent
CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2c3cc4c(cc3CC[N@@H+]5[C@@]2(CCC5)C=C1OC)OCO4)O)O,homoharringtonine,-7.453186,x0161,active-noncovalent
C[n+]1ccccc1CN=O,pralidoxime-chloride,-7.453171,x0678,active-noncovalent
C[n+]1ccccc1CN=O,pralidoxime,-7.453171,x0678,active-noncovalent
Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,glipizide,-7.451027,x0161,active-noncovalent
CC(=O)Nc1ccc(cc1)OC(=O)C,diacetamate,-7.450303,x0195,active-noncovalent
C[n+]1cccc(c1)OC(=O)N(C)C,mestinon,-7.448599,x0195,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@@H]2[C@H]([C@H]([C@@H](O2)CO)O)F,clevudine,-7.448004,x0749,active-covalent
c1cc(ccc1N)S(=O)(=O)N=C(N)N,sulfaguanidine,-7.447862,x0678,active-noncovalent
c1c2c(c(c(c1I)[O-])I)Oc3c(cc(c(c3I)[O-])I)C24c5c(c(c(c(c5Cl)Cl)Cl)Cl)C(=O)O4,rose-bengal-lactone,-7.447324,x0830,active-covalent
COc1cc(cn[n+]1c2ccccc2)N,amezinium,-7.445935,x0678,active-noncovalent
CS(=O)(=O)c1ccc(cc1)c2cnc(n3c2nnc3)NCc4ccco4,EED226,-7.445227,x0104,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)[N-]C(=O)CCl)OC)C,AGM-1470,-7.445002,x0749,active-covalent
c1cc(cc(c1)Nc2c(cccn2)C(=O)OCC[NH+]3CCOCC3)C(F)(F)F,morniflumate,-7.444160,x0434,active-noncovalent
C[N@@]1C(=C(c2c(cc(s2)Cl)S1(=O)=O)O)C(=O)Nc3ccccn3,lornoxicam,-7.441769,x0195,active-noncovalent
CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)[O-])NC(=[NH2+])N)NC(=O)C,peramivir,-7.441146,x1418,active-covalent
CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1,domiphen,-7.440799,x0161,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)OCc3ccccn3)c4[nH]ccn4,AZ-12080282,-7.440422,x0104,active-noncovalent
COc1cc(cc(c1)OC)COc2cc(c(cc2C(=O)CCC3CC[NH+](CC3)CCNS(=O)(=O)C)Cl)N,RS-39604,-7.439988,x1077,active-noncovalent
c1ccc(cc1)[C@H](C2CCCCC2)C(=O)NCCC[NH+]3CCCCCC3,MR-16728,-7.439721,x1077,active-noncovalent
C[Se]C[C@@H](C(=O)[O-])[NH3+],se-methylselenocysteine,-7.439632,x1077,active-noncovalent
CCOC(=O)C1=C(Oc2ccc(cc2[C@H]1[C@H](C#N)C(=O)OCC)Br)[NH3+],HA14-1,-7.438788,x0395,active-noncovalent
CCC(=O)c1ccc(cc1)OC[C@H](C[NH+]2CCN(CC2)c3ccccc3)O,centpropazine,-7.438686,x0161,active-noncovalent
CCOC(=O)[C@]1(CO1)CCCCCCOc2ccc(cc2)Cl,etomoxir,-7.438437,x0874,active-noncovalent
c1cc(c(cc1C(=O)N)N(=O)=O)I,iniparib,-7.437030,x0195,active-noncovalent
c1ccc(cc1)/C=C/C=O,cinnamaldehyde,-7.436707,x0195,active-noncovalent
C[C@@H]1c2cc(ccc2C(=O)N(Cc3c(c(n(n3)C)C#N)-c4cc(c(nc4)N)O1)C)F,lorlatinib,-7.435363,x0161,active-noncovalent
COc1c2c(nc(n1)N)n(cn2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O,nelarabine,-7.435084,x0104,active-noncovalent
c1c(cc(cc1C(F)(F)F)NC(=O)c2cnc(nc2C(F)(F)F)Cl)C(F)(F)F,SP-100030,-7.434964,x0104,active-noncovalent
c1cc2c(ccc(c2nc1)O)C(=O)[O-],IOX1,-7.434624,x0195,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,sodium-gluconate,-7.433662,x0397,active-noncovalent
CCC[C@@](C)(COC(=O)N)COC(=O)NC(C)C,carisoprodol,-7.432961,x0434,active-noncovalent
CC(C)OC(=O)C1=CN(CC(c2c1[nH]c3c2cccc3)(C)C)C(=O)c4ccc(c(c4)F)F,WAY-362450,-7.432894,x0161,active-noncovalent
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)[O-])C)C)O,INT-747,-7.431846,x0104,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)NC3CCOCC3)C(=O)Nc4c5cc(ccc5[nH]n4)Cc6cc(cc(c6)F)F,entrectinib,-7.431131,x0104,active-noncovalent
CN1C2C(N(C1=O)C)N(C(=O)N2C)C,mebicar,-7.431121,x0195,active-noncovalent
C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)OC(=O)C,fluorometholone-acetate,-7.428937,x0161,active-noncovalent
Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3ccnc(c3)C(C)(C)C(F)(F)F,alpelisib,-7.428156,x1077,active-noncovalent
Cc1cnc(nc1Nc2cccc(c2)S(=O)(=O)NC(C)(C)C)Nc3ccc(cc3)N4CC[NH+](CC4)C,TG-101209,-7.427381,x0161,active-noncovalent
C[C@H]1[C@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=[NH+]CCS4)C(=O)OCOC(=O)C(C)(C)C)[C@@H](C)O,tebipenem,-7.426876,x1077,active-noncovalent
Cc1c(c(no1)c2ccccc2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],cloxacillin,-7.425532,x0072,active-noncovalent
C1CCC(CC1)(CC(=O)[O-])C[NH3+],gabapentin,-7.425027,x0678,active-noncovalent
c1ccc(cc1)[C@H](C[NH2+]CCc2ccc(cc2)NC(=O)Cc3csc(n3)N)O,mirabegron,-7.424723,x0678,active-noncovalent
CC[C@](C)(C(=O)NCC(F)(F)F)Nc1ccnc(n1)c2c[nH]c3c2cccn3,decernotinib,-7.424261,x0946,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2CS[C@H](O2)CO,lamivudine,-7.423395,x0195,active-noncovalent
CCOc1cc(ccc1C(=O)OC)NC(=O)C,ethopabate,-7.422160,x0195,active-noncovalent
CCCn1c(=O)c2c([nH]c1=O)nc([nH]2)c3ccc(cc3)S(=O)(=O)[O-],PSB-1115,-7.422032,x0104,active-noncovalent
COc1ccc(cc1OC)Cc2c3cc(c(cc3ccn2)OC)OC,papaverine,-7.421810,x0072,active-noncovalent
CC(=O)Nc1ccc(cc1)O,paracetamol,-7.421527,x0678,active-noncovalent
c1ccc(c(c1)CNc2nnnn2c3cccc(c3Cl)Cl)Oc4ccccn4,A-839977,-7.421249,x0678,active-noncovalent
c1cc(c(cc1CC[NH3+])O)O,dopamine,-7.420176,x0678,active-noncovalent
COc1ccc(cc1)C(=O)N2CCCC2=O,aniracetam,-7.419021,x0161,active-noncovalent
c1nc(c2c(n1)n(c(n2)Br)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@](=O)(O4)[O-])O)N,8-bromo-cAMP,-7.418727,x0967,active-noncovalent
c1c(c(nc(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)N)F,fdcyd,-7.418592,x0195,active-noncovalent
CC(=O)Oc1ccccc1C(=O)[O-],aspirin,-7.418229,x0678,active-noncovalent
CCOc1ccccc1C(=O)[O-],2-ethoxybenzoic-acid,-7.418130,x0195,active-noncovalent
C#Cc1c[nH]c(=O)[nH]c1=O,eniluracil,-7.416646,x0678,active-noncovalent
COc1cc(cc(c1OC)OC)C[NH+]2CCN(CC2)c3ccc(cc3)F,V-51,-7.416143,x0161,active-noncovalent
CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)c5ccc(cc5)N(C)C)C)OC(=O)C,ulipristal,-7.415710,x1077,active-noncovalent
CCOC(=O)CC(=O)N1CCS[C@H]1COc2ccccc2OC,moguisteine,-7.414721,x0072,active-noncovalent
C1[C@@H]2[C@H]([C@H]([C@@H](O2)n3c4c(c(=O)[nH]c(n4)N)nc3Br)O)O[P@@](=O)(O1)[O-],8-bromo-cGMP,-7.413481,x1077,active-noncovalent
c1ccc2c(c1)N(c3ccccc3S2)C(=O)CN4CC[NH+](CC4)Cc5ccc6c(c5)OCO6,fenoverine,-7.412993,x0874,active-noncovalent
Cc1c([nH]cn1)CC[NH3+],4-methylhistamine,-7.412735,x1093,active-noncovalent
CC(C)C(=O)Nc1ncc(s1)c2cc(nn2c3c(cccc3Cl)Cl)C(F)F,LIMKi-3,-7.411934,x0678,active-noncovalent
CC(C)[NH2+]C[C@@H](c1ccc(cc1)NS(=O)(=O)C)O,sotalol,-7.411757,x0830,active-covalent
CCCCCCCCCCCCCC(=O)OC(C)C,isopropyl-myristate,-7.411432,x0161,active-noncovalent
CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1[C@H](O1)C(=O)[O-],loxistatin-acid,-7.409754,x0397,active-noncovalent
C[C@@H]([NH+]1[C@@H]2CC(C[C@H]1CC2)C(=O)[O-])c3cc4c(c(ccc4cc3)O[C@H]5CC[C@H](CC5)C(F)(F)F)C(F)(F)F,autotaxin-modulator-1,-7.408940,x0072,active-noncovalent
C=c1c(=O)/c(=C\[O-])/c(c[nH]1)CO,pyridoxal,-7.408602,x0678,active-noncovalent
c1ccc(cc1)C(=O)CC#N,CL-225385,-7.408493,x0161,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CCO,etofylline,-7.408077,x0195,active-noncovalent
C[C@@H](Cc1cnc[nH]1)[NH3+],alpha-methylhistamine-dihydrobromide-(S)-(+),-7.407391,x0540,active-noncovalent
C(C[C@H](C(=O)[O-])[NH3+])C[NH+]=C(N)N,L-Arginine,-7.406691,x0749,active-covalent
CC[NH+](CC)CCOC(=O)c1cc(c(cc1OC)N)Cl,SDZ-205-557,-7.406668,x0678,active-noncovalent
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)O,pravastatin,-7.403814,x0195,active-noncovalent
CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)n2ccc(=O)[nH]c2=O)OC(=O)C)OC(=O)C,uridine-triacetate,-7.403125,x0831,active-covalent
CN1C(=O)N(C(=O)[C@@]1(CO)c2ccccc2)c3ccc(c(c3)C(F)(F)F)C#N,GLPG0492,-7.401314,x0161,active-noncovalent
CCOCCn1c2ccccc2nc1C3CC[NH+](CC3)CCc4ccc(cc4)C(C)(C)C(=O)[O-],bilastine,-7.400405,x0161,active-noncovalent
CC(=O)Oc1cc(ccc1C(=O)[O-])C(F)(F)F,triflusal,-7.399758,x0161,active-noncovalent
CC(=O)c1ccc(c(c1)OC)OCCC[NH+]2CCC(CC2)c3c4ccc(cc4on3)F,iloperidone,-7.399706,x0104,active-noncovalent
CC(C)(C)Nc1c(c(cc([nH+]1)Nc2ccc(cc2)C(=O)N)N)C#N,TC-Mps1-12,-7.398635,x0434,active-noncovalent
CC(C)Cn1cnc2c1c(=O)n(c(=O)n2C)C,isbufylline,-7.397810,x0195,active-noncovalent
CSCC[C@H](C(=O)[O-])[NH3+],methionine,-7.397245,x0397,active-noncovalent
CNC(=O)c1ccccc1Nc2c(cnc(n2)Nc3ccc(cc3OC)N4CCOCC4)Cl,NVP-TAE226,-7.396210,x0161,active-noncovalent
CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)[O-])c5nc6ccccc6n5C)C,telmisartan,-7.395685,x0434,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)N(=O)=O,nimesulide,-7.393459,x0678,active-noncovalent
CN/C(=C\N(=O)=O)/[NH2+]CCSCc1csc(n1)C[NH+](C)C,nizatidine,-7.392585,x0104,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)/C=C/C#N,BAY-11-7085,-7.392424,x0749,active-covalent
C(CCC(=O)[O-])CC(=O)[O-],adipic-acid,-7.392212,x0397,active-noncovalent
Cc1cc(c(c(=O)[nH]1)CNC(=O)c2c(n(c3c2cccc3)[C@H](C)C4CCOCC4)C)OC,CPI-360,-7.391708,x0104,active-noncovalent
C[C@@H]([C@H](C)O)[C@@H](C(=O)[O-])[NH3+],ID-1101,-7.390915,x1077,active-noncovalent
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl,clobetasol-propionate,-7.389101,x0072,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)[N-]C(=O)CCl)OC)C,TNP-470,-7.387981,x0749,active-covalent
C1CCC(CC1)[NH2+]C2CCCCC2,dicyclohexylamine,-7.387631,x0678,active-noncovalent
COc1ccc(cc1OC)C[C@@H]2c3cc(c(cc3CC[NH2+]2)OC)OC,tetrahydropapaverine,-7.386902,x0195,active-noncovalent
Cc1c2cnc(nc2n(c(=O)c1C(=O)C)C3CCCC3)Nc4ccc(cn4)N5CC[NH2+]CC5,palbociclib,-7.386431,x0161,active-noncovalent
c1cc2cnccc2cc1NC(=O)NCC(=O)N3CCCC3,SGC-707,-7.385285,x0946,active-noncovalent
C(CCC(=O)[O-])CC[NH3+],aminocaproic-acid,-7.383017,x0734,active-covalent
CC[NH2+]C1(CCN(CC1)c2c3c(ncn2)n(c(n3)c4ccccc4Cl)c5ccc(cc5)Cl)C(=O)N,"CP-945,598",-7.382950,x1392,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)Cl,clofibric-acid,-7.382083,x0692,active-covalent
c1cc(c(cc1Cl)Cl)OCC(=O)N2CCC(CC2)NC(=O)CCCS,K-Ras(G12C)-inhibitor-6,-7.380242,x0161,active-noncovalent
CC(=O)NC1=[NH+]N([C@](S1)(C)c2ccccc2)C(=O)C,K-858,-7.379666,x0831,active-covalent
CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C,CPI-1189,-7.379025,x0749,active-covalent
c1ccc(cc1)c2ccc(cc2)NC(=O)c3ccccc3C(=O)[O-],kartogenin,-7.377553,x0967,active-noncovalent
C[C@H](Cc1cc2c(c(c1)C(=O)N)[N@@](CC2)CCCO)[NH2+]CCOc3ccccc3OCC(F)(F)F,silodosin,-7.377306,x1093,active-noncovalent
CCCCC1(C(=O)N(N(C1=O)c2ccccc2)c3ccccc3)COC(=O)CCC(=O)[O-],suxibuzone,-7.377217,x0678,active-noncovalent
COc1cc(ccc1O)CC=C,eugenol,-7.374389,x0161,active-noncovalent
CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)Cc2ccccc2,DVD-111,-7.374214,x0072,active-noncovalent
CC[C@@H]1[C@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@@]4([C@H]([C@@H]3[C@H]1O)CC[C@@H]4[C@H](C)CCC(=O)[O-])C)C)O,obeticholic-acid,-7.373323,x1077,active-noncovalent
CCOC(=O)C1=C(N(C(=C([C@H]1c2cccc(c2)N(=O)=O)C(=O)OC)C)CC#C)C,MRS1845,-7.373179,x0678,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,ursodiol,-7.370848,x0072,active-noncovalent
CC(C)[NH+](CCNC(=O)CN1CCCC1=O)C(C)C,pramiracetam,-7.370676,x0831,active-covalent
CN(C)c1c(nc(c(n1)N)C(=O)Nc2cccnc2)Cl,ACDPP,-7.370589,x0397,active-noncovalent
c1cc(c(cc1Cl)Cl)C(=O)NS(=O)(=O)c2ccc(s2)Br,tasisulam,-7.369979,x0195,active-noncovalent
Cc1cccc(c1NC(=O)[C@@H](C)[NH3+])C,tocainide,-7.368019,x0195,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)[N@@](C)c4cccc(c4)Cl)/[nH]c(=C)c1C(=O)N5CC[NH+](CC5)C,SU-11274,-7.367474,x0161,active-noncovalent
CCCCCCCCCCCCOS(=O)(=O)[O-],dodecyl-sulfate,-7.366870,x0161,active-noncovalent
c1ccc(cc1)C(=O)NCC(=O)[O-],hippuric-acid,-7.366289,x0107,active-noncovalent
c1ccc(cc1)Cn2cc(c3c2ccc(c3)c4ccc(cc4)OC(F)(F)F)C(=O)C(=O)[O-],tiplaxtinin,-7.365982,x0161,active-noncovalent
Cc1ccc(cc1)c2nc(on2)CSc3nnc(n3c4ccc(cc4)OC)c5ccncc5,JW-74,-7.365215,x0946,active-noncovalent
CN1[C@H](S(=O)(=O)CCC1=O)c2ccc(cc2)Cl,chlormezanone,-7.365206,x0072,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)[nH]c(n2)Br,pamabrom,-7.364717,x0678,active-noncovalent
COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O,genipin,-7.364646,x0161,active-noncovalent
C[C@@H](c1nc(cs1)c2ccc(cc2)C#N)[C@](Cn3cncn3)(c4ccc(cc4F)F)O,ravuconazole,-7.363572,x0874,active-noncovalent
CC[NH+](CC)CCOc1ccc-2c(c1)C(=O)c3c2ccc(c3)OCC[NH+](CC)CC,tilorone,-7.363031,x0434,active-noncovalent
CC(C)(c1cccc(n1)n2c3c(cnc(n3)Nc4ccc(cc4)N5CC[NH+](CC5)C)c(=O)n2CC=C)O,MK-1775,-7.361495,x0104,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)C[C@H](CC[C@@H](C(=O)[O-])[NH3+])[NH3+])O)O)N,sinefungin,-7.360650,x1093,active-noncovalent
C[C@]1(c2cccc(c2C(=C3[C@@H]1[C@@H]([C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)O)[O-])O)O,oxytetracycline,-7.360538,x0831,active-covalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H](C(=C2F)CO)O)O,RX-3117,-7.358811,x0678,active-noncovalent
C[C@@](CS(=O)(=O)c1ccc(cc1)F)(C(=O)Nc2ccc(c(c2)C(F)(F)F)C#N)O,bicalutamide,-7.358737,x0434,active-noncovalent
CC/[NH+]=C\1/N[C@@H]2[C@H]([C@@H]([C@H](O[C@@H]2S1)CO)O)O,thiamet-g,-7.357924,x0195,active-noncovalent
CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)O,isoflupredone-acetate,-7.357622,x0967,active-noncovalent
CCN1C[C@@H](n2c3c(c(c2C1=O)[O-])c(=O)n(nc3C(=O)NC)Cc4ccc(c(c4)Cl)F)C,MK-2048,-7.356881,x0161,active-noncovalent
CCN(c1ccccc1)C(=O)c2c(c3c(cccc3Cl)n(c2=O)C)[O-],laquinimod,-7.356830,x0161,active-noncovalent
CSC[C@@H]1CN(C(=O)O1)/N=C/c2ccc(o2)N(=O)=O,inimur,-7.356424,x0749,active-covalent
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)[O-],captopril,-7.356261,x0397,active-noncovalent
c1cc(ccc1N)S(=O)(=O)[N-]C(=O)N,sulfacarbamide,-7.356099,x0395,active-noncovalent
[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O,tartaric-acid,-7.354960,x0397,active-noncovalent
CC(=O)O[C@@H]1[C@@H](Sc2ccccc2N(C1=O)CC[NH+](C)C)c3ccc(cc3)OC,diltiazem,-7.354584,x0874,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3c4c2[C@H]5[C@@]67CC[N@@H+]([C@@H]([C@@]6(C4)O)Cc8c7c(c(cc8)O)O5)CC9CC9,N-benzylnaltrindole,-7.354385,x0434,active-noncovalent
CC[NH2+][C@]1(CCCCC1=O)c2cccs2,tiletamine,-7.354254,x0195,active-noncovalent
Cc1cc(nc(n1)n2c(cc(n2)C)OC)OC,epirizole,-7.353932,x0434,active-noncovalent
C[C@H]1Cc2cc3c(c(c2-c4c(cc(c(c4OC)OC)OC)C[C@@H]1C)OC)OCO3,schisandrin-b,-7.353252,x0195,active-noncovalent
C[C@]1([C@@H]([C@H](O[C@H]1n2cnc3c2nc([nH]c3=O)N)CO)O)O,2'-c-methylguanosine,-7.353133,x0874,active-noncovalent
C[NH+]1CCN(CC1)Cc2ccc(cc2)Nc3ncc(c(n3)Nc4ccccc4S(=O)(=O)N(C)C)Cl,TP-0903,-7.350684,x0161,active-noncovalent
C[NH2+][C@H]1C[C@H]([C@@H]([C@H]([C@@H]1O)O[C@H]2[C@H]([C@@H]3[C@H]([C@H](O2)CO)O[C@]4(O3)[C@@H]([C@H]([C@H]([C@H](O4)[C@@H](CO)[NH3+])O)O)O)O)O)[NH3+],hygromycin-b,-7.349528,x1093,active-noncovalent
CCN(CC)C(=S)SSC(=S)N(CC)CC,disulfiram,-7.349272,x0195,active-noncovalent
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5ccc(c(c5c4)C[NH+](C)C)O)O,topotecan,-7.348374,x0678,active-noncovalent
CC(=O)SC[C@@H](Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2,racecadotril,-7.347688,x0946,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)[O-],enoxolone,-7.343379,x0104,active-noncovalent
CCCCOc1cc(ccc1OC)C[C@H]2CNC(=O)N2,Ro-20-1724,-7.343188,x0678,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2,tetrahydrofolic-acid,-7.342076,x0104,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)[NH3+],ribostamycin-sulfate,-7.340278,x0195,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)[O-])O)O)O)O)O)O,calcium-gluceptate,-7.338240,x0397,active-noncovalent
C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)[O-])O)O)O)O)O)O,sodium-glucoheptonate,-7.338240,x0397,active-noncovalent
CCCCCCCC(=O)N[C@H](C[NH+]1CCCC1)[C@@H](c2ccc3c(c2)OCCO3)O,eliglustat,-7.336362,x0161,active-noncovalent
C[C@]1(C(=O)C=C(O1)C(=O)[O-])c2ccccc2,acifran,-7.335707,x0072,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCOCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)I,AM-281,-7.334095,x0161,active-noncovalent
C[N+](C)(C)C[C@@H](CC(=O)[O-])O,levocarnitine,-7.333771,x0830,active-covalent
[H]/N=C(/NCCC[C@@H](C(=O)[O-])[NH3+])\NN(=O)=O,NG-nitro-arginine,-7.333673,x0678,active-noncovalent
Cc1c(c(=O)n(c(=O)n1Cc2c(cccc2F)C(F)(F)F)C[C@@H](c3ccccc3)[NH2+]CCCC(=O)[O-])c4cccc(c4F)OC,elagolix,-7.333425,x0072,active-noncovalent
Cc1nc(cs1)/C=C(\C)/[C@@H]2C/C=C(\CCC[C@@H]([C@@H]([C@H](C(=O)C([C@H](CC(=O)O2)O)(C)C)C)O)C)/C,epothilone-d,-7.333379,x1077,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCC[N@H+](C2)Cc3ccccc3)c4cccc(c4)N(=O)=O)C(=O)OC,benidipine,-7.331946,x0161,active-noncovalent
CC(=O)N[C@H]1CCc2cc(c(c(c2-c3c1cc(=O)c(cc3)OC)OC)OC)OC,colchicine,-7.331703,x0874,active-noncovalent
C1[C@H]([C@H]([C@H]([C@@H]([N@H+]1CCO)CO)O)O)O,miglitol,-7.331421,x0946,active-noncovalent
Cc1cnc(s1)NC(=O)C2=C(c3ccccc3S(=O)(=O)[N@]2C)O,meloxicam,-7.331417,x0195,active-noncovalent
c1ccc(c(c1)C(=O)[O-])[S-],o-mercapto-benzoic-acid,-7.330590,x0195,active-noncovalent
C=c1c(=O)/c(=C\[O-])/c(c[nH]1)COP(=O)([O-])[O-],MC-1,-7.330033,x0397,active-noncovalent
CC1=CC[C@@H](CC1)C(=C)C,D-limonene,-7.329607,x0678,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)n(cn2)CC(=O)Nc3ccc(nn3)c4ccccc4,ETC-159,-7.329115,x0104,active-noncovalent
Cc1cc(cc(c1Oc2c(c(nc(n2)Nc3ccc(cc3)C#N)N)Br)C)C#N,etravirine,-7.328958,x0195,active-noncovalent
Cc1cc(c2cc(cc(c2n1)F)F)NC(=O)Nc3ccc(cc3)N(C)C,SB-408124,-7.324407,x0967,active-noncovalent
c1ccc2c(c1)COC23CC[NH+](CC3)CCCCc4cn(c5c4cccc5)c6ccc(cc6)F,siramesine,-7.323810,x0161,active-noncovalent
Cc1cn2c(c(cc(c2[nH+]1)C(=O)NCC3CC[NH+](CC3)CC(C)C)Cl)N,CJ-033466,-7.322286,x0967,active-noncovalent
C1C[N@@](C[C@H]([NH2+]1)C(=O)[O-])CCCP(=O)([O-])[O-],CPP,-7.321845,x0759,active-covalent
CC(=O)CCc1ccc(c(c1)OC)O,vanillylacetone,-7.321841,x0161,active-noncovalent
C[C@H](C(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)[O-])Oc3ccccc3,phenethicillin,-7.321492,x0072,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)OCOC(=O)C(C)(C)C)C,sulbactam-pivoxil,-7.319220,x0749,active-covalent
CC(C)CCNc1c(cccn1)C(=O)N2CC[NH+](CC2)Cc3ccccc3,NSI-189,-7.319119,x0874,active-noncovalent
CC(=O)c1ccc(c(c1)OC)O,apocynin,-7.318929,x0195,active-noncovalent
COC[C@H](Cn1ccnc1N(=O)=O)O,misonidazole,-7.317417,x0195,active-noncovalent
CCn1c2ccccc2n(c1=O)C3=C(C[N@@H+](CC3)CC4CCCCCCC4)CO,trap-101,-7.315215,x0161,active-noncovalent
Cc1ccc(c(=O)n1c2ccc(cc2)F)C(=O)Nc3ccc(c(c3)F)Oc4cc5cnn(c5cc4c6c[nH]nc6)C,LY2801653,-7.314072,x0104,active-noncovalent
Cc1cnc(nc1Nc2cccc(c2)S(=O)(=O)NC(C)(C)C)Nc3ccc(cc3)OCC[NH+]4CCCC4,TG-101348,-7.313903,x0874,active-noncovalent
CCN(CC)c1cc(nc2n1ncn2)C,trapidil,-7.313612,x0195,active-noncovalent
Cc1cc(c(c(c1)C)NS(=O)(=O)c2ccc(cc2)OC)C,GSK-37647,-7.313596,x0749,active-covalent
COc1ccc(cc1N2CC[NH2+]CC2)S(=O)(=O)Nc3cc(cc(c3OC)Cl)Cl,SB-399885,-7.311103,x0678,active-noncovalent
c1nc(nn1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,ribavirin,-7.309648,x0708,active-covalent
C([C@@H](C(=O)[O-])[NH3+])SSC[C@@H](C(=O)[O-])[NH3+],L-Cystine,-7.309270,x1418,active-covalent
CC(C)(CCCCCC(CCCCCC(C)(C)C(=O)[O-])O)C(=O)[O-],ETC-1002,-7.309196,x0874,active-noncovalent
c1cc2c(c(c1)N)c(=O)[nH][nH]c2=O,monosodium-alpha-luminol,-7.308018,x0195,active-noncovalent
CC(C)[N+](C)(CCC(c1ccccc1)(c2ccccc2)C(=O)N)C(C)C,isopropamide-iodide,-7.307547,x0195,active-noncovalent
C1[C@@H]2CC3(C[C@@H](C2=O)CC1C3)O,idramantone,-7.306119,x0354,active-noncovalent
C1CCC(CC1)NS(=O)(=O)[O-],cyclamic-acid,-7.305093,x0678,active-noncovalent
Cc1c(c2cc(ccc2n1C(=O)c3cccc(c3Cl)Cl)OC)CC[NH+]4CCOCC4,GW-405833,-7.304730,x0195,active-noncovalent
CCc1cccc(c1NC(=O)N2Cc3c([nH]nc3NC(=O)c4ccc(cc4)N5CC[NH+](CC5)C)C2)CC,PHA-680632,-7.304335,x0104,active-noncovalent
Cc1ccc(nc1c2cccc(c2)C(=O)[O-])NC(=O)C3(CC3)c4ccc5c(c4)OC(O5)(F)F,lumacaftor,-7.303419,x0104,active-noncovalent
c1c(ccc(c1)N2C(=O)c3c(ncnc3N)OCC2)[C@H]4CC[C@@H](CC4)CC(=O)[O-],PF-04620110,-7.302903,x1077,active-noncovalent
CCn1cnc(c1C(=O)NC)C(=O)NC,ethimizol,-7.301723,x0195,active-noncovalent
CCCN(CC1CC1)c2c(c(nc(n2)C)Nc3c(cc(cc3Cl)Cl)Cl)Cl,NBI-27914,-7.301192,x0874,active-noncovalent
C(CCCC(=O)NCCO)CCCC(=O)NCCO,adelmidrol,-7.298946,x0946,active-noncovalent
c1ccc2c(c1)C(=O)NS2(=O)=O,saccharin,-7.298658,x0678,active-noncovalent
CC1(c2ccc(cc2C(=O)N(C1=O)CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4)OC)C,gliquidone,-7.298075,x0161,active-noncovalent
COC[C@@]1(C(=O)C2CC[NH+]1CC2)CO,APR-246,-7.297840,x0354,active-noncovalent
CC[C@@H](C)SSc1[nH]ccn1,PX-12,-7.296520,x1093,active-noncovalent
c1ccc2c(c1)C(=O)c3ccccc3C2(Cc4ccnc(c4)F)Cc5ccnc(c5)F,DMP-543,-7.296119,x1077,active-noncovalent
CC(C)Nc1nc2cc(c(cc2n1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl,maribavir,-7.295496,x0749,active-covalent
C[C@@H]1COCC[N@@]1c2cc(nc(n2)c3ccnc4c3cc[nH]4)C5(CC5)[S@@](=N)(=O)C,AZD6738,-7.294543,x1412,active-covalent
CCOc1cc(ccc1OC)[C@@H](CS(=O)(=O)C)N2C(=O)c3cccc(c3C2=O)NC(=O)C,apremilast,-7.293816,x0874,active-noncovalent
CC(C)Nc1ncccn1,isaxonine,-7.293537,x1093,active-noncovalent
c1cc2c(cc1NC(=O)NCC(=O)N3CCCCC3)snn2,UNC-2327,-7.293296,x0434,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,theophylline,-7.292322,x0678,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,oxtriphylline,-7.292322,x0678,active-noncovalent
Cn1c2c(c(=O)n(c1=O)C)nc[nH]2,aminophylline,-7.292322,x0678,active-noncovalent
c1c([nH]cn1)CC[NH3+],histamine,-7.291480,x0397,active-noncovalent
C[C@@H](CCCC(C)(C)O)[NH3+],heptaminol,-7.290907,x0195,active-noncovalent
CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)[NH+]5CCOCC5)C)C)[N+]6(CCCC6)CC=C,rocuronium,-7.289984,x0104,active-noncovalent
CCn1c2c(cc(c1=O)c3ccc(cc3Cl)Cl)cnc(n2)Nc4ccc(c(c4)F)N5CC[NH2+]CC5,FRAX486,-7.289445,x0104,active-noncovalent
C1CS(=O)(=O)NC[N@@]1C[N@]2CCS(=O)(=O)NC2,taurolidine,-7.289390,x1077,active-noncovalent
Cc1cc(c(c(c1)C)S(=O)(=O)n2cc(cc2C)C)C,HJC-0350,-7.288846,x1311,active-covalent
CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,crystal-violet,-7.288476,x0072,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)[O-],bardoxolone,-7.287426,x0072,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,telbivudine,-7.287242,x1077,active-noncovalent
Cc1c(cc(cc1N(=O)=O)N(=O)=O)C(=O)N,dinitolmide,-7.283859,x0195,active-noncovalent
CC[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)NCc3ccccc3,roscovitine,-7.283674,x0195,active-noncovalent
c12c([nH]c(=O)[nH]1)[nH]c(=O)[nH]c2=O,uric-acid,-7.283333,x0678,active-noncovalent
c1ccc-2c(c1)CCCc3c2nnc(c3)NCC[NH+]4CCOCC4,SR-95639A,-7.282874,x1077,active-noncovalent
c1cc(ccc1[C@H](CCO)NC(=O)C2(CCN(CC2)c3c4cc[nH]c4ncn3)[NH3+])Cl,AZD5363,-7.282774,x0678,active-noncovalent
CCCCC#Cc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC,HEMADO,-7.281894,x0161,active-noncovalent
CC[N+](C)(CC)CCOC(=O)[C@](c1ccccc1)(C2CCCCC2)O,oxyphenonium,-7.281858,x0195,active-noncovalent
CC1(CCC(c2c1cc(c(c2Cl)O)C(=O)Nc3cc(c(c(c3)F)C(=O)[O-])F)(C)C)C,AGN-195183,-7.281340,x0104,active-noncovalent
CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C,tolbutamide,-7.279900,x0434,active-noncovalent
C[NH+]1CCN(CC1)C(=O)C[NH2+][C@@H]2C[C@H]2c3ccc(cc3)OCc4ccccc4,RN-1,-7.279611,x0104,active-noncovalent
CC(C)(C)CC(C)(C)c1ccc(cc1)O,tyloxapol,-7.277876,x0195,active-noncovalent
C/C=C/c1cc(c(cc1OC)OC)OC,alpha-Asarone,-7.277765,x0195,active-noncovalent
c1cncnc1C#N,4-pyrimidinecarbonitrile,-7.277214,x0540,active-noncovalent
c1c(nc(c(=O)[nH]1)C(=O)N)F,favipiravir,-7.276232,x0397,active-noncovalent
c1nc(c2c(n1)n(cn2)CCOCP(=O)([O-])[O-])N,adefovir,-7.275754,x0072,active-noncovalent
CCn1cc(c(=O)c2c1nc(nc2)N3CCCC3)C(=O)[O-],piromidic-acid,-7.275673,x0749,active-covalent
CCNC(=O)N(CCC[NH+](C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4c3c(c[nH]4)C[C@H]2[N@@H+](C1)CC=C,cabergoline,-7.275115,x1077,active-noncovalent
CC(C)[C@@]1(CC[C@H](C1)[NH2+][C@H]2CCOC[C@H]2OC)C(=O)N3CCc4c(cc(cn4)C(F)(F)F)C3,MK-0812,-7.272387,x0161,active-noncovalent
Cc1cc(n(n1)c2ccccc2)NC(=O)Nc3ccc(c(c3)F)F,ML-297,-7.271844,x0967,active-noncovalent
c1ccc2c(c1)[C@@H](N(C2=O)C3CCOCC3)C(=O)NCc4ccc(cc4)OC(F)(F)F,NAV-26,-7.271275,x0831,active-covalent
CC[N+](C)(C)Cc1ccccc1Br,bretylium,-7.271035,x0161,active-noncovalent
c1c(nc[nH]1)/C=C/C(=O)[O-],cis-urocanic-acid,-7.270299,x0678,active-noncovalent
CCC/[NH+]=C\1/N(C(=O)/C(=C/c2ccc(c(c2)Cl)OC[C@@H](CO)O)/S1)c3ccccc3C,ponesimod,-7.269185,x1077,active-noncovalent
[C@@H]1(C(=O)C(=C(C(=O)C1=O)[O-])[O-])O,tetroquinone,-7.266967,x0397,active-noncovalent
CCC(=O)c1cc(n(c1C)c2ccc(cc2)S(=O)(=O)N)c3ccc(cc3)Cl,A-867744,-7.266709,x0305,active-noncovalent
Cn1cc[nH]c1=S,methimazole,-7.266704,x0678,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@H](c3ccccc3)C(=O)[O-])C(=O)[O-])C,carbenicillin,-7.266460,x1077,active-noncovalent
C[C@]1(c2c(ccc(c2C(=C3[C@@H]1C[C@H]4[C@@H](C(=O)C(=C([C@]4(C3=O)O)[O-])C(=O)N)[NH+](C)C)[O-])O)Cl)O,chlortetracycline,-7.265966,x0831,active-covalent
c1cc(cnc1)C(=O)[O-],niacin,-7.265731,x0397,active-noncovalent
C[C@H](c1ncc(s1)C(=O)Nc2cc(c(cn2)Cl)C(F)(F)F)NC(=O)c3c(c(ncn3)N)Cl,MLN2480,-7.265237,x0104,active-noncovalent
C[NH+](C)CCCOc1cc(n(n1)Cc2ccccc2)C(=O)Nc3ccc(cc3)OC,CFM-1571,-7.264049,x1077,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@H]1CC[C@@H]2O)OC(=O)N(CCCl)CCCl,estramustine,-7.263798,x0104,active-noncovalent
Cc1ccc(cc1Nc2ccc\3c(c2)NC(=O)/C3=C\c4ccc[nH]4)NC(=O)Nc5cc(ccc5F)C(F)(F)F,GNF-5837,-7.263728,x0072,active-noncovalent
C1CC(=O)N[C@@H]1C(=O)N2CSC[C@H]2C(=O)[O-],pidotimod,-7.263474,x0678,active-noncovalent
c1ccnc(c1)C(=O)Nc2ccc(c(c2)Cl)Oc3ccc(cn3)Cl,VU-0422288,-7.260602,x0072,active-noncovalent
CCCCC[NH2+]CC(=O)N,milacemide,-7.258897,x0678,active-noncovalent
CC1=C(C(CC=C1)(C)C)C=O,safranal,-7.258222,x0678,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)O[C@H]5[C@@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,ginkgolide-b,-7.257959,x0874,active-noncovalent
CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,brivaracetam,-7.257905,x0749,active-covalent
Cc1csc2c1ncnc2N[C@@H](C)C[NH+]3CCN(CC3)S(=O)(=O)c4ccc(c(c4)Cl)Cl,LPA2-antagonist-1,-7.257020,x0107,active-noncovalent
CC(C)[NH2+]CC[N@](C(C)C)S(=O)(=O)c1ccc(cc1Cl)Cl,RN-1734,-7.256175,x0678,active-noncovalent
c1coc2c1[nH]c(c2)C(=O)[O-],SEP-227900,-7.255233,x0195,active-noncovalent
C[C@]12CC[C@H](C1(C)C)[C@H](C2=O)Br,3-bromocamphor,-7.253036,x0354,active-noncovalent
c1cc2c(cc1/C=C/N(=O)=O)OCO2,"MNS-(3,4-Methylenedioxy-nitrostyrene)",-7.252650,x0749,active-covalent
CC(C)(C(=O)[O-])Oc1ccc(cc1)CCNC(=O)c2ccc(cc2)Cl,bezafibrate,-7.252120,x0195,active-noncovalent
CS(=O)(=O)[N@@]1CCc2c1nc(nc2c3cnc(nc3)N)N4CCOCC4,CH5132799,-7.252045,x0678,active-noncovalent
C[C@H]1CCNC(=[NH2+])S1,aminomethyltransferase,-7.251394,x1077,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)CCOC(c3ccccc3)c4ccccc4,GBR-12783,-7.250877,x0195,active-noncovalent
C[C@@H]1C[N@@H+](C[C@H]1c2[nH]c(=O)c3cnn(c3n2)C4CCOCC4)Cc5ncccn5,PF-04447943,-7.250768,x0107,active-noncovalent
c1cc(ccc1[C@](C[NH3+])(CS(=O)(=O)[O-])O)Cl,2-hydroxysaclofen,-7.250540,x0161,active-noncovalent
CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(cc2)Cl,fenofibrate,-7.249400,x1077,active-noncovalent
c1nc2c(nc(nc2n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)N,2-chloroadenosine,-7.249277,x1412,active-covalent
Cn1cc(c2c1cccc2)C[NH2+]CC3CCN(CC3)c4ncc(cn4)C(=O)NO,JNJ-26481585,-7.249227,x0161,active-noncovalent
c1ccc(cc1)C(c2ccccc2)[NH2+]CCNC(c3ccccc3)c4ccccc4,AMN-082,-7.249079,x1077,active-noncovalent
c1cc(cnc1)CO,nicotinyl-alcohol-tartrate,-7.247877,x0397,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2C=O,calcium-levofolinate,-7.247639,x0395,active-noncovalent
c1c2c(cc(c1Cl)OC(F)(F)F)nc([nH]2)n3cc(cn3)C(=O)[O-],JNJ-42041935,-7.247526,x0678,active-noncovalent
CC(C)(Cc1ccccc1)[NH2+]C,mephentermine,-7.247328,x0678,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COc3ccccc3)C(=O)[O-])C,penicillin-v-potassium,-7.247251,x0831,active-covalent
CCOc1cc(ccc1C(=O)[O-])CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3,repaglinide,-7.246802,x1077,active-noncovalent
C(C[C@H](C(=O)[O-])[NH3+])CNC(=O)N,L-Citrulline,-7.245191,x0830,active-covalent
CCCCCCOc1c(nsn1)C2=CCC[N@@H+](C2)C,xanomeline,-7.245153,x0104,active-noncovalent
C=CC[NH+]1CCN(CC1)c2c(nc3ccccc3n2)C#N,3-AQC,-7.244846,x0874,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cccc3)NC(=O)Nc4ccccc4F,RSV604,-7.244839,x0874,active-noncovalent
CC[C@]1(C(=O)N(C(=O)N1)C)c2ccccc2,mephenytoin,-7.243958,x0434,active-noncovalent
CCOC(=O)n1ccn(c1=S)C,carbimazole,-7.243903,x0195,active-noncovalent
c1cc(c(cc1[C@H](C(=O)[O-])[NH3+])O)C(=O)[O-],4-carboxy-3-hydroxyphenylglycine-(RS),-7.242720,x0749,active-covalent
c1ccc(c(c1)C(=O)[O-])O,sodium-salicylate,-7.241326,x1093,active-noncovalent
c1ccc(c(c1)C(=O)[O-])O,salicylic-acid,-7.241326,x1093,active-noncovalent
c1cc2c(cccc2Cl)c(c1)S(=O)(=O)NCCCCCCCCCC[NH3+],A-7,-7.240339,x0749,active-covalent
CS(=O)(=O)n1cc2c(n1)C[N@@H+](C2)[C@@H]3C[C@@H]([C@H](OC3)c4cc(ccc4F)F)[NH3+],omarigliptin,-7.240102,x0072,active-noncovalent
CCc1cc(ccn1)C(=S)N,ethionamide,-7.240012,x0749,active-covalent
COc1cc(ccc1O)/C=C/C(=O)[O-],ferulic-acid,-7.238907,x0195,active-noncovalent
c1ccc2c(c1)C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O,thalidomide,-7.238844,x0195,active-noncovalent
CCCc1cc(ccn1)C(=S)N,protionamide,-7.238395,x1077,active-noncovalent
CCC(CC)[C@@H](c1ccc(cc1)Nc2nc3ccccc3s2)n4cncn4,talarozole,-7.238343,x0104,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])C(=O)N,L-asparagine,-7.237053,x0426,active-noncovalent
CCCCCC/C=C/C=C\CCCCCCCC(=O)[O-],"cis-9,trans-11-Conjugated-linoleic-acid",-7.236617,x0161,active-noncovalent
CC1(CCN(CC1)C(=O)Nc2nc3c(ccc(c3s2)N4CCOCC4)OC)O,tozadenant,-7.235772,x0161,active-noncovalent
C1CN(C(=[NH+]1)N)CC(=O)[O-],cyclocreatine,-7.235110,x1077,active-noncovalent
CN1[C@@H](CCC1=O)c2cccnc2,cotinine,-7.234568,x0195,active-noncovalent
CCOc1cc2c(cc1NC(=O)/C=C/C[NH+](C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)F,pelitinib,-7.233969,x0736,active-covalent
CCC(CC)CC1(CCCCC1)C(=O)Nc2ccccc2SC(=O)C(C)C,dalcetrapib,-7.233555,x0874,active-noncovalent
C[N@H+]1CCC=C(C1)C(=O)OC,arecoline,-7.232696,x0104,active-noncovalent
COCCC[NH+]1CCC(CC1)NC(=O)c2cc(c(c3c2OCC3)N)Cl,prucalopride,-7.232248,x1077,active-noncovalent
Cc1cccc(c1)C/N=N/c2cc(n3c(n2)cc(n3)c4ccncc4)N5CCOCC5,APY0201,-7.231820,x0161,active-noncovalent
C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)c4c(ccc(c4C(=C3C(=O)[C@@]2(C(=O)C(=C1[O-])C(=O)N)O)[O-])O)Cl)O,meclocycline-sulfosalicylate,-7.229702,x0831,active-covalent
C[C@@H](CCCC(C)C)[NH3+],octodrine,-7.227858,x0195,active-noncovalent
CCCCCCCCCCCCCCCc1cccc(c1)OCC(=O)NCCO,PDP-EA,-7.227537,x0104,active-noncovalent
CC(=O)Nc1ccccc1,acetanilide,-7.226410,x0195,active-noncovalent
CCC(=O)N(c1ccccc1)C2(CC[NH+](CC2)CCc3cccs3)COC,sufentanil,-7.224805,x0072,active-noncovalent
CN(C)c1ccccc1C[N@H+]2CCC[N@]([C@@H]2c3ccncc3)Cc4ccccc4N(C)C,GANT-61,-7.224788,x0874,active-noncovalent
c1ccc(cc1)c2cc(n(n2)c3ccccc3)NC(=O)c4ccc(cc4)N(=O)=O,VU29,-7.222107,x0104,active-noncovalent
Cc1cc(cc(c1N)C)Oc2ccc3c(c2)n(c(n3)COc4ccc(cc4)C[C@H]5C(=O)[N-]C(=O)S5)C,efatutazone,-7.221126,x0104,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@@H]3CCCO3)N,SQ-22536,-7.220680,x0195,active-noncovalent
COc1ccc(cc1OC)CC[NH2+]Cc2ccc(c(c2)OC)OCc3ccc(nc3)Cl,SBE-13,-7.220505,x0104,active-noncovalent
Cc1c(nc(n1c2ccc(cc2)OC(F)(F)F)C)C#Cc3ccnc(c3)Cl,CTEP,-7.218218,x0104,active-noncovalent
CC(=O)NCCCCCC(=O)[O-],acexamic-acid,-7.216861,x0749,active-covalent
c1cc2c(c(c1)OCC(COc3cccc4c3c(=O)cc(o4)C(=O)[O-])O)c(=O)cc(o2)C(=O)[O-],cromoglicic-acid,-7.216455,x0104,active-noncovalent
C[C@@H]([C@@H]([C@H]1CNc2c(c(=O)[nH]c(n2)N)N1)O)O,sapropterin,-7.216211,x0195,active-noncovalent
C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)[O-])C)C)(C)C)O,oleanolic-acid,-7.215147,x0678,active-noncovalent
CC[C@](CC(=O)N)(c1ccccc1)O,3-hydroxy-3-phenylpentanamide,-7.214869,x1077,active-noncovalent
C([C@@H](C(=O)[O-])S)C(=O)[O-],mercaptosuccinic-acid,-7.214594,x0397,active-noncovalent
CN(C[C@H](CO)O)C(=O)c1c(c(c(c(c1I)NC(=O)COC)I)C(=O)NC[C@H](CO)O)I,iopromide,-7.213267,x1077,active-noncovalent
c1cc(ccc1C[C@@H](C(=O)[O-])/N=C\2/[C@@H](C(=O)C23CCCCC3)Br)Nc4c5cnccc5ccn4,CT-7758,-7.213022,x1077,active-noncovalent
Cc1c(c(=O)n2ccccc2n1)CC[NH+]3CCC(CC3)C(=O)c4ccc(cc4)F,pirenperone,-7.212084,x1077,active-noncovalent
c1cc(c2c(c1)ncc(n2)c3cnn(c3)C4CC[NH2+]CC4)c5cc(c(c(c5)F)C[NH+]6CCOCC6)F,NVP-BSK805,-7.212049,x0161,active-noncovalent
CN(CC(=O)[O-])C(=[NH2+])N,creatine,-7.211684,x0107,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2c3nc(cs3)C(=O)c4ccc(cc4)F)[NH2+]C,LCL-161,-7.211381,x1077,active-noncovalent
CCCn1c2c(c(=O)[nH]c1=O)nc[nH]2,enprofylline,-7.211030,x0397,active-noncovalent
CC(C)(C)C(=O)NCCCC(=O)[O-],pivagabine,-7.209982,x0397,active-noncovalent
CC(C)(C)c1ccc(cc1)C(=O)Nc2cn3cc(ccc3[nH+]2)n4ccnc4,TC-ASK-10,-7.209290,x0104,active-noncovalent
c1nc(nc(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)N,decitabine,-7.208980,x0397,active-noncovalent
CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2N(=O)=O)C(=O)OC,nifedipine,-7.208480,x0946,active-noncovalent
C[N@H+]1CC[C@H](C[C@@H]1c2[nH]c3ccccc3n2)NC(=O)Nc4ccc(cc4)C#N,glasdegib,-7.205805,x0104,active-noncovalent
CCCC(C)(COC(=O)N)COC(=O)N,meprobamate,-7.205605,x1077,active-noncovalent
Cc1c(ccc(c1F)S(=O)(=O)C)C(=O)N2CCOc3ccc(cc3C2)c4ccc(nc4)N,XL388,-7.205416,x0107,active-noncovalent
CCC1(C(=O)NC(=O)N(C1=O)C)CC,metharbital,-7.205359,x0678,active-noncovalent
CCCCCCCCCCCCCC(=O)O,miriplatin,-7.203644,x0161,active-noncovalent
C[NH+]1CCC(CC1)NC(=O)c2cc(on2)c3c(cc(cc3Oc4ccc(cc4)N(=O)=O)O)O,NMS-E973,-7.203517,x1077,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)CNC(=O)c2cc(c(c(c2)OC)OC)OC,trimethobenzamide,-7.202495,x0161,active-noncovalent
c1c(c(nc(=O)n1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)N)I,fiacitabine,-7.201056,x0195,active-noncovalent
C[C@H](c1ccccn1)[NH2+]NC(=S)/N=N/C(=S)Nc2ccccc2Cl,N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)h,-7.200891,x0397,active-noncovalent
c1cc(ccc1C(=O)NCC(=O)[O-])N,4-aminohippuric-acid,-7.200277,x0107,active-noncovalent
C/C(=N\NC(=O)[C@@H](c1c2ccccc2c(=O)[nH]n1)NC(=O)c3ccccc3)/c4cccc(c4)Br,AC-55541,-7.200106,x0678,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2NC(=O)c3cccc(c3)OC)C(=O)OC,WDR5-0103,-7.199833,x0104,active-noncovalent
CC1(C(=O)Nc2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)C,R406,-7.199767,x0195,active-noncovalent
CC(Oc1ccc(cc1)O)(P(=O)([O-])[O-])P(=O)([O-])[O-],L-690330,-7.198024,x0678,active-noncovalent
c1[nH]c(c(n1)C(=O)N)O,SM-108,-7.196554,x0678,active-noncovalent
C1C=CN(C=C1C(=O)N)CC(=O)N,caricotamide,-7.195629,x0104,active-noncovalent
C[C@@H]1CCC[C@@H](N1NC(=O)c2ccc(c(c2)S(=O)(=O)N)Cl)C,clopamide,-7.195360,x0678,active-noncovalent
COc1cc2c(cc1C(=O)N)c(ccn2)Oc3ccc(c(c3)Cl)NC(=O)NC4CC4,lenvatinib,-7.194967,x0072,active-noncovalent
Cc1c(onc1C2CC[NH+](CC2)CCc3ccccc3)c4ccc(cc4)Cl,L-741742,-7.194885,x0161,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)Cc3ccc4c(c3)OCO4,piribedil,-7.194218,x0104,active-noncovalent
COc1ccc(cc1N)CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,ON-01500,-7.193934,x0072,active-noncovalent
CCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,levocarnitine-propionate,-7.193191,x0734,active-covalent
c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,inosine,-7.192561,x1077,active-noncovalent
C[C@@H]1CO/C(=[NH+]\c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5nccs5)/N1,ARRY-334543,-7.192212,x0395,active-noncovalent
CC1(Cc2cnc(nc2-c3c1c(nn3C)C(=O)NC)Nc4ccc(cc4)N5CC[NH+](CC5)C)C,PHA-848125,-7.190920,x0104,active-noncovalent
C[C@H]1CC[C@@H]2[C@]13CC[C@@]([C@H](C3)C2(C)C)(C)O,cedrol,-7.189905,x0678,active-noncovalent
CC(=O)Nc1cccc(c1)O,metacetamol,-7.189803,x0195,active-noncovalent
CNC(=O)c1cc(ccn1)COc2c3c(cco3)c(nn2)Nc4ccc(cc4)Cl,telatinib,-7.187358,x0072,active-noncovalent
COc1cc(nc(n1)O[C@H](C(=O)[O-])C(c2ccccc2)(c3ccccc3)OC)OC,darusentan,-7.187346,x0195,active-noncovalent
C[NH+](C)CCCSC(=[NH2+])N,dimaprit,-7.186809,x0195,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC,pentobarbital,-7.186369,x0678,active-noncovalent
C[N@H+]1CC[C@H](C1)Oc2cc(ccc2C(F)(F)F)NS(=O)(=O)c3cc(c(cc3Br)OC)OC,SB-706375,-7.185539,x0161,active-noncovalent
C(C[NH3+])C(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],pamidronate,-7.184543,x0397,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2c(c(cc(c2OC)Cl)Cl)O,raclopride,-7.183842,x0195,active-noncovalent
CCOc1ccccc1OCC[NH2+][C@H](C)Cc2ccc(c(c2)S(=O)(=O)N)OC,tamsulosin,-7.183609,x0072,active-noncovalent
CCOc1ccccc1C(=O)N,ethenzamide,-7.182890,x0195,active-noncovalent
CCCc1c(ccc(c1O)C(=O)C)OCCCOc2ccc(cc2)OCC(=O)[O-],L-165041,-7.182696,x0104,active-noncovalent
CCc1ccc(cc1)C2=CC(Sc3c2cc(cc3)C#Cc4ccc(cc4)C(=O)[O-])(C)C,AGN-194310,-7.182004,x0072,active-noncovalent
CC(C)[C@@H]1[C@H]2CC[C@H](C2)[C@H]1[NH3+],AGN-192403,-7.181125,x1382,active-covalent
C[C@@H](OC(=O)C(C)C)OC(=O)NCC1(CCCCC1)CC(=O)[O-],gabapentin-enacarbil,-7.180681,x1093,active-noncovalent
CCOC(=O)Nc1cc(nn2c1nnc2C)c3ccc(c(c3)NS(=O)(=O)C)C,bromosporine,-7.179783,x0072,active-noncovalent
COc1cc(ccc1)/C=N/N=C/c2cc(ccc2)OC,DMeOB,-7.179430,x0104,active-noncovalent
c1ccc(cc1)CCNN,phenelzine,-7.177473,x0195,active-noncovalent
CCOC(=O)c1cc(c(nc1C)N2CCC(CC2)C(=O)NS(=O)(=O)Cc3ccccc3)C#N,AZD1283,-7.177125,x0104,active-noncovalent
CC(C)(C)[C@@H]1CCc2c(sc(c2C(=O)[O-])NC(=O)c3ccco3)C1,CaCCinh-A01,-7.177065,x0749,active-covalent
CC(C)(C)c1c(c(=O)[nH]o1)C[C@@H](C(=O)[O-])[NH3+],ATPA,-7.176110,x0195,active-noncovalent
CC(C)(C)[NH2+]C[C@@H](c1cc(c(c(c1)Cl)N)Cl)O,clenbuterol,-7.176079,x0749,active-covalent
C[C@@H](C[NH+](CCN(C[C@@H](C)O)C[C@@H](C)O)C[C@H](C)O)O,editol,-7.176039,x1077,active-noncovalent
CC(C)n1c2ccc(cc2nn1)C(=O)[O-],IBC-293,-7.175660,x0708,active-covalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N,mizoribine,-7.173338,x0195,active-noncovalent
C[C@@H]1C[N@@H+]([C@H](CN1C(=O)c2cc3c(cc2Cl)n(cc3C(=O)C(=O)N(C)C)C)C)Cc4ccc(cc4)F,talmapimod,-7.173151,x0161,active-noncovalent
CCOc1cc2c(cc1NC(=O)/C=C/C[NH+](C)C)c(c(cn2)C#N)Nc3ccc(c(c3)Cl)OCc4cccc(c4)F,HKI-357,-7.172997,x0072,active-noncovalent
CCOc1cc(ccc1O)C=O,ethyl-vanillin,-7.171193,x0195,active-noncovalent
CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl,sorafenib,-7.169781,x0104,active-noncovalent
c1cc(c(c2c1nsn2)NC3=[NH+]CCN3)Cl,tizanidine,-7.166359,x0831,active-covalent
CCN(CC)C(=O)c1ccc(c(c1)OC)O,ethamivan,-7.165920,x0161,active-noncovalent
CC[NH+](CC)CC1CCN(CC1)c2ncc3c(n2)c(ncn3)Nc4ccc(c(c4)Cl)F,BIBU-1361,-7.165226,x0104,active-noncovalent
C[C@@H](CN1CC(=O)NC(=O)C1)[NH+]2CC(=O)NC(=O)C2,dexrazoxane,-7.161602,x0678,active-noncovalent
c1cc(ccc1C(=O)Nn2c(c3c(c2O)[C@H]4C=C[C@@H]3[C@H]5[C@@H]4C5)O)C(F)(F)F,tecovirimat,-7.160572,x1077,active-noncovalent
Cn1cnc2c1c(=O)n(c(=O)n2C)C,caffeine,-7.160553,x0195,active-noncovalent
c1ccc(cc1)/C=C/CN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4,cinnarazine,-7.158864,x0104,active-noncovalent
CC1=CC[C@H](C[C@@H]1O)C(C)(C)O,sobrepin,-7.158757,x0195,active-noncovalent
c1cc(c(cc1N)C(=O)[O-])O,mesalazine,-7.158207,x0397,active-noncovalent
C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)[C@H]3CCCO3)C(=O)[O-])O,faropenem,-7.157839,x0678,active-noncovalent
CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](CO)O,monostearin,-7.157495,x0072,active-noncovalent
C/C/1=C\CCC(=C)[C@H]2CC([C@@H]2CC1)(C)C,g-caryophyllene,-7.155902,x0195,active-noncovalent
CN(C)C(=[NH2+])c1ccc(cc1)C(=O)Nc2ccc(cc2C(=O)Nc3ccc(cn3)Cl)OC,betrixaban,-7.155660,x0161,active-noncovalent
Cc1cccc(c1O)C(=O)[O-],hydroxytoluic-acid,-7.154855,x0195,active-noncovalent
CCN(CC)S(=O)(=O)c1ccc(cc1)C(=O)[O-],etebenecid,-7.152837,x0749,active-covalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)I,idoxuridine,-7.152639,x0195,active-noncovalent
C[C@@]12CC[C@H]3[C@]([C@@]14[C@H](O4)C(=O)O[C@H]2c5ccoc5)(C(=O)C[C@@H]6[C@@]37COC(=O)C[C@@H]7OC6(C)C)C,limonin,-7.152341,x0104,active-noncovalent
C[C@]1([C@@H]2C[C@@H](C2(C)C)C[C@@H]1O)O,pinanediol,-7.151390,x0678,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2C[C@@H]([C@H](O2)CO)O,torcitabine,-7.150455,x0195,active-noncovalent
CC(C)c1cnn2c1nc(cc2NCc3ccccc3)NCCCCCC[NH3+],BS-181,-7.148095,x0161,active-noncovalent
C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,taurocholate,-7.146979,x1077,active-noncovalent
C[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)[nH]n3)c4ccc(cc4)F,aprepitant,-7.146827,x0104,active-noncovalent
CCOc1ccc(c2c1nccc2)S(=O)(=O)[O-],actinoquinol,-7.146725,x0195,active-noncovalent
Cc1cccn2c1ncc(c2=O)c3[n-]nnn3,pemirolast,-7.146090,x0195,active-noncovalent
CO/N=C/1\CN(C[C@@H]1C[NH3+])c2c(cc3c(=O)c(cn(c3n2)C4CC4)C(=O)[O-])F,gemifloxacin,-7.145956,x0874,active-noncovalent
COc1cccc(c1C2=NCc3cnc(nc3-c4c2cc(cc4)Cl)Nc5ccc(c(c5)OC)C(=O)[O-])F,alisertib,-7.144316,x0161,active-noncovalent
CC(C)C(=O)Oc1ccc(cc1[C@H](CC[NH+](C(C)C)C(C)C)c2ccccc2)CO,fesoterodine,-7.142383,x0967,active-noncovalent
Cc1cc(nn1Cc2ccnc(c2)N3CC[NH+](CC3)C4CC4)c5nc(no5)c6ccc(cc6)OC(F)(F)F,BAY-87-2243,-7.141499,x0104,active-noncovalent
CC[NH+](CC)CCNC(=O)c1cc(c(cc1OC)N)Cl,metoclopramide,-7.141313,x0830,active-covalent
CCCCCOC(=O)Nc1c(cn(c(=O)n1)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O)F,capecitabine,-7.139324,x0946,active-noncovalent
c1ccc(cc1)CCO,phenylethyl-alcohol,-7.138820,x0678,active-noncovalent
CCCCCCCCO,1-octanol,-7.137148,x0749,active-covalent
C=CC(=O)N1CCC[C@@H](C1)n2c3c(c(ncn3)N)n(c2=O)c4ccc(cc4)Oc5ccccc5,ONO-4059,-7.136615,x0104,active-noncovalent
CCOc1ccc(cc1)NC(=O)C,phenacetin,-7.136196,x0195,active-noncovalent
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)([O-])[O-],tenofovir,-7.134853,x0708,active-covalent
C(C[NH3+])C[NH2+]CCSP(=O)([O-])[O-],amifostine,-7.130889,x0708,active-covalent
c1ccc(cc1)c2cccc(c2)Cn3c(cnn3)c4cccc(c4)n5c6c(c(n5)c7ccc(cc7)Cl)c(ncn6)N,KB-SRC-4,-7.129788,x0161,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,cytarabine,-7.129302,x0107,active-noncovalent
c1ccc(c(c1)C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3nccs3)C(=O)[O-],phthalylsulfathiazole,-7.128944,x0104,active-noncovalent
CCN(CC)C(=O)N1CC[NH+](CC1)C,diethylcarbamazine,-7.128884,x0195,active-noncovalent
Cc1cccc(c1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,meclizine,-7.127591,x0195,active-noncovalent
CCOC(=O)Nc1ccc2c(c1)N(c3ccccc3S2)C(=O)CC[NH+]4CCOCC4,moracizine,-7.127420,x0195,active-noncovalent
C1CN[P@](=O)(OC1)N(CCCl)CCCl,cyclophosphamide,-7.126987,x0434,active-noncovalent
c1ccnc(c1)CC[NH3+],2-pyridylethylamine,-7.126884,x0195,active-noncovalent
c1cnc(nc1)N2CC[NH+](CC2)CCCCN3C(=O)CC4(CCCC4)CC3=O,buspirone,-7.126230,x0161,active-noncovalent
CC(C)[C@H]1c2ccc(cc2CC[C@@]1(CC[N@H+](C)CCCc3[nH]c4ccccc4n3)OC(=O)C5CC5)F,NNC-55-0396,-7.126084,x1077,active-noncovalent
Cc1c(cccc1Cl)S(=O)(=O)Nc2nc(cs2)CC(=O)N3CC[NH+](CC3)C,BVT-2733,-7.125951,x0678,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)/C(=C(/c2ccccc2)\Cl)/c3ccccc3,clomifene,-7.125950,x1077,active-noncovalent
CCCCCCCCCC[C@H]([C@H]1C=C[C@@H]2[C@H]([N@@]1Nc3ccc(cc3)N(=O)=O)C(=O)N(C2=O)c4ccccc4)O,A12B4C3,-7.124813,x0104,active-noncovalent
CCCCCCCCCCCCCCOS(=O)(=O)[O-],sodium-tetradecyl-sulfate,-7.124451,x0749,active-covalent
CCCC(=O)OCOC(=O)C(C)(C)C,pivanex,-7.124444,x0161,active-noncovalent
C1CCC(=NOC(=O)NCCCCCCNC(=O)ON=C2CCCCC2)CC1,RHC-80267,-7.123348,x0874,active-noncovalent
COc1c2[nH]c(cc2ccc1)c3nc(n4c3c(ncn4)N)[C@H]5CC[C@@H](CC5)C(=O)[O-],OSI-027,-7.123304,x0434,active-noncovalent
C[C@H](C[NH+](C)C)[C@@](C)(Cc1ccc(cc1)Cl)O,clobutinol,-7.122184,x0749,active-covalent
CCC(CC)(c1ccccc1)C(=O)OCCOCC[NH+](CC)CC,oxelaidin,-7.120561,x0161,active-noncovalent
C1[C@@H](CC[C@H](C1)C(=O)[O-])C[NH3+],tranexamic-acid,-7.117168,x0426,active-noncovalent
CC(=O)Nc1ccc(cc1)S(=O)(=O)[N-]c2ccc(cc2)N(=O)=O,sulfanitran,-7.116084,x0195,active-noncovalent
CCS(=O)(=O)[N@@]1CCC[C@H]2[C@@H]1C[C@H]3c4ccc(cc4CC[N@@H+]3C2)OC,RS-79948,-7.115642,x0161,active-noncovalent
C[C@@]1(CC(=O)c2ccccc2C1=O)S(=O)(=O)[O-],menadione-bisulfite,-7.114249,x0195,active-noncovalent
c1ccc(cc1)c2c(c(=O)[nH]c(n2)N)Br,bropirimine,-7.113606,x0195,active-noncovalent
CC(C)Cn1c2c(c(=O)n(c1=O)C)[nH]cn2,IBMX,-7.113242,x0195,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@]1(C(=O)C[C@@H]3[C@@H]2C(=O)C[C@H]4[C@@]3(CCC(=O)C4)C)C,dehydrocholate-acid,-7.112357,x0749,active-covalent
CCCCCCCNS(=O)(=O)c1cccc2c1cccc2Cl,SC-10,-7.111990,x0072,active-noncovalent
CC(=O)O[C@H]1C[C@H]2CC[C@@]1(C2(C)C)C,bornyl-acetate,-7.110511,x0195,active-noncovalent
CCCCC1CCC(CC1)c2nc(no2)c3ccncc3,PSN-375963,-7.109426,x0161,active-noncovalent
C([C@@H]1[C@H]([C@H]([C@@H](O1)n2c3c(c(=O)[nH]c(n3)N)sc2=O)O)O)O,"5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",-7.109203,x0104,active-noncovalent
C[C@]12[C@@H]3[C@H]4[C@@H]([C@@H]([C@]1(C[C@H]5[C@@]2(O5)C(=O)O3)O)C(=O)O4)C(C)(C)O,picrotin,-7.107205,x0072,active-noncovalent
CC(=O)N[C@@H](CS)C(=O)[O-],acetylcysteine,-7.105511,x0397,active-noncovalent
c1c(cc(c(c1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,diclofenamide,-7.105409,x0195,active-noncovalent
CSC[C@@H](C(=O)[O-])[NH3+],S-methylcysteine,-7.103190,x1077,active-noncovalent
CCCCCCCCCCCCN1CCCCCC1=O,laurocapram,-7.102621,x0104,active-noncovalent
CC[C@@H](Cc1c(cc(c(c1I)N)I)I)C(=O)[O-],iopanic-acid,-7.102503,x0749,active-covalent
c1c(c2c(ncnc2n1[C@@H]3[C@H]([C@H]([C@H](O3)CO)O)O)N)C(=O)N,sangivamycin,-7.101930,x0195,active-noncovalent
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,omega-3-acid-esters,-7.099202,x0161,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2CCCO2)F,ftorafur,-7.095570,x0161,active-noncovalent
CCNC(=O)CC[C@H](C(=O)[O-])[NH3+],L-Theanine,-7.095416,x0397,active-noncovalent
Cn1cc(c2c1cccc2)C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)N(C)Cc6ccccc6)O,FK-888,-7.094897,x0104,active-noncovalent
C[C@]([C@@H](CC(=O)[O-])C(=O)[O-])(C(=O)[O-])O,threo-2-methylisocitrate-(DL),-7.094349,x0397,active-noncovalent
c1c(cc(cc1C(=O)NCCO)C(=O)NCCO)C(=O)NCCO,LM-22A4,-7.094324,x0678,active-noncovalent
c1cc(cc(c1)O)O,resorcinol,-7.094061,x0678,active-noncovalent
CC(C)CNc1c2[nH+]cc(n2cc(n1)c3cccc4c3cccn4)c5ccc(cc5)C(=O)NC6CC6,Mps-BAY-2a,-7.094054,x0104,active-noncovalent
c1cc(c(c(c1)Cl)c2c3ccc(nn3cnc2=O)Sc4ccc(cc4F)F)Cl,VX-745,-7.090709,x0072,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)N(=O)=O)c2ccccc2C(F)(F)F)C(=O)OC,BAY-K-8644-(s)-(-),-7.090485,x0195,active-noncovalent
C[C@H]1CC[C@@H](CC1)n2c3nc(ncc3c4c2cncc4)Nc5nc6c(cc5)CN(CC6)C(=O)CO,AMG-925,-7.089983,x1077,active-noncovalent
COc1cc(c(cc1OC)OC)C=O,asaraldehyde,-7.086948,x0195,active-noncovalent
C(CC[NH+]=C(N)N)C[NH3+],agmatine,-7.086675,x0195,active-noncovalent
c1cc(sc1)[C@H]2C(=O)NCC[NH2+]2,tenilsetam,-7.086032,x1382,active-covalent
COc1ccc(cc1)n2c(nnc2SCCCN3C(=O)c4cccc5c4c(ccc5)C3=O)c6ccncc6,WIKI4,-7.085532,x0161,active-noncovalent
CCCCCCCCCCCCCCOc1ccc(o1)C(=O)[O-],KD-023,-7.084907,x0161,active-noncovalent
C(=C(/C(=O)[O-])\O)\C(=O)[O-],oxaloacetate,-7.083964,x0397,active-noncovalent
CC(=O)c1ccc(cc1O)OC,paeonol,-7.083340,x0749,active-covalent
CC1(OC[C@H](O1)COC(=O)CCc2ccc(cc2)OC[C@H](C[NH2+]CCNC(=O)N3CCOCC3)O)C,landiolol,-7.082905,x1077,active-noncovalent
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCOS(=O)(=O)[O-])C)C)O,INT-767,-7.082079,x0161,active-noncovalent
C[C@@H](C(=O)N[C@@H](c1ccccc1)C(=O)OC(C)(C)C)NC(=O)Cc2cc(cc(c2)F)F,DAPT,-7.081965,x0397,active-noncovalent
C[C@H]1[C@@H]2CC[C@]3([C@@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(\CCC=C(C)C)/C(=O)[O-])OC(=O)C)C)O)C,fusidic-acid,-7.081671,x0072,active-noncovalent
Cc1cn(c(=O)[nH]c1=O)[C@H]2C=C[C@H](O2)CO,stavudine,-7.081596,x0678,active-noncovalent
COc1c(cc(cn1)c2ccc3c(c2)c(ccn3)c4ccnnc4)NS(=O)(=O)c5ccc(cc5F)F,GSK2126458,-7.078689,x0967,active-noncovalent
c1ccc(c(c1)C(=O)N)O,salicylamide,-7.078387,x0195,active-noncovalent
C[NH+](C)CCOc1cc(ccc1NC(=O)[C@@H]2COc3ccccc3O2)c4c[nH]nc4,SR-3677,-7.078302,x0874,active-noncovalent
Cc1cc(ccc1N(C)C)Cn2cnc3c2C[C@H](N(C3)C(=O)C(c4ccccc4)c5ccccc5)C(=O)[O-],PD-123319,-7.077927,x0072,active-noncovalent
Cc1c(n(nc1C(=O)NN2CCCCC2)c3ccc(cc3Cl)Cl)c4ccc(cc4)OC,NIDA-41020,-7.076996,x0161,active-noncovalent
C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,decamethonium,-7.076600,x0749,active-covalent
C[C@]1([C@@H]([C@H](O[C@H]1n2ccc(nc2=O)N)CO)O)F,PSI-6130,-7.075310,x0195,active-noncovalent
C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])Cn3ccnn3,tazobactam,-7.073960,x1418,active-covalent
CCOP(=O)(Cc1ccc(cc1)C(=O)Nc2ccc(cc2C#N)Br)OCC,ibrolipim,-7.073559,x0104,active-noncovalent
c1cc(cc(c1)F)N2CNC(=O)C23CC[NH+](CC3)CCNC(=O)c4ccc(c(c4)F)F,ML-298,-7.071095,x0195,active-noncovalent
c1ccc-2c(c1)CCCc3c2nnc(c3)n4c(nc(n4)Nc5ccc6c(c5)CC[C@H](CC6)[NH+]7CCCC7)N,R-428,-7.069294,x0104,active-noncovalent
CC(C)c1ccccc1S(=O)(=O)c2cc(c3c(c2N(=O)=O)cccn3)N,PD-160170,-7.068833,x0072,active-noncovalent
Cc1cnc(cn1)CNC(=O)c2c(=O)c3ccc(nc3n4c2sc5c4cccc5)N6CCC[N@H+](CC6)C,CX-5461,-7.067456,x0104,active-noncovalent
C[C@H]1C[N@@H+](CC[C@@]1(C)c2cccc(c2)O)C[C@H](Cc3ccccc3)C(=O)NCC(=O)[O-],alvimopan,-7.066267,x0072,active-noncovalent
Cn1c(c[nH+]c1COC(=O)N)N(=O)=O,ronidazole,-7.064361,x1412,active-covalent
C1CN(C(=O)[C@H]1[NH3+])O,HA-966-(S)-(-),-7.062572,x0678,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)/C=C/C#N,BAY-11-7082,-7.061751,x0678,active-noncovalent
CC(C)(C)c1cc(cc(c1OC)c2ccc3cc(ccc3c2)NS(=O)(=O)C)n4ccc(=O)[nH]c4=O,dasabuvir,-7.060244,x0749,active-covalent
CCCc1ccc(cc1)C(=O)[O-],4-propylbenzoic-acid,-7.060189,x0749,active-covalent
c1ccc(cc1)CS(=O)(=O)Nc2ccc(c(c2)C(F)(F)F)c3ccc4c(c3)cnn4c5ccc(cc5)F,GSK9027,-7.056571,x0104,active-noncovalent
C[n+]1cccc(c1)C(=O)[O-],trigonelline,-7.052485,x0195,active-noncovalent
CC(C)([C@H](C(=O)[O-])[NH3+])S,penicillamine-(D),-7.051102,x0397,active-noncovalent
CC(C)(Cc1ccccc1)N(C)C(=O)C[NH+](CCO)CC(=O)N(C)C(C)(C)Cc2ccccc2,oxethazaine,-7.049588,x0104,active-noncovalent
CC(C)(CO)c1cc2cc(c(cc2n1C[C@H](CO)O)F)NC(=O)C3(CC3)c4ccc5c(c4)OC(O5)(F)F,tezacaftor,-7.049496,x0104,active-noncovalent
C(CC(=O)[O-])[C@@H](C(=O)[O-])NC(=O)N,carglumic-acid,-7.048933,x1478,active-covalent
CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC,tributyrin,-7.048782,x0195,active-noncovalent
CCCC(CCC)C(=O)Nc1ccn(c(=O)n1)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,LY2334737,-7.048708,x0161,active-noncovalent
CCc1nc2c(nc(cc2n1c3ccc(cc3)CCNC(=O)NS(=O)(=O)c4ccc(cc4)C)C)C,grapiprant,-7.047754,x0104,active-noncovalent
CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1[NH+]3CCCC3)C(=O)Cc4ccc(c(c4)Cl)Cl,spiradoline,-7.047631,x0874,active-noncovalent
Cc1cc(cc2c1ncc(c2Nc3cccc(c3)OC)C(=O)N)S(=O)(=O)c4cccc(c4)C(=O)N(C)C,GSK256066,-7.047472,x0195,active-noncovalent
C[C@H](c1ccc(cc1CCCC(=O)[O-])F)[N@@](c2cc(ccc2F)F)S(=O)(=O)c3ccc(cc3)Cl,BMS-299897,-7.045794,x1077,active-noncovalent
CC(=O)[C@H]1CC[C@H]2[C@@]1(CC[C@@H]3[C@@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CCC(=O)[O-])C)C,pregnenolone-succinate,-7.045090,x0104,active-noncovalent
COc1ccc(cc1OC)C(=O)Nc2c(c3c(s2)CCCC3)C(=O)N,TCS-359,-7.043690,x0195,active-noncovalent
CNc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,N6-methyladenosine,-7.043509,x0749,active-covalent
[H]/N=C(/NCCC[C@@H](C(=O)OC)[NH3+])\NN(=O)=O,L-NAME,-7.040486,x0678,active-noncovalent
CC(=O)OCC(=O)[C@@]12[C@@H](C[C@H]3[C@@]1(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)OC6(O2)CCCC6,amcinonide,-7.039162,x1077,active-noncovalent
c1cc2c(cc1C(=O)CC[NH+]3CCN(CC3)C(=O)OCc4cc(cc(c4)Cl)Cl)oc(=O)[nH]2,PF-8380,-7.039152,x0395,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2CCCCCC2,tolazamide,-7.038291,x0434,active-noncovalent
CCCc1c2c(cc3c1oc(cc3=O)C(=O)[O-])c(=O)cc(n2CC)C(=O)[O-],nedocromil,-7.036067,x0749,active-covalent
c1ccc(cc1)[C@@H](C(=O)[O-])O,mandelic-acid,-7.032335,x0678,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=S)NC1=O)CC=C,thiamylal,-7.031550,x1077,active-noncovalent
CC[NH2+][C@@H]1C[C@@H](S(=O)(=O)c2c1cc(s2)S(=O)(=O)N)C,dorzolamide,-7.031237,x0749,active-covalent
CNC(=O)C[NH+]1CCC(CC1)Oc2cc3c(cc2OC)ncnc3Nc4cccc(c4F)Cl,AZD8931,-7.030771,x0104,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)C(=O)N(C2=O)CCCC[NH+]3CCN(CC3)c4ccccn4,piricapiron,-7.030288,x0161,active-noncovalent
C(CC(=O)C=[N+]=N)[C@@H](C(=O)[O-])[NH3+],diazooxonorleucine,-7.030227,x0195,active-noncovalent
c1c(c(c[nH]c1=O)Cl)[O-],gimeracil,-7.029076,x0678,active-noncovalent
Cn1cc(c2c1cccc2)c3ccnc(n3)Nc4cc(c(cc4OC)N(C)CC[NH+](C)C)NC(=O)C=C,osimertinib,-7.028326,x0104,active-noncovalent
Cc1[nH]c(=O)c2cc(ccc2n1)CN(C)c3ccc(s3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],raltitrexed,-7.027585,x0072,active-noncovalent
c1cc(c(nc1)C(=O)[O-])C(=O)[O-],quinolinic-acid,-7.027446,x0397,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,gemcitabine,-7.027234,x0195,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)Nc2nc(cs2)c3cccc(c3)N(=O)=O,Ro-61-8048,-7.026592,x0434,active-noncovalent
[H]/N=C/1\[C@H](C(=O)C2=C(C1=O)[C@@H]([C@]3([N@@]2C[C@@H]4[C@H]3[NH2+]4)OC)COC(=O)N)C,mitomycin-c,-7.026125,x0195,active-noncovalent
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]4[C@H](O3)CO[P@@](=O)(O4)[O-])O)N,cyclic-AMP,-7.025957,x0749,active-covalent
Cc1cccc(c1OC(=O)C)C(=O)[O-],cresopirine,-7.024745,x1418,active-covalent
C[C@@H]([NH2+]Cc1cc(cc2c1[nH]c(=O)c(=O)[nH]2)Br)P(=O)([O-])[O-],CGP-78608,-7.024529,x1458,active-covalent
CC1=NC(=C)[C@H]([C@@H]([C@H]1C(=O)OC)c2ccccc2OC(F)F)C(=O)OC,riodipine,-7.020562,x0749,active-covalent
CCNC(=O)[C@@H]1[C@H]([C@@H]([C@@H](O1)n2cnc3c2nc(nc3N)NCCc4ccc(cc4)CCC(=O)[O-])O)O,CGS-21680,-7.018566,x0072,active-noncovalent
Cc1cc2cc(ccc2n(c1=O)C)NS(=O)(=O)c3ccc(cc3OC)C#N,NI-57,-7.018385,x0072,active-noncovalent
C[C@@]1(CSC(=N1)c2ccc(cc2O)OCCOCCOC)C(=O)[O-],SP-420,-7.017741,x0104,active-noncovalent
c1c(cc(c(c1N(=O)=O)[O-])O)N(=O)=O,OR-486,-7.017367,x0397,active-noncovalent
c1cc2c(cc(c(c2nc1)O)I)S(=O)(=O)[O-],chiniofon,-7.016592,x0195,active-noncovalent
Cc1cnc(cn1=O)COC,proacipimox,-7.016461,x0397,active-noncovalent
C(CC(=O)N)[C@@H](C(=O)[O-])[NH3+],glutamine-(l),-7.016332,x0107,active-noncovalent
CCS(=O)(=O)N1CCC(CC1)[C@@H](C)n2c(c(c3c2cccc3)C(=O)NCc4c(cc([nH]c4=O)C)OC)C,CPI-169,-7.016264,x0104,active-noncovalent
C1[C@H](NC(=O)S1)C(=O)[O-],procysteine,-7.015034,x0397,active-noncovalent
C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)[O-],clavulanate,-7.014199,x0678,active-noncovalent
C[C@H]([C@@H](C(=O)[O-])[NH3+])O,L-threonine,-7.013843,x0426,active-noncovalent
C[C@@H](C(=O)N1Cc2ccccc2C[C@H]1C(=O)[O-])[NH2+][C@@H](CCc3ccccc3)C(=O)[O-],quinaprilat,-7.010143,x1392,active-covalent
Cc1ccc(c(c1c2ccc3c(c2)ccc(n3)C)N)C(=O)c4c(n(n(c4=O)c5ccccc5)C)c6ccccc6,AMG-PERK-44,-7.007693,x0107,active-noncovalent
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[n-]nnn3)[C@@H](C(C)C)C(=O)[O-],valsartan,-7.007352,x1077,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2c(ccc(c2OC)Br)OC,remoxipride,-7.007163,x0104,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N@]2CCCC[C@@H]2C(=O)Nc3nc(cs3)c4ccc(cc4)OC,ML-277,-7.006354,x0161,active-noncovalent
Cc1c(sc(n1)NC(=O)N2CCC[C@H]2C(=O)N)c3csc(n3)C(C)(C)C,A66,-7.004224,x0104,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@@H](C[C@]4([C@@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F,halcinonide,-7.001339,x0874,active-noncovalent
CN(Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],methotrexate,-7.000900,x0104,active-noncovalent
CN(C)C(=[NH2+])NC(=[NH2+])N,metformin,-6.999578,x0195,active-noncovalent
CC[NH+](CC)CCC(=O)N1c2ccccc2Sc3c1cc(cc3)NC(=O)OCC,ethacizin,-6.997653,x0104,active-noncovalent
CO/N=C(/c1csc(n1)N)\C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)CSC(=O)c4ccco4)C(=O)[O-],ceftiofur,-6.996276,x0072,active-noncovalent
CCC(=O)OCN1C(=O)C=CC1=O,MIRA-1,-6.994695,x0195,active-noncovalent
CCCc1cc(=O)[nH]c(=S)[nH]1,propylthiouracil,-6.994293,x1382,active-covalent
CC[C@H](C)c1ccc(cc1)NC(=O)Cn2cnc3c2c(=O)n(c(=O)n3C)C,TCS-5861528,-6.993474,x0104,active-noncovalent
C1CC1CCCCCCCCC(=O)N(CCC(=O)[O-])O,TC-E-5002,-6.990997,x0104,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H](C5(C)C)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)[O-],corosolic-acid,-6.989219,x1077,active-noncovalent
CCC[C@@H](C(=O)Nc1cn(cn1)C(C)(C)C[NH2+]CC(C)(C)C)[NH2+][C@H]2CCc3cc(cc(c3C2)F)F,PF-03084014,-6.989083,x0434,active-noncovalent
C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,cholic-acid,-6.989046,x0874,active-noncovalent
CC(C)SC(=[NH2+])N,S-Isopropylisothiourea,-6.988349,x0195,active-noncovalent
C[C@@H]1[C@H](OC(=O)N1Cc2cc(ccc2c3cc(c(cc3OC)F)C(C)C)C(F)(F)F)c4cc(cc(c4)C(F)(F)F)C(F)(F)F,anacetrapib,-6.986848,x0107,active-noncovalent
Cc1nc(no1)Cn2cnc3c2c(=O)n(c(=O)n3C)C,CH-170,-6.985542,x0397,active-noncovalent
CCOC(=O)Nc1c[n+](no1)N2CCOCC2,molsidomine,-6.984628,x0161,active-noncovalent
COCCN(c1nc(cs1)c2ccccc2)C(=O)c3cc(c(c(c3)OC)OC)OC,eact,-6.983391,x0195,active-noncovalent
c1c2c(cc(c1Cl)S(=O)(=O)N)S(=O)(=O)NCN2,hydrochlorothiazide,-6.983059,x0749,active-covalent
CC(C)(c1cc(cc(c1)C(F)(F)F)C(=O)N[C@@H]2CCc3ccc(cc3C2)Oc4ccnc5c4CCC(=O)N5)[NH3+],ML-786,-6.982310,x0104,active-noncovalent
CC(C)(C)C[C@H]1[C@]2(c3ccc(cc3NC2=O)Cl)[C@H]([C@@H]([NH2+]1)C(=O)NC4CCC(CC4)O)c5cccc(c5F)Cl,SAR405838,-6.981516,x0434,active-noncovalent
C(CC(=O)N)[C@@H](C(=O)[O-])NC(=O)C[NH3+],gly-gln,-6.981233,x0107,active-noncovalent
CCS(=O)(=O)CCn1c([nH+]cc1N(=O)=O)C,tinidazole,-6.980912,x0195,active-noncovalent
CC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,sulpiride,-6.980053,x0946,active-noncovalent
CCCCCC[C@H](C/C=C\CCCCCCCC(=O)[O-])O,ricinoleic-acid,-6.979123,x0104,active-noncovalent
CN(C1CCCCC1)C(=O)CCCOc2ccc3c(c2)ccc(=O)[nH]3,cilostamide,-6.977753,x0749,active-covalent
COc1ccc(c(c1OC)OC)CN2CC[NH+](CC2)C(c3ccc(cc3)F)c4ccc(cc4)F,lomerizine,-6.977340,x1077,active-noncovalent
COc1ccc(cc1)n2c3c(c(n2)C(=O)N)CCN(C3=O)c4ccc(cc4)N5CCCCC5=O,apixaban,-6.976688,x0104,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)C(=O)[O-],candesartan,-6.974200,x0397,active-noncovalent
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,dihydroergocristine,-6.973650,x0434,active-noncovalent
CCCCCCCC(=O)OC[C@@H](CO)O,monoctanoin,-6.971525,x0749,active-covalent
CCOC(=O)C1=C(NC(=C([C@@H]1c2cccc(c2)N(=O)=O)C(=O)OC)C)C,nitrendipine,-6.970303,x0946,active-noncovalent
Cn1cnc(=[NH2+])c2c1nc[nH]2,3-methyladenine,-6.969131,x0426,active-noncovalent
CC[NH+](CC)CCNC(=O)c1cc(c(cc1OC)N)Br,bromopride,-6.964396,x0830,active-covalent
CCO[C@H]1[C@@H]([C@H]([C@H](O1)[C@@H](COCc2ccccc2)OCc3ccccc3)OCc4ccccc4)O,tribenoside,-6.963276,x0678,active-noncovalent
COc1ccc2c(n1)c(c3ccc(cc3n2)Cl)Nc4cc(c(c(c4)C[NH+]5CCCC5)O)C[NH+]6CCCC6,pyronaridine,-6.962176,x0161,active-noncovalent
CNc1nc(cc(n1)NCc2ccc(cc2Cl)NS(=O)(=O)C)c3ccccn3,TC-G-1008,-6.958504,x0161,active-noncovalent
C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3,cantharidin,-6.957710,x0678,active-noncovalent
C[C@H]1[C@@](CC[N@@H+](C1)[C@H]2CC[C@@](CC2)(c3ccc(cc3)F)C#N)(C(=O)[O-])c4ccccc4,levocabastine,-6.954379,x0107,active-noncovalent
Cn1cnc(c1Sc2c-3ncnc3nc[nH]2)N(=O)=O,azathioprine,-6.953889,x0749,active-covalent
CCc1cc(ccc1C[NH+]2CC(C2)C(=O)[O-])/C(=N/OCc3ccc(c(c3)C(F)(F)F)C4CCCCC4)/C,siponimod,-6.952504,x0104,active-noncovalent
C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O,ascorbic-acid,-6.952201,x0397,active-noncovalent
c1c(c(c(c(c1I)NC(=O)CCCCC(=O)Nc2c(cc(c(c2I)C(=O)[O-])I)I)I)C(=O)[O-])I,iodipamide,-6.950761,x0434,active-noncovalent
CCCc1c(ccc(c1O)C(=O)C)OC[C@@H](COc2ccc3c(=O)cc(oc3c2CCC)C(=O)[O-])O,FPL-55712,-6.950739,x0072,active-noncovalent
c1cc(oc1/C=N/NC(=O)N)N(=O)=O,nitrofurazone,-6.950427,x0678,active-noncovalent
COC(=O)N/N=C/c1cn(=O)c2ccccc2n1=O,carbadox,-6.949158,x0678,active-noncovalent
c1cc2c(nc1)NC(=O)[C@@]23Cc4ccc(cc4C3)NC(=O)CN5[C@@H](C[NH2+]C6(C5=O)CCCC6)c7cc(cc(c7)F)F,MK-3207,-6.947433,x0072,active-noncovalent
COc1cc(ccc1O)C=O,vanillin,-6.947381,x0195,active-noncovalent
C=C[C@@H](CCC(=O)[O-])[NH3+],vigabatrin,-6.946140,x0107,active-noncovalent
c1cc(c(cc1O)S(=O)(=O)[O-])O,etamsylate,-6.946067,x0397,active-noncovalent
Cc1nc(nc2c1cc(c(=O)n2[C@H]3CC[C@@H](CC3)OCCO)c4cnc(cc4)OC)N,PF-04691502,-6.945398,x0678,active-noncovalent
CC(C)(CO)[C@H](C(=O)NCCCO)O,dexpanthenol,-6.943398,x0104,active-noncovalent
CC(=O)NCCCCCCNC(=O)C,hexamethylenebisacetamide,-6.940607,x0161,active-noncovalent
CC(=CCC[C@@](C)(C=C)O)C,linalool,-6.938700,x0195,active-noncovalent
CCCCNc1nc(c(cn1)c2ncc(cc2)C[NH+]3CCOCC3)N[C@H]4CC[C@@H](CC4)O,UNC2250,-6.936693,x0161,active-noncovalent
CCOc1cc(cc(c1OCC(=O)OC)Cl)/C=c/2\c(=C)[nH]n(c2=O)c3ccccc3,SJ-172550,-6.935921,x1077,active-noncovalent
Cc1cccc(c1)O,metacresol,-6.935145,x0678,active-noncovalent
COc1cc(ccc1Nc2ncc(c(n2)Nc3cccc(c3)NC(=O)C=C)C(F)(F)F)NC4C[NH+](C4)CCF,CNX-2006,-6.934228,x0161,active-noncovalent
c1ccnc(c1)N2CC[NH+](CC2)CCCC(=O)c3ccc(cc3)F,azaperone,-6.933517,x0195,active-noncovalent
c1ccc2c(c1)n(=O)c(nn2=O)N,tirapazamine,-6.933386,x0195,active-noncovalent
CCN(CC)C(=O)c1cccc(c1)C,diethyltoluamide,-6.933324,x0072,active-noncovalent
c1c(c(=O)[nH]c(=O)n1[C@H]2C[C@@H]([C@H](O2)CO)O)/C=C/Br,brivudine,-6.932117,x0195,active-noncovalent
C([C@@H]([C@H]([C@H]([C@H](C(=O)[O-])O)O)O)O)O,hexonic-acid,-6.930202,x0397,active-noncovalent
C[NH+]1CCN(CC1)S(=O)(=O)c2ccc(cc2)c3cnc(c(n3)C(=O)Nc4cccnc4)N,AZD2858,-6.927661,x0104,active-noncovalent
Cc1ccc(o1)C[N+](C)(C)C,5-methylfurmethiodide,-6.927426,x0195,active-noncovalent
CN(C(=O)N[C@H]1[C@@H]([C@@H]([C@@H](O[C@@H]1O)CO)O)O)N=O,streptozotocin,-6.926556,x0749,active-covalent
C[NH+]1CCN(CC1)C(=O)[C@H]2[C@H]3CC[C@@H]([C@@H]2C(=O)[O-])O3,LB-100,-6.926182,x0104,active-noncovalent
CN1C(=O)N(C(=O)[C@]12C[N@H+](C[C@H]2c3ccc(cc3)C#N)Cc4cc(cs4)C(=O)[O-])c5cc(cc(c5)Cl)Cl,BMS-587101,-6.925756,x0072,active-noncovalent
c1cc(cc(c1)OCC(=O)[O-])C[N@@](Cc2ccc(cc2)n3cccn3)S(=O)(=O)c4cccnc4,taprenepag,-6.925707,x0678,active-noncovalent
CC1(CCC(CC1)C(C)(C)O)O,terpene,-6.924755,x0195,active-noncovalent
CCCCCN(CCCCC)C(=O)[C@@H](CCC(=O)[O-])NC(=O)c1ccc(c(c1)Cl)Cl,lorglumide,-6.922289,x0967,active-noncovalent
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)C(=O)Nc4cc(cc(c4)n5cc(nc5)C)C(F)(F)F,nilotinib,-6.921753,x0967,active-noncovalent
c1ccc(c(c1)NS(=O)(=O)c2cc(c(cc2F)Cl)C(=O)N3CC[N@@H+]4CCC[C@@H]4C3)F,ABT-639,-6.921333,x0946,active-noncovalent
CC(=CCC/C(=C/CC/C(=C/CSC[C@@H](C(=O)[O-])NC(=O)C)/C)/C)C,acetyl-farnesyl-cysteine,-6.921150,x0104,active-noncovalent
C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C,levomenthol,-6.919027,x0195,active-noncovalent
CC(C)[N@]1Cc2cc(ccc2[N@](S1(=O)=O)CC[N@H+]3CCC(=CC3)c4c[nH]c5c4ccc(c5)F)S(=O)(=O)C,LY393558,-6.918391,x0104,active-noncovalent
C[NH2+]CCc1cnc[nH]1,N-alpha-Methylhistamine-dihydrochloride,-6.917665,x1093,active-noncovalent
CCOC(=S)SSC(=S)OCC,dixanthogen,-6.916988,x0678,active-noncovalent
c1cc(ccc1NC(=O)CCC(=O)[O-])S(=O)(=O)Nc2nccs2,succinylsulfathiazole,-6.910339,x0104,active-noncovalent
CCc1cc(c(cc1OCCCCCC(C)(C)c2n[n-]nn2)O)C(=O)C,LY255283,-6.909581,x1077,active-noncovalent
CCCC[C@@H](CC)COC(=O)C[C@H](C(=O)OC[C@H](CC)CCCC)S(=O)(=O)[O-],docusate,-6.908270,x0967,active-noncovalent
CCn1c2c(c(ncn2)N)nc1OCC,ANR-94,-6.907362,x0540,active-noncovalent
CN([C@@H]1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O)C(=O)/C=C/c7ccoc7,nalfurafine,-6.906093,x0874,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H](C)C(=O)N2[C@@H]3CCCC[C@@H]3C[C@H]2C(=O)[O-],trandolapril,-6.905635,x0874,active-noncovalent
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]2[C@H](C[C@]4([C@@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)[O-])O)C)O,hydrocortisone-hemisuccinate,-6.905630,x0395,active-noncovalent
Cc1cccc(n1)CC[NH+]2CCC(CC2)C(=O)c3ccc(cc3)NS(=O)(=O)C,E-4031,-6.905343,x1077,active-noncovalent
Cc1ccc(cc1NC(=O)c2cc(nn2C)C)Oc3ccc4[nH+]c(cn4n3)NC(=O)C5CC5,TAK-593,-6.905018,x0072,active-noncovalent
CCOC(=O)c1ccc(cc1)c2ccc(cc2)OC(=O)N(C)Cc3cccc(c3)c4ccncc4,WWL-113,-6.903438,x0104,active-noncovalent
c1cc(cc(c1)NC(=O)Nc2cc(ccc2c3ccsc3)S(=O)(=O)NC4CC4)C(F)(F)F,AGI-6780,-6.903009,x1093,active-noncovalent
c1cc(c(cc1N(=O)=O)N(=O)=O)Cl,"2,4-dinitrochlorobenzene",-6.898301,x0195,active-noncovalent
CN1c2c(=O)[nH]c(nc2NC[C@@H]1CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])N,metafolin,-6.896361,x0104,active-noncovalent
Cc1ccc(cc1C2CC[NH+](CC2)Cc3ccc(cc3)Oc4ccc(c(c4)F)F)NC(=O)C(C)C,SNAP-94847,-6.896015,x0104,active-noncovalent
CCCNC(=O)Nc1ccc(cc1Cl)Oc2c3cc(c(cc3ncn2)OC)OC,KRN-633,-6.895981,x0072,active-noncovalent
Cc1c(cc(cn1)NC(=O)c2ccc(c(c2)C(F)(F)F)C[NH+]3CCN(CC3)C)Nc4nccc(n4)c5cccnc5,flumatinib,-6.894921,x0104,active-noncovalent
c1ccc(cc1)CS(=O)(=O)F,phenylmethylsulfonyl-fluoride,-6.893592,x0195,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)NC(=O)N[NH+]2C[C@H]3CCC[C@H]3C2,gliclazide,-6.893043,x0161,active-noncovalent
C1C[NH2+]CC(=C1)C(=O)[O-],guvacine,-6.892298,x0397,active-noncovalent
Cc1cc(c(cc1c2cc3cnc(nc3nc2C)NC)NC(=O)NCCC(C)(C)C)F,LY3009120,-6.891865,x0395,active-noncovalent
Cc1cc(n(n1)c2nc(cc(n2)NC(=O)C)c3cccc(n3)N4CCC(CC4)OC)C,TC-G-1004,-6.890007,x0161,active-noncovalent
c1cc(oc1)C[S@@](=O)CC(=O)NC/C=C\COc2cc(ccn2)C[NH+]3CCCCC3,lafutidine,-6.885114,x0434,active-noncovalent
CCS(=O)(=O)[N@@](C)[C@H]1c2cc(ccc2OC([C@@H]1O)(C)C)C#N,"chromanol-293B-(-)-[3R,4S]",-6.883930,x0678,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)Nc4cccc(c4)C(=O)[O-])C(=O)[O-])[C@@H](C)O,ertapenem,-6.883097,x0161,active-noncovalent
Cc1cc2c([nH]1)ccc(c2F)Oc3c4cc(c(cc4ncn3)OCCC[NH+]5CCCC5)OC,cediranib,-6.880923,x0395,active-noncovalent
COc1cc2c(ccnc2cc1OC)Oc3ccc(cc3)NC(=O)C4(CC4)C(=O)Nc5ccc(cc5)F,cabozantinib,-6.880868,x0104,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)N2CCOCC2,trimetozine,-6.880165,x0946,active-noncovalent
C1[C@H](ON=C1Cl)[C@H](C(=O)[O-])[NH3+],acivicin,-6.880086,x0397,active-noncovalent
CCc1ccc(o1)/C=C/C(=O)Nc2ccc(cc2)C(=O)C,heclin,-6.879212,x0161,active-noncovalent
c1c(cc(cc1N(=O)=O)N(=O)=O)C(=O)N,nitromide,-6.878201,x0195,active-noncovalent
C[C@@]1([C@@H]2CC[C@@H](C2)C1(C)C)[NH2+]C,mecamylamine,-6.875599,x0354,active-noncovalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@H]([C@]5(C)C(=O)[O-])OC(=O)C)C)C)[C@@H]2[C@H]1C)C)C,acetyl-11-keto-beta-boswellic-acid,-6.871237,x0104,active-noncovalent
c1cc(cc(c1)Br)c2cc(nc3c2c(ncn3)N)c4ccc(nc4)N5CCOCC5,ABT-702,-6.867449,x0161,active-noncovalent
C1C[N@@]([P@](=O)(OC1)NCCCl)CCCl,ifosfamide,-6.866999,x1093,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)C[NH+]3CCN(CC3)C(=O)Oc4ccc(cc4)N(=O)=O,JZL-195,-6.865613,x0104,active-noncovalent
CCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(CC(=O)[C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)C)C)C(=O)CCl,clobetasone-butyrate,-6.862772,x1077,active-noncovalent
Cc1c(c(=O)n2c(n1)CCCC2)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,risperidone,-6.862376,x0161,active-noncovalent
Cc1cccc(c1OC(=O)N(c2ccc(cc2OC)OC)c3ccnc(n3)Nc4ccc(cc4)N5CC[NH+](CC5)C)C,WH-4-023,-6.861629,x0104,active-noncovalent
c1c(cc(cc1O)O)O,phloroglucin,-6.860658,x0678,active-noncovalent
c1ccc2c(c1)C(=O)N(S2(=O)=O)CCCC[NH+]3CCN(CC3)c4ncccn4,ipsapirone,-6.860624,x0874,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@H](C2=O)N3C(=O)[C@H]([NH2+]C3(C)C)c4ccccc4)C(=O)[O-])C,hetacillin,-6.860322,x0072,active-noncovalent
CCS(=O)(=O)Nc1ccc2c(c1)c(c([nH]2)O)/C(=N\c3ccc(cc3)C[NH+]4CCCCC4)/c5ccccc5,hesperadin,-6.857933,x0874,active-noncovalent
CC(C)C(=O)SCCCCC[C@@H](C(=O)NC12CC3CC(C1)CC(C3)C2)NC(=O)OC(C)(C)C,TCS-HDAC6-20b,-6.855196,x0161,active-noncovalent
CCOCc1cc(c(c(c1)OC)c2ccc(cc2)C[C@@H](C(=O)[O-])NC(=O)c3c(cccc3F)F)OC,firategrast,-6.853431,x0104,active-noncovalent
Cn1c(=O)n2cnc(c2nn1)C(=O)N,temozolomide,-6.853195,x0195,active-noncovalent
CC[C@@H]1C(=O)N(c2cnc(nc2[N@@]1C3CCCC3)Nc4ccc(cc4OC)C(=O)NC5CC[NH+](CC5)C)C,BI-2536,-6.850269,x0104,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccsc3)C(=O)[O-])C(=O)[O-])C,ticarcillin,-6.849438,x0678,active-noncovalent
Cn1c(c[nH+]c1N(=O)=O)COP(=O)(NCCBr)NCCBr,TH-302,-6.848451,x0678,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3ncc(c(n3)Oc4cccc(c4)NC(=O)C=C)Cl,WZ-3146,-6.846328,x0161,active-noncovalent
CC(C)C[C@@H](CC(=O)[O-])C[NH3+],pregabalin,-6.845840,x1374,active-covalent
C[NH+]1CCN(CC1)c2ncc(c(n2)N)c3cc(cc(c3Cl)Cl)Cl,sipatrigine,-6.845108,x0874,active-noncovalent
C[C@@H](OC(=O)C)OC(=O)[C@H]1[C@H](CS[C@H]\2N1C(=O)/C2=N/C(=O)/C(=N\OC)/c3ccco3)COC(=O)N,cefuroxime-axetil,-6.844593,x0104,active-noncovalent
CN(C)NC(=O)CCC(=O)[O-],daminozide,-6.844227,x0107,active-noncovalent
c1cc(c(c(c1)F)C(=O)NC(=O)Nc2cc(c(cc2Cl)OC([C@@H](C(F)(F)F)F)(F)F)Cl)F,lufenuron,-6.843878,x0104,active-noncovalent
CC[C@H](C)n1cc(c2c1cc(cc2C(=O)NCc3c(cc([nH]c3=O)C)C)c4ccc(nc4)N5CC[NH2+]CC5)C,GSK2816126,-6.843451,x0678,active-noncovalent
C[N@H+](C/C=C/c1ccc(cc1)Cl)Cc2ccccc2[N@@](CCO)S(=O)(=O)c3ccc(cc3)OC,KN-93,-6.842664,x0678,active-noncovalent
CC(C)Cc1c(nc(s1)N)c2ccc(o2)P(=O)([O-])[O-],CS-917,-6.839567,x1385,active-covalent
CCC[C@@H](C(=O)OCC)[NH2+][C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)[O-],perindopril,-6.837787,x0161,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)N,bethanechol,-6.837536,x0195,active-noncovalent
Cc1ccc(cc1)O,cresol,-6.833539,x0678,active-noncovalent
COc1cc(c(c2c1OCO2)c3c(cc(c4c3OCO4)OC)C(=O)OC)CO,bicyclol,-6.831580,x0104,active-noncovalent
CC1(C(=O)[N-]C(=O)O1)C,dimethadione,-6.829866,x0397,active-noncovalent
CCCC(=O)N1CCCN(CC1)c2nc3cc(c(cc3c(n2)N)OC)OC,bunazosin,-6.828152,x0195,active-noncovalent
CC[C@]1(CC(=O)NC1=O)C,ethosuximide,-6.826540,x0678,active-noncovalent
CCC[C@@H]1C[C@H]([N@@H+](C1)C)C(=O)N[C@@H]([C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O,lincomycin,-6.826063,x0434,active-noncovalent
CCCCCCCC(=O)[O-],caprylic-acid,-6.825423,x0759,active-covalent
c1cc(c(nc1)C(=O)[O-])CC(=O)[O-],homoquinolinic-acid,-6.825365,x0397,active-noncovalent
c1cc(nc(c1)C[C@]2(CC[C@H](CC2)Oc3c(c(ccc3)Cl)F)C(=O)[O-])Nc4sccn4,MK-5108,-6.825205,x0434,active-noncovalent
c1cc(cc(c1)N)C(=O)N,3-amino-benzamide,-6.822288,x0195,active-noncovalent
C(CCl)NC(=O)N(CCCl)N=O,carmustine,-6.821645,x0397,active-noncovalent
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)SC(C)(C)Sc2cc(c(c(c2)C(C)(C)C)O)C(C)(C)C,probucol,-6.821153,x0830,active-covalent
c1cc(cc(c1)C(F)(F)F)C(=O)NCC(=O)N[C@@H]2CC[N@H+](C2)Cc3ccc(cc3)Cl,Teijin-compound-1,-6.818528,x0161,active-noncovalent
C[C@@H]1[C@H]([C@H]([C@@H](O1)n2cc(c(=O)[nH]c2=O)F)O)O,doxifluridine,-6.818216,x0195,active-noncovalent
Cc1[nH+]cc(n1CCO)N(=O)=O,metronidazole,-6.818151,x0195,active-noncovalent
COc1ccc(cc1)O,mequinol,-6.815259,x0678,active-noncovalent
Cc1c(c(no1)c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],oxacillin,-6.815174,x0072,active-noncovalent
c1cc(ccc1C[NH3+])S(=O)(=O)N,mafenide,-6.814958,x0161,active-noncovalent
c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N,acadesine,-6.814649,x0195,active-noncovalent
COc1ccccc1N2CC[NH+](CC2)CCN(c3ccccn3)C(=O)C4CCCCC4,WAY-100635,-6.813808,x0434,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)OC,bardoxolone-methyl,-6.813228,x0072,active-noncovalent
CCC1(CC(=O)NC(=O)C1)C,bemegride,-6.810605,x0678,active-noncovalent
CC[C@]1(C(=O)N(C(=O)O1)C)C,paramethadione,-6.809840,x0678,active-noncovalent
CCc1c(ccc(n1)C)O,emoxipin,-6.808307,x1093,active-noncovalent
[C@@H](C(F)(F)F)(OC(F)F)Cl,isoflurane,-6.807446,x0195,active-noncovalent
CC[C@@H](C(=O)N)N1CCCC1=O,levetiracetam,-6.806917,x0678,active-noncovalent
CCCCCCCC/C=C\CCCCCCCC(=O)NCc1ccc(c(c1)OC)O,olvanil,-6.806349,x0161,active-noncovalent
c1cc(ccc1C(=O)[O-])S(=O)(=O)N(Cl)Cl,halazone,-6.805539,x0749,active-covalent
CC(=O)OCC(COC(=O)C)OC(=O)C,triacetin,-6.805501,x0195,active-noncovalent
C(CC#N)CSC(=[NH2+])N,kevetrin,-6.804411,x0195,active-noncovalent
c1cc(c(cc1N(=O)=O)Cl)C(=O)N,aklomide,-6.801215,x0195,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)C(=O)Nc3c4c([nH]n3)CN(C4)C(=O)[C@@H](c5ccccc5)OC,danusertib,-6.801111,x0104,active-noncovalent
Cc1csc(n1)S(=O)(=O)[N@](CC(C)C)c2cc3c(cc2OCc4ccc(cc4)C(=O)[O-])CCC3,ONO-8130,-6.800794,x0678,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)C)O)[NH3+])O,daunorubicin,-6.800050,x0161,active-noncovalent
C([C@@H](C[NH3+])O)C(=O)[O-],aminohydroxybutyric-acid,-6.799708,x0397,active-noncovalent
c1cc(c(c(c1NS(=O)(=O)[N@@]2CC[C@H](C2)F)F)C(=O)c3c[nH]c4c3cc(cn4)c5cnc(nc5)C6CC6)F,PLX8394,-6.799100,x0195,active-noncovalent
COc1cc(cc(c1OC)OC)/C=C/C(=O)N,cintriamide,-6.798541,x0195,active-noncovalent
Cc1cc(nc2c1c(c(cc2N[C@H](C)CCC[NH3+])OC)Oc3cccc(c3)C(F)(F)F)OC,tafenoquine,-6.796340,x0161,active-noncovalent
C[NH+](C)C1(CCC2(CC1)c3c(c4cc(ccc4[nH]3)F)CCO2)c5ccccc5,cebranopadol,-6.796281,x1077,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@@H]([C@H]([C@@H]1O)O)O)O)O)O,inositol,-6.795132,x0397,active-noncovalent
c1cc(cc(c1)C(=O)NCCO)c2cc(ncn2)Nc3ccc(cc3)OC(F)(F)F,GNF-5,-6.793793,x0161,active-noncovalent
c1ccc(cc1)c2cnn3c2ncc(c3)c4ccc(cc4)OCC[NH+]5CCOCC5,DMH4,-6.793792,x0104,active-noncovalent
COCCNC(=O)Cn1cnc(n1)N(=O)=O,sanazole,-6.793581,x0397,active-noncovalent
CC[C@@H](C)[C@@H](C(=O)[O-])[NH3+],isoleucine,-6.793243,x1077,active-noncovalent
CC1(OC[C@@H]([C@@H](O1)c2ccccc2)NC(=O)Nc3ccc(cc3Br)Br)C,JNJ-10397049,-6.792242,x0967,active-noncovalent
c1cc(ncc1CN2CCN=C2NN(=O)=O)Cl,imidacloprid,-6.792168,x0749,active-covalent
Cc1c(cccc1C(=O)Nc2ccc(nc2)N3C[C@H](O[C@H](C3)C)C)c4ccc(cc4)OC(F)(F)F,sonidegib,-6.789901,x0104,active-noncovalent
CC(=O)OC[C@@H](C(=O)[O-])[NH3+],o-acetyl-L-serine,-6.789260,x0397,active-noncovalent
c1c(cc(c(c1Cl)n2c(c(c(n2)C#N)[S@](=O)C(F)(F)F)N)Cl)C(F)(F)F,fipronil,-6.789096,x0104,active-noncovalent
C[C@@H]1NC(=[NH+]C(=[NH+]1)N(C)C)N,imeglimin,-6.788079,x1077,active-noncovalent
c1c(on[n+]1N2CCOCC2)N,linsidomine,-6.785273,x0195,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c(c(c3)O)C(=O)CCc4ccc(cc4)O)O)CO)O)O)O)O)O,naringin-dihydrochalcone,-6.785189,x0395,active-noncovalent
C1CC(=O)N2C1CCC2=O,rolziracetam,-6.784109,x0195,active-noncovalent
CC[NH+](CC)CCNC(=O)c1cc(ccc1OC)S(=O)(=O)C,tiapride,-6.783593,x0161,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O,cabaletta,-6.783356,x0195,active-noncovalent
C(CCC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-])CC[NH3+],neridronic-acid,-6.781166,x0397,active-noncovalent
c1cnc(nc1)C#N,2-cyanopyrimidine,-6.779339,x0195,active-noncovalent
CCCCCCCCCCC(C)(C)C(=O)Nc1c(cc(cc1OC)OC)OC,CI-976,-6.778949,x0434,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)NCCCCCC(=O)[O-],capobenic-acid,-6.777803,x1077,active-noncovalent
CSc1nc2ccc3c(c2s1)sc(n3)NC(=O)C(c4ccccc4)c5ccccc5,Gue-1654,-6.774632,x0104,active-noncovalent
COc1ccc(cc1OC)c2cc(=O)c3c(o2)c(c(c(c3OC)OC)OC)OC,nobiletin,-6.773530,x0161,active-noncovalent
Cn1cnc2c1c(=O)[nH]c(=O)n2C,theobromine,-6.771730,x0678,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NC[C@H]2CNc3c(c(=O)[nH]c(n3)N)N2C=O,leucovorin,-6.770385,x0104,active-noncovalent
CCc1cc2c(cc1N3CCC(CC3)[NH+]4CCOCC4)C(c5c(c6ccc(cc6[nH]5)C#N)C2=O)(C)C,alectinib,-6.768570,x0104,active-noncovalent
COc1cccc(c1)NC(=O)/C=C/c2ccc(cc2)Cl,SB-366791,-6.767305,x0161,active-noncovalent
c1ccc(c(c1)CO)O,salicyl-alcohol,-6.765286,x0678,active-noncovalent
CC(C)[C@@H](Cc1ccc(c(c1)OCCCOC)OC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)[NH3+],aliskiren-hemifumarate,-6.765131,x0434,active-noncovalent
C(CCl)NP(=O)(NCCCl)[O-],palifosfamide,-6.761575,x0397,active-noncovalent
CC(=O)N[C@@H](C(=O)[O-])C(C)(C)SN=O,SNAP,-6.761235,x0678,active-noncovalent
C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3(C2)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O,ginkgolide-a,-6.760429,x0874,active-noncovalent
C1[C@H]([C@H]([C@@H]([C@H]([NH2+]1)CO)O)O)O,1-deoxymannojirimycin,-6.757922,x0397,active-noncovalent
CC(=O)Nc1ccc(cc1)S(=O)(=O)c2ccc(cc2)NC(=O)C,acedapsone,-6.757399,x0874,active-noncovalent
c1ccc2c(c1)C[C@@H](C(=O)N2C[C@H](CO)O)NC(=O)c3cc4cc(sc4[nH]3)Cl,GPi-688,-6.756771,x0104,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C[NH3+])O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)[NH3+],ribostamycin,-6.756208,x0195,active-noncovalent
CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)[O-],alpha-linolenic-acid,-6.755825,x0072,active-noncovalent
C1CCc2nnnn2CC1,pentylenetetrazol,-6.755241,x0195,active-noncovalent
C[N@]1C(=C(c2ccccc2S1(=O)=O)O)C(=O)Nc3ccccn3,piroxicam,-6.754350,x0195,active-noncovalent
COc1ccc(cc1NCC(=O)[O-])CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,rigosertib,-6.754086,x1077,active-noncovalent
C[C@@]12CC[C@@H](C1(C)C)CC2=O,camphor-(+),-6.752044,x0354,active-noncovalent
Cc1c(n(c2c1cc(cc2)C(=O)N[C@@H](C)c3ccc(cc3)N(=O)=O)Cc4ccc(cc4)c5ccccc5C(=O)[O-])C,SR-1664,-6.751905,x0395,active-noncovalent
c1cc2c(c(c1)NC(=O)C[NH+]3CCN(CC3)C(=O)[C@H]4[C@@H]([C@@H]([C@H](O4)n5cnc6c5ncnc6N)O)O)CNC2=O,EB-47,-6.748909,x0104,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC/C=C/c2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OC,pranidipine,-6.743464,x0072,active-noncovalent
Cn1c2ccc(cc2nc1Nc3ccc(cc3)C(F)(F)F)Oc4ccnc(c4)c5[nH]cc([nH+]5)C(F)(F)F,RAF265,-6.743401,x0104,active-noncovalent
c1ccc2c(c1)OC[C@@H](O2)C[NH2+]CCCOc3ccc4c(c3)OCO4,osemozotan,-6.742275,x0434,active-noncovalent
Cc1ccc(cc1O)N(=O)=O,2-methyl-5-nitrophenol,-6.739691,x0195,active-noncovalent
CCN(CC)C[C@@H]1CCCC[N@H+]1CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,otenzepad,-6.737418,x0195,active-noncovalent
Cc1c(cccc1c2ccccc2)COc3cc(c(c(c3)OC)C[N@@H+]4CCCC[C@H]4C(=O)[O-])OC,PD1-PDL-inhibitor-1,-6.736674,x0161,active-noncovalent
c1cc2c(cc1C(c3ccc4c(c3)OCO4)(C5CCN(CC5)C(=O)OC(C(F)(F)F)C(F)(F)F)O)OCO2,KML29,-6.735508,x1077,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])[NH3+],L-leucine,-6.734673,x0397,active-noncovalent
C1C[C@H](N(C1)C(=O)C[NH3+])C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],trofinetide,-6.734662,x0107,active-noncovalent
C1C[NH2+][C@@H]([C@H]([C@@H]1O)O)CO,fagomine,-6.732061,x0397,active-noncovalent
Cc1cccc(c1n2c(=O)c3cnc(nc3n4c2nc5c4cccc5)Nc6ccc(cc6)N7CC[NH+](CC7)C)C,TC-S-7003,-6.730227,x0104,active-noncovalent
c1cc(ccc1C(=O)[O-])N,potassium-p-aminobenzoate,-6.729932,x0678,active-noncovalent
CCCCCCCCCCCCCCCCn1cc[n+](c1C)Cc2ccccc2,NH125,-6.729867,x0104,active-noncovalent
CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)[O-])O)O,aceneuramic-acid,-6.728955,x0830,active-covalent
CCCCCCCCCC(=O)OCCN1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,fluphenazine-decanoate,-6.728208,x0104,active-noncovalent
c1cn(c(=O)[nH]c1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,uridine,-6.727376,x0195,active-noncovalent
c1ccc(cc1)C(=O)[O-],benzoic-acid,-6.727146,x0195,active-noncovalent
CC[NH+](CC)CCNC(=O)c1ccc(cc1)NC(=O)C,acecainide,-6.726013,x0749,active-covalent
C[C@@H]1CN(C[C@@H]([NH2+]1)C)c2ccc(cc2)C(=O)Nc3cc([nH]n3)CCc4cc(cc(c4)OC)OC,AZD4547,-6.725709,x0104,active-noncovalent
c1ccc(cc1)c2ccc(nc2)NC(=O)CSc3nc4c(c(=O)n3c5ccccc5)SCC4,IWP-L6,-6.724668,x0397,active-noncovalent
C1CC(=O)N(C1)CC(=O)N,piracetam,-6.723598,x1382,active-covalent
c1cc(ccc1O)Cl,parachlorophenol,-6.721465,x0678,active-noncovalent
c1c(sc(n1)N2CCNC2=O)N(=O)=O,niridazole,-6.720467,x0195,active-noncovalent
C(C(N(C(C(C(F)(F)F)(F)F)(F)F)C(C(C(F)(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)(F)F,perfluamine,-6.718937,x0678,active-noncovalent
c1cc(ccc1O)S(=O)(=O)[O-],4-phenolsulfonic-acid,-6.718559,x0678,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,colforsin,-6.718480,x0072,active-noncovalent
COC(=O)C(Cc1ccc(cc1)OCCn2c3ccc(cc3sc2=O)C(=O)c4ccccc4)C(=O)OC,S26948,-6.716258,x0967,active-noncovalent
c1ccc(cc1)N2CN(C(=O)C23CC[NH+](CC3)CCCC(=O)c4ccc(cc4)F)Cc5cccc(c5)F,3'-fluorobenzylspiperone,-6.707654,x0161,active-noncovalent
Cc1ccc(cc1C(=O)Nc2ccc(c(c2)Cl)C(=O)N3Cc4cccn4Cc5c3cccc5)F,lixivaptan,-6.704662,x0104,active-noncovalent
CC1=C(C(=O)C(=C(C1=O)C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O)C,A0001,-6.696704,x0434,active-noncovalent
Cc1c(c(=O)n2c(n1)[C@H](CCC2)O)CC[NH+]3CCC(CC3)c4c5ccc(cc5on4)F,paliperidone,-6.696205,x0749,active-covalent
c1c(cc(c(c1NC(=O)C(=O)[O-])Cl)NC(=O)C(=O)[O-])C#N,lodoxamide,-6.696201,x0195,active-noncovalent
C[C@@H](c1nccs1)NC(=O)Nc2ccc(cc2OC)Oc3ccnc4c3cc(c(c4)OC)OC,KI-20227,-6.693755,x0104,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C)OC)OCCOCC[NH+](C)C,UNC0321,-6.693455,x0434,active-noncovalent
c1ccc(cc1)C2=N[C@@H](C(=O)Nc3c2cccc3F)NC(=O)[C@H](CCC(F)(F)F)[C@H](CC4CC4)C(=O)N,BMS-983970,-6.692356,x0967,active-noncovalent
c1ccc(cc1)CCCN2CC[NH+](CC2)CCOC(c3ccccc3)c4ccccc4,GBR-12935,-6.691256,x0072,active-noncovalent
c1ccc(cc1)COc2cc(ccc2)c3c4c(n(c3)[C@H]5C[C@@H](C5)C[NH+]6CCCC6)ncnc4N,NVP-ADW742,-6.690422,x0161,active-noncovalent
Cc1cccc(c1)C/N=N/c2cc(nc(n2)OCCc3ccccn3)N4CCOCC4,STA-5326,-6.688016,x0161,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(nc2)Nc3ncc(c(n3)c4cc5c(c(c4)F)nc(n5C(C)C)C)F,abemaciclib,-6.687015,x0161,active-noncovalent
CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H]([C@H]([C@H]([C@]34CO4)O2)O)OC(=O)C)C)COC(=O)C,anguidine,-6.685803,x0678,active-noncovalent
C(CNCC[NH2+]CCN)[NH3+],trientine,-6.685519,x0195,active-noncovalent
CC[N@@H+](CCCCOC(=O)c1ccc(c(c1)OC)OC)[C@@H](C)Cc2ccc(cc2)OC,mebeverine,-6.685260,x0395,active-noncovalent
Cc1[nH+]cc(n1C)N(=O)=O,dimetridazole,-6.684147,x0195,active-noncovalent
CC(C)[C@H](CO)Nc1nc(c2c(n1)n(cn2)C(C)C)Nc3ccc(c(c3)Cl)C(=O)[O-],purvalanol-b,-6.684000,x1077,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Oc4cccc(c4)NC(=O)C=C)Cl,WZ-4002,-6.681519,x0161,active-noncovalent
Cc1c(noc1N(C(=O)C)S(=O)(=O)c2ccc(cc2)N)C,sulfisoxazole-acetyl,-6.681178,x0678,active-noncovalent
C1[C@H]([C@H]([C@@H](C=C1C(=O)[O-])O)O)O,shikimic-acid,-6.680902,x0397,active-noncovalent
CO[C@@H]1[C@@H]([C@H](O[C@H]1n2cnc3c2ncnc3NC4CCCCC4)CO)O,SDZ-WAG-994,-6.680842,x0195,active-noncovalent
C(OC(C(F)(F)F)C(F)(F)F)F,sevoflurane,-6.680532,x0195,active-noncovalent
CC(C)(CC[C@](CC(=O)OC)(C(=O)O[C@H]1[C@@H]2c3cc4c(cc3CC[N@H+]5[C@@]2(CCC5)C=C1OC)OCO4)O)O,harringtonine,-6.680471,x0195,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=O)Nc2ccccc2C(=O)[O-],tranilast,-6.676440,x0678,active-noncovalent
CCCC(CCC)C(=O)[O-],valproic-acid,-6.672935,x0397,active-noncovalent
CCCC(CCC)C(=O)[O-],divalproex-sodium,-6.672935,x0397,active-noncovalent
CC(=O)N[C@H]1CCSC1=O,citiolone,-6.672120,x1382,active-covalent
CCCCCCCCC(=O)N[C@H](C[NH+]1CCCC1)[C@@H](c2ccc3c(c2)OCCO3)O,genz-123346,-6.670636,x0678,active-noncovalent
c1c(cnc(=O)[nH]1)F,5-FP,-6.668768,x0426,active-noncovalent
C[N@@]1C(=C(c2c(ccs2)S1(=O)=O)O)C(=O)Nc3ccccn3,tenoxicam,-6.667237,x1093,active-noncovalent
CC[N@H+]1CCC[C@@H]1CNC(=O)c2cc(c(cc2OC)N)S(=O)(=O)CC,amisulpride,-6.667191,x1077,active-noncovalent
CC[N@@H+]1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N,levosulpiride,-6.666968,x0678,active-noncovalent
C[C@H]1[C@@H]2C[C@@H]3[C@@]45CO[C@@]([C@@H]4[C@H](C(=O)O3)OC(=O)/C=C(\C)/C(C)C)([C@H]([C@@H]([C@@H]5[C@]2(CC(=O)C1=O)C)O)O)C(=O)OC,bruceantin,-6.666441,x1077,active-noncovalent
C[C@H]1CS[C@@H]2/C(=N\C(=O)/C(=N\OC)/c3csc(n3)N)/C(=O)N2[C@H]1C(=O)OCOC(=O)C(C)(C)C,cefetamet-pivoxil,-6.665365,x0161,active-noncovalent
CC(=O)Nc1ccc(cc1)CC(=O)[O-],actarit,-6.664743,x0195,active-noncovalent
CC[NH+](CC)CCOc1ccc(cc1)Nc2ncc3cc(c(=O)n(c3n2)C)c4c(cccc4Cl)Cl,PD-166285,-6.661061,x0104,active-noncovalent
c1ccc(c(c1)NS(=O)(=O)c2ccc(cc2Cl)NC(=O)c3ccccn3)Cl,VU0364439,-6.660601,x0104,active-noncovalent
CC(C)S(=O)(=O)c1ccccc1Nc2cc(nc3c2cc[nH]3)Nc4ccc(cc4OC)N5CCC(CC5)O,Mps1-IN-1,-6.659744,x0434,active-noncovalent
c1ccnc(c1)C(=O)[O-],picolinic-acid,-6.658438,x1382,active-covalent
CCOC(=O)c1ccccc1OC(=O)CCCCCCCC(=O)Oc2ccccc2C(=O)OCC,TU-2100,-6.654632,x0104,active-noncovalent
Cc1ccc(cc1S(=O)(=O)N(C)C)N(=O)=O,BRL-50481,-6.652535,x0195,active-noncovalent
C[N+](C)(C)CCOC(=O)N,carbachol,-6.651458,x0195,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])OP(=O)([O-])[O-],dexfosfoserine,-6.650231,x0397,active-noncovalent
CCCCOC(=O)C(=C)C#N,enbucrilate,-6.649953,x0749,active-covalent
Cc1c(c(=O)n2ccsc2n1)CC[NH+]3CCC(=C(c4ccccc4)c5ccc(cc5)F)CC3,R-59022,-6.649329,x1077,active-noncovalent
Cc1ccc(cc1)C(=O)N(CCC[NH3+])[C@@H](c2nc3cc(ccc3c(=O)n2Cc4ccccc4)Cl)C(C)C,ispinesib,-6.643319,x0107,active-noncovalent
c1c(c([nH]c(=O)n1)N)F,flucytosine,-6.641623,x0397,active-noncovalent
C=CC(=O)Nc1ccc2c(c1)c(ncn2)Nc3ccc(c(c3)Cl)OCc4cccc(c4)F,AST-1306,-6.638890,x0678,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CCC[N@]3CCC[C@@H](N3C2=O)C(=O)[O-],cilazapril,-6.635386,x0678,active-noncovalent
CC(C)c1ccc(cc1)NC(=O)Cn2cnc3c2c(=O)n(c(=O)n3C)C,HC-030031,-6.633213,x0107,active-noncovalent
COc1cc(cc(c1OC)OC)C(=S)N2CCOCC2,sulmetozine,-6.629495,x0072,active-noncovalent
c1ccc(c(c1)C(=O)[O-])OP(=O)([O-])[O-],fosfosal,-6.628698,x0692,active-covalent
Cc1c[nH]c2c1c(ncn2)N3CCC(CC3)(C[NH3+])C(=O)Nc4cccc(c4)OC(=O)N(C)C,LX7101,-6.627611,x0161,active-noncovalent
C([C@@H]([C@@H]1[C@@H]([C@@H]2[C@H](O1)O[C@@H](O2)C(Cl)(Cl)Cl)O)O)O,chloralose,-6.626921,x1077,active-noncovalent
c1c(cc(cc1C(F)(F)F)NC(=O)Nc2c(cc(cc2Br)Br)c3n[n-]nn3)C(F)(F)F,NS-5806,-6.623809,x0161,active-noncovalent
CCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C,trimethylolpropane-triacrylate,-6.623683,x0195,active-noncovalent
Cc1c[nH]c(=O)n(c1=O)CCC[NH+]2CCN(CC2)c3ccccc3OCC(F)(F)F,RS-100329,-6.623541,x0874,active-noncovalent
CC(=CCC[C@@]1(C=Cc2c(c3c(c(c2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)[O-])[O-])C)C,gambogic-acid,-6.623364,x0104,active-noncovalent
C[C@@H](C(=O)NCC(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC[S@](=O)C)CO)NC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],FK-33-824,-6.622825,x0072,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-])OC(=O)N(CCCl)CCCl,estramustine-phosphate,-6.622704,x0104,active-noncovalent
c1cc2n(c(=O)c1)C[C@H]3C[C@@H]2C[N@@H+](C3)CC[N@@]4C[C@@H]5C[C@H](C4)c6cccc(=O)n6C5,CC4,-6.622642,x1077,active-noncovalent
c1cc(cn(=O)c1)C(=O)[O-],oxiniacic-acid,-6.621933,x0397,active-noncovalent
CCC(CC)Nc1c(nc(c(n1)C)c2ccc(cc2OC)OC(F)(F)F)OC,NGD-98-2,-6.621778,x0161,active-noncovalent
CC(=O)N1CC[NH+](CC1)C,1-acetyl-4-methylpiperazine,-6.621731,x0195,active-noncovalent
C[C@H](c1ccccc1C(F)(F)F)Oc2cc(sc2C(=O)N)n3cnc4c3cc(cc4)CN5CC[NH+](CC5)C,GSK461364,-6.621489,x0161,active-noncovalent
CC1(C2CCC(O1)(CC2)C)C,eucalyptol,-6.620468,x0354,active-noncovalent
CC(C)NC(=O)c1ccc(cn1)C#Cc2ccncc2,LSN-2463359,-6.618568,x1348,active-covalent
Cc1ccc(cc1)C(=O)O[C@H]([C@H](C(=O)[O-])OC(=O)c2ccc(cc2)C)C(=O)[O-],C106,-6.617877,x0397,active-noncovalent
CCCCCCCCCCCCCCOC(=O)c1cccnc1,myristyl-nicotinate,-6.616635,x0072,active-noncovalent
COc1ccccc1N2CCN(CC2)c3c4cc(c(cc4nc(n3)C5CC5)OC)OC,ML314,-6.615392,x0874,active-noncovalent
COC(=O)CCC(=O)C[NH3+],methyl-aminolevulinate,-6.614754,x0161,active-noncovalent
c1cc2c(c[nH]c2c(c1)NS(=O)(=O)c3ccc(cc3)S(=O)(=O)N)Cl,indisulam,-6.613886,x0831,active-covalent
c1cn(c(=O)[nH]c1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO[P@@](=O)([O-])O[P@@](=O)([O-])OP(=O)([O-])[O-])O)O,uridine-5'-triphosphate,-6.613816,x0678,active-noncovalent
Cn1c(cc(=O)n(c1=O)C)NCC[N@H+](CCCc2ccc(cc2)N(=O)=O)CCO,nifekalant,-6.612022,x0831,active-covalent
c1ccc(cc1)C(c2ccccc2)C(=O)N3CC[NH+](CC3)C[C@@H](COc4cccc5c4cccn5)O,dofequidar,-6.605924,x0072,active-noncovalent
CCC(=O)OCC(=O)[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2[C@@H](CC4=CC(=O)C=C[C@]34C)Cl)O)C)C)OC(=O)CC,alclometasone-dipropionate,-6.605162,x1077,active-noncovalent
C(CCCCNC(=O)C(Cl)Cl)CCCNC(=O)C(Cl)Cl,WIN-18446,-6.602551,x0104,active-noncovalent
c1ccc(cc1)C(c2ccccc2)C(=O)Nc3ccc(cc3)S(=O)(=O)Nc4nccs4,ICA-121431,-6.600619,x1093,active-noncovalent
CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2,piperonyl-butoxide,-6.600555,x0195,active-noncovalent
C1[C@H]2N1C(=O)NC2=[NH2+],imexon,-6.598052,x0104,active-noncovalent
c1c(cc(c(c1O)O)O)C(=O)[O-],gallic-acid,-6.597979,x0195,active-noncovalent
CCC1(C(=O)CC=NC1=O)CC,pyrithyldione,-6.593908,x0678,active-noncovalent
CN1CC(=O)NC1=[NH2+],creatinine,-6.591959,x1077,active-noncovalent
CNC(=O)c1ccc2c(c1)CCO[C@H]2CC[NH+]3CCN(CC3)c4ccc(cc4)C(=O)N,PNU-142633,-6.588407,x0107,active-noncovalent
C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)[NH2+]C(CO)CO,voglibose,-6.587879,x0107,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])[S@](=O)[O-],L-Cysteinesulfinic-acid,-6.587493,x0397,active-noncovalent
Cc1ccccc1C(=O)Nc2ccc(cc2)C(=O)N3CCC[C@H](c4c3cccc4)[NH+](C)C,mozavaptan,-6.587044,x0678,active-noncovalent
c1cc(cnc1)C[NH+]2CCC(CC2)n3c4c(cn3)c(nc(n4)c5ccc6c(c5)cc[nH]6)N7CCOCC7,WAY-600,-6.585862,x0107,active-noncovalent
CC(C)(C(=O)N[C@@H](CS)C(=O)[O-])S,bucillamine,-6.585582,x0397,active-noncovalent
C=CCNc1nc(nc(n1)N2CC[NH+](CC2)C(c3ccc(cc3)F)c4ccc(cc4)F)NCC=C,almitrine,-6.584793,x0161,active-noncovalent
Cc1cc(cc2c1nc(nn2)Nc3ccc(cc3)OCC[NH+]4CCCC4)c5cc(ccc5Cl)O,TG-100572,-6.583385,x0104,active-noncovalent
CC(C)c1c(c(c(n1CC[C@H](C[C@H](CC(=O)[O-])O)O)c2ccc(cc2)F)c3ccccc3)C(=O)Nc4ccccc4,atorvastatin,-6.583282,x0305,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)C)c2cccc(c2)N(=O)=O)C(=O)OCCOC,nimodipine,-6.582630,x0946,active-noncovalent
C(C(CO)OP(=O)([O-])[O-])O,beta-glycerophosphoric-acid,-6.582582,x0397,active-noncovalent
Cc1ncn(n1)c2c3c(c(c[nH]3)C(=O)C(=O)N4CCN(CC4)C(=O)c5ccccc5)c(cn2)OC,BMS-626529,-6.581596,x0161,active-noncovalent
c1cc(c(cc1Nc2c3cc(cc(c3ncc2C#N)Cl)NCc4cn(nn4)CC[NH+]5CCCCCC5)Cl)F,cot-inhibitor-1,-6.579896,x0161,active-noncovalent
C[C@@]1([C@@H]([C@@H](O[C@H]1n2ccc(nc2=O)N)CO)O)O,NM107,-6.579246,x0678,active-noncovalent
COc1ccccc1O,guaiacol,-6.578890,x0678,active-noncovalent
CC(=O)Nc1ccc(cc1)C(=O)[O-],acedoben,-6.577055,x0749,active-covalent
c1ccc2c(c1)CC[N@H+](C2)C[C@H](CNC(=O)c3cc(ncn3)NC4COC4)O,EPZ015666,-6.576731,x0874,active-noncovalent
CCOC(=O)C[C@@H](C(=O)OCC)SP(=S)(OC)OC,malathion,-6.574487,x1385,active-covalent
Cn1cc(c2c1cccc2)C3=C(C(=O)NC3=O)c4cn(c5c4cccc5)C6CC[NH+](CC6)Cc7ccccn7,enzastaurin,-6.573524,x0072,active-noncovalent
Cc1nc(cs1)/C=C(\C)/[C@@H]2C[C@H]3C(O3)(CCC[C@@H]([C@@H]([C@H](C(=O)C([C@H](CC(=O)N2)O)(C)C)C)O)C)C,ixabepilone,-6.571754,x0874,active-noncovalent
C[C@H]1COCC[N@@]1c2c3ccc(nc3nc(n2)[N@@]4CCOC[C@@H]4C)c5cccc(c5)C(=O)NC,AZD2014,-6.571436,x0434,active-noncovalent
C1N2CN3CN1C[N+](C2)(C3)C/C=C\Cl,"1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",-6.571005,x1311,active-covalent
COc1cc2c(cc1OCCC[NH+]3CCOCC3)c(ncn2)Nc4ccc(c(c4)Cl)F,gefitinib,-6.570576,x0104,active-noncovalent
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1[NH3+])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)[NH3+])O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)C[NH3+])O)O)[NH3+])O)O)[NH3+],paromomycin,-6.565146,x0395,active-noncovalent
C1C[NH2+][C@H](C[C@H]1CP(=O)([O-])[O-])C(=O)[O-],selfotel,-6.565018,x1348,active-covalent
Cc1ccc(c(c1)C(=O)N2CCN(CC[C@H]2C)c3nc4cc(ccc4o3)Cl)n5nccn5,suvorexant,-6.563778,x0107,active-noncovalent
CN1CC[NH+](CC1)CCCCn2c(cn(c2=O)/N=C/c3ccc(o3)c4ccc(cc4)Cl)[O-],azimilide,-6.562619,x0104,active-noncovalent
C(CC(=O)[O-])C(=O)C[NH3+],5-aminolevulinic-acid,-6.562369,x0107,active-noncovalent
COC(=O)/C=C/C(=O)N[C@@H]1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC6CC6)O)O,beta-funaltrexamine,-6.562361,x0395,active-noncovalent
C(CNCCNCC[NH2+]CCN)[NH3+],tetraethylenepentamine,-6.560149,x1334,active-covalent
CSCC[C@@H](C(=O)[O-])[NH3+],L-methionine,-6.557175,x0397,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CCl)O)O)CCl)O)O)Cl)O,sucralose,-6.557084,x1334,active-covalent
C[Se]CC[C@@H](C(=O)[O-])[NH3+],selenomethionine,-6.556980,x1077,active-noncovalent
CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c2cc(c(c(c2O)Cl)OCCN3CC[NH+](CC3)C)Cl,JTE-607,-6.555426,x0104,active-noncovalent
COCCOc1ccc(cc1)N2CC[NH+](CC2)CCn3c4c(cn3)c5nc(nn5c(n4)N)c6ccco6,preladenant,-6.554716,x0305,active-noncovalent
C1[C@@H](O1)Cn2c(=O)n(c(=O)n(c2=O)C[C@H]3CO3)C[C@H]4CO4,teroxirone,-6.554161,x0195,active-noncovalent
CCN1CC[NH+](CC1)Cc2ccc(cc2)c3cc4c([nH]3)ncnc4N[C@H](C)c5ccccc5,AEE788,-6.551585,x0395,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)N(C)C(=O)C)I)C(=O)N[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O)CO)O)O)I,metrizamide,-6.549838,x0072,active-noncovalent
CC(C)(C)c1cnc(o1)CSc2cnc(s2)NC(=O)C3CC[NH2+]CC3,BMS-387032,-6.549581,x0195,active-noncovalent
CN(C(=S)c1ccccc1)NC(=O)CC(=O)NN(C)C(=S)c2ccccc2,elesclomol,-6.549118,x1077,active-noncovalent
Cc1c(c(c(c(c1N)C)C)NCC(=O)N(C)C2CC[NH+](CC2)Cc3ccc(cc3)C(=O)N)C,SUN-11602,-6.548300,x0104,active-noncovalent
c1ccc(c(c1)c2nc-3ccn(cc3n2)Cc4ccc(nn4)c5ccc(cc5C(F)(F)F)C(F)(F)F)F,tegobuvir,-6.547794,x0104,active-noncovalent
COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)[C@@H]4COc5ccccc5O4,doxazosin,-6.546585,x1077,active-noncovalent
CC(C)([C@@H](C(=O)[O-])[NH3+])S,penicillamine-(racemic),-6.545851,x0689,active-covalent
C1C[C@H]([NH2+]C1)C(=O)[O-],L-proline,-6.542516,x0397,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)N,para-toluenesulfonamide,-6.541236,x0161,active-noncovalent
C1CN1P(=S)(N2CC2)N3CC3,thiotepa,-6.536787,x0678,active-noncovalent
Cc1/c(=C/c2c3cc(ccc3[nH]c2O)S(=O)(=O)Cc4c(cccc4Cl)Cl)/[nH]c(=C)c1C(=O)N5CCC[C@@H]5C[NH+]6CCCC6,PHA-665752,-6.532330,x0104,active-noncovalent
Cc1c2c(cc(nc2n(n1)C)NNC(=O)Nc3cc(nc(c3)Cl)Cl)C(C)C,JTE-013,-6.532018,x1392,active-covalent
COc1cc(c(cc1C(=O)N[C@@H]2CC[N@H+](C[C@@H]2OC)CCCOc3ccc(cc3)F)Cl)N,cisapride,-6.529933,x0104,active-noncovalent
COP(=O)([C@H](c1ccc(cc1)Cl)OP(=O)(OC)OC)OC,mifobate,-6.527545,x0434,active-noncovalent
[H]/N=C(\Sc1c(cccc1)N)/[C@@H]([C@H](/C(=N/[H])/Sc2c(cccc2)N)C#N)C#N,U-0126,-6.527519,x1077,active-noncovalent
CCCCS(=O)(=O)N[C@@H](Cc1ccc(cc1)OCCCCC2CC[NH2+]CC2)C(=O)[O-],tirofiban,-6.524443,x0104,active-noncovalent
C[N@]1CCOCCN(C(=O)C2=Cc3cc(ccc3-c4c(c5ccc(cc5n4C2)C(=O)NS1(=O)=O)C6CCCCC6)OC)C,TMC647055,-6.524429,x0104,active-noncovalent
C[C@H]1Cc2cc3c(c(c2-c4c(cc(c(c4OC)OC)OC)C[C@]1(C)O)OC)OCO3,schisandrol-b,-6.522957,x0195,active-noncovalent
CC(C)(C)c1cc(c(cc1NC(=O)c2c[nH]c3ccccc3c2=O)O)C(C)(C)C,ivacaftor,-6.520783,x1093,active-noncovalent
C[NH2+][C@H]1CN(C[C@@H]1OC)c2ccc3c(=O)c(cn(c3n2)c4nccs4)C(=O)[O-],voreloxin,-6.520636,x0104,active-noncovalent
CCCC(CCC)C(=O)N,valpromide,-6.515154,x0874,active-noncovalent
Cc1c[nH]nc1,fomepizole,-6.513643,x0678,active-noncovalent
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H]([NH2+]C3)C(=O)N(C)C)C(=O)[O-])[C@@H](C)O,meropenem,-6.512314,x0195,active-noncovalent
C[N@@](c1c(cccn1)CNc2c(cnc(n2)Nc3ccc4c(c3)CC(=O)N4)C(F)(F)F)S(=O)(=O)C,PF-562271,-6.512026,x0678,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H]2N1C(=O)C(=O)N2)O)O)O)O,kifunensine,-6.512012,x0397,active-noncovalent
C[NH+](C)CC[C@@](c1cccc2c1cccc2)([C@H](c3ccccc3)c4cc5cc(ccc5nc4OC)Br)O,bedaquiline,-6.509989,x0967,active-noncovalent
c1ccc(cc1)CO,benzyl-alcohol,-6.508918,x0678,active-noncovalent
c1c[nH+]cc(c1N)N,amifampridine,-6.505768,x0354,active-noncovalent
C[C@H](C(=O)[O-])O,ammonium-lactate,-6.505556,x0397,active-noncovalent
CC(C)OP(=O)(OC(C)C)F,isoflurophate,-6.504571,x0397,active-noncovalent
C(C[NH+]=C(N)N)C(=O)[O-],guanidinopropionic-acid,-6.500461,x0678,active-noncovalent
C[N@]1[C@H](Nc2cc(c(cc2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F,polythiazide,-6.498771,x0107,active-noncovalent
CCCCC[C@@H](C)[NH3+],tuaminoheptane,-6.497232,x1077,active-noncovalent
Cc1ccccc1/N=N/c2ccc(c(c2)C)NC(=O)c3ccnn3C,CH223191,-6.494285,x0104,active-noncovalent
C1C[C@H]([C@@H]2[C@@H]([C@@H](C[N@H+]2C1)O)O)O,swainsonine,-6.493390,x1418,active-covalent
c1c(cc(c(c1I)[O-])I)I,AM-24,-6.493266,x0195,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])SS(=O)(=O)[O-],S-Sulfo-L-cysteine-sodium-salt,-6.491928,x0397,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)Cc2c(oc(n2)c3ccc(cc3)C(=O)NCc4cccnc4)C,STF-118804,-6.487862,x0395,active-noncovalent
c1cn(c(=O)nc1N)[C@H]2CO[C@H](S2)CO,apricitabine,-6.480754,x1386,active-covalent
C/C(=C\[C@H](C(=O)[O-])[NH3+])/CP(=O)([O-])[O-],CGP-37849,-6.478532,x0397,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)c3c(cccc3OC)OC)C(=O)[O-])C,methicillin,-6.477583,x0749,active-covalent
C1CNc2c(c(=O)c2=O)N(C1)CCP(=O)([O-])[O-],perzinfotel,-6.476451,x1311,active-covalent
CC1=[NH+]CC[C@H](N1)C(=O)[O-],ectoine-zwitterion,-6.473692,x0678,active-noncovalent
CC(C)[NH2+]CCN(c1ccc2c(c1)nc(cn2)c3cnn(c3)C)c4cc(cc(c4)OC)OC,erdafitinib,-6.472165,x0161,active-noncovalent
Cc1ccc(cc1)S(=O)(=O)[N-]c2ccc3c(c2)c(cn3CC(=O)N[C@@H](CC(C)C)C(=O)[O-])C(=O)C(F)(F)F,NTRC-824,-6.467732,x0434,active-noncovalent
CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C,butalbital,-6.467599,x0195,active-noncovalent
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)[NH2+]C)O)[NH2+]C)O)O,spectinomycin,-6.465862,x0195,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)O[C@H]2CC[N@H+](C2)Cc3ccccc3)c4cccc(c4)N(=O)=O)C(=O)OC,barnidipine,-6.464103,x0161,active-noncovalent
C[C@H]([C@@H](Cc1cccc(c1)C(=[NH2+])N)C(=O)OC)NC(=O)c2ccc(cc2)c3ccn(=O)cc3,otamixaban,-6.464006,x0678,active-noncovalent
CC(=O)Nc1c(cc(c(c1I)C(=O)[O-])I)I,acetriazoic-acid,-6.461906,x0195,active-noncovalent
CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)[O-])C,sulbactam,-6.461625,x0678,active-noncovalent
C1CC1(C(=O)[O-])[NH3+],ACPC,-6.460526,x1077,active-noncovalent
C([C@H]([C@@H]([C@H]([C@@H](CO)O)O)O)O)O,sorbitol,-6.459620,x0397,active-noncovalent
C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,mannitol-D,-6.458498,x0397,active-noncovalent
c1ccc(cc1)OCCN2CCCc3c2cccc3CNc4ccc(c(c4)F)CCC(=O)[O-],AS-2034178,-6.456038,x0104,active-noncovalent
CCS(=O)(=O)c1cccc(c1)c2cc(c(c3c2c4cc(cnc4[nH]3)C)C)C(=O)NC5CC[NH+](CC5)C,TAK-901,-6.455890,x0104,active-noncovalent
CC(C)c1cccc2c1nc(cc2c3ccccc3)c4ccc([nH]4)c5ccc(cc5)C(=O)[O-],ER-50891,-6.455600,x0104,active-noncovalent
C(CCl)[NH+](CCCl)CCCl,trichlormethine,-6.453944,x0434,active-noncovalent
CCCc1cn(c2c1nc([nH]c2=O)c3cc(ccc3OCCC)S(=O)(=O)N4CC[NH+](CC4)CCO)CC,mirodenafil,-6.453191,x0161,active-noncovalent
Cc1c(cccc1F)NC(=O)Nc2ccc(c(c2[O-])S(=O)(=O)[C@H]3CCCNC3)Cl,danirixin,-6.451350,x1077,active-noncovalent
CCC[C@@H]([C@H](CC)CO)O,"2-ethyl-1,3-hexanediol",-6.450663,x0195,active-noncovalent
CN(C(=O)N[C@H]1CC[C@@H](CC1)CC[NH+]2CCN(CC2)c3c(c(ccc3)Cl)Cl)C,cariprazine,-6.450283,x0104,active-noncovalent
Cc1cc(c(c(=O)o1)C(=O)C)[O-],dehydroacetic-acid,-6.446742,x0397,active-noncovalent
Cc1cc(=O)[nH]c(=S)[nH]1,methylthiouracil,-6.446671,x0678,active-noncovalent
C1C[N@@H+]2C[C@@H]([C@H]([C@@H]([C@H]2[C@H]1O)O)O)O,castanospermine,-6.445244,x0195,active-noncovalent
c1cc(c(c(c1)F)F)[C@@H]2CC[C@H](c3c(cccn3)[C@H]2[NH3+])OC(=O)N4CCC(CC4)n5c6cccnc6[nH]c5=O,BMS-927711,-6.441045,x0967,active-noncovalent
c1ccnc(c1)C[NH2+]Cc2ccc(cc2)C[N@@]3CCCNCC[NH2+]CCC[NH2+]CC3,AMD-3465,-6.437649,x1077,active-noncovalent
C1C[NH+](CC[N@@](CCN(CC[N@]1CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-],gadoterate-meglumine,-6.436503,x1385,active-covalent
CC1=[NH+]C[C@@H]([C@H](N1)C(=O)[O-])O,5-hydroxyectoine,-6.435124,x0678,active-noncovalent
CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)N[C@H](CC3CCC3)C(=O)C(=O)N)C,boceprevir,-6.431930,x0161,active-noncovalent
C[C@@]1(CCOC(=O)C1)O,"mevalonic-d,-l-acid-lactone",-6.430621,x0195,active-noncovalent
c1c(c(cc(c1N)S(=O)(=O)N)S(=O)(=O)N)C(=C(Cl)Cl)Cl,clorsulon,-6.426647,x0749,active-covalent
C/C=C\1/[C@@H](C(=CO[C@@H]1O[C@@H]2[C@@H]([C@H]([C@H]([C@@H](O2)CO)O)O)O)C(=O)OC)CC(=O)OCCc3ccc(c(c3)O)O,oleuropein,-6.423532,x0434,active-noncovalent
CCCNS(=O)(=O)Nc1c(c(ncn1)OCCOc2ncc(cn2)Br)c3ccc(cc3)Br,macitentan,-6.419363,x0161,active-noncovalent
C[NH2+]CC(=O)[O-],sarcosine,-6.414515,x0397,active-noncovalent
COc1cccc(c1)c2ccc(c(c2)F)NC(=O)C3=C(CCC3)C(=O)[O-],SC-12267,-6.414360,x0104,active-noncovalent
c1cc(ccc1N)S(=O)(=O)N,sulfanilamide,-6.414182,x0678,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)[NH3+])O)O)O,glucosamine,-6.412652,x0107,active-noncovalent
CC(=O)N[C@H]1[C@@H]([C@@H]([C@@H](O[C@@H]1O)CO)O)O,N-acetylmannosamine,-6.410317,x0749,active-covalent
CS(=O)(=O)OCCCCOS(=O)(=O)C,busulfan,-6.407554,x0749,active-covalent
CC1(C(=O)N(C(=O)O1)C)C,trimethadione,-6.405789,x0195,active-noncovalent
Cc1c(cc(cn1)Cl)NCc2ccc(s2)C(=O)N[C@@H](CC3CCCC3)C(=O)NC4CC4,GSK2830371,-6.404488,x1077,active-noncovalent
[C@@H]([C@@H](C(=O)[O-])S)(C(=O)[O-])S,dimercaptosuccinic-acid,-6.403480,x0397,active-noncovalent
Cc1c(oc(=O)o1)CCl,80841-78-7,-6.402489,x0195,active-noncovalent
CCC(=O)NC[C@H](Cc1ccc(cc1)OCCc2c(oc(n2)c3ccccc3)C)/N=C(/C)\CC(=O)c4ccc(cc4)C(F)(F)F,GW-6471,-6.394127,x0104,active-noncovalent
[H]/N=C(\SC)/[C@@H]([C@H](/C(=N/[H])/SC)C#N)C#N,U-0124,-6.393508,x0678,active-noncovalent
C[C@@H](CC(=O)[O-])O,beta-Hydroxybutyrate,-6.390899,x0397,active-noncovalent
CC1(C2C[C@H](C(O1)([C@H](C2)O)C)O)C,epomediol,-6.390732,x0678,active-noncovalent
[H]/N=C/1\[C@@H]2N(C1=O)[C@H]([C@@H](CS2)COC(=O)C)C(=O)[O-],7-aminocephalosporanic-acid,-6.385460,x0678,active-noncovalent
CC(C)[C@@H](/C=C(\C)/C(=O)[O-])N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)c1ccccc1)[NH2+]C,taltobulin,-6.384556,x0967,active-noncovalent
CC[NH2+]CCC[NH2+]CCCC[NH2+]CCC[NH2+]CC,"1,12-Besm",-6.384076,x0104,active-noncovalent
CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c1ncnc2N)OCOC(=O)C(C)(C)C,adefovir-dipivoxil,-6.382543,x1077,active-noncovalent
CNC(=O)c1ccccc1Nc2cc(ncc2C(F)(F)F)Nc3ccc(cc3OC)N4CCOCC4,VS-4718,-6.382465,x0161,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])S,L-cysteine,-6.381304,x0397,active-noncovalent
c1ccc(cc1)NC(=O)OC[C@H](C[NH+]2CCCCC2)OC(=O)Nc3ccccc3,diperodon,-6.380083,x1077,active-noncovalent
CCOP(=O)([C@@H](C)NC(=O)N(CCCl)N=O)OCC,fotemustine,-6.379870,x0397,active-noncovalent
CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)NC,ilomastat,-6.379023,x0434,active-noncovalent
Cc1nnc(o1)C(=O)NC(C)(C)c2nc(c(c(=O)n2C)[O-])C(=O)NCc3ccc(cc3)F,raltegravir,-6.378845,x0749,active-covalent
c1cc(cc(c1)F)C#Cc2ccc(cn2)C(=O)NC3CCC3,VU0360172,-6.378730,x1077,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)c1cc(n(n1)c2ccnc3c2ccc(c3)Cl)c4c(cccc4OC)OC,TC-NTR1-17,-6.377967,x0395,active-noncovalent
CCOC(=O)c1ccc(nc1)C#Cc2ccc3c(c2)C(CCS3)(C)C,tazarotene,-6.377547,x0104,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O[C@@H]6CCCCO6,pirarubicin,-6.376424,x0104,active-noncovalent
COc1cc(ccc1Nc2ncc(c(n2)Nc3ccccc3NS(=O)(=O)C)Cl)N4CCOCC4,CZC-54252,-6.376280,x0967,active-noncovalent
C(C(=O)O)C(CC(=O)O)(C(=O)O)O,lithium-citrate,-6.375349,x0397,active-noncovalent
CC(C)(c1ccc(cc1)OC[C@H]2CO2)c3ccc(cc3)OC[C@H]4CO4,BADGE,-6.373281,x0104,active-noncovalent
C(CC(=O)[O-])C[NH3+],gamma-aminobutyric-acid,-6.370827,x0397,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)C,acetyl-l-leucine,-6.368969,x0397,active-noncovalent
COc1cc2c(cc1NC(=O)/C=C/C[NH+]3CCCCC3)c(ncn2)Nc4ccc(c(c4)Cl)F,dacomitinib,-6.367520,x0104,active-noncovalent
CC(C)(C)[C@@]1(C[C@H]2[C@@]3([C@]14[C@H](C(=O)O[C@H]4OC3=O)O)CC(=O)O2)O,bilobalide,-6.367469,x0678,active-noncovalent
CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/c4ccc(cn4)c5cccc(c5)F)[C@H](OC3=O)C,vorapaxar,-6.364000,x0072,active-noncovalent
Cc1cc(ccc1c2ccc(cc2)C(=O)Nc3ccc(c(c3)N4CC[NH+](CC4)C)OC)c5nc(on5)C,GR-127935,-6.361451,x0305,active-noncovalent
c1ccc(cc1)/C=C/C[NH+]2CCN(CC2)CCOC(c3ccc(cc3)F)c4ccc(cc4)F,GBR-13069,-6.361447,x0104,active-noncovalent
CC1([C@H](N2[C@@H](S1)[C@H](C2=O)NC(=O)[C@H](c3ccccc3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)[O-])C,mezlocillin,-6.358181,x1077,active-noncovalent
Cc1c(c(=O)n2ccsc2n1)CC[NH+]3CCC(=C(c4ccc(cc4)F)c5ccc(cc5)F)CC3,ritanserin,-6.356082,x0434,active-noncovalent
c1ccc(cc1)Oc2ccc(cc2)CNC(=O)c3nc(no3)c4cc(c(c(c4)Br)[O-])Br,IOWH032,-6.355387,x0434,active-noncovalent
c1cc(oc1CO)CO,"2,5-furandimethanol",-6.355311,x0678,active-noncovalent
c1ccc(cc1)O,phenol,-6.355002,x0678,active-noncovalent
CN(C)C(=S)SSC(=S)N(C)C,thiram,-6.352805,x0678,active-noncovalent
CCOC(=O)N1CSC[C@@H]1C(=O)[O-],telmesteine,-6.350442,x0749,active-covalent
CCC1(C(=O)NC(=O)NC1=O)CC,barbital,-6.349185,x0354,active-noncovalent
C1C[N@](C[C@@H]([NH2+]1)C(=O)[O-])C/C=C/P(=O)([O-])[O-],midafotel,-6.348824,x0678,active-noncovalent
CC(C)C[C@H]([C@H](CSc1cccs1)C(=O)NO)C(=O)N[C@@H](Cc2ccccc2)C(=O)NC,batimastat,-6.345408,x0195,active-noncovalent
CC(=O)N1CC[N+](CC1)(C)C,"4-acetyl-1,1-dimethylpiperazinium",-6.345225,x0195,active-noncovalent
CC(C)(C)c1ccc(cc1)CN2CC[NH+](CC2)[C@H](c3ccccc3)c4ccc(cc4)Cl,buclizine,-6.344145,x0678,active-noncovalent
CS(=O)(=O)c1ccc(nc1)c2nnc(n2c3ccccc3Cl)/C=C/c4nnc(o4)c5ccc(cc5)C#N,G007-LK,-6.339536,x0104,active-noncovalent
CC(C)C[N@@](C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)c4ccc(cc4)N,darunavir,-6.337689,x0161,active-noncovalent
CCCC(=O)C1CCN(CC1)c2c3c(ncn2)CCN(C3)C(=O)c4ccc(cc4)c5ccccc5,PK-THPP,-6.337166,x0161,active-noncovalent
Cc1c2c(=O)[nH]c(nn2c(n1)[C@@H](CCCc3ccccc3)[C@@H](C)O)Cc4ccc(c(c4)OC)OC,bay-60-7550,-6.336129,x0107,active-noncovalent
CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)NC(=O)C)O,ceramide,-6.335195,x0874,active-noncovalent
c1cc(cn(=O)c1)CO,mepiroxol,-6.335049,x0397,active-noncovalent
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)[NH3+])C(=O)[O-])C,6-aminopenicillanic-acid,-6.334925,x0678,active-noncovalent
C[C@@H](C(=O)N[C@H]1c2ccccc2-c3ccccc3N(C1=O)C)NC(=O)[C@H](c4cc(cc(c4)F)F)O,LY411575,-6.334172,x0195,active-noncovalent
COc1ccc(cc1OC)/C=C/C(=C/C(=O)/C=C/c2ccc(c(c2)OC)OC)/O,ASC-J9,-6.333081,x0104,active-noncovalent
C1CC1Nc2nc(nc(n2)N)N,cyromazine,-6.331579,x0195,active-noncovalent
CC(=O)O[C@@H]1C[C@@H]2[C@](C=CC(=O)C2(C)C)([C@@H]3[C@@]1(C45[C@H](O4)C(=O)O[C@H]([C@@]5(CC3)C)c6ccoc6)C)C,gedunin,-6.331065,x0104,active-noncovalent
C1C[C@]([C@H]2[C@@H]1[C@@H]2C(=O)[O-])(C(=O)[O-])[NH3+],eglumetad,-6.328829,x0678,active-noncovalent
C[C@@H](C[NH+]1CCC(CC1)n2c3ccc(cc3[nH]c2=O)Cl)NC(=O)c4ccc5ccccc5c4,VU0155069,-6.328038,x0072,active-noncovalent
CN(C)C(=O)C(CC[NH+]1CCC(CC1)(c2ccc(cc2)Cl)O)(c3ccccc3)c4ccccc4,loperamide,-6.326635,x0874,active-noncovalent
c1ccc(cc1)C(=O)NNC(=O)c2ccc(cc2)CNS(=O)(=O)c3ccc(c(c3)Cl)F,TCN201,-6.321129,x1077,active-noncovalent
C#CC[C@H](Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],pralatrexate,-6.320901,x0161,active-noncovalent
CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,treosulfan,-6.314137,x0678,active-noncovalent
Cc1c(cccc1O)C(=O)N[C@@H](CSc2ccccc2)[C@@H](C[N@@H+]3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,nelfinavir,-6.314024,x0678,active-noncovalent
Cc1ccc(c(c1)NC(=O)Nc2ccc(cc2)c3cccc4c3c([nH]n4)N)F,linifanib,-6.308022,x1093,active-noncovalent
CCC(=O)N1CCN(CC1)c2ccc(cc2C(F)(F)F)n3c(=O)ccc4c3c5cc(ccc5nc4)c6cc7ccccc7nc6,torin-1,-6.306356,x0161,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)[N@]2c3ccc(cc3[C@@]([C@@H]2C(=O)N4CCC[C@H]4C(=O)N)(c5ccccc5Cl)O)Cl,relcovaptan,-6.305134,x0678,active-noncovalent
Cc1c(n(nc1C(=O)NCc2cccnc2)c3ccc(cc3Cl)Cl)c4ccc(cc4)Cl,MJ-15,-6.303871,x0161,active-noncovalent
C[C@@H]1CN(C[C@@H](O1)C)c2nc3c(ccc(n3)c4ccc(c(c4)CO)OC)c(n2)N5CCOCC5,ku-0063794,-6.301973,x0104,active-noncovalent
CC(C)(C)c1cc(n(n1)C)C(=O)N[C@@H](Cc2cccc(c2)Cl)C(=O)NCC#N,cathepsin-inhibitor-1,-6.299233,x1077,active-noncovalent
COc1cc(cc(c1)OC)C(=O)NNC(=O)Nc2cccc3c2cccc3,TC-O-9311,-6.297140,x0874,active-noncovalent
Cn1cc(cn1)c2cc3c(ccc4ccc(cc4c3=O)NS(=O)(=O)[N@](C)C[C@@H]5COCCO5)nc2,MK-2461,-6.295341,x0161,active-noncovalent
CC[C@@H]1C[C@@H](c2cc(ccc2N1C(=O)OCC)C(F)(F)F)N(Cc3cc(cc(c3)C(F)(F)F)C(F)(F)F)C(=O)OC,torcetrapib,-6.290599,x0434,active-noncovalent
C(C(=O)[O-])[NH3+],AZD4282,-6.288817,x0397,active-noncovalent
CN(CCOP(=O)([O-])[O-])C(=[NH2+])N,creatinol-phosphate,-6.288644,x0678,active-noncovalent
Cc1cc(n(n1)c2cccc(c2)[C@H](CC(=O)[O-])C[N@H+]3CC[C@H](C3)CCc4ccc5c(n4)NCCC5)C,integrin-antagonist-1,-6.286559,x0195,active-noncovalent
CCSC(=[NH2+])N,EIT-hydrobromide,-6.284570,x0195,active-noncovalent
CCCCc1[nH+]c(cn1c2ccc(cc2)Oc3ccc(cc3)Cl)c4ccc(cc4)OCCC[NH+](CC)CC,azeliragon,-6.280085,x1249,active-noncovalent
c1ccc2c(c1)C3(C(=O)N2)OCC4(CO3)COC5(c6ccccc6NC5=O)OC4,JW-67,-6.277957,x1077,active-noncovalent
Cc1cc(cc(c1)NC(=O)Nc2ccc(cc2)OS(=O)(=O)N)C,S4,-6.274925,x0161,active-noncovalent
CCCCCCCCNC(=O)/C(=C/c1cn(c2c1cccc2)CCC[NH+](C)C)/C#N,dynole-34-2,-6.273475,x0161,active-noncovalent
C[C@H]1[C@H](O1)P(=O)([O-])[O-],fosfomycin,-6.271924,x0397,active-noncovalent
COc1ccc(cc1OP(=O)([O-])[O-])CS(=O)(=O)/C=C/c2c(cc(cc2OC)OC)OC,briciclib,-6.271150,x0874,active-noncovalent
C1[C@H]([C@H]([C@@H]([C@](O1)(CO)O)O)O)O,tagatose,-6.265881,x0397,active-noncovalent
CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,calpeptin,-6.265189,x0195,active-noncovalent
C[C@@H](C(=O)[O-])[NH3+],L-alanine,-6.264976,x0397,active-noncovalent
C[C@@H](C(=O)[O-])[NH3+],alanine,-6.264976,x0397,active-noncovalent
CC(=O)Nc1ncc(s1)N(=O)=O,nithiamide,-6.264691,x0195,active-noncovalent
CC1(CC(CC(N1[O-])(C)C)O)C,tempol,-6.263585,x0678,active-noncovalent
Cc1c2ccc(cc2oc(=O)c1Cc3ccnc(c3F)NS(=O)(=O)NC)Oc4ncccn4,Ro-5126766,-6.262840,x0104,active-noncovalent
c1ccc(c(c1)[C@@H](C(=O)NC2CC(C2)(F)F)N(c3cc(cnc3)F)C(=O)[C@@H]4CCC(=O)N4c5cc(ccn5)C#N)Cl,ivosidenib,-6.262630,x0072,active-noncovalent
C1[C@H](CN(C1=O)CC(=O)N)O,oxiracetam,-6.261655,x0678,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@]([C@H]2O)(CO)O)CO)O)O)O)O,lactulose,-6.258671,x0397,active-noncovalent
C[C@@H](Cn1cnc2c1ncnc2N)OC[P@@](=O)(N[C@H](C)C(=O)OC(C)C)Oc3ccccc3,tenofovir-alafenamide,-6.257431,x0161,active-noncovalent
CC(=O)N[C@@H]1C[C@@H]([C@H](O[C@H]1O[C@H]2[C@@H]([C@H]([C@@H](O[C@@H]2C(=O)[O-])O)O)O)CO)O,hyaluronic-acid,-6.257191,x0967,active-noncovalent
CC(C)(C(=O)[O-])Sc1ccc(cc1)CCN(CCCCC2CCCCC2)C(=O)NC3CCCCC3,GW-7647,-6.256680,x1077,active-noncovalent
CC(=O)O[C@H]1C[C@@]2([C@@H](O2)CC[C@]3([C@H](O3)C[C@H]4CC(=O)C(=C)[C@@H]1C4(C)C)C)C,hypoestoxide,-6.256434,x1077,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CCC(=O)[O-])C)(C)C(=O)[O-],carbenoxolone,-6.254039,x0104,active-noncovalent
COc1cccc(c1)c2cc(nc(n2)N)NCc3ccc4c(c3)OCO4,BML-284,-6.253788,x0161,active-noncovalent
CNC(=O)[C@@H](c1ccccc1)[N@H+]2CCc3cc(c(cc3[C@@H]2CCc4ccc(cc4)C(F)(F)F)OC)OC,almorexant,-6.251147,x0434,active-noncovalent
c1(=O)[nH]c(=O)n(c(=O)n1Cl)Cl,troclosene,-6.250667,x0678,active-noncovalent
C(/C(=C/C(=O)[O-])/C(=O)[O-])C(=O)[O-],cis-aconitic-acid,-6.250174,x0397,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,lacitol,-6.247335,x0161,active-noncovalent
CCOc1ccccc1n2c(=O)c3ccccc3nc2[C@@H](C)[NH+]4CCN(CC4)C(=O)COc5ccc(cc5)Cl,erastin,-6.245820,x0104,active-noncovalent
Cn1c(ccn1)c2c3ccccc3c(nn2)N4CCC(CC4)N(C)C(=O)c5ccc(cc5C(F)(F)F)F,taladegib,-6.245088,x0104,active-noncovalent
C1CCN(C1)C(=S)S,pyrrolidine-dithiocarbamate,-6.243721,x0195,active-noncovalent
Cc1c(cc(c(=O)n1c2cccc(c2)C(F)(F)F)C(=O)NCc3ccc(cn3)S(=O)(=O)C)c4ccnn4C,AZD9668,-6.242570,x0434,active-noncovalent
C1[C@@H]([C@@H]2[C@H](O1)[C@@H](CO2)ON(=O)=O)O,isosorbide-mononitrate,-6.241794,x0195,active-noncovalent
CC(=O)OCC[N+](C)(C)C,acetylcholine,-6.241586,x0161,active-noncovalent
CCOCOC[C@H](C[C@H](C)C(=O)NO)NC(=O)c1ccc(cc1)Oc2ccccc2,ONO-4817,-6.240033,x1077,active-noncovalent
c1ccc2c(c1)c(ccn2)C(=O)N[C@H]3CCN([C@@H](C3)Cc4ccc(cc4)Cl)C(=O)c5cc(cc(c5)C(F)(F)F)C(F)(F)F,AV-608,-6.237064,x0434,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)[O-],quinapril,-6.235715,x0107,active-noncovalent
CC(C)(C#Cc1cc2c(cc1NC(=O)C=C)c(ncn2)Nc3ccc(c(c3)Cl)F)[NH+]4CCN(CC4)C,AV-412,-6.233950,x0305,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])(C(=O)CO)O)[NH3+])O,doxorubicin,-6.232330,x0161,active-noncovalent
C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC(C)(C)CNC(=O)[C@@H](C(C)C)[NH3+])C,valnemulin,-6.231472,x1077,active-noncovalent
C1CC(=O)N[C@@H]1C(=O)[O-],pidolic-acid,-6.229568,x0397,active-noncovalent
COCc1nnc(n1c2ccc(nc2)OC)N3CC(C3)Oc4ccc(cc4Cl)F,PF-3274167,-6.229277,x1077,active-noncovalent
CCOC(=O)[C@H](C)Oc1cccc2c1ccn(c2=O)CC(=O)Nc3ccc4c(c3)OCCO4,SID-7969543,-6.225727,x0104,active-noncovalent
Cc1cc(nc(n1)N)Nc2ccc(cc2)NC(=O)c3ccc(cc3)Nc4ccnc5c4cccc5,SGI-1027,-6.225705,x0305,active-noncovalent
Cc1c(cc(cc1F)C(=O)NC2CC2)c3ccc(cn3)C(=O)NCC(C)(C)C,losmapimod,-6.224504,x0874,active-noncovalent
c1c(o[nH]c1=O)C[NH3+],muscimol,-6.222374,x0708,active-covalent
C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@H]([C@]5(C)C(=O)[O-])OC(=O)C)C)C)[C@@H]2[C@H]1C)C)C,AKBA,-6.219287,x0072,active-noncovalent
C[C@@H]1CCC[C@@H]([NH2+]1)C,"2,6-dimethylpiperidine",-6.217931,x0354,active-noncovalent
Cc1c(c(=O)ccn1C)[O-],deferiprone,-6.215428,x0195,active-noncovalent
COCC[NH+]1CCC(CC1)(C(=O)NO)S(=O)(=O)c2ccc(cc2)Oc3ccc(cc3)OC(F)(F)F,SD-2590,-6.215165,x0161,active-noncovalent
Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)CO,tedizolid,-6.214591,x0104,active-noncovalent
C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,meglumine,-6.214108,x0195,active-noncovalent
CNc1cc2c(cc1F)c(=O)n(c(=O)[nH]2)c3ccc(cc3)NC(=O)NS(=O)(=O)c4ccc(s4)Cl,elinogrel,-6.212714,x0104,active-noncovalent
COc1ccc(cc1)C2(CCOCC2)CNC(=O)c3ccc(cc3)NC(=O)c4ccco4,JW-55,-6.212562,x0104,active-noncovalent
C1[C@H](C[NH2+][C@H]1C(=O)[O-])O,L-Hydroxyproline,-6.212473,x0397,active-noncovalent
C[NH+]1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)O,scopine,-6.211310,x0354,active-noncovalent
C(CC(=O)[O-])CO,sodium-oxybate,-6.211149,x0397,active-noncovalent
c1ccc2cc(ccc2c1)S(=O)(=O)N3CCN(CC3)c4ncc(cn4)C(=O)NO,R306465,-6.211020,x0831,active-covalent
c1c[nH+]ccc1N,dalfampridine,-6.206439,x0678,active-noncovalent
c1cc(ccc1c2c(c(nc(c2C#N)SCc3csc(n3)c4ccc(cc4)Cl)N)C#N)OCCO,capadenoson,-6.204699,x0967,active-noncovalent
c1ccc(cc1)CCCC[P@@](=O)(CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3)[O-],fosinoprilat,-6.203476,x0195,active-noncovalent
CN(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)N=O,2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose,-6.202899,x0678,active-noncovalent
c1cc(ccc1C(=O)[O-])S(=O)(=O)N,carzenide,-6.200413,x1493,active-covalent
CSc1ccccc1Nc2c3c(c(ncn3)NCC4CC4)nc(n2)N5CC[NH2+]CC5,KHK-IN-1,-6.200347,x0161,active-noncovalent
C([C@H]([C@@H](C(=O)CO)O)O)O,xylose,-6.198619,x0397,active-noncovalent
C[N+](C)(C)NCCC(=O)[O-],meldonium,-6.194065,x0759,active-covalent
CCOC(=O)[C@H](CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@H](c2ccccc2)C(=O)OCC)[NH3+],ezatiostat,-6.192182,x0072,active-noncovalent
C1(C(C(C(C(C1Br)Br)Br)Br)Br)Br,"1,2,3,4,5,6-hexabromocyclohexane",-6.188857,x0195,active-noncovalent
c1cc2c(cc1NC(=O)Nc3ccc4c(c3)cc(cc4O)S(=O)(=O)[O-])cc(cc2O)S(=O)(=O)[O-],AMI-1,-6.188503,x0072,active-noncovalent
CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,topiramate,-6.187458,x0072,active-noncovalent
c1cc(c(cc1N(=O)=O)N(=O)=O)[O-],"2,4-dinitrophenol",-6.177756,x0195,active-noncovalent
C(=O)(N)/N=N/C(=O)N,azodicarbonamide,-6.175929,x0397,active-noncovalent
CC(C)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C,C34,-6.174691,x0195,active-noncovalent
CC1(CCCC([NH+]1C)(C)C)C,pempidine,-6.173277,x1418,active-covalent
C1C[NH2+]CC=C1C(=O)[O-],isoguvacine,-6.172853,x0426,active-noncovalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C,ginsenoside-c-k,-6.170712,x0072,active-noncovalent
CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)c2cccc(c2)NS(=O)(=O)c3ccc(cn3)C(F)(F)F)[O-])CCc4ccccc4,tipranavir,-6.170661,x0678,active-noncovalent
C1[NH+]2CN3CN1CN(C2)C3,methenamine,-6.170158,x0354,active-noncovalent
C1CCN(CC1)c2c3c(c(nc(n3)N(CCO)CCO)N4CCCCC4)nc(n2)N(CCO)CCO,dipyridamole,-6.167103,x0161,active-noncovalent
C(CC(=O)[O-])[C@H](CP(=O)([O-])[O-])C(=O)[O-],PMPA,-6.163751,x1478,active-covalent
c1c(c(c(c(c1I)[O-])I)[O-])I,riodoxol,-6.162321,x0397,active-noncovalent
CCCCCON=O,amyl-nitrite,-6.161128,x0195,active-noncovalent
C(C(F)(F)F)OCC(F)(F)F,flurothyl,-6.159462,x0195,active-noncovalent
C[NH+](C)CCOc1ccc(cc1)c2[nH]c(c(n2)c3ccc4c(c3)CC[C@@H]4N=O)c5ccncc5,SB-590885,-6.157538,x0107,active-noncovalent
C([C@@H]([C@@H]1[C@H]([C@H](C(=O)O1)O)O)O)O,sodium-ascorbate,-6.155290,x0195,active-noncovalent
C=CCS[S@@](=O)CC=C,allicin,-6.153313,x0195,active-noncovalent
C1[C@H](C(=O)NO1)[NH3+],cycloserine-(d),-6.152460,x0708,active-covalent
c1ccc(cc1)[C@H](C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4ccc(cc4)C(=O)N)C(=O)[O-])S(=O)(=O)[O-],cefsulodin,-6.152397,x0967,active-noncovalent
C[C@@H](C(=O)N[C@@H](C)P(=O)([O-])[O-])[NH3+],alafosfalin,-6.152182,x0397,active-noncovalent
CCCCCCCCOc1ccccc1C(=O)Nc2ccc(cc2)C(=O)OCC[N+](C)(CC)CC,otilonium,-6.144907,x0104,active-noncovalent
CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/c1c(cc(c(c1C)C)OC)C,etretinate,-6.139826,x0104,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)N(C)C(=O)C)I)C(=O)[O-])I,metrizoic-acid,-6.134947,x0104,active-noncovalent
C1N2CN3CN1C[N+](C2)(C3)CCO,Y-11,-6.131771,x0734,active-covalent
C1[C@@H](O1)[C@@H]([C@@H]([C@@H]2CO2)O)O,dianhydrogalactitol,-6.129712,x0397,active-noncovalent
C(CC[NH3+])C[NH3+],putrescine,-6.129576,x0708,active-covalent
c1c(c(=O)[nH]c(=O)[nH]1)F,5-fluorouracil,-6.128564,x0678,active-noncovalent
c1cc(c(nc1)[N@]2CCC(=CC2)C(=O)Nc3ccc(cc3)S(=O)(=O)C(F)(F)F)C(F)(F)F,A-784168,-6.127667,x0104,active-noncovalent
CCCCCOc1c(ccc2c1[nH]c(=O)c(c2)C(=O)NCc3ccc4c(c3)OCO4)OC,JTE-907,-6.124097,x0104,active-noncovalent
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CC[NH3+])O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)[NH3+])O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+],amikacin,-6.121760,x0434,active-noncovalent
CC(C)S(=O)(=O)c1ccccc1Nc2ncnc(n2)Nc3ccc(cc3OC)N4CCC(CC4)N5CC[NH+](CC5)C,ASP3026,-6.113815,x0104,active-noncovalent
C[Si](C)(C)O[Si](C)(C)C,dimethicone,-6.111279,x0161,active-noncovalent
COc1ccc(cc1OC)S(=O)(=O)[N@@]2CCC[N@](CC2)S(=O)(=O)c3ccc(c(c3)OC)OC,SB-756050,-6.111258,x1077,active-noncovalent
C([C@@H](C(=O)[O-])[NH3+])n1c(=O)[n-]c(=O)o1,L-Quisqualic-acid,-6.103328,x0195,active-noncovalent
C[C@@H]1C(=O)NC(=O)N1,5-methylhydantoin-(D),-6.101764,x0397,active-noncovalent
c1ccc(c(c1)N)S(=O)(=O)N,2-aminobenzenesulfonamide,-6.101264,x0678,active-noncovalent
[C@@H]1(C(=O)NC(=O)N1)NC(=O)N,allantoin,-6.096950,x0397,active-noncovalent
COP(=O)(OC)OC=C(Cl)Cl,dichlorvos,-6.096808,x1311,active-covalent
Cc1c(c(c2ccccc2n1)c3ccc4c5c3nccc5CCO4)[C@@H](C(=O)[O-])OC(C)(C)C,BI-224436,-6.093194,x0831,active-covalent
CNC(=O)c1cc(ccn1)Oc2ccc(c(c2)F)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl,regorafenib,-6.092853,x0104,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cn2)C(C)(C)NC(=O)c3cc4c(cc3F)c(=O)c5ccccc5[nH]4,BMS-566419,-6.091782,x0104,active-noncovalent
c1cc(cc(c1)C(F)(F)F)CC(=O)Nc2cc(ccc2F)Oc3ccc4c(c3C#N)sc(n4)NC(=O)C5CC5,TAK-632,-6.088855,x0434,active-noncovalent
CC(=O)NCC(=O)N[C@H](CCC(=O)[O-])C(=O)[O-],N-acetylglycyl-D-glutamic-acid,-6.088543,x0678,active-noncovalent
Cc1c(cccc1Cl)S(=O)(=O)Nc2c3c(nc(n2)NCCc4ccccc4)CC[N@H+](C3)Cc5ccccc5,CaMKII-IN-1,-6.087747,x1077,active-noncovalent
c1ccc(cc1)/C=C/C(=O)N[C@@H](C(Cl)(Cl)Cl)NC(=S)Nc2ccc(cc2)Cl,sal003,-6.086724,x0195,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@H]([C@@H]([C@@H]1Cl)Cl)Cl)Cl)Cl)Cl,lindane,-6.085452,x0072,active-noncovalent
c1cc(ccc1CN2CC[NH+](CC2)Cc3ccncc3)c4ccc(cc4F)C(C(F)(F)F)(C(F)(F)F)O,SR-2211,-6.084247,x0104,active-noncovalent
CC1=C([C@H](C(=C(N1)C)C(=O)OCCC[NH+]2CCC(CC2)(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,dexniguldipine,-6.079570,x0104,active-noncovalent
C([C@H]1[C@@H]([C@H]([C@@H](C(=O)O1)O)O)O)O,gluconolactone,-6.077347,x0195,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)[O-],ramipril,-6.076232,x0831,active-covalent
Cc1cc(ncn1)c2ccc3c(c2)CC[C@H]3[NH+]4CC5(C4)CCN(CC5)C(=O)Cc6cn7cc(sc7[nH+]6)C,PF-05190457,-6.075219,x0395,active-noncovalent
c1cc(cc(c1)Oc2ccc(cn2)C(F)(F)F)C=C3CCN(CC3)C(=O)Nc4cccnn4,PF-04457845,-6.074865,x0967,active-noncovalent
C1CN(C(=O)[C@@H]1[NH3+])O,HA-966-(R)-(+),-6.074100,x0195,active-noncovalent
C(CC(=O)NCCO)CO,etoxybamide,-6.073131,x0195,active-noncovalent
c1cc(cnc1)C(=O)OCC(COC(=O)c2cccnc2)(COC(=O)c3cccnc3)COC(=O)c4cccnc4,niceritrol,-6.072967,x0434,active-noncovalent
Cc1cc([nH]n1)Nc2cc(nc(n2)Sc3ccc(cc3)NC(=O)C4CC4)N5CC[NH+](CC5)C,tozasertib,-6.060990,x0072,active-noncovalent
CCc1nn(c(=O)n1CCOc2ccccc2)CCC[NH+]3CCN(CC3)c4cccc(c4)Cl,nefazodone,-6.057721,x0161,active-noncovalent
C[N@@H+]1CCc2cc(c3cc2[C@H]1Cc4ccc(c(c4)Oc5ccc(cc5)C[C@H]6c7c(cc8c(c7O3)OCO8)CC[N@H+]6C)OC)OC,cepharanthine,-6.054167,x0104,active-noncovalent
CC1=CC(=O)[N-]S(=O)(=O)O1,acesulfame-potassium,-6.053989,x0107,active-noncovalent
Cc1ccc(cc1Nc2ncc(cn2)c3cncnc3)NC(=O)c4ccc(c(c4)C(F)(F)F)C[N@@H+]5CC[C@H](C5)N(C)C,bafetinib,-6.053698,x0305,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)ON(=O)=O)ON(=O)=O,isosorbide-dinitrate,-6.053446,x0195,active-noncovalent
C/C(=C/C(=O)[O-])/O,lithium-acetoacetate,-6.053140,x0397,active-noncovalent
CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,N-acetyl-D-glucosamine,-6.051872,x0161,active-noncovalent
CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-],aceglutamide,-6.051047,x0678,active-noncovalent
CCC[C@H](c1ccc2c(c1)OCO2)NC(=O)N3[C@H](C(C3=O)(CC)CC)Oc4ccc(cc4)C(=O)N5CC[NH+](CC5)C,DMP-777,-6.048290,x0104,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2Cc3cc(c(cc3C[C@H]2C(=O)[O-])OC)OC,moexipril,-6.047195,x0161,active-noncovalent
C(CC(=O)[O-])C(=O)[O-],succinic-acid,-6.045701,x0397,active-noncovalent
C[C@H](c1nnc2n1cc(cc2F)c3cnn(c3)C)n4ccc5c(c4=O)cc(cn5)OCCOC,AMG-337,-6.044123,x0161,active-noncovalent
c1ccc2c(c1)[nH]c(=O)n2C3CC[NH+](CC3)CCNC(=O)c4cc5cc(ccc5[nH]4)F,FIPI,-6.042112,x0434,active-noncovalent
C[N+](C)(C)CC(=O)[O-],betaine,-6.036696,x0397,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O,sucrose,-6.036209,x0161,active-noncovalent
CC[C@@H]1C(=O)/N=C(/C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)\C(C)C,romidepsin,-6.031364,x0678,active-noncovalent
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@H](C(=O)NC)C(C)(C)C,marimastat,-6.031151,x0195,active-noncovalent
C[NH+](CCCl)CCCl,mechlorethamine,-6.030697,x0104,active-noncovalent
COC(=O)/C=C/C(=O)OC,dimethyl-fumarate,-6.027863,x0749,active-covalent
CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C1=O)(C)CC(=O)[O-])c2cccc(c2)Cl)c3ccc(cc3)Cl,AMG-232,-6.026146,x0678,active-noncovalent
Cn1cc(cn1)c2ccc(cc2)S(=O)(=O)n3ccc(c3)/C=C/C(=O)Nc4ccccc4N,4SC-202,-6.025577,x0161,active-noncovalent
CCCC(=O)[O-],sodium-butyrate,-6.025297,x0397,active-noncovalent
CC([N@@H+]([C@H]1C[C@H](C1)CCc2nc3c([nH]2)ccc(c3)C(C)(C)C)C[C@H]4O[C@H]([C@@H]([C@@H]4O)O)n5c6ncnc(c6nc5)N)C,EPZ-5676,-6.020384,x0434,active-noncovalent
C(=O)([O-])P(=O)([O-])[O-],foscarnet,-6.019588,x0397,active-noncovalent
CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@@H]1[C@H](C([C@@H](O1)n2ccc(nc2=O)N)(F)F)O,gemcitabine-elaidate,-6.010929,x0305,active-noncovalent
CC(C)(C)C[NH2+]Cc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,omadacycline,-6.010816,x0395,active-noncovalent
C[C@@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O)O)O)O,L-(+)-Rhamnose-Monohydrate,-6.010091,x0397,active-noncovalent
CCc\1c(c2/cc\3/c(c(c(n3)/cc\4/c(c(c(n4)/cc\5/c(c(c(n5)/cc1\n2)C)C=C)C)CCC(=O)[O-])CCC(=O)[O-])C)C,protoporphyrin-ix,-6.006186,x0161,active-noncovalent
Cc1c(c(on1)C)c2ccc3c(c2)nc(n3C[C@H](C)[NH+]4CCOCC4)CCc5ccc(c(c5)Cl)OC,SGC-CBP30,-6.006063,x1077,active-noncovalent
CN(C)C(=S)SC(=S)N(C)C,tetramethylthiuram-monosulfide,-6.000518,x0397,active-noncovalent
c1cc(oc1CO)C=O,5-HMF,-5.999448,x0195,active-noncovalent
C[C@@H](Cc1ccccc1)Oc2cc(cc(c2)O[C@@H](C)COC)C(=O)Nc3ccc(cn3)C(=O)[O-],GKA-50,-5.998562,x1077,active-noncovalent
CC(=C)[C@H]1C[NH2+][C@@H]([C@H]1CC(=O)[O-])C(=O)[O-],kainic-acid,-5.996588,x0678,active-noncovalent
C[C@@H](c1c(c(=O)c2cc(ccc2o1)F)c3cccc(c3)F)n4c5c(c(n4)c6ccc(c(c6)F)OC(C)C)c(ncn5)N,TGR-1202,-5.995760,x0161,active-noncovalent
CCn1c2c(c(=O)n(c1=O)CC)n(c(n2)/C=C/c3ccc(c(c3)OC)OC)C,istradefylline,-5.995617,x0104,active-noncovalent
[C@@H](C(Cl)(Cl)Cl)(NC(=O)N[C@H](C(Cl)(Cl)Cl)O)O,dicloralurea,-5.995288,x0195,active-noncovalent
CCC[C@@H](c1cccnc1)Nc2c(cnc(n2)c3ccc(c(c3)OC)NC(=O)NCC)C,CYT-997,-5.988197,x0161,active-noncovalent
CCC(C)(C)C(=O)[O-],HQK-1001,-5.987889,x0397,active-noncovalent
C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O,alpha-D-glucopyranose,-5.986013,x0397,active-noncovalent
C[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)Cc5ccccc5)OC)OC,BIX-01294,-5.983993,x0104,active-noncovalent
C[NH+]1CCN(CC1)CCCOc2cc3c(cc2OC)c(c(cn3)C#N)Nc4cc(c(cc4Cl)Cl)OC,bosutinib,-5.977585,x0104,active-noncovalent
CC(C)(C)N(=Cc1ccc(cc1S(=O)(=O)[O-])S(=O)(=O)[O-])=O,NXY-059,-5.972500,x0830,active-covalent
c1c([nH]c(=O)[nH]c1=O)C(=O)[O-],orotic-acid,-5.968839,x0397,active-noncovalent
CC1([C@]2(C(=O)/C(=C\c3ccc(cc3)/C=C/4\C(=O)[C@@]5(C([C@H]4CC5)(C)C)CS(=O)(=O)[O-])/[C@@H]1CC2)CS(=O)(=O)[O-])C,ecamsule-triethanolamine,-5.963475,x0161,active-noncovalent
CC(C)[C@@](CCC[N@@H+](C)CCc1ccc(c(c1)OC)OC)(C#N)c2ccc(c(c2)OC)OC,verapamil,-5.957987,x0434,active-noncovalent
CCNC(=O)C#Cc1ccc2c(c1)[nH]c(c2/C(=N\c3ccc(cc3)C[NH+](C)C)/c4ccccc4)O,BI-847325,-5.956319,x0678,active-noncovalent
C[C@@H]1CC[C@@H](C[N@@]1c2cc(nc(n2)NC)c3ccc4c(c3)n[nH]c4N)C(=O)NC5CCCCC5,GSK2334470,-5.955046,x1077,active-noncovalent
C[C@@H](C(=O)NCC(=O)[O-])S,tiopronin,-5.948997,x1402,active-covalent
c1c2c(c-3cc(c(=O)c(c3oc2c(c(c1I)[O-])I)I)I)c4c(c(c(c(c4Cl)Cl)Cl)Cl)C(=O)[O-],rose-bengal,-5.948451,x0831,active-covalent
CCCCCC[C@@H]1[C@H]([C@@H](OC(=O)[C@@H]([C@H](OC1=O)C)NC(=O)c2cccc(c2O)NC=O)C)OC(=O)CC(C)C,antimycin-a,-5.943910,x0434,active-noncovalent
C1C(=O)NCC(=O)N1,piperazinedione,-5.934034,x0397,active-noncovalent
c1ccc(cc1)CCCCOc2ccc(cc2)C(=O)Nc3cccc4c3oc(cc4=O)c5[n-]nnn5,pranlukast,-5.921621,x0161,active-noncovalent
[C@H](C(OC(F)F)(F)F)(F)Cl,enflurane,-5.918174,x0195,active-noncovalent
CC[C@H](C)[C@@H](CC)C(=O)N,valnoctamide,-5.918057,x0397,active-noncovalent
C(/C=C/C(=O)[O-])O,trans-4-Hydroxycrotonic-acid,-5.915820,x0397,active-noncovalent
Cn1c(=O)cnn(c1=O)CCCC[NH+]2CCN(CC2)c3ncccn3,F-11440,-5.913647,x0967,active-noncovalent
C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[NH3+])O,epirubicin,-5.908774,x0072,active-noncovalent
c1c[nH]c(=S)[nH]c1=O,2-thiouracil,-5.908463,x0678,active-noncovalent
CCN(CC)C(=S)S,ditiocarb-sodium-trihydrate,-5.906865,x0195,active-noncovalent
Cc1ccc(cc1C#Cc2c[nH+]c3n2nccc3)C(=O)Nc4ccc(c(c4)C(F)(F)F)C[NH+]5CCN(CC5)C,ponatinib,-5.897119,x0072,active-noncovalent
COP(=O)([C@H](C(Cl)(Cl)Cl)O)OC,metrifonate,-5.890461,x0678,active-noncovalent
CCC[C@@H](C)C1(C(=O)NC(=S)NC1=O)CC,thiopental,-5.886500,x0874,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O,forskolin,-5.886298,x1077,active-noncovalent
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@@H]5C[C@@H]6c7cccc8c7c(c[nH]8)C[C@H]6[N@@H+](C5)C,dihydroergotamine,-5.886262,x0434,active-noncovalent
CO[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2OC,dimethyl-isosorbide,-5.885822,x0195,active-noncovalent
Cc1nc(cs1)/C=C(\C)/[C@H]2C[C@H]3[C@](O3)(CCC[C@@H]([C@@H]([C@H](C(=O)C([C@@H](CC(=O)O2)O)(C)C)C)O)C)C,epothilone-b,-5.884714,x0161,active-noncovalent
C(P(=O)([O-])[O-])P(=O)([O-])[O-],medronic-acid,-5.884517,x0397,active-noncovalent
C=COCC(F)(F)F,fluroxene,-5.883624,x0195,active-noncovalent
CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3NCc4cccc(c4)I)O)O,IB-MECA,-5.881217,x0104,active-noncovalent
CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)OC(=O)CC[NH+](C)C,colforsin-daproate,-5.878110,x1077,active-noncovalent
COc1cc(c(c2c1OCO2)c3c(cc(c4c3OCO4)OC)C(=O)OC)C(=O)OC,bifendate,-5.876218,x1093,active-noncovalent
c1([nH]c(=O)[nH]c(=O)n1)C(=O)[O-],oxonic-acid,-5.875919,x0397,active-noncovalent
COC(=O)[C@H](CS)[NH3+],mecysteine,-5.873409,x1077,active-noncovalent
CC[NH2+][C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@@](CO2)(C)O)[NH2+]C)O)O)O[C@@H]3[C@@H](CC=C(O3)C[NH3+])[NH3+])[NH3+],netilmicin,-5.867146,x0161,active-noncovalent
C/C=C/C=C/C(=O)[O-],sorbic-acid,-5.865325,x1402,active-covalent
CC(O)(P(=O)([O-])[O-])P(=O)([O-])[O-],etidronic-acid,-5.864782,x0397,active-noncovalent
C[C@H]1C(=O)NC(=O)N1,5-methylhydantoin-(L),-5.862810,x0397,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC(C)C)c2ccccc2N(=O)=O)C(=O)OC,nisoldipine,-5.862644,x0195,active-noncovalent
CC(C)(C)CC(=O)Nc1c(cc(cc1F)C(=O)/N=c\2/n(ccs2)COP(=O)([O-])[O-])F,Lu-AA-47070,-5.862073,x0161,active-noncovalent
C1[C@H]([NH2+]CS1)C(=O)[O-],timonacic,-5.857564,x0397,active-noncovalent
CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](c3ccc(cc3)F)C(F)(F)F,VBY-825,-5.851007,x0195,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)O)OC)OCO5)O)O,etoposide,-5.850513,x0305,active-noncovalent
C=CCNC(=S)N,allylthiourea,-5.850431,x1077,active-noncovalent
C([C@@H]1[C@@H]([C@@H]([C@@H]([C@@H](O1)O)F)O)O)O,2-fluoro-2-deoxy-D-galactose,-5.846755,x0397,active-noncovalent
c1c[nH]c2c1c(ncn2)c3cnn(c3)C4(C[NH+](C4)C5CCN(CC5)C(=O)c6ccnc(c6F)C(F)(F)F)CC#N,itacitinib,-5.845541,x0104,active-noncovalent
CC(C)C[N@](C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)c3ccc(cc3)N,amprenavir,-5.843825,x1077,active-noncovalent
Cc1c(c(=O)n(n1CC(C)(C)O)c2ccccc2)C(=O)Nc3ccc(cn3)Oc4ccnc5c4ccc(c5)OC,AMG458,-5.843764,x0395,active-noncovalent
CC(C)(CNc1nc(nc(n1)Nc2ccnc(c2)C(F)(F)F)c3cccc(n3)C(F)(F)F)O,enasidenib,-5.841792,x0195,active-noncovalent
C[N@@H+](CCc1ccc(cc1)NS(=O)(=O)C)CCOc2ccc(cc2)NS(=O)(=O)C,dofetilide,-5.833112,x0874,active-noncovalent
CC[C@@H](C)Nc1cc(c(cc1C(=O)N)C)C(=O)NC2C[C@H]3CC[C@@H](C2)N3c4ccc(cn4)C(=O)C5CC5,XL888,-5.833009,x1093,active-noncovalent
C[C@](C(=O)Nc1ccc(cc1Cl)S(=O)(=O)c2ccc(cc2)C(=O)N(C)C)(C(F)(F)F)O,AZD7545,-5.831319,x0072,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@@H](C)C(=O)N2[C@H](CN(C2=O)C)C(=O)[O-],imidapril,-5.821062,x0749,active-covalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC(C)(C)C[N@@H+](C)CCC(c2ccccc2)c3ccccc3)c4cccc(c4)N(=O)=O)C(=O)OC,lercanidipine,-5.820556,x0434,active-noncovalent
c1csc(n1)N,aminothiazole,-5.819404,x0397,active-noncovalent
CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)Nc2ccc(cc2OC)C(=O)[O-])c3cccc(c3F)Cl)(C#N)c4ccc(cc4F)Cl,idasanutlin,-5.817652,x0678,active-noncovalent
Cc1ccc(c(c1)C(=O)N2C[C@@H](CC[C@H]2C)COc3ccc(cn3)F)c4ncccn4,MK-6096,-5.816286,x0678,active-noncovalent
CCc1cnc(nc1)N2CCC(CC2)c3nc(cs3)COc4ccc(cc4)n5cnnn5,MBX-2982,-5.814882,x0967,active-noncovalent
C[N+](C)(CCO)CF,fluoromethylcholine,-5.814754,x0678,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)Nc3c(nc(s3)c4ncco4)c5ccccc5)[NH2+]C,CUDC-427,-5.810103,x0104,active-noncovalent
C[C@@H]1C[NH+](C[C@@H](O1)C)CC(=O)Nc2ccc3c(c2)Cc4cccc(c4S3)c5cc(=O)cc(o5)N6CCOCC6,KU-60019,-5.808309,x0104,active-noncovalent
CC(C)C(C)(C)C,triptan,-5.802810,x0195,active-noncovalent
C1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O,2-deoxyglucose,-5.801751,x0397,active-noncovalent
CCN1CCCC1=O,1-ethyl-2-pyrrolidone,-5.793274,x0195,active-noncovalent
CNC(=O)c1ccc(cc1)Nc2ncc(c(n2)NCc3c(nccn3)[N@@](C)S(=O)(=O)C)C(F)(F)F,defactinib,-5.791530,x0161,active-noncovalent
Cc1ccc(cc1OC)C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3c(nc4ccccc4n3)Nc5cc(cc(c5)OC)OC,SAR-245409,-5.791416,x0104,active-noncovalent
c1c(cc(c2c1CCc3cc(cnc3[C@@H]2C4CCN(CC4)C(=O)CC5CCN(CC5)C(=O)N)Br)Br)Cl,lonafarnib,-5.787611,x0434,active-noncovalent
CCC[NH+]1CCN(CC1)c2ccc(cc2)C(=O)NC3(CCCCC3)C(=O)NCC#N,balicatib,-5.784652,x0104,active-noncovalent
c1cc(ccc1c2c(ncnc2OCCOc3ncc(cn3)Br)NS(=O)(=O)N)Br,ACT-132577,-5.761244,x0830,active-covalent
CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,tricaprylin,-5.758681,x0161,active-noncovalent
C[NH+](C)CCS,captamine,-5.755614,x0678,active-noncovalent
B(c1cccc(c1)COc2ccc(cc2)/C=C\3/C(=O)N(C(=O)S3)Cc4ccc(cc4)F)(O)O,HA-130,-5.754289,x0072,active-noncovalent
c1cc(c[n+](c1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N,nadide,-5.750131,x0678,active-noncovalent
CC(C)(C)c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O,terfenadine,-5.745995,x0161,active-noncovalent
CNC(=O)c1c(cccc1F)Nc2c3cc[nH]c3nc(n2)Nc4cc5c(cc4OC)CCN5C(=O)C[NH+](C)C,GSK1838705A,-5.745381,x0195,active-noncovalent
C[C@H](Cc1ccc2c(c1)OC(O2)(C(=O)[O-])C(=O)[O-])[NH2+]C[C@@H](c3cccc(c3)Cl)O,CL316243,-5.744147,x0387,active-noncovalent
C[C@@]1(Cn2cc([nH+]c2O1)N(=O)=O)COc3ccc(cc3)N4CCC(CC4)Oc5ccc(cc5)OC(F)(F)F,delamanid,-5.738438,x0305,active-noncovalent
c1c[nH]c(=O)[nH]c1=O,uracil,-5.734784,x0678,active-noncovalent
CC(C)(C)C(=O)CN1c2ccccc2[N@@](C[C@H](C1=O)NC(=O)Nc3cccc(c3)C(=O)[O-])C4CCCCC4,nastorazepide,-5.733604,x1077,active-noncovalent
Cc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)C[NH+]5CCN(CC5)C,masitinib,-5.724760,x0104,active-noncovalent
C[NH+](C)C1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4ccccc4P(=O)(C)C)Cl,AP26113,-5.720325,x0161,active-noncovalent
C1[C@]([C@@H]2[C@H]([C@@H]2S1(=O)=O)C(=O)[O-])(C(=O)[O-])[NH3+],LY2140023,-5.714149,x1478,active-covalent
C([C@H](C([C@H](CO)O)O)O)O,ribitol,-5.703939,x0397,active-noncovalent
CNC(=O)c1cc(ccn1)Oc2ccc(cc2)Nc3ncc(c(n3)Nc4cccc(c4)NC(=O)C=C)F,CNX-774,-5.703188,x0104,active-noncovalent
CN(C)c1nc(nc(n1)N(C)C)N(C)C,altretamine,-5.702348,x0195,active-noncovalent
CC(=O)/N=c\1/n(nc(s1)S(=O)(=O)N)C,methazolamide,-5.699786,x0195,active-noncovalent
C(NC(=O)N[C@@H]1C(=O)NC(=O)N1CO)NC(=O)N[C@@H]2C(=O)NC(=O)N2CO,imidurea,-5.698697,x0874,active-noncovalent
C(CO)N(c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I)C(=O)CO,ioversol,-5.697652,x1077,active-noncovalent
CC[NH+](CC)CCCCC1CC[NH+](CC1)CC(=O)N2c3ccccc3C(=O)Nc4c2nccc4,AQ-RA741,-5.690072,x1077,active-noncovalent
CC(C)(C)c1ccc(cc1)C(=O)CCC[NH+]2CCC(CC2)OC(c3ccccc3)c4ccccc4,ebastine,-5.686779,x0104,active-noncovalent
C(=[NH2+])(N)N,guanidine,-5.680868,x0104,active-noncovalent
C[NH+]1CCN(CC1)c2ccc(cc2)Nc3nc4ccsc4c(n3)Oc5cccc(c5)NC(=O)C=C,olmutinib,-5.678802,x0104,active-noncovalent
C(=O)(C(Cl)(Cl)Cl)[O-],trichloroacetic-acid,-5.678425,x1478,active-covalent
COc1cc(ccc1O)C[C@@H](CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@@H](Cc3ccc(c(c3)OC)O)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,secoisolariciresinol-diglucoside,-5.674377,x0104,active-noncovalent
Cn1cc(cn1)c2cc3c(ccc4ccc(cc4c3=O)CS(=O)(=O)NCc5ccccn5)nc2,MK-8033,-5.673971,x0161,active-noncovalent
Cc1cc(ccc1CNC(=O)N2CCC[C@H]2C(=S)N3CCC[N@H+](CC3)C)C(=O)N4Cc5cnn(c5Nc6c4cccc6)C,TC-OT-39,-5.673542,x0072,active-noncovalent
Cc1ccc(nc1)S(=O)(=O)Nc2c(c(nc(n2)c3ccncc3)OC)Oc4ccccc4OC,SPP301,-5.672186,x0397,active-noncovalent
CC(C)(c1ccccc1CC[C@H](c2cccc(c2)/C=C/c3ccc4ccc(cc4n3)Cl)SCC5(CC5)CC(=O)[O-])O,montelukast,-5.666364,x0104,active-noncovalent
Cc1cc(=O)c(c[nH]1)C(=O)N[C@H](c2ccc(cc2)O)C(=O)/N=C/3\[C@@H]4N(C3=O)[C@H]([C@@H](CS4)CSc5nnnn5C)C(=O)[O-],cefpiramide,-5.666209,x0434,active-noncovalent
C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,tenofovir-disoproxil,-5.662706,x0072,active-noncovalent
C[C@@H](C[N+](C)(C)C)OC(=O)C,methacholine,-5.659296,x0195,active-noncovalent
COc1cc(ccc1OCC[NH+]2CCCC2)n3cnc4cc(sc4c3=O)c5ccc(cc5)Cl,GW-803430,-5.657758,x0104,active-noncovalent
CN1CCCC1=O,N-methylpyrrolidone,-5.654041,x0678,active-noncovalent
C(C#N)C(=O)NN,cyacetacide,-5.650732,x0195,active-noncovalent
C(C(=O)C(=O)[O-])Br,3-bromopyruvate,-5.647339,x0397,active-noncovalent
CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2nc(nc3NCc4cccc(c4)I)Cl)O)O,CF102,-5.646518,x0104,active-noncovalent
C[NH+](C)CCCC(=O)Nc1ccc(cc1)C(=O)Nc2cccc(c2)Nc3ncc(c(n3)c4c[nH]c5c4cccc5)Cl,THZ1-R,-5.643341,x0104,active-noncovalent
Cc1[nH]ccn1,2-methylimidazole,-5.640254,x0195,active-noncovalent
COC(C(Cl)Cl)(F)F,methoxyflurane,-5.638490,x0195,active-noncovalent
Cn1c2ccc(cc2nc1CNc3ccc(cc3)C(=[NH2+])N)C(=O)N(CCC(=O)[O-])c4ccccn4,dabigatran,-5.636972,x0104,active-noncovalent
CNC(=O)N(C)N=O,nitrosodimethylurea,-5.633204,x0397,active-noncovalent
Cc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2cnn3C4CCCC4)c5ccc(cc5)C[NH+]6CCOCC6)C,EPZ005687,-5.629704,x0104,active-noncovalent
[C@@H](C(F)(F)F)(Cl)Br,halothane,-5.628587,x0678,active-noncovalent
CCCCCCCCCCCCCCCCNc1ccc(cc1)C(=O)[O-],cetaben,-5.628390,x0395,active-noncovalent
c1(=O)n(c(=O)n(c(=O)n1Cl)Cl)Cl,symclosene,-5.627815,x0195,active-noncovalent
CN(C)C(=O)CCS[C@@H](c1cccc(c1)/C=C/c2ccc3ccc(cc3n2)Cl)SCCC(=O)[O-],MK-571,-5.610676,x0395,active-noncovalent
Cc1ccc(cn1)Oc2ccc(cc2C)Nc3c4cc(ccc4ncn3)/C=C/CNC(=O)COC,CP-724714,-5.607467,x0072,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)NC(=O)C)I)C(=O)[O-])I,diatrizoic-acid,-5.603374,x0195,active-noncovalent
CN(C)c1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](Cc4ccc(cc4)OC)[NH3+])O,puromycin,-5.601845,x0387,active-noncovalent
CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C,narlaprevir,-5.600502,x0395,active-noncovalent
Cc1c(cccc1NC(=O)C)Nc2ncnc(n2)N3CCC(CC3)OCc4ccc(cc4)OC(F)(F)F,TC-N-1752,-5.599213,x0104,active-noncovalent
C([C@H](C(=O)[O-])NC(=O)CP(=O)([O-])[O-])C(=O)[O-],sparfosate,-5.590744,x0734,active-covalent
Cc1c(c(ncn1)C)C(=O)N2CCC(CC2)(C)[N@H+]3CC[N@@]([C@H](C3)C)[C@@H](COC)c4ccc(cc4)C(F)(F)F,vicriviroc,-5.589211,x0104,active-noncovalent
CC(=O)Nc1c(c(c(c(c1I)C(=O)[O-])I)C(=O)NC)I,iothalamic-acid-d3,-5.586296,x0967,active-noncovalent
C(CSCCO)O,thiodiglycol,-5.582596,x0195,active-noncovalent
Cc1c2c(c(n(c1=O)C)Nc3ccc(cc3F)I)c(=O)n(c(=O)n2c4cccc(c4)NC(=O)C)C5CC5,trametinib,-5.575613,x0434,active-noncovalent
CCC(=O)O[C@H](C(C)C)O[P@@](=O)(CCCCc1ccccc1)CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3,fosinopril,-5.570315,x0678,active-noncovalent
Cc1c(ccc(n1)S(=O)(=O)C)Nc2c(c(ncn2)OC3CCN(CC3)C(=O)OC(C)C)OC,APD597,-5.565404,x0104,active-noncovalent
CCCN(CCC)C(=O)C1=Cc2ccc(cc2[NH+]=C(C1)N)c3ccc(cc3)C(=O)N4CCCC4,motolimod,-5.565011,x0104,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)[C@@H](c4ccc(cc4)O)C(=O)[O-])OC)OC2)C(=O)[O-],moxalactam,-5.560779,x0387,active-noncovalent
c1cnc([nH]1)N(=O)=O,azomycin-(2-nitroimidazole),-5.558534,x0195,active-noncovalent
COC1[C@@H]([C@H](C([C@@H]([C@@H]1O)O)O)O)O,pinitol,-5.556323,x0354,active-noncovalent
CCOc1c2ccccc2c(c3c1CN(C3=O)c4ccc(cc4)CC(=O)NS(=O)(=O)c5ccccc5)OCC,GW-627368,-5.549321,x1077,active-noncovalent
c1nnc(s1)N,aminothiadiazole,-5.542072,x0397,active-noncovalent
CC(=CCOc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)[O-])OCC=C(C)C)C,sofalcone,-5.541036,x0395,active-noncovalent
CC(C)(CC(=O)[O-])O,beta-hydroxy-beta-methylbutyrate,-5.539313,x0107,active-noncovalent
CC(=O)Nc1nnc(s1)S(=O)(=O)N,acetazolamide,-5.539082,x0195,active-noncovalent
CN([C@@H](C[NH+]1CCCC1)c2ccc(cc2)c3cccc(c3)C(=O)N)C(=O)CN4c5cc(c(cc5OCC4=O)Cl)Cl,GSK-1562590,-5.538746,x0072,active-noncovalent
c1cc(c(nc1)N2CCN(CC2)C(=O)Nc3ccc(cn3)C(F)(F)F)C(F)(F)F,JNJ-17203212,-5.534068,x1077,active-noncovalent
CCC(CC)(C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)NC1(CCCC1)C(=O)NC(c2ccc(cc2)F)c3ccc(cc3)F)NC(=O)C(C)C,MM-102,-5.533144,x0072,active-noncovalent
C(P(=O)([O-])[O-])(P(=O)([O-])[O-])(Cl)Cl,clodronic-acid,-5.513465,x0397,active-noncovalent
CCCSc1nc(c2c(n1)n(nn2)[C@@H]3C[C@@H]([C@@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@@H]4c5ccc(c(c5)F)F,ticagrelor,-5.513294,x0434,active-noncovalent
C(C(CO)(N(=O)=O)Br)O,bronopol,-5.511801,x0678,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]c(=O)on5)C(=O)OCc6c(oc(=O)o6)C,azilsartan-medoxomil,-5.507347,x0967,active-noncovalent
COc1cccc(c1c2cc(nn2c3ccnc4c3ccc(c4)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)[O-])OC,meclinertant,-5.507149,x0678,active-noncovalent
CO/N=C(\c1csc(n1)N)/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)C[n+]4cccc5c4CCC5)C(=O)[O-],cefpirome,-5.504015,x0874,active-noncovalent
c1ccc(cc1)Oc2cccc(c2)CN([C@H]3CCCc4c3cccc4)C(=O)c5cc(c(cc5C(=O)[O-])C(=O)[O-])C(=O)[O-],A-317491,-5.503983,x1093,active-noncovalent
C[C@H](CC(C)(C)O)O,hexylene-glycol,-5.492071,x0397,active-noncovalent
C1C(CN1C(=O)CBr)(N(=O)=O)N(=O)=O,RRx-001,-5.483812,x0678,active-noncovalent
C[NH+]1CCN(CC1)C2CCN(CC2)c3ccc(c(c3)OC)Nc4ncc(c(n4)Nc5ccccc5P(=O)(C)C)Cl,brigatinib,-5.483525,x0104,active-noncovalent
c1ccc(cc1)C(C[N@H+](CCCOc2cccc(c2)CC(=O)[O-])Cc3cccc(c3Cl)C(F)(F)F)c4ccccc4,GW-3965,-5.479935,x0434,active-noncovalent
c1cc(oc1/C=N/NC(=O)c2cc(cc(c2[O-])N(=O)=O)N(=O)=O)N(=O)=O,nifursol,-5.476471,x0874,active-noncovalent
C[N+](C)(C)CCO,choline,-5.472346,x0678,active-noncovalent
C([C@H]([C@H](CO)O)O)O,erythritol,-5.464944,x0397,active-noncovalent
CC(C)c1nc(on1)N2CCC(CC2)COc3ccc(nc3)c4ccc(cc4)S(=O)(=O)C,GSK1292263,-5.456628,x0104,active-noncovalent
CCOC(=O)C(=O)C,ethyl-pyruvate,-5.455226,x0195,active-noncovalent
C1CCN(C1)C#N,N-cyanopyrrolidine,-5.454401,x0195,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NCc2cnc3c(n2)c(nc(n3)N)N,aminopterin,-5.449107,x0104,active-noncovalent
CC(=O)C(=O)[O-],2-oxopropanoate,-5.448891,x0689,active-covalent
CC(=O)N1CC[NH+](CC1)CCOc2ccc(cc2)C3CCN(CC3)C4=[NH+]n5c(nnc5C(F)(F)F)CC4,AZD3514,-5.446208,x0104,active-noncovalent
CS(=O)(=O)CS(=O)(=O)OCCCl,clomesone,-5.445204,x0161,active-noncovalent
CC#CC(=O)N1CCC[C@H]1c2nc(c3n2ccnc3N)c4ccc(cc4)C(=O)Nc5ccccn5,acalabrutinib,-5.444638,x0104,active-noncovalent
Cc1ccn(n1)c2cc(ccc2[C@H](C(F)(F)F)Oc3cc(nc(n3)N)c4ccc(cc4)C[C@@H](C(=O)[O-])[NH3+])Cl,telotristat,-5.439402,x0072,active-noncovalent
CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C,aloxistatin,-5.434238,x0107,active-noncovalent
[O-]P(=O)([O-])F,sodium-monofluorophosphate,-5.433599,x0397,active-noncovalent
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)c3ccc(cc3)C[NH2+]Cc4cn[nH]n4,radezolid,-5.433087,x0395,active-noncovalent
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,isosorbide,-5.423580,x0195,active-noncovalent
CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2c(c(nc(n2)c3ncccn3)OCCO)Oc4ccccc4OC,bosentan,-5.420772,x0874,active-noncovalent
COc1cc(c(cc1C(=O)CCCC[NH+]2CCC3(CC2)C(=O)NC(=O)N3)NS(=O)(=O)c4ccc(cc4)C(F)(F)F)OC,RS-102221,-5.419090,x0678,active-noncovalent
C[C@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H]([N@H+](CCO2)Cc3[nH]c(=O)n(n3)P(=O)([O-])[O-])c4ccc(cc4)F,fosaprepitant-dimeglumine,-5.410882,x0107,active-noncovalent
CNC(=O)c1ccccc1Nc2c(cnc(n2)Nc3ccc4c(c3OC)CCC[C@@H](C4)N5CC[NH+](CC5)CCO)Cl,CEP-37440,-5.407353,x0967,active-noncovalent
Cc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2c(cn3C(C)C)C)c4ccc(nc4)N5CC[NH+](CC5)C)C,GSK503,-5.406768,x0305,active-noncovalent
CS(=O)(=O)OCOS(=O)(=O)C,MDMS,-5.404891,x0195,active-noncovalent
CCCC(=O)C1(CCN(CC1)C(=O)[C@@H](Cc2ccc(cc2)OC)NC(=O)[C@H](Cc3cncn3C)[NH3+])c4ccccc4,BMS-470539,-5.397507,x0072,active-noncovalent
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)O,10-deacetylbaccatin,-5.397257,x0831,active-covalent
CC(=O)NCCCS(=O)(=O)[O-],acamprosate,-5.396482,x0831,active-covalent
C(CN(CC(=O)[O-])CC(=O)[O-])[NH+](CC(=O)[O-])CC(=O)[O-],ethylenediaminetetraacetic-acid,-5.394145,x0195,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCC[N@@H+](C)Cc2ccccc2)c3cccc(c3)N(=O)=O)C(=O)OC,nicardipine,-5.390266,x0195,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-],piperacillin,-5.370619,x0072,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,ouabain,-5.369911,x0072,active-noncovalent
CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)[O-])NC(=O)c1ccc(c(c1)Cl)Cl,dexloxiglumide,-5.368523,x0161,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCC[NH+]2CCC(CC2)(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,niguldipine-(S)-(+),-5.364377,x0104,active-noncovalent
COc1cccc(c1)c2ccc(cc2)[C@H](C(F)(F)F)Oc3cc(nc(n3)N)c4ccc(cc4)C[C@@H](C(=O)[O-])[NH3+],LX1031,-5.352212,x0072,active-noncovalent
C([C@H](C=O)O)O,dihydroxyacetone,-5.349813,x0397,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H](c1ccc(cc1)N(=O)=O)O)NC(=O)C(Cl)Cl,chloramphenicol-palmitate,-5.337623,x0967,active-noncovalent
CCNC(=O)Nc1ccc(cc1)c2nc3c(c(n2)N4CCOC[C@@H]4C)CC[N@H+](C3)C5COC5,GDC-0349,-5.336406,x0678,active-noncovalent
Cc1cc(ccc1c2ccccc2)CCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N[C@H](C)c3ccccc3)C(C)(C)C,UK-356618,-5.334187,x0678,active-noncovalent
CCCCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1[C@@H]([C@H](CO1)O)O)O,sorbitan-monostearate,-5.331585,x0305,active-noncovalent
C[C@@H]1Cc2c(c(cc(c2O)NC(=O)/C(=C/C=C\[C@@H]([C@H](/C(=C/[C@@H]([C@H]([C@H](C1)OC)O)C)/C)OC(=O)N)OC)/C)O)NCC=C,retaspimycin,-5.325270,x0967,active-noncovalent
Cc1ccc(cc1Nc2nccc(n2)c3cccnc3)NC(=O)c4ccc(cc4)C[NH+]5CCN(CC5)C,imatinib,-5.324320,x0104,active-noncovalent
CCNC(=O)NS(=O)(=O)c1c(cc(s1)CC(C)C)c2ccc(cc2)Cn3c(c(nc3c4ccccc4)OC)C=O,AVE-0991,-5.311554,x0072,active-noncovalent
CC(=O)c1ccc(cc1)c2ccc(cc2)C(=O)NCCCC[NH+]3CCN(CC3)c4ccccc4OC,GR-103691,-5.308193,x0104,active-noncovalent
C(F)(F)(F)S(=O)(=O)O,bismuth(iii)-trifluoromethanesulfonate,-5.307137,x0354,active-noncovalent
C[C@@H](C(=O)Nc1c(c(c(c(c1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O,iopamidol,-5.305582,x0749,active-covalent
CN(CCOc1ccc(cc1)C[C@H](C(=O)[O-])Nc2ccccc2C(=O)c3ccccc3)c4ccccn4,GW-1929,-5.300721,x0759,active-covalent
C(C[NH3+])CS(=O)(=O)[O-],tramiprosate,-5.272611,x0397,active-noncovalent
B1(OC(=O)C[C@](O1)(CC(=O)[O-])C(=O)[O-])[C@H](CC(C)C)NC(=O)CNC(=O)c2cc(ccc2Cl)Cl,ixazomib-citrate,-5.260876,x0107,active-noncovalent
Cc1cc(ccn1)Cn2c(c(c3ccnc(c3c2=O)OCc4ncccn4)c5cc(c(c(c5)OC)OC)OC)C(=O)OC,T-0156,-5.246767,x1077,active-noncovalent
COc1ncc(cc1)[C@]2(CC[C@H](CC2)[N@H+]3C[C@@H](CC3)NC(=O)CNC(=O)c4cc(ccc4)C(F)(F)F)O,INCB-3284,-5.239776,x0395,active-noncovalent
CC(C)(c1ccc(cc1)C(=O)CCC[NH+]2CCC(CC2)OC(c3ccccc3)c4ccccc4)C(=O)[O-],carebastine,-5.224197,x0395,active-noncovalent
CC(C)CC(=O)N,isovaleramide,-5.209608,x0397,active-noncovalent
c1cc(c(cc1CC[NH2+]CCC(=O)N(CC[NH2+]CCc2ccc(c3c2OCC(=O)N3)O)C4CCCCC4)Cl)Cl,AZ505,-5.205215,x0072,active-noncovalent
c1cc(ccc1CC(=O)N2CCC[C@]23C[C@@H]4N(C3=O)[C@H](CCS4)C(=O)N)NC(=O)COc5ccc(cc5Cl)Cl,ST-2825,-5.198265,x0104,active-noncovalent
c1ccc2c(c1)cccc2Oc3nc(c4c(n3)n(cn4)C5CCCCC5)Nc6ccc(cc6)N7CCOCC7,purmorphamine,-5.197366,x0104,active-noncovalent
CC(=O)N(C(=O)NC)OC(=O)NC,caracemide,-5.193930,x0831,active-covalent
COc1ccc(cc1)/C=C/CCCCOc2ccc(cc2CCC(=O)[O-])C(=O)c3cccc(c3)C(=O)[O-],LY223982,-5.179435,x0104,active-noncovalent
C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)[O-])/C)[C@H](C)O,mupirocin,-5.174232,x0104,active-noncovalent
COc1ccc(cc1)C(=O)C2CC[NH+](CC2)CC(=O)N(Cc3[nH]c(=O)c4c(n3)CCOC4)CC5CC5,NVP-TNKS656,-5.171504,x0678,active-noncovalent
c1ccc(cc1)CCc2ccc(cc2)COc3ccccc3CC[N@@H+](CCCCC(=O)[O-])Cc4ccc(cc4)C(=O)[O-],cinaciguat,-5.161856,x0104,active-noncovalent
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](c2ccc(cc2)O)C(=O)/N=C/3\[C@@H]4N(C3=O)[C@H]([C@@H](CS4)CSc5nnnn5C)C(=O)[O-],cefoperazone,-5.156762,x1077,active-noncovalent
C(CS(=O)(=O)[O-])CS(=O)(=O)[O-],eprodisate,-5.151101,x0397,active-noncovalent
CC(C)(C)[NH2+]CC(=O)Nc1cc(c2c(c1O)C(=C3[C@@H](C2)C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C3=O)O)C(=O)N)[O-])[NH+](C)C)[O-])N(C)C,tigecycline,-5.149228,x0395,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4cccc(c4)NC(=O)C=C)C(F)(F)F,rociletinib,-5.144532,x0434,active-noncovalent
CCCCCCCCCCCCCCCCO[P@](=O)([O-])OCC[N+](C)(C)C,miltefosine,-5.141628,x1077,active-noncovalent
CCOC(=O)N,urethane,-5.139531,x1077,active-noncovalent
Cn1cc(nc1)c2cc3c(s2)c(ccn3)Oc4ccc(cc4F)NC(=S)NC(=O)Cc5ccccc5,MGCD-265,-5.138147,x0967,active-noncovalent
CCC(CON(=O)=O)(CON(=O)=O)CON(=O)=O,propatylnitrate,-5.128494,x1418,active-covalent
CC[C@@H]1[C@@H]([C@H]2[C@](O2)(/C=C/C(=O)[C@H](C[C@H]([C@H]([C@@H]([C@@H](CC(=O)O1)O)C)O[C@@H]3[C@H]([C@@H](C[C@@H](O3)C)[NH+](C)C)O)CC=O)C)C)C,rosamicin,-5.126755,x0104,active-noncovalent
CCOC(=O)[C@H](CCc1ccccc1)[NH2+][C@H]2CS[C@@H](CN(C2=O)CC(=O)[O-])c3cccs3,temocapril,-5.126462,x0072,active-noncovalent
Cc1ccc(cc1NC(=O)c2ccc(cc2)Nc3nc4ccccc4c(n3)c5ccccc5)C[NH2+]C,BMS-833923,-5.120314,x0104,active-noncovalent
Cn1nc(nn1)c2ccc(cn2)c3ccc(cc3F)N4C[C@@H](OC4=O)COP(=O)([O-])[O-],tedizolid-phosphate,-5.112308,x1077,active-noncovalent
C(CCO)CO,"1,4-butanediol",-5.108727,x0397,active-noncovalent
CC(C)(C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)C[N@](c4c3cccc4)S(=O)(=O)C)[NH3+],ibutamoren,-5.089655,x0104,active-noncovalent
COc1cccc2c1[nH]c3c(c2=O)cccc3C(=O)Nc4ccc(cc4)CC[N@@H+]5CCc6cc(c(cc6C5)OC)OC,elacridar,-5.088918,x0395,active-noncovalent
CCc1c(cc(c(c1CC(=O)N(CCOC)CCOC)C(=O)c2ccc(c(c2)OC)OCC[NH+]3CCOCC3)O)O,KW-2478,-5.088754,x0072,active-noncovalent
C[C@]12CC[C@@H]3c4ccc(cc4C[C@H]([C@H]3[C@@H]1CC[C@@H]2O)CCCCCCCCC[S@@](=O)CCCC(C(F)(F)F)(F)F)O,fulvestrant,-5.086489,x0104,active-noncovalent
CC[C@H]([C@@H]1[C@H](C[C@](O1)(CC)[C@@H]2CC[C@@]([C@@H](O2)C)(CC)O)C)C(=O)[C@@H](C)[C@H]([C@H](C)CCc3ccc(c(c3C(=O)[O-])O)C)O,lasalocid,-5.082517,x0072,active-noncovalent
C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C=O)O)OC)O,peruvoside,-5.080227,x0072,active-noncovalent
C(C(CO)(CO)[NH3+])O,trometamol,-5.053106,x0397,active-noncovalent
C[NH+](C)CCn1c(nnn1)SC[C@@H]2CS[C@@H]3/C(=N\C(=O)Cc4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],cefotiam,-5.039997,x0072,active-noncovalent
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)NCc3cc(ccc3Oc4ccc5c(c4)cnn5CCO)F,pexmetinib,-5.023005,x0161,active-noncovalent
COc1cc(ccc1c2cnco2)NC(=O)Nc3cccc(c3)CNC(=O)O[C@H]4CCOC4,merimepodib,-5.021338,x0104,active-noncovalent
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc2ccccc2Cl,ambenonium,-5.018453,x0874,active-noncovalent
c1cc(ccc1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NCc2cnc3c(n2)c(=O)[nH]c(n3)N,folic-acid,-5.014051,x0072,active-noncovalent
CCCn1c(=O)c2c([nH]c(n2)c3ccc(cc3)S(=O)(=O)N4CCN(CC4)c5ccc(cc5)Cl)[nH]c1=O,PSB-603,-5.009697,x0395,active-noncovalent
CC[C@](C)(C#C)O,meparfylon,-5.007377,x1077,active-noncovalent
CC(C)(C(Cl)(Cl)Cl)O,chlorobutanol,-5.002996,x0354,active-noncovalent
Cc1c(c2c3c(cc(c2O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H](/C=C/O[C@@]4(C(=O)c3c1O4)C)OC)C)OC(=O)C)C)O)C)O)C)/C)O)O,rifamycin,-5.001520,x0967,active-noncovalent
CN1CC[NH+](CC1)CCOc2cc3c(c(c2)OC4CCOCC4)c(ncn3)Nc5c(ccc6c5OCO6)Cl,saracatinib,-4.996169,x0161,active-noncovalent
C[C@@]1(CO[C@@H]([C@@H]([C@H]1[NH2+]C)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C[NH3+])O)O)O)[NH3+])NC(=O)[C@H](C[NH3+])O)O,isepamicin,-4.994531,x0104,active-noncovalent
C[N@H+]1CCc2c(sc(n2)C(=O)N[C@H]3C[C@@H](CC[C@@H]3NC(=O)C(=O)Nc4ccc(cn4)Cl)C(=O)N(C)C)C1,edoxaban,-4.992864,x0434,active-noncovalent
c1ccc(cc1)C2(CC2)NC(=O)c3c4ccc(cc4nc(c3C[NH+]5CCC(CC5)[NH+]6CCCCC6)c7cccc(c7)C(F)(F)F)Br,GSK-2193874,-4.984833,x0395,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C/C=C(/C(=O)/N=C/2\CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)\C)C)O)OC,geldanamycin,-4.982176,x0305,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)O[C@@H]2C[C@@H]3C[N@H+]4CCc5c6ccccc6[nH]c5[C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC,deserpidine,-4.969789,x0104,active-noncovalent
CC(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],spaglumic-acid,-4.960925,x0830,active-covalent
C(CS(=O)(=O)[O-])[NH3+],taurine,-4.958286,x0397,active-noncovalent
C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@@H]3c4cc5c(cc4[C@H]([C@@H]6[C@@H]3COC6=O)c7cc(c(c(c7)OC)OP(=O)([O-])[O-])OC)OCO5)O)O,etoposide-phosphate,-4.954970,x0104,active-noncovalent
C([C@@H](CS(=O)(=O)[O-])S)S,DMPS,-4.937604,x1077,active-noncovalent
C(C(Br)(Br)Br)O,tribromoethanol,-4.929557,x0354,active-noncovalent
CC(C)S(=O)(=O)c1ccccc1Nc2c(cnc(n2)Nc3ccc(cc3OC)N4CCC(CC4)N5CC[NH+](CC5)C)Cl,NVP-TAE684,-4.926045,x0104,active-noncovalent
B1(OC(=O)C(O1)(CC(=O)[O-])CC(=O)[O-])[C@H](CC(C)C)NC(=O)CNC(=O)c2cc(ccc2Cl)Cl,MLN9708,-4.922093,x0072,active-noncovalent
CC[NH+]1CCN(CC1)c2ccc(cc2)Nc3cc(ncn3)N(C)C(=O)Nc4c(c(cc(c4Cl)OC)OC)Cl,NVP-BGJ398,-4.917869,x0104,active-noncovalent
C(CS)[NH3+],cysteamine,-4.913909,x1093,active-noncovalent
COC(=O)Nc1ccc(cc1)c2nc3c(cnn3C4CCN(CC4)C(=O)OC)c(n2)N5CCOCC5,WYE-354,-4.907535,x0072,active-noncovalent
CCC(C)(C)O,amylene-hydrate,-4.898151,x0678,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OCCN2CC[NH+](CC2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC,manidipine,-4.881680,x0395,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)P2(=O)OCC(CO2)(C)C)c3cccc(c3)N(=O)=O)C(=O)OCCN(Cc4ccccc4)c5ccccc5,efonidipine-monoethanolate,-4.864570,x0434,active-noncovalent
CCCC(=O)Nc1c2c(ncn1)n(cn2)[C@H]3[C@@H]([C@H]4[C@H](O3)CO[P@@](=O)(O4)[O-])OC(=O)CCC,bucladesine,-4.850514,x1077,active-noncovalent
C([C@H](CS)S)O,dimercaprol,-4.841746,x0678,active-noncovalent
C[NH+]1CCN(CC1)C2CCN(CC2)C(=O)c3ccc(c(c3)OC)Nc4ncc5c(n4)N(c6ccccc6C(=O)N5C)C,LRRK2-IN-1,-4.839262,x0072,active-noncovalent
CCc\1c(c2/cc\3/c(c(c(n3)/c(c\4/c(c(c(n4)/cc/5\nc(/cc1\n2)[C@H]([C@@H]5CC)C)C)C(=O)[O-])/CC(=O)[O-])CCC(=O)[O-])C)C,chlorophyllin,-4.835413,x0967,active-noncovalent
Cc1cccc(c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N4CC[NH+](CC4)CCO)Cl,dasatinib,-4.826037,x0104,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c4c(c3)O[C@@H](CC4=O)c5ccc(cc5)O)[O-])CO)O)O)O)O)O,naringin,-4.796121,x0104,active-noncovalent
C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F,RTA-408,-4.784365,x0305,active-noncovalent
C(=O)(C(=O)O)O,bismuth-oxalate,-4.783651,x0397,active-noncovalent
c1cc(ccc1c2cn(cc(c2=O)C(=O)Nc3ccc(c(c3)F)Oc4ccnc(c4Cl)N)COP(=O)([O-])[O-])F,BMS-817378,-4.779683,x0072,active-noncovalent
CC(C)c1c(c(no1)c2c(cccc2Cl)Cl)COc3ccc(c(c3)Cl)/C=C/c4cccc(c4)C(=O)[O-],GW-4064,-4.779024,x0072,active-noncovalent
COc1ncc2cc(c(=O)[nH]c2n1)C(=O)Nc3cc(ccc3Cl)C(=O)NCc4cccc(c4)Cl,TC-S-7004,-4.778556,x0395,active-noncovalent
CC(C)(c1ccc(cc1)[C@H](CCC[NH+]2CCC(CC2)C(c3ccccc3)(c4ccccc4)O)O)C(=O)[O-],fexofenadine,-4.774792,x0072,active-noncovalent
c1cc(ccc1CCCCn2ccnn2)OCc3coc(n3)/C=C/c4ccc(cc4)C(F)(F)F,mubritinib,-4.773646,x0305,active-noncovalent
CC(C)[N@H+](CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)n3ccc4c3ncnc4N)O)O,EPZ004777,-4.773143,x0104,active-noncovalent
C[NH+](C)C/C=C/C(=O)Nc1cc2c(cc1O[C@H]3CCOC3)ncnc2Nc4ccc(c(c4)Cl)F,afatinib,-4.763764,x0104,active-noncovalent
Cc1c(c(c(c2c1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)CCC(=O)[O-])C,D-alpha-tocopheryl-succinate,-4.746251,x0104,active-noncovalent
COc1ccc(cn1)C2(CCC(CC2)[N@@H+]3CC[C@H](C3)NC(=O)CNC(=O)c4cccc(c4)C(F)(F)F)O,INCB-003284,-4.734503,x0305,active-noncovalent
Cc1cc(cc(c1c2cccc(c2)COc3ccc4c(c3)OC[C@H]4CC(=O)[O-])C)OCCCS(=O)(=O)C,TAK-875,-4.731983,x0072,active-noncovalent
C[C@@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[O-])NC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],BW-180C,-4.725129,x0104,active-noncovalent
C1[C@@H](O1)CCl,sevelamer,-4.719880,x0195,active-noncovalent
CC(C)OC(=O)N1CCC(CC1)Oc2c3cnn(c3ncn2)c4ccc(cc4F)S(=O)(=O)C,APD668,-4.711292,x0104,active-noncovalent
CC(=O)Nc1ccc(cc1)NC(=S)NC(=O)c2ccc(cc2)C(C)(C)C,tenovin-1,-4.707722,x0104,active-noncovalent
CC(C)(C)Sc1c2cc(ccc2n(c1CC(C)(C)C(=O)[O-])Cc3ccc(cc3)Cl)OCc4ccc5ccccc5n4,quiflapon,-4.698779,x0434,active-noncovalent
[H]/N=c\1/ccn(n1CCO)C[C@@H]2CS[C@@H]3/C(=N\C(=O)/C(=N\OC)/c4csc(n4)N)/C(=O)N3[C@H]2C(=O)[O-],cefoselis,-4.689401,x0874,active-noncovalent
Cc1c(c(c(c2c1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)OC(=O)CCC(=O)OCCO)C,tocofersolan,-4.688037,x0305,active-noncovalent
COc1ccc(cc1Cl)CNc2c(cnc(n2)N3CCC[C@H]3CO)C(=O)NCc4ncccn4,avanafil,-4.684586,x0161,active-noncovalent
CC(C)(CO)[C@@H](C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](C(C)(C)CO)O)O,pantethine,-4.682490,x0397,active-noncovalent
C1CNCC[NH2+]1,piperazine,-4.675085,x0354,active-noncovalent
Cc1cc(c2c(c1)c(cc(n2)c3ccccn3)C(=O)Nc4ccc(cc4)S(=O)(=O)Nc5c(c(no5)C)C)C,ML-193,-4.674056,x0104,active-noncovalent
CC(=O)N(C[C@H](CO)O)c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I,iohexol,-4.673427,x1077,active-noncovalent
CC1=C([C@H](C(=C(N1)[NH3+])C(=O)OC2C[NH+](C2)C(c3ccccc3)c4ccccc4)c5cccc(c5)N(=O)=O)C(=O)OC(C)C,azelnidipine,-4.652868,x0072,active-noncovalent
CC[NH+](CC)CCCCNc1ncc2cc(c(nc2n1)NC(=O)NC(C)(C)C)c3cc(cc(c3)OC)OC,PD-173074,-4.648826,x0104,active-noncovalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc2ccc(cc2)O)/C)/C,fenretinide,-4.648245,x0395,active-noncovalent
CC(C)C(=O)N,isobutyramide,-4.639351,x0434,active-noncovalent
C[NH+](C)C/C=C/C(=O)Nc1ccc(cc1)C(=O)Nc2cccc(c2)Nc3ncc(c(n3)c4c[nH]c5c4cccc5)Cl,THZ1,-4.625995,x0395,active-noncovalent
C[N@H+](CCCN1CCc2cc(c(cc2CC1=O)OC)OC)C[C@@H]3Cc4c3cc(c(c4)OC)OC,ivabradine,-4.623213,x1077,active-noncovalent
CC(C)(C/C=C/C(=O)N(C)[C@H](Cc1ccc2ccccc2c1)C(=O)N(C)[C@H](Cc3ccccc3)C(=O)NC)[NH3+],tabimorelin,-4.621974,x0072,active-noncovalent
CC[NH+](CC)CCCCNc1ncc2cc(c(nc2n1)NC(=O)NC(C)(C)C)c3c(cccc3Cl)Cl,PD-161570,-4.615630,x0434,active-noncovalent
C(=C(Cl)Cl)Cl,trichloroethylene,-4.604517,x0195,active-noncovalent
CC(C)[N@H+](CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)n3cc(c4c3ncnc4N)Br)O)O,SGC-0946,-4.595750,x0434,active-noncovalent
CC[NH+]1CCN(CC1)C(=O)Cc2ccc(cc2)Nc3ncc(c(n3)Nc4ccc(cc4)C(=O)Nc5ccccc5Cl)F,aurora-a-inhibitor-i,-4.574037,x0161,active-noncovalent
CCCCCCCCCCCCCCCCCCO[P@@](=O)([O-])OC1CC[N+](CC1)(C)C,perifosine,-4.558517,x0104,active-noncovalent
C(C(=O)O)(Cl)Cl,dichloroacetate,-4.558117,x0678,active-noncovalent
C1COC1=O,propiolactone,-4.556714,x0195,active-noncovalent
CCCc1nc(c2n1nc([nH]c2=O)c3cc(ccc3OCC)S(=O)(=O)N4CC[NH+](CC4)CC)C,vardenafil,-4.555899,x0072,active-noncovalent
CCCOCCn1c2cc(ncc2nc(c1=O)N3CC[NH+](CC3)CCO)c4ccc(nc4)OC,PF-03049423,-4.553438,x0434,active-noncovalent
C[C@H](CO)O,propylene-glycol,-4.550414,x0397,active-noncovalent
CCCCc1nn(c(=O)n1Cc2ccc(cc2)c3ccccc3S(=O)(=O)NC(=O)c4c(ccs4)C)c5ccccc5C(F)(F)F,L-161982,-4.541470,x0434,active-noncovalent
C(=N[NH3+])(N)N,aminoguanidine,-4.528815,x0397,active-noncovalent
CC(C)[C@@](CCC[N@@H+](C)CCc1ccc(c(c1)OC)OC)(C#N)c2cc(c(c(c2)OC)OC)OC,gallopamil,-4.519376,x0161,active-noncovalent
c1cc(cc(c1)N=C=S)NC(=S)NCCCCNC(=S)Nc2cccc(c2)N=C=S,MRS2578,-4.509168,x0104,active-noncovalent
CCCCCCCCCCCCCCCC(=O)O[C@@H](CC(=O)[O-])C[N+](C)(C)C,palmitoylcarnitine,-4.487021,x0434,active-noncovalent
CCCCN(CCCC)C(=O)C[N@H+]1C[C@@H]([C@H]([C@@H]1c2ccc(cc2)OC)C(=O)[O-])c3ccc4c(c3)OCO4,atrasentan,-4.482717,x0678,active-noncovalent
Cn1c(nnn1)SC[C@@H]2CS[C@H]3/C(=N\C(=O)/C(=N/OC)/c4csc(n4)N)/C(=O)N3[C@@H]2C(=O)[O-],cefmenoxime,-4.456473,x0104,active-noncovalent
Cc1cc(c(c(c1)C(=O)NO)[N@@](Cc2ccccc2)S(=O)(=O)c3ccc(cc3)OCCNC(=O)c4cc5ccccc5o4)C,WAY-170523,-4.451686,x0678,active-noncovalent
CCOc1ncc(cn1)Cc2cn(c(nc2=O)SCc3ccc(cc3)F)c4ccc(cc4)C(=O)OCC,GW-1100,-4.440808,x0434,active-noncovalent
C(CS(=O)(=O)[O-])S,mesna,-4.433568,x0397,active-noncovalent
c1ccc(cc1)Cn2c3ccccc3nc2c4ccc(cc4)OC[C@H](C5CC[NH2+]CC5)n6c7ccccc7nc6c8ccccc8,deltarasin,-4.422210,x0305,active-noncovalent
C=CC(=O)O,acrylate,-4.420043,x0678,active-noncovalent
C(=O)(N)NO,hydroxyurea,-4.410717,x0397,active-noncovalent
CC(C)NC(=O)Nc1ccc(cc1C(=O)NCC(=O)N[C@H]2CCCC[C@H]2NC(=O)c3ccc(cc3)SC)C(F)(F)F,BMS-CCR2-22,-4.409105,x0678,active-noncovalent
CC(C)c1c2ccccc2n(c1S(=O)(=O)c3ccc(cc3)OCCC[N@@H+](C)CCc4ccc(c(c4)OC)OC)C,SR-33805,-4.404728,x0104,active-noncovalent
Cc1cccc(c1NC(=O)CN2CC[NH+](CC2)CCCC(c3ccc(cc3)F)c4ccc(cc4)F)C,lidoflazine,-4.388555,x0967,active-noncovalent
Cc1cc(cc(c1)C(=O)N(C)[C@H](Cc2ccc(cc2)c3ccccc3)C(=O)N[C@@H](Cc4c[nH]c5c4cccc5)C(=O)[O-])C,IRL-2500,-4.388355,x0104,active-noncovalent
CCOC(=O)[C@H](Cc1ccc(cc1)c2cc(nc(n2)N)O[C@H](c3ccc(cc3n4ccc(n4)C)Cl)C(F)(F)F)[NH3+],telotristat-ethyl,-4.385844,x0104,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3=C2)O)c6ccc(=O)oc6)C)C)O)O)O,proscillaridin-a,-4.362801,x0395,active-noncovalent
CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,12-O-tetradecanoylphorbol-13-acetate,-4.344871,x0072,active-noncovalent
c1cc(ccc1N(=O)=O)OC(=O)N2CCC(CC2)C(c3ccc4c(c3)OCO4)(c5ccc6c(c5)OCO6)O,JZL-184,-4.341135,x0072,active-noncovalent
CCCC[C@@]1(CS(=O)(=O)c2cc(c(cc2[C@H](N1)c3ccccc3)OC)C[NH2+]C(CC(=O)[O-])CC(=O)[O-])CC,GSK2330672,-4.318656,x0072,active-noncovalent
CN(Cc1ccccc1)C(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]4CCCN4C(=O)Nc5ccccc5N(=O)=O,SDZ-NKT-343,-4.308163,x0161,active-noncovalent
Cc1c(c2c3c(cc(c2O)NC(=O)/C(=C\C=C/[C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H]([C@H]([C@H](/C=C/O[C@@]4(C(=O)c3c1O4)C)OC)C)C(=O)OC)C)O)C)O)C)/C)O)O,rifamycin-sv,-4.301668,x0104,active-noncovalent
CCc1c(nc(c(n1)C(=O)N)Nc2ccc(c(c2)OC)N3CCC(CC3)N4CC[NH+](CC4)C)NC5CCOCC5,gilteritinib,-4.282518,x0104,active-noncovalent
c1cc2c(cc[nH+]c2cc1Cl)N3CC[NH+](CC3)CCC[NH+]4CCN(CC4)c5cc[nH+]c6c5ccc(c6)Cl,piperaquine-phosphate,-4.279236,x0395,active-noncovalent
CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(c1)NC(=O)Nc2ccc(c(c2)OC)c3cnco3,AVN-944,-4.277953,x0104,active-noncovalent
c1ccc(cc1)Oc2ncc(cn2)C(=O)Nc3ccc(cc3)N4CCC(CC4)C(=O)N5CCOCC5,TFC-007,-4.253759,x0305,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)/N=C/2\CC(=O)/C(=N/CC=C)/[C@@H](C1)C2=O)/C)OC)OC(=O)N)\C)C)O)OC,tanespimycin,-4.249344,x0072,active-noncovalent
CCc1c(/c/2c/c3n/c(c\c4c(c(/c(/n4)c/c5c(c(/c(/n5)c/c1n2)C)CCC(=O)[O-])CCC(=O)OC)C)/[C@]6(C3=CCC(=C6C(=O)OC)C(=O)OC)C)C,verteporfin,-4.240665,x1249,active-noncovalent
CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc2cccc(c2)[N+](C)(C)C,demecarium,-4.224185,x0831,active-covalent
CCCCCCCCCCOc1cc2c(cc1OCC)[nH]cc(c2=O)C(=O)OCC,decoquinate,-4.221389,x0072,active-noncovalent
C[N+]1(CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5c6c(cc(c5OC)OC)CC[N+]([C@@H]6Cc7ccc(c(c7)O3)OC)(C)C)OC)C,metocurine,-4.210902,x0395,active-noncovalent
CC[C@@]1(C[C@@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)N)O)O)CC)C)C(=O)OC)O,vindesine,-4.158147,x0072,active-noncovalent
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4C[N@H+]([C@@H]5Cc6c7c(cccc7[nH]c6Br)C5=C4)C)O,bromocriptine,-4.156972,x0434,active-noncovalent
Cc1ncc(s1)C(=O)N[C@@H](COC)C(=O)N[C@@H](COC)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@]3(CO3)C,oprozomib,-4.155789,x0678,active-noncovalent
CCOc1cc(ccc1C2=[NH+][C@@]([C@](N2C(=O)N3CC[NH+](CC3)CCCS(=O)(=O)C)(C)c4ccc(cc4)Cl)(C)c5ccc(cc5)Cl)C(C)(C)C,RG7112,-4.152674,x0967,active-noncovalent
CNC=O,N-methylformamide,-4.152661,x1093,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c4c(c3)O[C@@H](CC4=O)c5cc(cc(c5)OC)O)[O-])CO)O)O)O)O)O,neohesperidin,-4.152086,x0104,active-noncovalent
CCCCCCCCCCCCCCCCOc1nc2ccc(cc2c(=O)o1)C,cetilistat,-4.146159,x0072,active-noncovalent
Cc1cc(ccc1Oc2ccn3c(c2)ncn3)Nc4c5cc(ccc5ncn4)c6ccc(o6)CNCCS(=O)(=O)C,HER2-Inhibitor-1,-4.126129,x0161,active-noncovalent
c1c(ccc(c1)Cl)OCC(=O)N[C@H]2CC[C@@H](CC2)NC(=O)COc3ccc(cc3)Cl,ISRIB,-4.111131,x0104,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C,retinyl-palmitate,-4.078928,x0072,active-noncovalent
CC(C)Oc1cccc(c1)CC(=O)N2CCC[C@](C2)(CC[N+]34CCC(CC3)(CC4)c5ccccc5)c6ccc(c(c6)Cl)Cl,SR-140333,-4.070627,x0395,active-noncovalent
CNC(=O)Nc1ccc(cc1)c2nc3c(cnn3C4CCC5(CC4)OCCO5)c(n2)N6C[C@H]7CC[C@@H](C6)O7,WYE-125132,-4.008029,x1093,active-noncovalent
CN(Cc1cc2c(s1)c(nc(n2)c3ccc(nc3)OC)N4CCOCC4)c5ncc(cn5)C(=O)NO,CUDC-907,-3.987087,x0104,active-noncovalent
C=CC[N@@+]12[C@@H]3[C@@]4([C@H]/5N(c6c4cccc6)/C=C/7\[C@@H]8N(c9c(cccc9)[C@]84[C@H]6[N@+](C/C(=C\CO)/[C@@H]7C6)(CC4)CC=C)/C=C5/[C@@H](C3)/C(=C/CO)/C1)CC2,alcuronium,-3.978959,x0305,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccc(cc1)OCc2ccccc2)C(=O)NC(C)(C)C)[N@@H+](C)Cc3ccc(cc3)C(C)(C)C,PD-173212,-3.960006,x0104,active-noncovalent
c1ccc(cc1)N(c2ccccc2)c3ncc(cn3)C(=O)NCCCCCCC(=O)NO,ACY-1215,-3.955331,x0072,active-noncovalent
CCOc1ccc(cc1)n2c(=O)c3cccnc3nc2[C@@H](C)N(Cc4cccnc4)C(=O)Cc5ccc(cc5)OC(F)(F)F,AMG-487,-3.945235,x0072,active-noncovalent
CCCCCCCCCC(=O)OC1(CC[NH+](CC1)CCCC(=O)c2ccc(cc2)F)c3ccc(cc3)Cl,haloperidol-decanoate,-3.936732,x0305,active-noncovalent
CC[N+](Cc1ccccc1)(CCC/N=C\2/C(=O)C/C(=N\CCC[N+](Cc3ccccc3)(CC)CC)/C(=O)C2)CC,benzoquinonium-dibromide,-3.918353,x0104,active-noncovalent
CC(=O)NO,acetohydroxamic-acid,-3.917711,x0397,active-noncovalent
Cc1cc2c(c(c1)C)[N@](CCC[C@@H]2N(c3nn(nn3)C)Cc4cc(cc(c4)C(F)(F)F)C(F)(F)F)C[C@H]5CC[C@@H](CC5)C(=O)[O-],evacetrapib,-3.885365,x1249,active-noncovalent
CC(C)[NH+]1CCC(CC1)N(C)c2c3cc(c(cc3nc(n2)C4CCCCC4)OCCC[NH+]5CCCC5)OC,UNC0737,-3.881845,x0678,active-noncovalent
c1cc(c(c(c1)F)F)[C@@H]2CC[C@H](C(=O)N(C2)CC(F)(F)F)NC(=O)N3CCC(CC3)n4c5cccnc5[nH]c4=O,telcagepant,-3.880137,x0104,active-noncovalent
C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)C[N+](C)(C)CCCCCCCCCC[N+](C)(C)CC(=O)O[C@@H]2C[C@@H](CC[C@H]2C(C)C)C)C(C)C,decamethoxine,-3.879157,x0072,active-noncovalent
c1ccc(cc1)NC(=O)Nc2ccc(cc2)c3ccc(cc3)C(=O)[C@@H]4CCC[C@H]4C(=O)[O-],A-922500,-3.870493,x0072,active-noncovalent
CC(C)(C)CC(=O)N(Cc1cccc(c1)OC)[C@H]2C[C@H]([N@@H+](C2)Cc3ccc4c(c3)OCO4)C(=O)N5CC[NH2+]CC5,CUR-61414,-3.863431,x1093,active-noncovalent
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[n-]nn4)C(=O)OCc5c(oc(=O)o5)C)C(C)(C)O,olmesartan-medoxomil,-3.863416,x0434,active-noncovalent
c1cc(c(c(c1)Cl)COCCOCCCCCC[NH2+]C[C@@H](c2ccc(c(c2)CO)O)O)Cl,vilanterol,-3.849598,x0104,active-noncovalent
CC(C)(C)c1ccc(cc1)C(=O)NC(=S)Nc2ccc(cc2)NC(=O)CCCC[NH+](C)C,tenovin-6,-3.848937,x0072,active-noncovalent
COc1ccc2c(c1)[nH]c3c2CC[N@H+]4[C@@H]3C[C@H]5[C@@H](C4)C[C@H]([C@@H]([C@H]5C(=O)OC)OC)OC(=O)c6cc(c(c(c6)OC)OC)OC,reserpine,-3.840379,x0104,active-noncovalent
C1[C@H](NC(=[NH+][C@H]1O)N)[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H](CCC[NH3+])[NH3+],viomycin,-3.833158,x0967,active-noncovalent
CS(=O)(=O)CCNCc1nc(cs1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F,GW-583340,-3.815665,x0072,active-noncovalent
C[C@@H](OC(=O)[C@H]1[C@H](CS[C@H]\2N1C(=O)/C2=N/C(=O)/C(=N\OC)/c3csc(n3)N)COC)OC(=O)OC(C)C,cefpodoxime,-3.812372,x0072,active-noncovalent
CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)C(C)C,daucosterol,-3.811380,x0305,active-noncovalent
C(=O)(N)N,urea,-3.808804,x0397,active-noncovalent
CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCC[NH3+])O)O)O,deferoxamine-mesylate,-3.798992,x0434,active-noncovalent
CC[N@H+]1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2[C@@H]([C@@]([C@H]31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)c7ccccc7n8c(cc(c8O)C)O,methyllycaconitine,-3.792978,x0072,active-noncovalent
CC(C)(c1cc(no1)NC(=O)Nc2cccc(c2)Oc3c4cc(c(cc4ncn3)OC)OC)C(F)(F)F,CEP-32496,-3.785359,x0104,active-noncovalent
CC1=C([C@@H](C(=C(N1)C)C(=O)OC)c2ccc(cc2)N(=O)=O)C(=O)NCCC[NH+]3CCC(CC3)(c4ccccc4)c5ccccc5,SNAP-5089,-3.731285,x0967,active-noncovalent
CCCc1cc([nH]c(=O)c1CNC(=O)c2cc(cc3c2cnn3C(C)C)c4ccc(nc4)N5CC[NH+](CC5)C(C)C)C,UNC1999,-3.713251,x0305,active-noncovalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O)C,ginsenoside-rg3,-3.710058,x0305,active-noncovalent
CCOc1cn(nc1C(=O)Nc2ccc(c(c2)F)Oc3ccnc4c3cc(c(c4)OC)OC)c5ccc(cc5C)F,LDC1267,-3.710005,x0395,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)[O-],cefmetazole,-3.703678,x0397,active-noncovalent
CS(=O)(=O)F,methanesulfonyl-fluoride,-3.693915,x0195,active-noncovalent
CC(C)O,indium(iii)-isopropoxide,-3.650518,x1093,active-noncovalent
CS(=O)C,DMSO,-3.647074,x0195,active-noncovalent
CCc1cccc(c1NC(=O)c2c3c(n(n2)C)-c4c(cnc(n4)Nc5ccc(cc5OC(F)(F)F)C(=O)NC6CC[NH+](CC6)C)CC3)CC,NMS-P715,-3.620384,x1249,active-noncovalent
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)/N=C/2\CC(=O)/C(=N/CC[NH+](C)C)/[C@@H](C1)C2=O)/C)OC)OC(=O)N)\C)C)O)OC,alvespimycin,-3.573339,x0072,active-noncovalent
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5n[n-]nn5)C(=O)O[C@@H](C)OC(=O)OC6CCCCC6,candesartan-cilextil,-3.569921,x0967,active-noncovalent
C[C@H]([NH2+][C@H]1CC[C@@H](CC1)Nc2ncc(c(c2)c3nc(ccc3)NCC4(CCOCC4)C#N)Cl)COC,CDK9-IN-6,-3.545814,x0395,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)Oc2c(=O)c3c(cc(c(c3oc2c4ccc(cc4)OC)CC=C(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)[O-])O)O)O,icariin,-3.530054,x0104,active-noncovalent
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O,maytansinol-isobutyrate,-3.529337,x0967,active-noncovalent
C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O,oleandrin,-3.473563,x0072,active-noncovalent
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C\C=C(/Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O,ansamitocin-p-3,-3.462877,x0104,active-noncovalent
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)C4CCCCC4)OCCC[NH+]5CCCC5)OC,UNC0638,-3.459404,x0305,active-noncovalent
Cc1cccc(c1)NC(=O)Nc2cnn(c2)c3cccc(c3)C(=O)Nc4cc(c(c(c4)OC)OC)OC,SR-3576,-3.452864,x0104,active-noncovalent
c1cc(ccc1[C@]2(C[C@H]2C3CCCCC3)C(=O)Nc4ncc(s4)SCC[NH+]5CCCC5)S(=O)(=O)C6CC6,LY2608204,-3.419956,x0072,active-noncovalent
CCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)CC[NH2+]C[C@@H](COc3ccc(cc3)O)O,L-755507,-3.400533,x1077,active-noncovalent
C[NH+]1CCC(CC1)COc2cnc(nc2)c3cccc(c3)Cn4c(=O)ccc(n4)c5cccc(c5)C#N,EMD-1214063,-3.392385,x0104,active-noncovalent
COc1cc(cc(c1O)OC)[C@@H]2c3cc4c(cc3[C@H]([C@@H]5[C@@H]2C(=O)OC5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)c8cccs8)O)O)OCO4,teniposide,-3.367583,x0104,active-noncovalent
COCc1c(n2c(c1c3ccc(c(c3)F)NC(=O)Nc4cc(ccc4F)C(F)(F)F)c(ncn2)N)C[NH+]5CCOCC5,ACTB-1003,-3.359243,x0072,active-noncovalent
C[N@@]([C@@H](Cc1ccc(cc1)OS(=O)(=O)c2cccc3c2ccnc3)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7c6ccnc7,KN-62,-3.346978,x0104,active-noncovalent
CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)[O-])OC)C,fumagillin,-3.281434,x1249,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn(c(=O)n1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,enocitabine,-3.280086,x0104,active-noncovalent
Cc1c(cn2c1c(ncn2)Nc3ccc4c(c3)cnn4Cc5cccc(c5)F)NC(=O)OC[C@@H]6COCC[NH2+]6,BMS-599626,-3.237447,x0395,active-noncovalent
CS(=O)(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F,lapatinib,-3.236952,x0072,active-noncovalent
Cc1ccc(cc1Cl)N(CCC[NH+]2CCC(CC2)Cc3ccc(cc3)C(=O)N)C(=O)C4CCN(CC4)C(=O)C,TAK-220,-3.225996,x0305,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3cc(c(c(c3)O)C(=O)CCc4ccc(c(c4)O)OC)O)CO)O)O)O)O)O,neohesperidin-dihydrochalcone,-3.191289,x0072,active-noncovalent
c1cc(c2c3c1C[C@@H]4[C@]5([C@]3(CC[N@@H+]4CC6CC6)[C@@H](O2)c7c(c8c([nH]7)[C@H]9[C@@]12CC[N@@H+]([C@@H]([C@@]1(C8)O)Cc1c2c(c(cc1)O)O9)CC1CC1)C5)O)O,nor-Binaltorphimine-dihydrochloride,-3.168701,x0072,active-noncovalent
CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC,rebastinib,-3.130574,x0305,active-noncovalent
CC(=O)N1CCN(CC1)c2ccc(c(c2)OC)Nc3c(cnc(n3)Nc4ccc(cc4OC)N5CCN(CC5)C(=O)C)Cl,KRCA-0008,-3.120428,x0967,active-noncovalent
COc1cc(cc(c1OC)OC)C(=O)OCCC[N@H+]2CCC[N@](CC2)CCCOC(=O)c3cc(c(c(c3)OC)OC)OC,dilazep,-3.073029,x0967,active-noncovalent
Cc1cc(ccc1c2ccc(cc2)C(=O)Nc3ccc(c(c3)OCC[NH+](C)C)OC)c4nc(on4)C,SB-216641,-3.017460,x0305,active-noncovalent
CON,methoxyamine,-2.995533,x0195,active-noncovalent
C[C@@H]\1C/C(=C/C[C@@H]2C[C@@H](C[C@@]3(O2)C/C(=N/OC)/[C@@H]([C@H](O3)/C(=C/C(C)C)/C)C)OC(=O)[C@@H]4C=C([C@H]([C@@H]5[C@]4(/C(=C/C=C1)/CO5)O)O)C)/C,moxidectin,-2.927108,x0967,active-noncovalent
C[C@@H](C(=O)N[C@@H](Cc1ccc(cc1)OC)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(CO3)C)NC(=O)C[NH+]4CCOCC4,ONX-0914,-2.914200,x0104,active-noncovalent
Cc1ccc(cc1C#Cc2cc3cn[nH]c3nc2)C(=O)Nc4ccc(c(c4)C(F)(F)F)C[NH+]5CCN(CC5)C,GZD824,-2.907241,x0395,active-noncovalent
CC(C)(C)NC(=O)[C@@H]1C[N@@](CC[N@H+]1C[C@H](C[C@@H](Cc2ccccc2)C(=O)N[C@H]3c4ccccc4C[C@H]3O)O)Cc5cccnc5,indinavir,-2.900762,x0104,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCO,docosanol,-2.888496,x0395,active-noncovalent
CCO/N=C(\c1nc(sn1)NP(=O)([O-])[O-])/C(=O)/N=C/2\[C@@H]3N(C2=O)[C@H]([C@@H](CS3)Sc4nc(cs4)c5cc[n+](cc5)C)C(=O)[O-],ceftaroline-fosamil,-2.882991,x0072,active-noncovalent
CC(C)[NH+]1CCC(CC1)Nc2c3cc(c(cc3nc(n2)N4CCC(CC4)(F)F)OCCC[NH+]5CCCC5)OC,UNC0642,-2.866310,x0887,dimer-interface
c1ccc(cc1)NC(=O)Nc2ccc(cc2)c3ccc(cc3)C(=O)[C@@H]4CCC[C@@H]4C(=O)[O-],A922500,-2.863720,x1385,active-covalent
Cc1c(cccc1NC(=O)c2cc3c(s2)CCCC3)c4cn(c(=O)c(n4)Nc5ccc(cc5)[C@H]6C(=O)N(CC[N@@H+]6C)C)C,GDC-0834,-2.859759,x0305,active-noncovalent
Cc1cc(ccc1c2ccc(cc2)S(=O)(=O)C)OCc3nnc(n3c4cccnc4)SC5CCCC5,NMS-873,-2.797006,x0072,active-noncovalent
CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(cc1)OC)c2ncccn2,thonzonium,-2.782665,x0305,active-noncovalent
c1cc(c(cc1C[C@H](C(=O)[O-])OC(=O)/C=C/c2ccc(c3c2[C@H]([C@@H](O3)c4ccc(c(c4)O)O)C(=O)O[C@H](Cc5ccc(c(c5)O)O)C(=O)[O-])O)O)O,salvianolic-acid-B,-2.747507,x0305,active-noncovalent
CC(C)C[C@@H](C(=O)N[C@H](Cc1cn(c2c1cccc2)C)C(=O)N[C@H](Cc3ccccn3)C(=O)[O-])NC(=O)N4CCCCCC4,FR-139317,-2.719013,x0161,active-noncovalent
C[C@@H](c1cccn2c1[nH+]c(c2)c3ccc(cc3)C[C@@H](CNC(=O)C[NH+](C)C)NC(=O)c4ccc(c(c4)Cl)OC(C)C)O,GSK923295,-2.687134,x1249,active-noncovalent
CC(Oc1c(cc2c(c1)[C@@H](N(C(=O)C2)c3ccc(cc3)N(C[C@H]4CC[C@@H](CC4)[N@H+]5CC(=O)N(CC5)C)C)c6ccc(cc6)Cl)OC)C,CGM097,-2.684456,x1249,active-noncovalent
COc1c(cnc(n1)OC)c2ccc3c(c2)ncc(c3Nc4cc(cc(c4)Oc5cc(cc(c5)F)F)C(=O)[O-])S(=O)(=O)NC6CC6,GSK-2837808A,-2.668043,x0305,active-noncovalent
Cc1ccc(cc1)n2c(cc(n2)C(C)(C)C)NC(=O)Nc3ccc(c4c3cccc4)OCC[NH+]5CCOCC5,doramapimod,-2.652793,x0305,active-noncovalent
CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,sucrose-octaacetate,-2.647281,x0395,active-noncovalent
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)[NH2+][C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO,acarbose,-2.630922,x0104,active-noncovalent
COCCN1CC[NH+](CC1)Cc2ccc(cc2)c3c4c([nH]n3)-c5cccc(c5C4=O)NC(=O)N[NH+]6CCOCC6,RGB-286638,-2.629794,x0305,active-noncovalent
COC(=O)Nc1ccc(cc1)c2nc3c(cnn3C4CC[NH+](CC4)Cc5cccnc5)c(n2)N6CCOCC6,WYE-687,-2.584447,x0305,active-noncovalent
CSCC[C@@H](C(=O)[O-])NC(=O)[C@@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],metenkephalin,-2.578515,x0434,active-noncovalent
CCN(c1cc(cc(c1C)C(=O)NCc2c(cc([nH]c2=O)C)C)c3ccc(cc3)C[NH+]4CCOCC4)C5CCOCC5,tazemetostat,-2.578074,x0072,active-noncovalent
Cc1nc(c(cn1)CN(/C(=C(/SS/C(=C(/N(C=O)Cc2c(nc(nc2)C)N)\C)/CCOC(=O)C(C)C)\CCOC(=O)C(C)C)/C)C=O)N,sulbutiamine,-2.550045,x0104,active-noncovalent
Cc1cccc(c1OCC(=O)N[C@@H](Cc2ccccc2)[C@H](C[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O)C,lopinavir,-2.535317,x0104,active-noncovalent
N(=O)[O-],sodium-nitrite,-2.463639,x0397,active-noncovalent
CC(=O)N(C)c1c(c(c(c(c1I)C(=O)NCC(=O)Nc2c(c(c(c(c2I)C(=O)[O-])I)C(=O)NCCO)I)I)C(=O)NC)I,ioxaglic-acid,-2.435351,x0072,active-noncovalent
Cc1ccn2c(c1)nc3c2c4c(c5c3c6c(c(c5O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C\C=C(/C(=O)N4)\C)C)O)C)O)C)OC(=O)C)C)OC)C)O,rifaximin,-2.387988,x0967,active-noncovalent
Cc1ccccc1NC(=O)Nc2ccc(cc2)CC(=O)N3CCOC[C@H]3C(=O)N4CCC(CC4)CC(=O)[O-],TCS-2314,-2.294621,x0104,active-noncovalent
CCC1=C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)C[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC,vinorelbine,-2.257041,x0072,active-noncovalent
CC[N@@H+](CCCOc1ccc2c(c1)ncnc2Nc3cc([nH]n3)CC(=O)Nc4cccc(c4)F)CCO,barasertib-HQPA,-2.226013,x0305,active-noncovalent
COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3Cc4ccc(c5c4[C@]2([C@H]1O5)CC[N@@H+]3CC=C)O)O,naloxegol,-2.207886,x0678,active-noncovalent
CC(C)(C)CC(C)(C)c1cc(c(c(c1)n2nc3ccccc3n2)O)Cc4cc(cc(c4O)n5nc6ccccc6n5)C(C)(C)CC(C)(C)C,bisoctrizole,-2.163276,x0967,active-noncovalent
CCCCc1c(c2cc(ccc2o1)NS(=O)(=O)C)C(=O)c3ccc(cc3)OCCC[NH+](CCCC)CCCC,dronedarone,-2.152409,x1249,active-noncovalent
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)[NH+]7CCCCC7,irinotecan,-2.139241,x0305,active-noncovalent
C[C@H]1[C@@H](C(CC(=O)C1=O)(C)C)/C=C/C(=C/C=C/C(=C/C/C=C/[C@@H](C)/C=C/C=C(\C)/C=C/C2=C(C(=O)C(=O)CC2(C)C)C)/C)/C,astaxanthin,-2.114104,x0887,dimer-interface
CC[C@@H]1[C@@]([C@@H]([C@H]([N@@H+](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)C)O)(C)O,azithromycin,-2.093890,x0395,active-noncovalent
c1cc(cc(c1)C(=O)NCC(=O)N2C[C@H](CC2)[NH2+][C@H]3CC[C@@](CC3)(O)c4ncc(cc4)c5ncccn5)C(F)(F)F,PF-04136309,-2.091549,x1249,active-noncovalent
Cn1c(nnn1)SCC2=C(N3[C@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)[O-])S4)OC)SC2)C(=O)[O-],cefotetan,-2.091514,x0104,active-noncovalent
CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N,ATN-161,-1.987623,x0072,active-noncovalent
Cc1c(ccc2c1oc(c(c2=O)NC(=O)c3ccc(c(c3)CC=C(C)C)O)[O-])O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O,novobiocin,-1.986110,x0305,active-noncovalent
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)O)O)[N@H+]6CCO[C@@H](C6)OC)O,nemorubicin,-1.950070,x0104,active-noncovalent
CCOc1ccc(cn1)c2ccc(cc2)Cn3c4ccc(cc4c(c3CC(C)(C)C(=O)[O-])SC(C)(C)C)OCc5ccc(cn5)C,GSK2190915,-1.945213,x0305,active-noncovalent
CC[C@]1(CC[C@@H](O1)[C@@]2(CC[C@@]3(O2)C[C@@H]([C@H]([C@H](O3)[C@@H](C)[C@H]([C@H](C)C(=O)[O-])OC)C)O)C)[C@@H]4[C@H](C[C@@H](O4)[C@@H]5[C@H](C[C@H]([C@@](O5)(CO)O)C)C)C,monensin,-1.936404,x0072,active-noncovalent
CC[C@H]([C@H]1[C@@H](C[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C)C(=O)[O-],narasin,-1.919749,x1249,active-noncovalent
CN1CC[NH+](CC1)C2CCN(CC2)C(=O)Nc3cc(ccn3)Oc4ccc(c(c4)F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F,golvatinib,-1.847691,x0967,active-noncovalent
CC1=C2[C@H](C(=O)[C@@]3([C@@H](C[C@@H]4[C@]([C@H]3[C@H]([C@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](c5ccccc5)NC(=O)OC(C)(C)C)O)O)OC(=O)c6ccccc6)(CO4)OC(=O)C)OC)C)OC,cabazitaxel,-1.826178,x0305,active-noncovalent
CCOc1cc(ccc1Nc2ncc3c(n2)N(c4ccccc4C(=O)N3C)C5CCCC5)C(=O)N6CCC(CC6)N7CC[NH+](CC7)C,XMD17-109,-1.823357,x0072,active-noncovalent
C[N@H+]1CCc2cc(c3cc2[C@@H]1Cc4ccc(cc4)Oc5cc(ccc5OC)C[C@H]6c7c(cc(c(c7O3)OC)OC)CC[N@@H+]6C)OC,tetrandrine,-1.793901,x0104,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)O)(C)O,clarithromycin,-1.757130,x0395,active-noncovalent
CCCC[C@H](C(=O)[O-])NC(=O)[C@@H](Cc1cn(c2c1cccc2)C(=O)OC)NC(=O)[C@H](CC(C)(C)C)NC(=O)N3[C@@H](CCC[C@@H]3C)C,BQ-788,-1.751663,x0072,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCCCC(=O)[O-],pentacosanoic-acid,-1.748420,x0967,active-noncovalent
C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@@]6(CC[C@@H](O6)C(C)(C)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)(C)C)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O,astragaloside-a,-1.728050,x0887,dimer-interface
C[C@H](c1ccc(cc1)F)C(=O)Nc2ccc(cc2)c3ccc4nc(nn4c3)Nc5ccc(cc5OC)S(=O)(=O)C,Mps1-IN-5,-1.717288,x0305,active-noncovalent
C(CC(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)[O-])NC(=O)CC[C@@H](C(=O)[O-])[NH3+])C(=O)NCC(=O)[O-])[C@H](C(=O)[O-])[NH3+],NOV-002,-1.654280,x0072,active-noncovalent
C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)[O-])O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)[NH3+])O,natamycin,-1.649091,x0395,active-noncovalent
CC[NH+](CC)CCN(Cc1ccc(cc1)c2ccc(cc2)C(F)(F)F)C(=O)Cn3c4c(c(=O)nc3SCc5ccc(cc5)F)CCC4,darapladib,-1.647938,x0104,active-noncovalent
c1cc(cc(c1)O)c2/c3ccc([nH]3)/c(c/4\nc(/c(c\5/cc/c(/[nH]5)c(/c6n\c2\CC6)\c7cccc(c7)O)/c8cccc(c8)O)C=C4)/c9cccc(c9)O,temoporfin,-1.632973,x0967,active-noncovalent
c1cc2c(c(c1)O[C@@H]3[C@@H]([C@H]([C@H]([C@@H](O3)CO)O)O)O)c(c4c(c2c5c6cccc(c6c(c7c5cc(cc7O)C(=O)[O-])O)O[C@@H]8[C@@H]([C@H]([C@H]([C@@H](O8)CO)O)O)O)cc(cc4O)C(=O)[O-])O,sennoside-protonated,-1.608590,x0305,active-noncovalent
c1ccc(c(c1)c2ccc(cc2)C(F)(F)F)C(=O)NC3CC[NH+](CC3)CCCCC4(c5ccccc5-c6c4cccc6)C(=O)NCC(F)(F)F,lomitapide,-1.523471,x0395,active-noncovalent
CS(=O)(=O)Nc1ccc(cc1)c2coc3cc(ccc3c2=O)OCc4cccc(c4)C(=O)[O-],CVT-10216,-1.521028,x0072,active-noncovalent
CC(=O)N1c2ccccc2C[C@H]1COc3ccc4c(c3)c(c(n4Cc5ccc(cc5)c6ncc(cn6)OC)CC(C)(C)C(=O)[O-])SC(C)(C)C,AM679,-1.447694,x0395,active-noncovalent
C[N@H+]1CCc2cc(c(c-3c2[C@@H]1Cc4c3cc(c(c4)Oc5cc(c(cc5C[C@H]6c7cc(c(cc7CC[N@@H+]6C)OC)OC)OC)OC)OC)OC)OC,thaliblastine,-1.438519,x0104,active-noncovalent
Cc1c(cnn1c2ccc(cc2)Cl)C(=O)Nc3ccc(c(c3)C#N)N4CCC(CC4)[NH+]5CCOCC5,Y-320,-1.405975,x0305,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/c3ccc(c(c3)O)O)CO)OCCc4ccc(c(c4)O)O)O)O)O)O,verbascoside,-1.374299,x0104,active-noncovalent
Cc1ccc(cc1N2Cc3cnc(nc3N(C2=O)C)Nc4ccc(nc4)C)NC(=O)c5cccc(c5)C(F)(F)F,GNF-7,-1.349858,x0305,active-noncovalent
CCCCCCCCCCCCCCCCCCOC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC,edelfosine,-1.311466,x0887,dimer-interface
CCCCCCCCCCC[C@@H](C[C@@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O,orlistat,-1.309404,x0305,active-noncovalent
CC(C)[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)C5CCCCC5)OC)OCCC[NH+]6CCCCC6,UNC0646,-1.259492,x0692,active-covalent
CCn1c2cc(ncc2nc1c3c(non3)N)Oc4cccc(c4)NC(=O)c5ccc(cc5)OCC[NH+]6CCOCC6,GSK269962,-1.194234,x0305,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,roxithromycin,-1.179883,x0305,active-noncovalent
C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)[NH+](C)C,troleandomycin,-1.126679,x0967,active-noncovalent
c1c(ccc(c1)[C@H]2CC[C@@H](CC2)CC(=O)[O-])c3ncc(cc3)Nc4cnc(cc4)C(F)(F)F,LCQ908,-1.086777,x0305,active-noncovalent
CCc1c(n2cc(ccc2n1)Cl)C(=O)NCc3ccc(cc3)N4CCC(CC4)c5ccc(cc5)OC(F)(F)F,Q-203,-1.071368,x0305,active-noncovalent
Cc1cc(cc2c1nc(nn2)Nc3ccc(cc3)OCC[NH+]4CCCC4)c5cc(ccc5Cl)OC(=O)c6ccccc6,TG-100801,-0.923421,x0305,active-noncovalent
CC[C@H]([C@H]1CC[C@@H]([C@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)[O-],salinomycin,-0.891837,x0072,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@@H]([C@@H]([C@@H]([C@@H]([C@H]([C@@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,rifampin,-0.872080,x0967,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)[N@@]([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C)C(=O)OC)O,vinblastine,-0.777073,x0072,active-noncovalent
CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCc3ccccc3)NC(=O)C[NH+]4CCOCC4,carfilzomib,-0.748310,x1249,active-noncovalent
CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,benzonatate,-0.746037,x0967,active-noncovalent
CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,polidocanol,-0.719652,x0967,active-noncovalent
CC(C)Oc1ccc(cc1)NC(=O)N2CCN(CC2)c3c4cc(c(cc4ncn3)OCCC[NH+]5CCCCC5)OC,tandutinib,-0.700087,x0736,active-covalent
CCCC[P+](CCCC)(CCCC)Cc1ccc(cc1)NC(=O)[C@H](Cc2ccc3ccccc3c2)N/C(=[NH+]/C4CCCCC4)/NC5CCCCC5,WIN-64338,-0.656938,x0305,active-noncovalent
CC(C)(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)[C@H](C[N@](Cc2ccc(cc2)c3ccccn3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,atazanavir,-0.611841,x0305,active-noncovalent
CCN([C@H]1CC[C@@H](CC1)[N@H+](CCOC)C)c2c(c(cc(c2)C#CC[NH+]3CCOCC3)C(=O)NCc4c(=O)[nH]c(cc4C)C)C,EPZ011989,-0.567884,x0395,active-noncovalent
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@H]2C[N@H+]1C[C@H]([C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4)O,saquinavir,-0.564934,x0072,active-noncovalent
CC(C)C[N@@](C[C@H]([C@H](Cc1ccccc1)NC(=O)[C@H](C(C)(C)C)NC(=O)C[NH2+]Cc2cccc(c2)F)O)S(=O)(=O)c3cccc(c3)N,DPC-681,-0.562422,x0967,active-noncovalent
CC[C@@]12C=CC[N@@H+]3[C@@H]1[C@@]4(CC3)c5cc(c(cc5[N@@]([C@H]4[C@]([C@@H]2OC(=O)C)(C(=O)OC)O)C)OC)[C@]6(C[C@@H]7C[C@H](C[N@@H+](C7)CCc8c6[nH]c9c8cccc9)C(C)(F)F)C(=O)OC,vinflunine,-0.527314,x0072,active-noncovalent
C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](CC(=C5N=O)C)C(=O)O3)O)C)O[C@@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)\C)O[C@@H]1C7CCCCC7,selamectin,-0.506328,x0305,active-noncovalent
CC[C@@H](C(=O)N1C[C@H](C[C@H]1Cc2c3ccc(cc3[nH]c2c4c(c5ccc(cc5[nH]4)F)C[C@@H]6C[C@@H](CN6C(=O)[C@H](CC)NC(=O)[C@H](C)[NH2+]C)O)F)O)NC(=O)[C@H](C)[NH2+]C,birinapant,-0.505273,x0967,active-noncovalent
CC(C)[N@@H+]1CCCN(CC1)c2nc3cc(c(cc3c(n2)NC4CC[NH+](CC4)CC5CCCCC5)OC)OCCC[NH+]6CCCCC6,UNC0631,-0.488100,x0305,active-noncovalent
Cc1cc2c(cc1C)n(c-3nc(=O)[nH]c(=O)c3n2)C[C@@H]([C@@H]([C@H](CO[P@](=O)([O-])O[P@](=O)([O-])OC[C@@H]4[C@H]([C@@H]([C@H](O4)n5cnc6c5ncnc6N)O)O)O)O)O,flavin-adenine-dinucleotide,-0.435611,x0305,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)O)C)C)O)(C)O,erythromycin,-0.393077,x0072,active-noncovalent
CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CC[N+](CC4)(C)C)C)CC[C@]5([C@H]3C[C@@H]([C@H]5OC(=O)C)N6CC[N+](CC6)(C)C)C,pipecuronium,-0.322831,x0072,active-noncovalent
[C@@H]1([C@@H]([C@@H]([C@@H]([C@H]([C@@H]1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-],hexasodium-phytate,-0.291912,x0387,active-noncovalent
C[C@@H](C(=O)NCC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC[NH+]=C(N)N)C(=O)[O-])NC(=O)[C@H](Cc2ccc(cc2)O)[NH3+],dalargin,-0.281180,x0967,active-noncovalent
CC(C)C[C@@H](C(=O)[O-])NC(=O)[C@H](CCC(=O)[O-])NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(=O)[O-])NC(=O)[C@H](CCSC)NC=O,foxy-5,-0.280158,x0104,active-noncovalent
CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)Oc4c5cc(ccc5c(cn4)OC)Cl)NC(=O)OC(C)(C)C,asunaprevir,-0.198820,x0967,active-noncovalent
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)Oc3c(=O)c4c(cc(cc4oc3c5ccc(c(c5)OCCO)OCCO)OCCO)[O-])O)O)O)O)O)O,troxerutin,-0.193997,x0305,active-noncovalent
c1cc2c(c(c1)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)c4c(cc(cc4[O-])C(=O)[O-])[C@H]2[C@H]5c6cccc(c6C(=O)c7c5cc(cc7[O-])C(=O)[O-])O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O,sennoside-a,-0.057472,x0967,active-noncovalent
COc1cc2c(ccnc2cc1OCCC[NH+]3CCOCC3)Oc4ccc(cc4F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F,foretinib,-0.051521,x1249,active-noncovalent
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](Cc2ccccc2)c3nccs3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)[NH+](C)C,dolastatin-10,-0.049036,x1249,active-noncovalent
CC[N@@H+](CCCOc1ccc2c(c1)ncnc2Nc3cc(n[nH]3)CC(=O)Nc4cccc(c4)F)CCOP(=O)([O-])[O-],barasertib,-0.042818,x1249,active-noncovalent
c1cc(ccc1c2nc(nc(n2)N3[C@@H]4CC[C@H]3COC4)N5CCOCC5)NC(=O)Nc6ccncc6,PKI-179,0.040004,x0104,active-noncovalent
c1c(cnc(c1Cl)N2CCC(CC2)C(=O)[O-])C(=O)Nc3nc(c(s3)N4CC[NH+](CC4)C5CCCCC5)c6cc(cs6)Cl,avatrombopag,0.068045,x0887,dimer-interface
Cc1ccccc1NC(=O)Nc2ccc(cc2)CC(=O)N(C)[C@@H](CC(C)C)C(=O)NCC[C@@H](C(=O)[O-])NC(=O)[C@@H]3CCC[N@]3S(=O)(=O)c4cc(cc(c4)Cl)Cl,BIO-5192,0.078660,x0967,active-noncovalent
CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4Cc5cccc(c5C4)F)C(=O)NS(=O)(=O)C6CC6,danoprevir,0.136663,x0305,active-noncovalent
c1cc(cc(c1)/c/2c\3/nc(/c(c/4\[nH]/c(c(\c5n/c(c(\c6[nH]c2cc6)/c7cc(ccc7)O)/C=C5)/c8cc(ccc8)O)/cc4)/c9cc(ccc9)O)C=C3)O,m-THP,0.246221,x0967,active-noncovalent
C[C@@H](OC(=O)[C@@H]1[C@@H](CS[C@@H]\2N1C(=O)/C2=N/C(=O)Cc3csc(n3)N)CSc4nnnn4CC[NH+](C)C)OC(=O)OC5CCCCC5,cefotiam-cilexetil,0.299327,x0305,active-noncovalent
CCCCCCCCCc1ccc(cc1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO,nonoxynol-9,0.519851,x1249,active-noncovalent
CC[C@@]1(C[C@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@H+](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CC[N@H+]9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,vincristine,0.604120,x0072,active-noncovalent
C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,tacrolimus,0.604666,x0967,active-noncovalent
CC(C)c1nc(cs1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C[C@@H]([C@H](Cc3ccccc3)NC(=O)OCc4cncs4)O,ritonavir,0.619766,x0104,active-noncovalent
C[C@@H]\1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)/C(=C1\C2(C)C)/OC(=O)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)c7ccccc7)O,paclitaxel,0.685393,x1249,active-noncovalent
CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)c5cnccn5,telaprevir,0.691559,x0104,active-noncovalent
c1cncc(c1)C(=O)O[C@H]2[C@@H]([C@@H]([C@@H]([C@H]([C@@H]2OC(=O)c3cnccc3)OC(=O)c4cnccc4)OC(=O)c5cnccc5)OC(=O)c6cnccc6)OC(=O)c7cnccc7,inositol-hexanicotinate,0.819163,x0305,active-noncovalent
CCCCCCCC[NH+]=c1ccn(cc1)CCCCCCCCCCn2ccc(=[NH+]CCCCCCCC)cc2,octenidine,0.836347,x0426,active-noncovalent
CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](/C(=C(\C(=O)O1)/C)/[O-])C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nc4)c5cccnc5)C,telithromycin,0.910923,x0305,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)OC(=O)CC)(C)O)C)C)O)(C)O,erythromycin-estolate,1.003206,x0104,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H]([C@@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/[NH+]=C/N5CCCCC5)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,FCE-22250,1.128292,x0771,active-covalent
CCCCCCCCCCCCCCCC(=O)OCCC1CC[NH+](CC1)CCCN2c3ccccc3Sc4c2cc(cc4)S(=O)(=O)N(C)C,pipotiazine-palmitate,1.136590,x0967,active-noncovalent
CCCCCCOC(=O)NC(=[NH2+])c1ccc(cc1)NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c4ccccn4,dabigatran-etexilate,1.146603,x0786,active-covalent
C[C@@H]1[C@H](C[C@]2([C@H]([C@H]3[C@@]([C@H](C[C@@H]4[C@]3(CO4)OC(=O)C)O)(C(=O)C(=O)[C@@H]1C2(C)C)C)OC(=O)c5ccccc5)O)OC(=O)[C@@H]([C@H](c6ccccc6)NC(=O)OC(C)(C)C)O,docetaxel,1.287066,x0072,active-noncovalent
c1ccnc(c1)CC(=O)Nc2nnc(s2)CCCCc3ccc(nn3)NC(=O)Cc4cccc(c4)OC(F)(F)F,CB-839,1.295661,x0887,dimer-interface
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3[O-])C(=O)c5cccc(c5C4=O)OC)[O-])([C@H](C=O)NNC(=O)CCCCCN6C(=O)C=CC6=O)O)[NH3+])O,aldoxorubicin,1.302299,x0749,active-covalent
CC[C@H]1/C=C(/C[C@@H](C[C@H]([C@@H]2[C@@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H]([C@H]([C@@H](CC1=O)O)C)/C(=C/[C@H]4CC[C@@H]([C@H](C4)OC)O)/C)O)C)OC)OC)C)\C,ascomycin,1.368575,x1249,active-noncovalent
C[C@@H](C(=O)N[C@@H](CC(C)C)[C@H](CC(=O)[O-])O)NC(=O)C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C)O,pepstatin,1.514513,x0967,active-noncovalent
C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)[NH+](C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)[NH+](C)C,spiramycin,1.558240,x0887,dimer-interface
Cc1c(ccc2c1nc(cc2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)c7nc(cs7)C(C)C)OC,simeprevir,1.703806,x0967,active-noncovalent
CC1(c2c3ccccc3ccc2[N+](=C1/C=C/C=C/C=C/C=C\4/C(c5c6ccccc6ccc5N4CCCCS(=O)(=O)[O-])(C)C)CCCCS(=O)(=O)[O-])C,indocyanine-green,1.824265,x0305,active-noncovalent
CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)[NH+](C)C)O)(C)O)C)[NH2+][C@H](O2)COCCOC)C)(C)O,dirithromycin,1.906841,x0395,active-noncovalent
C/C=C(\C)/C(=O)N[C@@H](c1ccccc1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)/C(=C(/[C@@H]2C)\C3(C)C)/OC(=O)C)C)OC(=O)c6ccccc6)O)O,cephalomannine,2.027429,x1249,active-noncovalent
CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)Oc5c(nc6ccc(cc6n5)OC)CCCCC[C@@H]7C[C@H]7OC(=O)N1,grazoprevir,2.073240,x0967,active-noncovalent
CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@](C(=O)O1)(C)F)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCn4cc(nn4)c5cccc(c5)N)C,solithromycin,2.182832,x0305,active-noncovalent
CC(C)(C)OC(=O)NCCC(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](Cc3ccccc3)C(=O)N,pentagastrin,2.210760,x0072,active-noncovalent
CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@@H]([C@@H](O[C@@H]1SC)[C@H]([C@@H](C)Cl)NC(=O)[C@H]2C[C@@H](C[N@@H+]2C)CCC)O)O,clindamycin-palmitate,2.338536,x0104,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC,phosphatidylcholine,2.395462,x0691,active-covalent
CC(C)C1=C2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC[C@]2(CC1=O)[C@H](C[N@](CC[NH+](C)C)Cc6ccc(cc6)Cl)O)C)C)(C)C)OC(=O)CC(C)(C)C(=O)[O-])C,GSK2838232,2.426488,x0305,active-noncovalent
CCCCC(=O)OCC(=O)[C@@]1(Cc2c(c(c3c(c2[O-])C(=O)c4cccc(c4C3=O)OC)[O-])[C@H](C1)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O,valrubicin,2.488130,x0692,active-covalent
CC(C)(C)c1cc(no1)NC(=O)Nc2ccc(cc2)c3cn4c5ccc(cc5sc4[nH+]3)OCC[NH+]6CCOCC6,quizartinib,2.548322,x0887,dimer-interface
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(/C(=O)/N=c(/c2O)\c5=NC6(CC[NH+](CC6)CC(C)C)Nc35)\C)C)O)C)O)C)OC(=O)C)C)OC)C)O,rifabutin,2.551799,x0305,active-noncovalent
c1cc2c(cc1OC(F)(F)F)[nH]c(n2)c3ccc(cn3)OCCOCCOc4ccc(nc4)c5[nH]c6cc(ccc6n5)OC(F)(F)F,AI-10-49,2.673892,x0887,dimer-interface
CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)/C[C@H]2C[C@@H](OC(=O)C[C@@H](C[C@H]3C[C@@H](C([C@@](O3)(C[C@@H]4C/C(=C/C(=O)OC)/C[C@@H](O4)/C=C\C([C@@]1(O2)O)(C)C)O)(C)C)OC(=O)C)O)[C@@H](C)O,bryostatin-1,2.740692,x0305,active-noncovalent
CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C,pimecrolimus,2.800759,x0967,active-noncovalent
CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC,colfosceril-palmitate,2.855972,x0708,active-covalent
Cc1cnc(cn1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)Oc5c6ccccc6c7ccccc7n5)C(=O)NS(=O)(=O)C8CC8,paritaprevir,2.909720,x0967,active-noncovalent
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[NH+](C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,erythromycin-ethylsuccinate,3.089338,x0967,active-noncovalent
C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC(=O)CC(C)C)[NH+](C)C)O)CC=O)C)O,josamycin,3.100371,x1249,active-noncovalent
C[C@@H]1CC[C@@]2([C@@H]([C@@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@@H]5[C@H]4CC=C6[C@@]5(CC[C@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@@H](O7)CO)O[C@H]8[C@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1,dioscin,3.111700,x0967,active-noncovalent
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)C(=O)[O-])O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)[O-])O)O)O)C)(C)C(=O)[O-],ammonium-glycyrrhizinate,3.131017,x0305,active-noncovalent
CCCC[C@@H](CC)COc1ccc(c(c1)O)c2nc(nc(n2)c3ccc(cc3O)OC[C@H](CC)CCCC)c4ccc(cc4)OC,bemotrizinol,3.191931,x0771,active-covalent
CC(C)c1nc(cs1)CN(C)C(=O)N[C@@H](CC[NH+]2CCOCC2)C(=O)N[C@H](CC[C@H](Cc3ccccc3)NC(=O)OCc4cncs4)Cc5ccccc5,cobicistat,3.388076,x0354,active-noncovalent
CC[C@H]1[N@](c2nc(ncc2N(C1=O)C)Nc3c(cc(cc3)C(=O)N[C@H]4CC[C@@H](CC4)N5CC[NH+](CC5)CC6CC6)OC)C(C)C,volasertib,3.682001,x0769,active-covalent
CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,ivermectin,3.733904,x0305,active-noncovalent
Cc1c(c2c3c4c1O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)Nc(c2O)c(c3O)/C=N/N5CC[NH+](CC5)C6CCCC6)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O,rifapentine,3.853832,x0305,active-noncovalent
c1ccc2c(c1)CN(C(=O)N2)C3CCN(CC3)C(=O)N[C@H](Cc4cc(c(c(c4)Br)[O-])Br)C(=O)N[C@@H](CCCC[NH3+])C(=O)N5CCN(CC5)c6cc[nH+]cc6,BIBN4096,3.950773,x0887,dimer-interface
Cc1c(sc-2c1C(=N[C@H](c3n2c(nn3)C)CC(=O)Nc4ccc(cc4)OCCOCCOCCOCCNc5cccc6c5C(=O)N(C6=O)[C@H]7CCC(=O)NC7=O)c8ccc(cc8)Cl)C,ARV-825,4.079103,x1249,active-noncovalent
CCc1cc(c(cc1N2CCC(CC2)[NH+]3CCN(CC3)S(=O)(=O)C)OC)Nc4nccc(n4)c5c(nc6n5cccc6)c7ccc(c(c7)C(=O)Nc8c(cccc8F)F)OC,GSK1904529A,4.124027,x1249,active-noncovalent
CCCCCCCCCCCCCCCCCCCCCCCCCCCCO,1-octacosanol,4.147969,x0786,active-covalent
CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)[NH+](C)C)O)CC=O)C)O)C,midecamycin,4.308069,x1249,active-noncovalent
CC[C@H]\1CC[C@H]2[C@@H]([C@H]([C@H]([C@]3(O2)CC[C@H]([C@@H](O3)C[C@H](C)O)C)C)OC(=O)/C=C/[C@H]([C@@H]([C@H](C(=O)[C@@H]([C@H]([C@@H](C(=O)[C@@]([C@@H]([C@H](C/C=C/C=C1)C)O)(C)O)C)O)C)C)O)C)C,oligomycin-a,4.363648,x0887,dimer-interface
CC(C)[C@@H](C(=O)N1CCC[C@H]1c2[nH]c(c[nH+]2)c3ccc(cc3)c4ccc(cc4)c5c[nH+]c([nH]5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,daclatasvir,4.429354,x1249,active-noncovalent
CCCN(CCC)C(=O)[C@H](CCC(=O)OCCCN1CC[NH+](CC1)CCOC(=O)Cc2c(n(c3c2cc(cc3)OC)C(=O)c4ccc(cc4)Cl)C)NC(=O)c5ccccc5,proglumetacin,4.459786,x0305,active-noncovalent
C[NH+](C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6,PF-05212384,4.537680,x0689,active-covalent
c1ccc2c(c1)c(c[nH]2)C[C@@H]3C(=O)N4CCC[C@@H]4C(=O)N[C@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N3)CC(=O)[O-])CCCCNC(=[NH2+])N)C(=O)N,eptifibatide,4.596869,x1249,active-noncovalent
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,digoxin,5.015306,x0786,active-covalent
CC[NH+]1C(CC(CC1(C)C)Oc2ccc(nc2)C(=O)Nc3ccc(cc3)NC(=O)Nc4cc(on4)C(C)(C)C)(C)C,AC-710,5.063013,x1351,active-covalent
C[C@H](/N=N/C(=[NH2+])N)c1cc(cc(c1)[C@@H](/N=N/C(=[NH2+])N)C)NC(=O)CCCCCCCCC(=O)Nc2cc(cc(c2)[C@@H](/N=N/C(=[NH2+])N)C)/C(=N/NC(=[NH2+])N)/C,semapimod,5.256908,x0426,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@@H](C[C@@H](C(=O)[C@@H]([C@H](/C(=C/[C@@H](C(=O)C[C@@H](OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,sirolimus,5.741323,x0305,active-noncovalent
Cc1ccccc1NC(=O)Nc2ccc(cc2)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)[O-])C(=O)N[C@@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)[O-],BIO-1211,6.085115,x1249,active-noncovalent
CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,abamectin,6.146558,x1249,active-noncovalent
C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)[O-])C)O)C)O[C@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C,nanchangmycin,6.627116,x1249,active-noncovalent
CC[C@]1(C[C@H](c2c(cc3c(c2[O-])C(=O)c4c(cccc4[O-])C3=O)[C@@H]1C(=O)OC)O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)[NH+](C)C)O,aclarubicin,6.653972,x0689,active-covalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)O)O)C,gynostemma-extract,6.813796,x0731,active-covalent
C[C@H]1CC[C@]2([C@H]([C@H]3[C@@H](O2)C[C@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@]5(CC[C@H](C6)O[C@@H]7[C@@H]([C@H]([C@H]([C@@H](O7)CO)O[C@@H]8[C@@H]([C@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@@H]9[C@@H]([C@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)[NH2+]C1,solamargine,6.953574,x0786,active-covalent
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,ginsenoside-rd,7.288797,x0769,active-covalent
CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)NC(=O)C)OC)OC)\C)C,eprinomectin,7.298374,x0769,active-covalent
C[NH+](C)CC[C@H](CSc1ccccc1)Nc2ccc(cc2N(=O)=O)S(=O)(=O)NC(=O)c3ccc(cc3)N4CC[NH+](CC4)Cc5ccccc5c6ccc(cc6)Cl,ABT-737,7.336386,x0752,active-covalent
CC[C@H]1[C@H](/C=C(\C=C\C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)[NH+](C)C)O)CC[NH+]3C[C@@H](C[C@@H](C3)C)C)C)/C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC,tilmicosin,7.684663,x0967,active-noncovalent
C[N@+]1(CCc2cc(c(cc2[C@H]1Cc3cc(c(c(c3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N@@+]4(CCc5cc(c(cc5[C@H]4Cc6cc(c(c(c6)OC)OC)OC)OC)OC)C,mivacurium,7.899445,x0354,active-noncovalent
C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C8CCCCC8)C)O,doramectin,8.135318,x1249,active-noncovalent
C[N@+]1(CCc2cc(c(cc2[C@@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@@+]4(CCc5cc(c(cc5[C@@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,atracurium,8.169889,x1351,active-covalent
CC1(CCC(=C(C1)c2ccc(cc2)Cl)C[NH+]3CCN(CC3)c4ccc(c(c4)Oc5cc6cc[nH]c6nc5)C(=O)NS(=O)(=O)c7ccc(c(c7)N(=O)=O)NCC8CCOCC8)C,venetoclax,8.258307,x0354,active-noncovalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)Cc2ccc(cc2)O)[NH3+])C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,oxytocin,8.315126,x0305,active-noncovalent
C[N@@+]1(CCc2cc(c(cc2[C@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCc5cc(c(cc5[C@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,betaxolol,8.537491,x0305,active-noncovalent
C[N@@+]1(CCc2cc(c(cc2[C@H]1Cc3ccc(c(c3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCc5cc(c(cc5[C@H]4Cc6ccc(c(c6)OC)OC)OC)OC)C,cisatracurium,8.537491,x0305,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,everolimus,8.637960,x1384,active-covalent
CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C,coenzyme-q10,8.679152,x0354,active-noncovalent
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OP(=O)(C)C)C)/C)O)OC)C)C)/C)OC,deforolimus,8.736231,x0771,active-covalent
CC(C)[C@@H](C(=O)N1CCC[C@H]1c2[nH]c(c[nH+]2)c3ccc4c(c3)cc-5n4[C@@H](Oc6c5ccc(c6)c7c[nH+]c([nH]7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)c9ccccc9)NC(=O)OC,elbasvir,9.039070,x0769,active-covalent
CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)[NH+](C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC,tylosin,9.065078,x1425,active-covalent
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O,digitoxin,9.350161,x0786,active-covalent
Cc1c(c2ccccc2[nH]1)C[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc3c[nH]c4c3cccc4)C(=O)N[C@H](Cc5ccccc5)C(=O)N[C@@H](CCCC[NH3+])C(=O)N)NC(=O)[C@H](Cc6c[nH]cn6)[NH3+],examorelin,9.432355,x0731,active-covalent
CC(=O)N(CC(CN(c1c(c(c(c(c1I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I)C(=O)C)O)c2c(c(c(c(c2I)C(=O)NC[C@H](CO)O)I)C(=O)NC[C@H](CO)O)I,iodixanol,9.509068,x0426,active-noncovalent
C[C@H](C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)[O-])[NH3+])O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](Cc1ccccc1)C(=O)[O-],CTS21166,9.675095,x1384,active-covalent
C[C@@H](C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@H](Cc3ccccc3)C(=O)N[C@@H](CCCC[NH3+])C(=O)N)NC(=O)[C@@H](Cc4c[nH]c5c4cccc5)NC(=O)[C@H](Cc6c[nH]cn6)[NH3+],U-75799E,10.023323,x0731,active-covalent
C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@@H](C[C@@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,nystatin,10.098737,x0887,dimer-interface
CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc3ccccc3)N(C)C(=O)[C@@H](Cc4c[nH]c5c4cccc5)NC(=O)[C@H](CCC[NH+]=C(N)N)[NH3+],antagonist-g,10.837076,x1351,active-covalent
C[C@@H](C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H](c3ccccc3)c4cn(nn4)CCCCc5ccc(cc5)CCCCn6cc(nn6)[C@H](c7ccccc7)NC(=O)[C@@H]8CC[C@H]9N8C(=O)[C@H](CCCC9)NC(=O)[C@H](C)[NH2+]C)[NH2+]C,SM-164,10.933208,x0354,active-noncovalent
CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)OC(=O)C)[NH+](C)C)O)CC=O)C)OC(=O)C)C,miocamycin,11.194629,x0689,active-covalent
CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N2CCC[C@H]2C(=O)[O-])NC(=O)[C@H](Cc3ccc(cc3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC[NH+]=C(N)N)NC(=O)[C@H](CC(=O)[O-])[NH3+],TXA127,11.802439,x0769,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSCCCC(=O)N[C@H](C(=O)N1)Cc2ccc(cc2)OC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,carbetocin,11.826138,x0354,active-noncovalent
CC1(CCC(=C(C1)C[NH+]2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(c(c4)S(=O)(=O)C(F)(F)F)N[C@H](CC[NH+]5CCOCC5)CSc6ccccc6)c7ccc(cc7)Cl)C,navitoclax,11.900876,x0771,active-covalent
C[C@@H]1CC[C@@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,temsirolimus,11.933160,x0689,active-covalent
CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc2ccc(cc2)[C@@H]3CC[C@H](N3c4ccc(cc4)C(C)(C)C)c5ccc(cc5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,ombitasvir,12.023849,x0691,active-covalent
c1ccc(cc1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)Cc3ccc(cc3)O)[NH3+])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,lypressin,12.642646,x0689,active-covalent
C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O,amphotericin-b,12.829427,x0354,active-noncovalent
C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@H]3c4ccccc4C[C@H]3OCC#CC#CCO[C@@H]5Cc6ccccc6[C@@H]5NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)[NH2+]C)[NH2+]C,AZD5582,13.027397,x0354,active-noncovalent
c1cc(ccc1c2/c3cc/c(/n3)c(/c4cc/c(/n4)c(/c5n/c(c(\c6cc/c2/n6)/c7ccc(cc7)S(=O)(=O)[O-])/CC5)\c8ccc(cc8)S(=O)(=O)[O-])\c9ccc(cc9)S(=O)(=O)[O-])S(=O)(=O)[O-],TPPS4,13.273376,x0354,active-noncovalent
CCCCCCCCCCCCCCCCCC[NH+](CCCCCCCCCCCCCCCCCC)CCC[NH+](CCO)CCO,avridine,13.296442,x0749,active-covalent
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)\C)\C)/C)/C,beta-carotene,13.741607,x0749,active-covalent
CC[C@@H](C)n1c(=O)n(cn1)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5CO[C@](O5)(Cn6cncn6)c7ccc(cc7Cl)Cl,itraconazole,13.965454,x0786,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)Cc2ccc(cc2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O,atosiban,14.140432,x0354,active-noncovalent
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)[NH3+])O,adaptavir,14.253608,x0771,active-covalent
CC[C@@H]1C(=O)N(CC(=O)N([C@@H](C(=O)N[C@@H](C(=O)N([C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@@H](C(=O)N([C@@H](C(=O)N1)[C@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cyclosporin-a,14.538705,x0354,active-noncovalent
c1ccc(cc1)C[C@H]2C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)Cc4ccc(cc4)OCc5ccccc5)CCCC[NH3+])Cc6c[nH]c7c6cccc7)c8ccccc8)OC(=O)NCC[NH3+],pasireotide,14.828497,x1358,active-covalent
c1ccc(cc1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)Cc3ccc(cc3)O)[NH3+])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,vasopressin,14.996686,x0771,active-covalent
CC[C@@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@H]([C@@H](c4ccc(cc4)O)O)O)[C@@H](CC[NH3+])O)O)[NH2+]CCN)O,caspofungin,15.384632,x0540,active-noncovalent
C[C@H]([C@@H]1C(=O)N[C@H](CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCC[NH3+])Cc2c[nH]c3c2cccc3)Cc4ccccc4)NC(=O)[C@H](Cc5ccccc5)[NH3+])C(=O)N[C@H](CO)[C@@H](C)O)O,octreotide,15.578240,x0354,active-noncovalent
CC[C@@H](C)C[C@@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](c4ccc(cc4)O)O)O)[C@@H](CC[NH3+])O)O)[NH2+]CCN)O,caspofungin-acetate,15.918592,x1358,active-covalent
Cc1ccc(c2c1oc-3c(c(=O)c(c(c3n2)C(=O)N[C@@H]4[C@@H](OC(=O)[C@H](N(C(=O)CN(C(=O)[C@@H]5CCCN5C(=O)[C@H](NC4=O)C(C)C)C)C)C(C)C)C)N)C)C(=O)N[C@@H]6[C@@H](OC(=O)[C@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C,actinomycin-d,17.841331,x0691,active-covalent
CC[C@H]1[C@@H](C[C@](O[C@@H]1C)(O)[C@H]([C@H](O)[C@@H]([C@H]2OC(=O)/C=C/C=C/[C@@H]([C@@H](OC(=O)/C=C/C=C/[C@H]2C)[C@H]([C@@H](O)[C@@H]([C@@]3(O[C@@H]([C@H]([C@@H](C3)O[C@@H]4O[C@H]([C@H]([C@H](C4)O)O)C)CC)C)O)C)C)C)C)C)O[C@@H]5O[C@H]([C@H]([C@H](C5)O)O)C,azalomycin-b,18.087122,x0691,active-covalent
CC[C@H](C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC[C@H](C(=O)N[C@@H](C(=O)N1)CC[NH3+])NC(=O)[C@H](CC[NH3+])NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC[NH3+])NC(=O)CCCCC(C)C)[C@@H](C)O)CC[NH3+])CC[NH3+])[C@@H](C)CC,colistin-sulfate,18.149612,x0769,active-covalent
Cc1ccc(cc1NC(=O)c2cccc(c2)NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6c5c(cc(c6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)Nc7ccc(c8c7c(cc(c8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-],suramin,18.599680,x0354,active-noncovalent
CCc1c(c(c(c(c1Cl)[O-])Cl)O)C(=O)O[C@@H]2[C@H](O[C@H]([C@H]([C@H]2O)OC)OC/C/3=C\C=C\C[C@@H](/C(=C\[C@@H]([C@@H](/C(=C/C(=C/C[C@@H](OC3=O)[C@@H](C)O)/C)/C)O[C@H]4[C@@H]([C@H]([C@@H](C(O4)(C)C)OC(=O)C(C)C)O)O)CC)/C)O)C,fidaxomicin,18.676615,x1358,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,gonadorelin,18.739880,x1425,active-covalent
C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,valspodar,18.943077,x0354,active-noncovalent
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5cnc[nH]5)NC(=O)[C@@H]6CCC(=O)N6,alarelin,18.975462,x0755,active-covalent
Cc1ccc(c2c1oc-3c(c(=O)c(c(c3n2)C(=O)N[C@H]4[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]5CCCN5C(=O)[C@H](NC4=O)C(C)C)C)C)C(C)C)C)N)C)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C,dactinomycin,20.049067,x0540,active-noncovalent
c1ccc2c(c1)C[C@@H](N(C2)C(=O)[C@H](CO)NC(=O)[C@H](Cc3cccs3)NC(=O)CNC(=O)[C@@H]4C[C@H](CN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@@H](CCC[NH+]=C(N)N)[NH3+])O)C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)[O-],icatibant-acetate,21.704247,x1384,active-covalent
c1ccc(cc1)C[C@H]2C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N2)Cc3ccc(cc3)O)C(=O)N4CCC[C@@H]4C(=O)N[C@H](CCCNC(=[NH2+])N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,desmopressin-acetate,23.158699,x1351,active-covalent
CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1c3[nH]c(c[nH+]3)c4ccc-5c(c4)C(c6c5ccc(c6)c7ccc8c(c7)nc([nH]8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)(F)F)NC(=O)OC,ledipasvir,23.521370,x0786,active-covalent
C[C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](Cc4ccc(cc4)O)C(=O)[O-])C(=O)N[C@@H](CSSC[C@@H](C(=O)N3)[NH3+])C(=O)N[C@H](C(=O)N5CCC[C@H]5C(=O)N1)CC(=O)N)Cc6ccc(cc6)O)CCC(=O)[O-],linaclotide,24.575813,x0731,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,goserelin-acetate,24.895494,x0354,active-noncovalent
C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2Oc3c4cc5cc3Oc6ccc(cc6Cl)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7c8ccc(c(c8)-c9c(cc(cc9O)O)[C@H](NC(=O)[C@H]([C@@H](c1ccc(c(c1)Cl)O4)O)NC7=O)C(=O)[O-])O)CC(=O)N)NC(=O)[C@@H](CC(C)C)[NH2+]C)O)CO)O)O)(C)[NH3+])O,vancomycin,25.291874,x1384,active-covalent
Cc1c(cc2cc3c(c(c2c1O)[O-])C(=O)[C@H]([C@@H](C3)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]4C[C@H]([C@@H]([C@H](O4)C)O)O[C@H]5C[C@H]([C@@H]([C@H](O5)C)O)O[C@H]6C[C@]([C@@H]([C@H](O6)C)O)(C)O)O[C@H]7C[C@H]([C@H]([C@H](O7)C)O)O[C@H]8C[C@H]([C@@H]([C@H](O8)C)O)O,plicamycin,25.442841,x0786,active-covalent
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4c3cccc4)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6,leuprolide,25.672380,x0354,active-noncovalent
C[C@H](COC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)COC[C@@H](C)O)O)O)O,hydroxypropyl-beta-cyclodextrin,27.344244,x0769,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=[NH2+])N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](Cc2c[nH]c3c2cccc3)NC(=O)[C@H](Cc4ccc(cc4)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc5c[nH]c6c5cccc6)NC(=O)[C@H](Cc7cnc[nH]7)NC(=O)[C@@H]8CCC(=O)N8,triptorelin,28.267122,x1425,active-covalent
c1ccc(cc1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)Cc3ccc(cc3)O)NC(=O)CNC(=O)CNC(=O)C[NH3+])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCC[NH3+])C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,terlipressin,28.423651,x0759,active-covalent
CCCCCOc1ccc(cc1)c2cc(no2)c3ccc(cc3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](c7ccc(c(c7)OS(=O)(=O)[O-])O)O)O)[C@@H](CC(=O)N)O)C)O)O)O,micafungin,31.177338,x0771,active-covalent
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NC(=C)C(=O)N[C@H](C(=O)N[C@]23CCC(=N[C@@H]2c4csc(n4)[C@H]([C@H](OC(=O)c5cc(c6c(n5)[C@H]([C@H]([NH2+]1)C=C6)O)[C@H](C)O)C)NC(=O)c7csc(n7)[C@@H](NC(=O)[C@H]8CSC(=N8)/C(=C/C)/NC(=O)[C@@H](NC(=O)c9csc3n9)[C@@H](C)O)[C@@](C)([C@@H](C)O)O)c1nc(cs1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C,thiostrepton,32.741310,x0705,active-covalent
Cc1c(nc(nc1N)[C@H](CC(=O)N)[NH2+]C[C@@H](C(=O)N)N)C(=O)N[C@H]([C@H](c2cnc[nH]2)O[C@@H]3[C@@H]([C@@H]([C@H]([C@H](O3)CO)O)O)O[C@@H]4[C@H]([C@@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCC[NH2+]CCCC[NH3+])O,bleomycetin,36.713348,x1358,active-covalent
CC[C@H](C)CCCC(=O)N[C@@H](CC[NH3+])C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC[NH3+])C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC[NH3+])CC(C)C)CC(C)C)CC[NH3+])CC[NH3+])[C@@H](C)O,colistin,37.457230,x1380,active-covalent
CC[C@@H](c1cc(c(c(c1)OC)OC)OC)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc3ccc(c(c3)OC)OC)c4cccc(c4)OCC(=O)NCCNC(=O)COc5cccc(c5)[C@@H](CCc6ccc(c(c6)OC)OC)OC(=O)[C@@H]7CCCCN7C(=O)[C@@H](CC)c8cc(c(c(c8)OC)OC)OC,AP1903,40.394569,x1375,active-covalent
C/C=C(/C)\C(=O)O[C@@H]1[C@@H]([C@@]2([C@@H](C[C@@]3(C(=CC[C@H]4[C@]3(CC[C@H]5[C@@]4(CC[C@@H]([C@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)[O-])O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C)C)[C@H]2CC1(C)C)C)O)CO)OC(=O)C,escin,42.507744,x1385,active-covalent
C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=[NH2+])N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc3cccnc3)NC(=O)[C@@H](Cc4ccc(cc4)Cl)NC(=O)[C@@H](Cc5ccc6ccccc6c5)NC(=O)C,cetrorelix,42.572292,x0786,active-covalent
C[C@@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@H]([C@@H](O[C@@H]2Oc3c4cc5cc3Oc6ccc(cc6Cl)[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@@H]5C(=O)N[C@H]7c8ccc(c(c8)-c9c(cc(cc9O)O)[C@H](NC(=O)[C@H]([C@@H](c1ccc(c(c1)Cl)O4)O)NC7=O)C(=O)[O-])O)CC(=O)N)NC(=O)[C@H](CC(C)C)[NH3+])O)CO)O)O)(C)[NH3+])O,norvancomycin,48.590725,x0749,active-covalent
CC[C@@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@@H]([C@H](C)CC)N)CC(=O)N)CC(=O)O)Cc3cnc[nH]3)Cc4ccccc4,bacitracin-zinc,48.635643,x1334,active-covalent
CC[C@H](C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCC[NH3+])CCCCNC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@H](CCC(=O)[O-])NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@H](C)CC)[NH3+])CC(=O)N)CC(=O)[O-])Cc3c[nH]cn3)Cc4ccccc4,bacitracin,54.832169,x1311,active-covalent
C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC[NH3+])CC[NH3+])CC(C)C)CC(C)C)CC[NH3+])NC(=O)[C@H](CC[NH3+])NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC[NH3+])NC(=O)CCCCC(C)C)O,colistin-b-sulfate,55.385895,x0749,active-covalent
c1c(cc(c(c1O)O)O)C(=O)Oc2cc(cc(c2O)O)C(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@H](O3)OC(=O)c4cc(c(c(c4)OC(=O)c5cc(c(c(c5)O)O)O)O)O)OC(=O)c6cc(c(c(c6)OC(=O)c7cc(c(c(c7)O)O)O)O)O)OC(=O)c8cc(c(c(c8)OC(=O)c9cc(c(c(c9)O)O)O)O)O)OC(=O)c1cc(c(c(c1)OC(=O)c1cc(c(c(c1)O)O)O)O)O,tannic-acid,57.632347,x0749,active-covalent
CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@@H]1[C@@H]([C@H]([C@H]([C@@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@H]([C@@H](O2)CO)O[C@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O[C@@H]4[C@@H]([C@H]([C@H]([C@@H](O4)CO)O)O)O)NC(=O)C)O[C@]5(C[C@@H]([C@H]([C@@H](O5)[C@H]([C@H](CO)O)O)NC(=O)C)O)C(=O)[O-])O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O,ganglioside-gm1,64.244286,x0774,active-covalent
CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCC[NH3+])NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCC[NH+]=C(N)N)[NH3+],substance-p,71.406853,x1385,active-covalent
CCCCC/C=C/CCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1Oc2c3cc4cc2Oc5ccc(cc5Cl)[C@H]([C@H]6C(=O)N[C@@H](c7cc(cc(c7-c8cc(ccc8O)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]9c1cc(cc(c1)Oc1cc(ccc1O)[C@H](C(=O)N[C@@H](Cc1ccc(c(c1)Cl)O3)C(=O)N9)[NH3+])O)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)C(=O)[O-])O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)C)CO)O)O,teicoplanin-A2-1,81.402069,x1385,active-covalent
